


  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-3-nitrobenzoate
C8H6FNO4
329-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 F 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8351601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Methylamino-3-nitro-benzoic acid methyl ester. Aqueous 40% MeNH2 (26.00
mL, 303 mmol) was added dropwise to an ice-water cooled solution of
methyl 4-fluoro-3-nitro-benzoate (20.00 g, 101 mmol) in MeOH (100 mL) at
a rate which maintained the internal reaction temperature <40°C. The
resulting yellow slurry was stirred without external cooling for 15 min.,
during which the exotherm ceased. The solid was collected by filtration
and washed with H2O, then was vacuum dried to afford product. Bright
yellow solid, 20.79 g, 99%. 1H NMR (300 MHz, CD3CN) δ 8.69 (d, J=2.0 Hz,
1 H), 8.28 (br s, 1 H), 8.02 (ddd, J=9.1 Hz, J=2.1 Hz, J=0.7 Hz, 1 H),
6.99 (d, J=9.1 Hz, 1 H), 3.85 (s, 3 H), 3.04 (d, J=2.1 Hz, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of polyamides having a fused, bicyclic moiety for binding to
the minor groove of dsDNA
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Phillion, Dennis P.; Bashkin, James K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004099131 A2 2004-11-18

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-3-nitrobenzoate
C8H6FNO4
329-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 F 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36416600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular flavin catalysts for C-H functionalisation and derivatisation
of dehydroamino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rehpenn, Andreas; Walter, Alexandra; Storch, Golo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2022), 13(47), 14151-14156

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,4-dichloropyrimidine
C4HBrCl2N2
36082-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 N 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methyl-4-pyrimidinamine
C5H5BrClN3
205672-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 N 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36082-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205672-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34333780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structural optimization of potent epidermal growth factor
receptor (EGFR) inhibitors against L858R/T790M/C797S resistance mutation
for lung cancer treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Cheng; Wang, Xin; Huang, Zhi; Wang, Tianqi; Nie, Yongwei; Yang,
Shengyong; Xiang, Rong; Fan, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 237114381

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24184454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as potent and isoform selective
tumor-associated carbonic anhydrase IX/XII inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Uslu, Azize Gizem; Maz, Tugce Gur; Nocentini, Alessio; Banoglu, Erden;
Supuran, Claudiu T.; Caliskan, Burcu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 95103544

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
tert-Butoxycarbonyl-D-proline
C10H17NO4
37784-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=1
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[(methylamino)methyl]-1-pyrrolidinecarboxylate
C11H22N2O2
783325-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 3.7710 0.0 0
M  V30 2 O 2.1036 3.7710 0.0 0
M  V30 3 O 4.4136 5.1048 0.0 0
M  V30 4 C 1.3336 5.1048 0.0 0
M  V30 5 C 0.0000 4.3348 0.0 0
M  V30 6 C 0.5636 6.4384 0.0 0
M  V30 7 C 2.6674 5.8748 0.0 0
M  V30 8 C 6.9757 3.4208 0.0 0
M  V30 9 N 8.4820 3.1006 0.0 0
M  V30 10 C 9.5126 4.2450 0.0 0
M  V30 11 N 4.4136 2.4374 0.0 0
M  V30 12 C 5.9453 2.2764 0.0 0 CFG=1
M  V30 13 C 3.7873 1.0306 0.0 0
M  V30 14 C 6.2655 0.7700 0.0 0
M  V30 15 C 4.9319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 12 8 CFG=1
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 37784-17-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 783325-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4313770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 14044-65-6
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (a) (R)-2-Methylaminomethyl-1-Boc-pyrrolidine (R)-Boc-proline (4.8 g,
22.3 mmol) was suspended in 100 mL of THF.
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (5.13 g, 1.2 eq) was then
added to the solution, followed by 1-hydroxybenzotriazole (3.62 g, 1.2
eq) and N-methylmorpholine (3.7 mL, 1.5 eq). The reaction mixture was
stirred at room temperature for 30 minutes and 35 mL of methylamine in
THF (2.0 M, 3 eq) was added. The reaction mixture was stirred at room
temperature for 18 hours. It was then concentrated and the residue was
taken up in CH2Cl2 and washed with diluted NaHCO3, water, dilute 1 N
citric acid, brine, dried (with Na2SO4 and concentrated to yield 4.8 g of
the crude carboxamide intermediate. This material was dissolved in 100 mL
of anhydrous THF and cooled to 0°C. Borane THF (53 mL of the 1.0 M
solution, 2.5 eq) was added and the reaction mixture was allowed to warm
to room temperature and stirred at room temperature for 18 hours. It was
then cooled to 0°C. and carefully quenched with 50 mL of methanol. The
reaction mixture was concentrated under reduced pressure. The resulting
residue was redissolved in 50 mL of methanol and 100 mL of ethyl acetate
and concentrated under reduced pressure. This trituration and
concentration under reduced pressure was repeated three more times to
afford (R)-2-methylaminomethyl-1-Boc-pyrrolidine, which was then used
without further purification. Quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolotriazines and pyrazolotriazines as A2a adenosine
receptor antagonists for the treatment of Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, Chi; Petter, Russell C.; Kumaravel, Gnanasambandam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004092170 A2 2004-10-28

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17835738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationship study based on autoinducing peptide (AIP)
from dog pathogen S. schleiferi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gless, Bengt H.; Peng, Pai; Pedersen, Katja D.; Gotfredsen, Charlotte H.;
Ingmer, Hanne; Olsen, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(19), 5276-5279

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3519434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (156b) 2-Fluoro-4-methylamino-5-nitro-benzoic
acid ethyl ester A solution of the product obtained at 156a (2.50 g, 10.8
mmol) in 20 mL THF was cooled. 2 M methylamine (solution in THF) (11.5
mL, 23.0 mmol) was added. The mixture was allowed to stir at ambient
temperature for 15 min. The mixture was concentrated i.vac.. The residue
was taken up in water and dichloromethane. The aq. phase was washed with
dichloromethane. The combined organic phases were dried and concentrated
i.vac.. The residue was taken up in ethanol, filtered and washed with
ethanol. Yield: 1.72 g (66%) (544a) 4-(Methylamino)-3-nitrobenzoic acid
Prepared analogously to example 156b from 4-fluoro-3-nitrobenzoic acid
and 2 M methylamine (solution in THF) in THF. Yield: 99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-benzimidazole-5-carboxamides as therapeutic inhibitors
of enzymes belonging to the MAPEG family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pfau, Roland; Arndt, Kirsten; Doods, Henri; Hauel, Norbert; Klinder,
Klaus; Kuelzer, Raimund; Mack, Juergen; Priepke, Henning; Stenkamp, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010034796 A1 2010-04-01

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10807691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(Methylamino)-3-nitrobenzoic acid. Methylamine (150 ml of a 33%
solution in EtOH, 1.5 mol) was added to a solution of
4-fluoro-3-nitro-benzoic acid (25.0 g, 135 mmol) in MeOH (350 ml) with
vigorous stirring. After stirring at r.t. for 2 h, water was added to the
orange reaction mixture, the solution was cooled to 5 °C (ice bath) and
the pH was adjusted to 5 by slow addition of 5N HCl (until the orange red
color had turned to yellow). The precipitate formed was collected by
filtration and washed with 2 x 50 ml of distilled water. Drying in vacuo
for 18h gave 4-methylamino-3-nitrobenzoic acid, yellow solid, yield 26.2
g, 99%. Rf (CHCl3/MeOH 9/1): 0.21. 1H-NMR (400 MHz, (CD3)2SO): δ 3.00 (d,
J = 5.0 Hz, 3H), 3.33 (b, 1H), 7.04 (d, J = 9.2 Hz, 1H), 7.97 (dd, J =
9.2, 1.9 Hz, 1H), 8.51-8.57 (m, 1H), 8.6 (d, J = 1.9 Hz, 1H), 12.84 (b,
1H). 13C-NMR (100 MHz, (CD3)2SO): δ 29.9, 114.4, 116.8, 128.4, 130.4,
136.0, 148.0, 166.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Hypermodified Epothilone Analogs with Potent in Vitro
Antitumor Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuzniewski, Christian N.; Gertsch, Juerg; Wartmann, Markus; Altmann,
Karl-Heinz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(6), 1183-1186

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19200932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct peptide cyclization and one-pot modification using the MeDbz
linker
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gless, Bengt H.; Olsen, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(17), 10525-10534

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18016335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a secretoglobin 3A2 type C (98-139) fragment by Dawson's
native chemical ligation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kikuchi, Mariko; Kurotani, Reiko; Konno, Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2017), 58(43), 4145-4148

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-3-nitrobenzoate
C8H6ClNO4
53553-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Cl 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53553-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18646387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
4-chloro-2-(2,4-dichloro-6-methylphenoxy)-1-methyl-7-(pentan-3-yl)-1H-benzimidazole,
a novel CRF1 receptor antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mochizuki, Michiyo; Kojima, Takuto; Kobayashi, Katsumi; Kotani, Etsuo;
Ishichi, Yuji; Kanzaki, Naoyuki; Nakagawa, Hideyuki; Okuda, Teruaki;
Kosugi, Yohei; Yano, Takahiko; Sako, Yuu; Tanaka, Maiko; Aso, Kazuyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(5), 1556-1570

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-nitropyridine
C5H3ClN2O2
5470-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-2-pyridinamine
C6H7N3O2
4093-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5470-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4093-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3146879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0213] Example 18. Synthesis of Compound 29 and Compound 30 [0214]
Synthesis of N-methyl-3-nitropyridin-2-amine. Methylamine (33% in EtOH)
(110 mL, 883 mmol) was placed in a 500 mL three necked round bottom
flask. It was cooled to 0 °C using ice bath. 2-chloro-3-nitropyridine (20
g, 126 mmol) was added to the above solution in portions as this is an
exothermic reaction. After the addition was complete the reaction mixture
was stirred for 2 h at 0 °C and later 1 h at room temperature. Solvent
was concentrated and residue was taken in 500 mL of water and extracted
with EtOAc 3×150 mL Combine organic layer was dried over Na2SO4, filtered
and concentrated to give a solid. Bright orangish yellow solid (19 g,
98.5%).
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridyl carbene phosphorescent emitters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Yonggang; Xia, Chuanjun; Fiordeliso, James; Layek, Suman; Alleyne,
Bert; Dyatkin, Alexey Borisovich; Ansari, Scott; Beers, Scott; Barron,
Ed; Brooks, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012121936 A2 2012-09-13

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)methylene]methanamine
C8H8N2O2
877-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6747456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 2a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8208183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 1-(3-methoxyphenyl)-N-methylmethanamine (Compound 3) To a
solution of m-anisaldehyde (205 g, 1.5 mol) in methanol (800 mL) at room
temperature was added methylamine (130 mL of 40% in water, 1.5 mol). The
resulting solution was cooled to 0°C and sodium borohydride (83 g, 2.3
mol) was added in batches. The reaction solution was stirred at 0°C for 2
h, then warmed to room temperature, concentrated in vacuo and diluted
with water. The organic phase was separated, diluted with ethyl acetate,
washed with 1:1 water/brine, dried over sodium sulfate and concentrated
in vacuo to give the desired benzylamine (158.5 g, 70%) as a clear oil.
The combined aqueous extracts were extracted with dichloromethane (3x).
The combined methylene chloride extracts were washed with 1:1
water/brine, dried over sodium sulfate and concentrated in vacuo to give
additional benzylamine (66.7 g, 29%) as a clear oil:
1-(3-methoxyphenyl)-N-methylmethanamine (Compound 3), yield (158.5 g,
70%), (66.7 g, 29%) 1H NMR (300 MHz, CDCl3) δ 7.24 (t, J=8.4 Hz, 1H),
6.91-6.78 (m, 3H), 3.81 (s, 3H), 3.73 (s, 2H), 2.46 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of tetrahydroisoquinoline derivatives for
use as antidepressants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lobben, Paul; Zhao, Rulin; Wang, Bei; Chen, Bang-Chi; Liu, Shuang; Hu,
Min; Yang, Yuh-Lin Allen; Isherwood, Matthew; Amin, Rasidul; Cui, Wenge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009149259 A2 2009-12-10

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4933873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 1-(3-methoxyphenyl)-N-methylmethanamine (Compound 3) To a
solution of m-anisaldehyde (205 g, 1.5 mol) in methanol (800 mL) at room
temperature was added methylamine (130 mL of 40% in water, 1.5 mol). The
resulting solution was cooled to 0°C and sodium borohydride (83 g, 2.3
mol) was added in batches. The reaction solution was stirred at 0°C for 2
h, then warmed to room temperature concentrated in vacuo and diluted with
water. The organic phase was separated, diluted with ethyl acetate,
washed with 1:1 water/brine, dried over sodium sulfate and concentrated
in vacuo to give the desired benzylamine. The combined aqueous extracts
were extracted with dichloromethane (3x). The combined methylene chloride
extracts were washed with 1:1 water/brine, dried over sodium sulfate and
concentrated in vacuo to give additional benzylamine. Yield 158,5 g, 70%,
clear oil, 66.7 g, 29%, clear oil. 1H NMR (300 MHz, CDCl3) 7.24 (t, J=
8.4 Hz, 1H), 6.91-6.78 (m, 3H), 3.81 (s, 3H), 3.73 (s, 2H), 2.46 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of
methylnaphthyltetrahydroisoquinolinylpyridazinamine for use as
antidepressants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiu, Jun; Gao, Qi; Liu, Shuang; Hu, Min; Yang, Yuh-Lin Allen; Isherwood,
Matthew; Amin, Rasidul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009149258 A2 2009-12-10

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzaldehyde
C7H5BrO
6630-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Bromophenyl)methylene]methanamine
C8H8BrN
95547-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6630-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95547-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9701292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting-Group-Free Total Synthesis of Isoquinoline Alkaloids by
Nickel-Catalyzed Annulation of o-Halobenzaldimine with an Alkyne as the
Key Step
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Korivi, Rajendra Prasad; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(1), 282-287, S282/1-S282/30

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36230253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopropyl-(hetero)aryl-substituted ethylsulfonylpyridine derivatives as
antiparasitic agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Herle, Bart; Koolman, Hannes Fiepko; Long, Alan; Meier, Robin; Yonemura,
Ikki; Gagnepain, Julien
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023036934 A1 2023-03-16

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23894862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Preclinical Evaluation of
3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as
Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood
Disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chrovian, Christa C.; Soyode-Johnson, Akinola; Stenne, Brice; Pippel,
Daniel J.; Schoellerman, Jeffrey; Lord, Brian; Needham, Alexandra S.;
Xia, Chungfang; Coe, Kevin J.; Sepassi, Kia; Schoetens, Freddy; Scott,
Brian; Nguyen, Leslie; Jiang, Xiaohui; Koudriakova, Tatiana; Balana,
Bartosz; Letavic, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9181-9196

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19996315
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their
use as GluN2B receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chrovian, Christa C.; Letavic, Michael A.; Rech, Jason C.; Rudolph, Dale
A.; Johnson, Akinola Soyode; Stenne, Brice M.; Wall, Jessica L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018067786 A1 2018-04-12

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4797376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolo[1,5-a]pyrimidine-3-carboxamide
derivatives as JAK kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Li, Xiaobo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015073267 A1 2015-05-21

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11050108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
and its use for the synthesis of the antidepressant drug sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Sugata; D'Souza, Asha; Sadanand, Thomas; Rajgopal, Rama
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2004MU00992 A 2007-02-23

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6172760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 111-96-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-napthalenylidene]methanamine.
Compound of formula 3 A mixture of poly(ethylene glycol)-200 (125 ml),
4-(3,4-dichlorophenyl)-3,4-dihydro-1-(2H)-naphthalenone (25g, 0.086 mol.)
and methylamine (47.62g, 1.53 mol) is stirred at 48-50°C for 20 hrs in an
autoclave. Thereafter, water (100 ml) is added under stirring, the
product filtered, and washed with water (100ml). The product is suck
dried, and further dried in air oven at 55-60°C. Weight of dry
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-napthalenylidene]methanamine
is 26.0g (99.6%).
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-napthalenylidene]methanamine,
yield 26.0g (99.6%). M.P.145°C.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of
(1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthaleneamine
(sertraline) from 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jadav, Kanaksinh Jesingbhai; Chitturi, Trinadha Rao; Thennati, Rajamannar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004087732 A2 2004-10-14

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-(3-bromopropyl)carbamate
C16H22BrNO4
888313-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 8.5974 5.3348 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 O 9.3674 6.6685 0.0 0
M  V30 6 O 9.3674 4.0010 0.0 0
M  V30 7 C 7.0574 2.6673 0.0 0
M  V30 8 C 10.9074 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 5.1285 0.0 0
M  V30 11 C 12.4475 6.6685 0.0 0
M  V30 12 C 10.9074 8.2085 0.0 0
M  V30 13 Br 7.0574 0.0000 0.0 0
M  V30 14 C 2.4373 8.0022 0.0 0
M  V30 15 C 1.6672 6.6685 0.0 0
M  V30 16 C 3.9773 8.0022 0.0 0
M  V30 17 O 1.4068 9.1466 0.0 0
M  V30 18 C 2.4373 5.3348 0.0 0
M  V30 19 O 0.1609 6.9887 0.0 0
M  V30 20 C 4.7473 6.6685 0.0 0
M  V30 21 C 0.0000 8.5202 0.0 0
M  V30 22 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-[3-(methylamino)propyl]car...
C17H26N2O4
888313-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 6.2873 4.0010 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 O 7.0574 2.6673 0.0 0
M  V30 6 O 4.7473 4.0010 0.0 0
M  V30 7 C 9.3674 6.6685 0.0 0
M  V30 8 C 6.2873 1.3337 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 7.6212 0.5637 0.0 0
M  V30 11 C 5.5173 0.0000 0.0 0
M  V30 12 C 4.9537 2.1037 0.0 0
M  V30 13 N 11.6775 8.0022 0.0 0
M  V30 14 C 13.2175 8.0022 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 O 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 O 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888313-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888313-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9760579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3S)-(-)-3-tert-Butoxycarbonylamino-1,2-epoxy-4-phenylbutane
C15H21NO3
98737-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8502 0.0 0 CFG=1
M  V30 2 C 3.0800 2.8502 0.0 0
M  V30 3 N 5.3900 4.1839 0.0 0
M  V30 4 C 6.9300 4.1839 0.0 0
M  V30 5 O 7.7000 5.5175 0.0 0
M  V30 6 O 7.7000 2.8502 0.0 0
M  V30 7 C 9.2400 5.5175 0.0 0
M  V30 8 C 9.2400 3.9775 0.0 0
M  V30 9 C 10.7800 5.5175 0.0 0
M  V30 10 C 9.2400 7.0575 0.0 0
M  V30 11 C 5.3900 1.5166 0.0 0 CFG=2
M  V30 12 C 4.2104 0.5267 0.0 0
M  V30 13 O 5.6573 0.0000 0.0 0
M  V30 14 C 2.3100 4.1839 0.0 0
M  V30 15 C 3.0800 5.5175 0.0 0
M  V30 16 C 0.7700 4.1839 0.0 0
M  V30 17 C 2.3100 6.8513 0.0 0
M  V30 18 C 0.0000 5.5175 0.0 0
M  V30 19 C 0.7700 6.8513 0.0 0
M  V30 20 H 6.8371 2.0433 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2R)-2-hydroxy-3-(methylamino)-1-(phenylmethyl)propyl...
C16H26N2O3
160232-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 5 C 7.7000 6.6684 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 O 3.0800 4.0011 0.0 0
M  V30 8 O 9.2400 6.6684 0.0 0
M  V30 9 O 6.9300 8.0021 0.0 0
M  V30 10 N 4.6200 1.3336 0.0 0
M  V30 11 C 10.0100 8.0021 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 8.6764 8.7721 0.0 0
M  V30 14 C 10.7800 9.3358 0.0 0
M  V30 15 C 11.3436 7.2321 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98737-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160232-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-5324819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Probing pockets S2-S4' of the γ-secretase active site with
(hydroxyethyl)urea peptidomimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Esler, William P.; Das, Chittaranjan; Wolfe, Michael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(8), 1935-1938

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Nitrophenyl)methylene]methanamine
C8H8N2O2
121004-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121004-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8879304
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 2b.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[5-(3-methoxy-3-oxopropyl)-1-methyl-1H-imidazo...
C17H26N4O5
3037692-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.4394 5.3778 0.0 0
M  V30 2 O 8.4700 0.0000 0.0 0
M  V30 3 C 13.6258 4.3425 0.0 0
M  V30 4 C 15.0326 3.7162 0.0 0
M  V30 5 C 16.2784 4.6214 0.0 0
M  V30 6 O 17.6854 3.9949 0.0 0
M  V30 7 O 16.1175 6.1529 0.0 0
M  V30 8 C 18.9312 4.9001 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 O 3.0800 4.0011 0.0 0
M  V30 11 O 3.0800 1.3336 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 1.5400 5.5411 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 1.5400 2.4611 0.0 0
M  V30 16 C 10.0100 2.6673 0.0 0
M  V30 17 N 10.9152 3.9133 0.0 0
M  V30 18 N 10.9152 1.4214 0.0 0
M  V30 19 C 12.3798 3.4373 0.0 0
M  V30 20 C 12.3799 1.8973 0.0 0
M  V30 21 N 8.4700 2.6673 0.0 0
M  V30 22 C 7.7000 1.3336 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 6.1600 4.0011 0.0 0
M  V30 26 N 5.3900 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 26
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[1-methyl-5-[3-(methylamino)-3-oxopropyl]-1H-i...
C17H27N5O4
3037692-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.4394 5.3778 0.0 0
M  V30 2 O 8.4700 0.0000 0.0 0
M  V30 3 C 13.6258 4.3425 0.0 0
M  V30 4 C 15.0326 3.7162 0.0 0
M  V30 5 C 16.2784 4.6214 0.0 0
M  V30 6 N 17.6854 3.9949 0.0 0
M  V30 7 O 16.1175 6.1529 0.0 0
M  V30 8 C 18.9312 4.9001 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 O 3.0800 4.0011 0.0 0
M  V30 11 O 3.0800 1.3336 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 1.5400 5.5411 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 1.5400 2.4611 0.0 0
M  V30 16 C 10.0100 2.6673 0.0 0
M  V30 17 N 10.9152 3.9133 0.0 0
M  V30 18 N 10.9152 1.4214 0.0 0
M  V30 19 C 12.3798 3.4373 0.0 0
M  V30 20 C 12.3799 1.8973 0.0 0
M  V30 21 N 8.4700 2.6673 0.0 0
M  V30 22 C 7.7000 1.3336 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 6.1600 4.0011 0.0 0
M  V30 26 N 5.3900 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 26
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 21
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3037692-42-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037692-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40760765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as protein-stabilizing
deubiquitinase-targeting chimeras useful in treatment of cystic fibrosis
and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henning, Nathaniel James; Nomura, Daniel K.; Boike, Lydia; Marquess,
Daniel; Keitz, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024097355 A1 2024-05-10

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 3,5-dichloro-2-oxo-6-phenyl-1(2H)-pyrazineacetate
C19H14Cl2N2O3
308845-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 C 9.3360 3.8501 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 O 5.3348 1.5400 0.0 0
M  V30 8 Cl 2.6673 0.0000 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 N 4.0010 3.8501 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 N 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0
M  V30 18 C 1.3337 8.4702 0.0 0
M  V30 19 C 4.0010 8.4702 0.0 0
M  V30 20 C 2.6673 9.2402 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 10.6697 6.1601 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 12.0033 6.9302 0.0 0
M  V30 26 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 21
M  V30 7 1 6 11
M  V30 8 2 7 12
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 5-chloro-3-(methylamino)-2-oxo-6-phenyl-1(2H)-pyrazineacetate
C20H18ClN3O3
1026535-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0
M  V30 2 C 6.9300 6.6684 0.0 0
M  V30 3 O 8.4700 6.6684 0.0 0
M  V30 4 O 6.1600 8.0021 0.0 0
M  V30 5 C 9.2400 8.0021 0.0 0
M  V30 6 Cl 1.5400 2.6674 0.0 0
M  V30 7 O 4.6200 8.0021 0.0 0
M  V30 8 N 1.5400 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 3.8500 6.6684 0.0 0
M  V30 14 N 1.5400 5.3347 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 3.8500 1.3336 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 4.6200 0.0000 0.0 0
M  V30 20 C 6.9300 1.3336 0.0 0
M  V30 21 C 6.1600 0.0000 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 11.5500 6.6684 0.0 0
M  V30 24 C 11.5500 9.3358 0.0 0
M  V30 25 C 13.0900 6.6684 0.0 0
M  V30 26 C 13.0900 9.3358 0.0 0
M  V30 27 C 13.8600 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 22
M  V30 7 1 6 12
M  V30 8 2 7 13
M  V30 9 1 8 9
M  V30 10 1 8 15
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 308845-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1026535-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31311231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and screening of MASP-2 inhibitors, for use in drug development
and treatment of MASP-2-associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cutshall, Neil S.; Gage, Jennifer Lynn; Kwon, Do Yeon; Little, Thomas L.;
Metz, Markus; Nollert Von Specht, Peter Kurt; Tsoung, Jennifer; Nguyen,
Jeremiah H.; Davis, Melinda; Lemus, Robert Huerta; Keshipeddy, Santosh
Kumar; Goldstein, Sara Rebecca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021113686 A1 2021-06-10

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (5S)-5-[acetyl(phenylmethyl)amino]-2-oxo-1-piperidineacetate
C18H24N2O4
309912-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 C 2.6673 2.3100 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0
M  V30 5 O 1.3336 3.0800 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 O 10.6694 5.3900 0.0 0
M  V30 9 O 8.0020 5.3900 0.0 0
M  V30 10 C 10.6694 6.9300 0.0 0
M  V30 11 C 12.0031 7.7000 0.0 0
M  V30 12 O 9.3358 0.0000 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 N 8.0020 2.3100 0.0 0
M  V30 17 C 6.6684 0.0000 0.0 0
M  V30 18 C 8.0020 0.7700 0.0 0
M  V30 19 C 2.6673 5.3900 0.0 0
M  V30 20 C 2.6673 6.9300 0.0 0
M  V30 21 C 1.3336 4.6200 0.0 0
M  V30 22 C 1.3336 7.7000 0.0 0
M  V30 23 C 0.0000 5.3900 0.0 0
M  V30 24 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 2 12 18
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S)-5-[Acetyl(phenylmethyl)amino]-N-methyl-2-oxo-1-piperidineacetamide
C17H23N3O3
309912-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 6.6684 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 6.9300 8.0021 0.0 0
M  V30 4 C 8.4700 8.0021 0.0 0
M  V30 5 O 6.1600 9.3358 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 1.5400 1.3336 0.0 0
M  V30 9 O 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 O 0.0000 6.6684 0.0 0
M  V30 12 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 3.8500 8.0021 0.0 0
M  V30 15 N 2.3100 5.3347 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 1.5400 6.6684 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 6.6684 0.0 0
M  V30 21 C 10.7800 4.0011 0.0 0
M  V30 22 C 10.7800 6.6684 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 17
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 309912-80-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 309912-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6404962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(2S,4S)-4-[[[1-Benzyloxycarbonylpyrrolidine-2-carbonyl]
amino]piperidin-1-yl]acetic Acid Ethyl Ester (15a). To a solution of
Cbz-L-proline (183 mg, 0.73 mmol) in THF (5 mL) at -7 °C were added HOBt
(99 mg, 0.73 mmol), DCC (159 mg, 0.77 mmol), and 11c (147 mg, 0.73 mmol)
dissolved in THF (10 mL). The reaction mixture was stirred for 3 h at 0
°C and 19 h at room temperature. The mixture was filtrated and diluted
with EtOAc (10 mL). The solution was washed consecutively with brine, 0.5
N KHSO4, brine, 5% NaHCO3, and then brine; dried (MgSO4); and evaporated.
The residue was purified by flash chromatography (CHCl3-MeOH, 95:5) to
give pure 15a (193 mg, 61%) as a colorless oil:
(5S)-[5-(N,N-Acetylbenzylamino)-2-oxopiperidin-1-yl]-N-methylacetamide
(14). A solution of 13c (47 mg, 0.14 mmol) in ethanolic methylamine
solution (5 mL, 8.03 M in EtOH) was reacted and worked up as described
for 12 to give pure 14 (44 mg, 99%) as a colorless oil: TLC Rf 0.11 (CH2-
Cl2-MeOH, 95:5); [α]20 D -31.9° (c = 1.0, CHCl3); IR 3310, 2940, 1640
cm-1; 1H NMR (360 MHz) δ 1.78-1.95 (m, 1H), 2.05 (dddd, J = 12.2, 12.0,
11.8, 6.0, 1H), 2.10 (s, 3H), 2.43 (ddd, J = 17.7, 11.8, 6.1, 1H), 2.53
(ddd, J = 17.7, 6.0, 3.1, 1H), 2.77 (d, J = 5.0, 3H), 3.42 (dd, J = 11.4,
6.6, 1H), 3.47 (ddd, J = 11.4, 10.6, 1H), 3.79 (d, J = 15.3, 1H), 3.99
(d, J = 15.3, 1H), 4.52 (d, J = 17.9, 1H), 4.58 (d, J = 17.9, 1H), 4.76
(dddd, J = 12.0, 10.6, 6.6, 4.0, 1H), 6.45 (s, 1H), 7.12-7.43 (m, 5H);
EIMS 317 (M+). HRMS calcd for C17H23N3O3: 317.1739. Found: 317.1739.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiopure 4- and 5-aminopiperidin-2-ones: regiocontrolled synthesis and
conformational characterization as bioactive β-turn mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weber, Klaus; Ohnmacht, Ursula; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2000), 65(22), 7406-7416

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Heptanediol, 1-(4-methylbenzenesulfonate)
C14H22O4S
311805-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 6.6685 0.0 0 VAL=6
M  V30 2 O 6.1049 5.3347 0.0 0
M  V30 3 O 4.5649 8.0021 0.0 0
M  V30 4 O 6.6685 7.4385 0.0 0
M  V30 5 C 7.6449 5.3347 0.0 0
M  V30 6 C 8.4149 4.0011 0.0 0
M  V30 7 C 9.9549 4.0011 0.0 0
M  V30 8 C 10.7249 2.6674 0.0 0
M  V30 9 C 12.2649 2.6674 0.0 0
M  V30 10 C 13.0349 1.3336 0.0 0
M  V30 11 C 14.5749 1.3336 0.0 0
M  V30 12 O 15.3449 0.0000 0.0 0
M  V30 13 C 0.0000 3.5885 0.0 0
M  V30 14 C 4.0011 5.8985 0.0 0
M  V30 15 C 4.0011 4.3585 0.0 0
M  V30 16 C 2.6674 6.6685 0.0 0
M  V30 17 C 2.6674 3.5885 0.0 0
M  V30 18 C 1.3338 5.8985 0.0 0
M  V30 19 C 1.3338 4.3585 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Methylamino)-1-heptanol
C8H19NO
56188-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 C 4.0012 0.0000 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 9.3360 0.0000 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 N 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 0.7700 0.0 0
M  V30 10 C 12.0033 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 311805-13-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56188-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24507005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
2-Amino-3-(trifluoromethyl)benzoic acid
C8H6F3NO2
313-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 6.6687 4.6201 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyl-3-(trifluoromethyl)benzamide
C9H9F3N2O
1087161-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 2.1037 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5637 1.7464 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 8.0023 2.3101 0.0 0
M  V30 8 O 6.6685 4.6201 0.0 0
M  V30 9 C 9.3360 3.0801 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 313-12-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1087161-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9856253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(4-Methoxyphenyl)methylene]-2-methyl-5(4H)-oxazolone
C12H11NO3
31730-24-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.3628 0.0 0
M  V30 2 O 0.7103 0.0000 0.0 0
M  V30 3 C 0.1435 5.3914 0.0 0
M  V30 4 O 9.1059 4.4428 0.0 0
M  V30 5 C 10.4396 3.6728 0.0 0
M  V30 6 C 2.4374 2.1328 0.0 0
M  V30 7 C 1.0304 1.5063 0.0 0
M  V30 8 N 2.2763 3.6644 0.0 0
M  V30 9 O 0.0000 2.6509 0.0 0
M  V30 10 C 0.7700 3.9845 0.0 0
M  V30 11 C 5.1048 2.1328 0.0 0
M  V30 12 C 5.1048 3.6728 0.0 0
M  V30 13 C 6.4384 1.3628 0.0 0
M  V30 14 C 6.4384 4.4428 0.0 0
M  V30 15 C 7.7722 2.1328 0.0 0
M  V30 16 C 7.7722 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6 CFG=2
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-3-(4-methoxyphenyl)-N-methyl-2-propenamide
C13H16N2O3
1384247-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0
M  V30 6 O 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 O 10.7800 5.3347 0.0 0
M  V30 12 C 11.5500 6.6685 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31730-24-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1384247-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1235532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-arylidene-5-imidazolinones as synthetic analogs of
fluorescent protein chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng-Yu; Chen, Yun-Chung; Lin, Hao-Chun; Jhong, Yuandong; Chang,
Chih-Wei; Tsai, Ching-Hua; Kao, Chai-Lin; Chien, Tun-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(29), 5898-5907

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-nitrobenzoic acid
C7H4FNO4
317-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 F 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
124341-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 317-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124341-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23152673
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridines and related heterocycles as CBP and p300
degradation bivalent compds for treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Jing; Plewe, Michael Bruno; Wang, Jialiang; Han, Xiaoran; Chen,
Liqun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020173440 A1 2020-09-03

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
2-Amino-3-methoxybenzoic acid
C8H9NO3
3177-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 N 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-methoxy-N-methylbenzamide
C9H12N2O2
5081-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3177-80-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5081-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3448661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
5-Fluoro-2-nitrobenzoic acid
C7H4FNO4
320-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 0.7700 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzamide
C8H7FN2O3
878160-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 6.1600 5.3347 0.0 0
M  V30 3 O 3.8500 6.6685 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3347 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 F 4.6200 0.0000 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 320-98-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878160-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11716006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1185a) 5-Fluoro-2-nitro-benzoic acid (5.00 g, 0.0270 mol) in methylene
chloride (150 mL) was treated with oxalyl chloride (2.971 mL, 0.03511
mol), followed by N,N-dimethylformamide (40 μL, 0.0005 mol), and the
reaction mixture was heated at 50 °C for 1 hour. The solvent was removed
under reduced pressure, and the residue was azeotroped with benzene, then
disolved in tetrahydrofuran (50 mL) and treated with 2.000 M methylamine
in tetrahydrofuran (20.26 mL) at room temperature, overnight. The
reaction was stopped by addition of aqueous saturated sodium bicarbonate,
then water, and the solid product was collected by filtration, washed
with water and dried under vacuum. 5-Fluoro-N-methyl-2-nitro-benzamide
(5.35 g, 99%): yellow solid. 5-Fluoro-N-methyl-2-nitro-benzamide, yield
5.35 g, 99% LC/MS (ESI+): 199.03 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK
and c-Met kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmed, Gulzar; Bohnstedt, Adolph; Breslin, Henry Joseph; Burke, Jason;
Curry, Matthew A.; Diebold, James L.; Dorsey, Bruce; Dugan, Benjamin J.;
Feng, Daming; Gingrich, Diane E.; Guo, Tao; Ho, Koc-Kan; Learn, Keith S.;
Lisko, Joseph G.; Liu, Rong-Qiang; Mesaros, Eugen F.; Milkiewicz, Karen;
Ott, Gregory R.; Parrish, Jonathan; Theroff, Jay P.; Thieu, Tho V.;
Tripathy, Rabindranath; Underiner, Theodore L.; Wagner, Jason C.;
Weinberg, Linda; Wells, Gregory J.; You, Ming; Zificsak, Craig A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051547 A1 2008-05-02

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
5-Fluoro-2-nitrobenzoic acid
C7H4FNO4
320-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 O 0.7700 1.3338 0.0 0
M  V30 6 O 3.0800 0.0000 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzamide
C8H7FN2O3
878160-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 6.1600 5.3347 0.0 0
M  V30 3 O 3.8500 6.6685 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3347 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 F 4.6200 0.0000 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 320-98-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878160-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6273900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
2-(2,5-Dichloro-pyrimidin-4-ylamino)-N-methyl-5-(4-methyl-piperazin-1-yl)-benzamide.
To a solution of 5-fluoro-2-nitro-benzoic acid (10g, 54mmol) and oxalyl
chloride (6.1 mL, 70.2 mmol) in dichloromethane (300 mL),
N,N-dimethylformamide (80 μL) is added and the mixture is stirred for 1h
at 50°C. The solvent is removed under reduced pressure and the residue is
dissolved in THF. To the solution, 2N methylamine solution in THF is
added at 0 °C and the mixture is stirred at room temperature for 15
hours. Afetr addition of sat. sodium hydrogen carbonate aq., the mixture
is extracted with ethyl acetate and the combined organic layer is washed
with brine, dried over sodium sulfate, and concentrated in vacuo to give
5-fluoro-N-methyl-2-nitro-benzamide as a plase yellow slids (10.5g, 98%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bis(arylamino)pyrimidine derivatives as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imbach, Patricia; Kawahara, Eiji; Konishi, Kazuhide; Matsuura, Naoko;
Miyake, Takahiro; Ohmori, Osamu; Roesel, Johannes; Teno, Naoki; Umemura,
Ichiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006021454 A2 2006-03-02

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3168250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as ACSS2 modulators and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dixon, Darryl David; Grina, Jonas; Josey, John A.; Rizzi, James P.;
Schlachter, Stephen T.; Wallace, Eli M.; Wang, Bin; Wehn, Paul; Yang,
Hanbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015175845 A1 2015-11-19

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8403524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (5-Bromo-2-nitro-phenyl)-methyl-amine. Methylamine (2 M in
tetrahydrofuran, 11.4 mL) was added to a mixture of 4-
bromo-2-fluoro-1-nitro-benzene (2.50 g) and K2CO3 (1.90 g) in
N,N-dimethylformamide (40 mL). The resulting mixture was stirred at
ambient temperature overnight. Then, the mixture was concentrated under
reduced pressure and dichloromethane was added. The resulting mixture was
washed with 0.5 M aqueous HCl solution and brine and dried (MgSO4). The
solvent was removed to give the product as a solid.
(5-Bromo-2-nitro-phenyl)-methyl-amine. Yield: 2.60 g, 99%. Mass spectrum
(ESI+): m/z = 231/233 (Br) [M+H]4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylethyloxazinanone derivatives for use as
11β-hydroxysteroid dehydrogenase 1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Himmelsbach, Frank; Eckhardt, Matthias; Hamilton, Bradford S.;
Schuler-Metz, Annette; Zhuang, Linghang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010010157 A2 2010-01-28

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4131872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate IX.
(5-Bromo-2-nitro-phenyl)-methyl-amine. Methylamine (2 M in
tetrahydrofuran, 11.4 mL) was added to a mixture of
4-bromo-2-fluoro-1-nitro-benzene (2.50 g) and K2CO3 (1.90 g) in
dimethylformamide (40 mL). The resulting mixture was stirred at ambient
temperature overnight. Then, the mixture was concentrated under reduced
pressure and dichloromethane was added. The resulting mixture was washed
with 0.5 M aqueous HCl solution and brine and dried (MgSO4).
(5-Bromo-2-nitro-phenyl)-methyl-amine, as a solid. Yield: 2.60 g (99% of
theory). Mass spectrum ((ESI+): m/z = 231/233 (Br) [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,3-oxazinan-2-one derivatives as inhibitors of
11β-hydroxysteroid dehydrogenase type 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Claremon, David A.; He, Wei; McGeehan, Gerard; Singh, Suresh B.; Tice,
Colin M.; Xu, Zhenrong; Ye, Yuanjie; Zhao, Wei; Zhuang, Linghang;
Cacatian, Salvacion; Leftheris, Katerina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009017664 A1 2009-02-05

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21842084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of MeNH2/THF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spiroaminoindene piperidines as Shp2 phosphatase
inhibitors for the treatment of disorders associated with SHP2
deregulation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Alexander M.; Lescarbeau, Andre; Kelley, Elizabeth H.;
Shortsleeves, Kelley C.; Walters, W. Patrick; Murcko, Mark Andrew;
McLean, Thomas H.; Gunaydin, Hakan; Giordanetto, Fabrizio; Therrien, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019183367 A1 2019-09-26

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20854540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methyl amine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Alexander M.; Lescarbeau, Andre; Kelley, Elizabeth H.;
Shortsleeves, Kelley C.; DiPietro, Lucian V.; Walters, W. Patrick;
Murcko, Mark Andrew; Pierce, Levi Charles Thomas; Tang, Yong;
Giordanetto, Fabrizio; Greisman, Jack Benjamin; Maragakis, Paul; Bhat,
Sathesh; Dahlgeren, Markus Kristofer; Therrien, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018218133 A1 2018-11-29

$RFMT $RIREG SCHEME27 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Methyl N-[[(5S)-3-[3,5-difluoro-4-(tetrahydro-1,2,5-oxadiazepin-5(2H)-yl)ph...
C16H20F2N4O4S
952152-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.9630 6.1961 0.0 0
M  V30 2 C 13.1495 1.8104 0.0 0
M  V30 3 N 14.5563 2.4368 0.0 0
M  V30 4 C 15.8023 1.5316 0.0 0
M  V30 5 O 17.2091 2.1579 0.0 0
M  V30 6 S 15.6412 0.0000 0.0 0
M  V30 7 C 18.4550 1.2528 0.0 0
M  V30 8 F 4.9136 0.8182 0.0 0
M  V30 9 F 4.9136 6.1530 0.0 0
M  V30 10 N 9.5337 3.4855 0.0 0
M  V30 11 C 10.4389 2.2397 0.0 0
M  V30 12 C 10.4389 4.7316 0.0 0
M  V30 13 C 11.9036 2.7155 0.0 0 CFG=2
M  V30 14 O 11.9036 4.2555 0.0 0
M  V30 15 C 7.9936 3.4855 0.0 0
M  V30 16 C 7.2236 2.1519 0.0 0
M  V30 17 C 7.2236 4.8193 0.0 0
M  V30 18 C 5.6836 2.1519 0.0 0
M  V30 19 C 5.6836 4.8193 0.0 0
M  V30 20 C 4.9136 3.4855 0.0 0
M  V30 21 N 3.3736 3.4855 0.0 0
M  V30 22 C 2.7054 4.8731 0.0 0
M  V30 23 C 2.7054 2.0981 0.0 0
M  V30 24 C 1.2040 5.2157 0.0 0
M  V30 25 C 1.2040 1.7555 0.0 0
M  V30 26 N 0.0000 4.2555 0.0 0
M  V30 27 O 0.0000 2.7155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Methyl N-[[(5S)-3-[3,5-difluoro-4-[tetrahydro-2-[(methylamino)carbonyl]-1,2...
C18H23F2N5O5S
952153-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.0104 6.1961 0.0 0
M  V30 2 F 8.9610 0.8182 0.0 0
M  V30 3 F 8.9610 6.1529 0.0 0
M  V30 4 C 17.1968 1.8103 0.0 0
M  V30 5 N 18.6036 2.4368 0.0 0
M  V30 6 C 19.8495 1.5315 0.0 0
M  V30 7 O 21.2564 2.1579 0.0 0
M  V30 8 S 19.6885 0.0000 0.0 0
M  V30 9 C 22.5023 1.2528 0.0 0
M  V30 10 C 2.6599 4.9237 0.0 0
M  V30 11 N 1.3875 4.0562 0.0 0
M  V30 12 O 2.5449 6.4594 0.0 0
M  V30 13 C 0.0000 4.7244 0.0 0
M  V30 14 C 12.0410 3.4855 0.0 0
M  V30 15 C 11.2710 2.1519 0.0 0
M  V30 16 C 11.2710 4.8193 0.0 0
M  V30 17 C 9.7310 2.1519 0.0 0
M  V30 18 C 9.7310 4.8193 0.0 0
M  V30 19 C 8.9610 3.4855 0.0 0
M  V30 20 N 13.5810 3.4855 0.0 0
M  V30 21 C 14.4862 2.2396 0.0 0
M  V30 22 C 14.4862 4.7315 0.0 0
M  V30 23 C 15.9509 2.7155 0.0 0 CFG=2
M  V30 24 O 15.9509 4.2555 0.0 0
M  V30 25 N 7.4210 3.4855 0.0 0
M  V30 26 C 6.7528 4.8730 0.0 0
M  V30 27 C 6.7528 2.0981 0.0 0
M  V30 28 C 5.2514 5.2157 0.0 0
M  V30 29 C 5.2514 1.7553 0.0 0
M  V30 30 N 4.0474 4.2555 0.0 0
M  V30 31 O 4.0474 2.7155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 17
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 23 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 30
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 19 25
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 952152-87-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 952153-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-15028703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM crude intermediate isolated (2nd stage)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones
having thiocarbamate at C-5 on the A-ring and an amide- or
urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Hideyuki; Utsunomiya, Iwao; Shudo, Koichi; Fukuhara, Norio;
Iwaki, Tsutomu; Yasukata, Tatsuro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 69262-277

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(2-Bromoethyl)-4-chloro-α-methylbenzenemethanol
C10H12BrClO
324752-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 C 2.3101 2.6673 0.0 0
M  V30 3 C 1.7464 0.5637 0.0 0
M  V30 4 O 3.8501 0.0000 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 Br 0.0000 4.0012 0.0 0
M  V30 7 Cl 8.4151 4.4137 0.0 0
M  V30 8 C 4.4139 2.1037 0.0 0
M  V30 9 C 4.4139 3.6437 0.0 0
M  V30 10 C 5.7476 1.3337 0.0 0
M  V30 11 C 5.7476 4.4137 0.0 0
M  V30 12 C 7.0812 2.1037 0.0 0
M  V30 13 C 7.0812 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-methyl-α-[2-(methylamino)ethyl]benzenemethanol
C11H16ClNO
324752-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 1.3337 0.0 0
M  V30 2 C 6.1049 2.6673 0.0 0
M  V30 3 C 6.6686 0.5636 0.0 0
M  V30 4 O 4.5649 0.0000 0.0 0
M  V30 5 C 7.6450 2.6673 0.0 0
M  V30 6 N 8.4150 4.0011 0.0 0
M  V30 7 C 9.9550 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.4137 0.0 0
M  V30 9 C 4.0011 2.1037 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 4.0011 3.6437 0.0 0
M  V30 12 C 1.3338 2.1037 0.0 0
M  V30 13 C 2.6675 4.4137 0.0 0
M  V30 14 C 1.3338 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 324752-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 324752-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-299135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2. A mixture of 3,3,3-(4-Chlorophenyl)-hydroxylmethyl-1-bromoropane
(2, 1.04 g, 4.74 mmol), EtOH (5 mL) and H2NMe in H2O (10 mL, 40% w/w) was
heated at 135 0°C for 3 hours. The mixture was cooled down to room
temperature. 10 The mixture was extracted with Et2O (5mL × 2), dried over
MgSO4 and concentrated in vauco. Chromatographic purification on silica
gel (CH2Cl2/MeOH/NH2OH = 9/1/0.1) provided the compound.
3-(4-chlorophenyl)-3-hydroxyl-3-methyl-1-N-methylaminopropane (3). Yield:
1.01 g, (99%). MS m/z: (M + 214).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic-substituted piperidinols as chemokine receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Sone, Hiroki; Kotera,
Osamu; Harriman, Geraldine C. B.; Carson, Kenneth G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001009137 A1 2001-02-08

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(2-Bromoethyl)-4-chloro-α-methylbenzenemethanol
C10H12BrClO
324752-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 C 2.3101 2.6673 0.0 0
M  V30 3 C 1.7464 0.5637 0.0 0
M  V30 4 O 3.8501 0.0000 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 Br 0.0000 4.0012 0.0 0
M  V30 7 Cl 8.4151 4.4137 0.0 0
M  V30 8 C 4.4139 2.1037 0.0 0
M  V30 9 C 4.4139 3.6437 0.0 0
M  V30 10 C 5.7476 1.3337 0.0 0
M  V30 11 C 5.7476 4.4137 0.0 0
M  V30 12 C 7.0812 2.1037 0.0 0
M  V30 13 C 7.0812 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-methyl-α-[2-(methylamino)ethyl]benzenemethanol
C11H16ClNO
324752-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 1.3337 0.0 0
M  V30 2 C 6.1049 2.6673 0.0 0
M  V30 3 C 6.6686 0.5636 0.0 0
M  V30 4 O 4.5649 0.0000 0.0 0
M  V30 5 C 7.6450 2.6673 0.0 0
M  V30 6 N 8.4150 4.0011 0.0 0
M  V30 7 C 9.9550 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.4137 0.0 0
M  V30 9 C 4.0011 2.1037 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 4.0011 3.6437 0.0 0
M  V30 12 C 1.3338 2.1037 0.0 0
M  V30 13 C 2.6675 4.4137 0.0 0
M  V30 14 C 1.3338 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 324752-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 324752-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13513009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: A mixture of 3,3,3-(4-Chlorophenyl)-hydroxylmethyl-1-bromoropane
(2, 1.04 g, 4.74 mmol), EtOH (5 mL) and H2NMe in H2O (10 mL, 40% w/w) was
heated at 135 0°C for 3 hours. The mixture was cooled down to room
temperature. The mixture was extracted with Et2O (5mL × 2), dried over
MgSO4 and concentrated in vauco. Chromatographic purification on silica
gel (CH2Cl2/MeOH/NH2OH = 9/1/0.1).
3-(4-chlorophenyl)-3-hydroxyl-3-methyl-1-N-methylaminopropane (3), Yield:
1.01 g (99%). MS m/z: (M+ 214).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic-substituted piperidinols as chemokine receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Sone, Hiroki; Kotera,
Osamu; Harriman, Geraldine C. B.; Carson, Kenneth G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001009094 A2 2001-02-08

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(4-chlorophenyl)acetamide
C8H7Cl2NO
3289-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 Cl 9.3359 2.3100 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-2-(methylamino)acetamide
C9H11ClN2O
900641-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9302 2.6673 0.0 0
M  V30 3 C 8.4702 2.6673 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 N 9.2402 4.0010 0.0 0
M  V30 6 C 10.7802 4.0010 0.0 0
M  V30 7 Cl 0.0000 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3289-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900641-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10957400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylglycine
C13H17NO4
33125-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2074 0.0 0 CFG=2
M  V30 2 N 5.3900 2.8738 0.0 0
M  V30 3 C 5.3900 5.5411 0.0 0
M  V30 4 C 6.9300 2.8738 0.0 0
M  V30 5 O 4.6200 6.8749 0.0 0
M  V30 6 O 6.9300 5.5411 0.0 0
M  V30 7 O 7.7000 1.5400 0.0 0
M  V30 8 O 7.7000 4.2074 0.0 0
M  V30 9 C 9.2400 1.5400 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 C 10.7800 1.5400 0.0 0
M  V30 12 C 9.2400 0.0000 0.0 0
M  V30 13 C 3.0800 4.2074 0.0 0
M  V30 14 C 2.3100 2.8738 0.0 0
M  V30 15 C 2.3100 5.5411 0.0 0
M  V30 16 C 0.7700 2.8738 0.0 0
M  V30 17 C 0.7700 5.5411 0.0 0
M  V30 18 C 0.0000 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(methylamino)-2-oxo-1-phenylethyl]carbamate
C14H20N2O3
795310-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 6.1600 1.3338 0.0 0
M  V30 5 O 3.8500 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 1.5400 5.1285 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 1.5400 8.2085 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33125-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 795310-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11017768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane). tert-Butyl
(R)-(methylcarbamoyl)(phenyl)methylcarbamate (3d) [Boc-D-Phg-NHMe].
Following GP-III, from Boc-D-Phg-OH 2d (1.2 g, 4.78 mmol), title compound
3d was isolated as a white solid (1.25 g, > 99 %) mp 136°C
(EtOAc/pentane); [α]D -108.4 (c 1.0, MeOH); δH (300.14 MHz, CDCl3): 1.41
(3×s, 9 H), 2.74 (d, 3 H, 3JHH = 4.9 Hz), 5.21 (q, 1 H, 3JHH = 4.9 Hz),
5.92 (bs, 1 H), 6.34 (bs, 1 H), 7.25-7.38 (m, 5 H); δC (75.48 MHz,
CDCl3): 26.35 (q), 28.25/28.07 (2×3×q), 58.34/58.49 (2×d), 79.96 (s),
127.08 (2×d), 128.09 (s), 128.80 (2×d), 138.55 (s), 155.22 (s), 170.80
(s); MS-ES, m/z: 265.2 [M+H], 287.2 [M+Na]; MS-EI, m/z (%): 206 (3)
[M-C2H4NO], 190 (4) [M-C4H10O], 162 (1) [M-(56+CO2)], 150 (13) [206-56],
148 (2) [M-116], 133 (7) [206-74], 120 (3) [148-CH5N], 116 (3) [M-148],
106 (57) [150-CO2], 91 (3) [120-CO], 77 (44) [C6H5], 74 (3), 58 (19), 56
(36) [74-H2O], 51 (31), 44 (98), 41 (100); ES-EM for [C14H2ON2O3+Na]:
Calcd, 287.1366; Found, 287.1345. Anal. Calcd for C14H20N2O3: C, 63.62;
H, 7.63; N, 10.60. Found: C, 63.59; H, 7.43; N, 10.58.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-methyl-β-oxobenzenepropanoate
C12H14O3
33166-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-(3-methylphenyl)-2-propenoate
C13H17NO2
2614437-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 3.8500 0.0 0
M  V30 3 N 4.0011 6.1601 0.0 0
M  V30 4 C 6.6684 4.6201 0.0 0
M  V30 5 C 2.6673 6.9301 0.0 0
M  V30 6 O 8.0022 3.8500 0.0 0
M  V30 7 O 6.6684 6.1601 0.0 0
M  V30 8 C 9.3359 4.6201 0.0 0
M  V30 9 C 10.6695 3.8500 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33166-79-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614437-99-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23323022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-chloro-β-oxobenzenepropanoate
C11H11ClO3
33167-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(3-chlorophenyl)-3-(methylamino)-2-propenoate
C12H14ClNO2
2614438-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 3.8500 0.0 0
M  V30 3 N 4.0011 6.1601 0.0 0
M  V30 4 C 6.6684 4.6201 0.0 0
M  V30 5 C 2.6673 6.9301 0.0 0
M  V30 6 O 8.0022 3.8500 0.0 0
M  V30 7 O 6.6684 6.1601 0.0 0
M  V30 8 C 9.3359 4.6201 0.0 0
M  V30 9 C 10.6695 3.8500 0.0 0
M  V30 10 Cl 1.3337 0.0000 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33167-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23322968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloronicotinonitrile
C6H3ClN2
33252-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 Cl 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 N 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)-3-pyridinecarbonitrile
C7H7N3
261715-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 N 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 N 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33252-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 261715-36-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17486291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carboline derivatives as cGMP phosphodiesterase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bombrun, Agnes; Gellibert, Francoise
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000015639 A1 2000-03-23

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetyl-N-(3,4-dichlorophenyl)-N-[3-(4-oxo-1-piperidinyl)propyl]-4-piperidin...
C22H29Cl2N3O3
333992-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 5.3347 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 O 3.8500 4.0011 0.0 0
M  V30 5 C 8.4700 6.6684 0.0 0
M  V30 6 C 9.2400 8.0020 0.0 0
M  V30 7 Cl 6.1600 0.0000 0.0 0
M  V30 8 Cl 9.2400 0.0000 0.0 0
M  V30 9 C 1.5400 10.6694 0.0 0
M  V30 10 C 2.3100 12.0031 0.0 0
M  V30 11 O 0.0000 10.6694 0.0 0
M  V30 12 O 15.4000 8.0020 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 18 C 8.4700 1.3336 0.0 0
M  V30 19 C 3.8500 6.6684 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 4.6200 8.0020 0.0 0
M  V30 22 C 1.5400 8.0020 0.0 0
M  V30 23 C 3.8500 9.3358 0.0 0
M  V30 24 N 2.3100 9.3358 0.0 0
M  V30 25 N 10.7800 8.0020 0.0 0
M  V30 26 C 11.5500 9.3358 0.0 0
M  V30 27 C 11.5500 6.6684 0.0 0
M  V30 28 C 13.0900 9.3358 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 30 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 25
M  V30 9 1 7 16
M  V30 10 1 8 18
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 24
M  V30 14 2 12 30
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetyl-N-(3,4-dichlorophenyl)-N-[3-[4-(methylamino)-1-piperidinyl]propyl]-4...
C23H34Cl2N4O2
333991-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 5.3347 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 O 3.8500 4.0011 0.0 0
M  V30 5 C 8.4700 6.6684 0.0 0
M  V30 6 C 9.2400 8.0020 0.0 0
M  V30 7 Cl 6.1600 0.0000 0.0 0
M  V30 8 Cl 9.2400 0.0000 0.0 0
M  V30 9 C 1.5400 10.6694 0.0 0
M  V30 10 C 2.3100 12.0031 0.0 0
M  V30 11 O 0.0000 10.6694 0.0 0
M  V30 12 N 15.4000 8.0020 0.0 0
M  V30 13 C 16.1700 9.3358 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 9.2400 2.6673 0.0 0
M  V30 19 C 8.4700 1.3336 0.0 0
M  V30 20 C 3.8500 6.6684 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 4.6200 8.0020 0.0 0
M  V30 23 C 1.5400 8.0020 0.0 0
M  V30 24 C 3.8500 9.3358 0.0 0
M  V30 25 N 2.3100 9.3358 0.0 0
M  V30 26 N 10.7800 8.0020 0.0 0
M  V30 27 C 11.5500 9.3358 0.0 0
M  V30 28 C 11.5500 6.6684 0.0 0
M  V30 29 C 13.0900 9.3358 0.0 0
M  V30 30 C 13.0900 6.6684 0.0 0
M  V30 31 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 2 20
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 26
M  V30 9 1 7 17
M  V30 10 1 8 19
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 25
M  V30 14 1 12 13
M  V30 15 1 12 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333992-05-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333991-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12309858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Acetyl-N-(3,4-dichlorophenyl)-N-{3-[4-(methylamino)-1-piperidinyl]propyl}-4-piperidinecarboxamide
To a solution of the compound obtained in Example 208 (454mg, 1.00mmol)
in 1,2-dicholoroethane (10mL) were added a solution of 2.0M-methylamine
in THF (2.0mL, 4.0mmol), acetic acid (0.057mL, 1.0mmol), sodium
triacetoxyborohydridesodium triacetoxyborohydride (424mg, 2.00mmol),
successively, and the mixture was stirred at room temperature for 1.5
hours. To the mixture was added aqueous solution of 1N-sodium hydroxide
(15mL), and the mixture was stirred at room temperature for 30 minutes
and extracted with dichloromethane (15mL, 10mLx2). The organic layer was
dried over anhydrous sodium sulfate and concentrated under reduced
pressure to give the titled compound. (466mg, 0.99mmol, Yield 99%) as a
colorless oily substance.
1-Acetyl-N-(3,4-dichlorophenyl)-N-{3-[4-(methylamino)-1-piperidinyl]propyl}-4-piperidinecarboxamide,
yield (466mg, 0.99mmol, 99%). 1H NMR (CDCl3) δ 1.15-2.15 (12H, m), 2.06
(3H, s), 2.2-2.5 (3H, m), 2.30 (2H, t, J=7.3Hz), 2.42 (3H, s), 2.7-3.0
(3H, m), 3.66 (2H, t, J=7.7Hz), 3.78 (1H, br d, J=12.8Hz), 4.53 (1H, br
d, J=12.8Hz), 7.06 (1H, dd, J=2.4, 8.4Hz), 7.33 (1H, d, J=2.4Hz), 7.53
(1H, d, J=8.4Hz)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl-N-(heterocyclylalkyl)piperidinecarboxamides as CCR5
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imamura, Shinichi; Baba, Masanori; Sugihara, Yoshihiro; Kanzaki, Naoyuki;
Nishimura, Osamu; Hattori, Taeko; Hashiguchi, Shohei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2608807 A1 2001-04-12

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-bromomethylbenzoate
C9H8Br2O2
337536-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 Br 1.3336 5.3900 0.0 0
M  V30 7 Br 0.0000 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-methylisoindolin-1-one
C9H8BrNO
435273-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0607 0.0 0
M  V30 2 Br 6.6519 3.0012 0.0 0
M  V30 3 C 1.3627 0.0000 0.0 0
M  V30 4 C 2.6508 3.7712 0.0 0
M  V30 5 C 3.9844 3.0012 0.0 0
M  V30 6 C 1.5064 2.7406 0.0 0
M  V30 7 C 2.6508 5.3112 0.0 0
M  V30 8 C 5.3182 3.7712 0.0 0
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 N 2.1327 1.3338 0.0 0
M  V30 11 C 3.9844 6.0812 0.0 0
M  V30 12 C 5.3182 5.3112 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 337536-14-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 435273-55-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4118356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 66-99% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of aristolactam analogues and evaluation of their antitumor
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Young Lok; Kim, Joa Kyum; Choi, Sang-Un; Min, Yong-Ki; Bae,
Myung-Ae; Kim, Bum Tae; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(11), 3036-3040

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluorobenzaldehyde
C7H4F2O
34036-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[(3,4-difluorophenyl)methylene]-
C8H7F2N
2901107-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 C 8.4702 4.0010 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34036-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2901107-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35950073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Synthesis of α-Aminoboronic Acid Derivatives via
Copper-Catalyzed N-Alkylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zuccarello, Giuseppe; Batiste, Suzanne M.; Cho, Hyungdo; Fu, Gregory C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(6), 3330-3334

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluorobenzaldehyde
C7H4F2O
34036-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[(3,4-difluorophenyl)methylene]-
C8H7F2N
2901107-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 C 8.4702 4.0010 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34036-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2901107-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36059325
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed enantioselective synthesis of α-aminoboronic acid
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zuccarello, Giuseppe; Batiste, Suzanne M.; Cho, Hyungdo; Fu, Gregory C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2022), 1-11

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-fluoro-2-nitrobenzene
C6H3ClFNO2
345-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
15950-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 345-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15950-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(4-fluorophenyl)acetamide
C8H7ClFNO
351-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 Cl 9.3359 2.3100 0.0 0
M  V30 6 F 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)-2-(methylamino)acetamide
C9H11FN2O
900641-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9302 2.6673 0.0 0
M  V30 3 C 8.4702 2.6673 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 N 9.2402 4.0010 0.0 0
M  V30 6 C 10.7802 4.0010 0.0 0
M  V30 7 F 0.0000 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900641-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14608534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-(2-methoxyethyl)acetamide
C15H14ClNO4
354824-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 7.7000 1.3338 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 C 6.9300 0.0000 0.0 0
M  V30 6 O 9.2400 1.3338 0.0 0
M  V30 7 O 10.0100 5.3349 0.0 0
M  V30 8 C 11.5500 5.3349 0.0 0
M  V30 9 O 5.3900 5.3349 0.0 0
M  V30 10 Cl 5.3900 0.0000 0.0 0
M  V30 11 O 2.3100 0.0000 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 3.0800 1.3338 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 2.3100 5.3349 0.0 0
M  V30 19 C 0.7700 2.6674 0.0 0
M  V30 20 C 0.7700 5.3349 0.0 0
M  V30 21 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 2 9 13
M  V30 10 1 10 14
M  V30 11 2 11 16
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 17
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1,4-Dihydro-3-(methylamino)-1,4-dioxo-2-naphthalenyl]-N-(2-methoxyethyl)ac...
C16H18N2O4
1816975-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 5.3348 6.9302 0.0 0
M  V30 6 O 8.0022 6.9302 0.0 0
M  V30 7 O 10.6697 3.8501 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 N 6.6685 1.5400 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 O 4.0012 6.1601 0.0 0
M  V30 12 O 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 1.3337 1.5400 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 2 11 15
M  V30 12 2 12 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 354824-10-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1816975-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9369588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antiproliferative, DNA intercalation and redox cycling activities of
dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure-activity
relationship study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Si-Han Sherman; Sim, Mei-Yi; Yee, Wei-Loong Sherman; Yang, Tianming;
Yuen, Shyi-Peng John; Go, Mei-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2015), 10442-56

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Difluoronitrobenzene
C6H3F2NO2
364-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 F 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
704-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 704-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2699712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 197(A) 4-Fluoro-N-methyl-2-nitrobenzenamine 1,4-Difluoro-2-nitrobenzene
(2.63 g, 16.53 mmol) was dissolved in EtOH (9 mL) and Methylamine 40% in
Water (9 mL) was added dropwise at 0°C and the mixture was warming up to
RT overnight. 75 mL of water was added to the reaction mixture and the
orange solid was filtered and washed with water (2*10 ml) to afford 2.78
g of 4-fluoro-N-methyl-2-nitrobenzenamine (Yield : 99%) as an orange
crystaline solid. Rf (Cyclohexane/AcOEt : 80/20) =0.34 LCMS (RT) :
4.03min; MS (ES+) gave m/z : 171
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycle-containing alkynyl derivatives as modulators
of metabotropic glutamate receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bessis, Anne-Sophie; Bolea, Christelle; Bonnet, Beatrice; Epping-Jordan,
Mark; Poirier, Nicholas; Poli, Sonia-Maria; Rocher, Jean-Philippe;
Thollon, Yves
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005123703 A2 2005-12-29

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluoronitrobenzene
C6H3F2NO2
369-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 5.3901 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzenamine
C7H7FN2O2
124431-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 F 4.0011 0.0000 0.0 0
M  V30 5 N 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 369-34-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124431-92-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13453738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Chloro-N-(2-fluoro-4-nitrophenyl)-N-methylacetamide (7). A Hastelloy
reactor was charged with 1,2-difluoronitrobenzene (9.3 kg, 58 mol) and
toluene (47.7 kg) and was warmed to 40 °C. Methylamine, 40% aqueous (11.2
kg, 145 mol), was added in portions over 1 h; initially the reaction
endothermed to 36 °C followed by an exotherm to 42 °C. The reaction was
stirred at 40 °C for 20 h followed by heating to 60 °C to dissolve the
formed solids. Stirring was ended, two layers formed, and the aqueous
layer was removed. The organic layer was washed with water (10 kg) and
then further diluted with toluene (7.7 kg). The organic layer was
concentrated by distillation of approximately 10 L of toluene.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, multikilogram scale, industrial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Synthesis For a Long-Term Oxazolidinone Antibacterial
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choy, Allison; Colbry, Norman; Huber, Christian; Pamment, Michael; Van
Duine, Justin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2008), 12(5), 884-887

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Difluoronitrobenzene
C6H3F2NO2
369-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 5.3901 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzenamine
C7H7FN2O2
124431-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 F 4.0011 0.0000 0.0 0
M  V30 5 N 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 369-34-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124431-92-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1539945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (2-fluoro-4-nitro-phenyl)-methyl-amine(14). To
3,4-difluoro-nitrobeuzene (13, 5.0 g, 31.4 mmol) taken in dimethyl
sulfoxie (30 mL) was added 40% aqueous methylamine in portions. The
reaction was stirred at room temperature for 30 minutes. The reaction was
diluted with 150 mL of water and the resulting precipitate was filtered
and dried under vacuum to obtain solid (5.34 g) in 98% isolated yield.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-fluoro-1,3-dihydroindol-2-one oxazolidinones as
antibacterials.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grodeev, Mikhail Fedor; Josyula, Vara Prasad Venkata Nagendra; Luehr,
Gary Wayne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006106427 A1 2006-10-12

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(methoxycarbonyl)-β-oxobenzenepropanoate
C13H14O5
371249-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 C 9.3358 2.3101 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 O 12.0033 2.3101 0.0 0
M  V30 6 O 10.6697 4.6201 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 O 2.6673 4.6201 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 4.0010 2.3101 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[3-ethoxy-1-(methylamino)-3-oxo-1-propen-1-yl]benzoate
C14H17NO4
371249-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 C 8.4700 2.6674 0.0 0
M  V30 3 N 6.1600 1.3338 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 C 6.9300 0.0000 0.0 0
M  V30 6 O 10.7800 4.0011 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 O 1.5400 6.6685 0.0 0
M  V30 12 O 1.5400 4.0011 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 6.1600 6.6685 0.0 0
M  V30 19 C 4.6200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371249-81-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371249-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20752343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-(5-oxazolyl)-4(1H)-quinolinones as inhibitors of IMPDH
enzyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iwanowicz, Edwin J.; Watterson, Scott H.; Dhar, T. G. Murali; Pitts,
William J.; Gu, Henry H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001081340 A2 2001-11-01

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(hydroxyimino)acetate
C4H7NO3
37858-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 N 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxyimino)-N-methylacetamide
C3H6N2O2
40391-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37858-07-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40391-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9779001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(Hydroxyimino)-N-methylacetamide. A schlenk flask was charged with a
40% aqueous methylamine solution (7 mL) to which was added ethanol (7 mL)
and ethyl 2-(hydroxyimino)acetate (0.93 g, 7.98 mmol). The flask was
sealed and stirred for 5.5 hrs, nitrogen gas bubbled through the solution
for 1 hr, and the solution then concentrated under high vacuum. The
product as a white solid (0.81 g, 99%). 1H NMR (400 MHz, D2O) δ 7.63 (s,
1H), 2.84 (s, 3H). 13C NMR (400 MHz, D2O) δ 164.52, 144.02, 25.64. MS
(ESI): Calcd for C3H6N2O2: 102.09; observed: 103.2 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM N2 gas was bubble through the reaction in the last hour, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanistic Rationalization of Unusual Sigmoidal Kinetic Profiles in the
Machetti-De Sarlo Cycloaddition Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mower, Matthew P.; Blackmond, Donna G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2015), 137(6), 2386-2391

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2,2-dimethyl-7-benzofurancarboxaldehyde
C11H12O2
38002-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2537 4.0011 0.0 0
M  V30 2 O 7.7937 4.0011 0.0 0
M  V30 3 C 0.0000 2.8653 0.0 0
M  V30 4 C 1.0304 4.6502 0.0 0
M  V30 5 C 3.9437 2.6675 0.0 0
M  V30 6 C 3.1737 1.3338 0.0 0
M  V30 7 C 5.4837 2.6675 0.0 0
M  V30 8 O 2.9132 3.8118 0.0 0
M  V30 9 C 1.6674 1.6540 0.0 0
M  V30 10 C 3.9437 0.0000 0.0 0
M  V30 11 C 6.2537 1.3338 0.0 0
M  V30 12 C 1.5063 3.1855 0.0 0
M  V30 13 C 5.4837 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N,2,2-trimethyl-7-benzofuranmethanamine
C12H17NO
868755-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 N 7.3176 3.9437 0.0 0
M  V30 3 C 8.6513 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3165 3.1737 0.0 0
M  V30 7 C 1.9828 3.9437 0.0 0
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 C 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4838 0.0 0
M  V30 12 C 4.6501 5.4838 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3165 6.2538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38002-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868755-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8354827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 315 Preparation of
(E)-N-(2,2-Dimethyl-2,3-dihydro-benzofuran-7-ylmethyl)-N-methyl-3-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-yl)-acrylamide
a) (2,2-Dimethyl-2,3-dihydro-benzofuran-7-ylmethyl)-methyl-amine [1426]
2,2-Dimethyl-2,3-dihydro-benzofuran-7-carbaldehyde (281 mg, 1.59 mmol)
was dissolved in anhydrous methanol (7 ml).Methylamine (0.63 ml of 33%
solution in ethanol, 4.82 mmol) was added and the reaction was stirred
for 3 h. The solution was concentrated to a yellow oil and then dissolved
in anhydrous methanol (7 ml). Sodium borohydride (61.5 mg, 1.63 mmol) was
added and the mixture was stirred overnight at room temperature. Water (5
ml) was added and the solution was concentrated.Sodium hydroxide (20 ml,
1N) was added and the aqueous layer was extracted with ethyl acetate
(3×40 ml). Combined organic layers were dried over MgSO4, filtered and
concentrated to afford
(2,2-Dimethyl-2,3-dihydro-benzofuran-7-ylmethyl)-methyl-amine(303 mg,
99%) as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ 7.06-7.02 (m, 2H),
6.76-6.71 (m, 1H), 3.52 (s, 2H), 2.97 (s, 2H), 2.24 (s, 3H), 1.39 (s,
6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2,2-dimethyl-7-benzofurancarboxaldehyde
C11H12O2
38002-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2537 4.0011 0.0 0
M  V30 2 O 7.7937 4.0011 0.0 0
M  V30 3 C 0.0000 2.8653 0.0 0
M  V30 4 C 1.0304 4.6502 0.0 0
M  V30 5 C 3.9437 2.6675 0.0 0
M  V30 6 C 3.1737 1.3338 0.0 0
M  V30 7 C 5.4837 2.6675 0.0 0
M  V30 8 O 2.9132 3.8118 0.0 0
M  V30 9 C 1.6674 1.6540 0.0 0
M  V30 10 C 3.9437 0.0000 0.0 0
M  V30 11 C 6.2537 1.3338 0.0 0
M  V30 12 C 1.5063 3.1855 0.0 0
M  V30 13 C 5.4837 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N,2,2-trimethyl-7-benzofuranmethanamine
C12H17NO
868755-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 N 7.3176 3.9437 0.0 0
M  V30 3 C 8.6513 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3165 3.1737 0.0 0
M  V30 7 C 1.9828 3.9437 0.0 0
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 C 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4838 0.0 0
M  V30 12 C 4.6501 5.4838 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3165 6.2538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38002-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868755-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14506329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) (2,2-Dimethyl-2,3-dihydro-benzofuran-7-ylmethyl)-methyl-amine
2,2-Dimethyl-2,3-dihydro-benzofuran-7-carbaldehyde (281 mg, 1.59 mmol)
was dissolved in anhydrous methanol (7 ml). Methylamine (0.63 ml of 33%
solution in ethanol, 4.82 mmol) was added and the reaction was stirred
for 3 h. The solution was concentrated to a yellow oil and then dissolved
in anhydrous methanol (7 ml). Sodium borohydride (61.5 mg, 1.63 mmol) was
added and the mixture was stirred overnight at room temperature. Water (5
ml) was added and the solution was concentrated. Sodium hydroxide (20 ml,
1N) was added and the aqueous layer was extracted with ethyl acetate
(3×40 ml). Combined organic layers were dried over MgSO4, filtered and
concentrated to afford
(2,2-Dimethyl-2,3-dihydro-benzofuran-7-ylmethyl)-methyl-amine (303 mg,
99%) as a yellow oil: 1H NMR (300 MHz, DMSO-d 6) δ 7.06-7.02 (m, 2H),
6.76-6.71 (m, 1H), 3.52 (s, 2H), 2.97 (s, 2H), 2.24 (s, 3H), 1.39 (s,
6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(2,4-dimethylphenyl)acetamide
C10H12ClNO
39106-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 Cl 9.3358 2.3100 0.0 0
M  V30 6 C 2.6674 0.0000 0.0 0
M  V30 7 C 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethylphenyl)-2-(methylamino)acetamide
C11H16N2O
703399-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3349 0.0 0
M  V30 5 N 9.2400 5.3349 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39106-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 703399-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1842446
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-methylthiazole
C5H6ClNS
39238-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 Cl 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 S 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-4-thiazolemethanamine
C6H10N2S
144163-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 S 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39238-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 144163-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8344695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 408 (2S)-3-methyl-2-[{methyl[(2-methyl-1,3-thiazol-4-
yl)methyl]amino}carbonyl)amino]butanoic Acid.EXAMPLE
408A.N-methyl(2-methyl -1,3-thiazol-4-yl)methanamine
2-Methyl-4-(chloromethyl)thiazole (2.94 g, CAS#39238-07-8) was dissolved
in 40% methylamine (39 mL, 25 equivalents) at 25° C. for 1 h. The mixture
was evaporated and purified using 10% methanol/dichloromethane with 0.5%
NH4OH to give 2.83 g (99%) of the amine.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of HIV protease inhibitors, in particular imidazolidine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flentge, Charles A.; Chen, Hui-Ju; Degoey, David A.; Flosi, William J.;
Grampovnik, David J.; Huang, Peggy P.; Kempf, Dale J.; Klein, Larry L.;
Krueger, Allan C.; Madigan, Darold L.; Randolph, John T.; Sun, Minghua;
Yeung, Ming C.; Zhao, Chen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050131042 A1 2005-06-16

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-chloro-3-nitrobenzene
C6H3BrClNO2
3970-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 Cl 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3970-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20854695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taylor, Alexander M.; Lescarbeau, Andre; Kelley, Elizabeth H.;
Shortsleeves, Kelley C.; DiPietro, Lucian V.; Walters, W. Patrick;
Murcko, Mark Andrew; Pierce, Levi Charles Thomas; Tang, Yong;
Giordanetto, Fabrizio; Greisman, Jack Benjamin; Maragakis, Paul; Bhat,
Sathesh; Dahlgeren, Markus Kristofer; Therrien, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018218133 A1 2018-11-29

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-nitrobenzotrifluoride
C7H3ClF3NO2
402-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 F 6.9300 4.2073 0.0 0
M  V30 3 F 8.4700 2.6673 0.0 0
M  V30 4 F 6.9300 1.1273 0.0 0
M  V30 5 Cl 2.3100 0.0000 0.0 0
M  V30 6 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 O 0.0000 1.3336 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-5-trifluoromethylaniline
C8H7F3N2O2
883992-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0009 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 O 0.0000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0009 0.0 0
M  V30 7 F 6.9300 5.5409 0.0 0
M  V30 8 F 8.4700 4.0009 0.0 0
M  V30 9 F 6.9300 2.4609 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 4.6200 2.6673 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 5.3900 4.0009 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883992-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19957583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arenoazolylamines as antibiotic compounds and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meo, Paul; Khan, Nawaz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018037223 A1 2018-03-01

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-(4-Cyanophenyl)-9H-purine-6-carbonitrile
C13H6N6
403796-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 2.4581 0.0 0
M  V30 2 N 0.0000 2.9340 0.0 0
M  V30 3 C 12.6035 3.7827 0.0 0
M  V30 4 N 14.1437 3.7827 0.0 0
M  V30 5 C 5.5385 2.5368 0.0 0
M  V30 6 N 6.4435 3.7827 0.0 0
M  V30 7 C 4.0738 3.0127 0.0 0
M  V30 8 N 5.8586 1.0306 0.0 0
M  V30 9 C 5.5385 5.0287 0.0 0
M  V30 10 C 2.9294 1.9823 0.0 0
M  V30 11 N 4.0738 4.5527 0.0 0
M  V30 12 C 4.7141 0.0000 0.0 0
M  V30 13 N 3.2496 0.4760 0.0 0
M  V30 14 C 7.9835 3.7827 0.0 0
M  V30 15 C 8.7535 5.1165 0.0 0
M  V30 16 C 8.7535 2.4491 0.0 0
M  V30 17 C 10.2935 5.1165 0.0 0
M  V30 18 C 10.2935 2.4491 0.0 0
M  V30 19 C 11.0635 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 3 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(7,8-Dihydro-8-imino-7-methylpyrimido[5,4-d]pyrimidin-4-yl)amino]benzonitrile
C14H11N7
403796-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 2.6674 0.0 0
M  V30 4 C 13.0900 4.0011 0.0 0
M  V30 5 N 14.6300 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 N 4.6200 0.0000 0.0 0
M  V30 12 N 6.9300 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 N 1.5400 2.6674 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 9.2400 5.3349 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 10.7800 5.3349 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 16
M  V30 3 2 2 10
M  V30 4 1 3 14
M  V30 5 3 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403796-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 403796-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27638219
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 6-cyano-9-substituted-9H-purines and their ring
expansion to 8-(arylamino)-4-imino-3-methylpyrimidino[5,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Azini, Amal; Booth, Brian L.; Carpenter, Robert A.; Carvalho, Alice;
Marrelec, Elodie; Pritchard, Robin G.; Proenca, M. Fernanda J. R. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chemical Society, Perkin Transactions 1 (2001), (20),
2532-2537

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
N-Phthaloyl-L-alanine
C11H9NO4
4192-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7106 0.0 0 CFG=1
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.3470 1.3769 0.0 0
M  V30 4 O 6.5770 5.3780 0.0 0
M  V30 5 O 8.8870 4.0442 0.0 0
M  V30 6 O 4.6078 5.4211 0.0 0
M  V30 7 O 4.6078 0.0000 0.0 0
M  V30 8 N 5.0370 2.7106 0.0 0
M  V30 9 C 4.1320 3.9564 0.0 0
M  V30 10 C 4.1320 1.4647 0.0 0
M  V30 11 C 2.6673 3.4806 0.0 0
M  V30 12 C 2.6673 1.9406 0.0 0
M  V30 13 C 1.3336 4.2506 0.0 0
M  V30 14 C 1.3336 1.1706 0.0 0
M  V30 15 C 0.0000 3.4806 0.0 0
M  V30 16 C 0.0000 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 9
M  V30 7 2 7 10
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-1,3-Dihydro-N,α-dimethyl-1,3-dioxo-2H-isoindole-2-acetamide
C12H12N2O3
512827-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0 CFG=1
M  V30 2 C 7.4148 2.3101 0.0 0
M  V30 3 C 6.0811 0.0000 0.0 0
M  V30 4 N 8.7486 1.5400 0.0 0
M  V30 5 O 7.4148 3.8501 0.0 0
M  V30 6 C 10.0823 2.3101 0.0 0
M  V30 7 O 3.0203 0.1773 0.0 0
M  V30 8 O 5.7309 4.8721 0.0 0
M  V30 9 N 4.7475 2.3101 0.0 0
M  V30 10 C 3.3405 1.6836 0.0 0
M  V30 11 C 4.5865 3.8416 0.0 0
M  V30 12 C 2.3101 2.8281 0.0 0
M  V30 13 C 3.0801 4.1618 0.0 0
M  V30 14 C 0.7700 2.8281 0.0 0
M  V30 15 C 2.3101 5.4955 0.0 0
M  V30 16 C 0.0000 4.1618 0.0 0
M  V30 17 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 10
M  V30 8 2 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4192-28-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 512827-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11268321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane).
(S)-N-Methyl-2-(1,3-dioxoisoindolin-2-yl)propanamide (3h)
[PhtN-L-Ala-NHMe]. Following GP-III, from PhtN-L-Ala- OH 3h (2.19 g, 10
mmol), title compound 3h was isolated as a white solid (2.3 g, > 99 %);
mp 175-176°C (Et2O/pentane); [α]D -1.3 (c 1.01, CH2Cl2); δH (300.14 MHz,
CDCl3): 1.69 (d, 3 H, 3JHH = 7.4 Hz), 2.80 (d, 3 H, 3JHH = 4.8 Hz), 4.89
(q, 1 H, 3JHH = 7.4 Hz), 6.30 (bs, 1 H), 7.73 (2×dd, 2 H, 4JHH = 3.0 Hz,
3JHH = 5.5 Hz), 7.84 (2×dd, 2 H, 4JHH = 3.0 Hz, 3JHH = 5.5 Hz); δC (75.48
MHz, CDCl3): 15.19 (q), 26.47 (q), 49.39 (d), 123.39 (2×d), 131.83 (2×s),
134.16 (2×d), 167.79 (2×s), 169.73 (s); MS-ES, m/z: 233 [M+H], 255
[M+Na]; EI, m/z (%): 232 (1) [M], 213 (1), 275 (67) [M-C2H4NO], 274 (100)
[M-C2H5NO], 160 (10) [174-CH4], 148 (12) [174-C2H6], 130 (28) [M-C4H8NO],
104 (10) [147-CHNO], 76 (13), 55 (5). Analytical and spectral data agree
with literature.9 formula C12H12N2O3, M = 232.24, colorless crystal 0.40
× 0.15 × 0.10 mm, a = 10.929(1), b = 11.064(1), c = 9.906(1) Å , β =
96.12(1)°, ν = 1191.0(2) Å 3, ρcalcd = 1.295 g cm-3, μ = 7.87 cm-1,
empirical absorption correction (0.744 ≤ T ≤ 0.925), Z = 4, monoclinic,
space group Cc (No. 9), λ = 1.54178 Å , T = 223 K, ω and θ scans, 3222
reflections collected (±h, ±k, (l), [(sin θ)/λ] = 0.58 Å -1, 1594
independent (Rint = 0.031) and 1514 observed reflections [I ≥ 2 σ(I)],
159 refined parameters, R = 0.041, wR2 = 0.114, Flack parameter 0.4(3),
max residual electron density 0.22 (-0.12) e Å -3; hydrogen at nitrogen
atom N2 was obtained from difference Fourier calculations, others were
calculated and all refined as riding atoms.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME51 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2′,4′-Trichloroacetophenone
C8H5Cl3O
4252-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 Cl 0.0000 4.0010 0.0 0
M  V30 5 Cl 3.8501 0.0000 0.0 0
M  V30 6 Cl 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,4-Dichlorophenyl)-4-hydroxy-3-methyl-2-thiazolidinethione
C10H9Cl2NOS2
1426223-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9689 1.1359 0.0 0
M  V30 2 C 1.6752 0.9403 0.0 0
M  V30 3 Cl 5.3479 0.0000 0.0 0
M  V30 4 S 0.0000 3.8419 0.0 0
M  V30 5 Cl 9.9679 2.6675 0.0 0
M  V30 6 C 3.8079 2.6675 0.0 0
M  V30 7 N 2.3016 2.3473 0.0 0
M  V30 8 C 3.9689 4.1990 0.0 0
M  V30 9 C 1.5316 3.6810 0.0 0
M  V30 10 S 2.5620 4.8255 0.0 0
M  V30 11 C 5.3479 2.6675 0.0 0
M  V30 12 C 6.1179 1.3338 0.0 0
M  V30 13 C 6.1179 4.0011 0.0 0
M  V30 14 C 7.6579 1.3338 0.0 0
M  V30 15 C 7.6579 4.0011 0.0 0
M  V30 16 C 8.4279 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 12
M  V30 4 2 4 9
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4252-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1426223-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9006311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Typical procedure for the synthesis of
4-(2,4-dichlorophenyl)-4-hydroxy-3-methyl-thiazolidine-2-thione 2c A
mixture of potassium acetate (980 mg, 10 mmol) and 40% methylamine (770
mg, 10 mmol) in methanol (6 mL) was stirred in an ice bath. The
temperature was maintained below 10 °C throughout the reaction. Then, a
solution of carbon disulfide (0.62 mL, 10 mmol) in methanol (1 mL) was
added to the reaction mixture over 10 minutes and stirring was continued
for 2.5 h. In the next step, 2,2,4-trichloroacetophenone (559 mg, 2.5
mmol) was added portionwise to the cold mixture and stirring was
continued for 1.5 h. Then, water (10mL) was added to the reaction mixture
and left in refrigerator overnight. The resulting precipitate was
separated by filtration and dried to give compound 2c. Yield 99%. Mp
171-173 °C; IR (KBr, 1/cm): 3216, 1586, 1560, 1476, 1464, 1384, 1222,
1187, 1115, 1073, 991, 936, 871, 810; 1H NMR (500 MHz, DMSO-d6): 2.76 (s,
3H, CH3), 3.38 (d, 1H, H-thiazolidine, J = 12.7 Hz), 3.76 (d, 1H,
H-thiazolidine, J = 12.7 Hz), 7.58 (dd, 1H, H-phenyl, J = 8.6 and 2.1Hz),
7.72 (d, 1H, H-phenyl, J = 2.1Hz), 7.87 (d, 1H, H-phenyl, J = 8.6Hz),
8.06 (s, 1H, OH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Straightforward synthesis of thiazoline-incorporated chalconoids from
phenacyl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ayati, Adile; Emami, Saeed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2013), 17(1), 41-47

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
2-Amino-4-methoxybenzoic acid
C8H9NO3
4294-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methoxy-N-methylbenzamide
C9H12N2O2
104775-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 N 3.8501 0.0000 0.0 0
M  V30 6 O 8.4702 2.6673 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 C 3.8501 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.1601 4.0010 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4294-95-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104775-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9571906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-5-nitropyrimidin-4-amine
C4H3ClN4O2
4316-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Cl 2.3101 5.3350 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 N 4.6201 4.0012 0.0 0
M  V30 10 N 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Methyl-5-nitro-4,6-pyrimidinediamine
C5H7N5O2
4094-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 N 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 N 4.0012 0.7700 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4316-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4094-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16946658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 76189-55-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-catalyzed amination of chloro-substituted 5-nitropyrimidines
with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Meng-Meng; Mei, Qiong; Zhang, Yi-Xiao; Bai, Peng; Guo, Xiang-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(3), 583-587

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
2-Amino-3-methylbenzoic acid
C8H9NO2
4389-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N,3-dimethylbenzamide
C9H12N2O
870997-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4389-45-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870997-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5590438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Benzyloxy)benzaldehyde
C14H12O2
4397-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 O 12.3203 4.0010 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 10.0102 2.6673 0.0 0
M  V30 11 C 3.0801 1.3337 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Phenylmethoxy)phenyl]methylene]methanamine
C15H15NO
1225182-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 N 12.3203 4.0010 0.0 0
M  V30 5 C 13.8603 4.0010 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 7.7002 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 9.2402 4.0010 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 3.0801 1.3337 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 2.3101 2.6673 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4397-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1225182-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10306371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 15a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-[(2-Chloroethyl)amino][1,1′-biphenyl]-3-carbonitrile
C15H13ClN2
443998-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 10.6697 5.3901 0.0 0
M  V30 4 C 12.0033 4.6201 0.0 0
M  V30 5 C 13.3370 5.3901 0.0 0
M  V30 6 Cl 14.6707 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 0.0000 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 9.3358 3.0801 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-[[2-(Methylamino)ethyl]amino][1,1′-biphenyl]-3-carbonitrile
C16H17N3
443998-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 N 10.6698 5.3901 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 5.3901 0.0 0
M  V30 6 N 14.6708 4.6201 0.0 0
M  V30 7 C 16.0046 5.3901 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 6.6687 3.0801 0.0 0
M  V30 15 C 6.6687 4.6201 0.0 0
M  V30 16 C 8.0023 2.3101 0.0 0
M  V30 17 C 8.0023 5.3901 0.0 0
M  V30 18 C 9.3360 3.0801 0.0 0
M  V30 19 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443998-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 443998-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6245505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-12-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a stirred solution of crude aminoalkyl
chloride (1.07 g, 4.18 mmol) in propionitrile (25 mL) was added
dimethylamine (3.14 mL, 6.27 mmol; 2 M in THF), NaI (0.934 g, 6.27 mmol),
Na2CO3 (0.665 g, 6.27 mmol) and heated to 80ºC in a sealed tube for 12 h.
The reaction mixture was then cooled to rt and diluted with EtOAc and
water. The layers were separated and the organic layer was then dried,
concentrated and chromatographed to yield 1.18 g (> 99%) of diamine 22 as
a yellow oil:
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl ureas as potent and orally efficacious melanin concentrating
hormone receptor 1 antagonists for the treatment of obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palani, Anandan; Shapiro, Sherry; McBriar, Mark D.; Clader, John W.;
Greenlee, William J.; Spar, Brian; Kowalski, Timothy J.; Farley,
Constance; Cook, John; van Heek, Margaret; Weig, Blair; O'Neill, Kim;
Graziano, Michael; Hawes, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(15), 4746-4749

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,5-Trimethoxybenzaldehyde
C10H12O4
4460-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 C 5.3348 7.7002 0.0 0
M  V30 5 O 4.0012 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6687 2.3101 0.0 0
M  V30 8 C 8.0023 3.0801 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,4,5-Trimethoxyphenyl)methylene]methanamine
C11H15NO3
1246401-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 O 4.0012 6.9302 0.0 0
M  V30 5 C 2.6675 7.7002 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4460-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246401-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4879257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 3b.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoronitrobenzene
C6H3F2NO2
446-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
120381-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120381-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17145238
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoreactivity of monofluorinated 2-azidobenzimidazoles towards
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kanitz, Nils Eckhard; Lindel, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2016), 71(12), 1287-1300

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoronitrobenzene
C6H3F2NO2
446-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
120381-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120381-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14858258
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Fluoro-N-methyl-2-nitroaniline (27b). Methylamine solution (40%, 38.4
g) was added dropwise to 2,4-difluoro-1-nitrobenzene 26 (25.0 g, 157
mmol) at 0 °C over 15 min. After completion of the addition, the reaction
mixture was stirred at 0 °C for 1.5 h. To the mixture was added water
(500 mL) and the resulting crystals were collected by filtration.
Compound 27b (26.4 g, 99%) as a yellow crystalline solid. mp 105-106 °C.
1H NMR (DMSO-d 6, 300 MHz): δ 2.94 (d, J = 4.8 Hz, 3H), 6.53 (ddd, J =
2.7, 7.8, 10.2 Hz, 1H), 6.78 (dd, J = 2.7, 12.3 Hz, 1H), 8.17 (dd, J =
6.3, 9.6 Hz, 1H), 8.32 (br s, 1H). Anal. Calcd for C7H7FN2O2: C, 49.41;
H, 4.15; N, 16.46. Found: C, 49.15; H, 4.20; N, 16.45.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, use of DMF as co-solvent abolished regioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel DFG-Out RAF/Vascular Endothelial Growth
Factor Receptor 2 (VEGFR2) Inhibitors. 1. Exploration of [5,6]-Fused
Bicyclic Scaffolds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okaniwa, Masanori; Hirose, Masaaki; Imada, Takashi; Ohashi, Tomohiro;
Hayashi, Youko; Miyazaki, Tohru; Arita, Takeo; Yabuki, Masato; Kakoi,
Kazuyo; Kato, Juran; Takagi, Terufumi; Kawamoto, Tomohiro; Yao, Shuhei;
Sumita, Akihiko; Tsutsumi, Shunichirou; Tottori, Tsuneaki; Oki, Hideyuki;
Sang, Bi-Ching; Yano, Jason; Aertgeerts, Kathleen; Yoshida, Sei;
Ishikawa, Tomoyasu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(7), 3452-3478

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzaldehyde
C7H5FO
446-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Fluorophenyl)methylene]methanamine
C8H8FN
116529-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 F 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-52-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 116529-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15503831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 12a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-DL-phenylalanine
C14H19NO4
4530-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimethylet...
C15H22N2O3
88815-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 N 5.3900 1.3336 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 O 9.2400 5.3347 0.0 0
M  V30 9 O 6.9300 6.6685 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 8.6764 7.4385 0.0 0
M  V30 13 C 10.7800 8.0021 0.0 0
M  V30 14 C 11.3436 5.8985 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4530-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88815-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21626117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and compositions for treating conditions such as cancer
associated with STING activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roush, William R.; Venkatraman, Shankar; Glick, Gary; Seidel, Hans Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020010092 A1 2020-01-09

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzaldehyde
C8H5F3O
455-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Trifluoromethyl)phenyl]methylene]methanamine
C9H8F3N
911101-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911101-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10584955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 19a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Fluorophenyl)methylene]methanamine
C8H8FN
1246401-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 F 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246401-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2106903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 12b.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
4-[[[(5-Methyl-2-pyrazinyl)amino]carbonyl]amino]-3-(3-pyridinylmethoxy)benzoi...
C19H17N5O4
457098-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6684 0.0 0
M  V30 2 C 3.0800 6.6684 0.0 0
M  V30 3 N 7.7000 6.6684 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 N 10.0100 8.0021 0.0 0
M  V30 6 O 10.0100 5.3347 0.0 0
M  V30 7 C 4.6200 1.3336 0.0 0
M  V30 8 O 5.3900 0.0000 0.0 0
M  V30 9 O 3.0800 1.3336 0.0 0
M  V30 10 C 16.1700 8.0021 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 5.3900 2.6673 0.0 0
M  V30 16 C 6.9300 2.6673 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 3.0800 9.3358 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 2.3100 10.6694 0.0 0
M  V30 21 N 0.0000 9.3358 0.0 0
M  V30 22 C 0.7700 10.6694 0.0 0
M  V30 23 C 11.5500 8.0021 0.0 0
M  V30 24 C 12.3200 6.6684 0.0 0
M  V30 25 N 12.3200 9.3358 0.0 0
M  V30 26 N 13.8600 6.6684 0.0 0
M  V30 27 C 13.8600 9.3358 0.0 0
M  V30 28 C 14.6300 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 23
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 15
M  V30 12 1 10 28
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[[[(5-methyl-2-pyrazinyl)amino]carbonyl]amino]-3-(3-pyridinylmetho...
C20H20N6O3
457098-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 8.0020 0.0 0
M  V30 2 C 3.0800 8.0020 0.0 0
M  V30 3 N 7.7000 8.0020 0.0 0
M  V30 4 C 9.2400 8.0020 0.0 0
M  V30 5 N 10.0100 9.3358 0.0 0
M  V30 6 O 10.0100 6.6684 0.0 0
M  V30 7 C 4.6200 2.6673 0.0 0
M  V30 8 N 5.3900 1.3336 0.0 0
M  V30 9 O 3.0800 2.6673 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 16.1700 9.3358 0.0 0
M  V30 12 C 5.3900 6.6684 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 5.3900 4.0011 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 3.0800 10.6694 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 2.3100 12.0031 0.0 0
M  V30 22 N 0.0000 10.6694 0.0 0
M  V30 23 C 0.7700 12.0031 0.0 0
M  V30 24 C 11.5500 9.3358 0.0 0
M  V30 25 C 12.3200 10.6694 0.0 0
M  V30 26 N 12.3200 8.0020 0.0 0
M  V30 27 N 13.8600 10.6694 0.0 0
M  V30 28 C 13.8600 8.0020 0.0 0
M  V30 29 C 14.6300 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 24
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 16
M  V30 12 1 8 10
M  V30 13 1 11 29
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 457098-17-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 457098-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5631907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-Methoxy-4-[3-(5-methypyrazin-2-yl)-ureido]-N-(2-pyridin-2-yethyl)-benzamide
To a stirred solution of
3-methoxy-4-[3-(5-methypyrazin-2-yl)-ureido]-benzoic acid (30 mg, 0.1
mmol) in 1 mL NMP at RT in a capped reaction vial was added HBTU (42 mg,
0.11 mmol). The suspension was stirred for 15 minutes and then treated
with 2-ethylaminopyridine (13.2 μL, 0.11 mmol) followed by Hunigs Base
(35 μL, 0.2 mmol). After stirring ovemight, NMP was removed by bulb to
bulb transfer at 70 °C under high vacuum and the residue stirred with a
mixture of CH2Cl2 (10 mL) and 10% Na2CO3 (10 mL) until complete
dissolution occurred. The organics were isolated, dried (MgSO4), filtered
and concentrated. The residue was triturated with EtOAc to produce a
solid which was isolated by filtration.
N-Methy4-[3-(5-methypyrazin-2-yl)-ureido]-3-(pyridin-3-ylmethoxy)-benzamide
Prepared according to the procedure of Compound 208 using methylamine
(99% yleld). 1 (400 MHz, d6-DMSO) δ 10.25 (s, 1H), 8.80 (s, 1H), 8.60 (m,
3H), 8.26 (d, 1H), 8.03 (d, 1H), 7.78 (s, 1H), 7.52 (m, 2H), 7.37 (m,
1H), 5.34 (s, 2H), 2.79 (d, 3H), 2.36 (s, 3H) LRMS (apci, positive) m/e
393.2 (M+1)
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl and heteroaryl urea selective Chk1 inhibitors for use
as radiosensitizers and chemosensitizers for treating diseases and
conditions related to DNA damage or lesions in DNA replication
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keegan, Kathleen S.; Kesicki, Edward A.; Gaudino, John Joseph; Cook, Adam
Wade; Cowen, Scott Douglas; Burgess, Laurence Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002070494 A1 2002-09-12

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-methyl-5-[2-[(methylsulfonyl)oxy]ethyl]-1H-indole-3-carboxylate
C20H21NO5S
459449-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0028 4.8308 0.0 0
M  V30 2 O 5.5383 5.3067 0.0 0
M  V30 3 O 7.3232 3.3246 0.0 0
M  V30 4 C 4.3938 4.2763 0.0 0
M  V30 5 C 6.6526 8.1629 0.0 0
M  V30 6 C 12.7336 2.8738 0.0 0
M  V30 7 C 14.2736 2.8738 0.0 0
M  V30 8 O 15.0436 1.5400 0.0 0
M  V30 9 S 16.5836 1.5400 0.0 0 VAL=6
M  V30 10 C 16.5836 0.0000 0.0 0
M  V30 11 O 18.1236 1.5400 0.0 0
M  V30 12 O 16.5836 3.0800 0.0 0
M  V30 13 C 9.6536 5.5411 0.0 0
M  V30 14 C 8.1474 5.8612 0.0 0
M  V30 15 C 10.4236 6.8747 0.0 0
M  V30 16 C 10.4236 4.2074 0.0 0
M  V30 17 C 7.9864 7.3929 0.0 0
M  V30 18 N 9.3932 8.0192 0.0 0
M  V30 19 C 11.9636 6.8747 0.0 0
M  V30 20 C 11.9636 4.2074 0.0 0
M  V30 21 C 12.7336 5.5411 0.0 0
M  V30 22 C 2.9292 4.7521 0.0 0
M  V30 23 C 2.6091 6.2586 0.0 0
M  V30 24 C 1.7847 3.7217 0.0 0
M  V30 25 C 1.1444 6.7344 0.0 0
M  V30 26 C 0.3202 4.1976 0.0 0
M  V30 27 C 0.0000 5.7039 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 2-methyl-5-[2-(methylamino)ethyl]-1H-indole-3-carboxylate
C20H22N2O2
459449-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 O 5.3900 3.7710 0.0 0
M  V30 3 O 7.6999 5.1048 0.0 0
M  V30 4 C 4.6200 5.1048 0.0 0
M  V30 5 C 5.5674 0.7102 0.0 0
M  V30 6 C 12.9850 3.8614 0.0 0
M  V30 7 C 14.4497 3.3855 0.0 0
M  V30 8 N 15.5941 4.4159 0.0 0
M  V30 9 C 17.0588 3.9401 0.0 0
M  V30 10 C 9.2316 2.2764 0.0 0
M  V30 11 C 7.6999 2.4373 0.0 0
M  V30 12 C 9.5518 0.7700 0.0 0
M  V30 13 C 10.3760 3.3068 0.0 0
M  V30 14 C 7.0736 1.0306 0.0 0
M  V30 15 N 8.2180 0.0000 0.0 0
M  V30 16 C 11.0163 0.2941 0.0 0
M  V30 17 C 11.8407 2.8310 0.0 0
M  V30 18 C 12.1608 1.3245 0.0 0
M  V30 19 C 3.0800 5.1048 0.0 0
M  V30 20 C 2.3100 3.7710 0.0 0
M  V30 21 C 2.3100 6.4384 0.0 0
M  V30 22 C 0.7700 3.7710 0.0 0
M  V30 23 C 0.7700 6.4384 0.0 0
M  V30 24 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459449-29-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459449-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13207319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Methy5-(2-methylamino-ethyl)-1H-indole-3-carboxylic acid benzyl ester A
mixture of 5-(2-methanesulfonyloxy-ethyl)-2-methy li7-indole-3-carboxylic
acid benzyl ester (500 mg, 1.29 mmol, Example 56, Step D) in 29%
methylamine in ethanol solution (6 mL) was stirred at room temperature
overnight and then partitioned between methylene chloride and water. The
organic phase was washed with water and brine, dried over Na2SO4 and
filtered. The filtrate was concentrated in vacuo to give a residue, which
was triturated with diethyl ether to give the desired product. White
foam, yield (410 mg, 99%). mp 65-68°C; MS(APCI+): m/z 323.1 (MH+); Anal.
Calcd for C20H22N2O2·.0.5H2O: C, 72.48; H, 7.00; N, 8.45. Found: C,
72.21; H, 6.85; N, 8.34.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of functionalized indoles, benzimidazolones and related
heterocycles as modulators of CCR-5 chemokine receptor and use in
treating patients with HIV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harriman, Geraldine C. B.; Carson, Kenneth G.; Flynn, Daniel L.; Solomon,
Michael E.; Song, Yuntao; Trivedi, Bharat K.; Roth, Bruce D.; Kolz,
Christine N.; Pham, Ly; Sun, Kuai-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002072549 A1 2002-09-19

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzaldehyde
C7H5FO
459-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Fluorophenyl)methylene]methanamine
C8H8FN
104156-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104156-56-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4196955
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 12c.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,4-dihydro-1′-(phenylmethyl)spiro[1H-2-benzopyran-1,4′-piperidine]-3-a...
C24H29NO3
477352-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7802 6.6685 0.0 0
M  V30 2 C 12.3203 6.6685 0.0 0
M  V30 3 O 13.0903 8.0023 0.0 0
M  V30 4 O 13.0903 5.3348 0.0 0
M  V30 5 C 14.6303 8.0023 0.0 0
M  V30 6 C 15.4003 9.3360 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 7.7002 4.0012 0.0 0
M  V30 9 C 8.4702 2.6675 0.0 0
M  V30 10 O 8.4702 5.3348 0.0 0
M  V30 11 C 6.9302 2.6675 0.0 0
M  V30 12 C 6.9302 5.3348 0.0 0
M  V30 13 C 10.0102 2.6675 0.0 0
M  V30 14 C 7.7002 1.3337 0.0 0
M  V30 15 C 10.0102 5.3348 0.0 0
M  V30 16 C 5.3901 2.6675 0.0 0
M  V30 17 C 5.3901 5.3348 0.0 0
M  V30 18 C 10.7802 4.0012 0.0 0
M  V30 19 C 10.7802 1.3337 0.0 0
M  V30 20 C 8.4702 0.0000 0.0 0
M  V30 21 N 4.6201 4.0012 0.0 0
M  V30 22 C 10.0102 0.0000 0.0 0
M  V30 23 C 2.3101 5.3348 0.0 0
M  V30 24 C 0.7700 5.3348 0.0 0
M  V30 25 C 3.0801 6.6685 0.0 0
M  V30 26 C 0.0000 6.6685 0.0 0
M  V30 27 C 2.3101 8.0023 0.0 0
M  V30 28 C 0.7700 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 21
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 2 13 19
M  V30 20 1 14 20
M  V30 21 1 15 18
M  V30 22 1 16 21
M  V30 23 1 17 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-N-methyl-1′-(phenylmethyl)spiro[1H-2-benzopyran-1,4′-piperidine]-...
C23H28N2O2
477352-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6685 0.0 0
M  V30 2 C 2.3100 6.6685 0.0 0
M  V30 3 N 1.5400 8.0021 0.0 0
M  V30 4 O 1.5400 5.3347 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 C 11.5500 4.0011 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 O 6.1600 5.3347 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 1.3336 0.0 0
M  V30 19 C 6.1600 0.0000 0.0 0
M  V30 20 N 10.0100 4.0011 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 C 12.3200 5.3347 0.0 0
M  V30 23 C 13.8600 5.3347 0.0 0
M  V30 24 C 11.5500 6.6685 0.0 0
M  V30 25 C 14.6300 6.6685 0.0 0
M  V30 26 C 12.3200 8.0021 0.0 0
M  V30 27 C 13.8600 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 20
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 17
M  V30 21 1 15 20
M  V30 22 1 16 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 477352-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477352-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3298406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(1'-Benzyl-3,4-dihydrospiro[[2]benzopyran-1,4'-piperidin]-3-yl)-N-methylacetamide
(18). Compound 12 (97 mg, 0.25 mmol) was stirred for 11 d in a solution
of CH3NH2 in EtOH (3 M, 3 mL) at room temperature. The solvent was
removed under reduced pressure, and the crude product was purified by
flash chromatography (2 cm, EtOAc:acetone = 9:1, 10 mL) to afford a
colorless oil, yield 90 mg (99%). R f = 0.03, IR (base, film): ν˜ (cm-1)
3298 (N-H); 2937, 2820 (C-H); 1648 (amide I); 1561 (amide II); 1097, 1049
(C-O); 740, 700 (C-H). 1H NMR (base, CDCl3): δ (ppm) 1.70 (dd, J = 13.4,
2.5 Hz, 1 H, N(CH2CH 2)2), 1.89 (td, J = 12.8, 4.5 Hz, 1 H, N(CH2CH 2)2),
2.03-2.12 (m, 1 H, N(CH2CH 2)2), 2.20-2.33 (m, 2 H, N(CH2CH 2)2 (1 H),
N(CH2CH 2)2 (1 H)), 2.39 (dd, J = 11.0, 2.1 Hz, 1 H, N(CH2CH 2)2), 2.46
(dd, J = 14.3, 8.2 Hz, 1 H, ArCH 2CH), 2.57 (dd, J = 14.3, 3.5 Hz, 1 H,
ArCH 2CH), 2.64-2.85 (m, 4 H, N(CH 2CH2)2 (2 H), CH 2CONH (2 H)), 2.87
(d, J = 4.9 Hz, 3 H, CONHCH3), 3.56 (s, 2 H, NCH2Ph), 4.12- 4.23 (m, 1 H,
ArCH2CH), 6.18 (br s, 1 H, CONHCH3), 7.06 (d, J = 7.0 Hz, 1 H, arom),
7.11-7.40 (m, 8 H, arom). MS (EI): m/z 364 [M+], 273 [M+ - CH2Ph], 91
[CH2Ph+]. HRMS: calcd for C23H28N2O2, 364.2151; found, 364.2152.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel σ Receptor Ligands. Part 2. SAR of
Spiro[[2]benzopyran-1,4'-piperidines] and
Spiro[[2]benzofuran-1,4'-piperidines] with Carbon Substituents in
Position 3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maier, Christoph A.; Wuensch, Bernhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(22), 4923-4930

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1H-Indol-3-ylmethylene)methanamine
C10H10N2
22980-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 C 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22980-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3979502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 10a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
N-Phthaloyl-(S)-phenylalanine
C17H13NO4
5123-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 2.7106 0.0 0 CFG=2
M  V30 2 C 7.3470 4.0442 0.0 0
M  V30 3 C 7.3470 1.3769 0.0 0
M  V30 4 O 8.8870 1.3769 0.0 0
M  V30 5 O 6.5770 0.0431 0.0 0
M  V30 6 O 4.6078 0.0000 0.0 0
M  V30 7 O 4.6078 5.4211 0.0 0
M  V30 8 N 5.0370 2.7106 0.0 0
M  V30 9 C 4.1320 1.4647 0.0 0
M  V30 10 C 4.1320 3.9564 0.0 0
M  V30 11 C 2.6673 1.9406 0.0 0
M  V30 12 C 2.6673 3.4806 0.0 0
M  V30 13 C 1.3336 1.1706 0.0 0
M  V30 14 C 1.3336 4.2506 0.0 0
M  V30 15 C 0.0000 1.9406 0.0 0
M  V30 16 C 0.0000 3.4806 0.0 0
M  V30 17 C 8.8870 4.0442 0.0 0
M  V30 18 C 9.6570 5.3780 0.0 0
M  V30 19 C 9.6570 2.7106 0.0 0
M  V30 20 C 11.1970 5.3780 0.0 0
M  V30 21 C 11.1970 2.7106 0.0 0
M  V30 22 C 11.9670 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-1,3-Dihydro-N-methyl-1,3-dioxo-α-(phenylmethyl)-2H-isoindole-2-acetamide
C18H16N2O3
795310-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5770 4.0011 0.0 0 CFG=2
M  V30 2 C 7.3470 5.3347 0.0 0
M  V30 3 C 7.3470 2.6674 0.0 0
M  V30 4 N 6.5770 1.3338 0.0 0
M  V30 5 O 8.8870 2.6674 0.0 0
M  V30 6 C 7.3470 0.0000 0.0 0
M  V30 7 O 4.6078 6.7116 0.0 0
M  V30 8 O 4.6078 1.2905 0.0 0
M  V30 9 N 5.0370 4.0011 0.0 0
M  V30 10 C 4.1320 5.2469 0.0 0
M  V30 11 C 4.1320 2.7552 0.0 0
M  V30 12 C 2.6673 4.7711 0.0 0
M  V30 13 C 2.6673 3.2311 0.0 0
M  V30 14 C 1.3336 5.5411 0.0 0
M  V30 15 C 1.3336 2.4611 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 18 C 8.8870 5.3347 0.0 0
M  V30 19 C 9.6570 6.6685 0.0 0
M  V30 20 C 9.6570 4.0011 0.0 0
M  V30 21 C 11.1970 6.6685 0.0 0
M  V30 22 C 11.1970 4.0011 0.0 0
M  V30 23 C 11.9670 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 2 7 10
M  V30 9 2 8 11
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5123-55-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 795310-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-44440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane).
(S)-N-Methyl-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanamide (3j)
[PhtN-L-Phe-NHMe]. Following GP-III, from PhtN-L-Phe-OH 2j (1.39 g, 5
mmol), title compound 3j was isolated as a white solid (1.53 g, > 99 %);
mp 192°C (CH2Cl2/pentane); [α]D -115.9 (c 1.01, CH2Cl2); δH (300.14 MHz,
CDCl3-CD3OD (4:1)): 2.79 (d, 3 H, 3JHH = 4.7 Hz), 3.48- 3.65 (m, 2 H),
5.06 (dd, 1 H, 3JHH = 7.2 Hz, 3JHH = 9.2 Hz), 7.06-7.19 (bs+m, 6 H),
7.66-7.72 (m, 2 H), 7.72-7.78 (m, 2 H); δC (75.48 MHz, CDCl3-CD3OD
(4:1)): 26.18 (q), 34.30 (dd), 55.29 (d), 123.09 (2 d), 126.57 (d),
128.29 (2×d), 128.54 (2×d), 131.23 (2×s), 134.02 (2×d), 136.63 (s),
167.93 (2×s), 169.41 (s); GC-MS-CI, m/z: 309 [M+H]; GC-MS-EI, m/z (%):
308 (10) [M], 277 (7) [M-CH5N], 250 (65) [M-C2H4NO], 232 (90) [C6H4], 204
(15), 189 (20), 161 (98), 160 (100) [M-C8H6NO2], 148 (25), 131 (93), 104
(80), 91 (48), 76 (68), 65 (18), 58 (30), 50 (10); GC-MS-EM for
[C18H16N2O3]: Calcd, 308.1161; Found, 308.1174. Anal. Calcd for
C18H16N2O3: C, 70.12; H, 5.23; N, 9.09. Found: C, 69.16; H, 4.90; N,
8.79.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetylbutyrolactone
C6H8O3
517-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 O 0.7104 0.1773 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 1.0306 1.6836 0.0 0
M  V30 7 C 2.2765 3.8416 0.0 0
M  V30 8 O 0.0000 2.8281 0.0 0
M  V30 9 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 6
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dihydro-3-[1-(methylamino)ethylidene]-2(3H)-furanone
C7H11NO2
24776-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6217 0.0 0
M  V30 5 O 0.7103 3.9845 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0
M  V30 7 C 1.0306 2.4782 0.0 0
M  V30 8 C 2.2765 0.3202 0.0 0
M  V30 9 O 0.0000 1.3337 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 6 CFG=2
M  V30 4 1 2 4
M  V30 5 2 5 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 517-23-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24776-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1098676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of β -Amino-α , β -Unsaturated
Esters and Ketones; General Procedure Amine 2 (12 mmol, pure amine, or
ammonia or amine in an aqueous solution) was added dropwise to the
suspension of silica gel (100 mg, 10 mg for diketone, Qingdao Ocean
Chemical Industrial Co.) in the dicarbonylic compound 1 (10 mmol) and the
resulting mixture was stirred at room temperature for 10 min-24 hr
(monitored by TLC). For liquid products, crude products were obtained
after removal of silica gel by filtration. Pure liquid products were
obtained by purification on a silica gel column. For solid products,
crude products were obtained after extraction with dichloromethane and
removal of solvent. The purification was performed by column
chromatography on silica gel using hexane /acetone as eluent. Table1. 3q,
yield 99%. Mp(°C): 107-108 (96-98)[37]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient and effective method for synthesizing
β-amino-α,β-unsaturated esters and ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Yuanhe; Zhang, Qihan; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2004), 34(5), 909-916

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxylic acid, 5-bromo-, 1,3-dimethyl ester
C10H9BrO4
51760-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 O 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N1,N3-dimethyl-1,3-benzenedicarboxamide
C10H11BrN2O2
1393439-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 N 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51760-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393439-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3305121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and methods for treating bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Janetka, James W.; Han, Zhenfu; Hultgren, Scott; Pinkner, Jerome S.;
Cusumano, Corinne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120309701 A1 2012-12-06

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxylic acid, 5-bromo-, 1,3-dimethyl ester
C10H9BrO4
51760-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 O 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N1,N3-dimethyl-1,3-benzenedicarboxamide
C10H11BrN2O2
1393439-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 N 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51760-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393439-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10611533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Dimethyl 5-bromobenzene-1,3-dicarboxylate (10.6 g, 36.8 mmol) was
dissolved in a 33 wt % solution of methylamine in EtOH (30 mL) and
stirred for 6 h at RT. The precipitate that formed during the reaction
was filtered. 5.3 g (53%) of the intermediate
5-bromo-N1,N3-dimethyl-benzene-1,3-dicarboxamide as a white solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mannoside compounds for treating Urinary tract bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Janetka, James W.; Han, Zhenfu; Hultgren, Scott; Pinkner, Jerry;
Cusumano, Corrine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012109263 A1 2012-08-16

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxylic acid, 5-bromo-, 1,3-dimethyl ester
C10H9BrO4
51760-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 O 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 O 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N1,N3-dimethyl-1,3-benzenedicarboxamide
C10H11BrN2O2
1393439-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.6201 0.0 0
M  V30 2 N 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 6.1601 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 1.3337 3.8501 0.0 0
M  V30 7 O 2.6673 6.1601 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 Br 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51760-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393439-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11689610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4′-(α-D-Mannopyranosyloxy)-N,N′-dimethyl-3′-(trifluoromethyl)
biphenyl-3,5-dicarboxamide (7) and
N1,N3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene-1,3-dicarboxamide
(9). Dimethyl 5-bromobenzene-1,3-dicarboxylate (10.6 g, 36.8 mmol) was
dissolved in a 33 wt % solution of methylamine in EtOH (30 mL) and the
mixture was stirred for 6 h at room temperature. The precipitate that
formed during the reaction was filtered to give 5.3 g (53%) of the
intermediate 5-bromo-N1,N3-dimethylbenzene-1,3-dicarboxamide as a white
solid. Concentration of the remaining filtrate yielded an additional
product. 4.6 g (46%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lead Optimization Studies on FimH Antagonists: Discovery of Potent and
Orally Bioavailable Ortho-Substituted Biphenyl Mannosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Chorell, Erik; Crowley,
Jan M.; Cusumano, Corinne K.; Campbell, Scott; Henderson, Jeffrey P.;
Hultgren, Scott J.; Janetka, James W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(8), 3945-3959

$RFMT $RIREG SCHEME71 STEP1
$RXN



  3  1
$MOL
Methyl (1S,2R)-2-[[(phenylmethoxy)carbonyl]amino]cyclobutanecarboxylate
C14H17NO4
517913-98-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0021 2.3100 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 5.3349 2.3100 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 C 11.5934 3.2722 0.0 0
M  V30 7 O 13.1334 3.2722 0.0 0
M  V30 8 O 10.8234 4.6060 0.0 0
M  V30 9 C 13.9034 4.6060 0.0 0
M  V30 10 C 9.3358 1.5400 0.0 0 CFG=2
M  V30 11 C 10.8234 1.9386 0.0 0 CFG=1
M  V30 12 C 9.7343 0.0525 0.0 0
M  V30 13 C 11.2220 0.4511 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 1.3338 1.5400 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 1.3338 4.6200 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 11 6 CFG=1
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (1R,2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]cyclobutanecarboxylate
C11H19NO4
868364-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.9813 3.8360 0.0 0
M  V30 2 O 10.3149 4.6060 0.0 0
M  V30 3 O 8.9813 2.2960 0.0 0
M  V30 4 C 11.6486 3.8360 0.0 0
M  V30 5 N 5.3900 2.8736 0.0 0
M  V30 6 C 3.8500 2.8736 0.0 0
M  V30 7 O 3.0800 1.5400 0.0 0
M  V30 8 O 3.0800 4.2074 0.0 0
M  V30 9 C 1.5400 1.5400 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 1.5400 3.0800 0.0 0
M  V30 13 C 7.6475 4.6060 0.0 0 CFG=2
M  V30 14 C 6.1600 4.2074 0.0 0 CFG=1
M  V30 15 C 7.2489 6.0935 0.0 0
M  V30 16 C 5.7614 5.6949 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 14 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1R,2S)-2-[[[(1S,2R)-2-[(methylamino)carbonyl]cyclobutyl]amin...
C19H25N3O4
1401734-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5935 3.2198 0.0 0
M  V30 2 N 13.1335 3.2198 0.0 0
M  V30 3 O 10.8234 1.8860 0.0 0
M  V30 4 N 8.0022 4.1820 0.0 0
M  V30 5 C 6.6685 4.9520 0.0 0
M  V30 6 O 5.3347 4.1820 0.0 0
M  V30 7 O 6.6685 6.4920 0.0 0
M  V30 8 C 4.0011 4.9520 0.0 0
M  V30 9 C 16.7246 2.2575 0.0 0
M  V30 10 N 18.0582 1.4875 0.0 0
M  V30 11 O 16.7246 3.7975 0.0 0
M  V30 12 C 19.3920 2.2575 0.0 0
M  V30 13 C 10.8234 4.5535 0.0 0 CFG=1
M  V30 14 C 9.3358 4.9520 0.0 0 CFG=2
M  V30 15 C 11.2220 6.0410 0.0 0
M  V30 16 C 9.7344 6.4395 0.0 0
M  V30 17 C 13.9035 1.8860 0.0 0 CFG=1
M  V30 18 C 15.3909 1.4875 0.0 0 CFG=2
M  V30 19 C 13.5047 0.3986 0.0 0
M  V30 20 C 14.9924 0.0000 0.0 0
M  V30 21 C 2.6674 4.1820 0.0 0
M  V30 22 C 2.6674 2.6420 0.0 0
M  V30 23 C 1.3338 4.9520 0.0 0
M  V30 24 C 1.3338 1.8720 0.0 0
M  V30 25 C 0.0000 4.1820 0.0 0
M  V30 26 C 0.0000 2.6420 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 14 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 21
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 18 9 CFG=3
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 517913-98-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 868364-62-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401734-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11761399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 617-86-7
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 59616-64-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of the β -Peptides. The MeO-protected
amino acid or precursor peptide is dissolved in 1:10 THF-water, and 0.25
M NaOH is added. The mixture is stirred at 0 °C for 2 h. The mixture is
washed with CH2Cl2 before being acidified to pH 2 with 2 M HCl. The
aqueous layer is extracted with EtOAc, and the organic layer is dried
over MgSO4, filtered, and evaporated under high vacuum to produce the
corresponding carboxylic acid. This compound is used directly in next
step without further purification. The N-Boc-protected amino acid or
precursor peptide is dissolved in dry CH2Cl2 and Et3SiH and TFA are
added. The mixture is stirred at room temperature for 2 h. The reaction
mixture is concentrated under reduced pressure obtaining the free amine,
which is used in next step without further purification. After this, a
solution containing the free carboxylic acid, the free amine, DIPEA (3
equiv), and FDPP (1.2 equiv) in anhydrous DMF is stirred at room
temperature overnight. Then, ethyl acetate is added, and the combined
organic layers are washed with saturated aqueous NaHCO3. The organic
layer is dried over MgSO4, and solvents are removed under reduced
pressure. The residue is purified by column chromatography to afford the
desired peptide. Dipeptide 6. Purified by column chromatography (EtOAc).
Isolated yield 130 mg (99%); colorless crystals (EtOAc/ pentane). mp
184-186 °C; [α ]25D -73 (c 0.6 in CH2-Cl2); IR (ATR) 3419, 3314, 2970,
1726, 1643 cm-1; IR (CDCl3) 3460, 3425, 2953, 1714, 1661 cm-1; 1H NMR
(CDCl3, 600 MHz) δ 7.35 (c. a, 5H), 6.15 (br.s, 1H), 6.58 (d, J= 7.3 Hz,
1H), 5.34 (br. s, 1H), 5.07 (c. a, 2H), 4.66 (m, 1H), 4.47 (m, 1H), 3.10
(c. a, 2H), 2.68 (d, J= 4.2 Hz, 3H), 2.39-2.21 (c. a, 4H), 1.94 (c. a,
4H); 13C NMR (CDCl3, 150 MHz) δ 173.8 (2C), 173.1, 155.6, 136.8, 128.7,
128.2, 128.1, 66.6, 46.3 (4C), 45.9, 44.8, 28.7, 26.7, 30.6 (4C), 29.3,
19.6, 19.3; HRMS (ESI-TOF) m/z calcd for C19H25N3O4Na (M + Na)+ 382.1737,
found 382.1736.
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Secondary Structure of Short β-Peptides as the Chiral Expression of
Monomeric Building Units: A Rational and Predictive Model
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorrea, Esther; Pohl, Gabor; Nolis, Pau; Celis, Sergio; Burusco, Kepa K.;
Branchadell, Vicenc; Perczel, Andras; Ortuno, Rosa M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(21), 9795-9806

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
6-Chloronicotinic acid
C6H4ClNO2
5326-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5326-23-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2272631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) Chloro-N-methyl-nicotinamide To a mixture of 63.0 g (0.40 mol)
6-chloronicotinic acid and 37.7 ml (0.52 mol) thionylchloride was added
340 ml toluene and 0.92 ml (12.0 mmol) DMF. The brown suspension was
heated to 95°C and stirred at 95°C for 1.5 h. The solvent was
subsequently removed and the residue treated with 340 ml CH2Cl2. This
solution was cooled to 2°C and treated with 81.0 g (1.2 mol)
methylaminhydrochloride. To the so formed brown suspension was added at
-2°C to -6 °C dropwise over 75 min. 167.5 ml (1.2 mol) NEt3 (the reaction
was finished after further 30 min.). The reaction mixture was poured onto
400 ml brine and 100 ml sat. aqueous sodium carbonate and extracted. The
aqueous phase was extracted with total 2.4 I CH2Cl2. The organic phases
were washed with 400 ml sat. aqueous sodium carbonate and 400 ml brine,
combined, dried over MgSO4. The solvent was removed under reduced
pressure to give 67.5 g (98.9%) product as brown crystals.
Chloro-N-methyl-nicotinamide, Yield 67.5 g (98.9%). m.p. 147.5-148.0°C;
MS(EI):m/e = 172(13), 171 (18), 170 ([M] 37), 169(47), 142(34), 140(100),
135(67), 112(43).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of pyridine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hilpert, Hans; Hoffmann-Emery, Fabienne; Rimmler, Goesta; Rogers-Evans,
Mark; Stahr, Helmut Werner; Waldmeier, Pius
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1103546 A1 2001-05-30

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzo-18-crown-6
C16H23NO8
53408-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 5.3901 0.0 0 VAL=5
M  V30 2 O 13.3370 4.6201 0.0 0
M  V30 3 O 12.0033 6.9302 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 9.3360 5.3901 0.0 0
M  V30 7 O 6.6685 5.3901 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 6.6685 2.3101 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 C 6.6685 6.9302 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 5.3348 7.7002 0.0 0
M  V30 15 C 5.3348 0.0000 0.0 0
M  V30 16 O 4.0010 6.9302 0.0 0
M  V30 17 O 4.0010 0.7700 0.0 0
M  V30 18 C 2.6673 7.7002 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0
M  V30 22 O 1.3337 5.3901 0.0 0
M  V30 23 O 1.3337 2.3101 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 25 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
14-[2-(Methylamino)-5-nitrophenoxy]-3,6,9,12-tetraoxatetradecan-1-ol
C17H28N2O8
194923-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 5.3901 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 5.3901 0.0 0
M  V30 4 O 8.0022 4.6201 0.0 0
M  V30 5 C 9.3360 5.3901 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 O 12.0033 5.3901 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 C 14.6708 5.3901 0.0 0
M  V30 10 O 16.0045 4.6201 0.0 0
M  V30 11 C 17.3382 5.3901 0.0 0
M  V30 12 C 18.6718 4.6201 0.0 0
M  V30 13 O 20.0057 5.3901 0.0 0
M  V30 14 C 21.3393 4.6201 0.0 0
M  V30 15 C 22.6730 5.3901 0.0 0
M  V30 16 O 24.0067 4.6201 0.0 0
M  V30 17 N 1.3337 6.9302 0.0 0
M  V30 18 C 0.0000 7.7002 0.0 0
M  V30 19 N 1.3337 0.7700 0.0 0 VAL=5
M  V30 20 O 0.0000 0.0000 0.0 0
M  V30 21 O 2.6673 0.0000 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 2.6673 3.0801 0.0 0
M  V30 25 C 0.0000 4.6201 0.0 0
M  V30 26 C 1.3337 2.3101 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 23
M  V30 19 2 19 20
M  V30 20 2 19 21
M  V30 21 1 19 26
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53408-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1557969
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Podands 2a-c; General Procedure A mixture of
4'-nitrobenzocrown ether 1a-c (4 mmol) and a 35% solution of MeNH2 in
anhyd EtOH (50 mL) was heated in a sealed tube at 100 °C for 48 h (water
bath). The tube was then opened, the mixture was concentrated in vacuo,
and the residue was purified by column chromatography on silica gel. The
products were eluted successively with a benzene-EtOAc mixture (1:1),
EtOAc, and an EtOAc-EtOH mixture (5:1) for 2a, successively with EtOAc
and an EtOAc-MeOH mixture (5: 1) for 2b, or successively with EtOAc and
an EtOAc-EtOH mixture (5:1) for 2c. Podands 2a-c were isolated as yellow
oils in excellent yields (Tables 1, 2). 2c, yellow ellow oil, yield 99%.
Rf: 0.48; IR (KBr) (cm-1): 3345 (NH, OH), 1495 (NO2); Molecular Formula:
C17H28N2O8; HRMS m/z Calcd: 388.1845; Found: 388.1857; 1H NMR (CDCl3, 500
MHz, 25 °C) δ 2.96 (m, 4 H, CH3N, OH), 3.61 (m, 2 H, CH2O), 3.67-3.72 (m,
14 H, 7 CH2O), 3.89 (m, 2 H, CH2CH2OAr), 4.23 (m, 2 H, CH2OAr), 5.64 (br
m, 1 H, NH), 6.43 (d, 1 H, J = 8.9, H-3), 7.59 (d, 1 H, J = 2.2, H-6),
7.90 (dd, 1 H, J = 8.9, 2.2, H-4); 13C NMR (CDCl3, 125 MHz, 25 °C) δ
29.59 (q, J = 136.8, CH3N), 61.56 (t, J = 142.1, CH2OH), 68.12 (t, J =
145.0, CH2OAr), 69.28 (t, J = 143.7, CH2CH2OAr), 70.08 (t, J = 141.2,
CH2O), 70.38 (3 CH2O), 70.43 (CH2O), 70.46 (CH2O), 72.52 (t, CH2O, J =
140.9), 106.13 (dd, J = 162.5, 4.8, C-3), 106.15 (dd, J = 162.5, 4.8,
C-6), 120.41 (dd, J = 166.9, 4.3, C-4), 136.38 (C-5), 144.11, 145.79
(C-1, C-2); MS m/z (%): 388 (M+, 38), 168 (70), 89 (100), 73 (71), 61
(56), 60 (67).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel ring transformation of nitrobenzocrown ethers as a route to
nitrobenzoazacrown compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, Sergei P.; Dmitrieva, Svetlana N.; Churakova, Marina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2003), (4), 593-597

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
2-Amino-6-methoxybenzoic acid
C8H9NO3
53600-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 4.6201 0.0 0
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 O 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 N 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-methoxy-N-methylbenzamide
C9H12N2O2
56934-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 N 0.7700 4.0011 0.0 0
M  V30 3 O 3.0800 5.3349 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 5.3900 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 0.7700 1.3338 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53600-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56934-53-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5296144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Quinolinecarboxaldehyde
C10H7NO
5470-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Quinolinylmethylene)methanamine
C11H10N2
1072270-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 N 4.0012 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5470-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072270-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14558376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 17a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,2-Dioxathiane, 5-methylene-, 2-oxide
C4H6O3S
548482-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 O 3.8500 2.6673 0.0 0
M  V30 8 S 4.6201 1.3337 0.0 0 VAL=4
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-ol, 2-[(methylamino)methyl]-
C5H11NO
2171131-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 548482-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171131-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-004-CAS-23566393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diazepinone derivatives as capsid assembly modulators and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuduk, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020239863 A1 2020-12-03

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,2-Dioxathiane, 5-methylene-, 2-oxide
C4H6O3S
548482-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 O 3.8500 2.6673 0.0 0
M  V30 8 S 4.6201 1.3337 0.0 0 VAL=4
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-ol, 2-[(methylamino)methyl]-
C5H11NO
2171131-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 548482-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171131-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24387258
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic derivatives as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grosse, Sandrine Celine; Deratt, Lindsey Graham; Vandyck, Koen;
Raboisson, Pierre Jean-Marie Bernard; Pieters, Serge Maria Aloyssius;
Kesteleyn, Bart Rudolf Romanie; Verschueren, Wim Gaston; Berke, Jan
Martin; LeComte, Morgan Charles R.; Martinez Lamenca, Carolina; Jonckers,
Tim Hugo Maria; Deng, Gang; Jiang, Yimin; Xu, Yanping; Cheng, Zhangling;
Hu, Lili; Kuduk, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020243135 A1 2020-12-03

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,2-Dioxathiane, 5-methylene-, 2-oxide
C4H6O3S
548482-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 O 3.8500 2.6673 0.0 0
M  V30 8 S 4.6201 1.3337 0.0 0 VAL=4
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propen-1-ol, 2-[(methylamino)methyl]-
C5H11NO
2171131-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 548482-49-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171131-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-004-CAS-19928788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diazepinone derivatives useful for treatment of hepatitis
B infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuduk, Scott; Hartman, George D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018005883 A1 2018-01-04

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
3-Methoxy-2-methylbenzoic acid
C9H10O3
55289-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 C 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N,2-dimethylbenzamide
C10H13NO2
95330-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 4.0012 4.6201 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55289-06-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95330-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11578232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isochromanone-based urotensin-II receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lehmann, Fredrik; Currier, Erika A.; Olsson, Roger; Hacksell, Uli;
Luthman, Kristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2005), 13(8), 3057-3068

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
3-Methoxy-2-methylbenzoic acid
C9H10O3
55289-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 C 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N,2-dimethylbenzamide
C10H13NO2
95330-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 4.0012 4.6201 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 55289-06-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95330-29-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3674994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isochromanones as urotensin II receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andersson, Carl-Magnus; Kary, May-Britt; Lehmann, Per Fredrik; Luthman,
Ingridkristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003104216 A1 2003-12-18

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Difluoroethyl)benzaldehyde
C9H8F2O
55805-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.5637 2.8737 0.0 0
M  V30 3 F 1.3337 0.0000 0.0 0
M  V30 4 F 0.0000 0.7700 0.0 0
M  V30 5 C 7.4938 1.5400 0.0 0
M  V30 6 O 8.2638 2.8737 0.0 0
M  V30 7 C 2.8737 1.5400 0.0 0
M  V30 8 C 3.6437 2.8737 0.0 0
M  V30 9 C 3.6437 0.2064 0.0 0
M  V30 10 C 5.1838 2.8737 0.0 0
M  V30 11 C 5.1838 0.2064 0.0 0
M  V30 12 C 5.9538 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Difluoroethyl)-N-methylbenzenemethanamine
C10H13F2N
1782342-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.5637 2.8737 0.0 0
M  V30 3 F 1.3337 0.0000 0.0 0
M  V30 4 F 0.0000 0.7700 0.0 0
M  V30 5 C 7.4938 1.5400 0.0 0
M  V30 6 N 8.2638 2.8737 0.0 0
M  V30 7 C 9.8039 2.8737 0.0 0
M  V30 8 C 2.8737 1.5400 0.0 0
M  V30 9 C 3.6437 0.2064 0.0 0
M  V30 10 C 3.6437 2.8737 0.0 0
M  V30 11 C 5.1838 0.2064 0.0 0
M  V30 12 C 5.1838 2.8737 0.0 0
M  V30 13 C 5.9538 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55805-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1782342-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(2-methoxyphenyl)acetamide
C9H10ClNO2
55860-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 6.9300 2.6674 0.0 0
M  V30 5 Cl 8.4700 5.3349 0.0 0
M  V30 6 O 1.5400 4.0011 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxyphenyl)-2-(methylamino)acetamide
C10H14N2O2
1016756-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 N 8.0022 3.0800 0.0 0
M  V30 6 C 9.3359 2.3100 0.0 0
M  V30 7 O 1.3337 0.7700 0.0 0
M  V30 8 C 0.0000 0.0000 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55860-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016756-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10679226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzenesulfonyl chloride
C7H4ClNO2S
56542-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-N-methylbenzenesulfonamide
C8H8N2O2S
56542-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 3.4375 4.4137 0.0 0
M  V30 4 O 1.8975 1.7464 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 N 9.3360 3.8501 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56542-67-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56542-62-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14708861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 97 2-(3-Fluoro-phenyl)-pyrimidine-5-carboxylic acid
3-methylsulfamoyl-benzylamide Step 1: A flask containing DCM (90 mL) and
methylamine in water (40 wt %, 7.5 mmol) is chilled in an ice water bath
with magnetic stirring. 3-Cyano-benzenesulfonyl chloride (5 g, 2.49 mmol)
is added along with DCM (10 mL) to wash down the sides of the flask.
After 30 min, concentrated HCl in water is added at 0&#x00B0;C, until the
reaction is acidic (pH<4). Water (50 mL) is added and DCM is removed in
vacuo. The residue is filtered to afford
3-cyano-N-methyl-benzenesulfonamide as a solid (99%). MS: 195 (M+H); 1H
NMR (300 MHz, CDCl3): &#x03B4; 2.76 (d, 3H), 4.48 (broad-s, N-H), 7.7 (t,
1H), 7.9 (d, 1H), 8.13 (d, 1H), 8.19 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine amide derivatives as prostaglandin D synthase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aldous, Suzanne C.; Jiang, John Ziqi; Lu, Jinqi; Ma, Liang; Mu, Lan;
Munson, Harry Randall; Sabol, Jeffrey Stephen; Thurairatnam, Sukanthini;
Vandeusen, Christopher Loren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007041634 A1 2007-04-12

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[(4-Methoxyphenyl)methylene]-2-phenyl-5(4H)-oxazolone
C17H13NO3
57427-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7854 6.8425 0.0 0
M  V30 2 O 2.7246 8.2052 0.0 0
M  V30 3 O 11.1202 3.7624 0.0 0
M  V30 4 C 12.4539 4.5324 0.0 0
M  V30 5 C 2.7844 4.2207 0.0 0
M  V30 6 N 4.2907 4.5409 0.0 0
M  V30 7 O 2.0143 5.5544 0.0 0
M  V30 8 C 4.4517 6.0725 0.0 0
M  V30 9 C 3.0448 6.6988 0.0 0
M  V30 10 C 2.1579 2.8138 0.0 0
M  V30 11 C 0.6263 2.6528 0.0 0
M  V30 12 C 3.0631 1.5679 0.0 0
M  V30 13 C 0.0000 1.2459 0.0 0
M  V30 14 C 2.4368 0.1611 0.0 0
M  V30 15 C 0.9052 0.0000 0.0 0
M  V30 16 C 7.1191 6.0725 0.0 0
M  V30 17 C 8.4527 6.8425 0.0 0
M  V30 18 C 7.1191 4.5324 0.0 0
M  V30 19 C 9.7865 6.0725 0.0 0
M  V30 20 C 8.4527 3.7624 0.0 0
M  V30 21 C 9.7865 4.5324 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 1 16
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 1 3 21
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dihydro-5-[(4-methoxyphenyl)methylene]-3-methyl-2-phenyl-4H-imidazol-4-one
C18H16N2O2
475046-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4828 5.7154 0.0 0
M  V30 2 C 5.7854 6.8425 0.0 0
M  V30 3 O 2.7246 8.2053 0.0 0
M  V30 4 O 11.1202 3.7624 0.0 0
M  V30 5 C 12.4539 4.5325 0.0 0
M  V30 6 C 2.7844 4.2208 0.0 0
M  V30 7 N 4.2907 4.5409 0.0 0
M  V30 8 N 2.0144 5.5544 0.0 0
M  V30 9 C 4.4518 6.0725 0.0 0
M  V30 10 C 3.0448 6.6988 0.0 0
M  V30 11 C 2.1579 2.8138 0.0 0
M  V30 12 C 3.0631 1.5679 0.0 0
M  V30 13 C 0.6263 2.6529 0.0 0
M  V30 14 C 2.4368 0.1611 0.0 0
M  V30 15 C 0.0000 1.2459 0.0 0
M  V30 16 C 0.9052 0.0000 0.0 0
M  V30 17 C 7.1191 6.0725 0.0 0
M  V30 18 C 8.4528 6.8425 0.0 0
M  V30 19 C 7.1191 4.5325 0.0 0
M  V30 20 C 9.7866 6.0725 0.0 0
M  V30 21 C 8.4528 3.7624 0.0 0
M  V30 22 C 9.7866 4.5325 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9 CFG=2
M  V30 3 1 2 17
M  V30 4 2 3 10
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57427-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 475046-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16287803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild, Efficient, One-Pot Synthesis of Imidazolones Promoted by
N,O-Bistrimethylsilylacetamide (BSA)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muselli, Mickael; Colombeau, Ludovic; Hedouin, Jonathan; Hoarau,
Christophe; Bischoff, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(20), 2819-2825

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-oxo[1,1′-biphenyl]-4-propanoate
C17H16O3
57477-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 O 8.0022 6.9302 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 O 10.6697 6.9302 0.0 0
M  V30 7 C 13.3370 5.3901 0.0 0
M  V30 8 C 14.6707 4.6201 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3337 0.0000 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-[1,1′-biphenyl]-4-yl-3-(methylamino)-2-propenoate
C18H19NO2
2614438-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 C 9.3358 4.6201 0.0 0
M  V30 3 N 8.0022 6.9302 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 C 6.6685 7.7002 0.0 0
M  V30 6 O 12.0033 4.6201 0.0 0
M  V30 7 O 10.6697 6.9302 0.0 0
M  V30 8 C 13.3370 5.3901 0.0 0
M  V30 9 C 14.6707 4.6201 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 0.0000 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57477-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-09-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23328479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-nitrobenzene
C6H4BrNO2
577-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Br 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 577-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2085658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-2-nitroaniline (Table 2-7) The reaction of
2-nitrobromobenzene (2.020 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%) produced 1. 514 g (99.5 %) of
N-methyl-2-nitroaniline as orange crystals. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.95-2.97(d, J = 4.8 Hz, 3H), 6.66-6.70(t, J = 7.5 Hz, 1H),
6.97-7.00(d, J = 8.4 Hz, 1H), 7.53-7.58(t, J = 7.5 Hz, 1H), 8.05-8.08(d,
J = 8.4 Hz, 1H), 8.16(s, 1H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 29.1,
113.6, 114.3, 125.6, 130.4, 136.0, 145.5.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3389157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as selective inhibitors of the p110
delta isoform of PI3K for treating inflammation, immune diseases and
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heald, Robert; Price, Stephen; Safina, Brian; Savy, Pascal Pierre
Alexandre; Seward, Eileen Mary; Sutherlin, Daniel P.; Waszkowycz, Bohdan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120202785 A1 2012-08-09

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Methoxyphenyl)methylene]methanamine
C9H11NO
16928-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16928-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9163487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 3d.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1,3-dinitrobenzene
C6H3ClN2O4
606-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 3.0800 0.0 0 VAL=5
M  V30 2 O 1.3336 4.6200 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 Cl 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,6-dinitroaniline
C7H7N3O4
5910-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5910-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16324711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a 7-arylaminobenzimidazole series as novel CRF1 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mochizuki, Michiyo; Kori, Masakuni; Kono, Mitsunori; Yano, Takahiko;
Sako, Yuu; Tanaka, Maiko; Kanzaki, Naoyuki; Gyorkos, Albert C.; Corrette,
Christopher P.; Aso, Kazuyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(19), 4675-4691

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1,3-dinitrobenzene
C6H3ClN2O4
606-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 3.0800 0.0 0 VAL=5
M  V30 2 O 1.3336 4.6200 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 Cl 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,6-dinitroaniline
C7H7N3O4
5910-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 4 O 6.6686 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 606-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5910-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13063514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Benzimidazoles As Novel Corticotropin-Releasing
Factor 1 Receptor Antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mochizuki, Michiyo; Kori, Masakuni; Kobayashi, Katsumi; Yano, Takahiko;
Sako, Yuu; Tanaka, Maiko; Kanzaki, Naoyuki; Gyorkos, Albert C.; Corrette,
Christopher P.; Cho, Suk Young; Pratt, Scott A.; Aso, Kazuyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2551-2566

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl diethoxyacetate
C8H16O4
6065-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 O 4.6200 2.6674 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 O 3.8500 6.6685 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 6.9300 6.6685 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Diethoxy-N-methylacetamide
C7H15NO3
1331832-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 O 4.6200 4.0011 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6065-82-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331832-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10653478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,2-Diethoxy- N -methylacetamide (6). A mixture of ethyl diethoxyacetate
(15 g, 85.2 mmol) and MeNH2 (40% in H2O, 15 mL) was stirred at room
temperature (rt) overnight. The mixture was evaporated. a clear oil was
used without further purification (13.6 g, 99%). 1H NMR (300 MHz, CDCl3)
δ = 6.62 (br s, 1H), 4.79 (s, 1H), 3.72 - 3.53 (m, 4H), 2.84 (d, J = 4.8
Hz, 3H), 1.24 (t, J = 7.1 Hz, 6H).tR : 4.3min; Wavelength: 210nm; Purity:
100.0%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amidine-Oximes: Reactivators for Organophosphate Exposure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kalisiak, Jaroslaw; Ralph, Erik C.; Zhang, Jun; Cashman, John R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(9), 3319-3330

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,6S,7aR)-6-[[(1,1-dimethylethoxy)carbonyl]amino]hexahydro-5-oxo-1H-...
C14H22N2O5
608526-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.7566 3.3778 0.0 0
M  V30 2 O 13.2213 2.9019 0.0 0
M  V30 3 O 11.4364 4.8841 0.0 0
M  V30 4 C 14.3657 3.9323 0.0 0
M  V30 5 O 8.3955 5.3184 0.0 0
M  V30 6 N 5.3348 3.9556 0.0 0
M  V30 7 C 4.0010 3.1856 0.0 0
M  V30 8 O 2.6673 3.9556 0.0 0
M  V30 9 O 4.0010 1.6455 0.0 0
M  V30 10 C 1.3337 3.1856 0.0 0
M  V30 11 C 0.5637 4.5192 0.0 0
M  V30 12 C 0.0000 2.4155 0.0 0
M  V30 13 C 2.1037 1.8519 0.0 0
M  V30 14 N 9.1059 2.6675 0.0 0
M  V30 15 C 8.3359 1.3338 0.0 0 CFG=2
M  V30 16 C 10.6122 2.3473 0.0 0 CFG=2
M  V30 17 C 8.0753 3.8119 0.0 0
M  V30 18 C 6.8294 1.6540 0.0 0
M  V30 19 C 9.3663 0.1893 0.0 0
M  V30 20 C 10.7732 0.8156 0.0 0
M  V30 21 C 6.6685 3.1856 0.0 0 CFG=1
M  V30 22 H 7.5659 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 22 CFG=1
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 16 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(2S,5S,7aR)-hexahydro-5-[(methylamino)carbonyl]-3-oxo-1H-pyrr...
C14H23N3O4
608526-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.7566 3.3778 0.0 0
M  V30 2 N 13.2213 2.9019 0.0 0
M  V30 3 O 11.4364 4.8841 0.0 0
M  V30 4 C 14.3657 3.9323 0.0 0
M  V30 5 O 8.3955 5.3184 0.0 0
M  V30 6 N 5.3348 3.9556 0.0 0
M  V30 7 C 4.0010 3.1856 0.0 0
M  V30 8 O 2.6673 3.9556 0.0 0
M  V30 9 O 4.0010 1.6455 0.0 0
M  V30 10 C 1.3337 3.1856 0.0 0
M  V30 11 C 2.1037 1.8519 0.0 0
M  V30 12 C 0.0000 2.4155 0.0 0
M  V30 13 C 0.5637 4.5192 0.0 0
M  V30 14 N 9.1059 2.6675 0.0 0
M  V30 15 C 8.3359 1.3338 0.0 0 CFG=2
M  V30 16 C 10.6122 2.3473 0.0 0 CFG=2
M  V30 17 C 8.0753 3.8119 0.0 0
M  V30 18 C 6.8294 1.6540 0.0 0
M  V30 19 C 9.3663 0.1893 0.0 0
M  V30 20 C 10.7732 0.8156 0.0 0
M  V30 21 C 6.6685 3.1856 0.0 0 CFG=1
M  V30 22 H 7.5659 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 22 CFG=1
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 16 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 608526-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 608526-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1725286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3S,5R,8S)-N'-Methyl-3-[N-(Boc)amino]-1-azabicyclo-[3.3.0]octan-2-one
8-Carboxamide (23). An aqueous solution of methylamine (40 wt %) was
slowly heated from 30°C to 60°C and the evolving methylamine gas was
bubbled through a solution of (3S,5R,8S)-methyl 3-[N-(Boc)amino]-1-
azabicyclo[3.3.0]octan-2-one 8-carboxylate (21, 19 mg, 0.064 mmol) in
MeOH (2 mL) at 0 °C for 2 h. The reaction mixture was warmed to rt,
capped, and left for 18 h. The volatiles were removed by bubbling argon
and the residue was concentrated under vacuum, yielding carboxamide 23 as
a white foam (19 mg, 99%):
(3S,5R,8S)-N'-Methyl-3-[N-(Boc)amino]-1-azabicyclo-[3.3.0]octan-2-one
8-Carboxamide (23). yield 19 mg, 99%. Rf = 0.51 (10% MeOH/CH2Cl2); [α]20
D -41.6 (c 4.33, MeOH); 1H NMR δ 1.38 (s, 9H), 1.51-1.65 (m, 1H),
1.91-1.94 (m, 1H), 2.07 (q, 1H, J = 10.8 Hz), 2.29-2.37 (m, 2H), 2.58
(quintet, 1H, J = 6.1 Hz), 2.75 (d, 3H, J = 4.6 Hz), 3.72 (heptet, 1H, J
= 5.1 Hz), 4.06 (d, 1H, J = 8.1 Hz), 4.19-4.27 (m, 1H), 5.29 (d, 1H, J =
6.4 Hz), 7.20 (s, 1H); 13C NMR δ 26.7, 28.5, 29.6, 34.5, 35.7, 56.9,
58.1, 59.8, 80.5, 156.0, 170.5, 170.8; HRMS calcd for C14H24N3O4 298.1767
(MH)+, found 298.1774.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Synthesis of Enantiopure Pyrrolizidinone Amino Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dietrich, Evelyne; Lubell, William D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(18), 6988-6996

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-oxocyclopentanecarboxylate
C8H12O3
611-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 O 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6218 0.0 0
M  V30 5 C 7.7722 1.8517 0.0 0
M  V30 6 O 0.7103 3.9845 0.0 0
M  V30 7 C 2.4374 1.8517 0.0 0
M  V30 8 C 1.0304 2.4782 0.0 0
M  V30 9 C 2.2765 0.3202 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 8
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(methylamino)-1-cyclopentene-1-carboxylate
C9H15NO2
10412-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8384 3.7710 0.0 0
M  V30 2 O 6.3784 3.7710 0.0 0
M  V30 3 O 4.0684 5.1048 0.0 0
M  V30 4 C 7.1484 5.1048 0.0 0
M  V30 5 C 8.6884 5.1048 0.0 0
M  V30 6 N 1.5063 3.4208 0.0 0
M  V30 7 C 0.0000 3.1006 0.0 0
M  V30 8 C 4.0684 2.4374 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0
M  V30 10 C 4.6947 1.0306 0.0 0
M  V30 11 C 2.2167 0.7700 0.0 0
M  V30 12 C 3.5503 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10412-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5959174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of β -Amino-α , β -Unsaturated
Esters and Ketones; General Procedure Amine 2 (12 mmol, pure amine, or
ammonia or amine in an aqueous solution) was added dropwise to the
suspension of silica gel (100 mg, 10 mg for diketone, Qingdao Ocean
Chemical Industrial Co.) in the dicarbonylic compound 1 (10 mmol) and the
resulting mixture was stirred at room temperature for 10 min-24 hr
(monitored by TLC). For liquid products, crude products were obtained
after removal of silica gel by filtration. Pure liquid products were
obtained by purification on a silica gel column. For solid products,
crude products were obtained after extraction with dichloromethane and
removal of solvent. The purification was performed by column
chromatography on silica gel using hexane /acetone as eluent. Table1. 3l,
yield 99%. Mp(°C): 44-45 (45-46)[33]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient and effective method for synthesizing
β-amino-α,β-unsaturated esters and ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Yuanhe; Zhang, Qihan; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2004), 34(5), 909-916

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-5-methyl-4-[(4-phenoxyphenyl)amino]pyrrolo[1,2-b]pyridazine-6-carboxy...
C22H16N4O3
612082-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 12.2604 2.6839 0.0 0
M  V30 3 C 7.7000 6.6685 0.0 0
M  V30 4 N 6.1600 6.6685 0.0 0
M  V30 5 C 15.3210 4.0467 0.0 0
M  V30 6 O 15.3210 2.5067 0.0 0
M  V30 7 O 16.6548 4.8167 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 C 10.0100 5.3347 0.0 0
M  V30 11 N 12.3200 6.6685 0.0 0
M  V30 12 C 12.5806 4.1903 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 13.8264 6.3482 0.0 0
M  V30 15 N 11.5500 8.0021 0.0 0
M  V30 16 C 13.9874 4.8167 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 C 6.9300 2.6674 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 5.3900 2.6674 0.0 0
M  V30 22 C 5.3900 5.3347 0.0 0
M  V30 23 C 4.6200 4.0011 0.0 0
M  V30 24 C 2.3100 2.6674 0.0 0
M  V30 25 C 3.0800 1.3336 0.0 0
M  V30 26 C 0.7700 2.6674 0.0 0
M  V30 27 C 2.3100 0.0000 0.0 0
M  V30 28 C 0.0000 1.3336 0.0 0
M  V30 29 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 18
M  V30 3 1 2 12
M  V30 4 3 3 4
M  V30 5 1 3 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 8 23
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-N,5-dimethyl-4-[(4-phenoxyphenyl)amino]pyrrolo[1,2-b]pyridazine-6-car...
C23H19N5O2
612082-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 4.0011 0.0 0
M  V30 2 C 12.2602 2.6839 0.0 0
M  V30 3 C 7.7000 6.6685 0.0 0
M  V30 4 N 6.1600 6.6685 0.0 0
M  V30 5 C 15.3210 4.0467 0.0 0
M  V30 6 N 16.6548 4.8167 0.0 0
M  V30 7 O 15.3210 2.5067 0.0 0
M  V30 8 C 17.9884 4.0467 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 10.0100 5.3347 0.0 0
M  V30 12 N 12.3200 6.6685 0.0 0
M  V30 13 C 12.5806 4.1903 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 13.8264 6.3482 0.0 0
M  V30 16 N 11.5500 8.0021 0.0 0
M  V30 17 C 13.9874 4.8167 0.0 0
M  V30 18 C 10.0100 8.0021 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 6.9300 2.6674 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 5.3900 2.6674 0.0 0
M  V30 23 C 5.3900 5.3347 0.0 0
M  V30 24 C 4.6200 4.0011 0.0 0
M  V30 25 C 2.3100 2.6674 0.0 0
M  V30 26 C 3.0800 1.3336 0.0 0
M  V30 27 C 0.7700 2.6674 0.0 0
M  V30 28 C 2.3100 0.0000 0.0 0
M  V30 29 C 0.0000 1.3336 0.0 0
M  V30 30 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 19
M  V30 3 1 2 13
M  V30 4 3 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 1 9 24
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 612082-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612082-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7413243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolopyridazine MEK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhong; Kim, Soong-Hoon; Barbosa, Stephanie A.; Huynh, Tram;
Tortolani, David R.; Leavitt, Kenneth J.; Wei, Donna D.; Manne,
Veeraswamy; Ricca, Carolyn S.; Gullo-Brown, Johnni; Poss, Michael A.;
Vaccaro, Wayne; Salvati, Mark E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(3), 628-632

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl benzoylacetate
C10H10O3
614-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 4.6200 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C11H13NO2
2139332-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 N 4.0011 0.7700 0.0 0
M  V30 4 C 6.6684 2.3100 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 O 8.0022 3.0800 0.0 0
M  V30 7 O 6.6684 0.7700 0.0 0
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 614-27-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139332-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23327549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrylium, 4-(4-bromophenyl)-2,6-diphenyl-, tetrafluoroborate(1-) (1:1)
C23H16BrO.BF4
61636-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 12.0033 14.6302 0.0 0
M  V30 2 C 6.6685 11.5502 0.0 0
M  V30 3 C 5.3348 12.3202 0.0 0
M  V30 4 C 6.6685 10.0101 0.0 0
M  V30 5 C 4.0012 11.5502 0.0 0
M  V30 6 C 5.3348 9.2401 0.0 0
M  V30 7 O 4.0012 10.0101 0.0 0 CHG=1 VAL=3
M  V30 8 C 8.0022 12.3202 0.0 0
M  V30 9 C 8.0022 13.8602 0.0 0
M  V30 10 C 9.3360 11.5502 0.0 0
M  V30 11 C 9.3360 14.6302 0.0 0
M  V30 12 C 10.6697 12.3202 0.0 0
M  V30 13 C 10.6697 13.8602 0.0 0
M  V30 14 C 2.6673 12.3202 0.0 0
M  V30 15 C 2.6673 13.8602 0.0 0
M  V30 16 C 1.3337 11.5502 0.0 0
M  V30 17 C 1.3337 14.6302 0.0 0
M  V30 18 C 0.0000 12.3202 0.0 0
M  V30 19 C 0.0000 13.8602 0.0 0
M  V30 20 C 5.3348 7.7001 0.0 0
M  V30 21 C 4.0012 6.9301 0.0 0
M  V30 22 C 6.6685 6.9301 0.0 0
M  V30 23 C 4.0012 5.3900 0.0 0
M  V30 24 C 6.6685 5.3900 0.0 0
M  V30 25 C 5.3348 4.6200 0.0 0
M  V30 26 B 6.0017 1.5400 0.0 0 CHG=3 VAL=4
M  V30 27 F 4.4617 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 28 F 7.5417 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 29 F 6.0017 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 30 F 6.0017 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 14
M  V30 9 2 6 7
M  V30 10 1 6 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 4-(4-bromophenyl)-1-methyl-2,6-diphenyl-, tetrafluoroborate(1-) (...
C24H19BrN.BF4
1254972-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 9.2401 0.0 0
M  V30 2 Br 12.0033 14.6302 0.0 0
M  V30 3 C 4.0012 11.5502 0.0 0
M  V30 4 N 4.0012 10.0101 0.0 0 CHG=1 VAL=4
M  V30 5 C 5.3348 12.3202 0.0 0
M  V30 6 C 5.3348 9.2401 0.0 0
M  V30 7 C 6.6685 11.5502 0.0 0
M  V30 8 C 6.6685 10.0101 0.0 0
M  V30 9 C 2.6673 12.3202 0.0 0
M  V30 10 C 2.6673 13.8602 0.0 0
M  V30 11 C 1.3337 11.5502 0.0 0
M  V30 12 C 1.3337 14.6302 0.0 0
M  V30 13 C 0.0000 12.3202 0.0 0
M  V30 14 C 0.0000 13.8602 0.0 0
M  V30 15 C 5.3348 7.7001 0.0 0
M  V30 16 C 4.0012 6.9301 0.0 0
M  V30 17 C 6.6685 6.9301 0.0 0
M  V30 18 C 4.0012 5.3900 0.0 0
M  V30 19 C 6.6685 5.3900 0.0 0
M  V30 20 C 5.3348 4.6200 0.0 0
M  V30 21 C 8.0022 12.3202 0.0 0
M  V30 22 C 9.3360 11.5502 0.0 0
M  V30 23 C 8.0022 13.8602 0.0 0
M  V30 24 C 10.6697 12.3202 0.0 0
M  V30 25 C 9.3360 14.6302 0.0 0
M  V30 26 C 10.6697 13.8602 0.0 0
M  V30 27 B 6.0017 1.5400 0.0 0 CHG=3 VAL=4
M  V30 28 F 4.4617 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 29 F 7.5417 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 6.0017 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 31 F 6.0017 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 1 7 21
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61636-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1254972-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10897167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1N-methyl-2,6-diphenyl-4-p-bromophenylpyridinium tetrafluoroborate;
[Rf-Br](BF4): The pyrylium salt [TPyrH2Br](BF4) (1.80 g, 3.79 mmol) and
anhydrous sodium acetate (2.0 g) were suspended in absolute EtOH (48 mL),
and a solution of methylamine in EtOH (8.03 M, d = 0.759; 0.311 g or 0.41
mL, 3.29 mmol) was then added. The solution mixture was heated under
reflux whilst stirring and under argon for 2 days. The reaction medium
was then stored overnight at 4 °C and the precipitate was filtered off
and washed with Et2O. The product was extracted from the solid with
CH2Cl2, evaporated to dryness under reduced pressure and recrystallized
from a mixture of EtOAc and CH2Cl2. The recrystallized product was washed
with Et2O and dried in oven, yielding the pure product as a white
microcrystalline solid (m = 1.592 g, 99 %). 1H NMR (500 MHz, CD3CN, 25
°C, ppm): δ 8.18 (s, 2H; HA3); 7.91 (d, 2H, J = 8.5 Hz; HD3); 7.78 (d,
2H, J = 8.5 Hz; HD2); 7.73-7.69 (m, 10H; HC2, C3, C4); 3.76 (s, 3H;
HMe(A1)). 13C NMR (126 MHz, CD3CN, 25 °C, ppm): δ 158.13; 155.0; 133.91;
133.88; 133.8; 132.3; 131.1; 130.3; 130.1; 127.6; 126.7; 46.2. ESI-MS:
m/z: calcd for C24H19BrN: 400.07 (99%) [M-BF4, 79Br]+, 402.07 (100%)
[M+2-BF4, 81Br]+; found: 400.12 (100%) [M-BF4, 79Br]+, 402.12 (80%)
[M+2-BF4, 81Br]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing Multifunctional Expanded Pyridiniums: Properties of Branched
and Fused Head-to-Tail Bipyridiniums
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fortage, Jerome; Peltier, Cyril; Nastasi, Francesco; Puntoriero, Fausto;
Tuyeras, Fabien; Griveau, Sophie; Bedioui, Fethi; Adamo, Carlo; Ciofini,
Ilaria; Campagna, Sebastiano; Laine, Philippe P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(46), 16700-16713

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzoyl chloride
C7H4Cl2O
618-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methylbenzamide
C8H8ClNO
18370-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18370-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-16180113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deuterodechlorination of Aryl/Heteroaryl Chlorides Catalyzed by a
Palladium/Unsymmetrical NHC System
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuriyama, Masami; Hamaguchi, Norihisa; Yano, Gemba; Tsukuda, Kotaro;
Sato, Kanako; Onomura, Osamu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(19), 8934-8946

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Formylbenzoic acid
C8H6O3
619-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylimino)methyl]benzoic acid
C9H9NO2
35003-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-66-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35003-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11282537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 4a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methylfurfural
C6H6O2
620-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 O 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-2-furanmethanamine
C7H11NO
14668-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 O 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14668-91-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40172279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic synthesis of amino-esters as precursors of ammonium
salt-based surfactants from 5-hydroxymethylfurfural (HMF)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moriana Herraiz, Carlos; Arias, Karen S.; Climent, Maria J.; Iborra,
Sara; Corma, Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2024), 26(16), 9118-9131

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 4,6-dichloro-1-methyl-, ethyl ester
C12H11Cl2NO2
620175-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 0.0000 0.0 0
M  V30 2 C 4.5603 6.6519 0.0 0
M  V30 3 C 7.6212 5.2891 0.0 0
M  V30 4 O 8.9548 4.5191 0.0 0
M  V30 5 O 7.6212 6.8291 0.0 0
M  V30 6 C 10.2887 5.2891 0.0 0
M  V30 7 C 11.6223 4.5191 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 6.1266 2.9875 0.0 0
M  V30 12 C 3.8501 1.3337 0.0 0
M  V30 13 N 4.8805 5.1456 0.0 0
M  V30 14 C 2.3101 4.0010 0.0 0
M  V30 15 C 6.2875 4.5191 0.0 0
M  V30 16 C 2.3101 1.3337 0.0 0
M  V30 17 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-4473769
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N,1-Dimethyl-1H-indole-2-carboxamide [0744]A suspension of ethyl
4,6-dichloro-1-methyl-1H-indole-2-carboxylate (1.06 g, 3.90 mmole) in 2.0
M CH3NH2/CH3OH (40 mL) in a sealed pressure bottle was heated in an oil
bath preset at 50° C. A homogeneous solution formed within 2.5 hr. The
reaction was kept at 50° C. for 17.5 hr, during which time a solid
precipitated. The mixture was cooled to RT and poured into H2O (40 mL).
The resulting mixture was concentrated on the rotavap to remove the
methanol, and the solid was collected by suction filtration. This was
washed with plenty of H2O and dried in high vacuum at 45-50° C. to afford
the title compound (0.99 g, 99%) as an off-white solid:. 1H NMR (400 MHz,
CDCl3) δ 7.29 (s, 1H), 7.16 (d, J=1.5 Hz, 1H), 6.86 (s, 1H), 6.21 (br s,
1H), 4.02 (s, 3H), 3.02 (d, J=4.9 Hz, 3H); MS (ES) m/e 257 and 259
(M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 4,6-dichloro-1-methyl-, ethyl ester
C12H11Cl2NO2
620175-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 0.0000 0.0 0
M  V30 2 C 4.5603 6.6519 0.0 0
M  V30 3 C 7.6212 5.2891 0.0 0
M  V30 4 O 8.9548 4.5191 0.0 0
M  V30 5 O 7.6212 6.8291 0.0 0
M  V30 6 C 10.2887 5.2891 0.0 0
M  V30 7 C 11.6223 4.5191 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 6.1266 2.9875 0.0 0
M  V30 12 C 3.8501 1.3337 0.0 0
M  V30 13 N 4.8805 5.1456 0.0 0
M  V30 14 C 2.3101 4.0010 0.0 0
M  V30 15 C 6.2875 4.5191 0.0 0
M  V30 16 C 2.3101 1.3337 0.0 0
M  V30 17 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-13173072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 4,6-dichloro-1-methyl-, ethyl ester
C12H11Cl2NO2
620175-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 0.0000 0.0 0
M  V30 2 C 4.5603 6.6519 0.0 0
M  V30 3 C 7.6212 5.2891 0.0 0
M  V30 4 O 8.9548 4.5191 0.0 0
M  V30 5 O 7.6212 6.8291 0.0 0
M  V30 6 C 10.2887 5.2891 0.0 0
M  V30 7 C 11.6223 4.5191 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 6.1266 2.9875 0.0 0
M  V30 12 C 3.8501 1.3337 0.0 0
M  V30 13 N 4.8805 5.1456 0.0 0
M  V30 14 C 2.3101 4.0010 0.0 0
M  V30 15 C 6.2875 4.5191 0.0 0
M  V30 16 C 2.3101 1.3337 0.0 0
M  V30 17 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N,1-dimethyl-1H-indole-2-carboxamide
C11H10Cl2N2O
620175-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 0.0000 0.0 0
M  V30 2 C 4.5603 6.6519 0.0 0
M  V30 3 C 7.6212 5.2891 0.0 0
M  V30 4 N 8.9550 4.5191 0.0 0
M  V30 5 O 7.6212 6.8291 0.0 0
M  V30 6 C 10.2887 5.2891 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 6.1266 2.9875 0.0 0
M  V30 11 C 3.8501 1.3337 0.0 0
M  V30 12 N 4.8807 5.1456 0.0 0
M  V30 13 C 2.3101 4.0010 0.0 0
M  V30 14 C 6.2875 4.5191 0.0 0
M  V30 15 C 2.3101 1.3337 0.0 0
M  V30 16 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7602937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure bottle used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-oxo-2-naphthalenepropanoate
C15H14O3
62550-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-(2-naphthalenyl)-2-propenoate
C16H17NO2
2614438-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6675 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 N 7.7002 1.3338 0.0 0
M  V30 4 C 9.2402 4.0012 0.0 0
M  V30 5 C 6.9302 0.0000 0.0 0
M  V30 6 O 10.0102 5.3348 0.0 0
M  V30 7 O 10.0102 2.6675 0.0 0
M  V30 8 C 11.5503 5.3348 0.0 0
M  V30 9 C 12.3203 6.6687 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 C 4.6201 1.3338 0.0 0
M  V30 13 C 3.0801 4.0012 0.0 0
M  V30 14 C 3.0801 1.3338 0.0 0
M  V30 15 C 2.3101 2.6675 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 15
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62550-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23326587
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-fluoro-1,3-dinitrobenzene
C6H2ClFN2O4
62558-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 Cl 4.0011 6.1600 0.0 0
M  V30 5 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 6 O 6.6685 6.1600 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 F 4.0011 0.0000 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-2,6-dinitrobenzenamine
C7H6FN3O4
82366-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.1600 0.0 0
M  V30 2 C 2.6674 6.9300 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 4 O 6.6685 6.1600 0.0 0
M  V30 5 O 8.0021 3.8500 0.0 0
M  V30 6 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 O 1.3336 6.1600 0.0 0
M  V30 9 F 4.0011 0.0000 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62558-39-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82366-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15043108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Fluoro-N-methyl-2,6-dinitroaniline To 1.35 g (6.12 mmol) of
2-chloro-5-fluoro-1,3-dinitrobenzene in 20 mL of THF at 0 °C was added
6.1 mL (12 mmol) of 2N methylamine in THF. The cold bath was removed and
the reaction was stirred at room temperature for 45 minutes. The solution
was concentrated, diluted with ether and washed with saturated sodium
bicarbonate solution. The resulting organic solution was dried over
sodium sulfate, filtered and concentrated giving 1.30 g (99%) of the
title compound as a bright orange powder. 1H NMR (DMSO-d 6) δ 2.70 (d, J
= 5.5 Hz, 3H), 8.20 (br s, 1H), 8.29 (d, J = 8.2 Hz, 2H).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nitrogen-containing fused heterocyclic compounds like
benzimidazoles and benzothiazoles as CRF receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gyorkos, Albert Charles; Corrette, Christopher Peter; Cho, Suk Young;
Turner, Timothy Mark; Pratt, Scott Alan; Aso, Kazuyoshi; Kori, Masakuni;
Gyoten, Michiyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005044793 A2 2005-05-19

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Diethylamino)-2-methoxybenzaldehyde
C12H17NO2
63400-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 5.3901 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 C 1.3337 7.7002 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 O 4.0012 0.0000 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 3.0801 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-methoxy-3-[(methylimino)methyl]benzenamine
C13H20N2O
1800562-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 6.9301 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 C 2.6675 8.4701 0.0 0
M  V30 4 C 0.0000 6.9301 0.0 0
M  V30 5 C 1.3337 9.2401 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 N 4.0011 1.5400 0.0 0
M  V30 8 C 4.0011 0.0000 0.0 0
M  V30 9 O 8.0022 3.8500 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 C 4.0011 6.1601 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 6.9301 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 6.6684 6.1601 0.0 0
M  V30 16 C 6.6684 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63400-63-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800562-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5586195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strong electron donation induced differential nonradiative decay pathways
for para and meta GFP chromophore analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Tanmay; Mandal, Mrinal; Gude, Venkatesh; Bag, Partha Pratim;
Mandal, Prasun K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Physical Chemistry Chemical Physics (2015), 17(32), 20515-20521

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
2-Amino-3-chlorobenzoic acid
C7H6ClNO2
6388-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-chloro-N-methylbenzamide
C8H9ClN2O
18343-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6388-47-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18343-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7722001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[2-[4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-2-oxoacetyl]-4-f...
C21H24FN3O6
639519-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1279 4.2074 0.0 0
M  V30 2 C 9.8979 2.8738 0.0 0
M  V30 3 O 9.8979 5.5411 0.0 0
M  V30 4 O 9.1279 1.5400 0.0 0
M  V30 5 F 8.4675 7.4356 0.0 0
M  V30 6 C 2.6091 5.5320 0.0 0
M  V30 7 O 1.4645 6.5624 0.0 0
M  V30 8 O 2.2889 4.0256 0.0 0
M  V30 9 C 0.0000 6.0865 0.0 0
M  V30 10 C 16.0579 2.8738 0.0 0
M  V30 11 O 16.8279 1.5400 0.0 0
M  V30 12 O 16.8279 4.2074 0.0 0
M  V30 13 C 18.3679 1.5400 0.0 0
M  V30 14 C 18.3679 3.0800 0.0 0
M  V30 15 C 19.9079 1.5400 0.0 0
M  V30 16 C 18.3679 0.0000 0.0 0
M  V30 17 C 6.6827 5.4533 0.0 0
M  V30 18 C 5.2181 4.9774 0.0 0
M  V30 19 C 7.5879 4.2074 0.0 0
M  V30 20 C 7.0028 6.9596 0.0 0
M  V30 21 C 4.0736 6.0078 0.0 0
M  V30 22 N 5.2181 3.4374 0.0 0
M  V30 23 C 6.6827 2.9616 0.0 0
M  V30 24 C 5.8585 7.9901 0.0 0
M  V30 25 C 4.3938 7.5143 0.0 0
M  V30 26 N 11.4379 2.8738 0.0 0
M  V30 27 C 12.2079 4.2074 0.0 0
M  V30 28 C 12.2079 1.5400 0.0 0
M  V30 29 C 13.7479 4.2074 0.0 0
M  V30 30 C 13.7479 1.5400 0.0 0
M  V30 31 N 14.5179 2.8738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 2 2 4
M  V30 5 1 2 26
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 31
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-[4-fluoro-7-[(methylamino)carbonyl]-1H-indol-3-yl]-2-o...
C21H25FN4O5
639519-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1279 4.2074 0.0 0
M  V30 2 C 9.8979 2.8738 0.0 0
M  V30 3 O 9.8979 5.5411 0.0 0
M  V30 4 O 9.1279 1.5400 0.0 0
M  V30 5 F 8.4675 7.4356 0.0 0
M  V30 6 C 2.6091 5.5320 0.0 0
M  V30 7 N 1.4645 6.5624 0.0 0
M  V30 8 O 2.2889 4.0256 0.0 0
M  V30 9 C 0.0000 6.0865 0.0 0
M  V30 10 C 16.0579 2.8738 0.0 0
M  V30 11 O 16.8279 1.5400 0.0 0
M  V30 12 O 16.8279 4.2074 0.0 0
M  V30 13 C 18.3679 1.5400 0.0 0
M  V30 14 C 18.3679 0.0000 0.0 0
M  V30 15 C 19.9079 1.5400 0.0 0
M  V30 16 C 18.3679 3.0800 0.0 0
M  V30 17 C 6.6827 5.4533 0.0 0
M  V30 18 C 5.2181 4.9774 0.0 0
M  V30 19 C 7.5879 4.2074 0.0 0
M  V30 20 C 7.0028 6.9596 0.0 0
M  V30 21 C 4.0736 6.0078 0.0 0
M  V30 22 N 5.2181 3.4374 0.0 0
M  V30 23 C 6.6827 2.9616 0.0 0
M  V30 24 C 5.8585 7.9901 0.0 0
M  V30 25 C 4.3938 7.5143 0.0 0
M  V30 26 N 11.4379 2.8738 0.0 0
M  V30 27 C 12.2079 1.5400 0.0 0
M  V30 28 C 12.2079 4.2074 0.0 0
M  V30 29 C 13.7479 1.5400 0.0 0
M  V30 30 C 13.7479 4.2074 0.0 0
M  V30 31 N 14.5179 2.8738 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 2 2 4
M  V30 5 1 2 26
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 31
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 639519-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 639519-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15437167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of intermediate 2. A mixture of intermediate 1 (1.0 g, 2.3
mmol) and 40% methylamine in water (40 mL) was heated to 70°C in a sealed
flask for 5hr. The resulting solution was then concentrated in
rotoevaporator and dried in vacuo to afford intermediate 2 which was used
in next step without further purification. Yield 1.0 g, 99%. 1H NMR (500
MHz, CDCl3): 8.12-8.11 (m, 1H); 7.44 - 7.39 (m, 1H); 7.00 - 6.94 (m, 1H);
6.38 - 6.29 (m, 1H); 3.72 - 3.47 (m, 8H); 3.07 - 3.05 (d, 3H); 1.55 (s,
9H). MS (ESI+): 334 (M+H- Boc) + .
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolyl-, azaindolyl-, and related heterocyclic
sulfonylureidopiperazines for treatment of HIV and AIDS.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kadow, John F.; Regueiro-Ren, Alicia; Xue, Qiufen May
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004000210 A2 2003-12-31

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
3-[4-[(3-Fluorophenyl)methoxy]phenyl]-2-methyl-2-propenoic acid
C17H15FO3
649740-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 4.6201 0.0 0
M  V30 2 C 10.6697 3.8500 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 2.6675 3.8500 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 F 16.0045 3.8500 0.0 0
M  V30 10 C 8.0022 3.8500 0.0 0
M  V30 11 C 6.6686 4.6201 0.0 0
M  V30 12 C 8.0022 2.3100 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 6.6686 1.5400 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 12.0034 4.6201 0.0 0
M  V30 17 C 13.3370 3.8500 0.0 0
M  V30 18 C 12.0034 6.1601 0.0 0
M  V30 19 C 14.6707 4.6201 0.0 0
M  V30 20 C 13.3370 6.9301 0.0 0
M  V30 21 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-[(3-Fluorophenyl)methoxy]phenyl]-N,2-dimethyl-2-propenamide
C18H18FNO2
649740-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0035 5.3901 0.0 0
M  V30 2 C 13.3372 4.6201 0.0 0
M  V30 3 C 14.6708 5.3901 0.0 0
M  V30 4 C 13.3372 3.0801 0.0 0
M  V30 5 N 16.0045 4.6201 0.0 0
M  V30 6 O 14.6708 6.9302 0.0 0
M  V30 7 C 17.3383 5.3901 0.0 0
M  V30 8 O 6.6687 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 F 0.0000 3.0801 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 9.3360 5.3901 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 9.3360 2.3101 0.0 0
M  V30 16 C 8.0023 3.0801 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 2.6675 3.0801 0.0 0
M  V30 19 C 4.0012 0.7700 0.0 0
M  V30 20 C 1.3338 2.3101 0.0 0
M  V30 21 C 2.6675 0.0000 0.0 0
M  V30 22 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 17
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 649740-32-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 649740-33-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1774724
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cinnamide derivatives useful as selective MAO-B inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jolidon, Synese; Rodriguez, Sarmiento Rosa Maria; Thomas, Andrew William;
Wostl, Wolfgang; Wyler, Rene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004007429 A1 2004-01-22

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(E)-(Methylimino)methyl]phenol
C8H9NO
107910-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107910-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22952429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[[5-(chlorosulfonyl)-1,2-benzisoxazol-3-yl]carbonyl]amin...
C20H16ClN3O6S
668970-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2638 6.6685 0.0 0
M  V30 2 N 6.7238 6.6685 0.0 0
M  V30 3 O 9.0338 5.3348 0.0 0
M  V30 4 S 14.3191 6.5781 0.0 0 VAL=6
M  V30 5 Cl 15.4635 5.5477 0.0 0
M  V30 6 O 13.2885 5.4337 0.0 0
M  V30 7 O 15.3495 7.7227 0.0 0
M  V30 8 C 3.6437 6.6685 0.0 0
M  V30 9 O 2.1037 6.6685 0.0 0
M  V30 10 O 4.4137 8.0022 0.0 0
M  V30 11 C 1.3337 8.0022 0.0 0
M  V30 12 C 2.6673 8.7722 0.0 0
M  V30 13 C 0.5637 9.3360 0.0 0
M  V30 14 C 0.0000 7.2322 0.0 0
M  V30 15 C 3.6437 1.3337 0.0 0
M  V30 16 N 2.8737 0.0000 0.0 0
M  V30 17 C 10.5654 8.1633 0.0 0
M  V30 18 C 9.0338 8.0022 0.0 0
M  V30 19 C 10.8856 9.6696 0.0 0
M  V30 20 C 11.7100 7.1327 0.0 0
M  V30 21 N 8.4075 9.4091 0.0 0
M  V30 22 O 9.5519 10.4396 0.0 0
M  V30 23 C 12.3503 10.1454 0.0 0
M  V30 24 C 13.1745 7.6087 0.0 0
M  V30 25 C 13.4947 9.1150 0.0 0
M  V30 26 C 5.9538 5.3348 0.0 0
M  V30 27 C 4.4137 5.3348 0.0 0
M  V30 28 C 6.7238 4.0012 0.0 0
M  V30 29 C 3.6437 4.0012 0.0 0
M  V30 30 C 5.9538 2.6673 0.0 0
M  V30 31 C 4.4137 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 27
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 3 15 16
M  V30 17 1 15 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-cyano-2-[[[5-[(methylamino)sulfonyl]-1,2-benzisoxazol-3-y...
C21H20N4O6S
668970-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2638 6.6685 0.0 0
M  V30 2 N 6.7238 6.6685 0.0 0
M  V30 3 O 9.0338 5.3348 0.0 0
M  V30 4 S 14.3189 6.5781 0.0 0 VAL=6
M  V30 5 N 15.4635 5.5477 0.0 0
M  V30 6 O 15.3495 7.7227 0.0 0
M  V30 7 O 13.2885 5.4337 0.0 0
M  V30 8 C 16.9281 6.0235 0.0 0
M  V30 9 C 3.6437 6.6685 0.0 0
M  V30 10 O 2.1037 6.6685 0.0 0
M  V30 11 O 4.4137 8.0022 0.0 0
M  V30 12 C 1.3337 8.0022 0.0 0
M  V30 13 C 2.6673 8.7722 0.0 0
M  V30 14 C 0.5637 9.3360 0.0 0
M  V30 15 C 0.0000 7.2322 0.0 0
M  V30 16 C 3.6437 1.3337 0.0 0
M  V30 17 N 2.8737 0.0000 0.0 0
M  V30 18 C 10.5654 8.1633 0.0 0
M  V30 19 C 9.0338 8.0022 0.0 0
M  V30 20 C 10.8856 9.6696 0.0 0
M  V30 21 C 11.7098 7.1327 0.0 0
M  V30 22 N 8.4074 9.4091 0.0 0
M  V30 23 O 9.5519 10.4396 0.0 0
M  V30 24 C 12.3503 10.1454 0.0 0
M  V30 25 C 13.1745 7.6087 0.0 0
M  V30 26 C 13.4947 9.1150 0.0 0
M  V30 27 C 5.9538 5.3348 0.0 0
M  V30 28 C 4.4137 5.3348 0.0 0
M  V30 29 C 6.7238 4.0012 0.0 0
M  V30 30 C 3.6437 4.0012 0.0 0
M  V30 31 C 5.9538 2.6673 0.0 0
M  V30 32 C 4.4137 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 25
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 28
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 3 16 17
M  V30 18 1 16 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 668970-32-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 668970-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9517569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Benzyl
2-({[5-(chlorosulfonyl)-1,2-benzisoxazol-3-yl]carbonyl}amino)-5-cyanobenzoate
(410 mg, 0.83 mmol) was dissolved in dry CH2Cl2 (10 mL) and treated with
pyrrolidine (0.145 mL, 1.74 mmol, Aldrich) resulting in a cream colored
precipitate. After 15 minutes, the reaction mixture was diluted to 200 mL
with CH2Cl2 and washed 2x with 1.0 M HCl and 1x with brine (175 mL each).
The golden organic solution was dried over Na2SO4 and filtered.
Evaporation of the solvent followed by drying under high vacuum.
tert-Butyl 5-cyano-2-[{(5-[(methylamino)sulfonyl]-1,2-benzisoxazol-3-yl}
carbonyl)amino]benzoate Prepared from methylamine and tert-butyl
2-({[5-(chlorosulfonyl)-1,2-benzisoxazol-3-yl]carbonyl}amino)-5-cyanobenzoate
in 99% yield according to the general procedure except that CH2Cl2 was
replaced by THF as the solvent. Product was used without purification due
to very poor solubility in organic solvents. 1H NMR (DMSO-d6) δ ppm 1.60
(s, 9 H) 2.44 (d, J=4.98 Hz, 3 H) 7.75 (q, J=4.98 Hz, 1 H) 8.16 (m, 3 H)
8.41 (d, J=2.07 Hz, 1 H) 8.61 (d, J=1.04 Hz, 1 H) 8.76 (d, J=8.92 Hz, 1
H) 12.46 (s, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of antibacterial benzoic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thorarensen, Atli; Ruble, Craig J.; Fisher, Jed F.; Romero, Donna L.;
Beauchamp, Thomas J.; Northuis, Jill M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004018428 A1 2004-03-04

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
2-Amino-5-methoxybenzoic acid
C8H9NO3
6705-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-methoxy-N-methylbenzamide
C9H12N2O2
104775-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6705-03-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104775-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7439450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-nitro-1H-pyrazole-1-acetate
C6H7N3O4
6715-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 C 7.5415 1.8517 0.0 0
M  V30 3 O 8.8752 2.6218 0.0 0
M  V30 4 O 7.5415 0.3117 0.0 0
M  V30 5 C 10.2089 1.8517 0.0 0
M  V30 6 N 0.9051 1.4946 0.0 0 VAL=5
M  V30 7 O 0.2787 2.9014 0.0 0
M  V30 8 O 0.0000 0.2487 0.0 0
M  V30 9 N 4.8741 1.8517 0.0 0
M  V30 10 C 3.4672 2.4781 0.0 0
M  V30 11 N 4.7131 0.3202 0.0 0
M  V30 12 C 2.4368 1.3337 0.0 0
M  V30 13 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitro-1H-pyrazole-1-acetamide
C6H8N4O3
1339619-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 C 7.5415 1.8517 0.0 0
M  V30 3 N 8.8752 2.6218 0.0 0
M  V30 4 O 7.5415 0.3117 0.0 0
M  V30 5 C 10.2089 1.8517 0.0 0
M  V30 6 N 0.9051 1.4946 0.0 0 VAL=5
M  V30 7 O 0.2787 2.9014 0.0 0
M  V30 8 O 0.0000 0.2487 0.0 0
M  V30 9 N 4.8741 1.8517 0.0 0
M  V30 10 C 3.4672 2.4781 0.0 0
M  V30 11 N 4.7131 0.3202 0.0 0
M  V30 12 C 2.4368 1.3337 0.0 0
M  V30 13 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6715-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1339619-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10804205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: A solution of methyl 2-(4-nitro-1H-pyrazol-1-yl)acetate (150 g,
0.81 mol) and methylamine in ethanol (2 L) was heated to reflux and
stirred overnight. The reaction mixture was then allowed to cool and
filtered. The filter cake was washed with EtOAc (800 mL) and dried in
vacuum to give product. N-methyl-2-(4-nitro-1H-pyrazol-1-yl)acetamide as
a light yellow solid (148 g, 99%). 1H NMR (400 MHz, d6-DMSO): δ 8.82 (s,
1H), 8.24 (s, 1H), 8.15 (d, J=4.4 Hz, 1H), 4.85 (s, 2H), 2.61 (d, J=4.4
Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl pyrimidine analogues as Jak inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Freeman, Jay; Reader, Valerie; Addison, Glynn; Ramsden, Nigel; Scanlon,
Jane Elizabeth; Harrison, Richard John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013014162 A1 2013-01-31

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-cyclopentyl-9-methyl-9H-purin-6-amine
C11H14BrN5
671820-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 3.0012 0.0 0
M  V30 2 C 0.0000 3.0608 0.0 0
M  V30 3 Br 1.3626 0.0000 0.0 0
M  V30 4 C 3.9845 3.0012 0.0 0
M  V30 5 C 2.6509 3.7712 0.0 0
M  V30 6 C 5.3182 3.7712 0.0 0
M  V30 7 N 3.6644 1.4948 0.0 0
M  V30 8 N 1.5063 2.7406 0.0 0
M  V30 9 N 2.6509 5.3113 0.0 0
M  V30 10 N 5.3182 5.3113 0.0 0
M  V30 11 C 2.1326 1.3338 0.0 0
M  V30 12 C 3.9845 6.0813 0.0 0
M  V30 13 C 7.9857 3.7712 0.0 0
M  V30 14 C 9.3925 3.1447 0.0 0
M  V30 15 C 8.1466 5.3028 0.0 0
M  V30 16 C 10.4229 4.2893 0.0 0
M  V30 17 C 9.6529 5.6230 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-Cyclopentyl-N8,9-dimethyl-9H-purine-6,8-diamine
C12H18N6
674289-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 4.3349 0.0 0
M  V30 2 C 0.0000 4.3945 0.0 0
M  V30 3 N 1.3626 1.3338 0.0 0
M  V30 4 C 2.1326 0.0000 0.0 0
M  V30 5 C 3.9845 4.3349 0.0 0
M  V30 6 C 2.6509 5.1049 0.0 0
M  V30 7 C 5.3182 5.1049 0.0 0
M  V30 8 N 3.6644 2.8284 0.0 0
M  V30 9 N 1.5063 4.0743 0.0 0
M  V30 10 N 2.6509 6.6449 0.0 0
M  V30 11 N 5.3182 6.6449 0.0 0
M  V30 12 C 2.1326 2.6675 0.0 0
M  V30 13 C 3.9845 7.4150 0.0 0
M  V30 14 C 7.9857 5.1049 0.0 0
M  V30 15 C 9.3925 4.4784 0.0 0
M  V30 16 C 8.1466 6.6365 0.0 0
M  V30 17 C 10.4229 5.6230 0.0 0
M  V30 18 C 9.6529 6.9566 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 14
M  V30 3 1 2 9
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 671820-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 674289-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11716638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of disubstituted
N6-cyclopentyladenine analogues the search for a neutral antagonist with
high affinity for the adenosine A1 receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Ligt, Rianne A. F.; van der Klein, Pieter A. M.; von Frijtag Drabbe
Kunzel, Jacobien K.; Lorenzen, Anna; Ait El Maate, Fatna; Fujikawa,
Shelly; van Westhoven, Rosemarijn; van den Hoven, Thijs; Brussee,
Johannes; IJzerman, Ad P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(1), 139-149

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
5-(Hydroxymethyl)furfural
C6H6O3
67-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 O 7.5415 1.8517 0.0 0
M  V30 3 C 0.9052 1.4946 0.0 0
M  V30 4 O 0.0000 0.2487 0.0 0
M  V30 5 C 4.8742 1.8517 0.0 0
M  V30 6 O 3.4672 2.4782 0.0 0
M  V30 7 C 4.7131 0.3202 0.0 0
M  V30 8 C 2.4368 1.3337 0.0 0
M  V30 9 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Methylamino)methyl]-2-furanmethanol
C7H11NO2
66357-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 N 7.5415 1.8517 0.0 0
M  V30 3 C 8.8752 2.6218 0.0 0
M  V30 4 C 0.9052 1.4946 0.0 0
M  V30 5 O 0.0000 0.2487 0.0 0
M  V30 6 C 4.8742 1.8517 0.0 0
M  V30 7 O 3.4672 2.4782 0.0 0
M  V30 8 C 4.7131 0.3202 0.0 0
M  V30 9 C 2.4368 1.3337 0.0 0
M  V30 10 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 67-47-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66357-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40172244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic synthesis of amino-esters as precursors of ammonium
salt-based surfactants from 5-hydroxymethylfurfural (HMF)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moriana Herraiz, Carlos; Arias, Karen S.; Climent, Maria J.; Iborra,
Sara; Corma, Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2024), 26(16), 9118-9131

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl vinylphosphonate
C6H13O3P
682-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 2.3100 0.0 0 VAL=5
M  V30 2 O 2.3100 2.3100 0.0 0
M  V30 3 O 5.3900 2.3100 0.0 0
M  V30 4 C 3.8500 0.7700 0.0 0
M  V30 5 O 3.8500 3.8500 0.0 0
M  V30 6 C 1.5400 3.6436 0.0 0
M  V30 7 C 6.1600 3.6436 0.0 0
M  V30 8 C 2.5164 0.0000 0.0 0
M  V30 9 C 0.0000 3.6436 0.0 0
M  V30 10 C 7.7000 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[2-(methylamino)ethyl]phosphonate
C7H18NO3P
67264-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 2 C 4.7710 5.3348 0.0 0
M  V30 3 O 3.2310 2.6675 0.0 0
M  V30 4 O 2.6673 4.7712 0.0 0
M  V30 5 O 5.3348 3.2311 0.0 0
M  V30 6 C 6.3111 5.3348 0.0 0
M  V30 7 C 4.0010 1.3338 0.0 0
M  V30 8 C 1.3337 4.0012 0.0 0
M  V30 9 N 7.0811 6.6687 0.0 0
M  V30 10 C 3.2310 0.0000 0.0 0
M  V30 11 C 0.0000 4.7712 0.0 0
M  V30 12 C 8.6211 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 682-30-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67264-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-23599484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical
compositions containing them and their uses as pro-apoptotic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davidson, James Edward Paul; Novak, Tibor; Paczal, Attila; Kotschy,
Andras; Starck, Jerome-Benoit; Murray, James Brooke; Bedford, Simon;
Chanrion, Maia; Colland, Frederic; Desos, Patrice; Dodsworth, Mark
Philip; Dunkel, Petra; Herner, Andras; Madarasz, Zoltan; Maragno, Ana
Leticia; Molnar, Mark; Nyerges, Miklos; Parsons, Rachel Jane; Rudasova,
Monika; Strofek, Agnes; Szigeti, Marianna; Timari, Matyas Pal; Webb, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021018857 A1 2021-02-04

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-methylbenzoic acid
C8H7BrO2
68837-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2-dimethylbenzamide
C9H10BrNO
893420-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68837-59-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3757448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of isochromanone based urotensin II receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lehmann, Fredrik; Currier, Erika A.; Olsson, Roger; Ma, Jian-Nong;
Burstein, Ethan S.; Hacksell, Uli; Luthman, Kristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(13), 4844-4854

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[4-(Acetyloxy)-2-buten-1-yl]-2-bromo-6-(1-hydroxypentyl)-5-methoxy-1,4-naph...
C22H25BrO6
693784-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 6.1601 0.0 0
M  V30 2 C 0.0000 6.9302 0.0 0
M  V30 3 O 0.0000 8.4702 0.0 0
M  V30 4 C 4.0010 4.6201 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 O 5.3348 3.8501 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 O 5.3348 11.5503 0.0 0
M  V30 11 C 6.6685 6.1601 0.0 0
M  V30 12 C 8.0022 6.9302 0.0 0
M  V30 13 C 9.3358 6.1601 0.0 0
M  V30 14 C 10.6697 6.9302 0.0 0
M  V30 15 O 12.0033 6.1601 0.0 0
M  V30 16 C 13.3370 6.9302 0.0 0
M  V30 17 C 14.6707 6.1601 0.0 0
M  V30 18 O 13.3370 8.4702 0.0 0
M  V30 19 Br 2.6673 13.0903 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 4.0010 9.2402 0.0 0
M  V30 23 C 1.3337 9.2402 0.0 0
M  V30 24 C 4.0010 6.1601 0.0 0
M  V30 25 C 5.3348 8.4702 0.0 0
M  V30 26 C 4.0010 10.7802 0.0 0
M  V30 27 C 1.3337 10.7802 0.0 0
M  V30 28 C 5.3348 6.9302 0.0 0
M  V30 29 C 2.6673 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 2 3 23
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 26
M  V30 11 1 11 12
M  V30 12 1 11 28
M  V30 13 2 12 13 CFG=2
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 29
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 2 24 28
M  V30 28 1 25 28
M  V30 29 1 26 29
M  V30 30 2 27 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[4-(Acetyloxy)-2-buten-1-yl]-6-(1-hydroxypentyl)-5-methoxy-2-(methylamino)-...
C23H29NO6
693784-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 O 1.5400 6.6684 0.0 0
M  V30 4 O 4.6200 12.0031 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.1600 4.0009 0.0 0
M  V30 7 O 8.4700 5.3347 0.0 0
M  V30 8 C 6.9300 2.6673 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 C 8.4700 8.0020 0.0 0
M  V30 12 C 9.2400 9.3358 0.0 0
M  V30 13 C 10.7800 9.3358 0.0 0
M  V30 14 C 11.5500 10.6694 0.0 0
M  V30 15 O 13.0900 10.6694 0.0 0
M  V30 16 C 13.8600 12.0031 0.0 0
M  V30 17 C 15.4000 12.0031 0.0 0
M  V30 18 O 13.0900 13.3367 0.0 0
M  V30 19 N 1.5400 12.0031 0.0 0
M  V30 20 C 0.0000 12.0031 0.0 0
M  V30 21 C 3.8500 8.0020 0.0 0
M  V30 22 C 4.6200 9.3358 0.0 0
M  V30 23 C 4.6200 6.6684 0.0 0
M  V30 24 C 2.3100 8.0020 0.0 0
M  V30 25 C 6.1600 9.3358 0.0 0
M  V30 26 C 3.8500 10.6694 0.0 0
M  V30 27 C 6.1600 6.6684 0.0 0
M  V30 28 C 1.5400 9.3358 0.0 0
M  V30 29 C 6.9300 8.0020 0.0 0
M  V30 30 C 2.3100 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 2 3 24
M  V30 4 2 4 26
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 2 12 13 CFG=2
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 20
M  V30 20 1 19 30
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 21 24
M  V30 24 2 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 1 25 29
M  V30 29 1 26 30
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 693784-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693784-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-13585146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (±)-pyranonaphthoquinone derivatives, a Cdc25A phosphatase
inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shimbashi, Akiko; Ishikawa, Yuichi; Nishiyama, Shigeru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(5), 939-941

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-[(1R)-3-chloro-1-phenylpropoxy]benzene
C15H14BrClO
696613-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 2 O 4.6201 5.3348 0.0 0
M  V30 3 C 4.6201 2.6675 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 Cl 4.6201 0.0000 0.0 0
M  V30 6 Br 3.0801 8.0023 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 C 7.7002 2.6675 0.0 0
M  V30 9 C 7.7002 5.3348 0.0 0
M  V30 10 C 9.2402 2.6675 0.0 0
M  V30 11 C 9.2402 5.3348 0.0 0
M  V30 12 C 10.0102 4.0012 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 2.3101 6.6687 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 0.7700 6.6687 0.0 0
M  V30 17 C 0.7700 4.0012 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(2-Bromophenoxy)-N-methylbenzenepropanamine
C16H18BrNO
696612-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 O 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 Br 3.0801 9.3360 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 7.7002 4.0012 0.0 0
M  V30 10 C 7.7002 6.6685 0.0 0
M  V30 11 C 9.2402 4.0012 0.0 0
M  V30 12 C 9.2402 6.6685 0.0 0
M  V30 13 C 10.0102 5.3348 0.0 0
M  V30 14 C 3.0801 6.6685 0.0 0
M  V30 15 C 2.3101 8.0023 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 8.0023 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696613-06-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 696612-95-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13818395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Embodiment 4. Synthesis of
(R)-(-)-N-Methyl-3-(2-bromophenoxy)-3-phenylpropanamine (MBPP). Compound
1-B (1.31 g, 4.02 mmole) was dissolved in an aqueous solution of ethanol
(40 ml) and methylamine (80 ml), and heated to reflux for 30 h. After
cooling, the solution was extracted with chloroform (100 ml, twice), and
an organic layer was decanted. The organic layer was dried over anhydrous
sodium sulfate, and dried by evaporation under vacuum. product as oil
(1.28 g, 99.2%). The chemical structure of the oil product was analysed
through 1H and 13C NMR spectra-MS, and the data was as follows. 1H and
13C NMR spectra: 1H NMR (CDCl3) δ 7.49 (dd, J = 7.8 and 1.5 Hz, 1H, Ph),
7.29 (m, 5H, Ph), 7.03 (td, J = 7.8 and 1.2 Hz, 1H, Ph), 6.72 (m, 2H,
Ph), 5.31 (dd, J = 8.1 and 4.5 Hz, 1H, H3), 2.81 (m, 2H, H2), 2.43 (s,
3H, CH3), 2.22 (m, 1H, H1), 2.07 (m, 1H, H1), 1.64 (s, 1H, NH). 13C NMR
(CDCl3) δ 154.24, 141.07, 133.19, 128.61, 128.10, 127.64, 125.75, 121.71,
114.99, 112.55 (Ph), 79.66 (CH), 48.31 and 38.53 (CH2CH3N), 36.46 (CH3).
MS: m/z is 321 and 319 (M+), 240 (M+-Br).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for preparation of
N-methyl-3-(2-tributylstannylphenoxy)-3-phenylpropanamine, and use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Show-Wen; Lin, Cheng-Hsien; Lin, Tsyh-Lang; Hsu, Cheng-Fang; Chang,
Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110313183 A1 2011-12-22

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4R,6S,6aS)-4-(6-Chloro-9H-purin-9-yl)-3a,5,6,6a-tetrahydro-3-phenyl-...
C17H14ClN5O2
696613-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0117 7.2335 0.0 0
M  V30 2 Cl 10.1276 7.9443 0.0 0
M  V30 3 C 3.0128 4.6118 0.0 0 CFG=2
M  V30 4 C 3.7828 5.9455 0.0 0 CFG=1
M  V30 5 C 3.1737 3.0801 0.0 0
M  V30 6 C 1.5063 4.9320 0.0 0 CFG=1
M  V30 7 C 2.7522 7.0899 0.0 0
M  V30 8 N 1.7669 2.4537 0.0 0
M  V30 9 C 1.3454 6.4635 0.0 0 CFG=2
M  V30 10 O 0.7363 3.5983 0.0 0
M  V30 11 N 5.3143 6.1064 0.0 0
M  V30 12 C 6.0844 7.4401 0.0 0
M  V30 13 C 6.3448 4.9620 0.0 0
M  V30 14 C 7.5907 7.1199 0.0 0
M  V30 15 N 5.6085 8.9048 0.0 0
M  V30 16 N 7.7518 5.5883 0.0 0
M  V30 17 C 8.6213 8.2644 0.0 0
M  V30 18 C 6.6389 10.0493 0.0 0
M  V30 19 N 8.1454 9.7290 0.0 0
M  V30 20 C 4.5074 2.3101 0.0 0
M  V30 21 C 4.5074 0.7700 0.0 0
M  V30 22 C 5.8412 3.0801 0.0 0
M  V30 23 C 5.8412 0.0000 0.0 0
M  V30 24 C 7.1749 2.3101 0.0 0
M  V30 25 C 7.1749 0.7700 0.0 0
M  V30 26 H 4.5191 4.2916 0.0 0
M  V30 27 H 0.0000 5.2521 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 26 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 11 CFG=3
M  V30 9 2 5 8
M  V30 10 1 5 20
M  V30 11 1 6 9
M  V30 12 1 6 10
M  V30 13 1 6 27 CFG=3
M  V30 14 1 7 9
M  V30 15 1 8 10
M  V30 16 1 11 12
M  V30 17 1 11 13
M  V30 18 1 12 14
M  V30 19 2 12 15
M  V30 20 2 13 16
M  V30 21 1 14 16
M  V30 22 2 14 17
M  V30 23 1 15 18
M  V30 24 1 17 19
M  V30 25 2 18 19
M  V30 26 2 20 21
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 2 22 24
M  V30 30 2 23 25
M  V30 31 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 6 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4R,6S,6aS)-3a,5,6,6a-Tetrahydro-4-[6-(methylamino)-9H-purin-9-yl]-3-...
C18H18N6O2
696614-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.1901 9.1791 0.0 0
M  V30 2 N 10.3059 4.7366 0.0 0
M  V30 3 C 11.7706 5.2125 0.0 0
M  V30 4 C 2.4782 5.4081 0.0 0 CFG=2
M  V30 5 C 3.8118 6.1781 0.0 0 CFG=1
M  V30 6 C 1.8517 4.0011 0.0 0
M  V30 7 C 1.3336 6.4385 0.0 0 CFG=1
M  V30 8 C 3.4917 7.6843 0.0 0
M  V30 9 N 0.3202 4.1620 0.0 0
M  V30 10 C 1.9601 7.8453 0.0 0 CFG=2
M  V30 11 O 0.0000 5.6685 0.0 0
M  V30 12 N 5.2188 5.5516 0.0 0
M  V30 13 C 6.5524 6.3216 0.0 0
M  V30 14 C 5.5390 4.0453 0.0 0
M  V30 15 C 7.6968 5.2912 0.0 0
M  V30 16 N 6.8726 7.8280 0.0 0
M  V30 17 N 7.0705 3.8842 0.0 0
M  V30 18 C 9.1615 5.7670 0.0 0
M  V30 19 C 8.3372 8.3039 0.0 0
M  V30 20 N 9.4817 7.2735 0.0 0
M  V30 21 C 2.6217 2.6675 0.0 0
M  V30 22 C 1.8517 1.3338 0.0 0
M  V30 23 C 4.1617 2.6675 0.0 0
M  V30 24 C 2.6217 0.0000 0.0 0
M  V30 25 C 4.9317 1.3338 0.0 0
M  V30 26 C 4.1617 0.0000 0.0 0
M  V30 27 H 3.6226 4.3775 0.0 0
M  V30 28 H 0.1893 7.4689 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 27 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 12 CFG=3
M  V30 10 2 6 9
M  V30 11 1 6 21
M  V30 12 1 7 10
M  V30 13 1 7 11
M  V30 14 1 7 28 CFG=3
M  V30 15 1 8 10
M  V30 16 1 9 11
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 17
M  V30 23 2 15 18
M  V30 24 1 16 19
M  V30 25 1 18 20
M  V30 26 2 19 20
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696613-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 696614-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-523298
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From cyclopentadiene to isoxazoline-carbocyclic nucleosides: a rapid
access to biological molecules through nitrosocarbonyl chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadrelli, Paolo; Scrocchi, Roberto; Caramella, Pierluigi; Rescifina,
Antonio; Piperno, Anna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(16), 3643-3651

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-(methylphenylamino)benzenepropanoate
C18H21NO3
70044-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 N 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 O 7.7000 6.6685 0.0 0
M  V30 8 O 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 10.0100 8.0021 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 7.7000 1.3336 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 6.9300 0.0000 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-N-methyl-β-(methylphenylamino)benzenepropanamide
C17H20N2O2
1018836-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70044-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4466361
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenoxyacetyl chloride
C8H7ClO2
701-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 Cl 6.6685 0.0000 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenoxyacetamide
C9H11NO2
15422-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 701-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15422-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-23778744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intensified Continuous Flow Synthesis and Workup of 1,5-Disubstituted
Tetrazoles Enhanced by Real-Time Process Analytics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sagmeister, Peter; Kaldre, Dainis; Sedelmeier, Joerg; Moessner,
Christian; Puentener, Kurt; Kummli, Dominique; Williams, Jason D.; Kappe,
C. Oliver
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2021), 25(5), 1206-1214

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl hydrogen N-[(1,1-dimethylethoxy)carbonyl]-L-glutamate
C11H19NO6
72086-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 O 2.3100 2.6674 0.0 0
M  V30 9 O 8.4700 5.3347 0.0 0
M  V30 10 O 6.1600 6.6685 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 O 2.3100 8.0021 0.0 0
M  V30 15 O 0.0000 6.6685 0.0 0
M  V30 16 C 10.5736 5.8985 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0
M  V30 18 C 7.9064 7.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N2-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-L-glutamine methyl ester
C12H22N2O5
1418206-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 4.0011 0.0 0 CFG=2
M  V30 2 N 4.4137 4.0011 0.0 0
M  V30 3 C 6.7237 5.3348 0.0 0
M  V30 4 C 6.7237 2.6675 0.0 0
M  V30 5 C 3.6437 5.3348 0.0 0
M  V30 6 C 8.2637 5.3348 0.0 0
M  V30 7 O 5.9537 1.3337 0.0 0
M  V30 8 O 8.2637 2.6675 0.0 0
M  V30 9 O 2.1037 5.3348 0.0 0
M  V30 10 O 4.4137 6.6686 0.0 0
M  V30 11 C 9.0337 6.6686 0.0 0
M  V30 12 C 6.7237 0.0000 0.0 0
M  V30 13 C 1.3337 6.6686 0.0 0
M  V30 14 N 10.5738 6.6686 0.0 0
M  V30 15 O 8.2637 8.0022 0.0 0
M  V30 16 C 0.0000 5.8986 0.0 0
M  V30 17 C 0.5636 8.0022 0.0 0
M  V30 18 C 2.6673 7.4386 0.0 0
M  V30 19 C 11.3438 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72086-72-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1418206-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13784066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods of promoting neuron growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murray, Thomas F.; Gerwick, William H.; Pereira-Badilla, Alban R.; Kale,
Andrew; Byrum, Tara; Debonsi, Hosana; Moore, Bradley S.; Gilson, Michael
Kenneth; Fenley, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013009923 A1 2013-01-17

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,3-benzodioxole-4-carboxaldehyde
C8H5BrO3
72744-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 1.6672 0.0 0
M  V30 2 O 6.4792 2.4373 0.0 0
M  V30 3 Br 5.1456 4.7473 0.0 0
M  V30 4 C 2.4781 1.6672 0.0 0
M  V30 5 C 1.1444 2.4373 0.0 0
M  V30 6 C 3.8119 2.4373 0.0 0
M  V30 7 O 2.1579 0.1609 0.0 0
M  V30 8 C 1.1444 3.9773 0.0 0
M  V30 9 O 0.0000 1.4068 0.0 0
M  V30 10 C 3.8119 3.9773 0.0 0
M  V30 11 C 0.6263 0.0000 0.0 0
M  V30 12 C 2.4781 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(5-Bromo-1,3-benzodioxol-4-yl)methylene]methanamine
C9H8BrNO2
1207666-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 1.6672 0.0 0
M  V30 2 N 6.4792 2.4373 0.0 0
M  V30 3 C 7.8129 1.6672 0.0 0
M  V30 4 Br 5.1456 4.7473 0.0 0
M  V30 5 C 2.4781 1.6672 0.0 0
M  V30 6 C 3.8119 2.4373 0.0 0
M  V30 7 C 1.1444 2.4373 0.0 0
M  V30 8 O 2.1579 0.1609 0.0 0
M  V30 9 C 3.8119 3.9773 0.0 0
M  V30 10 C 1.1444 3.9773 0.0 0
M  V30 11 O 0.0000 1.4068 0.0 0
M  V30 12 C 0.6263 0.0000 0.0 0
M  V30 13 C 2.4781 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72744-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1207666-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1926698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting-Group-Free Total Synthesis of Isoquinoline Alkaloids by
Nickel-Catalyzed Annulation of o-Halobenzaldimine with an Alkyne as the
Key Step
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Korivi, Rajendra Prasad; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2010), 16(1), 282-287, S282/1-S282/30

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,4-dimethyl-β-oxobenzenepropanoate
C13H16O3
72835-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(3,4-dimethylphenyl)-3-(methylamino)-2-propenoate
C14H19NO2
2614438-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 N 5.3348 6.1601 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 O 8.0022 6.1601 0.0 0
M  V30 8 C 10.6697 4.6201 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 2.6673 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72835-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23326862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 6-chloro-, methyl ester
C7H6ClNO2
73781-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 N 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 73781-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19077076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and discovery of thioether and nicotinamide containing sorafenib
analogs as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Shaofeng; He, Zuopeng; Huang, Mindong; Wang, Ningning; He,
Zongzhong; Kong, Xiangkai; Yao, Jianwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(9), 2381-2391

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxylic acid, 6-chloro-, methyl ester
C7H6ClNO2
73781-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 N 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 73781-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14369774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of thiourea and
nicotinamide-containing sorafenib analogs as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kong, Xiangkai; Yao, Zeyu; He, Zuopeng; Xu, Wenfang; Yao, Jianwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2015), 6(5), 867-870

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2,5-difluoro-3-nitrobenzene
C6H2BrF2NO2
741721-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0 VAL=5
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 F 2.6674 6.1600 0.0 0
M  V30 5 Br 0.0000 4.6200 0.0 0
M  V30 6 F 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-fluoro-N-methyl-6-nitrobenzenamine
C7H6BrFN2O2
1845693-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 4 O 0.7700 1.3338 0.0 0
M  V30 5 O 3.0800 0.0000 0.0 0
M  V30 6 Br 2.3100 6.6685 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 741721-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1845693-81-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl N-(6-hydroxyhexyl)carbamate
C11H23NO3
75937-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 15 O 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[6-(methylamino)hexyl]carbamate
C12H26N2O2
1013915-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 6.6687 1.5400 0.0 0
M  V30 4 O 2.6675 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 0.5638 2.8737 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 2.1038 0.2064 0.0 0
M  V30 12 C 10.6698 2.3101 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 13.3372 2.3101 0.0 0
M  V30 15 N 14.6708 1.5400 0.0 0
M  V30 16 C 16.0046 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75937-12-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013915-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31348011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 87413-09-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Probenecid compounds for the treatment of inflammasome-mediated lung
disease and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murphy, Chris; Farquhar, Ronald; Dolle, Roland E.; Navia, Manuel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022005881 A1 2022-01-06

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(5-Fluoro-2-nitrophenyl)-1,3-dioxolane
C9H8FNO4
773102-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.4374 1.5400 0.0 0 VAL=5
M  V30 2 O 2.4374 0.0000 0.0 0
M  V30 3 O 1.1037 2.3100 0.0 0
M  V30 4 F 7.7722 4.6201 0.0 0
M  V30 5 C 3.7710 3.8500 0.0 0
M  V30 6 C 3.7710 2.3100 0.0 0
M  V30 7 C 5.1047 4.6201 0.0 0
M  V30 8 C 5.1047 1.5400 0.0 0
M  V30 9 C 6.4385 3.8500 0.0 0
M  V30 10 C 6.4385 2.3100 0.0 0
M  V30 11 C 2.4374 4.6201 0.0 0
M  V30 12 O 1.0304 3.9936 0.0 0
M  V30 13 O 2.2765 6.1516 0.0 0
M  V30 14 C 0.0000 5.1381 0.0 0
M  V30 15 C 0.7700 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,3-Dioxolan-2-yl)-N-methyl-4-nitrobenzenamine
C10H12N2O4
1852521-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.4374 1.5400 0.0 0 VAL=5
M  V30 2 O 2.4374 0.0000 0.0 0
M  V30 3 O 1.1036 2.3100 0.0 0
M  V30 4 N 7.7722 4.6201 0.0 0
M  V30 5 C 9.1058 3.8501 0.0 0
M  V30 6 C 3.7711 3.8501 0.0 0
M  V30 7 C 3.7711 2.3100 0.0 0
M  V30 8 C 5.1047 4.6201 0.0 0
M  V30 9 C 5.1047 1.5400 0.0 0
M  V30 10 C 6.4385 3.8501 0.0 0
M  V30 11 C 6.4385 2.3100 0.0 0
M  V30 12 C 2.4374 4.6201 0.0 0
M  V30 13 O 2.2763 6.1516 0.0 0
M  V30 14 O 1.0304 3.9936 0.0 0
M  V30 15 C 0.7700 6.4718 0.0 0
M  V30 16 C 0.0000 5.1381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 773102-64-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1852521-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8570583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Radiolabeling method to prepared fluorinated compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wynn, Duncan George; Fairway, Steven Michael; Glaser, Matthias Eberhard;
Newington, Ian; Smith, Gareth Edwin; Khan, Imtiaz Ahmed; Grigg, Julian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016000798 A1 2016-01-07

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6,8,9-Hexahydro-12-nitro-1,4,7,10-benzotetraoxacyclododecin
C12H15NO6
78554-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3359 2.3100 0.0 0 VAL=5
M  V30 2 O 9.3359 0.7700 0.0 0
M  V30 3 O 10.6695 3.0800 0.0 0
M  V30 4 C 5.3348 3.0800 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 6.6684 2.3100 0.0 0
M  V30 7 O 4.0011 2.3100 0.0 0
M  V30 8 C 6.6684 5.3901 0.0 0
M  V30 9 O 4.0011 5.3901 0.0 0
M  V30 10 C 8.0022 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 O 1.3337 0.7700 0.0 0
M  V30 17 O 0.0000 4.6201 0.0 0
M  V30 18 C 1.3337 2.3100 0.0 0
M  V30 19 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-[2-(Methylamino)-5-nitrophenoxy]ethoxy]ethoxy]ethanol
C13H20N2O6
194923-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 9.2400 6.6684 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 11.5500 8.0021 0.0 0
M  V30 7 O 13.0900 8.0021 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 15.4000 9.3358 0.0 0
M  V30 10 O 16.1700 10.6694 0.0 0
M  V30 11 N 4.6200 1.3336 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 N 1.5400 6.6684 0.0 0 VAL=5
M  V30 14 O 0.0000 6.6684 0.0 0
M  V30 15 O 2.3100 8.0021 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 20
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78554-67-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10681473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Podands 2a-c; General Procedure A mixture of 4'-nitrobenzocrown ether
1a-c (4 mmol) and a 35% solution of MeNH2 in anhyd EtOH (50 mL) was
heated in a sealed tube at 100 °C for 48 h (water bath). The tube was
then opened, the mixture was concentrated in vacuo, and the residue was
purified by column chromatography on silica gel. The products were eluted
successively with a benzene-EtOAc mixture (1:1), EtOAc, and an EtOAc-EtOH
mixture (5:1) for 2a, successively with EtOAc and an EtOAc-MeOH mixture
(5: 1) for 2b, or successively with EtOAc and an EtOAc-EtOH mixture (5:1)
for 2c. Podands 2a-c were isolated as yellow oils in excellent yields
(Tables 1, 2). 2a, yellow oil, yield 99%. Rf: 0.65; IR (KBr) (cm-1): 3415
(NH, OH), 1493 (NO2); Molecular Formula: C13H20N2O6; HRMS m/z Calcd:
300.1321; Found: 300.1333; 1H NMR (CDCl3, 500 MHz, 25 °C) δ 2.95 (m, 4 H,
CH3N, OH), 3.65 (m, 2 H, CH2O), 3.73 (m, 6 H, 2 CH2O, CH2OH), 3.89 (m, 2
H, CH2CH2OAr), 4.23 (m, 2 H, CH2OAr), 5.74 (br m, 1 H, NH), 6.46 (d, 1 H,
J = 8.9, H-3), 7.62 (d, 1 H, J = 2.1, H-6), 7.93 (dd, 1 H, J = 8.9, 2.1,
H-4); 13C NMR (CDCl3, 125 MHz, 25 °C) δ 29.54 (q, J = 136.7, CH3N), 61.80
(t, J = 142.8, CH2OH), 67.94 (t, J = 144.3, CH2OAr), 69.34 (t, J = 142.0,
CH2CH2OAr), 70.19 (t, J = 140.3, CH2O), 70.64 (t, J = 141.2, CH2O), 72.40
(t, J = 140.8, CH2O), 106.08 (dd, J = 163.0, 4.9, C-6), 106.29 (dd, J =
161.6, 5.8, C-3), 120.53 (dd, J = 166.8, 4.3, C-4), 136.47 (C- 5),
144.11, 145.80 (C-1, C-2); MS m/z (%): 300 (M+, 100), 168 (84), 167 (34),
133 (33), 121 (32), 89 (93).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel ring transformation of nitrobenzocrown ethers as a route to
nitrobenzoazacrown compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, Sergei P.; Dmitrieva, Svetlana N.; Churakova, Marina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2003), (4), 593-597

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
2-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-fluoro-4-pentenoic acid
C10H16FNO4
795310-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 F 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [3-fluoro-1-[(methylamino)carbonyl]-3-butenyl]-, 1,1-dimethyle...
C11H19FN2O3
795310-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 O 6.9300 6.6685 0.0 0
M  V30 11 O 6.9300 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 F 4.6200 0.0000 0.0 0
M  V30 14 C 8.4700 6.6685 0.0 0
M  V30 15 C 8.4700 5.1285 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 8.4700 8.2085 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 795310-36-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 795310-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15276933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane). tert-Butyl
1-(methylcarbamoyl)-3-fluorobut-3-enylcarbamate (3f) [Boc-Fap-NHMe].
Following GP-III, from Boc-Fap-OH 2f (474 mg, 2.03 mmol), title compound
3f was isolated as an oil which was crystallized from CH2Cl2/pentane
(1:1) in a freezer (493 mg, > 99 %): mp 112-113°C (CH2Cl2/pentane); NMR
shows carbamate dynamics resulted in 13C and 19F NMR signal broadening;
δH (300.14 MHz, CDCl3): 1.44 (3×s, 9 H), 2.50-2.76 (2×m, 2 H), 2.81 (d, 3
H, 3JHH = 4.8 Hz), 4.37 (dd, 1 H, 3JHF = 49.6 Hz, 2JHH = 2.9 Hz), 4.35
(dd, 1 H, 3JHH = 7.2 Hz, 3JHH = 7.6 Hz), 4.63 (dd, 1 H, 3JHF = 17.1 Hz,
2JHH = 2.9 Hz), 5.33 (d, 1 H, 3JHH = 8.4 Hz), 6.60 (bs, 1 H); δC (75.48
MHz, CDCl3, major/minor): 26.13 (q), 28.18/28.24 (2×3×q), 35.23 (ddd,
2JCF = 27.3 Hz), 51.99 (d), 80.30 (s), 93.08 (ddd, 2JCF = 18.8 Hz),
155.50 (s), 162.41 (d, 1JCF = 255.8 Hz), 171.31 (s); δF (282.37 MHz,
CDCl3): For major rotamer: -96.06 (m, 1 F); For minor rotamer: -96.62 (m,
1 F); MS-ES, m/z: 247 [M+H], 269 [M+Na]; MS-EI, m/z (%): 246 (4) [M], 231
(1) [M-CH3], 213 (1) [M-(CH2+HF)], 190 (13) [M-57], 188 (23) [M-58], 187
(5) [M-59], 173 (12) [M-74], 145 (1) [190-CO2] or [173-CO], 132 (21)
[188-57], 110 (2), 88 (54) [188-(77+CO2)], 74 (4) [C4H10O], 58 (15)
[C2H4NO], 57 (100) [C4H9]; ES-EM for [C11H19FN2O3+Na]: Calcd, 269.1272;
Found, 269.1263. Anal. Calcd for C11H19FN2O3: C, 53.65; H, 7.78; N,
11.37. Found: C, 53.67; H, 7.64; N, 11.37.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-3-(methoxymethyl)-2-naphthalenecarboxal...
C23H24O6
79606-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 O 5.3347 0.7700 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 8.0020 0.7700 0.0 0
M  V30 5 O 9.3358 0.0000 0.0 0
M  V30 6 O 9.3358 9.2400 0.0 0
M  V30 7 C 10.6694 10.0100 0.0 0
M  V30 8 O 1.3336 4.6200 0.0 0
M  V30 9 C 0.0000 5.3900 0.0 0
M  V30 10 O 12.0031 7.7000 0.0 0
M  V30 11 C 13.3367 6.9300 0.0 0
M  V30 12 O 1.3336 7.7000 0.0 0
M  V30 13 C 1.3336 9.2400 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 8.0020 5.3900 0.0 0
M  V30 16 C 6.6684 3.0800 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 18 C 8.0020 6.9300 0.0 0
M  V30 19 C 8.0020 2.3100 0.0 0
M  V30 20 C 9.3358 3.0800 0.0 0
M  V30 21 C 10.6694 5.3900 0.0 0
M  V30 22 C 9.3358 7.7000 0.0 0
M  V30 23 C 10.6694 6.9300 0.0 0
M  V30 24 C 5.3347 5.3900 0.0 0
M  V30 25 C 4.0009 4.6200 0.0 0
M  V30 26 C 5.3347 6.9300 0.0 0
M  V30 27 C 2.6673 5.3900 0.0 0
M  V30 28 C 4.0009 7.7000 0.0 0
M  V30 29 C 2.6673 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 19
M  V30 6 1 6 7
M  V30 7 1 6 22
M  V30 8 1 8 9
M  V30 9 1 8 27
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 1 12 13
M  V30 13 1 12 29
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 24
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-3-(methoxymethyl)-N-methyl-2-naphthalen...
C24H29NO5
741292-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0020 3.8500 0.0 0
M  V30 2 O 8.0020 2.3100 0.0 0
M  V30 3 C 9.3358 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 N 4.0009 1.5400 0.0 0
M  V30 6 C 4.0009 0.0000 0.0 0
M  V30 7 O 4.0009 10.7800 0.0 0
M  V30 8 C 2.6673 11.5500 0.0 0
M  V30 9 O 12.0031 6.1600 0.0 0
M  V30 10 C 13.3367 6.9300 0.0 0
M  V30 11 O 1.3336 9.2400 0.0 0
M  V30 12 C 0.0000 8.4700 0.0 0
M  V30 13 O 12.0031 9.2400 0.0 0
M  V30 14 C 12.0031 10.7800 0.0 0
M  V30 15 C 6.6684 6.1600 0.0 0
M  V30 16 C 5.3347 6.9300 0.0 0
M  V30 17 C 6.6684 4.6200 0.0 0
M  V30 18 C 4.0009 6.1600 0.0 0
M  V30 19 C 5.3347 8.4700 0.0 0
M  V30 20 C 5.3347 3.8500 0.0 0
M  V30 21 C 4.0009 4.6200 0.0 0
M  V30 22 C 2.6673 6.9300 0.0 0
M  V30 23 C 4.0009 9.2400 0.0 0
M  V30 24 C 2.6673 8.4700 0.0 0
M  V30 25 C 8.0020 6.9300 0.0 0
M  V30 26 C 9.3358 6.1600 0.0 0
M  V30 27 C 8.0020 8.4700 0.0 0
M  V30 28 C 10.6694 6.9300 0.0 0
M  V30 29 C 9.3358 9.2400 0.0 0
M  V30 30 C 10.6694 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 23
M  V30 9 1 9 10
M  V30 10 1 9 28
M  V30 11 1 11 12
M  V30 12 1 11 24
M  V30 13 1 13 14
M  V30 14 1 13 30
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 21
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79606-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 741292-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9659921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and anti-HIV activities of retrojusticidin B analogs and
azalignans
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sagar, Kadali S.; Chang, Chia-Chuan; Wang, Wei-Kung; Lin, Jung-Yaw; Lee,
Shoei-Sheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(15), 4045-4054

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenepropanal
C9H9BrO
80793-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 Br 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenepropanamine
C10H14BrN
886763-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 N 9.2401 4.0010 0.0 0
M  V30 5 C 10.7801 4.0010 0.0 0
M  V30 6 Br 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80793-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886763-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19797645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Radical-mediated direct C-H amination of arenes with secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cosgrove, Sebastian C.; Plane, John M. C.; Marsden, Stephen P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2018), 9(32), 6647-6652

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-oxo-1,3-benzodioxole-5-propanoate
C12H12O5
81581-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7046 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 9.0382 1.5400 0.0 0
M  V30 5 O 10.3720 2.3100 0.0 0
M  V30 6 O 9.0382 0.0000 0.0 0
M  V30 7 C 11.7057 1.5400 0.0 0
M  V30 8 C 13.0394 2.3100 0.0 0
M  V30 9 C 2.3698 2.3100 0.0 0
M  V30 10 C 2.3698 3.8501 0.0 0
M  V30 11 C 3.7034 1.5400 0.0 0
M  V30 12 O 0.9052 1.8342 0.0 0
M  V30 13 C 3.7034 4.6201 0.0 0
M  V30 14 O 0.9052 4.3259 0.0 0
M  V30 15 C 5.0373 2.3100 0.0 0
M  V30 16 C 0.0000 3.0800 0.0 0
M  V30 17 C 5.0373 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(1,3-benzodioxol-5-yl)-3-(methylamino)-2-propenoate
C13H15NO4
2614438-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 4.7473 0.0 0
M  V30 2 C 6.4794 3.9773 0.0 0
M  V30 3 N 5.1456 6.2873 0.0 0
M  V30 4 C 7.8131 4.7473 0.0 0
M  V30 5 C 3.8119 7.0574 0.0 0
M  V30 6 O 9.1467 3.9773 0.0 0
M  V30 7 O 7.8131 6.2873 0.0 0
M  V30 8 C 10.4804 4.7473 0.0 0
M  V30 9 C 11.8142 3.9773 0.0 0
M  V30 10 C 2.4782 1.6672 0.0 0
M  V30 11 C 1.1446 2.4373 0.0 0
M  V30 12 C 3.8119 2.4373 0.0 0
M  V30 13 O 2.1580 0.1609 0.0 0
M  V30 14 C 1.1446 3.9773 0.0 0
M  V30 15 O 0.0000 1.4068 0.0 0
M  V30 16 C 3.8119 3.9773 0.0 0
M  V30 17 C 0.6265 0.0000 0.0 0
M  V30 18 C 2.4782 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81581-27-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23323932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
2-Amino-3-fluorobenzoic acid
C7H6FNO2
825-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-fluoro-N-methylbenzamide
C8H9FN2O
1017789-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 825-22-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017789-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11985588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (4-nitrobenzoyl)acetate
C11H11NO5
838-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 O 10.6697 3.8501 0.0 0
M  V30 6 O 9.3360 6.1601 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 4.0010 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-(4-nitrophenyl)-2-propenoate
C12H14N2O4
2614438-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 N 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 5.3348 6.9302 0.0 0
M  V30 6 O 10.6697 3.8501 0.0 0
M  V30 7 O 9.3360 6.1601 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 O 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 4.0010 1.5400 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 838-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23325882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-9-(phenylmethyl)-9H-purine
C12H9ClN4
84003-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 3.7710 0.0 0
M  V30 2 Cl 0.0000 3.8614 0.0 0
M  V30 3 C 3.7534 2.2764 0.0 0
M  V30 4 N 5.2850 2.4374 0.0 0
M  V30 5 C 3.4333 0.7700 0.0 0
M  V30 6 N 2.6091 3.3068 0.0 0
M  V30 7 C 5.9114 1.0306 0.0 0
M  V30 8 N 4.7669 0.0000 0.0 0
M  V30 9 C 1.9686 0.2941 0.0 0
M  V30 10 C 1.1444 2.8310 0.0 0
M  V30 11 N 0.8242 1.3247 0.0 0
M  V30 12 C 7.5950 3.7710 0.0 0
M  V30 13 C 8.3650 2.4374 0.0 0
M  V30 14 C 8.3650 5.1048 0.0 0
M  V30 15 C 9.9050 2.4374 0.0 0
M  V30 16 C 9.9050 5.1048 0.0 0
M  V30 17 C 10.6750 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9-(phenylmethyl)-9H-purin-2-amine
C13H13N5
1107661-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 N 10.6751 3.8614 0.0 0
M  V30 3 C 12.1398 3.3855 0.0 0
M  V30 4 C 6.9217 2.2764 0.0 0
M  V30 5 N 5.3900 2.4374 0.0 0
M  V30 6 C 7.2418 0.7700 0.0 0
M  V30 7 N 8.0661 3.3068 0.0 0
M  V30 8 C 4.7637 1.0306 0.0 0
M  V30 9 C 8.7064 0.2941 0.0 0
M  V30 10 N 5.9081 0.0000 0.0 0
M  V30 11 C 9.5308 2.8310 0.0 0
M  V30 12 N 9.8509 1.3247 0.0 0
M  V30 13 C 3.0800 3.7710 0.0 0
M  V30 14 C 2.3100 2.4374 0.0 0
M  V30 15 C 2.3100 5.1048 0.0 0
M  V30 16 C 0.7700 2.4374 0.0 0
M  V30 17 C 0.7700 5.1048 0.0 0
M  V30 18 C 0.0000 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84003-57-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1107661-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15506455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 9-Benzyl-N-methyl-9H-purin-2-amine (5b; modified from the
literature10,11). To a 350 mL glass-walled pressure vessel was added
9-benzyl-2-chloropurine (0.084 g, 0.34 mmol), 40% aqueous methylamine
(0.90 mL, 10 mmol), and absolute ethanol (10 mL). The mixture was heated
to 105 °C for 16 h, then cooled and filtered through a plug of silica gel
using 2% methanol in dichloromethane as the eluent. After evaporation of
the solvent, 5b was obtained as a white solid (0.081 g, 99%):. m.p.
181-183.5 °C; 1H NMR (methanol-d4, 300 MHz): δ 2.90 (s, 3H), 5.28 (s,
2H), 7.28 (m, 5H), 7.98 (s, 1H), 8.47 (s, 1H); 13 C NMR (CDCl3, 300 MHz):
δ 28.84, 46.49, 127.18, 127.87, 128.26, 128.93, 135.71, 141.47, 149.61,
153.30, 160.44; HRMS calcd for C13H13N5 [M+ H]+: 240.1241, found:
240.1244.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Photophysical Behavior, and Electronic Structure of Push-Pull
Purines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Butler, Roslyn S.; Cohn, Pamela; Tenzel, Phillip; Abboud, Khalil A.;
Castellano, Ronald K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2009), 131(2), 623-633

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6E)-2,3-Anhydro-6,7,8,9-tetradeoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-8...
C19H30N2O5
847779-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1663 5.4513 0.0 0
M  V30 2 N 9.5000 6.2213 0.0 0
M  V30 3 O 8.1663 3.9113 0.0 0
M  V30 4 C 4.4628 4.0739 0.0 0
M  V30 5 C 3.9361 2.6269 0.0 0
M  V30 6 C 4.9260 1.4471 0.0 0
M  V30 7 C 4.3993 0.0000 0.0 0
M  V30 8 C 6.4426 1.7146 0.0 0
M  V30 9 C 0.4987 7.8509 0.0 0
M  V30 10 C 0.0000 5.8511 0.0 0
M  V30 11 O 11.8765 7.8415 0.0 0
M  V30 12 C 5.2927 6.2213 0.0 0 CFG=1
M  V30 13 C 6.8327 6.2213 0.0 0 CFG=1
M  V30 14 O 6.0627 7.5549 0.0 0
M  V30 15 C 3.8455 6.7480 0.0 0 CFG=1
M  V30 16 C 3.4729 5.2537 0.0 0 CFG=1
M  V30 17 O 2.5395 7.5640 0.0 0
M  V30 18 O 1.9367 5.1462 0.0 0
M  V30 19 C 1.3598 6.5741 0.0 0
M  V30 20 C 10.8336 5.4513 0.0 0 CFG=1
M  V30 21 C 12.1061 6.3188 0.0 0
M  V30 22 C 10.7186 3.9156 0.0 0
M  V30 23 N 13.5776 5.8648 0.0 0
M  V30 24 C 11.8474 2.8681 0.0 0
M  V30 25 C 14.1403 4.4314 0.0 0
M  V30 26 C 13.3703 3.0976 0.0 0
M  V30 27 H 5.0252 4.7047 0.0 0
M  V30 28 H 4.5205 8.1321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 20 2 CFG=3
M  V30 5 2 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 19
M  V30 11 1 10 19
M  V30 12 2 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 27
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 28 CFG=1
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 15 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6E)-2,6,7,8,9-Pentadeoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-8-methyl-2-...
C20H35N3O5
847779-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2766 5.9716 0.0 0 CFG=1
M  V30 2 C 6.6102 6.7416 0.0 0 CFG=1
M  V30 3 O 5.2766 4.4316 0.0 0
M  V30 4 C 7.9439 5.9716 0.0 0
M  V30 5 N 6.6102 8.2816 0.0 0
M  V30 6 N 9.2777 6.7416 0.0 0
M  V30 7 O 7.9439 4.4316 0.0 0
M  V30 8 C 7.9439 9.0516 0.0 0
M  V30 9 C 4.0864 4.0011 0.0 0
M  V30 10 C 3.3164 2.6673 0.0 0
M  V30 11 C 4.0864 1.3337 0.0 0
M  V30 12 C 3.3164 0.0000 0.0 0
M  V30 13 C 5.6265 1.3337 0.0 0
M  V30 14 C 0.8384 8.4090 0.0 0
M  V30 15 C 0.0000 6.5261 0.0 0
M  V30 16 O 11.6542 8.3620 0.0 0
M  V30 17 C 3.9429 6.7416 0.0 0 CFG=1
M  V30 18 C 3.3164 5.3348 0.0 0 CFG=1
M  V30 19 O 2.7984 7.7722 0.0 0
M  V30 20 O 1.7849 5.4957 0.0 0
M  V30 21 C 1.4647 7.0021 0.0 0
M  V30 22 C 10.6113 5.9716 0.0 0 CFG=1
M  V30 23 C 11.8837 6.8391 0.0 0
M  V30 24 C 10.4963 4.4359 0.0 0
M  V30 25 N 13.3553 6.3852 0.0 0
M  V30 26 C 11.6251 3.3883 0.0 0
M  V30 27 C 13.9181 4.9516 0.0 0
M  V30 28 C 13.1480 3.6180 0.0 0
M  V30 29 H 4.8481 7.9875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 22 6 CFG=3
M  V30 10 2 9 10
M  V30 11 1 18 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 21
M  V30 16 1 15 21
M  V30 17 2 16 23
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 29 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 2 17 18 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847779-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847779-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-12580439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A diversity-oriented synthetic approach to bengamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sarabia, Francisco; Sanchez-Ruiz, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2005), 46(7), 1131-1135

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-galacto-Non-6-enonamide, 2,3-anhydro-6,7,8,9-tetradeoxy-N-[(3S)-hexahydro-2...
C19H30N2O5
847779-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1663 5.4513 0.0 0
M  V30 2 N 9.5000 6.2213 0.0 0
M  V30 3 O 8.1663 3.9113 0.0 0
M  V30 4 C 4.4628 4.0739 0.0 0
M  V30 5 C 3.9361 2.6269 0.0 0
M  V30 6 C 4.9260 1.4471 0.0 0
M  V30 7 C 4.3993 0.0000 0.0 0
M  V30 8 C 6.4426 1.7146 0.0 0
M  V30 9 C 0.4987 7.8509 0.0 0
M  V30 10 C 0.0000 5.8511 0.0 0
M  V30 11 O 11.8765 7.8415 0.0 0
M  V30 12 C 5.2927 6.2213 0.0 0 CFG=2
M  V30 13 C 6.8327 6.2213 0.0 0 CFG=2
M  V30 14 O 6.0627 7.5549 0.0 0
M  V30 15 C 3.8455 6.7480 0.0 0 CFG=1
M  V30 16 C 3.4729 5.2537 0.0 0 CFG=1
M  V30 17 O 2.5395 7.5640 0.0 0
M  V30 18 O 1.9367 5.1462 0.0 0
M  V30 19 C 1.3598 6.5741 0.0 0
M  V30 20 C 10.8336 5.4513 0.0 0 CFG=1
M  V30 21 C 12.1061 6.3188 0.0 0
M  V30 22 C 10.7186 3.9156 0.0 0
M  V30 23 N 13.5776 5.8648 0.0 0
M  V30 24 C 11.8474 2.8681 0.0 0
M  V30 25 C 14.1403 4.4314 0.0 0
M  V30 26 C 13.3703 3.0976 0.0 0
M  V30 27 H 5.0252 4.7047 0.0 0
M  V30 28 H 4.5205 8.1321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 20 2 CFG=3
M  V30 5 2 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 19
M  V30 11 1 10 19
M  V30 12 2 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 27
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 28 CFG=1
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 15 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6E)-2,6,7,8,9-Pentadeoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-8-methyl-2-...
C20H35N3O5
847779-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2766 5.9716 0.0 0 CFG=2
M  V30 2 C 6.6102 6.7416 0.0 0 CFG=2
M  V30 3 O 5.2766 4.4316 0.0 0
M  V30 4 C 7.9439 5.9716 0.0 0
M  V30 5 N 6.6102 8.2816 0.0 0
M  V30 6 N 9.2777 6.7416 0.0 0
M  V30 7 O 7.9439 4.4316 0.0 0
M  V30 8 C 7.9439 9.0516 0.0 0
M  V30 9 C 4.0864 4.0011 0.0 0
M  V30 10 C 3.3164 2.6673 0.0 0
M  V30 11 C 4.0864 1.3337 0.0 0
M  V30 12 C 3.3164 0.0000 0.0 0
M  V30 13 C 5.6265 1.3337 0.0 0
M  V30 14 C 0.8384 8.4090 0.0 0
M  V30 15 C 0.0000 6.5261 0.0 0
M  V30 16 O 11.6542 8.3620 0.0 0
M  V30 17 C 3.9429 6.7416 0.0 0 CFG=1
M  V30 18 C 3.3164 5.3348 0.0 0 CFG=1
M  V30 19 O 2.7984 7.7722 0.0 0
M  V30 20 O 1.7849 5.4957 0.0 0
M  V30 21 C 1.4647 7.0021 0.0 0
M  V30 22 C 10.6113 5.9716 0.0 0 CFG=1
M  V30 23 C 11.8837 6.8391 0.0 0
M  V30 24 C 10.4963 4.4359 0.0 0
M  V30 25 N 13.3553 6.3852 0.0 0
M  V30 26 C 11.6251 3.3883 0.0 0
M  V30 27 C 13.9181 4.9516 0.0 0
M  V30 28 C 13.1480 3.6180 0.0 0
M  V30 29 H 4.8481 7.9875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 22 6 CFG=3
M  V30 10 2 9 10
M  V30 11 1 18 9 CFG=1
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 21
M  V30 16 1 15 21
M  V30 17 2 16 23
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 29 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 2 17 18 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847779-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847779-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-7743484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A diversity-oriented synthetic approach to bengamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sarabia, Francisco; Sanchez-Ruiz, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2005), 46(7), 1131-1135

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Dimethoxyphenyl)amino](methylthio)methylene]-2,2-dimethyl-1,3-dioxan...
C16H19NO6S
849217-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 5.3348 0.0 0
M  V30 2 N 6.5698 4.0012 0.0 0
M  V30 3 S 6.5698 6.6687 0.0 0
M  V30 4 C 5.7998 8.0023 0.0 0
M  V30 5 O 4.2597 2.6675 0.0 0
M  V30 6 O 4.2597 8.0023 0.0 0
M  V30 7 C 0.0000 6.3248 0.0 0
M  V30 8 C 0.0000 4.3449 0.0 0
M  V30 9 O 11.1899 1.3337 0.0 0
M  V30 10 C 10.4199 0.0000 0.0 0
M  V30 11 O 12.7299 4.0012 0.0 0
M  V30 12 C 13.4999 5.3348 0.0 0
M  V30 13 C 4.2597 5.3348 0.0 0
M  V30 14 C 3.4897 4.0012 0.0 0
M  V30 15 C 3.4897 6.6687 0.0 0
M  V30 16 O 1.9497 4.0012 0.0 0
M  V30 17 O 1.9497 6.6687 0.0 0
M  V30 18 C 1.1797 5.3348 0.0 0
M  V30 19 C 8.1098 4.0012 0.0 0
M  V30 20 C 8.8798 2.6675 0.0 0
M  V30 21 C 8.8798 5.3348 0.0 0
M  V30 22 C 10.4199 2.6675 0.0 0
M  V30 23 C 10.4199 5.3348 0.0 0
M  V30 24 C 11.1899 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 13
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 5 14
M  V30 7 2 6 15
M  V30 8 1 7 18
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(3,4-Dimethoxyphenyl)amino](methylamino)methylene]-2,2-dimethyl-1,3-dioxa...
C16H20N2O6
849217-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 5.3348 0.0 0
M  V30 2 N 6.5698 4.0012 0.0 0
M  V30 3 N 6.5698 6.6687 0.0 0
M  V30 4 C 5.7998 8.0023 0.0 0
M  V30 5 O 4.2597 2.6675 0.0 0
M  V30 6 O 4.2597 8.0023 0.0 0
M  V30 7 C 0.0000 6.3248 0.0 0
M  V30 8 C 0.0000 4.3449 0.0 0
M  V30 9 O 11.1899 1.3337 0.0 0
M  V30 10 C 10.4199 0.0000 0.0 0
M  V30 11 O 12.7299 4.0012 0.0 0
M  V30 12 C 13.4999 5.3348 0.0 0
M  V30 13 C 4.2597 5.3348 0.0 0
M  V30 14 C 3.4897 4.0012 0.0 0
M  V30 15 C 3.4897 6.6687 0.0 0
M  V30 16 O 1.9497 4.0012 0.0 0
M  V30 17 O 1.9497 6.6687 0.0 0
M  V30 18 C 1.1797 5.3348 0.0 0
M  V30 19 C 8.1098 4.0012 0.0 0
M  V30 20 C 8.8798 2.6675 0.0 0
M  V30 21 C 8.8798 5.3348 0.0 0
M  V30 22 C 10.4199 2.6675 0.0 0
M  V30 23 C 10.4199 5.3348 0.0 0
M  V30 24 C 11.1899 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 13
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 5 14
M  V30 7 2 6 15
M  V30 8 1 7 18
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849217-86-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 849217-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14416476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-94-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide. A
mixture of
5-[(3,4-dimethoxy-phenylamino)-methylsulfanyl-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione
(0.50 g, 1.4 mmol), methylamine (2 M in THF, 0.75 mL 1.5 mmol), HgCl2
(0.38 g, 1.4 mmol) in THF (5 mL) was stirred at room temperature for 30
minutes. The mixture was extracted with DCM and water (3X) and dried with
Na2SO4. Concentration in vacuo afforded
5-[(3,4-dimethoxy-phenylamino)-methylamino-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione
as a yellow solid (0.48 g, 99% yield) and this compound was used without
further purification.
5-[(3,4-dimethoxy-phenylamino)-methylamino-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione,
(0.48 g, 99% yield) LCMS: m/z 335 (M-H)-.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolines and quinazolines as inhibitors of c-Met and
other tyrosine kinases and therapeutic uses against proliferative
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bannen, Lynne Canne; Chan, Diva Sze-ming; Chen, Jeff; Dalrymple, Lisa
Esther; Forsyth, Timothy Patrick; Huynh, Tai Phat; Jammalamadaka, Vasu;
Khoury, Richard George; Leahy, James William; Mac, Morrison B.; Mann,
Grace; Mann, Larry W.; Nuss, John M.; Parks, Jason Jevious; Takeuchi,
Craig Stacy; Wang, Yong; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005030140 A2 2005-04-07

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl (βS)-4-(ethoxycarbonyl)-β-[[(9H-fluoren-9-ylmethoxy)carbony...
C28H30N2O6S
853406-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 9.3358 0.0 0
M  V30 2 O 6.7708 9.3358 0.0 0
M  V30 3 C 7.5408 8.0020 0.0 0
M  V30 4 N 9.0808 8.0020 0.0 0
M  V30 5 O 6.7708 6.6684 0.0 0
M  V30 6 C 9.8508 6.6684 0.0 0 CFG=2
M  V30 7 C 9.0808 5.3347 0.0 0
M  V30 8 C 9.8508 4.0011 0.0 0
M  V30 9 O 9.0808 2.6673 0.0 0
M  V30 10 O 11.3908 4.0011 0.0 0
M  V30 11 C 9.8508 1.3336 0.0 0
M  V30 12 C 8.5172 0.5636 0.0 0
M  V30 13 C 10.6208 0.0000 0.0 0
M  V30 14 C 11.1846 2.1037 0.0 0
M  V30 15 C 15.0066 8.3436 0.0 0
M  V30 16 O 16.4134 7.7173 0.0 0
M  V30 17 O 14.8457 9.8751 0.0 0
M  V30 18 C 17.6594 8.6224 0.0 0
M  V30 19 C 19.0662 7.9960 0.0 0
M  V30 20 C 4.4608 10.6695 0.0 0
M  V30 21 C 5.0873 12.0763 0.0 0
M  V30 22 C 2.9292 10.8304 0.0 0
M  V30 23 C 3.9427 13.1069 0.0 0
M  V30 24 C 6.5518 12.5521 0.0 0
M  V30 25 C 2.6091 12.3368 0.0 0
M  V30 26 C 1.7849 9.8000 0.0 0
M  V30 27 C 4.2629 14.6131 0.0 0
M  V30 28 C 6.8720 14.0586 0.0 0
M  V30 29 C 1.1444 12.8127 0.0 0
M  V30 30 C 0.3202 10.2759 0.0 0
M  V30 31 C 5.7276 15.0890 0.0 0
M  V30 32 C 0.0000 11.7821 0.0 0
M  V30 33 C 11.3908 6.6684 0.0 0
M  V30 34 N 12.2960 7.9143 0.0 0
M  V30 35 S 12.2960 5.4225 0.0 0
M  V30 36 C 13.7607 7.4384 0.0 0
M  V30 37 C 13.7607 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 36
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 25
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 2 25 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 2 30 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-(methylamino)-3-o...
C25H25N3O5S
1994385-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 8.0020 0.0 0
M  V30 2 O 6.7708 8.0020 0.0 0
M  V30 3 C 7.5408 6.6684 0.0 0
M  V30 4 N 9.0808 6.6684 0.0 0
M  V30 5 O 6.7708 5.3347 0.0 0
M  V30 6 C 9.8508 5.3347 0.0 0 CFG=2
M  V30 7 C 9.0808 4.0011 0.0 0
M  V30 8 C 9.8508 2.6673 0.0 0
M  V30 9 N 9.0808 1.3336 0.0 0
M  V30 10 O 11.3908 2.6673 0.0 0
M  V30 11 C 9.8508 0.0000 0.0 0
M  V30 12 C 15.0066 7.0100 0.0 0
M  V30 13 O 16.4134 6.3835 0.0 0
M  V30 14 O 14.8457 8.5415 0.0 0
M  V30 15 C 17.6594 7.2887 0.0 0
M  V30 16 C 19.0662 6.6624 0.0 0
M  V30 17 C 4.4608 9.3358 0.0 0
M  V30 18 C 5.0873 10.7426 0.0 0
M  V30 19 C 2.9292 9.4968 0.0 0
M  V30 20 C 3.9427 11.7731 0.0 0
M  V30 21 C 6.5518 11.2185 0.0 0
M  V30 22 C 2.6091 11.0030 0.0 0
M  V30 23 C 1.7849 8.4663 0.0 0
M  V30 24 C 4.2629 13.2795 0.0 0
M  V30 25 C 6.8720 12.7249 0.0 0
M  V30 26 C 1.1444 11.4791 0.0 0
M  V30 27 C 0.3202 8.9422 0.0 0
M  V30 28 C 5.7276 13.7553 0.0 0
M  V30 29 C 0.0000 10.4485 0.0 0
M  V30 30 C 11.3908 5.3347 0.0 0
M  V30 31 N 12.2960 6.5806 0.0 0
M  V30 32 S 12.2960 4.0889 0.0 0
M  V30 33 C 13.7607 6.1047 0.0 0
M  V30 34 C 13.7607 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 30
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 33
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 22
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 1 24 28
M  V30 30 2 25 28
M  V30 31 1 26 29
M  V30 32 2 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 853406-89-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1994385-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16264154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6485-79-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (reagen, stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Pyridine Synthase Recognition Sequences Allows a
Modular Solid-Phase Route to Thiopeptide Variants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wever, Walter J.; Bogart, Jonathan W.; Bowers, Albert A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2016), 138(41), 13461-13464

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(trifluoromethyl)benzaldehyde
C8H4BrF3O
861928-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 F 0.9764 2.1038 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 3.6436 0.5638 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 O 0.0000 5.3349 0.0 0
M  V30 7 Br 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-(trifluoromethyl)benzenemethanamine
C9H9BrF3N
1702083-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3338 0.0 0
M  V30 2 F 2.5164 2.1038 0.0 0
M  V30 3 F 3.0800 0.0000 0.0 0
M  V30 4 F 5.1836 0.5638 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 1.5400 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 Br 8.4700 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 861928-27-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1702083-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Diethyl 2,5-dibromo-α1,α4-bis(ethoxycarbonyl)-3,6-dioxo-1,4-cyclohexadien...
C20H22Br2O10
862191-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 7.7000 0.0 0
M  V30 2 C 4.0011 6.9300 0.0 0
M  V30 3 C 5.3347 9.2400 0.0 0
M  V30 4 O 2.6674 7.7000 0.0 0
M  V30 5 O 4.0011 5.3900 0.0 0
M  V30 6 O 4.0011 10.0100 0.0 0
M  V30 7 O 6.6685 10.0100 0.0 0
M  V30 8 C 1.3338 6.9300 0.0 0
M  V30 9 C 4.0011 11.5500 0.0 0
M  V30 10 C 0.0000 7.7000 0.0 0
M  V30 11 C 2.6674 12.3200 0.0 0
M  V30 12 Br 5.3347 4.6200 0.0 0
M  V30 13 O 8.0021 9.2400 0.0 0
M  V30 14 O 8.0021 3.0800 0.0 0
M  V30 15 Br 10.6696 7.7000 0.0 0
M  V30 16 C 10.6696 4.6200 0.0 0
M  V30 17 C 10.6696 3.0800 0.0 0
M  V30 18 C 12.0032 5.3900 0.0 0
M  V30 19 O 12.0032 2.3100 0.0 0
M  V30 20 O 9.3358 2.3100 0.0 0
M  V30 21 O 13.3369 4.6200 0.0 0
M  V30 22 O 12.0032 6.9300 0.0 0
M  V30 23 C 12.0032 0.7700 0.0 0
M  V30 24 C 14.6705 5.3900 0.0 0
M  V30 25 C 13.3369 0.0000 0.0 0
M  V30 26 C 16.0043 4.6200 0.0 0
M  V30 27 C 6.6685 6.9300 0.0 0
M  V30 28 C 6.6685 5.3900 0.0 0
M  V30 29 C 8.0021 7.7000 0.0 0
M  V30 30 C 8.0021 4.6200 0.0 0
M  V30 31 C 9.3358 6.9300 0.0 0
M  V30 32 C 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 12 28
M  V30 13 2 13 29
M  V30 14 2 14 30
M  V30 15 1 15 31
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 32
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Diethyl 1,2,3,4,5,6,7,8-octahydro-1,5-dimethyl-2,4,6,8-tetraoxobenzo[1,2-...
C18H18N2O8
1104854-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.3817 0.0 0
M  V30 2 O 2.6675 5.1517 0.0 0
M  V30 3 O 4.0012 2.8417 0.0 0
M  V30 4 C 1.3337 4.3817 0.0 0
M  V30 5 C 0.0000 5.1517 0.0 0
M  V30 6 O 6.1871 1.9163 0.0 0
M  V30 7 O 10.3091 6.4942 0.0 0
M  V30 8 C 7.6286 8.4104 0.0 0
M  V30 9 O 4.3514 7.7139 0.0 0
M  V30 10 C 8.8677 0.0000 0.0 0
M  V30 11 C 12.4951 4.0287 0.0 0
M  V30 12 O 13.8287 3.2587 0.0 0
M  V30 13 O 12.4951 5.5688 0.0 0
M  V30 14 C 15.1626 4.0287 0.0 0
M  V30 15 C 16.4962 3.2587 0.0 0
M  V30 16 O 12.1449 0.6966 0.0 0
M  V30 17 C 6.7418 4.5254 0.0 0
M  V30 18 C 7.7722 5.6699 0.0 0
M  V30 19 C 5.3348 5.1517 0.0 0
M  V30 20 C 7.2177 3.0608 0.0 0
M  V30 21 C 9.2785 5.3496 0.0 0
M  V30 22 N 7.0022 7.0036 0.0 0
M  V30 23 C 5.4958 6.6834 0.0 0
M  V30 24 C 8.7240 2.7405 0.0 0
M  V30 25 C 9.7544 3.8850 0.0 0
M  V30 26 N 9.4940 1.4068 0.0 0
M  V30 27 C 11.1614 3.2587 0.0 0
M  V30 28 C 11.0005 1.7270 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 20
M  V30 7 2 7 21
M  V30 8 1 8 22
M  V30 9 2 9 23
M  V30 10 1 10 26
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 27
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 16 28
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 862191-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1104854-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-760321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of diethyl
octahydrobenzodipyrroletetrone dicarboxylates (XIII) and
tetrahydrobenzodipyrroletetrones (XIV) Reaction of 0.01 mol
tetraethyl-2,5-dibromo-3,6-dioxo-1,4-cyclohexadiene-1,4-dimalonate (XI)
with 0.025 mol of the required primary amines (Scheme 2) was carried out
with an excess (100 mL) of 95 % ethanol. The reaction mixture was then
refluxed for 2 h, concentrated to about a half of its volume. Dark brown
solids of the corresponding diethyl octahydrotetraoxobenzodipyrrole
dicarboxylate derivatives XIIIa-XIIIh were precipitated out, collected,
and recrystallized from aqueous ethanol. The yield was almost
quantitative. The amines used in this reaction included aniline,
p-toluidine, p-anisidine, p-chloroaniline, benzylamine, methylamine,
ethylamine, and ethanolamine. Diethyl
1,2,3,4,5,6,7,8-octahydro-2,4,6,8-tetraoxo-1,5-diphenylbenzo[1,2-b:4,5-b’]-dipyrrole-3,7-dicarboxylate
(XIIIa) Diethyl
1,2,3,4,5,6,7,8-octahydro-2,4,6,8-tetraoxo-1,5-dimethylbenzo[1,2-b:4,5-b’]-dipyrrole-3,7-dicarboxylate
(XIIIf) This product was obtained by refluxing an excess of methylamine
solution (5 mL) with 5.82 g of XI. The substance was obtained as brown
plates from aqueous ethanol. It was of brown color in concentrated H2SO4
but changed to reddish brown on dilution with H2O. Formula: C18H18N2O8; M
r: 390.33; w i(calc.)/%: C 55.38, H 4.64, N 7.17, w i(found)/%: C 55.36,
H 4.90, N 7.01; M.p.: 283°C; M.S.: m/z: 390 (M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new quinoxalinophenazinediones and
tetrahydrobenzodipyrrolotetrones of biological interest
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hammam, Ahmed S.; Youssef, Mohamed S. K.; Atta, Ferial M.; Mohamed, Thana
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Papers (2008), 62(2), 194-206

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethoxybenzaldehyde
C9H10O3
86-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 O 6.6687 2.3101 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,3-Dimethoxyphenyl)methylene]methanamine
C10H13NO2
722495-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 1.3337 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-51-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 722495-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2774369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 3a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
4,6,7,9-Tetrahydro-9,9-dimethyl-4-oxo-3-(phenylmethoxy)pyrimido[2,1-c][1,4]ox...
C17H18N2O5
870562-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.4744 0.0 0
M  V30 2 C 1.7145 2.4845 0.0 0
M  V30 3 O 6.0670 6.6685 0.0 0
M  V30 4 C 6.0670 1.3338 0.0 0
M  V30 5 O 7.6070 1.3338 0.0 0
M  V30 6 O 5.2970 0.0000 0.0 0
M  V30 7 O 7.6070 4.0011 0.0 0
M  V30 8 C 8.3770 5.3347 0.0 0
M  V30 9 C 2.9870 4.0011 0.0 0
M  V30 10 N 3.7570 5.3347 0.0 0
M  V30 11 N 3.7570 2.6674 0.0 0
M  V30 12 C 1.4470 4.0011 0.0 0
M  V30 13 C 5.2970 5.3347 0.0 0
M  V30 14 C 2.9870 6.6685 0.0 0
M  V30 15 C 5.2970 2.6674 0.0 0
M  V30 16 O 0.6770 5.3347 0.0 0
M  V30 17 C 6.0670 4.0011 0.0 0
M  V30 18 C 1.4470 6.6685 0.0 0
M  V30 19 C 9.9170 5.3347 0.0 0
M  V30 20 C 10.6870 4.0011 0.0 0
M  V30 21 C 10.6870 6.6685 0.0 0
M  V30 22 C 12.2270 4.0011 0.0 0
M  V30 23 C 12.2270 6.6685 0.0 0
M  V30 24 C 12.9970 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 12
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6,7,9-Tetrahydro-N,9,9-trimethyl-4-oxo-3-(phenylmethoxy)pyrimido[2,1-c][1,4...
C18H21N3O4
1289648-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.0021 0.0 0
M  V30 2 C 0.0000 4.8080 0.0 0
M  V30 3 C 1.7145 3.8181 0.0 0
M  V30 4 O 7.6070 5.3347 0.0 0
M  V30 5 C 8.3770 6.6685 0.0 0
M  V30 6 C 6.0670 2.6674 0.0 0
M  V30 7 N 5.2970 1.3336 0.0 0
M  V30 8 O 7.6070 2.6674 0.0 0
M  V30 9 C 6.0670 0.0000 0.0 0
M  V30 10 N 3.7570 6.6685 0.0 0
M  V30 11 C 2.9870 5.3347 0.0 0
M  V30 12 C 5.2970 6.6685 0.0 0
M  V30 13 C 2.9870 8.0021 0.0 0
M  V30 14 N 3.7570 4.0011 0.0 0
M  V30 15 C 1.4470 5.3347 0.0 0
M  V30 16 C 6.0670 5.3347 0.0 0
M  V30 17 C 1.4470 8.0021 0.0 0
M  V30 18 C 5.2970 4.0011 0.0 0
M  V30 19 O 0.6770 6.6685 0.0 0
M  V30 20 C 9.9170 6.6685 0.0 0
M  V30 21 C 10.6870 8.0021 0.0 0
M  V30 22 C 10.6870 5.3347 0.0 0
M  V30 23 C 12.2270 8.0021 0.0 0
M  V30 24 C 12.2270 5.3347 0.0 0
M  V30 25 C 12.9970 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 18
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 870562-18-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289648-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22584686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocycle amide isosteres: An approach to overcoming resistance for
HIV-1 integrase strand transfer inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peese, Kevin M.; Narasimhulu Naidu, B.; Patel, Manoj; Li, Chen; Langley,
David R.; Terry, Brian; Protack, Tricia; Gali, Volodymyr; Lin, Zeyu;
Samanta, Himadri K.; Zheng, Ming; Jenkins, Susan; Dicker, Ira B.;
Krystal, Mark R.; Meanwell, Nicholas A.; Walker, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(3), 126784

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
3-Amino-2-methoxy-4-pyridinecarboxylic acid
C7H8N2O3
870997-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 O 1.3337 4.6201 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 N 4.0011 4.6201 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 N 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-2-methoxy-N-methyl-4-pyridinecarboxamide
C8H11N3O2
1087161-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 N 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 870997-81-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1087161-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14115508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-5-methylbenzenesulfonyl chloride
C8H9ClO3S
88040-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0 VAL=6
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 O 0.9764 2.1038 0.0 0
M  V30 4 O 3.6436 0.5638 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N,5-dimethylbenzenesulfonamide
C9H13NO3S
675864-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 5.3348 0.0 0 VAL=6
M  V30 2 N 1.5400 6.6687 0.0 0
M  V30 3 O 0.9764 4.5648 0.0 0
M  V30 4 O 3.6437 6.1048 0.0 0
M  V30 5 C 0.0000 6.6687 0.0 0
M  V30 6 O 5.3901 5.3348 0.0 0
M  V30 7 C 6.9302 5.3348 0.0 0
M  V30 8 C 2.3101 0.0000 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 13 C 3.0801 1.3338 0.0 0
M  V30 14 C 4.6201 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88040-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 675864-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24821760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Aroylsulfonamide-Photofragmentation (ASAP)-A Versatile Route to Biaryls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wessig, Pablo; Krebs, Saskia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(46), 6367-6374

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(2,6-dichlorophenyl)-2-(methylthio)-5-pyrimidinecarboxamide
C12H8Cl3N3OS
880616-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 O 4.6201 5.3348 0.0 0
M  V30 4 Cl 6.9302 6.6687 0.0 0
M  V30 5 S 11.5503 4.0012 0.0 0
M  V30 6 C 12.3203 2.6675 0.0 0
M  V30 7 Cl 3.0801 5.3348 0.0 0
M  V30 8 Cl 3.0801 0.0000 0.0 0
M  V30 9 C 6.9302 4.0012 0.0 0
M  V30 10 C 7.7002 5.3348 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 N 9.2402 5.3348 0.0 0
M  V30 13 N 9.2402 2.6675 0.0 0
M  V30 14 C 10.0102 4.0012 0.0 0
M  V30 15 C 3.0801 2.6675 0.0 0
M  V30 16 C 2.3101 4.0012 0.0 0
M  V30 17 C 2.3101 1.3338 0.0 0
M  V30 18 C 0.7700 4.0012 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 16
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,6-Dichlorophenyl)-4-(methylamino)-2-(methylthio)-5-pyrimidinecarboxamide
C13H12Cl2N4OS
1799561-17-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 N 4.6201 5.3348 0.0 0
M  V30 3 O 4.6201 2.6675 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 7.7002 0.0000 0.0 0
M  V30 6 S 11.5503 4.0012 0.0 0
M  V30 7 C 12.3203 5.3348 0.0 0
M  V30 8 Cl 3.0801 2.6675 0.0 0
M  V30 9 Cl 3.0801 8.0023 0.0 0
M  V30 10 C 6.9302 4.0012 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 C 7.7002 5.3348 0.0 0
M  V30 13 N 9.2402 2.6675 0.0 0
M  V30 14 N 9.2402 5.3348 0.0 0
M  V30 15 C 10.0102 4.0012 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 2.3101 6.6687 0.0 0
M  V30 19 C 0.7700 4.0012 0.0 0
M  V30 20 C 0.7700 6.6687 0.0 0
M  V30 21 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 17
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 880616-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799561-17-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19401562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidopyrimidinones useful as WEE-1 kinase inhibitors
for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hewitt, Peter; Burkamp, Frank; Wilkinson, Andrew; Miel, Hugues; O'Dowd,
Colin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018162932 A1 2018-09-13

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(Phenylmethoxy)-2-quinolinecarboxaldehyde
C17H13NO2
88238-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 10.0100 2.6674 0.0 0
M  V30 4 O 11.5500 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 7.7000 6.6685 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 N 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 6.9300 8.0021 0.0 0
M  V30 11 C 4.6200 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 10.0100 5.3347 0.0 0
M  V30 14 C 5.3900 8.0021 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 3.0800 1.3336 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 C 0.0000 1.3336 0.0 0
M  V30 20 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 15
M  V30 4 2 3 4
M  V30 5 1 3 12
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[8-(Phenylmethoxy)-2-quinolinyl]methylene]methanamine
C18H16N2O
656228-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 10.0100 5.3347 0.0 0
M  V30 4 N 11.5500 5.3347 0.0 0
M  V30 5 C 12.3200 6.6685 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3336 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 N 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3336 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 16
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88238-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 656228-72-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14616953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular sensitization of europium(III) luminescence by
8-benzyloxyquinoline in aqueous solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maffeo, Davide; Williams, J. A. Gareth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganica Chimica Acta (2003), 355127-136

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4336238
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-2-nitroaniline (Table 2-30) The reaction of
2-nitrochlorobenzene (1.576 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%), produced 1.511 g (99.3 %) product.
1H NMR (300 MHz, d 6-DMSO) δ (ppm): 2.95–2.97(d, J = 4.8 Hz, 3H),
6.66–6.70(t, J = 7.5 Hz, 1H), 6.97–7.00(d, J = 8.4 Hz, 1H), 7.53–7.58(t,
J = 7.5 Hz, 1H), 8.05–8.08(d, J = 8.4 Hz, 1H), 8.16(s, 1H); 13C NMR (75
MHz, d 6-DMSO) δ (ppm): 29.1, 113.6, 114.3, 125.6, 130.4, 136.0, 145.5.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2R,3R,3aR,7aR)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-3a-hydr...
C17H28N2O7Si
887486-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 3.4334 0.0 0
M  V30 2 Si 4.9112 2.2889 0.0 0
M  V30 3 C 3.8806 1.1445 0.0 0
M  V30 4 C 6.0556 1.2585 0.0 0
M  V30 5 C 3.7667 3.3193 0.0 0
M  V30 6 C 5.0252 0.1140 0.0 0
M  V30 7 C 2.8502 0.0000 0.0 0
M  V30 8 C 2.7363 2.1749 0.0 0
M  V30 9 O 4.1620 3.8423 0.0 0
M  V30 10 O 7.9110 8.8113 0.0 0
M  V30 11 O 0.0000 4.6038 0.0 0
M  V30 12 O 12.5310 6.1438 0.0 0
M  V30 13 C 5.4658 4.8980 0.0 0 CFG=2
M  V30 14 C 6.3710 6.1438 0.0 0 CFG=2
M  V30 15 C 4.0011 5.3738 0.0 0 CFG=2
M  V30 16 O 5.4658 7.3897 0.0 0
M  V30 17 C 4.0011 6.9138 0.0 0 CFG=1
M  V30 18 C 2.6674 4.6038 0.0 0
M  V30 19 C 2.6674 7.6838 0.0 0
M  V30 20 C 1.3338 5.3738 0.0 0
M  V30 21 O 1.3338 6.9138 0.0 0
M  V30 22 N 7.9110 6.1438 0.0 0
M  V30 23 C 8.6810 7.4776 0.0 0
M  V30 24 C 8.6810 4.8102 0.0 0
M  V30 25 N 10.2210 7.4776 0.0 0
M  V30 26 C 10.2210 4.8102 0.0 0
M  V30 27 C 10.9910 6.1438 0.0 0
M  V30 28 H 4.1620 8.4454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 15 9 CFG=3
M  V30 10 2 10 23
M  V30 11 2 11 20
M  V30 12 2 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 14 22 CFG=1
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 1 17 19
M  V30 21 1 17 28 CFG=3
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Uridine, 2′-O-[(1,1-dimethylethyl)dimethylsilyl]-3′-C-[2-(methylamino)-2-oxoe...
C18H31N3O7Si
195391-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.1043 6.5626 0.0 0
M  V30 2 Si 5.7707 7.3326 0.0 0
M  V30 3 C 4.4371 8.1026 0.0 0
M  V30 4 C 6.5407 8.6662 0.0 0
M  V30 5 C 5.0007 5.9989 0.0 0
M  V30 6 C 5.2071 9.4362 0.0 0
M  V30 7 C 3.1033 8.8726 0.0 0
M  V30 8 C 3.6671 6.7689 0.0 0
M  V30 9 C 9.1202 5.4510 0.0 0
M  V30 10 C 10.6602 5.4510 0.0 0
M  V30 11 N 11.4302 6.7848 0.0 0
M  V30 12 O 11.4302 4.1174 0.0 0
M  V30 13 C 12.9702 6.7848 0.0 0
M  V30 14 O 9.7572 3.4910 0.0 0
M  V30 15 C 8.7796 1.4068 0.0 0
M  V30 16 O 8.1532 0.0000 0.0 0
M  V30 17 O 3.5696 2.0564 0.0 0
M  V30 18 O 0.0000 6.0210 0.0 0
M  V30 19 C 7.1043 5.0226 0.0 0 CFG=2
M  V30 20 C 5.8585 4.1174 0.0 0 CFG=2
M  V30 21 C 8.3502 4.1174 0.0 0 CFG=1
M  V30 22 O 6.3343 2.6527 0.0 0
M  V30 23 C 7.8743 2.6527 0.0 0 CFG=1
M  V30 24 N 4.3938 4.5932 0.0 0
M  V30 25 C 3.2494 3.5628 0.0 0
M  V30 26 C 4.0736 6.0996 0.0 0
M  V30 27 N 1.7847 4.0387 0.0 0
M  V30 28 C 2.6091 6.5755 0.0 0
M  V30 29 C 1.4645 5.5451 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 21 14 CFG=3
M  V30 15 1 15 16
M  V30 16 1 23 15 CFG=1
M  V30 17 2 17 25
M  V30 18 2 18 29
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 20 24 CFG=1
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 20 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 887486-63-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195391-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15334861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3'-β-carbamoylmethylcytidine (CAMC) and its derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ichikawa, Satoshi; Minakawa, Noriaki; Shuto, Satoshi; Tanaka, Motohiro;
Sasaki, Takuma; Matsuda, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2006), 4(7), 1284-1296

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Oxa-6,10,14-triazaheptadecan-17-oic acid, 6,10,14-trimethyl-3-oxo-, methyl ...
C17H35N3O4
888011-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 9.3358 2.3101 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 O 2.6673 0.0000 0.0 0
M  V30 11 N 12.0033 2.3101 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 13.3370 1.5400 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 C 14.6708 2.3101 0.0 0
M  V30 16 C 16.0045 1.5400 0.0 0
M  V30 17 N 17.3382 2.3101 0.0 0
M  V30 18 C 18.6718 1.5400 0.0 0
M  V30 19 C 17.3382 3.8501 0.0 0
M  V30 20 C 20.0055 2.3101 0.0 0
M  V30 21 C 21.3393 1.5400 0.0 0
M  V30 22 O 22.6730 2.3101 0.0 0
M  V30 23 O 21.3393 0.0000 0.0 0
M  V30 24 C 24.0067 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4,8,12-Tetramethyl-15-oxo-4,8,12,16-tetraazaheptadecanamide
C17H37N5O2
888011-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 9.3358 2.3101 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 N 1.3337 2.3101 0.0 0
M  V30 10 O 2.6673 0.0000 0.0 0
M  V30 11 N 12.0033 2.3101 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 13.3370 1.5400 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 C 14.6708 2.3101 0.0 0
M  V30 16 C 16.0045 1.5400 0.0 0
M  V30 17 N 17.3382 2.3101 0.0 0
M  V30 18 C 18.6718 1.5400 0.0 0
M  V30 19 C 17.3382 3.8501 0.0 0
M  V30 20 C 20.0055 2.3101 0.0 0
M  V30 21 C 21.3393 1.5400 0.0 0
M  V30 22 N 22.6730 2.3101 0.0 0
M  V30 23 O 21.3393 0.0000 0.0 0
M  V30 24 C 24.0067 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888011-56-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888011-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1194674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new stepwise synthesis of a family of propylamines derived from diatom
silaffins and their activity in silicification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annenkov, Vadim V.; Patwardhan, Siddharth V.; Belton, David;
Danilovtseva, Elena N.; Perry, Carole C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2006), (14),
1521-1523

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,23-Dimethyl 4,8,12,16,20-pentamethyl-4,8,12,16,20-pentaazatricosanedioate
C25H53N5O4
888011-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 2.3101 0.0 0
M  V30 2 C 10.6697 1.5400 0.0 0
M  V30 3 C 13.3370 1.5400 0.0 0
M  V30 4 C 12.0033 3.8501 0.0 0
M  V30 5 C 9.3358 2.3101 0.0 0
M  V30 6 C 14.6707 2.3101 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 16.0045 1.5400 0.0 0
M  V30 9 N 6.6685 2.3101 0.0 0
M  V30 10 N 17.3382 2.3101 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 18.6718 1.5400 0.0 0
M  V30 14 C 17.3382 3.8501 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 20.0055 2.3101 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 21.3393 1.5400 0.0 0
M  V30 19 O 1.3337 2.3101 0.0 0
M  V30 20 O 2.6673 0.0000 0.0 0
M  V30 21 N 22.6730 2.3101 0.0 0
M  V30 22 C 0.0000 1.5400 0.0 0
M  V30 23 C 24.0067 1.5400 0.0 0
M  V30 24 C 22.6730 3.8501 0.0 0
M  V30 25 C 25.3403 2.3101 0.0 0
M  V30 26 C 26.6742 1.5400 0.0 0
M  V30 27 N 28.0078 2.3101 0.0 0
M  V30 28 C 29.3415 1.5400 0.0 0
M  V30 29 C 28.0078 3.8501 0.0 0
M  V30 30 C 30.6753 2.3101 0.0 0
M  V30 31 C 32.0090 1.5400 0.0 0
M  V30 32 O 33.3427 2.3101 0.0 0
M  V30 33 O 32.0090 0.0000 0.0 0
M  V30 34 C 34.6763 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 23 25
M  V30 25 1 25 26
M  V30 26 1 26 27
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 30 31
M  V30 31 1 31 32
M  V30 32 2 31 33
M  V30 33 1 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N23,4,8,12,16,20-Heptamethyl-4,8,12,16,20-pentaazatricosanediamide
C25H55N7O2
888011-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 2.3101 0.0 0
M  V30 2 C 10.6697 1.5400 0.0 0
M  V30 3 C 13.3370 1.5400 0.0 0
M  V30 4 C 12.0033 3.8501 0.0 0
M  V30 5 C 9.3358 2.3101 0.0 0
M  V30 6 C 14.6707 2.3101 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 16.0045 1.5400 0.0 0
M  V30 9 N 6.6685 2.3101 0.0 0
M  V30 10 N 17.3382 2.3101 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 18.6718 1.5400 0.0 0
M  V30 14 C 17.3382 3.8501 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 20.0055 2.3101 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 21.3393 1.5400 0.0 0
M  V30 19 N 1.3337 2.3101 0.0 0
M  V30 20 O 2.6673 0.0000 0.0 0
M  V30 21 N 22.6730 2.3101 0.0 0
M  V30 22 C 0.0000 1.5400 0.0 0
M  V30 23 C 24.0067 1.5400 0.0 0
M  V30 24 C 22.6730 3.8501 0.0 0
M  V30 25 C 25.3403 2.3101 0.0 0
M  V30 26 C 26.6742 1.5400 0.0 0
M  V30 27 N 28.0078 2.3101 0.0 0
M  V30 28 C 29.3415 1.5400 0.0 0
M  V30 29 C 28.0078 3.8501 0.0 0
M  V30 30 C 30.6753 2.3101 0.0 0
M  V30 31 C 32.0090 1.5400 0.0 0
M  V30 32 N 33.3427 2.3101 0.0 0
M  V30 33 O 32.0090 0.0000 0.0 0
M  V30 34 C 34.6763 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 23 25
M  V30 25 1 25 26
M  V30 26 1 26 27
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 30 31
M  V30 31 1 31 32
M  V30 32 2 31 33
M  V30 33 1 32 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888011-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888011-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5490239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new stepwise synthesis of a family of propylamines derived from diatom
silaffins and their activity in silicification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annenkov, Vadim V.; Patwardhan, Siddharth V.; Belton, David;
Danilovtseva, Elena N.; Perry, Carole C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2006), (14),
1521-1523

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-5-methylene-4-(3-pyridinyl)-1,3-dioxolan-2-one
C10H9NO3
890094-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0959 1.3161 0.0 0
M  V30 2 C 4.9846 0.0000 0.0 0
M  V30 3 O 7.1895 4.9524 0.0 0
M  V30 4 C 4.0010 2.5620 0.0 0
M  V30 5 O 4.6275 3.9690 0.0 0
M  V30 6 C 5.1456 1.5316 0.0 0
M  V30 7 C 6.1591 3.8079 0.0 0
M  V30 8 O 6.4792 2.3016 0.0 0
M  V30 9 C 2.6673 3.3320 0.0 0
M  V30 10 C 2.6673 4.8721 0.0 0
M  V30 11 C 1.3337 2.5620 0.0 0
M  V30 12 C 1.3337 5.6421 0.0 0
M  V30 13 N 0.0000 3.3320 0.0 0
M  V30 14 C 0.0000 4.8721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3,4,5-trimethyl-5-(3-pyridinyl)-2-oxazolidinone
C11H14N2O3
899372-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9689 5.1959 0.0 0
M  V30 2 C 0.8946 4.6110 0.0 0
M  V30 3 O 2.7774 5.4492 0.0 0
M  V30 4 C 0.0000 2.4899 0.0 0
M  V30 5 O 2.2418 0.0000 0.0 0
M  V30 6 C 3.8079 3.6643 0.0 0
M  V30 7 C 2.3016 3.9845 0.0 0
M  V30 8 O 3.9689 2.1328 0.0 0
M  V30 9 N 1.5316 2.6508 0.0 0
M  V30 10 C 2.5620 1.5064 0.0 0
M  V30 11 C 5.3479 3.6643 0.0 0
M  V30 12 C 6.1179 2.3307 0.0 0
M  V30 13 C 6.1179 4.9980 0.0 0
M  V30 14 C 7.6579 2.3307 0.0 0
M  V30 15 N 7.6579 4.9980 0.0 0
M  V30 16 C 8.4279 3.6643 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 890094-81-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 899372-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-14291562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of oxazolidinones 2 and 3 (general
procedure). Amine (10 mmol) was added (ammonia, methylamine, and
ethylamine were used as aqueous solutions) to a solution of the
corresponding dioxolanone 1 (10 mmol) in acetonitrile (7 mL). The
reaction mixture was kept at 45 °C for 3-10 h until the starting reagents
were consumed (TLC). The solvent was evapo rated, most of oxazolidinones
being obtained as yellow oils. In all cases, the oils were crystallized
from MTBE. 4-hydroxy-3,4,5-trimethyl-5-(pyridin-3-yl)oxazolidin-2-one
(3b), yield 99%. mp: 170-172 °C; Found: C 59.55 %, H 6.33 %, N 12.52 %;
Calculated: C 59.45 %, H 6.35 %, N 12.6 %; Molecular formula: C11H14N2O3;
M: 222; m/z (Irel (%)): 222 (3), 145 (5), 122 (100), 104 (21), 78 (23),
73 (32), 56 (37), 51 (25), 43 (77).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 39:61 trans:cis (orientation of methyl groups)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural features of diastereomeric oxazolidin-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chudinov, Yu. B.; Gashev, S. B.; Strelenko, Yu. A.; Starikova, Z. A.;
Antipin, M. Yu.; Semenov, V. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2007), 56(1), 140-147

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon-11C disulfide
CS2
89037-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0 MASS=11
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylcarbamodithioic-11C acid
C2H5NS2
1362255-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 MASS=11
M  V30 2 N 2.6673 2.3101 0.0 0
M  V30 3 S 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89037-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1362255-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-11188171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [11C]Carbon Disulfide: A Versatile Reagent for PET Radiolabelling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, Philip W.; Bender, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2012), 18(2), 433-436, S433/1-S433/5

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-5-nitro-4-pyrimidinamine
C5H5ClN4O2
89283-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N4-Dimethyl-5-nitro-2,4-pyrimidinediamine
C6H9N5O2
5177-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 N 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 N 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89283-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5177-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6442986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,4-(dimethylamino)-5-nitropyrimidine To a solution of
2-chloro-4-(methylamino)-5-nitropyrimidine (0.644 g, 3.42 mmol,
synthesized from the above procedure) in ethanol (20 mL) is added 2M
methyl amine in THF (10 mL). After stirring for 3 hours at room
temperature, the solvent is removed under vacuum. The solid is washed
with water, dried to afford the title compound (620 mg, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[3-(2-amino-7-oxo-7,8-dihydropteridin-6-yl)phenyl]
benzamides as protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Pingda; Wang, Xia; Gray, Nathanael Schiander; Liu, Yi; Sim, Taebo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006002367 A1 2006-01-05

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Propyl-2-benzofurancarboxaldehyde
C12H12O2
894851-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.8721 0.0 0
M  V30 2 C 7.1955 4.3962 0.0 0
M  V30 3 C 8.3399 5.4266 0.0 0
M  V30 4 C 6.0811 1.5400 0.0 0
M  V30 5 O 6.0811 0.0000 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 4.5864 3.8416 0.0 0
M  V30 8 C 2.3101 2.8281 0.0 0
M  V30 9 C 2.3101 5.4955 0.0 0
M  V30 10 C 4.7473 2.3101 0.0 0
M  V30 11 O 3.3405 1.6836 0.0 0
M  V30 12 C 0.7700 2.8281 0.0 0
M  V30 13 C 0.7700 5.4955 0.0 0
M  V30 14 C 0.0000 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-propyl-2-benzofuranmethanamine
C13H17NO
894851-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 2.6091 0.0 0
M  V30 2 C 3.5773 1.4645 0.0 0
M  V30 3 C 4.0533 0.0000 0.0 0
M  V30 4 C 6.5770 5.3195 0.0 0
M  V30 5 N 7.3470 6.6533 0.0 0
M  V30 6 C 8.8870 6.6533 0.0 0
M  V30 7 C 2.6673 4.5495 0.0 0
M  V30 8 C 4.1320 4.0736 0.0 0
M  V30 9 C 2.6673 6.0895 0.0 0
M  V30 10 C 1.3336 3.7795 0.0 0
M  V30 11 C 5.0370 5.3195 0.0 0
M  V30 12 O 4.1320 6.5655 0.0 0
M  V30 13 C 1.3336 6.8595 0.0 0
M  V30 14 C 0.0000 4.5495 0.0 0
M  V30 15 C 0.0000 6.0895 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8884111
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) Methyl-(3-propyl-benzofuran-2-ylmethyl)amine [1347] To
3-propyl-benzofuran-2-carbaldehyde (1.36 g, 72.2 mmol) was added
methylamine (29 mL of a 2 M solution in methanol, 58 mmol). The resulting
mixture was stirred overnight at room temperature under nitrogen. The
mixture was concentrated under reduced pressure. The residue was taken up
in ethanol (20 mL) and the solution was cooled in an ice-bath. NaBH4 (490
mg, 10.8 mmol) was added in one portion. The mixture was concentrated
under reduced pressure and the residue taken up in 1 M NaOH. The mixture
was extracted with Et2O (3×). The combined organics were washed, dried
(Na2SO4), filtered and concentrated under reduced pressure to give the
title compound (1.68 g, 99%) as a yellow oil. 1H NMR (300 MHz, DMSO-d6) δ
7.60-7.54 (m, 1H), 7.49 (dd, J=7.2, 1.2 Hz, 1H), 7.25-7.20 (m, 2H), 3.76
(s, 2H), 2.65 (t, J=7.2 Hz, 2H), 2.30 (d, J=9.3 Hz, 3H), 1.99 (s, 1H),
1.66-1.58 (m, 2H), 0.94-0.86 (m, 3H); ESI MS m/z 204 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Propyl-2-benzofurancarboxaldehyde
C12H12O2
894851-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.8721 0.0 0
M  V30 2 C 7.1955 4.3962 0.0 0
M  V30 3 C 8.3399 5.4266 0.0 0
M  V30 4 C 6.0811 1.5400 0.0 0
M  V30 5 O 6.0811 0.0000 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 4.5864 3.8416 0.0 0
M  V30 8 C 2.3101 2.8281 0.0 0
M  V30 9 C 2.3101 5.4955 0.0 0
M  V30 10 C 4.7473 2.3101 0.0 0
M  V30 11 O 3.3405 1.6836 0.0 0
M  V30 12 C 0.7700 2.8281 0.0 0
M  V30 13 C 0.7700 5.4955 0.0 0
M  V30 14 C 0.0000 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-propyl-2-benzofuranmethanamine
C13H17NO
894851-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 2.6091 0.0 0
M  V30 2 C 3.5773 1.4645 0.0 0
M  V30 3 C 4.0533 0.0000 0.0 0
M  V30 4 C 6.5770 5.3195 0.0 0
M  V30 5 N 7.3470 6.6533 0.0 0
M  V30 6 C 8.8870 6.6533 0.0 0
M  V30 7 C 2.6673 4.5495 0.0 0
M  V30 8 C 4.1320 4.0736 0.0 0
M  V30 9 C 2.6673 6.0895 0.0 0
M  V30 10 C 1.3336 3.7795 0.0 0
M  V30 11 C 5.0370 5.3195 0.0 0
M  V30 12 O 4.1320 6.5655 0.0 0
M  V30 13 C 1.3336 6.8595 0.0 0
M  V30 14 C 0.0000 4.5495 0.0 0
M  V30 15 C 0.0000 6.0895 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-86-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15278887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) Methyl-(3-propyl-benzofuran-2-ylmethyl)amine To
3-propyl-benzofuran-2-carbaldehyde (1.36 g, 72.2 mmol) was added
methylamine (29 mL of a 2 M solution in methanol, 58 mmol). The resulting
mixture was stirred overnight at room temperature under nitrogen. The
mixture was concentrated under reduced pressure. The residue was taken up
in ethanol (20 mL) and the solution was cooled in an ice-bath. NaBH4 (490
mg, 10.8 mmol) was added in one portion. The mixture was concentrated
under reduced pressure and the residue taken up in 1 M NaOH. The mixture
was extracted with Et2O (3×). The combined organics were washed, dried
(Na2SO4), filtered and concentrated under reduced pressure to give the
title compound (1.68 g, 99%) as a yellow oil: 1H NMR (300 MHz, DMSO-d 6)
δ 7.60-7.54 (m, 1H), 7.49 (dd, J = 7.2, 1.2 Hz, 1H), 7.25-7.20 (m, 2H),
3.76 (s, 2H), 2.65 (t, J = 7.2 Hz, 2H), 2.30 (d, J = 9.3 Hz, 3H), 1.99
(s, 1H), 1.66-1.58 (m, 2H), 0.94-0.86 (m, 3H); ESI MS m/z 204 (M+H)+.
C13H17NO Exact Mass: 203.13.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzoyl-2,5-dihydro-2-(2-methylpropyl)-1H-pyrrole-2-carboxylic acid
C16H19NO3
908076-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4533 2.6528 0.0 0
M  V30 2 C 9.3586 1.4068 0.0 0
M  V30 3 C 8.7321 0.0000 0.0 0
M  V30 4 C 10.8901 1.5679 0.0 0
M  V30 5 C 6.9216 4.0318 0.0 0
M  V30 6 O 8.2554 4.8018 0.0 0
M  V30 7 O 5.5880 4.8018 0.0 0
M  V30 8 C 4.6201 3.9865 0.0 0
M  V30 9 O 5.3901 5.3202 0.0 0
M  V30 10 C 6.9216 2.4918 0.0 0
M  V30 11 N 5.3901 2.6528 0.0 0
M  V30 12 C 7.2420 0.9855 0.0 0
M  V30 13 C 4.7638 1.2459 0.0 0
M  V30 14 C 5.9081 0.2154 0.0 0
M  V30 15 C 3.0800 3.9865 0.0 0
M  V30 16 C 2.3100 2.6528 0.0 0
M  V30 17 C 2.3100 5.3202 0.0 0
M  V30 18 C 0.7700 2.6528 0.0 0
M  V30 19 C 0.7700 5.3202 0.0 0
M  V30 20 C 0.0000 3.9865 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 8 9
M  V30 9 1 8 11
M  V30 10 1 8 15
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzoyl-2,5-dihydro-N-methyl-2-(2-methylpropyl)-1H-pyrrole-2-carboxamide
C17H22N2O2
908076-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9684 2.3100 0.0 0
M  V30 2 N 2.6346 1.5400 0.0 0
M  V30 3 O 5.3021 1.5400 0.0 0
M  V30 4 C 2.6346 0.0000 0.0 0
M  V30 5 C 2.4367 3.6891 0.0 0
M  V30 6 C 1.5315 4.9349 0.0 0
M  V30 7 C 2.1580 6.3417 0.0 0
M  V30 8 C 0.0000 4.7739 0.0 0
M  V30 9 C 6.2700 2.3553 0.0 0
M  V30 10 O 5.5000 1.0216 0.0 0
M  V30 11 C 3.9684 3.8500 0.0 0
M  V30 12 N 5.5000 3.6891 0.0 0
M  V30 13 C 3.6481 5.3563 0.0 0
M  V30 14 C 6.1263 5.0959 0.0 0
M  V30 15 C 4.9819 6.1263 0.0 0
M  V30 16 C 7.8100 2.3553 0.0 0
M  V30 17 C 8.5800 1.0216 0.0 0
M  V30 18 C 8.5800 3.6891 0.0 0
M  V30 19 C 10.1200 1.0216 0.0 0
M  V30 20 C 10.1200 3.6891 0.0 0
M  V30 21 C 10.8900 2.3553 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 12
M  V30 11 1 9 16
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908076-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908076-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11346705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Amide Coupling of 16{1- 5,1-3} (Protocol F). A
5 mL microwave tube was charged with 3,4-dehydroproline 16{1,2} (20 mg,
0.073 mmol, 1 equiv), PS-carbodiimide (11 mg, 0.15 mmol, 2 equiv),
1-hydroxybenzotriazole (9.9 mg, 0.073 mmol, 1 equiv), and methylamine
13{1} (33 wt % in water) (0.021 mL, 0.22 mmol, 3 equiv) in
dichloromethane (1 mL) and capped. The suspension was irradiated in an
Emrys Optimizer microwave reactor (250 W) at 60 °C for 30 min (for
nonvolatile amines irradiation was performed at 100 °C for 10 min). After
it was cool to room temperature, the reaction mixture was filtered
through an SPE-cartridge (prepacked with 500 mg silica-bound carbonate
and preconditioned with 2 mL of CH2Cl2) and washed with dichloromethane
(3 x 2 mL). The eluants were collected via gravity filtration.
Evaporation of all volatile components in a centrifugal vacuum evaporator
(Genevac HT-4) provided the desired amide 10{1,2,1} (21.0 mg, 99%).
rac-1-Benzoyl-2-isobutyl-N-methyl-2,5-dihydro-1H-pyrrole-2-carboxamide
(10{1,2,1}). Colorless oil, yield (99%, 21.0 mg). 1H NMR (300.1 MHz, 290
K, CDCl3): δ 7.82 (bs, 1H), 7.47-7.37 (m, 5H), 6.01 (d, J = 6.2 Hz, 1H),
5.76 (d, J = 6.4 Hz, 1H), 4.25 (d, J = 15.1 Hz, 1H), 4.13 (d, J = 15.2
Hz, 1H), 2.83 (d, J = 4.7 Hz, 3H), 2.71 (dd, J = 14.3, 5.8 Hz, 1H), 2.00
(dd, J = 14.5, 5.2 Hz, 1H), 1.70-1.63 (m, 1H), 0.97 (d, J = 8.0 Hz, 3H),
0.95 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, 290 K, CDCl3): δ 173.8,
171.1, 137.5, 132.6, 129.7, 128.6, 125.7, 123.1, 79.2, 58.5, 41.0, 26.4,
24.8, 24.4, 23.5. IR (film): ν 3350, 2955, 1659, 1640, 1622, 1531, 1409
cm-1. HRMS (EI) Calcd for [M - CONHCH3]+ C15H18NO: 228.1388. Found:
228.1387. MS (EI) m/z (relative intensity in %): 228 (41), 105 (100).
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4,6-bis[(3,5-dimethylphenyl)amino]-1,3,5-triazine-2-carboxylate
C21H23N5O2
909015-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 5.3347 0.0 0
M  V30 2 C 4.6200 2.6673 0.0 0
M  V30 3 O 5.3900 1.3336 0.0 0
M  V30 4 O 3.0800 2.6673 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 N 4.6200 8.0021 0.0 0
M  V30 7 C 9.2400 10.6694 0.0 0
M  V30 8 C 13.8600 8.0021 0.0 0
M  V30 9 C 0.0000 10.6694 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 N 6.9300 6.6684 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 5.3900 6.6684 0.0 0
M  V30 16 N 4.6200 5.3347 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 11.5500 6.6684 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 0.7700 9.3358 0.0 0
M  V30 27 C 0.7700 6.6684 0.0 0
M  V30 28 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 15
M  V30 8 1 6 23
M  V30 9 1 7 20
M  V30 10 1 8 21
M  V30 11 1 9 26
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Bis[(3,5-dimethylphenyl)amino]-N-methyl-1,3,5-triazine-2-carboxamide
C21H24N6O
1185918-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 5.3347 0.0 0
M  V30 2 C 4.6200 2.6673 0.0 0
M  V30 3 N 5.3900 1.3336 0.0 0
M  V30 4 O 3.0800 2.6673 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 N 4.6200 8.0021 0.0 0
M  V30 7 C 9.2400 10.6694 0.0 0
M  V30 8 C 13.8600 8.0021 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 0.0000 10.6694 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 N 6.9300 6.6684 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 5.3900 6.6684 0.0 0
M  V30 16 N 4.6200 5.3347 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 11.5500 6.6684 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 22 C 11.5500 9.3358 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 2.3100 6.6684 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 0.7700 6.6684 0.0 0
M  V30 27 C 0.7700 9.3358 0.0 0
M  V30 28 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 15
M  V30 8 1 6 23
M  V30 9 1 7 20
M  V30 10 1 8 21
M  V30 11 1 9 26
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 909015-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1185918-94-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10865255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anarchy in the solid state: structural dependence on glass-forming
ability in triazine-based molecular glasses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wuest, James D.; Lebel, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(36), 7393-7402

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[3-[7-(Methoxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazolo[3,4-b]pyridin-5-yl]...
C21H16N6O2
916325-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 2.4581 0.0 0
M  V30 2 O 1.4647 1.4277 0.0 0
M  V30 3 C 0.0000 1.9036 0.0 0
M  V30 4 C 16.6254 6.9691 0.0 0
M  V30 5 O 17.9592 6.1991 0.0 0
M  V30 6 C 7.1587 6.4933 0.0 0
M  V30 7 C 8.6234 6.9691 0.0 0
M  V30 8 N 6.2535 7.7391 0.0 0
M  V30 9 C 8.6234 8.5091 0.0 0
M  V30 10 C 9.9570 6.1991 0.0 0
M  V30 11 N 7.1587 8.9850 0.0 0
M  V30 12 N 9.9570 9.2791 0.0 0
M  V30 13 C 11.2907 6.9691 0.0 0
M  V30 14 C 11.2907 8.5091 0.0 0
M  V30 15 C 6.6828 5.0286 0.0 0
M  V30 16 N 5.2181 4.5527 0.0 0
M  V30 17 N 7.5880 3.7827 0.0 0
M  V30 18 C 5.2181 3.0127 0.0 0
M  V30 19 C 6.6828 2.5368 0.0 0
M  V30 20 C 4.0738 1.9823 0.0 0
M  V30 21 C 7.0030 1.0304 0.0 0
M  V30 22 C 4.3939 0.4759 0.0 0
M  V30 23 C 5.8586 0.0000 0.0 0
M  V30 24 C 12.6245 6.1991 0.0 0
M  V30 25 C 13.9581 6.9691 0.0 0
M  V30 26 C 12.6245 4.6591 0.0 0
M  V30 27 C 15.2917 6.1991 0.0 0
M  V30 28 N 13.9581 3.8891 0.0 0
M  V30 29 C 15.2917 4.6591 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 27
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 13 24
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[3-[7-(Methoxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazolo[3,4-b]pyridin-5-yl]...
C22H21N7O
916326-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 2.4581 0.0 0
M  V30 2 O 1.4647 1.4277 0.0 0
M  V30 3 C 0.0000 1.9036 0.0 0
M  V30 4 C 16.6254 6.9691 0.0 0
M  V30 5 N 17.9590 6.1991 0.0 0
M  V30 6 C 19.2928 6.9691 0.0 0
M  V30 7 C 8.6234 6.9691 0.0 0
M  V30 8 C 7.1587 6.4933 0.0 0
M  V30 9 C 8.6234 8.5091 0.0 0
M  V30 10 C 9.9570 6.1991 0.0 0
M  V30 11 N 6.2535 7.7391 0.0 0
M  V30 12 N 7.1587 8.9850 0.0 0
M  V30 13 N 9.9570 9.2791 0.0 0
M  V30 14 C 11.2907 6.9691 0.0 0
M  V30 15 C 11.2907 8.5091 0.0 0
M  V30 16 C 6.6828 5.0286 0.0 0
M  V30 17 N 5.2181 4.5527 0.0 0
M  V30 18 N 7.5880 3.7827 0.0 0
M  V30 19 C 5.2181 3.0127 0.0 0
M  V30 20 C 6.6828 2.5368 0.0 0
M  V30 21 C 4.0738 1.9823 0.0 0
M  V30 22 C 7.0030 1.0304 0.0 0
M  V30 23 C 4.3939 0.4759 0.0 0
M  V30 24 C 5.8586 0.0000 0.0 0
M  V30 25 C 12.6243 6.1991 0.0 0
M  V30 26 C 13.9581 6.9691 0.0 0
M  V30 27 C 12.6243 4.6591 0.0 0
M  V30 28 C 15.2917 6.1991 0.0 0
M  V30 29 N 13.9581 3.8891 0.0 0
M  V30 30 C 15.2917 4.6591 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 14 25
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916325-96-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916326-04-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13372208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as
antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Ronghui; Connolly, Peter J.; Lu, Yanhua; Chiu, George; Li,
Shengjian; Yu, Yang; Huang, Shenlin; Li, Xun; Emanuel, Stuart L.;
Middleton, Steven A.; Gruninger, Robert H.; Adams, Mary;
Fuentes-Pesquera, Angel R.; Greenberger, Lee M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(15), 4297-4302

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethoxy-6-phenyl-1,3,5-triazine
C13H15N3O2
91959-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 6.9302 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 C 10.6697 6.9302 0.0 0
M  V30 4 O 5.3348 2.3101 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 4.0012 6.1601 0.0 0
M  V30 8 N 5.3348 6.9302 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 N 6.6685 4.6201 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 2.6673 8.4702 0.0 0
M  V30 15 C 1.3337 6.1601 0.0 0
M  V30 16 C 1.3337 9.2402 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-N-methyl-6-phenyl-1,3,5-triazin-2-amine
C12H14N4O
1493706-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 5.3901 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 4.0012 4.6201 0.0 0
M  V30 7 N 5.3348 5.3901 0.0 0
M  V30 8 N 4.0012 3.0801 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 N 6.6685 3.0801 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7002 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91959-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493706-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41800596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controlling hydrogen transfer dynamics in adaptive semihydrogenation of
alkynes: Unveiling and directing outer- vs. inner-sphere mechanisms
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chugh, Vishal; Wu, Jiajun; Leutzsch, Markus; Randel, Helena;
Weyhermueller, Thomas; Auer, Alexander A.; Fares, Christophe; Werle,
Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chem Catalysis (2024), 4(9), 101078

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethoxy-6-phenyl-1,3,5-triazine
C13H15N3O2
91959-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 6.9302 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 C 10.6697 6.9302 0.0 0
M  V30 4 O 5.3348 2.3101 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 4.0012 6.1601 0.0 0
M  V30 8 N 5.3348 6.9302 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 N 6.6685 4.6201 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 2.6673 8.4702 0.0 0
M  V30 15 C 1.3337 6.1601 0.0 0
M  V30 16 C 1.3337 9.2402 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-N-methyl-6-phenyl-1,3,5-triazin-2-amine
C12H14N4O
1493706-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 5.3901 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 C 6.6685 0.0000 0.0 0
M  V30 6 C 4.0012 4.6201 0.0 0
M  V30 7 N 5.3348 5.3901 0.0 0
M  V30 8 N 4.0012 3.0801 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 N 6.6685 3.0801 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7002 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91959-53-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493706-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33833332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Adaptive Rhodium Catalyst to Control the Hydrogenation Network of
Nitroarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chugh, Vishal; Chatterjee, Basujit; Chang, Wei-Chieh; Cramer, Hanna H.;
Hindemith, Carsten; Randel, Helena; Weyhermueller, Thomas; Fares,
Christophe; Werle, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(36), e202205515

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-methyl-2-butenoate
C6H10O2
924-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-methyl-3-(methylamino)butanoate
C7H15NO2
89855-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.5400 0.0 0
M  V30 2 C 3.6439 2.3101 0.0 0
M  V30 3 N 1.5400 2.8737 0.0 0
M  V30 4 C 3.0801 0.2064 0.0 0
M  V30 5 C 0.9764 0.7700 0.0 0
M  V30 6 C 4.9775 1.5400 0.0 0
M  V30 7 C 0.0000 2.8737 0.0 0
M  V30 8 O 6.3112 2.3101 0.0 0
M  V30 9 O 4.9775 0.0000 0.0 0
M  V30 10 C 7.6450 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 924-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89855-40-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24189137
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dichlorophenyl benzoxazole compounds, compositions and
methods for stabilizing transthyretin and inhibiting transthyretin
misfolding
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tait, Bradley Dean; Labaudiniere, Richard F.; Salvino, Joseph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021154842 A1 2021-08-05

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromophenyl)-2-(1-pyrrolidinyl)ethanone
C12H14BrNO
927892-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 2.5795 0.0 0
M  V30 2 C 3.9098 1.2459 0.0 0
M  V30 3 O 3.9098 3.9132 0.0 0
M  V30 4 Br 10.8399 2.5795 0.0 0
M  V30 5 C 6.2198 2.5795 0.0 0
M  V30 6 C 6.9898 1.2459 0.0 0
M  V30 7 C 6.9898 3.9132 0.0 0
M  V30 8 C 8.5299 1.2459 0.0 0
M  V30 9 C 8.5299 3.9132 0.0 0
M  V30 10 C 9.2999 2.5795 0.0 0
M  V30 11 N 2.3698 1.2459 0.0 0
M  V30 12 C 1.4646 2.4918 0.0 0
M  V30 13 C 1.4646 0.0000 0.0 0
M  V30 14 C 0.0000 2.0159 0.0 0
M  V30 15 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Bromophenyl)-N-methyl-1-pyrrolidineethanamine
C13H19BrN2
1003873-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6799 2.6673 0.0 0
M  V30 2 C 3.9098 4.0010 0.0 0
M  V30 3 N 3.9098 1.3337 0.0 0
M  V30 4 C 4.6799 0.0000 0.0 0
M  V30 5 Br 10.8400 2.6673 0.0 0
M  V30 6 C 6.2199 2.6673 0.0 0
M  V30 7 C 6.9899 4.0010 0.0 0
M  V30 8 C 6.9899 1.3337 0.0 0
M  V30 9 C 8.5299 4.0010 0.0 0
M  V30 10 C 8.5299 1.3337 0.0 0
M  V30 11 C 9.3000 2.6673 0.0 0
M  V30 12 N 2.3698 4.0010 0.0 0
M  V30 13 C 1.4646 2.7551 0.0 0
M  V30 14 C 1.4646 5.2469 0.0 0
M  V30 15 C 0.0000 3.2310 0.0 0
M  V30 16 C 0.0000 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 927892-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003873-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8289636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) 1-(4-bromophenyl)-N-methyl-2-(1-pyrrolidinyl)ethanamine
1-(4-Bromophenyl)-2-(1-pyrrolidinyl)ethanone (4.45 g, 16.6 mmol) and
methyl amine (33 mL, 66.4 mmol of 2 M solution in THF) were dissolved in
75 mL THF and maintained for 15 minutes at room temperature. NaBH3CN
(3.13 g, 49.8 mmol) was added and the reaction mixture was treated with 1
mL acetic acid and stirred at room temperature for 4 days. The solvent
was removed under reduced pressure. The residue was dissolved in 100 mL
of EtOAc and washed with sodium bicarbonate (100 mL) and then brine (100
mL). The organic layer was dried over Na2SO4, filtered, and concentrated
under reduced pressure to give 4.7 g (99%) of the title compound as a
yellow oil. MS (ES) m/e 284 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[1-biphenylyl-(morpholinyl- and
pyrrolidinyl)ethyl]glycinamide derivatives as antagonists of urotensin II
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neeb, Michael J.; Sehon, Clark A.; Viet, Andrew Q.; Goodman, Krista B.;
Wang, Gren Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008011551 A1 2008-01-24

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,9-Dimethoxydibenz[c,e]oxepin-5,7-dione
C16H12O5
92965-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4100 0.7725 0.0 0
M  V30 2 O 7.5352 0.0000 0.0 0
M  V30 3 O 0.3427 5.4876 0.0 0
M  V30 4 C 0.0000 6.9890 0.0 0
M  V30 5 O 10.9003 3.8963 0.0 0
M  V30 6 C 11.6703 5.2299 0.0 0
M  V30 7 C 4.7575 4.1257 0.0 0
M  V30 8 C 6.2802 3.8963 0.0 0
M  V30 9 C 3.6286 3.0782 0.0 0
M  V30 10 C 4.4148 5.6271 0.0 0
M  V30 11 C 7.0503 2.5625 0.0 0
M  V30 12 C 7.0503 5.2299 0.0 0
M  V30 13 C 3.7437 1.5425 0.0 0
M  V30 14 C 2.1570 3.5322 0.0 0
M  V30 15 C 2.9432 6.0811 0.0 0
M  V30 16 C 6.4877 1.1290 0.0 0
M  V30 17 C 8.5903 2.5625 0.0 0
M  V30 18 C 8.5903 5.2299 0.0 0
M  V30 19 O 5.0160 0.6750 0.0 0
M  V30 20 C 1.8143 5.0336 0.0 0
M  V30 21 C 9.3603 3.8963 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 16
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 2 15 20
M  V30 21 1 16 19
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dimethoxy-2′-[(methylamino)carbonyl][1,1′-biphenyl]-2-carboxylic acid
C17H17NO5
2810828-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 O 6.9302 2.6675 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 8.0023 0.0 0
M  V30 6 O 7.7002 9.3360 0.0 0
M  V30 7 O 5.3901 8.0023 0.0 0
M  V30 8 O 0.7700 5.3348 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 O 11.5503 5.3348 0.0 0
M  V30 11 C 12.3203 4.0012 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 4.6201 4.0012 0.0 0
M  V30 14 C 4.6201 6.6685 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 3.0801 6.6685 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 6.9302 5.3348 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 7.7002 4.0012 0.0 0
M  V30 21 C 9.2402 6.6685 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92965-27-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2810828-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40140057
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Therapeutic uses of urolithin derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greten, Florian; Denk, Dominic; Andreux, Penelope; Dugi, Klaus Andreas;
Rinsch, Christopher L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024025953 A2 2024-02-01

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,9-Dimethoxydibenz[c,e]oxepin-5,7-dione
C16H12O5
92965-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4100 0.7725 0.0 0
M  V30 2 O 7.5352 0.0000 0.0 0
M  V30 3 O 0.3427 5.4876 0.0 0
M  V30 4 C 0.0000 6.9890 0.0 0
M  V30 5 O 10.9003 3.8963 0.0 0
M  V30 6 C 11.6703 5.2299 0.0 0
M  V30 7 C 4.7575 4.1257 0.0 0
M  V30 8 C 6.2802 3.8963 0.0 0
M  V30 9 C 3.6286 3.0782 0.0 0
M  V30 10 C 4.4148 5.6271 0.0 0
M  V30 11 C 7.0503 2.5625 0.0 0
M  V30 12 C 7.0503 5.2299 0.0 0
M  V30 13 C 3.7437 1.5425 0.0 0
M  V30 14 C 2.1570 3.5322 0.0 0
M  V30 15 C 2.9432 6.0811 0.0 0
M  V30 16 C 6.4877 1.1290 0.0 0
M  V30 17 C 8.5903 2.5625 0.0 0
M  V30 18 C 8.5903 5.2299 0.0 0
M  V30 19 O 5.0160 0.6750 0.0 0
M  V30 20 C 1.8143 5.0336 0.0 0
M  V30 21 C 9.3603 3.8963 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 16
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 2 15 20
M  V30 21 1 16 19
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Dimethoxy-2′-[(methylamino)carbonyl][1,1′-biphenyl]-2-carboxylic acid
C17H17NO5
2810828-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 O 6.9302 2.6675 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 8.0023 0.0 0
M  V30 6 O 7.7002 9.3360 0.0 0
M  V30 7 O 5.3901 8.0023 0.0 0
M  V30 8 O 0.7700 5.3348 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 O 11.5503 5.3348 0.0 0
M  V30 11 C 12.3203 4.0012 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 4.6201 4.0012 0.0 0
M  V30 14 C 4.6201 6.6685 0.0 0
M  V30 15 C 3.0801 4.0012 0.0 0
M  V30 16 C 3.0801 6.6685 0.0 0
M  V30 17 C 2.3101 5.3348 0.0 0
M  V30 18 C 6.9302 5.3348 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 7.7002 4.0012 0.0 0
M  V30 21 C 9.2402 6.6685 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92965-27-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2810828-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34132743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Urolithin derivatives treating neuronal and mitochondrial
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rinsch, Christopher L.; Andreux, Penelope; Sutton, Jonathan Mark; Seward,
Eileen M.; Knight, Jamie D.; Linney, Ian; Sennhenn, Peter C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022162471 A1 2022-08-04

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,5-Dimethoxyphenyl)methylene]methanamine
C10H13NO2
114943-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 114943-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7004416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 3c.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl benzoylacetate
C11H12O3
94-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C12H15NO2
53256-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53256-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23328035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl benzoylacetate
C11H12O3
94-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C12H15NO2
53256-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53256-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6866937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bismacrocyclic inhibitors of hepatitis C NS3/4a protease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McCauley, John A.; Rudd, Michael T.; Nguyen, Kevin T.; McIntyre, Charles
J.; Romano, Joseph J.; Bush, Kimberly J.; Varga, Sandor L.; Ross, Charles
W. III; Carroll, Steven S.; DiMuzio, Jillian; Stahlhut, Mark W.; Olsen,
David B.; Lyle, Terry A.; Vacca, Joseph P.; Liverton, Nigel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2008), 47(47), 9104-9107

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl benzoylacetate
C11H12O3
94-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenoic acid, 3-(methylamino)-3-phenyl-, ethyl ester
C12H15NO2
81051-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 2.3100 1.3338 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 O 4.6200 5.3347 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 94-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81051-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2370978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step1: Ethyl 3-(methylamino)-3-phenylacrylate Acetic acid (44.7 mL, 780
mmol) was added to a solution of ethyl benzoylacetate (30 g, 156 mmol)
and methyl amine (2M in THF, 390 mL, 780 mmol) in EtOH (150 mL). The
reaction mixture was heated to reflux and stirred for 15 h. The reaction
mixture was concentrated and partitioned between DCM and 1M HCl. The
layers were separated, and the organic layer was dried over Na2SO4,
filtered and concentrated to give the title compound (32 g, 99% yield)
which was used with no further purification. Ethyl
3-(methylamino)-3-phenylacrylate, yield (32 g, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as HCV NS3 protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mccauley, John A.; Liverton, Nigel J.; Harper, Steven; Mcintyre, Charles
A.; Rudd, Michael T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009108507 A1 2009-09-03

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-ethylbenzeneethanol
C10H13BrO
943741-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 O 8.4700 5.3349 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Br 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-ethyl-N-methylbenzeneethanamine
C11H16BrN
943741-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 N 8.0021 2.3100 0.0 0
M  V30 4 C 9.3358 3.0800 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 Br 0.0000 5.3900 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 1.3336 3.0800 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 943741-46-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943741-48-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-6371160
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7143-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-bromo-2-ethylphenyl)-N-methylethanamine. Mesyl anhydride(430 mg,
2.46 mmol) was added portionwise to a solution of 36B (470 mg, 2.05 mmol)
in CH2Cl2 (10 mL) and Et3N (0.57 mL, 4.1 mmol) at 0°C. After stirring for
15 h at ambient temperature,the mixture was diluted with CH2Cl2 (80 mL),
washed with 1.0 M HCl, NaHCO3, brine, dried over Na2SO4and concentrated
in vacuo. The crude mesylate was dissolved in EtOAc (20 mL) and methyl
amine (33%, 5 mL) and heated in a pressure tube for 2 h. The reaction
mixture was concentrated in vacuo to afford 36C (500 mg, 99%) as a yellow
oil. MS (ESI) m/z 242.0/244.0 (M+H)+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as serine protease coagulation factor VIIa
inhibitors useful as anticoagulants and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priestley, E. Scott; Cheney, Daniel L.; Wurtz, Nicholas R.; Glunz, Peter
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007076431 A1 2007-07-05

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzoyl-2,5-dihydro-2-methyl-1H-pyrrole-2-carboxylic acid
C13H13NO3
946057-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.2931 0.0 0
M  V30 2 O 4.0011 0.7531 0.0 0
M  V30 3 C 7.9877 1.5316 0.0 0
M  V30 4 O 7.8266 0.0000 0.0 0
M  V30 5 O 9.3945 2.1579 0.0 0
M  V30 6 C 5.9716 1.1031 0.0 0
M  V30 7 N 5.3348 3.0631 0.0 0
M  V30 8 C 6.7416 2.4368 0.0 0
M  V30 9 C 5.4957 4.5947 0.0 0
M  V30 10 C 7.7722 3.5812 0.0 0
M  V30 11 C 7.0022 4.9150 0.0 0
M  V30 12 C 2.6673 3.0631 0.0 0
M  V30 13 C 1.3337 2.2931 0.0 0
M  V30 14 C 2.6673 4.6031 0.0 0
M  V30 15 C 0.0000 3.0631 0.0 0
M  V30 16 C 1.3337 5.3732 0.0 0
M  V30 17 C 0.0000 4.6031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzoyl-2,5-dihydro-N,2-dimethyl-1H-pyrrole-2-carboxamide
C14H16N2O2
946057-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0168 4.1914 0.0 0
M  V30 2 N 7.5568 4.1914 0.0 0
M  V30 3 O 5.2468 2.8578 0.0 0
M  V30 4 C 8.3268 2.8578 0.0 0
M  V30 5 C 6.6538 6.1516 0.0 0
M  V30 6 C 4.0009 3.0800 0.0 0
M  V30 7 O 5.3347 2.3100 0.0 0
M  V30 8 C 5.2468 5.5252 0.0 0
M  V30 9 N 4.0009 4.6200 0.0 0
M  V30 10 C 4.7709 6.9898 0.0 0
M  V30 11 C 2.7551 5.5252 0.0 0
M  V30 12 C 3.2309 6.9898 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 1.3336 3.0800 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 1.3336 0.0000 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 1 6 13
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946057-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946057-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13460607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%). 10{2,2,1}, yield 99%. Purity 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,5R)-1-Acetyl-2,5-dihydro-2-methyl-5-(phenylmethyl)-1H-pyrrole-2-carbo...
C15H17NO3
946057-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 2.5369 0.0 0
M  V30 2 O 1.9822 1.0722 0.0 0
M  V30 3 O 0.0000 2.8571 0.0 0
M  V30 4 C 1.2909 4.5865 0.0 0
M  V30 5 C 3.2472 1.0304 0.0 0
M  V30 6 C 1.7824 0.5546 0.0 0
M  V30 7 O 4.3916 0.0000 0.0 0
M  V30 8 C 6.3080 2.3932 0.0 0
M  V30 9 C 2.5369 3.6813 0.0 0 CFG=1
M  V30 10 N 3.5673 2.5369 0.0 0
M  V30 11 C 3.3068 5.0150 0.0 0
M  V30 12 C 4.9742 3.1632 0.0 0 CFG=2
M  V30 13 C 4.8132 4.6948 0.0 0
M  V30 14 C 7.6416 3.1632 0.0 0
M  V30 15 C 8.9753 2.3932 0.0 0
M  V30 16 C 7.6416 4.7033 0.0 0
M  V30 17 C 10.3090 3.1632 0.0 0
M  V30 18 C 8.9753 5.4733 0.0 0
M  V30 19 C 10.3090 4.7033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 9 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 12 8 CFG=1
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,5R)-1-Acetyl-2,5-dihydro-N,2-dimethyl-5-(phenylmethyl)-1H-pyrrole-2-c...
C16H20N2O2
946057-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3932 0.0 0
M  V30 2 C 7.0618 1.0306 0.0 0
M  V30 3 C 8.5264 0.5546 0.0 0
M  V30 4 O 5.9173 0.0000 0.0 0
M  V30 5 C 9.0179 4.5864 0.0 0
M  V30 6 N 10.4249 3.9601 0.0 0
M  V30 7 O 8.8570 6.1181 0.0 0
M  V30 8 C 11.6707 4.8653 0.0 0
M  V30 9 C 8.8025 2.5368 0.0 0
M  V30 10 C 5.3347 3.1632 0.0 0 CFG=2
M  V30 11 N 6.7417 2.5368 0.0 0
M  V30 12 C 5.4958 4.6948 0.0 0
M  V30 13 C 7.7721 3.6814 0.0 0 CFG=1
M  V30 14 C 7.0021 5.0150 0.0 0
M  V30 15 C 2.6674 3.1632 0.0 0
M  V30 16 C 2.6674 4.7032 0.0 0
M  V30 17 C 1.3336 2.3932 0.0 0
M  V30 18 C 1.3336 5.4732 0.0 0
M  V30 19 C 0.0000 3.1632 0.0 0
M  V30 20 C 0.0000 4.7032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 13 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 13 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946057-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946057-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6471593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%). 10{4,1,1}, yield 99%. Purity 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,5R)-1-Acetyl-2,5-dihydro-5-methyl-2-(phenylmethyl)-1H-pyrrole-2-carbo...
C15H17NO3
946057-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4512 1.8828 0.0 0
M  V30 2 C 3.4910 1.2459 0.0 0
M  V30 3 O 1.9595 1.0849 0.0 0
M  V30 4 O 4.3963 0.0000 0.0 0
M  V30 5 C 1.4070 2.2235 0.0 0
M  V30 6 C 1.5679 0.6919 0.0 0
M  V30 7 O 0.0000 2.8498 0.0 0
M  V30 8 C 1.4070 5.5739 0.0 0
M  V30 9 C 4.1175 2.6528 0.0 0 CFG=2
M  V30 10 N 2.6528 3.1287 0.0 0
M  V30 11 C 5.0226 3.8987 0.0 0
M  V30 12 C 2.6528 4.6687 0.0 0 CFG=2
M  V30 13 C 4.1175 5.1446 0.0 0
M  V30 14 C 6.7848 2.6528 0.0 0
M  V30 15 C 8.1185 1.8828 0.0 0
M  V30 16 C 6.7848 4.1928 0.0 0
M  V30 17 C 9.4523 2.6528 0.0 0
M  V30 18 C 8.1185 4.9628 0.0 0
M  V30 19 C 9.4523 4.1928 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 9 2 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 10
M  V30 9 1 12 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,5R)-1-Acetyl-2,5-dihydro-N,5-dimethyl-2-(phenylmethyl)-1H-pyrrole-2-c...
C16H20N2O2
946057-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4512 3.2898 0.0 0
M  V30 2 C 3.4910 2.6528 0.0 0
M  V30 3 N 4.3963 1.4070 0.0 0
M  V30 4 O 1.9595 2.4919 0.0 0
M  V30 5 C 3.7699 0.0000 0.0 0
M  V30 6 C 1.4070 3.6304 0.0 0
M  V30 7 C 1.5679 2.0989 0.0 0
M  V30 8 O 0.0000 4.2567 0.0 0
M  V30 9 C 1.4070 6.9809 0.0 0
M  V30 10 C 4.1175 4.0598 0.0 0 CFG=2
M  V30 11 N 2.6528 4.5356 0.0 0
M  V30 12 C 5.0226 5.3056 0.0 0
M  V30 13 C 2.6528 6.0756 0.0 0 CFG=2
M  V30 14 C 4.1175 6.5515 0.0 0
M  V30 15 C 6.7848 4.0598 0.0 0
M  V30 16 C 8.1185 3.2898 0.0 0
M  V30 17 C 6.7848 5.5998 0.0 0
M  V30 18 C 9.4523 4.0598 0.0 0
M  V30 19 C 8.1185 6.3698 0.0 0
M  V30 20 C 9.4523 5.5998 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 10 2 CFG=3
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 1 13 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946057-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946057-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10729373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%).
rac-(2R/S,5R/S)-1-Acetyl-2-benzyl-5-methyl-N-methyl-2,5-dihydro-1H-pyrrole-2-carboxamide
(10{5,1,1}): According to general Protocol F, 3,4-dehydroproline 16{5,1}
(17.0 mg, 0.066 mmol, 1 equiv), PS-Carbodiimide (0.10 mg, 0.13 mmol, 2
equiv), 1-hydroxybenzotriazole (9.0 mg, 0.066 mmol, 1 equiv), methylamine
13{1} (33 wt% in water) (0.018 mL, 0.20 mmol, 3 equiv) in dichloromethane
(1 mL) afforded 10{5,1,1} (18 mg, 98%) Purity 99%. 1H NMR (300.1 MHz, 290
K, CDCl3) δ 7.72 (bs, 1H), 7.23-7.19 (m, 3H), 7.07-7.04 (m, 2H), 5.97
(dd, J = 6.3, 1.7 Hz, 1H), 5.54 (dd, J = 6.3, 2.0 Hz, 1H), 4.05- 3.95 (m,
1H), 3.94 (d, J = 13.7 Hz, 1H), 3.15 (d, J = 13.6 Hz, 1H), 2.84 (d, J =
4.8 Hz, 3H), 2.09 (s, 3H), 1.22 (d, J = 6.3 Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1-Methyl (2R,5R)-2,5-dihydro-5-methyl-2-(phenylmethyl)-1H-pyrrole-1,2-dic...
C15H17NO4
946057-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.8828 0.0 0
M  V30 2 C 5.9612 1.2459 0.0 0
M  V30 3 O 7.4928 1.0849 0.0 0
M  V30 4 O 5.0560 0.0000 0.0 0
M  V30 5 C 8.0453 2.2235 0.0 0
M  V30 6 O 9.4523 2.8498 0.0 0
M  V30 7 O 7.8844 0.6919 0.0 0
M  V30 8 C 10.6981 1.9447 0.0 0
M  V30 9 C 8.0453 5.5739 0.0 0
M  V30 10 C 5.3347 2.6528 0.0 0 CFG=2
M  V30 11 N 6.7994 3.1287 0.0 0
M  V30 12 C 4.4295 3.8987 0.0 0
M  V30 13 C 6.7994 4.6687 0.0 0 CFG=2
M  V30 14 C 5.3347 5.1446 0.0 0
M  V30 15 C 2.6674 2.6528 0.0 0
M  V30 16 C 2.6674 4.1928 0.0 0
M  V30 17 C 1.3338 1.8828 0.0 0
M  V30 18 C 1.3338 4.9628 0.0 0
M  V30 19 C 0.0000 2.6528 0.0 0
M  V30 20 C 0.0000 4.1928 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 10 2 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 1 13 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (2R,5R)-2,5-dihydro-5-methyl-2-[(methylamino)carbonyl]-2-(phenylme...
C16H20N2O3
946057-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.2898 0.0 0
M  V30 2 C 5.9612 2.6528 0.0 0
M  V30 3 N 5.0560 1.4070 0.0 0
M  V30 4 O 7.4928 2.4919 0.0 0
M  V30 5 C 5.6823 0.0000 0.0 0
M  V30 6 C 8.0453 3.6304 0.0 0
M  V30 7 O 9.4523 4.2567 0.0 0
M  V30 8 O 7.8844 2.0989 0.0 0
M  V30 9 C 10.6981 3.3515 0.0 0
M  V30 10 C 8.0453 6.9809 0.0 0
M  V30 11 C 5.3347 4.0598 0.0 0 CFG=2
M  V30 12 N 6.7994 4.5356 0.0 0
M  V30 13 C 4.4295 5.3056 0.0 0
M  V30 14 C 6.7994 6.0756 0.0 0 CFG=2
M  V30 15 C 5.3347 6.5515 0.0 0
M  V30 16 C 2.6674 4.0598 0.0 0
M  V30 17 C 1.3338 3.2898 0.0 0
M  V30 18 C 2.6674 5.5998 0.0 0
M  V30 19 C 0.0000 4.0598 0.0 0
M  V30 20 C 1.3338 6.3698 0.0 0
M  V30 21 C 0.0000 5.5998 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 11 2 CFG=1
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 1 7 9
M  V30 11 1 14 10 CFG=1
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946057-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946057-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12860837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%). 10{5,3,1}, yield 99%. Purity 96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
9-[2,5-Anhydro-4-C-carboxy-3-O-(phenylmethyl)-α-L-lyxofuranosyl]-9H-purin-6-a...
C18H17N5O5
946530-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1225 1.5397 0.0 0
M  V30 2 O 5.0917 0.0000 0.0 0
M  V30 3 O 3.8046 2.3362 0.0 0
M  V30 4 O 4.0009 3.9048 0.0 0
M  V30 5 C 4.0009 5.4448 0.0 0
M  V30 6 N 14.5792 6.5162 0.0 0
M  V30 7 C 6.4714 2.2827 0.0 0 CFG=1
M  V30 8 C 5.3347 3.1348 0.0 0 CFG=1
M  V30 9 O 7.6402 2.9342 0.0 0
M  V30 10 C 6.5967 0.7121 0.0 0
M  V30 11 C 7.7514 2.1019 0.0 0 CFG=1
M  V30 12 C 8.9286 3.0061 0.0 0 CFG=1
M  V30 13 O 7.7790 0.7021 0.0 0
M  V30 14 N 10.3724 3.5420 0.0 0
M  V30 15 C 10.7875 5.0250 0.0 0
M  V30 16 C 11.6546 2.6888 0.0 0
M  V30 17 C 12.3262 5.0885 0.0 0
M  V30 18 N 9.9632 6.3257 0.0 0
M  V30 19 N 12.8621 3.6447 0.0 0
M  V30 20 C 13.0406 6.4528 0.0 0
M  V30 21 C 10.6776 7.6900 0.0 0
M  V30 22 N 12.2162 7.7536 0.0 0
M  V30 23 C 2.6673 6.2148 0.0 0
M  V30 24 C 2.6673 7.7548 0.0 0
M  V30 25 C 1.3336 5.4448 0.0 0
M  V30 26 C 1.3336 8.5248 0.0 0
M  V30 27 C 0.0000 6.2148 0.0 0
M  V30 28 C 0.0000 7.7548 0.0 0
M  V30 29 H 9.1394 1.4347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 4 5
M  V30 5 1 8 4 CFG=1
M  V30 6 1 5 23
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 29 CFG=1
M  V30 17 1 12 14 CFG=1
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 15 18
M  V30 22 2 16 19
M  V30 23 1 17 19
M  V30 24 2 17 20
M  V30 25 1 18 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[2,5-Anhydro-4-C-[(methylamino)carbonyl]-3-O-(phenylmethyl)-α-L-lyxofuranos...
C19H20N6O4
946530-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1225 2.2827 0.0 0
M  V30 2 N 5.0917 0.7431 0.0 0
M  V30 3 O 3.8046 3.0794 0.0 0
M  V30 4 C 3.7428 0.0000 0.0 0
M  V30 5 O 4.0009 4.6480 0.0 0
M  V30 6 C 4.0009 6.1880 0.0 0
M  V30 7 N 14.5792 7.2594 0.0 0
M  V30 8 C 6.4714 3.0259 0.0 0 CFG=1
M  V30 9 C 5.3347 3.8780 0.0 0 CFG=1
M  V30 10 O 7.6402 3.6774 0.0 0
M  V30 11 C 6.5967 1.4553 0.0 0
M  V30 12 C 7.7514 2.8450 0.0 0 CFG=1
M  V30 13 C 8.9286 3.7493 0.0 0 CFG=1
M  V30 14 O 7.7790 1.4453 0.0 0
M  V30 15 N 10.3724 4.2852 0.0 0
M  V30 16 C 10.7875 5.7682 0.0 0
M  V30 17 C 11.6546 3.4320 0.0 0
M  V30 18 C 12.3262 5.8317 0.0 0
M  V30 19 N 9.9632 7.0689 0.0 0
M  V30 20 N 12.8621 4.3879 0.0 0
M  V30 21 C 13.0406 7.1960 0.0 0
M  V30 22 C 10.6776 8.4332 0.0 0
M  V30 23 N 12.2162 8.4968 0.0 0
M  V30 24 C 2.6673 6.9580 0.0 0
M  V30 25 C 1.3336 6.1880 0.0 0
M  V30 26 C 2.6673 8.4980 0.0 0
M  V30 27 C 0.0000 6.9580 0.0 0
M  V30 28 C 1.3336 9.2680 0.0 0
M  V30 29 C 0.0000 8.4980 0.0 0
M  V30 30 H 9.1394 2.1779 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 9 5 CFG=1
M  V30 7 1 6 24
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 30 CFG=1
M  V30 18 1 13 15 CFG=1
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 2 17 20
M  V30 24 1 18 20
M  V30 25 2 18 21
M  V30 26 1 19 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 946530-50-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946530-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1367926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of LNA nucleosides as
adenosine A3 receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ravn, Jacob; Qvortrup, Katrine; Rosenbohm, Christoph; Koch, Troels
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(16), 5440-5447

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
3-(Cyclopentylsulfonyl)benzoic acid
C12H14O4S
956235-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 3.0801 0.0 0 VAL=6
M  V30 2 O 4.5411 4.4137 0.0 0
M  V30 3 O 3.0011 1.7464 0.0 0
M  V30 4 C 9.1059 3.0801 0.0 0
M  V30 5 O 9.1059 4.6201 0.0 0
M  V30 6 O 10.4396 2.3101 0.0 0
M  V30 7 C 5.1048 2.3101 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 5.1048 0.7700 0.0 0
M  V30 10 C 7.7722 2.3101 0.0 0
M  V30 11 C 6.4384 0.0000 0.0 0
M  V30 12 C 7.7722 0.7700 0.0 0
M  V30 13 C 2.4374 3.8501 0.0 0
M  V30 14 C 2.2763 5.3816 0.0 0
M  V30 15 C 1.0304 3.2236 0.0 0
M  V30 16 C 0.7700 5.7018 0.0 0
M  V30 17 C 0.0000 4.3682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-(cyclopentylsulfonyl)-N-methyl-
C13H17NO3S
956235-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 3.0801 0.0 0 VAL=6
M  V30 2 O 3.0011 1.7464 0.0 0
M  V30 3 O 4.5411 4.4137 0.0 0
M  V30 4 C 9.1059 3.0801 0.0 0
M  V30 5 N 10.4396 2.3101 0.0 0
M  V30 6 O 9.1059 4.6201 0.0 0
M  V30 7 C 11.7733 3.0801 0.0 0
M  V30 8 C 5.1048 2.3101 0.0 0
M  V30 9 C 6.4384 3.0801 0.0 0
M  V30 10 C 5.1048 0.7700 0.0 0
M  V30 11 C 7.7722 2.3101 0.0 0
M  V30 12 C 6.4384 0.0000 0.0 0
M  V30 13 C 7.7722 0.7700 0.0 0
M  V30 14 C 2.4373 3.8501 0.0 0
M  V30 15 C 2.2763 5.3816 0.0 0
M  V30 16 C 1.0304 3.2236 0.0 0
M  V30 17 C 0.7700 5.7018 0.0 0
M  V30 18 C 0.0000 4.3682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 11
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 956235-16-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956235-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9105403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(Cyclopentylsulfonyl)-N-methylbenzamide To a solution of 1410 mg (5.545
mmol) of Intermediate 65 in 47 ml of chloroform (ethanol free), cooled to
0-5°C, three drops of anhydrous dimethylformamide and 0.75 ml (1128 mg,
8.887 mmol) of oxalyl chloride were added. The reaction mixture was
stirred 15 minutes at 0-5°C and 2 hours at room temperature, then was
concentrated at reduced pressure. Chloroform (ethanol free) was added to
the residue and the solution was concentrated again (x2). The obtained
residue was dissolved in 28 ml of anhydrous tetrahydrofuran and cooled to
-30°C. A solution of 19 ml (38 mmol) of commercially available 2M
solution of methyl amine in tetrahydrofuran, diluted with 20 ml of
tetrahydrofuran, was slowly added. The reaction mixture was left to warm
to room temperature and the stirring was continued for 16 hours. After
this reaction time, the reaction mixture was concentrated under reduced
pressure. The obtained residue was dissolved in chloroform and the
organic solution was washed with water (x2). The organic phase was
separated, dried (MgSO4), and concentrated under reduced pressure.
Chloroform was added to the residue and the solution was concentrated to
dryness (x2).The title product was obtained as an oil (1467 mg, 99%).
3-(Cyclopentylsulfonyl)-N-methylbenzamide, yield 1467 mg, 99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(2-Amino-1-hydroxyethyl)phenol derivatives as agonists of the β2
adrenergic receptor, their preparation, pharmaceutical compositions, and
use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Prat Quinones, Maria; Perez Crespo, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007124898 A1 2007-11-08

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-β-alanine methyl ester
C5H11NO2
24549-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24549-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8674205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1298062-16-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, ionic liquid catalyst used, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a novel ionic liquid with both Lewis and Bronsted acid sites
and its catalytic activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Xuezheng; Qi, Chenze
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2011), 12(9), 808-812

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-β-alanine methyl ester
C5H11NO2
24549-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24549-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14932664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1360467-48-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, Michael addition, mechanism
studied, scalable, ionic liquid used (catalyst), catalyst recyclable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel ionic liquid with both Lewis and Bronsted acid sites for Michael
addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xiaoyue; Ye, Weidong; Song, Xiaohua; Ma, Wenxin; Lao, Xuejun;
Shen, Runpu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2011), 127438-7444

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenyl-4,6-bis(2-propen-1-yloxy)-1,3,5-triazine
C15H15N3O2
964-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 7.7002 0.0 0
M  V30 2 C 9.3360 6.9302 0.0 0
M  V30 3 C 10.6697 7.7002 0.0 0
M  V30 4 C 12.0033 6.9302 0.0 0
M  V30 5 O 5.3348 3.0801 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 6.6685 0.7700 0.0 0
M  V30 8 C 8.0022 0.0000 0.0 0
M  V30 9 C 4.0012 6.9302 0.0 0
M  V30 10 N 5.3348 7.7002 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 6.6685 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 N 6.6685 5.3901 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 2.6673 9.2402 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 1.3337 10.0102 0.0 0
M  V30 19 C 0.0000 7.7002 0.0 0
M  V30 20 C 0.0000 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-phenyl-6-(2-propen-1-yloxy)-1,3,5-triazin-2-amine
C13H14N4O
2824176-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 5.3901 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 C 10.6697 5.3901 0.0 0
M  V30 4 C 12.0033 4.6201 0.0 0
M  V30 5 N 5.3348 0.7700 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 N 5.3348 5.3901 0.0 0
M  V30 9 N 4.0012 3.0801 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 N 6.6685 3.0801 0.0 0
M  V30 13 C 2.6673 5.3901 0.0 0
M  V30 14 C 2.6673 6.9302 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 1.3337 7.7002 0.0 0
M  V30 17 C 0.0000 5.3901 0.0 0
M  V30 18 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 964-85-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2824176-71-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33833325
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Adaptive Rhodium Catalyst to Control the Hydrogenation Network of
Nitroarenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chugh, Vishal; Chatterjee, Basujit; Chang, Wei-Chieh; Cramer, Hanna H.;
Hindemith, Carsten; Randel, Helena; Weyhermueller, Thomas; Fares,
Christophe; Werle, Christophe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(36), e202205515

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-thiazolecarboxylate
C12H18N2O4S
96929-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.3158 5.8826 0.0 0
M  V30 2 O 12.7226 5.2562 0.0 0
M  V30 3 O 11.1547 7.4142 0.0 0
M  V30 4 C 13.9684 6.1614 0.0 0
M  V30 5 C 15.3754 5.5351 0.0 0
M  V30 6 C 6.1600 4.2074 0.0 0
M  V30 7 N 5.3900 2.8736 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 O 3.0800 1.5400 0.0 0
M  V30 10 O 3.0800 4.2074 0.0 0
M  V30 11 C 1.5400 1.5400 0.0 0
M  V30 12 C 1.5400 3.0800 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 10.0699 4.9774 0.0 0
M  V30 16 N 8.6052 5.4533 0.0 0
M  V30 17 C 10.0699 3.4374 0.0 0
M  V30 18 C 7.7000 4.2074 0.0 0
M  V30 19 S 8.6052 2.9616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-[(methylamino)carbonyl]-2-thiazolyl]methyl]carbamate
C11H17N3O3S
1266095-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 O 2.6673 2.3101 0.0 0
M  V30 5 O 4.0010 0.0000 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 2.1037 0.2064 0.0 0
M  V30 10 C 11.9711 2.6672 0.0 0
M  V30 11 N 12.8764 3.9131 0.0 0
M  V30 12 O 12.5976 1.2602 0.0 0
M  V30 13 C 14.4079 3.7521 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 N 9.4091 1.6836 0.0 0
M  V30 16 S 8.1633 3.8416 0.0 0
M  V30 17 C 10.4396 2.8281 0.0 0
M  V30 18 C 9.6696 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96929-05-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1266095-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11075391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3.9 tert-Butyl (4-carbamoylthiazol-2-yl)methylcarbamate (6). 15 (5 g, 17
mmol) was dissolved in methylamine-alcoholic solution (20 ml) and stirred
at room temperature for 1.5 h. After solvent removal by rotary
evaporation, the residue was crystallized from ethyl acetate-light
petroleum ether. Compound 6 as a white solid, yield 4.5 g, 98.5%. Mp
127-128δC; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.03 (s, 1H, C=CHS), 5.25
(brs, 1H, NH), 4.59 (d, J = 5.7 Hz, 2H, CH2), 3.00 (d, J = 5.4 Hz, 3H,
NHCH3), 1.47 (s, 9H, (CH3)3C); HRESIMS: m/z 294.0883 [M + Na]+ (calcd for
C11H17N3O3NaS, 294.0882).
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield 65% from Boc-Gly over three steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise total synthesis of largazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Qiong; Wang, Li-Ping; Jiao, Xiao-Zhen; Liu, Xiao-Yu; Wu, Qian; Xie,
Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Asian Natural Products Research (2010), 12(11-12), 940-949

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-chloro-4-fluorophenyl)acetamide
C8H6Cl2FNO
96980-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 Cl 9.3360 2.3101 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-4-fluorophenyl)-2-(methylamino)acetamide
C9H10ClFN2O
1040320-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3349 0.0 0
M  V30 5 N 9.2400 5.3349 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 F 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96980-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1040320-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6094428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde
C5H4OS
98-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-thiophenemethanamine
C6H9NS
58255-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 S 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58255-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11913096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxidation of secondary amines by molecular oxygen and cyclohexanone
monooxygenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Colonna, Stefano; Pironti, Vincenza; Carrea, Giacomo; Pasta, Piero;
Zambianchi, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(3), 569-575

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine
C6H4Cl2N4
98141-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 C 6.6520 4.5603 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 C 2.6675 4.6201 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 C 2.9877 6.1264 0.0 0
M  V30 8 N 4.0012 2.3101 0.0 0
M  V30 9 N 5.1456 4.8805 0.0 0
M  V30 10 N 1.3337 2.3101 0.0 0
M  V30 11 N 4.5192 6.2873 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,1-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C7H8ClN5
5326-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6520 4.6201 0.0 0
M  V30 2 C 7.9857 3.8501 0.0 0
M  V30 3 C 0.0000 4.5603 0.0 0
M  V30 4 Cl 3.9845 0.0000 0.0 0
M  V30 5 C 3.9845 4.6201 0.0 0
M  V30 6 C 2.6509 3.8501 0.0 0
M  V30 7 C 5.3182 3.8501 0.0 0
M  V30 8 C 3.6644 6.1264 0.0 0
M  V30 9 N 1.5065 4.8805 0.0 0
M  V30 10 N 2.6509 2.3101 0.0 0
M  V30 11 N 5.3182 2.3101 0.0 0
M  V30 12 N 2.1328 6.2873 0.0 0
M  V30 13 C 3.9845 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98141-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5326-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22987931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA
Synthetase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Torrie, Leah S.; Robinson, David A.; Thomas, Michael G.; Hobrath, Judith
V.; Shepherd, Sharon M.; Post, John M.; Ko, Eun-Jung; Ferreira, Rafael
Alves; Mackenzie, Claire J.; Wrobel, Karolina; Edwards, Darren P.;
Gilbert, Ian H.; Gray, David W.; Fairlamb, Alan H.; De Rycker, Manu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2020), 6(5), 1044-1057

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-chloro-4-methylphenyl)acetamide
C9H9Cl2NO
99585-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 Cl 9.3360 2.3101 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-4-methylphenyl)-2-(methylamino)acetamide
C10H13ClN2O
1016815-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3349 0.0 0
M  V30 5 N 9.2400 5.3349 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99585-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016815-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1567196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Carboxybenzaldehyde
C8H6O3
119-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylamino)methyl]benzoic acid
C9H11NO2
527705-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 527705-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14824140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New protected protecting groups for the 5'-hydroxy group of
deoxynucleosides by use of 2-(hydroxymethyl)- and
2-[(methylamino)methyl]benzoyl skeletons and oxidatively cleavable
tritylthio and (4-methoxytrityl)thio groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seio, Kohji; Utagawa, Eri; Sekine, Mitsuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2004), 87(9), 2318-2333

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9984036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM air-sensitive product, stored in cold
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Heterocyclic Product Space for the Castagnoli-Cushman Three-Component
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dar'in, Dmitry; Bakulina, Olga; Chizhova, Maria; Krasavin, Mikhail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(15), 3930-3933

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-4-amino-4-oxo-2-butenoate
C5H7NO3
155063-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 O 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-3-(methylamino)-4-oxobutanoate
C6H12N2O3
1021333-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155063-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021333-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8495764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for N-alkyl-DL-isoasparagine
β-methyl esters To a methanolic solution (8 ml) of methyl maleamate (0.01
mol), methanol solution (4 ml) of amine (0.01 mol) was added at 0 °C. The
reaction mixture was stirred for 24 h at 20 °C. The solvent was
evaporated in vacuo to dryness. A transparent oil of
N-alkyl-DL-isoasparagine β-methyl esters was obtained in good yield.
N-methyl-DL-isoasparagine β-methyl ester, Yield: 98%, Ratio of i/a: 100.
1H-NMR (DMSO-d6, 600 MHz): δ = 2.21 (3 H, s, NCH3), 2.39 (1 H, dd, 3J2 =
8.27 Hz, 2J3 = 15.38 Hz HC-H), 2.57 (1 H, dd, 3J1 = 5.58 Hz, 2J3 = 15.38
Hz, H-CH), 3.29 (1 H, dd, 3J1 = 5.58 Hz, 3J2 = 8.27 Hz, C-H), 3.59 (3 H,
s, OCH3), 7.11 (1 H, s, NH), 7.48 (1 H, s, NH). 13C-NMR: 33.5 (3-CH2),
37.1 ( N-Me), 47.1 (OMe), 60.8 (2-CH), 172.8 (4-C═O) 174.0 (1-C═O) MW=
160.17 ESI-MS m/z: 160.19 M + H]+ Anal. Calc. for C6H12N2O3 C= 44.99%
H=7.55% N=17.49% Found C = 45.13 % H = 7.62 % N = 17.41 %. CH i (ppm):
3.29, CH a (ppm): 3.18.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic and quantum chemical study on the regioselective addition of
amines to methyl maleamate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Racz, Akos; Varadi, Andras; Mazak, Karoly; Kokosi, Jozsef; Noszal, Bela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Modeling (2013), 19(9), 3683-3694

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23316761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinations comprising benzodioxol as GLP-1R agonists for use in the
treatment of NASH/NAFLD and related diseases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aspnes, Gary E.; Bagley, Scott W.; Curto, John M.; Dowling, Matthew;
Edmonds, David James; Fernando, Dilinie; Flanagan, Mark E.; Futatsugi,
Kentaro; Griffith, David Andrew; Huard, Kim; Ingle, Gajendra; Jiao,
Wenhua; Lacasse, Shawn M.; Lian, Yajing; Limberakis, Chris; Londregan,
Allyn T.; Mathiowetz, Alan M.; Piotrowski, David Walter; Ruggeri, Roger
B.; Wiglesworth, Kristin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020234726 A1 2020-11-26

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21674726
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-,
and 7-aza-benzimidazoles as GLP-1R agonists for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aspnes, Gary Erik; Bagley, Scott W.; Curto, John M.; Edmonds, David
James; Flanagan, Mark E.; Futatsugi, Kentaro; Griffith, David A.; Huard,
Kim; Lian, Yajing; Limberakis, Chris; Londregan, Allyn T.; Mathiowetz,
Alan M.; Piotrowski, David W.; Riggeri, Roger B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA3045644 A1 2019-12-13

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20204541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole-6-carboxylic acids as GLP-1 receptor
agonists useful in treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aspnes, Gary Erik; Bagley, Scott W.; Curto, John M.; Dowling, Matthew S.;
Edmonds, David James; Flanagan, Mark E.; Futatsugi, Kentaro; Griffith,
David A.; Huard, Kim; Ingle, Gajendra; Jiao, Wenhua; Limberakis, Chris;
Mathiowetz, Alan M.; Piotrowski, David W.; Ruggeri, Roger B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2988721 A1 2018-06-16

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3,4-Dimethoxyphenyl)propionic acid
C11H14O4
2107-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 C 7.7002 5.3348 0.0 0
M  V30 7 C 9.2402 5.3348 0.0 0
M  V30 8 O 10.0102 4.0012 0.0 0
M  V30 9 O 10.0102 6.6687 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 C 2.3101 4.0012 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 5.3901 4.0012 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,4-dimethoxydihydrocinnamate
C12H16O4
27798-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 C 7.7001 5.3348 0.0 0
M  V30 7 C 9.2401 5.3348 0.0 0
M  V30 8 O 10.0101 6.6686 0.0 0
M  V30 9 O 10.0101 4.0011 0.0 0
M  V30 10 C 11.5501 6.6686 0.0 0
M  V30 11 C 3.0800 2.6675 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 5.3901 4.0011 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2107-70-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27798-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25241592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecar...
C16H22BrN3O4
2589532-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperaz...
C16H23BrN4O3
2589532-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37237052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinoxaline derivatives as PARP inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamerlik, Petra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023118085 A1 2023-06-29

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecar...
C16H22BrN3O4
2589532-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-bromo-6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperaz...
C16H23BrN4O3
2589532-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31138217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Quinoxalines as anti-cancer drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Packer, Martin John; Degorce, Sebastien Louis; Johannes, Jeffrey Wallace;
Hande, Sudhir Mahadeo; Ghosh, Avipsa; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021260092 A1 2021-12-30

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14650033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Haloarylsulfonamides: multiple cyclization pathways to skeletally
diverse benzofused sultams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rayabarapu, Dinesh Kumar; Zhou, Aihua; Jeon, Kyu Ok; Samarakoon,
Thiwanka; Rolfe, Alan; Siddiqui, Hina; Hanson, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(16), 3180-3188

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-(bromomethyl)-4,5-dimethoxybenzoate
C11H12Br2O4
1042722-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 Br 2.6675 7.7002 0.0 0
M  V30 7 Br 1.3337 5.3901 0.0 0
M  V30 8 O 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,3-dihydro-5,6-dimethoxy-2-methyl-1H-isoindol-1-one
C11H12BrNO3
1042722-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.0812 6.6686 0.0 0
M  V30 2 O 0.3504 3.2909 0.0 0
M  V30 3 O 7.6213 4.0011 0.0 0
M  V30 4 C 8.3913 5.3348 0.0 0
M  V30 5 C 0.0000 6.6229 0.0 0
M  V30 6 O 6.0812 1.3338 0.0 0
M  V30 7 C 5.3112 0.0000 0.0 0
M  V30 8 C 3.7712 5.3348 0.0 0
M  V30 9 C 3.0012 4.0011 0.0 0
M  V30 10 C 5.3112 5.3348 0.0 0
M  V30 11 C 2.7406 6.4793 0.0 0
M  V30 12 C 3.7712 2.6675 0.0 0
M  V30 13 C 1.4947 4.3213 0.0 0
M  V30 14 C 6.0812 4.0011 0.0 0
M  V30 15 N 1.3338 5.8529 0.0 0
M  V30 16 C 5.3112 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1042722-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042722-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-484551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: < Step 3> Methyl
3-bromo-2-(bromomethyl)benzoate (5.27 g, 17 mmol) obtained in Step 2 was
dissolved in of tetrahydrofuran, 40% methylamine aqueous solution (7.5
mi, 86 mmol) was added thereto, and the mixture was allowed to react for
2 hours at room temperature. The solvent was removed under a low
pressure, and the resulting residue was diluted with water and extracted
with ethyl acetate. The resulting organic layer was washed with saturated
sodium, dried over anhydrous magnesium sulfate, and the solvent was
removed under a reduced pressure. The resulting residue was subjected to
silica gel column chromatography. <Step 1> The procedure of Step 3 of
Example 1 was repeated except for using methyl
3-bromo-2-(bromomethyl)-4,5-dimethoxybenzoate obtained in Step 2 of
Example 5 as a starting material instead of methyl
3-bromo-2-(bromomethyl)benzoate to obtain
4-bromo-5,6-dimethoxy-2-methylisoindolin-1-one (98%). 1H NMR (300 MHz,
CDCl3) δ 7.26 (s, 1H), 4.23 (s, 2H), 3.93 (s, 3H), 3.92 (s, 3H), 3.20 (s,
3H). 13C NMR (125 MHz, CDCl3) δ 168.1, 154.5, 149.5, 134.7, 129.6, 112.6,
106.2, 61.1,56.6, 52.5,29.8. MS (EI): theoretical value for
C11H12BrNO3-285(m/z), real value-284.9 (M+, 95), 286.9 (96), 255.9 (100),
206.0 (42).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenanthrene lactam derivatives having anticancer activity
and method for the preparation thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heo, Jung Nyoung; Kim, Bum Tae; Min, Yong Ki; Choi, Sang Un; Lee, Hyuk;
Chang, Sung Youn; Park, No Kyun; Kim, Joa Kyum; Kim, Young Ha; Park, Mi
Kyung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009051417 A2 2009-04-23

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
5-Methyl-3-phenylisoxazole-4-carboxylic acid
C11H9NO3
1136-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 1.1444 0.0 0
M  V30 2 O 2.1559 0.0000 0.0 0
M  V30 3 O 4.6927 0.8242 0.0 0
M  V30 4 C 0.0000 2.1797 0.0 0
M  V30 5 C 3.6156 3.8549 0.0 0
M  V30 6 C 2.7104 2.6091 0.0 0
M  V30 7 N 2.7104 5.1008 0.0 0
M  V30 8 C 1.2459 3.0849 0.0 0
M  V30 9 O 1.2459 4.6250 0.0 0
M  V30 10 C 5.1556 3.8549 0.0 0
M  V30 11 C 5.9256 5.1886 0.0 0
M  V30 12 C 5.9256 2.5213 0.0 0
M  V30 13 C 7.4656 5.1886 0.0 0
M  V30 14 C 7.4656 2.5213 0.0 0
M  V30 15 C 8.2357 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-3-phenyl-4-isoxazolecarboxamide
C12H12N2O2
60986-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 2.6092 0.0 0
M  V30 2 N 2.1559 1.4647 0.0 0
M  V30 3 O 4.6927 2.2889 0.0 0
M  V30 4 C 2.6317 0.0000 0.0 0
M  V30 5 C 0.0000 3.6444 0.0 0
M  V30 6 C 3.6156 5.3196 0.0 0
M  V30 7 C 2.7104 4.0738 0.0 0
M  V30 8 N 2.7104 6.5655 0.0 0
M  V30 9 C 1.2459 4.5496 0.0 0
M  V30 10 O 1.2459 6.0897 0.0 0
M  V30 11 C 5.1556 5.3196 0.0 0
M  V30 12 C 5.9256 6.6534 0.0 0
M  V30 13 C 5.9256 3.9860 0.0 0
M  V30 14 C 7.4656 6.6533 0.0 0
M  V30 15 C 7.4656 3.9860 0.0 0
M  V30 16 C 8.2357 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1136-45-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60986-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-503557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of a series of highly potent activators of the Nurr1
signaling pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hintermann, Samuel; Chiesi, Michele; von Krosigk, Ulrike; Mathe, Daniele;
Felber, Richard; Hengerer, Bastian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(1), 193-196

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitropyridine
C5H3ClN2O2
13091-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-pyridinamine
C6H7N3O2
1633-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13091-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11179734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 121.
8-(4-Fluorophenyl)-9-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one.
Example 121A. N-Methyl-3-nitropyridin-4-amine. To a suspension of
4-chloro-3-nitropyridine (2 g, 12.6 mmol) in dichloromethane (15 mL) was
cautiously added methyl amine (25% solution in water, 10 mL, 63 mmol).
The reaction mixture was heated to 40 °C. After stirring for 1 h, the
mixture was poured into water (20 mL), and the precipitate was collected
by filtration and dried in vacuo.
8-(4-Fluorophenyl)-9-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one.
(1.9 g, yield 98%) as a yellow solid. LC-MS (ESI) m/z: 154 (M+1)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydropyridophthalazinone derivatives as poly(ADP-ribose)polymerase
(PARP) inhibitors and their preparation and use for the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Bing; Chu, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011130661 A1 2011-10-20

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitropyridine
C5H3ClN2O2
13091-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-pyridinamine
C6H7N3O2
1633-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13091-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11899796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 121.
8-(4-Fluorophenyl)-9-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one.
Example 121A. N-Methyl-3-nitropyridin-4-amine. To a suspension of
4-chloro-3-nitropyridine (2 g, 12.6 mmol) in dichloromethane (15 mL) was
cautiously added methyl amine (25% solution in water, 10 mL, 63 mmol).
The reaction mixture was heated to 40 °C. After stirring for 1 h, the
mixture was poured into water (20 mL), and the precipitate was collected
by filtration and dried in vacuo to afford the title compound (1.9 g,
yield 98%) as a yellow solid. LC-MS (ESI) m/z: 154 (M+1)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydropyridophthalazinone as inhibitors of
poly(adp-ribose)polymerase (PARP) for treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Bing; Chu, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2462361 A 2010-02-10

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-hydroxybenzaldehyde
C7H5ClO2
1927-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[(methylimino)methyl]phenol
C8H8ClNO
63770-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1927-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63770-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lithium Half-Salen Complexes: Synthesis, Structural Characterization and
Studies as Catalysts for rac-Lactide Ring-Opening Polymerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yali; Nichol, Gary S.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(40), 5557-5568

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
8-Bromo-1,6-naphthyridine-2-carboxylic acid
C9H5BrN2O2
197507-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3336 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 N 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-1,6-naphthyridine-2-carboxamide
C10H8BrN3O
875514-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6684 1.5400 0.0 0
M  V30 3 N 8.0022 2.3100 0.0 0
M  V30 4 O 6.6684 0.0000 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 C 2.6675 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 N 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 197507-55-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875514-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15638349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel naphthryidines and isoquinolines and their use as
CDK8/19 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schiemann, Kai; Blagg, Julian; Mallinger, Aurelie; Rink, Christian;
Sejberg, Jimmy; Honey, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016009076 A1 2016-01-21

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13213629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1b. 4-Chloro-N-methylpicolinamide (Compound 103). To a methanol
solution (4 mL) of compound 102 (10.0 g, 58.6 mmol) was added CH3NH2 (7.3
g, 234.4 mmol) in methanol at the temperature below 5°C. The mixture was
stirred at 0-5 °C for 2 h. The solvent was evaporated at 40-50 °C to give
the title compound 103 as a black yellow solid (9.8 g, 98%). LCMS: 171
[M+1]+; 1H NMR(DMSO-d6): δ 2.80 (d, 3H), 7.68 (dd, J1= 5.4 Hz, J2= 2.4
Hz, 1H), 7.97 (d, J= 2.4 Hz, 1H), 8.56 (d, 1H), 8.82 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-functional small molecules as anti-proliferative agents and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Xiong; Qian, Changgeng; Gould, Stephen; Zhai, Haixiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033747 A2 2008-03-20

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-tert-Butylsalicylaldehyde
C11H14O2
24623-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl)-6-[(methylimino)methyl]phenol
C12H17NO
479507-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 8.0023 2.3101 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24623-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479507-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lithium Half-Salen Complexes: Synthesis, Structural Characterization and
Studies as Catalysts for rac-Lactide Ring-Opening Polymerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yali; Nichol, Gary S.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(40), 5557-5568

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2,4-dinitro-N-[4-(octyloxy)phenyl]benzenamine
C20H24ClN3O5
1000054-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 Cl 4.0012 6.9302 0.0 0
M  V30 6 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 O 1.3337 6.9302 0.0 0
M  V30 9 O 12.0033 5.3901 0.0 0
M  V30 10 C 13.3370 4.6201 0.0 0
M  V30 11 C 14.6708 5.3901 0.0 0
M  V30 12 C 16.0045 4.6201 0.0 0
M  V30 13 C 17.3382 5.3901 0.0 0
M  V30 14 C 18.6718 4.6201 0.0 0
M  V30 15 C 20.0057 5.3901 0.0 0
M  V30 16 C 21.3393 4.6201 0.0 0
M  V30 17 C 22.6730 5.3901 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 4.0012 5.3901 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 8.0022 3.0801 0.0 0
M  V30 25 C 8.0022 4.6201 0.0 0
M  V30 26 C 9.3360 2.3101 0.0 0
M  V30 27 C 9.3360 5.3901 0.0 0
M  V30 28 C 10.6697 3.0801 0.0 0
M  V30 29 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 24
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 5 22
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 23
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-4,6-dinitro-N3-[4-(octyloxy)phenyl]-1,3-benzenediamine
C21H28N4O5
1000054-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 2 O 2.6673 0.0000 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 6 O 1.3337 6.9302 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 N 4.0012 6.9302 0.0 0
M  V30 9 C 5.3348 7.7002 0.0 0
M  V30 10 O 12.0033 5.3901 0.0 0
M  V30 11 C 13.3370 4.6201 0.0 0
M  V30 12 C 14.6708 5.3901 0.0 0
M  V30 13 C 16.0045 4.6201 0.0 0
M  V30 14 C 17.3382 5.3901 0.0 0
M  V30 15 C 18.6718 4.6201 0.0 0
M  V30 16 C 20.0057 5.3901 0.0 0
M  V30 17 C 21.3393 4.6201 0.0 0
M  V30 18 C 22.6730 5.3901 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 5.3348 3.0801 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 5.3348 4.6201 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 4.0012 5.3901 0.0 0
M  V30 25 C 8.0022 3.0801 0.0 0
M  V30 26 C 9.3360 2.3101 0.0 0
M  V30 27 C 8.0022 4.6201 0.0 0
M  V30 28 C 10.6697 3.0801 0.0 0
M  V30 29 C 9.3360 5.3901 0.0 0
M  V30 30 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 4 20
M  V30 5 1 4 25
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000054-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000054-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9069603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methylamino-5-(3-methylphenyl)amino-2,4-dinitrobenzene (S8).
Chloroarene (2.00 g, 6.50 mmol), methylamine (40 wt% in H2O, 2.02 g, 26.0
mmol), and EtOH (15 mL) were combined in a vial, which was later sealed
with a Teflon-lined screw-cap. The mixture was vigorously stirred at 70
°C for 24 h. After pouring the cooled reaction mixture into H2O (50 mL),
precipitated solids were collected by vacuum filtration, rinsed with H2O,
and dried under vacuum.
1-(4-Butylphenyl)-5-methylamino-2,4-dinitrobenzene as an orange powder,
yield 1.02 g, 98%. 1H NMR (300 MHz, CDCl3): δ 9.79 (br s, 1H), 9.29 (s,
1H), 8.24 (br s, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.23 (d, J = 8.8 Hz, 2H),
6.08 (s, 1H), 2.82 (d, J = 4.8 Hz, 3H), 2.65 (t, J = 7.7 Hz, 2H),
1.67-1.62 (m, 2H), 1.33-1.28 (m, 10H), 0.88 (t, J = 6.5 Hz, 3H); 13C NMR
(75 MHz, CDCl3): δ 149.3, 147.7, 142.0, 134.9, 129.8, 129.4, 125.2,
124.9, 124.3, 92.2, 35.5, 31.8, 31.3, 29.7, 29.4, 29.2, 22.6, 14.1; HRMS
m/z calcd for C21H29N4O4 [M+H+] 401.2186, found 401.2183.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phase-tunable fluorophores based upon benzobis(imidazolium) salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boydston, Andrew J.; Pecinovsky, Cory S.; Chao, Steven T.; Bielawski,
Christopher W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2007), 129(47), 14550-14551

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzoyl chloride
C8H7ClO2
100-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzamide
C9H11NO2
3400-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40148181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective synthesis of isoquinolinonediones through remote
unactivated C(sp3)-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Lei; Sun, Jun; Sun, Boxuan; Song, Shengjie; Li, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(36),
4818-4821

$RFMT $RIREG SCHEME192 STEP1
$RXN



  3  1
$MOL
L-Alanine methyl ester
C4H9NO2
10065-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0 CFG=1
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 N 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,3S)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3-diphenylcyclopropanecarbo...
C21H23NO4
214557-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 O 7.2557 7.9970 0.0 0
M  V30 11 O 4.6289 8.4603 0.0 0
M  V30 12 C 5.5412 5.9537 0.0 0 CFG=1
M  V30 13 C 4.7712 4.6201 0.0 0 CFG=2
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=2
M  V30 15 C 4.7712 3.0800 0.0 0
M  V30 16 C 3.4375 2.3100 0.0 0
M  V30 17 C 6.1048 2.3100 0.0 0
M  V30 18 C 3.4375 0.7700 0.0 0
M  V30 19 C 6.1048 0.7700 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 2.6675 6.7237 0.0 0
M  V30 22 C 2.6675 8.2638 0.0 0
M  V30 23 C 1.3337 5.9537 0.0 0
M  V30 24 C 1.3337 9.0338 0.0 0
M  V30 25 C 0.0000 6.7237 0.0 0
M  V30 26 C 0.0000 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 12 9 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=3
M  V30 16 1 14 21 CFG=1
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(2S,34S)-1-[[[(1S)-1-methyl-2-(methylamino)-2-oxoethyl]amino]...
C25H31N3O4
876625-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0463 4.9863 0.0 0
M  V30 2 C 7.0564 3.8066 0.0 0
M  V30 3 O 7.5831 2.3595 0.0 0
M  V30 4 O 5.5398 4.0740 0.0 0
M  V30 5 C 6.5932 1.1797 0.0 0
M  V30 6 C 7.7730 0.1899 0.0 0
M  V30 7 C 5.6034 0.0000 0.0 0
M  V30 8 C 5.4135 2.1696 0.0 0
M  V30 9 C 6.0030 6.1661 0.0 0
M  V30 10 N 5.0131 7.3458 0.0 0
M  V30 11 O 5.4763 4.7189 0.0 0
M  V30 12 C 3.4965 7.0784 0.0 0 CFG=1
M  V30 13 C 2.5065 8.2581 0.0 0
M  V30 14 C 2.9698 5.6313 0.0 0
M  V30 15 N 0.9899 7.9907 0.0 0
M  V30 16 O 3.0332 9.7052 0.0 0
M  V30 17 C 0.0000 9.1704 0.0 0
M  V30 18 C 7.5196 6.4335 0.0 0 CFG=2
M  V30 19 C 8.8533 7.2035 0.0 0 CFG=2
M  V30 20 C 7.5196 7.9735 0.0 0 CFG=2
M  V30 21 C 10.3933 7.2035 0.0 0
M  V30 22 C 11.1633 5.8698 0.0 0
M  V30 23 C 11.1633 8.5371 0.0 0
M  V30 24 C 12.7034 5.8698 0.0 0
M  V30 25 C 12.7034 8.5371 0.0 0
M  V30 26 C 13.4734 7.2035 0.0 0
M  V30 27 C 6.7496 9.3071 0.0 0
M  V30 28 C 7.5196 10.6410 0.0 0
M  V30 29 C 5.2096 9.3071 0.0 0
M  V30 30 C 6.7496 11.9746 0.0 0
M  V30 31 C 4.4396 10.6410 0.0 0
M  V30 32 C 5.2096 11.9746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 18 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14 CFG=1
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 21 1 19 21 CFG=1
M  V30 22 1 20 27 CFG=3
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 10065-72-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 214557-96-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876625-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8158222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM Boc removed by mild acidolysis, EDCI/HOAt or HATU/HOAt in DCM used, no
exptl. detail, reactant assumed, stepwise solution peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preferred 3D-structure of peptides rich in a severely conformationally
restricted cyclopropane analog of phenylalanine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crisma, Marco; De Borggraeve, Wim M.; Peggion, Cristina; Formaggio,
Fernando; Royo, Soledad; Jimenez, Ana I.; Cativiela, Carlos; Toniolo,
Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2005), 12(1), 251-260

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(phenylmethyl)-4-[[(trifluoromethyl)su...
C21H24F3N3O5S
1023954-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 5.9741 0.0000 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 4.6404 2.3101 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 2.6673 9.4349 0.0 0
M  V30 11 O 2.6673 10.9749 0.0 0
M  V30 12 O 1.3337 8.6648 0.0 0
M  V30 13 C 1.3337 11.7449 0.0 0
M  V30 14 C 2.1037 13.0786 0.0 0
M  V30 15 C 0.0000 12.5149 0.0 0
M  V30 16 C 0.5637 10.4112 0.0 0
M  V30 17 C 7.3078 4.9774 0.0 0
M  V30 18 C 6.5378 6.3112 0.0 0
M  V30 19 N 8.8478 4.9774 0.0 0
M  V30 20 C 7.3078 7.6449 0.0 0
M  V30 21 C 5.0150 6.0816 0.0 0
M  V30 22 C 9.6178 6.3112 0.0 0
M  V30 23 N 8.8478 7.6449 0.0 0
M  V30 24 C 6.7452 9.0785 0.0 0
M  V30 25 C 3.8860 7.1291 0.0 0
M  V30 26 C 5.2735 9.5323 0.0 0
M  V30 27 N 4.0012 8.6648 0.0 0
M  V30 28 C 11.9279 7.6449 0.0 0
M  V30 29 C 13.4679 7.6449 0.0 0
M  V30 30 C 11.1579 8.9786 0.0 0
M  V30 31 C 14.2379 8.9786 0.0 0
M  V30 32 C 11.9279 10.3122 0.0 0
M  V30 33 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 22
M  V30 10 1 9 28
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 2 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 23
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(phenylmethyl)-7H-pyri...
C21H28N4O2
1613666-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 5.3900 0.0 0
M  V30 4 C 12.9157 3.8500 0.0 0
M  V30 5 O 13.6857 5.1836 0.0 0
M  V30 6 O 13.6857 2.5164 0.0 0
M  V30 7 C 15.2257 5.1836 0.0 0
M  V30 8 C 15.2257 6.7236 0.0 0
M  V30 9 C 16.7657 5.1836 0.0 0
M  V30 10 C 15.2257 3.6436 0.0 0
M  V30 11 C 8.0021 4.6200 0.0 0
M  V30 12 C 8.0021 3.0800 0.0 0
M  V30 13 N 6.6684 5.3900 0.0 0
M  V30 14 C 9.2061 5.5802 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 9.2061 2.1198 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 18 C 10.7075 5.2375 0.0 0
M  V30 19 N 5.3347 3.0800 0.0 0
M  V30 20 C 10.7075 2.4625 0.0 0
M  V30 21 N 11.3757 3.8500 0.0 0
M  V30 22 C 2.6674 4.6200 0.0 0
M  V30 23 C 2.6674 3.0800 0.0 0
M  V30 24 C 1.3336 5.3900 0.0 0
M  V30 25 C 1.3336 2.3100 0.0 0
M  V30 26 C 0.0000 4.6200 0.0 0
M  V30 27 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 17
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 19
M  V30 22 1 18 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023954-07-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613666-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-955485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Buty4-(methylamino)-2-benzy5,6,8,9-tetrahydro-7H-p[4,5-d]azepine-7-carboxylate.To
a solution of tert-butyl
2-benzy4-{[(trifluoromethyl)sulfonyl]oxy}-5,6,8,9-tetrahydro-7Hp[4,5-d]azepine-7-carboxylate
(480 mg, 1.0 mmol) in DMA (15 ml) was added methylamine (2M, 3.0 mL, 5.9
mmol). The reaction mixture was stirred at room temperature for 16 h. The
solvent was removed under reduced pressure. The residue was dissolved in
EtOAc (100 mL), washed with 5% aqueous sodium carbonate (2x20 mL) then
saturated aqueous ammonium chloride (20 mL). The combined organics were
dried over magnesium sulfate, filtered and concentrated under reduced
pressure to yield the crude product. The crude material was purified by
flash column chromatography eluting with EtOAc:cHex 50:50 to 100:0 to
provide the desired product. White solid, yield:360 mg, 98%. 1H NMR (400
MHz, CD3 OD) δ: 1.39 (s,9H), 2.62-2.69 (m, 2H), 2.91 (s, 3H), 2.92-2.99
(m, 2H), 3.58-3.66 (m, 4H), 3.95 (s, 2H), 7.11-7.18 (m,1H), 7.19-7.27 (m,
2H), 7.30-7.35 (m, 2H); HPLC (6 min), Rt=2.3 min, ELSD >95% purity; LRMS
(ESI, APCI) m/z369 [M+H]+ .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multiparameter Optimization in CNS Drug Discovery: Design of
Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C)
Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and
5-HT2B Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storer, R. Ian; Brennan, Paul E.; Brown, Alan D.; Bungay, Peter J.;
Conlon, Kelly M.; Corbett, Matthew S.; DePianta, Robert P.; Fish, Paul
V.; Heifetz, Alexander; Ho, Danny K. H.; Jessiman, Alan S.; McMurray,
Gordon; de Oliveira, Cesar Augusto F.; Roberts, Lee R.; Root, James A.;
Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Skerten, Melanie;
Westbrook, Dominique; Wheeler, Simon; Whitlock, Gavin A.; Wright, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5258-5269

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[3,6,7,10,11-pentakis(hexyloxy)-2-triphenylenyl]oxy]acetate
C52H78O8
1034693-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 16.1700 0.0 0
M  V30 2 C 6.6684 15.4000 0.0 0
M  V30 3 C 5.3347 16.1700 0.0 0
M  V30 4 C 4.0009 15.4000 0.0 0
M  V30 5 C 2.6673 16.1700 0.0 0
M  V30 6 C 1.3336 15.4000 0.0 0
M  V30 7 C 0.0000 16.1700 0.0 0
M  V30 8 O 10.6694 17.7100 0.0 0
M  V30 9 C 9.3356 18.4800 0.0 0
M  V30 10 C 9.3356 20.0200 0.0 0
M  V30 11 O 8.0020 20.7900 0.0 0
M  V30 12 O 10.6694 20.7900 0.0 0
M  V30 13 C 8.0020 22.3300 0.0 0
M  V30 14 C 6.6684 23.1000 0.0 0
M  V30 15 O 8.0020 8.4700 0.0 0
M  V30 16 C 8.0020 6.9300 0.0 0
M  V30 17 C 6.6684 6.1600 0.0 0
M  V30 18 C 6.6684 4.6200 0.0 0
M  V30 19 C 5.3347 3.8500 0.0 0
M  V30 20 C 5.3347 2.3100 0.0 0
M  V30 21 C 4.0009 1.5400 0.0 0
M  V30 22 O 17.3378 13.8600 0.0 0
M  V30 23 C 17.3378 15.4000 0.0 0
M  V30 24 C 18.6714 16.1700 0.0 0
M  V30 25 C 18.6714 17.7100 0.0 0
M  V30 26 C 20.0051 18.4800 0.0 0
M  V30 27 C 20.0051 20.0200 0.0 0
M  V30 28 C 21.3389 20.7900 0.0 0
M  V30 29 O 10.6694 6.9300 0.0 0
M  V30 30 C 12.0031 6.1600 0.0 0
M  V30 31 C 12.0031 4.6200 0.0 0
M  V30 32 C 13.3367 3.8500 0.0 0
M  V30 33 C 13.3367 2.3100 0.0 0
M  V30 34 C 14.6703 1.5400 0.0 0
M  V30 35 C 14.6703 0.0000 0.0 0
M  V30 36 O 17.3378 10.7800 0.0 0
M  V30 37 C 18.6714 11.5500 0.0 0
M  V30 38 C 20.0051 10.7800 0.0 0
M  V30 39 C 21.3389 11.5500 0.0 0
M  V30 40 C 22.6725 10.7800 0.0 0
M  V30 41 C 24.0061 11.5500 0.0 0
M  V30 42 C 25.3398 10.7800 0.0 0
M  V30 43 C 10.6694 13.0900 0.0 0
M  V30 44 C 12.0031 13.8600 0.0 0
M  V30 45 C 10.6694 11.5500 0.0 0
M  V30 46 C 9.3356 13.8600 0.0 0
M  V30 47 C 13.3367 13.0900 0.0 0
M  V30 48 C 12.0031 15.4000 0.0 0
M  V30 49 C 12.0031 10.7800 0.0 0
M  V30 50 C 9.3356 10.7800 0.0 0
M  V30 51 C 9.3356 15.4000 0.0 0
M  V30 52 C 13.3367 11.5500 0.0 0
M  V30 53 C 14.6703 13.8600 0.0 0
M  V30 54 C 10.6694 16.1700 0.0 0
M  V30 55 C 12.0031 9.2400 0.0 0
M  V30 56 C 9.3356 9.2400 0.0 0
M  V30 57 C 14.6703 10.7800 0.0 0
M  V30 58 C 16.0041 13.0900 0.0 0
M  V30 59 C 10.6694 8.4700 0.0 0
M  V30 60 C 16.0041 11.5500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 51
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 54
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 56
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 22 23
M  V30 23 1 22 58
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 29 30
M  V30 30 1 29 59
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 36 37
M  V30 37 1 36 60
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 1 43 44
M  V30 44 2 43 45
M  V30 45 1 43 46
M  V30 46 2 44 47
M  V30 47 1 44 48
M  V30 48 1 45 49
M  V30 49 1 45 50
M  V30 50 2 46 51
M  V30 51 1 47 52
M  V30 52 1 47 53
M  V30 53 2 48 54
M  V30 54 2 49 52
M  V30 55 1 49 55
M  V30 56 2 50 56
M  V30 57 1 51 54
M  V30 58 1 52 57
M  V30 59 2 53 58
M  V30 60 2 55 59
M  V30 61 1 56 59
M  V30 62 2 57 60
M  V30 63 1 58 60
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[[3,6,7,10,11-pentakis(hexyloxy)-2-triphenylenyl]oxy]acetamide
C51H77NO7
1344736-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 62 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 6.9301 0.0 0
M  V30 2 C 12.0032 6.1601 0.0 0
M  V30 3 C 12.0032 4.6201 0.0 0
M  V30 4 C 13.3369 3.8500 0.0 0
M  V30 5 C 13.3369 2.3100 0.0 0
M  V30 6 C 14.6705 1.5400 0.0 0
M  V30 7 C 14.6705 0.0000 0.0 0
M  V30 8 O 8.0021 8.4701 0.0 0
M  V30 9 C 6.6684 9.2401 0.0 0
M  V30 10 C 5.3348 8.4701 0.0 0
M  V30 11 N 5.3348 6.9301 0.0 0
M  V30 12 O 4.0010 9.2401 0.0 0
M  V30 13 C 4.0010 6.1601 0.0 0
M  V30 14 O 17.3380 10.7801 0.0 0
M  V30 15 C 18.6716 11.5501 0.0 0
M  V30 16 C 20.0053 10.7801 0.0 0
M  V30 17 C 21.3391 11.5501 0.0 0
M  V30 18 C 22.6727 10.7801 0.0 0
M  V30 19 C 24.0064 11.5501 0.0 0
M  V30 20 C 25.3401 10.7801 0.0 0
M  V30 21 O 8.0021 16.1702 0.0 0
M  V30 22 C 6.6684 15.4002 0.0 0
M  V30 23 C 5.3348 16.1702 0.0 0
M  V30 24 C 4.0010 15.4002 0.0 0
M  V30 25 C 2.6673 16.1702 0.0 0
M  V30 26 C 1.3337 15.4002 0.0 0
M  V30 27 C 0.0000 16.1702 0.0 0
M  V30 28 O 17.3380 13.8602 0.0 0
M  V30 29 C 17.3380 15.4002 0.0 0
M  V30 30 C 18.6716 16.1702 0.0 0
M  V30 31 C 18.6716 17.7102 0.0 0
M  V30 32 C 20.0053 18.4802 0.0 0
M  V30 33 C 20.0053 20.0202 0.0 0
M  V30 34 C 21.3391 20.7902 0.0 0
M  V30 35 O 10.6695 17.7102 0.0 0
M  V30 36 C 9.3357 18.4802 0.0 0
M  V30 37 C 9.3357 20.0202 0.0 0
M  V30 38 C 8.0021 20.7902 0.0 0
M  V30 39 C 8.0021 22.3302 0.0 0
M  V30 40 C 6.6684 23.1003 0.0 0
M  V30 41 C 6.6684 24.6403 0.0 0
M  V30 42 C 12.0032 10.7801 0.0 0
M  V30 43 C 10.6695 11.5501 0.0 0
M  V30 44 C 13.3369 11.5501 0.0 0
M  V30 45 C 12.0032 9.2401 0.0 0
M  V30 46 C 10.6695 13.0901 0.0 0
M  V30 47 C 9.3357 10.7801 0.0 0
M  V30 48 C 13.3369 13.0901 0.0 0
M  V30 49 C 14.6705 10.7801 0.0 0
M  V30 50 C 10.6695 8.4701 0.0 0
M  V30 51 C 12.0032 13.8602 0.0 0
M  V30 52 C 9.3357 13.8602 0.0 0
M  V30 53 C 9.3357 9.2401 0.0 0
M  V30 54 C 14.6705 13.8602 0.0 0
M  V30 55 C 16.0043 11.5501 0.0 0
M  V30 56 C 12.0032 15.4002 0.0 0
M  V30 57 C 9.3357 15.4002 0.0 0
M  V30 58 C 16.0043 13.0901 0.0 0
M  V30 59 C 10.6695 16.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 50
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 53
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 55
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 57
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 28 29
M  V30 29 1 28 58
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 35 36
M  V30 36 1 35 59
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 42 43
M  V30 43 2 42 44
M  V30 44 1 42 45
M  V30 45 2 43 46
M  V30 46 1 43 47
M  V30 47 1 44 48
M  V30 48 1 44 49
M  V30 49 2 45 50
M  V30 50 1 46 51
M  V30 51 1 46 52
M  V30 52 2 47 53
M  V30 53 2 48 51
M  V30 54 1 48 54
M  V30 55 2 49 55
M  V30 56 1 50 53
M  V30 57 1 51 56
M  V30 58 2 52 57
M  V30 59 2 54 58
M  V30 60 1 55 58
M  V30 61 2 56 59
M  V30 62 1 57 59
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1034693-68-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1344736-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8053478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for the synthesis of TPDLCs 6-n. The mixture of
C18H6(OC6H13)5(OCH2COOC2H5) (5) (1.0 equiv.) and a primary amine (3 mL)
was heated to reflux under 80°C. The reaction was monitored by thin-layer
chromatography. After completion, the reaction was concentrated under
reduced pressure, and purified by column chromatography. TPDLCs 6-n were
then recrystallized from ethanol, and dried under high vacuum. 6-1:
2-(Methylcarbamoylmethoxy)-3,6,7,10,11-penta(hexyloxy)triphenylene. TPDLC
6-1 was synthesized by the reaction of 5 (150mg, 0.18mmol) with
methylamine (3mL, 21mmol) following the general procedure. The compound
as a white solid in yield 98%. 1H NMR (CDCl3, TMS, 600MHz) δ: 0.92-0.96
(m, 15H), 1.37-1.45 (m, 20H), 1.55-1.60 (m, 10H), 1.91-1.97 (m, 10H),
2.97 (d, J = 2.7Hz), 4.22-4.27 (m, 10H), 4.76 (s, 2H), 7.26 (s, 1H), 7.77
(s, 1H), 7.85 (b, 5H). IR (KBr) ν: 3422, 1691, 1659, 1618 cm-1. Anal.
calcd for C51H77NO7: C 75.05, H 9.51, N 1.72; found C 74.68, H 9.53, N
1.62.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Mesomorphism of Asymmetric Triphenylene Discotic Liquid
Crystals Bearing with Mono-Amido-Based Alkyl Soft Chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, K.-Q.; Guo, J.-Z.; Yu, W.-H.; Wang, L.; Hu, P.; Wang, B.-Q.;
Monobe, H.; Shimizu, Y.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Crystals and Liquid Crystals (2011), 54237-47

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-phenylthiourea
C8H10N2S
2724-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 3.0800 0.0 0
M  V30 4 S 5.3347 0.7700 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2724-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-19379521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antileishmanial thioureas: synthesis, biological activity and in silico
evaluations of new promising derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Viana, Gil Mendes; Soares, Deivid Costa; Santana, Marcos Vinicius; do
Amaral, Lilian Henriques; Meireles, Paloma Wetler; Nunes, Raquel Pinto;
Pereira da Silva, Luiz Claudio Rodrigues; Aguiar, Lucia Cruz de Sequeira;
Rodrigues, Carlos Rangel; Pereira de Sousa, Valeria; Castro, Helena
Carla; Abreu, Paula Alvarez; Sathler, Plinio Cunha; Saraiva, Elvira
Maria; Cabral, Lucio Mendes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2017), 65(10), 911-919

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3-Difluoro-1-(phenylmethyl)-4-piperidinone
C12H13F2NO
1039741-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 0.6770 0.0 0
M  V30 2 F 0.0000 1.7145 0.0 0
M  V30 3 F 0.9899 0.0000 0.0 0
M  V30 4 O 0.1830 3.7570 0.0 0
M  V30 5 N 4.1840 1.4470 0.0 0
M  V30 6 C 2.8504 0.6770 0.0 0
M  V30 7 C 4.1840 2.9870 0.0 0
M  V30 8 C 1.5166 1.4470 0.0 0
M  V30 9 C 2.8504 3.7570 0.0 0
M  V30 10 C 1.5166 2.9870 0.0 0
M  V30 11 C 6.8513 1.4470 0.0 0
M  V30 12 C 8.1851 0.6770 0.0 0
M  V30 13 C 6.8513 2.9870 0.0 0
M  V30 14 C 9.5187 1.4470 0.0 0
M  V30 15 C 8.1851 3.7570 0.0 0
M  V30 16 C 9.5187 2.9870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 3 8
M  V30 5 2 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3-Difluoro-N-methyl-1-(phenylmethyl)-4-piperidinamine
C13H18F2N2
2562385-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.8504 0.0 0
M  V30 2 F 8.3771 0.9899 0.0 0
M  V30 3 F 6.6627 0.0000 0.0 0
M  V30 4 N 9.2400 2.8504 0.0 0
M  V30 5 C 10.0100 4.1840 0.0 0
M  V30 6 N 4.6200 2.8504 0.0 0
M  V30 7 C 5.3900 1.5167 0.0 0
M  V30 8 C 5.3900 4.1840 0.0 0
M  V30 9 C 6.9300 1.5167 0.0 0
M  V30 10 C 6.9300 4.1840 0.0 0
M  V30 11 C 7.7000 2.8504 0.0 0
M  V30 12 C 2.3100 4.1840 0.0 0
M  V30 13 C 0.7700 4.1840 0.0 0
M  V30 14 C 3.0800 5.5177 0.0 0
M  V30 15 C 0.0000 5.5177 0.0 0
M  V30 16 C 2.3100 6.8515 0.0 0
M  V30 17 C 0.7700 6.8515 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 9
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1039741-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2562385-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37767351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; De Savi, Chris; Weiss, Matthew M.; Zhu, Xiao; Zheng,
Xiaozhang; Follows, Bruce C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023147594 A2 2023-08-03

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-difluoro-4-nitrobenzene
C6H2BrF2NO2
103977-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-fluoro-N-methyl-6-nitrobenzenamine
C7H6BrFN2O2
1393179-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 5.3900 1.3338 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103977-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393179-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40336531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, incremental addition of methylamine after 6h
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine and related heterocyclic compounds as CDK2
degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collier, Philip; Zheng, Xiaozhang; Zhu, Xiao; Ford, Melissa; Weiss,
Matthew M.; Aversa, Robert; Pennington, Lewis Dale; Comer, Eamon;
Mahasenan, Kiran Vijayakumari; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024039901 A2 2024-02-22

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-difluoro-4-nitrobenzene
C6H2BrF2NO2
103977-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-fluoro-N-methyl-6-nitrobenzenamine
C7H6BrFN2O2
1393179-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 5.3900 1.3338 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103977-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393179-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39101087
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD
Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Ji, Nan; Browne, Chris M.; Campbell,
Veronica; Chen, Dapeng; Enerson, Brad; Fei, Xue; Huang, Xin; Klaus,
Christine R.; Li, Haoran; Mayo, Michele; McDonald, Alice A.; Paul, Atanu;
Rong, Haojing; Sharma, Kirti; Shi, Yatao; Slavin, Anthony; Walther, Dirk
M.; Yuan, Karen; Zhang, Yi; Zhu, Xiao; Kelleher, Joe; Walker, Duncan;
Mainolfi, Nello
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(13), 10548-10566

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-difluoro-4-nitrobenzene
C6H2BrF2NO2
103977-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 5.3901 0.0000 0.0 0
M  V30 6 F 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-fluoro-N-methyl-6-nitrobenzenamine
C7H6BrFN2O2
1393179-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 5.3900 1.3338 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103977-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393179-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, incremental addition of methanamine, yield depends on
reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
3-(1,1-Dimethyl-2-propen-1-yl)-2,3-dihydro-1-(3-methyl-2-buten-1-yl)-2-oxo-1H...
C20H25NO3
1040732-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2896 5.4656 0.0 0
M  V30 2 C 4.0596 6.7994 0.0 0
M  V30 3 C 2.5196 6.7994 0.0 0
M  V30 4 C 1.7496 5.4656 0.0 0
M  V30 5 C 3.2896 8.1330 0.0 0
M  V30 6 C 2.6528 3.5057 0.0 0
M  V30 7 C 1.4069 4.4109 0.0 0
M  V30 8 O 0.0000 3.7844 0.0 0
M  V30 9 O 1.5679 5.9424 0.0 0
M  V30 10 O 5.3056 6.5772 0.0 0
M  V30 11 C 8.0160 4.6078 0.0 0
M  V30 12 C 9.1605 3.5774 0.0 0
M  V30 13 C 10.6251 4.0533 0.0 0
M  V30 14 C 10.9452 5.5597 0.0 0
M  V30 15 C 11.7696 3.0229 0.0 0
M  V30 16 C 4.0596 4.1320 0.0 0
M  V30 17 C 4.5356 2.6674 0.0 0
M  V30 18 C 5.3056 5.0372 0.0 0
M  V30 19 C 6.0756 2.6674 0.0 0
M  V30 20 C 3.7656 1.3336 0.0 0
M  V30 21 N 6.5515 4.1320 0.0 0
M  V30 22 C 6.8456 1.3336 0.0 0
M  V30 23 C 4.5356 0.0000 0.0 0
M  V30 24 C 6.0756 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 18
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethyl-2-propen-1-yl)-2,3-dihydro-N-methyl-1-(3-methyl-2-buten-1-yl)...
C21H28N2O2
1040732-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 3.5057 0.0 0
M  V30 2 C 2.6528 4.4109 0.0 0
M  V30 3 N 1.2459 3.7844 0.0 0
M  V30 4 O 2.8137 5.9424 0.0 0
M  V30 5 C 0.0000 4.6896 0.0 0
M  V30 6 C 4.5355 5.4656 0.0 0
M  V30 7 C 5.3055 6.7994 0.0 0
M  V30 8 C 3.7655 6.7994 0.0 0
M  V30 9 C 2.9955 5.4656 0.0 0
M  V30 10 C 4.5355 8.1331 0.0 0
M  V30 11 O 6.5515 6.5772 0.0 0
M  V30 12 C 9.2619 4.6078 0.0 0
M  V30 13 C 10.4064 3.5774 0.0 0
M  V30 14 C 11.8710 4.0533 0.0 0
M  V30 15 C 12.1911 5.5597 0.0 0
M  V30 16 C 13.0155 3.0229 0.0 0
M  V30 17 C 5.3055 4.1320 0.0 0
M  V30 18 C 5.7815 2.6674 0.0 0
M  V30 19 C 6.5515 5.0372 0.0 0
M  V30 20 C 7.3215 2.6674 0.0 0
M  V30 21 C 5.0115 1.3336 0.0 0
M  V30 22 N 7.7973 4.1320 0.0 0
M  V30 23 C 8.0915 1.3336 0.0 0
M  V30 24 C 5.7815 0.0000 0.0 0
M  V30 25 C 7.3215 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 17
M  V30 10 2 7 10
M  V30 11 2 11 19
M  V30 12 1 12 13
M  V30 13 1 12 22
M  V30 14 2 13 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1040732-46-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1040732-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13446220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[1-(3-Methylbut-2-enyl)-3-(2-methylbut-3-en-2-yl)-2-oxoindolin-3-yl]-
N-methylacetamide (18b). A solution of 17b (290 mg, 0.89 mmol),
pentafluorophenol (325 mg, 1.77 mmol), triethylamine (238 mL, d = 0.73,
1.77 mmol), and N-ethyl-N?-(3-dimethylaminopropyl)carbodiimide (EDC) HCl
salt (253 mg, 1.33 mmol) in THF (10 mL) was kept at room temperature for
2 h. Gaseous methylamine was passed through the reaction mixture at room
temperature. After acidification with 20% HCl, the resulted mixture was
extracted with diethyl ether. The extract was washed with brine, dried
over MgSO4, and concentrated under reduced pressure. The residue was
purified by silica gel column chromatography with AcOEt as an eluent to
give 18b, yield 295 mg, 98% as colorless crystals. mp 150-154 °C
(AcOEt-hexane); IR (CHCl3) 3462, 1688, 1611, 1528, 1489, 1468 cm-1; 1H
NMR (CDCl3, 300 MHz) δ 0.99 (s, 3H), 1.09 (s, 3H), 1.71 (s, 3H), 1.83 (s,
3H), 2.47 (d, 3H, J = 4.7 Hz), 2.68 (d, 1H, J = 13.9 Hz), 3.00 (d, 1H, J
= 13.9 Hz), 4.27 (dd, 1H, J = 15.6, 6.9 Hz), 4.39 (dd, 1H, J = 15.6, 6.1
Hz), 4.99 (dd, 1H, J =17.4, 1.3 Hz), 5.09 (m, 1H), 5.09 (dd, 1H, J =
10.8, 1.3 Hz), 5.37 (1H, br), 6.02 (dd, 1H, J = 17.4, 10.8 Hz), 6.76 (d,
1H, J = 7.5 Hz), 7.00 (t, 1H, J = 7.5 Hz), 7.19-7.26 (m, 2H); MS m/z 340
(M+, 17), 272 (100), 213 (26), 158 (67), 145 (23), 69 (15), 41 (9); HRMS
(EI) m/z calcd for C21H28N2O2 340.2151, found 340.2152. Anal. Calcd for
C21H28N2O2: C, 74.08; H, 8.29; N, 8.23. Found: C, 74.06; H, 8.43; N,
8.12. (-)-(3R)-18b: [α]23D -41.3 (c = 0.77, CHCl3). (+)-(3S)-18b: [α]23D
+41.7 ((c = 0.24, CHCl3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of (±)-flustramines A and C, (±)-flustramide A, and (-)-
and (+)-debromoflustramines A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasaki, Tomomi; Shinada, Masashi; Ohzono, Mayu; Ogawa, Atsuyo;
Terashima, Romi; Sakamoto, Masanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(15), 5959-5964

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-2-nitrobenzene
C9H10BrNO3
104147-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 Br 9.3359 3.0800 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 7 O 0.0000 5.3901 0.0 0
M  V30 8 O 2.6675 5.3901 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 1.3337 3.0800 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(2-nitrophenoxy)-1-propanamine
C10H14N2O3
1082846-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 N 9.2400 6.6685 0.0 0
M  V30 6 C 10.7800 6.6685 0.0 0
M  V30 7 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 O 2.3100 5.3347 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 1.5400 1.3338 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104147-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1082846-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11113849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-(4-bromobutoxy)benzene
C10H12Br2O
1044501-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 Br 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3-Bromophenoxy)-N-methyl-1-butanamine
C11H16BrNO
1195950-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1044501-90-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13171835
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
2,3,3′,4′-Benzophenonetetracarboxylic dianhydride
C17H6O7
104677-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.9845 0.0 0
M  V30 2 O 4.9609 2.6508 0.0 0
M  V30 3 O 2.7106 2.6675 0.0 0
M  V30 4 O 0.0000 7.3622 0.0 0
M  V30 5 O 10.2912 0.0000 0.0 0
M  V30 6 O 13.0018 4.6948 0.0 0
M  V30 7 C 3.4209 5.3182 0.0 0
M  V30 8 C 4.9609 5.3182 0.0 0
M  V30 9 C 2.6508 6.6520 0.0 0
M  V30 10 C 2.3904 4.1738 0.0 0
M  V30 11 C 5.7309 6.6520 0.0 0
M  V30 12 C 1.1445 6.3318 0.0 0
M  V30 13 C 3.4209 7.9856 0.0 0
M  V30 14 O 0.9835 4.8001 0.0 0
M  V30 15 C 4.9609 7.9856 0.0 0
M  V30 16 C 7.2709 3.9845 0.0 0
M  V30 17 C 8.0409 2.6508 0.0 0
M  V30 18 C 8.0409 5.3182 0.0 0
M  V30 19 C 9.5809 2.6508 0.0 0
M  V30 20 C 9.5809 5.3182 0.0 0
M  V30 21 C 10.3509 3.9845 0.0 0
M  V30 22 C 10.6114 1.5064 0.0 0
M  V30 23 C 11.8572 3.6643 0.0 0
M  V30 24 O 12.0183 2.1328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 1 16
M  V30 4 2 3 10
M  V30 5 2 4 12
M  V30 6 2 5 22
M  V30 7 2 6 23
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 21
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2,3-Dihydro-2-methyl-1,3-dioxo-1H-isoindol-5-yl)carbonyl]-2-methyl-1H-iso...
C19H12N2O5
2242960-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6517 3.0010 0.0 0
M  V30 2 O 6.6517 1.4610 0.0 0
M  V30 3 O 4.6947 0.3502 0.0 0
M  V30 4 O 0.0000 3.0607 0.0 0
M  V30 5 C 1.3626 0.0000 0.0 0
M  V30 6 O 12.5934 1.8304 0.0 0
M  V30 7 O 12.5934 7.2516 0.0 0
M  V30 8 C 14.5625 4.5410 0.0 0
M  V30 9 C 3.9844 3.0010 0.0 0
M  V30 10 C 5.3181 3.7710 0.0 0
M  V30 11 C 2.6506 3.7710 0.0 0
M  V30 12 C 3.6643 1.4947 0.0 0
M  V30 13 C 5.3181 5.3110 0.0 0
M  V30 14 C 1.5063 2.7406 0.0 0
M  V30 15 C 2.6506 5.3110 0.0 0
M  V30 16 N 2.1326 1.3336 0.0 0
M  V30 17 C 3.9844 6.0810 0.0 0
M  V30 18 C 7.9855 3.7710 0.0 0
M  V30 19 C 9.3192 3.0010 0.0 0
M  V30 20 C 7.9855 5.3110 0.0 0
M  V30 21 C 10.6528 3.7710 0.0 0
M  V30 22 C 9.3192 6.0810 0.0 0
M  V30 23 C 10.6528 5.3110 0.0 0
M  V30 24 C 12.1175 3.2951 0.0 0
M  V30 25 C 12.1175 5.7869 0.0 0
M  V30 26 N 13.0225 4.5410 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 18
M  V30 4 2 3 12
M  V30 5 2 4 14
M  V30 6 1 5 16
M  V30 7 2 6 24
M  V30 8 2 7 25
M  V30 9 1 8 26
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104677-79-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242960-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-19510178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric dianhydrides and methods of making the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chuang, Chun-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US10059682 B1 2018-08-28

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-(4-bromobutoxy)benzene
C10H12Br2O
105212-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 Br 10.6697 2.3101 0.0 0
M  V30 7 Br 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Bromophenoxy)-N-methyl-1-butanamine
C11H16BrNO
1004165-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 Br 1.3337 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105212-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004165-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15309891
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylacetamide
C3H6ClNO
96-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11939784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM C) Preparation of 2-chloro-N-methyl-acetamide The condensation of 34.5 kg
(283 mol) of ethyl chloroacetate and 24 kg (310 mol) of monomethylamine
(40% aqueous solution) is carried out in a reactor kept at a temperature
of -5°C. After completion of the addition of the amine the solution is
kept at steady temperature for a further 30 minutes, then diluted with
40.5 kg of water and pH is adjusted to acidic values (pH< 5) , to obtain
a 30% aqueous solution (99 kg), containing 2-chloro-N-methylacetamide.
Yield 29.7 kg, 276.2 mol, 98%.
$DTYPE RXN:VAR(1):NOTES
$DATUM unspecified reagent used to adjust pH in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM preparation of N,N'-bis[2,3-dihydroxypropyl]
-5-[(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzene dicarboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alessandroni, Laura; Ambrosetti, Patrizia; Argese, Maria; Geremia,
Renato; Moretti, Enrico; Valle, Vittorio; Ripa, Giorgio; Murru, Marcella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000032561 A1 2000-06-08

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(1-phenylcyclopropyl)-4-[[(trifluorome...
C23H26F3N3O5S
1065113-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.1840 3.4374 0.0 0
M  V30 2 S 2.8504 2.6674 0.0 0 VAL=6
M  V30 3 C 3.6204 1.3338 0.0 0
M  V30 4 O 1.5166 1.8974 0.0 0
M  V30 5 O 2.0804 4.0011 0.0 0
M  V30 6 F 5.1604 1.3338 0.0 0
M  V30 7 F 4.3904 0.0000 0.0 0
M  V30 8 F 2.8504 0.0000 0.0 0
M  V30 9 C 10.4313 6.5174 0.0 0
M  V30 10 O 11.2013 7.8511 0.0 0
M  V30 11 O 11.2013 5.1838 0.0 0
M  V30 12 C 12.7413 7.8511 0.0 0
M  V30 13 C 12.7413 9.3911 0.0 0
M  V30 14 C 14.2813 7.8511 0.0 0
M  V30 15 C 12.7413 6.3111 0.0 0
M  V30 16 C 1.5166 8.0574 0.0 0
M  V30 17 C 0.5268 6.8776 0.0 0
M  V30 18 C 0.0000 8.3248 0.0 0
M  V30 19 C 2.8504 7.2874 0.0 0
M  V30 20 N 2.8504 5.7474 0.0 0
M  V30 21 N 4.1840 8.0574 0.0 0
M  V30 22 C 4.1840 4.9774 0.0 0
M  V30 23 C 5.5177 7.2874 0.0 0
M  V30 24 C 5.5177 5.7474 0.0 0
M  V30 25 C 6.7218 8.2476 0.0 0
M  V30 26 C 6.7218 4.7872 0.0 0
M  V30 27 C 8.2231 7.9050 0.0 0
M  V30 28 C 8.2231 5.1299 0.0 0
M  V30 29 N 8.8913 6.5174 0.0 0
M  V30 30 C 2.0434 9.5046 0.0 0
M  V30 31 C 1.0535 10.6842 0.0 0
M  V30 32 C 3.5600 9.7719 0.0 0
M  V30 33 C 1.5802 12.1314 0.0 0
M  V30 34 C 4.0867 11.2191 0.0 0
M  V30 35 C 3.0968 12.3988 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 30
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(1-phenylcyclopropyl)-...
C23H30N4O2
1613666-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1639 0.7700 0.0 0
M  V30 2 C 4.8302 0.0000 0.0 0
M  V30 3 C 12.4112 3.8500 0.0 0
M  V30 4 O 13.1812 5.1836 0.0 0
M  V30 5 O 13.1812 2.5162 0.0 0
M  V30 6 C 14.7212 5.1836 0.0 0
M  V30 7 C 14.7212 3.6436 0.0 0
M  V30 8 C 16.2612 5.1836 0.0 0
M  V30 9 C 14.7212 6.7236 0.0 0
M  V30 10 C 3.4964 5.3900 0.0 0
M  V30 11 C 2.5065 6.5696 0.0 0
M  V30 12 C 4.0233 6.8370 0.0 0
M  V30 13 C 4.8302 4.6200 0.0 0
M  V30 14 N 6.1639 5.3900 0.0 0
M  V30 15 N 4.8302 3.0800 0.0 0
M  V30 16 C 7.4975 4.6200 0.0 0
M  V30 17 C 6.1639 2.3100 0.0 0
M  V30 18 C 7.4975 3.0800 0.0 0
M  V30 19 C 8.7015 5.5800 0.0 0
M  V30 20 C 8.7015 2.1198 0.0 0
M  V30 21 C 10.2030 5.2374 0.0 0
M  V30 22 C 10.2030 2.4625 0.0 0
M  V30 23 N 10.8712 3.8500 0.0 0
M  V30 24 C 2.5065 4.2102 0.0 0
M  V30 25 C 0.9899 4.4777 0.0 0
M  V30 26 C 3.0333 2.7631 0.0 0
M  V30 27 C 0.0000 3.2979 0.0 0
M  V30 28 C 2.0434 1.5834 0.0 0
M  V30 29 C 0.5268 1.8508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 24
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1065113-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613666-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13303698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
4-(methylamino)-2-(1-phenylcyclopropyl)-5,6,8,9-tetrahydro-7H-p[4,5-d]azepine-7-carboxylate.
A solution of methylamine (2.0M, 0.27 mL, 0.54 mmol) was added to a
solution of tert-butyl
2-(1-phenylcyclopropyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-5,6,8,9-tetrahydro-7Hp[4,5-d]azepine-7-carboxylate
(55 mg, 0.11 mmol) in acetonitrile (2.0 mL) at room temperature with
stirring. The mixture was stirred at room temperature for 20 h. The
solvent was evaporated in vacuoto provide the crude title compound. The
material was used in the subsequent reaction without further
purification. Brown gum,yield:40 mg, 98%. 1H NMR (400 MHz, CDCl3 ) δ:
1.21-1.80 (m, 4H), 1.42 (s, 9H), 2.55 (s, 2H); 2.78-2.98 (m, 5H),
3.47-3.72 (m, 4H), 7.12-7.45 (m, 5H); HPLC (6 min), Rt=2.10 min, ELSD
>95% purity; LRMS (ESI, APCI) m/z 395 [M+H]+ .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multiparameter Optimization in CNS Drug Discovery: Design of
Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C)
Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and
5-HT2B Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storer, R. Ian; Brennan, Paul E.; Brown, Alan D.; Bungay, Peter J.;
Conlon, Kelly M.; Corbett, Matthew S.; DePianta, Robert P.; Fish, Paul
V.; Heifetz, Alexander; Ho, Danny K. H.; Jessiman, Alan S.; McMurray,
Gordon; de Oliveira, Cesar Augusto F.; Roberts, Lee R.; Root, James A.;
Shanmugasundaram, Veerabahu; Shapiro, Michael J.; Skerten, Melanie;
Westbrook, Dominique; Wheeler, Simon; Whitlock, Gavin A.; Wright, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5258-5269

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-9-[(3aS,4R,6aS)-3a,6a-dihydro-2,2-dimethyl-6a-[(triphenylmethoxy...
C33H28Cl2N4O3
1067235-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.0725 0.0 0
M  V30 2 O 6.1600 6.0725 0.0 0
M  V30 3 C 6.9300 7.4062 0.0 0
M  V30 4 C 8.2094 10.9204 0.0 0
M  V30 5 C 10.2704 10.9204 0.0 0
M  V30 6 Cl 16.2763 2.6674 0.0 0
M  V30 7 Cl 11.6563 0.0000 0.0 0
M  V30 8 C 4.6200 4.5325 0.0 0
M  V30 9 C 5.9536 3.7625 0.0 0
M  V30 10 C 3.2862 3.7625 0.0 0
M  V30 11 C 5.9536 2.2225 0.0 0
M  V30 12 C 3.2862 2.2225 0.0 0
M  V30 13 C 4.6200 1.4525 0.0 0
M  V30 14 C 3.0800 6.0725 0.0 0
M  V30 15 C 2.3100 7.4062 0.0 0
M  V30 16 C 2.3100 4.7389 0.0 0
M  V30 17 C 0.7700 7.4062 0.0 0
M  V30 18 C 0.7700 4.7389 0.0 0
M  V30 19 C 0.0000 6.0725 0.0 0
M  V30 20 C 4.6200 7.6125 0.0 0
M  V30 21 C 3.2862 8.3825 0.0 0
M  V30 22 C 5.9536 8.3825 0.0 0
M  V30 23 C 3.2862 9.9225 0.0 0
M  V30 24 C 5.9536 9.9225 0.0 0
M  V30 25 C 4.6200 10.6925 0.0 0
M  V30 26 C 8.4700 7.4062 0.0 0 CFG=1
M  V30 27 C 10.0100 7.4062 0.0 0 CFG=1
M  V30 28 C 7.9940 5.9416 0.0 0
M  V30 29 O 7.9940 8.8709 0.0 0
M  V30 30 C 10.4859 5.9416 0.0 0 CFG=2
M  V30 31 O 10.4859 8.8709 0.0 0
M  V30 32 C 9.2400 5.0364 0.0 0
M  V30 33 C 9.2400 9.7761 0.0 0
M  V30 34 N 11.9504 5.4656 0.0 0
M  V30 35 C 12.4263 4.0011 0.0 0
M  V30 36 C 13.1963 6.3708 0.0 0
M  V30 37 C 13.9663 4.0011 0.0 0
M  V30 38 N 11.6563 2.6674 0.0 0
M  V30 39 N 14.4423 5.4656 0.0 0
M  V30 40 C 14.7363 2.6674 0.0 0
M  V30 41 C 12.4263 1.3336 0.0 0
M  V30 42 N 13.9663 1.3336 0.0 0
M  V30 43 H 11.5500 7.4062 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 3
M  V30 6 1 26 3 CFG=3
M  V30 7 1 4 33
M  V30 8 1 5 33
M  V30 9 1 6 40
M  V30 10 1 7 41
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 43 CFG=3
M  V30 35 2 28 32
M  V30 36 1 29 33
M  V30 37 1 30 32
M  V30 38 1 30 34 CFG=3
M  V30 39 1 31 33
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 2 35 38
M  V30 44 2 36 39
M  V30 45 1 37 39
M  V30 46 2 37 40
M  V30 47 1 38 41
M  V30 48 1 40 42
M  V30 49 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-9-[(3aS,4R,6aS)-3a,6a-dihydro-2,2-dimethyl-6a-[(triphenylmethoxy)met...
C34H32ClN5O3
1067235-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 7.0238 0.0 0
M  V30 2 O 5.3348 6.2538 0.0 0
M  V30 3 C 5.3348 4.7137 0.0 0
M  V30 4 C 4.6857 1.0304 0.0 0
M  V30 5 C 6.4706 0.0000 0.0 0
M  V30 6 N 15.7986 4.1444 0.0 0
M  V30 7 C 17.1323 4.9144 0.0 0
M  V30 8 Cl 13.1313 8.7645 0.0 0
M  V30 9 C 4.7710 8.3575 0.0 0
M  V30 10 C 4.0010 9.6911 0.0 0
M  V30 11 C 6.3111 8.3575 0.0 0
M  V30 12 C 4.7710 11.0248 0.0 0
M  V30 13 C 7.0811 9.6911 0.0 0
M  V30 14 C 6.3111 11.0248 0.0 0
M  V30 15 C 2.6673 7.7938 0.0 0
M  V30 16 C 2.6673 9.3338 0.0 0
M  V30 17 C 1.3337 7.0238 0.0 0
M  V30 18 C 1.3337 10.1039 0.0 0
M  V30 19 C 0.0000 7.7938 0.0 0
M  V30 20 C 0.0000 9.3338 0.0 0
M  V30 21 C 3.2310 5.6900 0.0 0
M  V30 22 C 4.0010 4.3563 0.0 0
M  V30 23 C 1.6910 5.6900 0.0 0
M  V30 24 C 3.2310 3.0226 0.0 0
M  V30 25 C 0.9209 4.3563 0.0 0
M  V30 26 C 1.6910 3.0226 0.0 0
M  V30 27 C 6.6685 3.9437 0.0 0 CFG=1
M  V30 28 C 8.0022 3.1737 0.0 0 CFG=1
M  V30 29 C 6.9887 5.4500 0.0 0
M  V30 30 O 5.5239 2.9131 0.0 0
M  V30 31 C 9.1467 4.2041 0.0 0 CFG=2
M  V30 32 O 7.6820 1.6672 0.0 0
M  V30 33 C 8.5202 5.6111 0.0 0
M  V30 34 C 6.1504 1.5063 0.0 0
M  V30 35 N 10.6530 3.8840 0.0 0
M  V30 36 C 11.7974 4.9144 0.0 0
M  V30 37 C 11.2794 2.4770 0.0 0
M  V30 38 C 13.1313 4.1444 0.0 0
M  V30 39 N 11.7974 6.4544 0.0 0
M  V30 40 N 12.8111 2.6381 0.0 0
M  V30 41 C 14.4649 4.9144 0.0 0
M  V30 42 C 13.1313 7.2245 0.0 0
M  V30 43 N 14.4649 6.4544 0.0 0
M  V30 44 H 9.3358 2.4037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 1 21
M  V30 5 1 2 3
M  V30 6 1 27 3 CFG=1
M  V30 7 1 4 34
M  V30 8 1 5 34
M  V30 9 1 6 7
M  V30 10 1 6 41
M  V30 11 1 8 42
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 1 28 44 CFG=1
M  V30 36 2 29 33
M  V30 37 1 30 34
M  V30 38 1 31 33
M  V30 39 1 31 35 CFG=1
M  V30 40 1 32 34
M  V30 41 1 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 2 36 39
M  V30 45 2 37 40
M  V30 46 1 38 40
M  V30 47 2 38 41
M  V30 48 1 39 42
M  V30 49 1 41 43
M  V30 50 2 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 27 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1067235-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1067235-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14274245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,6-Dichloropurine nucleoside 15 was converted to
6-methylamino-aminopurine nucleoside 16 (98%) using 40% methylamine.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Synthesis of Novel Apio Carbocyclic Nucleoside Analogues as
Potential Antiviral and Antitumor Agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeong, Lak Shin; Lee, Jeong A.; Moon, Hyung Ryong; Kim, Hea Ok; Lee, Kang
Man; Lee, Hyun Joo; Chun, Moon Woo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2007), 26(6-7), 721-724

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(3-Chloropropoxy)phenyl]-5-fluoro-2-(2-pyridinyl)-1H-benzimidazole
C21H17ClFN3O
1067911-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 8.7485 0.0 0
M  V30 2 O 11.1711 6.6888 0.0 0
M  V30 3 C 11.6471 8.1534 0.0 0
M  V30 4 C 13.1534 8.4736 0.0 0
M  V30 5 C 13.6293 9.9383 0.0 0
M  V30 6 Cl 15.1358 10.2585 0.0 0
M  V30 7 N 5.1457 5.4080 0.0 0
M  V30 8 C 4.5192 4.0012 0.0 0
M  V30 9 C 4.0012 6.4384 0.0 0
M  V30 10 N 2.9877 4.1621 0.0 0
M  V30 11 C 2.6675 5.6684 0.0 0
M  V30 12 C 4.0012 7.9785 0.0 0
M  V30 13 C 1.3338 6.4384 0.0 0
M  V30 14 C 2.6675 8.7485 0.0 0
M  V30 15 C 1.3338 7.9785 0.0 0
M  V30 16 C 6.6520 5.7282 0.0 0
M  V30 17 C 7.6825 4.5838 0.0 0
M  V30 18 C 7.1279 7.1929 0.0 0
M  V30 19 C 9.1889 4.9039 0.0 0
M  V30 20 C 8.6344 7.5131 0.0 0
M  V30 21 C 9.6648 6.3687 0.0 0
M  V30 22 C 5.2892 2.6673 0.0 0
M  V30 23 C 6.8293 2.6673 0.0 0
M  V30 24 N 4.5192 1.3337 0.0 0
M  V30 25 C 7.5993 1.3337 0.0 0
M  V30 26 C 5.2892 0.0000 0.0 0
M  V30 27 C 6.8293 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 11
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-[5-Fluoro-2-(2-pyridinyl)-1H-benzimidazol-1-yl]phenoxy]-N-methyl-1-propa...
C22H21FN4O
1067912-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 8.7484 0.0 0
M  V30 2 O 11.1710 6.6886 0.0 0
M  V30 3 C 11.6470 8.1533 0.0 0
M  V30 4 C 13.1533 8.4735 0.0 0
M  V30 5 C 13.6292 9.9382 0.0 0
M  V30 6 N 15.1356 10.2584 0.0 0
M  V30 7 C 15.6115 11.7230 0.0 0
M  V30 8 N 5.1455 5.4079 0.0 0
M  V30 9 C 4.5192 4.0010 0.0 0
M  V30 10 C 4.0011 6.4384 0.0 0
M  V30 11 N 2.9876 4.1621 0.0 0
M  V30 12 C 2.6675 5.6684 0.0 0
M  V30 13 C 4.0011 7.9784 0.0 0
M  V30 14 C 1.3337 6.4384 0.0 0
M  V30 15 C 2.6675 8.7484 0.0 0
M  V30 16 C 1.3337 7.9784 0.0 0
M  V30 17 C 6.6520 5.7281 0.0 0
M  V30 18 C 7.1278 7.1928 0.0 0
M  V30 19 C 7.6824 4.5837 0.0 0
M  V30 20 C 8.6343 7.5130 0.0 0
M  V30 21 C 9.1889 4.9039 0.0 0
M  V30 22 C 9.6647 6.3685 0.0 0
M  V30 23 C 5.2892 2.6673 0.0 0
M  V30 24 C 4.5192 1.3337 0.0 0
M  V30 25 N 6.8292 2.6673 0.0 0
M  V30 26 C 5.2892 0.0000 0.0 0
M  V30 27 C 7.5992 1.3337 0.0 0
M  V30 28 C 6.8292 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 12
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1067911-98-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1067912-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9554025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3
receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aslanian, Robert; Zhu, Xiaohong; Vaccaro, Henry A.; Shih, Neng-Yang;
Piwinski, John J.; Williams, Shirley M.; West, Robert E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(18), 5032-5036

$RFMT $RIREG SCHEME207 STEP1
$RXN



  3  1
$MOL
4-Bromo-3-(phenylmethoxy)-5-isoxazolemethanol
C11H10BrNO3
1072297-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.7106 0.0 0
M  V30 2 C 4.6200 4.0442 0.0 0
M  V30 3 Br 7.3594 0.0000 0.0 0
M  V30 4 C 10.5458 1.0353 0.0 0
M  V30 5 O 11.9526 1.6618 0.0 0
M  V30 6 C 6.9300 2.7106 0.0 0
M  V30 7 C 7.8352 1.4647 0.0 0
M  V30 8 N 7.8352 3.9564 0.0 0
M  V30 9 C 9.2998 1.9406 0.0 0
M  V30 10 O 9.2998 3.4806 0.0 0
M  V30 11 C 3.0800 4.0442 0.0 0
M  V30 12 C 2.3100 5.3780 0.0 0
M  V30 13 C 2.3100 2.7106 0.0 0
M  V30 14 C 0.7700 5.3780 0.0 0
M  V30 15 C 0.7700 2.7106 0.0 0
M  V30 16 C 0.0000 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 11
M  V30 4 1 3 7
M  V30 5 1 4 5
M  V30 6 1 4 9
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-bromo-3-(phenylmethoxy)-5-isoxazolyl]methyl]-N-methyl...
C17H21BrN2O4
2055347-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3349 2.3100 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 5.3349 3.8500 0.0 0
M  V30 5 O 2.6674 2.3100 0.0 0
M  V30 6 O 4.0011 0.0000 0.0 0
M  V30 7 C 1.3338 1.5400 0.0 0
M  V30 8 C 0.5638 2.8737 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 2.1038 0.2064 0.0 0
M  V30 11 Br 9.7293 0.1773 0.0 0
M  V30 12 O 11.9711 2.6671 0.0 0
M  V30 13 C 12.8763 3.9130 0.0 0
M  V30 14 C 8.0022 2.3100 0.0 0
M  V30 15 C 9.4090 1.6837 0.0 0
M  V30 16 O 8.1631 3.8415 0.0 0
M  V30 17 C 10.4396 2.8281 0.0 0
M  V30 18 N 9.6696 4.1617 0.0 0
M  V30 19 C 14.4079 3.7521 0.0 0
M  V30 20 C 15.3131 4.9979 0.0 0
M  V30 21 C 15.0342 2.3451 0.0 0
M  V30 22 C 16.8446 4.8370 0.0 0
M  V30 23 C 16.5659 2.1842 0.0 0
M  V30 24 C 17.4711 3.4301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 15
M  V30 12 1 12 13
M  V30 13 1 12 17
M  V30 14 1 13 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1072297-41-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055347-25-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-16462062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM buffered solution (citrate) in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective Michael-Claisen Cyclizations of γ-Oxa-α,β-unsaturated
Ketones en Route to 5-Oxatetracyclines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Fan; Wright, Peter M.; Myers, Andrew G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(1), 206-209

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-chlorobenzene
C6H4BrCl
108-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methylbenzenamine
C7H8ClN
7006-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-37-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7006-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10122894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-3-chloroaniline (Table 2-16) The reaction of
3-bromochlorobenzene (1.914 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%) produced 1.388 g (98.0 %) of
N-methyl-3-chloroaniline as colorless liquid. 1H NMR (300 MHz, d 6-DMSO)
δ (ppm): 2.65-2.66(d, J = 4.5 Hz, 3H), 5.96(s, 1H), 6.46-6.51(d, J = 14.7
Hz, 2H), 7.04-7.09(t, J = 8.1 Hz, 2H ); 13C NMR (75 MHz, d 6-DMSO) δ
(ppm): 29.9, 110.8, 110.9, 115.2, 130.6, 134.2, 151.7.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-(1-Piperidinylmethyl)phenoxy]benzaldehyde
C19H21NO2
1086400-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3359 3.0800 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 C 14.6707 3.0800 0.0 0
M  V30 4 O 16.0045 2.3100 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 C 6.6686 3.0800 0.0 0
M  V30 7 C 8.0022 0.7700 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 6.6686 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 10.6697 2.3100 0.0 0
M  V30 12 C 12.0034 3.0800 0.0 0
M  V30 13 C 10.6697 0.7700 0.0 0
M  V30 14 C 13.3370 2.3100 0.0 0
M  V30 15 C 12.0034 0.0000 0.0 0
M  V30 16 C 13.3370 0.7700 0.0 0
M  V30 17 N 2.6675 2.3100 0.0 0
M  V30 18 C 1.3338 3.0800 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 C 1.3338 0.0000 0.0 0
M  V30 22 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 2 17
M  V30 5 2 3 4
M  V30 6 1 3 14
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[3-(1-piperidinylmethyl)phenoxy]benzenemethanamine
C20H26N2O
1086400-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3358 3.0800 0.0 0
M  V30 2 C 4.0011 3.0800 0.0 0
M  V30 3 C 14.6705 3.0800 0.0 0
M  V30 4 N 16.0041 2.3100 0.0 0
M  V30 5 C 17.3379 3.0800 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 6.6685 3.0800 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 10.6694 2.3100 0.0 0
M  V30 13 C 12.0032 3.0800 0.0 0
M  V30 14 C 10.6694 0.7700 0.0 0
M  V30 15 C 13.3369 2.3100 0.0 0
M  V30 16 C 12.0032 0.0000 0.0 0
M  V30 17 C 13.3369 0.7700 0.0 0
M  V30 18 N 2.6674 2.3100 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 1.3338 3.0800 0.0 0
M  V30 21 C 1.3338 0.0000 0.0 0
M  V30 22 C 0.0000 2.3100 0.0 0
M  V30 23 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 9
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 3 15
M  V30 7 1 4 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1086400-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1086400-85-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4538651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D. Methyl-[3-(3-piperidin-1-ylmethyl-phenoxy)-benzyl]-amine. To a
solution of 3-(3-piperidin-1-ylmethyl-phenoxy)-benzaldehyde (0.56 g, 1.9
mmol) in MeOH (4.0 mL) at 0° C. were added MeNH2 (40% in H2O; 0.35 mL,
4.0 mmol) followed by NaBH4 (170.6 mg, 4.510 mmol). The mixture was
stirred at 0° C. for 3.5 h, then diluted with 1 N NaOH, stirred for 1 h,
and extracted with CH2Cl2. The combined organic layers were dried and
concentrated to give a pale yellow oil (410.0 mg, 98%). MS (ESI): mass
calcd. for C20H26N2O, 310.20; m/z found, 311.4 [M+H]+. 1H NMR (MeOD):
7.29-7.22 (m, 2H), 7.06-7.01 (m, 2H), 6.98-6.94 (m, 2H), 6.87-6.83 (m,
2H), 3.63 (s, 2H), 3.41 (s, 2H), 2.42-2.34 (m, 3H), 2.31 (s, 3H),
1.59-1.53 (m, 4H), 1.46-1.40 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diaryl-substituted tetrahydroisoquinolines as histamine H3
receptor and serotonin transporter modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keith, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008144305 A1 2008-11-27

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Bis(4-nitrophenyl)-1,4-butanedione
C16H12N2O6
108791-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.8501 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 O 6.6687 2.3101 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 10.6697 6.1601 0.0 0
M  V30 7 N 1.3338 6.9302 0.0 0 VAL=5
M  V30 8 O 1.3338 8.4702 0.0 0
M  V30 9 O 0.0000 6.1601 0.0 0
M  V30 10 N 16.0045 1.5400 0.0 0 VAL=5
M  V30 11 O 17.3383 2.3101 0.0 0
M  V30 12 O 16.0045 0.0000 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 5.3348 6.1601 0.0 0
M  V30 15 C 4.0012 3.8501 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 17 C 2.6675 4.6201 0.0 0
M  V30 18 C 2.6675 6.1601 0.0 0
M  V30 19 C 12.0035 3.8501 0.0 0
M  V30 20 C 13.3372 4.6201 0.0 0
M  V30 21 C 12.0035 2.3101 0.0 0
M  V30 22 C 14.6708 3.8501 0.0 0
M  V30 23 C 13.3372 1.5400 0.0 0
M  V30 24 C 14.6708 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 5 19
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 18
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,5-bis(4-nitrophenyl)-1H-pyrrole
C17H13N3O4
137596-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7418 2.4873 0.0 0
M  V30 2 N 14.8036 1.5400 0.0 0 VAL=5
M  V30 3 O 14.8036 0.0000 0.0 0
M  V30 4 O 16.1372 2.3100 0.0 0
M  V30 5 N 0.9051 4.4942 0.0 0 VAL=5
M  V30 6 O 0.0000 5.7401 0.0 0
M  V30 7 O 0.2787 3.0873 0.0 0
M  V30 8 C 9.4688 4.6200 0.0 0
M  V30 9 N 8.0620 3.9936 0.0 0
M  V30 10 C 9.3079 6.1516 0.0 0
M  V30 11 C 7.0314 5.1381 0.0 0
M  V30 12 C 7.8014 6.4718 0.0 0
M  V30 13 C 10.8024 3.8500 0.0 0
M  V30 14 C 12.1362 4.6200 0.0 0
M  V30 15 C 10.8024 2.3100 0.0 0
M  V30 16 C 13.4699 3.8500 0.0 0
M  V30 17 C 12.1362 1.5400 0.0 0
M  V30 18 C 13.4699 2.3100 0.0 0
M  V30 19 C 5.4999 4.9772 0.0 0
M  V30 20 C 4.8735 3.5702 0.0 0
M  V30 21 C 4.5946 6.2231 0.0 0
M  V30 22 C 3.3420 3.4093 0.0 0
M  V30 23 C 3.0631 6.0621 0.0 0
M  V30 24 C 2.4368 4.6552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 24
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 11 19
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108791-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 137596-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15209690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of dicationic 2,5-diarylpyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arafa, Reem K.; Brun, Reto; Werbovetz, Karl A.; Tanious, Farial A.;
Wilson, W. David; Boykin, David W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocyclic Communications (2004), 10(6), 423-428

$RFMT $RIREG SCHEME211 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenol
C6H6O
108-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentanal
C5H10O
110-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-(Methylamino)pentyl]phenol
C12H19NO
845674-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 4.0011 4.6201 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 C 5.3348 5.3901 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 9.3359 3.0800 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 1.3337 3.0800 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-95-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845674-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-6296039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of 3,4-dialkyl-3,4-dihydro-2H-1,3-benzoxazin-2-ones
and naphthoxazin-2-ones and their reactions with organolithium and
grignard reagents - preparation of N-[1-(2'-hydroxyphenyl)alkyl]amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cimarelli, Cristina; Palmieri, Gianni; Volpini, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canadian Journal of Chemistry (2004), 82(8), 1314-1321

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]benzoyl]-L-prolylglycine phenylmeth...
C26H31N3O6
1094297-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 8.0022 0.0 0
M  V30 2 O 5.3901 6.6685 0.0 0
M  V30 3 C 7.9523 8.3524 0.0 0
M  V30 4 N 9.4586 8.6725 0.0 0
M  V30 5 O 7.4764 6.8878 0.0 0
M  V30 6 C 10.4890 7.5281 0.0 0
M  V30 7 C 11.9955 7.8483 0.0 0
M  V30 8 O 13.0259 6.7039 0.0 0
M  V30 9 O 12.4713 9.3130 0.0 0
M  V30 10 C 14.5324 7.0241 0.0 0
M  V30 11 N 3.0801 5.3348 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 O 3.0801 2.6673 0.0 0
M  V30 14 O 0.7700 4.0010 0.0 0
M  V30 15 C 2.3101 1.3337 0.0 0
M  V30 16 C 0.9764 2.1037 0.0 0
M  V30 17 C 1.5400 0.0000 0.0 0
M  V30 18 C 3.6437 0.5637 0.0 0
M  V30 19 N 5.3901 9.3360 0.0 0
M  V30 20 C 6.9217 9.4969 0.0 0 CFG=2
M  V30 21 C 4.7638 10.7428 0.0 0
M  V30 22 C 7.2420 11.0032 0.0 0
M  V30 23 C 5.9082 11.7732 0.0 0
M  V30 24 C 3.0801 8.0022 0.0 0
M  V30 25 C 2.3101 6.6685 0.0 0
M  V30 26 C 2.3101 9.3360 0.0 0
M  V30 27 C 0.7700 6.6685 0.0 0
M  V30 28 C 0.7700 9.3360 0.0 0
M  V30 29 C 0.0000 8.0022 0.0 0
M  V30 30 C 15.5628 5.8795 0.0 0
M  V30 31 C 15.0869 4.4150 0.0 0
M  V30 32 C 17.0693 6.1997 0.0 0
M  V30 33 C 16.1174 3.2704 0.0 0
M  V30 34 C 18.0997 5.0553 0.0 0
M  V30 35 C 17.6238 3.5906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 20 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 11 25
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]benzoyl]-L-prolyl-N-methylglycinamide
C20H28N4O5
1094297-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.9538 0.0 0
M  V30 2 O 6.6685 4.4137 0.0 0
M  V30 3 C 9.7293 4.5910 0.0 0
M  V30 4 N 11.1940 4.1151 0.0 0
M  V30 5 O 8.5849 3.5606 0.0 0
M  V30 6 C 11.5142 2.6088 0.0 0
M  V30 7 C 12.9788 2.1328 0.0 0
M  V30 8 N 13.2990 0.6265 0.0 0
M  V30 9 O 14.1233 3.1634 0.0 0
M  V30 10 C 14.7637 0.1506 0.0 0
M  V30 11 N 4.0012 4.4137 0.0 0
M  V30 12 C 2.6673 3.6437 0.0 0
M  V30 13 O 2.6673 2.1037 0.0 0
M  V30 14 O 1.3337 4.4137 0.0 0
M  V30 15 C 1.3337 1.3337 0.0 0
M  V30 16 C 2.1037 0.0000 0.0 0
M  V30 17 C 0.0000 0.5637 0.0 0
M  V30 18 C 0.5637 2.6673 0.0 0
M  V30 19 N 8.0023 6.7238 0.0 0
M  V30 20 C 9.4091 6.0975 0.0 0 CFG=2
M  V30 21 C 8.1633 8.2554 0.0 0
M  V30 22 C 10.4396 7.2419 0.0 0
M  V30 23 C 9.6696 8.5755 0.0 0
M  V30 24 C 5.3348 6.7238 0.0 0
M  V30 25 C 4.0012 5.9538 0.0 0
M  V30 26 C 5.3348 8.2638 0.0 0
M  V30 27 C 2.6673 6.7238 0.0 0
M  V30 28 C 4.0012 9.0338 0.0 0
M  V30 29 C 2.6673 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 24
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 20 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1094297-21-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094297-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5485831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
2-(2-(2-(methylamino)-2-oxoethylcarbamoyl)pyrrolidine-1-carbonyl) phenyl
carbamate 6: The tripeptide 15 (0.5 g, 1 mmol) in 5 ml methanolic methyl
amine solution was stirred at room temperature for 6 h. The reaction
mixture was stripped off the solvent under reduced pressure and the
residue obtained was purified by column chromatography (eluent: ethyl
acetate/ Pet. ether: 90/10, Rf: 0.3) to afford 6 (0.4 g, 98%). [α]26 D:
-50° (c = 0.2, CHCl3); Colorless plate crystals were obtained from a
solvent mixture of dichloromethane and MeOH; mp: 196-198 °C; IR (CHCl3) ν
(cm- 1): 3360, 3018, 1716, 1666, 1620, 1593, 1520, 1456, 1418, 1369,
1300, 1215, 1157, 1047, 1024; 1H NMR (400 MHz, CDCl3)δ : 8.26 (s, 1H),
8.14-8.12 (d, J = 8.24 Hz, 1H), 7.43-7.30 (m, 2H), 7.06- 7.03 (t, J =
7.47 Hz, 1H), 6.96 (bs, 1H), 6.76 (bs, 1H), 4.54-4.51 (t, J = 7.51 Hz,
1H), 4.24-4.19 (dd, J = 7.24 Hz, J = 9.59 Hz, 1H), 3.82-3.77 (dd, J =
5Hz, J = 11.89 Hz, 1H),3.68-3.53 (m, 2H), 2.80-2.79 (d, J = 4.72 Hz, 3H),
2.32-2.17 (m, 2H), 2.14-2.05 (m, 1H), 1.93-1.84 (m, 1H), 1.51 (s, 9H);
13C NMR (100 MHz, CDCl3) δ: 172.3, 169.8, 169.7, 153.1, 137.1, 131.2,
127.3, 123.6, 122.0, 120.6, 80.6, 61.1, 50.7, 43.2, 29.2, 28.3, 26.2,
25.5; ESI-MS: 405.46 (M+H)+; 427.50 (M+Na)+; 443.43 (M+K)+; Elemental
Analysis calculated for C20H28N4O5: C, 59.39; H, 6.98; N, 13.85. Found:
C, 59.50; H, 7.06; N, 13.92.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sequence-specific unusual (1→2)-type helical turns in α/β-hybrid peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prabhakaran, Panchami; Kale, Sangram S.; Puranik, Vedavati G.;
Rajamohanan, P. R.; Chetina, Olga; Howard, Judith. A. K.; Hofmann,
Hans-Jorg; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(52), 17743-17754

$RFMT $RIREG SCHEME213 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Indandione
C9H6O2
606-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-(4-Bromophenyl)-6,7,8,10-tetrahydro-5,7,7-trimethyl-5H-indeno[1,2-b]quinol...
C25H22BrNO2
916756-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6252 9.2206 0.0 0
M  V30 2 C 2.2475 3.4898 0.0 0
M  V30 3 O 8.9160 4.2598 0.0 0
M  V30 4 C 7.2385 0.0000 0.0 0
M  V30 5 C 5.2586 0.0000 0.0 0
M  V30 6 Br 11.5833 8.8798 0.0 0
M  V30 7 C 4.9149 6.5698 0.0 0
M  V30 8 C 6.2485 5.7998 0.0 0
M  V30 9 C 3.5813 5.7998 0.0 0
M  V30 10 C 4.5947 8.0761 0.0 0
M  V30 11 C 6.2485 4.2598 0.0 0
M  V30 12 C 2.4367 6.8302 0.0 0
M  V30 13 N 3.5813 4.2598 0.0 0
M  V30 14 C 3.0631 8.2372 0.0 0
M  V30 15 C 4.9149 3.4898 0.0 0
M  V30 16 C 7.5822 3.4898 0.0 0
M  V30 17 C 0.9052 6.6693 0.0 0
M  V30 18 C 2.1580 9.4830 0.0 0
M  V30 19 C 4.9149 1.9498 0.0 0
M  V30 20 C 7.5822 1.9498 0.0 0
M  V30 21 C 0.0000 7.9151 0.0 0
M  V30 22 C 0.6263 9.3219 0.0 0
M  V30 23 C 6.2485 1.1798 0.0 0
M  V30 24 C 7.5822 6.5698 0.0 0
M  V30 25 C 8.9160 5.7998 0.0 0
M  V30 26 C 7.5822 8.1098 0.0 0
M  V30 27 C 10.2496 6.5698 0.0 0
M  V30 28 C 8.9160 8.8798 0.0 0
M  V30 29 C 10.2496 8.1098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 13
M  V30 3 2 3 16
M  V30 4 1 4 23
M  V30 5 1 5 23
M  V30 6 1 6 29
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 24
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 2 12 17
M  V30 19 1 13 15
M  V30 20 2 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 23
M  V30 27 2 21 22
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 606-23-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916756-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-8111667
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, optimized on catalyst loading, solvent, temperature,
TiO2 nanoparticles used as catalyst, no activity change of reused
catalyst observed, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple route to indeno[1,2-b]quinoline derivatives via a coupling
reaction catalyzed by TiO2 nanoparticles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdolmohammadi, Shahrzad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2013), 24(4), 318-320

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-fluorobenzene
C9H10BrFO
1129-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 C 9.2401 4.0010 0.0 0
M  V30 5 Br 10.7801 4.0010 0.0 0
M  V30 6 F 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Fluorophenoxy)-N-methyl-1-propanamine
C10H14FNO
883542-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 F 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1129-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883542-69-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10825440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-fluoro-3-methoxy-2-nitrobenzene
C7H5BrFNO3
1137869-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 F 2.3101 6.6687 0.0 0
M  V30 7 Br 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-methoxy-N-methyl-2-nitrobenzenamine
C8H9BrN2O3
1639289-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6675 6.9302 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 C 8.0023 3.8501 0.0 0
M  V30 8 Br 4.0012 0.0000 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1137869-91-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639289-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-550738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrrolidinone derivatives for use as BET
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blank, Jutta; Bold, Guido; Cotesta, Simona; Guagnano, Vito; Rueeger,
Heinrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014191906 A1 2014-12-04

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 1-(2-fluorophenyl)-5-[(3-methoxyphenyl)sulfony...
C19H17FN2O5S
1138037-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 5.6396 0.0 0 VAL=6
M  V30 2 O 6.1600 4.0996 0.0 0
M  V30 3 O 6.1600 7.1796 0.0 0
M  V30 4 F 10.6662 2.1049 0.0 0
M  V30 5 C 11.3158 7.3148 0.0 0
M  V30 6 O 12.7226 6.6885 0.0 0
M  V30 7 O 11.1547 8.8464 0.0 0
M  V30 8 C 13.9684 7.5937 0.0 0
M  V30 9 C 15.3754 6.9673 0.0 0
M  V30 10 O 1.5400 8.3071 0.0 0
M  V30 11 C 0.0000 8.3071 0.0 0
M  V30 12 N 8.6052 4.3938 0.0 0
M  V30 13 C 7.7000 5.6396 0.0 0
M  V30 14 N 10.0699 4.8696 0.0 0
M  V30 15 C 8.6052 6.8856 0.0 0
M  V30 16 C 10.0699 6.4096 0.0 0
M  V30 17 C 8.1294 2.9292 0.0 0
M  V30 18 C 9.1598 1.7847 0.0 0
M  V30 19 C 6.6229 2.6091 0.0 0
M  V30 20 C 8.6839 0.3202 0.0 0
M  V30 21 C 6.1471 1.1444 0.0 0
M  V30 22 C 7.1776 0.0000 0.0 0
M  V30 23 C 4.6200 5.6396 0.0 0
M  V30 24 C 3.8500 6.9734 0.0 0
M  V30 25 C 3.8500 4.3060 0.0 0
M  V30 26 C 2.3100 6.9734 0.0 0
M  V30 27 C 2.3100 4.3060 0.0 0
M  V30 28 C 1.5400 5.6396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 23
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 1-(2-fluorophenyl)-5-[(3-methoxyphenyl)sulfonyl]-N...
C18H16FN3O4S
1138038-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.8084 5.6396 0.0 0 VAL=6
M  V30 2 O 7.8084 4.0996 0.0 0
M  V30 3 O 7.8084 7.1796 0.0 0
M  V30 4 F 3.3024 2.1049 0.0 0
M  V30 5 C 2.6528 7.3148 0.0 0
M  V30 6 N 1.2459 6.6885 0.0 0
M  V30 7 O 2.8137 8.8464 0.0 0
M  V30 8 C 0.0000 7.5937 0.0 0
M  V30 9 O 12.4284 8.3071 0.0 0
M  V30 10 C 13.9684 8.3071 0.0 0
M  V30 11 N 5.3632 4.3938 0.0 0
M  V30 12 C 6.2684 5.6396 0.0 0
M  V30 13 N 3.8987 4.8696 0.0 0
M  V30 14 C 5.3632 6.8856 0.0 0
M  V30 15 C 3.8987 6.4096 0.0 0
M  V30 16 C 5.8391 2.9292 0.0 0
M  V30 17 C 4.8087 1.7847 0.0 0
M  V30 18 C 7.3455 2.6091 0.0 0
M  V30 19 C 5.2845 0.3202 0.0 0
M  V30 20 C 7.8214 1.1444 0.0 0
M  V30 21 C 6.7909 0.0000 0.0 0
M  V30 22 C 9.3484 5.6396 0.0 0
M  V30 23 C 10.1184 6.9734 0.0 0
M  V30 24 C 10.1184 4.3060 0.0 0
M  V30 25 C 11.6584 6.9734 0.0 0
M  V30 26 C 11.6584 4.3060 0.0 0
M  V30 27 C 12.4284 5.6396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 22
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 16
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138038-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4979952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 329
1-(2-fluorophenyl)-5-[(3-methoxyphenyl)sulfonyl]-N-methyl-1H-pyrazole-3-carboxamide
To ethyl
1-(2-fluorophenyl)-5-[(3-methoxyphenyl)sulfonyl]-1H-pyrazole-3-carboxylate
(144 mg) was added 40% methylamine-methanol solution (3 mL), and the
mixture was stirred at room temperature for 2 hr, and concentrated under
reduced pressure to give the title compound as a white solid (136 mg,
yield 98%). 1H-NMR (CDCl3) &#x03B4; : 2.96 (3H, d, J=4.9 Hz), 3.75 (3H,
s), 6.75-6.84 (1H, m), 6.98-7.03 (1H, m), 7.06-7.16 (3H, m), 7.22-7.41
(3H, m), 7.48-7.59 (2H, m). 1H-NMR (CDCl3) &#x03B4; : 2.96 (3H, d, J=4.9
Hz), 3.75 (3H, s), 6.75-6.84 (1H, m), 6.98-7.03 (1H, m), 7.06-7.16 (3H,
m), 7.22-7.41 (3H, m), 7.48-7.59 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-5-[(5-methyl-2-pyridinyl)thio]-1H-pyrazole-3-carboxaldehyde
C16H12ClN3OS
1138037-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 6.2078 0.0 0
M  V30 2 Cl 0.5546 4.0727 0.0 0
M  V30 3 C 4.7418 0.9052 0.0 0
M  V30 4 O 3.4960 0.0000 0.0 0
M  V30 5 C 12.0290 6.2078 0.0 0
M  V30 6 N 3.5673 4.7132 0.0 0
M  V30 7 C 5.0990 4.8741 0.0 0
M  V30 8 N 3.2471 3.2068 0.0 0
M  V30 9 C 5.7253 3.4672 0.0 0
M  V30 10 C 4.5809 2.4367 0.0 0
M  V30 11 C 2.5368 5.8576 0.0 0
M  V30 12 C 1.0306 5.5374 0.0 0
M  V30 13 C 3.0127 7.3223 0.0 0
M  V30 14 C 0.0000 6.6818 0.0 0
M  V30 15 C 1.9823 8.4666 0.0 0
M  V30 16 C 0.4760 8.1465 0.0 0
M  V30 17 C 7.4090 6.2078 0.0 0
M  V30 18 C 8.1790 7.5414 0.0 0
M  V30 19 N 8.1790 4.8741 0.0 0
M  V30 20 C 9.7190 7.5414 0.0 0
M  V30 21 C 9.7190 4.8741 0.0 0
M  V30 22 C 10.4890 6.2078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-N-methyl-5-[(5-methyl-2-pyridinyl)thio]-1H-pyrazole-3-meth...
C17H17ClN4S
1138037-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8689 7.7394 0.0 0
M  V30 2 Cl 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4367 0.0 0
M  V30 4 N 3.4960 1.5317 0.0 0
M  V30 5 C 3.6569 0.0000 0.0 0
M  V30 6 C 12.0289 7.7394 0.0 0
M  V30 7 N 3.5673 6.2447 0.0 0
M  V30 8 C 5.0989 6.4056 0.0 0
M  V30 9 N 3.2471 4.7384 0.0 0
M  V30 10 C 5.7253 4.9988 0.0 0
M  V30 11 C 4.5809 3.9684 0.0 0
M  V30 12 C 2.5368 7.3892 0.0 0
M  V30 13 C 1.0306 7.0689 0.0 0
M  V30 14 C 3.0127 8.8538 0.0 0
M  V30 15 C 0.0000 8.2134 0.0 0
M  V30 16 C 1.9823 9.9983 0.0 0
M  V30 17 C 0.4760 9.6780 0.0 0
M  V30 18 C 7.4089 7.7394 0.0 0
M  V30 19 C 8.1789 9.0731 0.0 0
M  V30 20 N 8.1789 6.4056 0.0 0
M  V30 21 C 9.7189 9.0731 0.0 0
M  V30 22 C 9.7189 6.4056 0.0 0
M  V30 23 C 10.4889 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12086246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 301
1-{1-(2-chlorophenyl)-5-[(5-methylpyridin-2-yl)thio]-1H-pyrazol-3-yl}-N-methylmethanamine
To a solution of
1-(2-chlorophenyl)-5-[(5-methylpyridin-2-yl)thio]-1H-pyrazole-3-carbaldehyde
(422 mg) in tetrahydrofuran (4 mL) were added 40% methylamine-methanol
solution (1.3 mL) and methanol (4 mL) at 0&#x00B0; C., and the mixture
was stirred at room temperature for 16 hr, and concentrated under reduced
pressure. The residue was dissolved in methanol (4 mL), and sodium
borohydride (60 mg) was added at 0&#x00B0; C. The mixture was stirred at
room temperature for 1 hr, and concentrated under reduced pressure.
Saturated aqueous sodium hydrogen carbonate solution was added to the
residue, and the mixture was extracted with ethyl acetate. The extract
was washed successively with saturated aqueous sodium hydrogen carbonate
solution, water and saturated brine, dried over anhydrous sodium sulfate,
and concentrated under reduced pressure to give the title compound as a
yellow oil (433 mg, yield 98%). 1H-NMR (CDCl3) &#x03B4; : 2.23 (3H, s),
2.52 (3H, s), 3.88 (2H, s), 6.70 (1H, s), 6.79-6.81 (1H, m), 7.19-7.35
(4H, m), 7.43-7.46 (1H, m), 8.15-8.16 (1H, m), 1H: not detected.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,3-dimethyl-2H-indazole
C9H9BrN2
1142189-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 0.0000 0.0 0
M  V30 2 C 7.9110 2.7104 0.0 0
M  V30 3 Br 0.0000 4.2504 0.0 0
M  V30 4 C 4.0011 3.4804 0.0 0
M  V30 5 C 4.0011 1.9404 0.0 0
M  V30 6 N 5.4658 3.9564 0.0 0
M  V30 7 C 2.6674 4.2504 0.0 0
M  V30 8 C 5.4658 1.4645 0.0 0
M  V30 9 C 2.6674 1.1704 0.0 0
M  V30 10 N 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 3.4804 0.0 0
M  V30 12 C 1.3338 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 2 9 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2,3-Trimethyl-2H-indazol-6-amine
C10H13N3
1376676-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 0.0000 0.0 0
M  V30 2 C 0.0000 2.7104 0.0 0
M  V30 3 N 7.9108 4.2504 0.0 0
M  V30 4 C 9.2446 3.4804 0.0 0
M  V30 5 C 3.9099 1.9404 0.0 0
M  V30 6 C 3.9099 3.4804 0.0 0
M  V30 7 C 2.4452 1.4645 0.0 0
M  V30 8 C 5.2436 1.1704 0.0 0
M  V30 9 C 5.2436 4.2504 0.0 0
M  V30 10 N 2.4452 3.9564 0.0 0
M  V30 11 N 1.5400 2.7104 0.0 0
M  V30 12 C 6.5772 1.9404 0.0 0
M  V30 13 C 6.5772 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1142189-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1376676-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24098380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (optimized on catalyst)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel process for preparation of pazopanib hydrochloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haas, Philipp Daniel; Steckel, Hartwig Andreas; Bellur Atici, Esen;
Yilmaz, Halil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021162647 A1 2021-08-19

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Glucopyranose, 2-deoxy-2-isoselenocyanato-, 1,3,4,6-tetraacetate
C15H19NO9Se
1142814-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 8.4700 0.0 0
M  V30 2 C 4.0011 9.2400 0.0 0
M  V30 3 C 4.0011 10.7800 0.0 0
M  V30 4 O 2.6673 8.4700 0.0 0
M  V30 5 O 2.6673 6.9300 0.0 0
M  V30 6 C 1.3336 6.1600 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 O 0.0000 6.9300 0.0 0
M  V30 9 C 8.0020 6.9300 0.0 0
M  V30 10 O 9.3358 6.1600 0.0 0
M  V30 11 C 10.6694 6.9300 0.0 0
M  V30 12 C 12.0031 6.1600 0.0 0
M  V30 13 O 10.6694 8.4700 0.0 0
M  V30 14 N 2.6673 3.8500 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 Se 2.6673 0.7700 0.0 0
M  V30 17 O 5.3347 2.3100 0.0 0
M  V30 18 C 6.6684 1.5400 0.0 0
M  V30 19 C 6.6684 0.0000 0.0 0
M  V30 20 O 8.0020 2.3100 0.0 0
M  V30 21 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 22 C 4.0011 6.1600 0.0 0 CFG=2
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 25 O 6.6684 4.6200 0.0 0
M  V30 26 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 15
M  V30 15 1 24 14 CFG=3
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 26 17 CFG=1
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 21 22 23 24 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C16H24N2O9Se
2892823-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 5.3347 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 N 0.7700 6.6684 0.0 0
M  V30 4 Se 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 O 4.6200 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 O 2.3100 1.3336 0.0 0
M  V30 10 O 4.6200 8.0021 0.0 0
M  V30 11 C 5.3900 9.3358 0.0 0
M  V30 12 C 6.9300 9.3358 0.0 0
M  V30 13 O 4.6200 10.6694 0.0 0
M  V30 14 O 7.7000 2.6673 0.0 0
M  V30 15 C 6.9300 1.3336 0.0 0
M  V30 16 C 5.3900 1.3336 0.0 0
M  V30 17 O 7.7000 0.0000 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 O 10.0100 6.6684 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 22 O 12.3200 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 24 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 25 C 5.3900 6.6684 0.0 0 CFG=2
M  V30 26 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 27 O 6.9300 6.6684 0.0 0
M  V30 28 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 25 10 CFG=3
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 26 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 28 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1142814-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892823-62-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34479329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbohydrate-derived bicyclic selenazolines as new dual inhibitors
(cholinesterases/OGA) against Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Velueta-Viveros, Martha; Martinez-Bailen, Macarena; Puerta, Adrian;
Romero-Hernandez, Laura L.; Kren, Vladimir; Merino-Montiel, Penelope;
Montiel-Smith, Sara; Fernandes, Miguel X.; Moreno-Vargas, Antonio J.;
Padron, Jose M.; Lopez, Oscar; Fernandez-Bolanos, Jose G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2022), 127105983

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanone, 2-bromo-1-(5-chloro-1H-indol-3-yl)-
C11H9BrClNO
115027-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 3.5673 0.6403 0.0 0
M  V30 4 Br 0.0000 2.6091 0.0 0
M  V30 5 C 0.5546 0.0000 0.0 0
M  V30 6 Cl 8.4784 2.9553 0.0 0
M  V30 7 C 4.4773 3.7253 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 4.4773 5.2653 0.0 0
M  V30 10 C 5.8111 2.9553 0.0 0
M  V30 11 C 2.1075 4.4953 0.0 0
M  V30 12 N 3.0127 5.7411 0.0 0
M  V30 13 C 5.8111 6.0353 0.0 0
M  V30 14 C 7.1447 3.7253 0.0 0
M  V30 15 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Chloro-1H-indol-3-yl)-2-(methylamino)-1-propanone
C12H13ClN2O
2764945-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 3.7710 0.0 0
M  V30 2 C 7.5950 3.7710 0.0 0
M  V30 3 O 5.2850 5.1048 0.0 0
M  V30 4 N 8.3650 5.1048 0.0 0
M  V30 5 C 8.3650 2.4374 0.0 0
M  V30 6 C 9.9050 5.1048 0.0 0
M  V30 7 Cl 0.0000 3.8614 0.0 0
M  V30 8 C 3.7534 2.2764 0.0 0
M  V30 9 C 5.2850 2.4374 0.0 0
M  V30 10 C 3.4333 0.7700 0.0 0
M  V30 11 C 2.6091 3.3068 0.0 0
M  V30 12 C 5.9114 1.0306 0.0 0
M  V30 13 N 4.7669 0.0000 0.0 0
M  V30 14 C 1.9686 0.2941 0.0 0
M  V30 15 C 1.1444 2.8310 0.0 0
M  V30 16 C 0.8242 1.3247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115027-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764945-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37063962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specialized combinations for mental disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Dalziel, Sean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107715 A1 2023-06-15

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanone, 2-bromo-1-(5-chloro-1H-indol-3-yl)-
C11H9BrClNO
115027-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 3.5673 0.6403 0.0 0
M  V30 4 Br 0.0000 2.6091 0.0 0
M  V30 5 C 0.5546 0.0000 0.0 0
M  V30 6 Cl 8.4784 2.9553 0.0 0
M  V30 7 C 4.4773 3.7253 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 4.4773 5.2653 0.0 0
M  V30 10 C 5.8111 2.9553 0.0 0
M  V30 11 C 2.1075 4.4953 0.0 0
M  V30 12 N 3.0127 5.7411 0.0 0
M  V30 13 C 5.8111 6.0353 0.0 0
M  V30 14 C 7.1447 3.7253 0.0 0
M  V30 15 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Chloro-1H-indol-3-yl)-2-(methylamino)-1-propanone
C12H13ClN2O
2764945-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 3.7710 0.0 0
M  V30 2 C 7.5950 3.7710 0.0 0
M  V30 3 O 5.2850 5.1048 0.0 0
M  V30 4 N 8.3650 5.1048 0.0 0
M  V30 5 C 8.3650 2.4374 0.0 0
M  V30 6 C 9.9050 5.1048 0.0 0
M  V30 7 Cl 0.0000 3.8614 0.0 0
M  V30 8 C 3.7534 2.2764 0.0 0
M  V30 9 C 5.2850 2.4374 0.0 0
M  V30 10 C 3.4333 0.7700 0.0 0
M  V30 11 C 2.6091 3.3068 0.0 0
M  V30 12 C 5.9114 1.0306 0.0 0
M  V30 13 N 4.7669 0.0000 0.0 0
M  V30 14 C 1.9686 0.2941 0.0 0
M  V30 15 C 1.1444 2.8310 0.0 0
M  V30 16 C 0.8242 1.3247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115027-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764945-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31874090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of advantageous tryptamine compositions for mental disorders
or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022061242 A1 2022-03-24

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(2-oxiranylmethyl)carbamate
C8H15NO3
115198-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.1037 0.0 0
M  V30 2 N 5.3348 1.3337 0.0 0
M  V30 3 C 4.0012 2.1037 0.0 0
M  V30 4 O 2.6675 1.3337 0.0 0
M  V30 5 O 4.0012 3.6437 0.0 0
M  V30 6 C 1.3337 2.1037 0.0 0
M  V30 7 C 0.5637 0.7700 0.0 0
M  V30 8 C 0.0000 2.8737 0.0 0
M  V30 9 C 2.1037 3.4374 0.0 0
M  V30 10 C 8.0023 1.3337 0.0 0
M  V30 11 C 8.7723 0.0000 0.0 0
M  V30 12 O 9.5424 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-hydroxy-3-(methylamino)propyl]carbamate
C9H20N2O3
1327336-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 2.6673 1.5400 0.0 0
M  V30 6 O 4.0012 3.8501 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 10.6697 1.5400 0.0 0
M  V30 11 C 2.1037 3.6437 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 0.5637 0.9764 0.0 0
M  V30 14 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115198-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1327336-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-7741241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A. (2-hydroxy-3-methylamino-propyl)-carbamic acid tert-butyl ester. A
solution of Oxiranylmethyl-carbamic acid tert-butyl ester (0.64 g, 3.7
mmol) in Ethanol (6 mL) was treated at room temperature with a 2.0M
solution of methylamine in THF (5 mL, 10 mmol). The reaction mixture was
stirred for 5 hours at 40°C. The solvent was evaporated in vacuo to yield
a gum which was used directly into the next step (0.75 g, 98%). 1H NMR
(400 MHz, CDCl3) δ 3.79 (bs, 1H), 3.32 (bs, 1H), 3.11-3.05 (m, 1H), 2.64
(dd, 1H), 2.53 (dd, 1H), 2.43 (s, 3H), 1.45 (s, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminothiazolones as estrogen related receptor-alpha
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bignan, Gilles; Gaul, Micheal; Xu, Guozhang; Zhao, Bao-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110200586 A1 2011-08-18

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Oxo-N-[3-(trifluoromethyl)phenyl]benzeneacetamide
C15H10F3NO2
1158519-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 O 4.0010 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 F 12.7733 2.8737 0.0 0
M  V30 8 F 13.3370 0.7700 0.0 0
M  V30 9 F 11.2333 0.2064 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 1 3 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 13
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methylimino)-N-[3-(trifluoromethyl)phenyl]benzeneacetamide
C16H13F3N2O
1158519-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 N 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 F 11.2333 0.9764 0.0 0
M  V30 9 F 13.3370 1.5400 0.0 0
M  V30 10 F 12.7733 3.6437 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 8.0022 3.0801 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 10.6697 3.0801 0.0 0
M  V30 21 C 9.3360 5.3901 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1158519-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1158519-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2706924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly enantioselective Pictet-Spengler reactions with α-keto
amide-derived ketimines: Access to an unusual class of quaternary α-amino
amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bou-Hamdan, Farhan R.; Leighton, James L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2009), 48(13), 2403-2406

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
5-Cyclopropyl-2-[4-(4-fluorophenoxy)phenyl]-6-[(methylsulfonyl)amino]-3-benzo...
C25H20FNO6S
1179986-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8940 9.3192 0.0 0
M  V30 2 O 4.4293 9.7952 0.0 0
M  V30 3 O 7.0384 10.3497 0.0 0
M  V30 4 N 2.8738 2.6674 0.0 0
M  V30 5 S 3.6438 1.3336 0.0 0 VAL=6
M  V30 6 C 4.4138 0.0000 0.0 0
M  V30 7 O 4.9774 2.1038 0.0 0
M  V30 8 O 2.3100 0.5636 0.0 0
M  V30 9 O 12.9557 10.2666 0.0 0
M  V30 10 F 18.2906 7.1866 0.0 0
M  V30 11 C 5.1838 6.6685 0.0 0
M  V30 12 C 5.9538 5.3347 0.0 0
M  V30 13 C 6.2142 7.8129 0.0 0
M  V30 14 C 3.6438 6.6685 0.0 0
M  V30 15 O 7.4601 5.6549 0.0 0
M  V30 16 C 5.1838 4.0011 0.0 0
M  V30 17 C 7.6210 7.1866 0.0 0
M  V30 18 C 2.8738 5.3347 0.0 0
M  V30 19 C 3.6438 4.0011 0.0 0
M  V30 20 C 8.9548 7.9566 0.0 0
M  V30 21 C 10.2884 7.1866 0.0 0
M  V30 22 C 8.9548 9.4966 0.0 0
M  V30 23 C 11.6221 7.9566 0.0 0
M  V30 24 C 10.2884 10.2666 0.0 0
M  V30 25 C 11.6221 9.4966 0.0 0
M  V30 26 C 1.3338 5.3347 0.0 0
M  V30 27 C 0.0000 6.1047 0.0 0
M  V30 28 C 0.0000 4.5647 0.0 0
M  V30 29 C 14.2895 9.4966 0.0 0
M  V30 30 C 14.2895 7.9566 0.0 0
M  V30 31 C 15.6231 10.2666 0.0 0
M  V30 32 C 15.6231 7.1866 0.0 0
M  V30 33 C 16.9568 9.4966 0.0 0
M  V30 34 C 16.9568 7.9566 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 25
M  V30 10 1 9 29
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 18 26
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyclopropyl-2-[4-(4-fluorophenoxy)phenyl]-N-methyl-6-[(methylsulfonyl)amino...
C26H23FN2O5S
1179985-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8941 9.3193 0.0 0
M  V30 2 N 4.4294 9.7952 0.0 0
M  V30 3 O 7.0385 10.3499 0.0 0
M  V30 4 C 4.1092 11.3016 0.0 0
M  V30 5 N 2.8738 2.6675 0.0 0
M  V30 6 S 3.6439 1.3337 0.0 0 VAL=6
M  V30 7 C 4.4139 0.0000 0.0 0
M  V30 8 O 2.3100 0.5636 0.0 0
M  V30 9 O 4.9775 2.1037 0.0 0
M  V30 10 O 12.9561 10.2666 0.0 0
M  V30 11 F 18.2909 7.1865 0.0 0
M  V30 12 C 5.1839 6.6685 0.0 0
M  V30 13 C 6.2143 7.8130 0.0 0
M  V30 14 C 5.9539 5.3348 0.0 0
M  V30 15 C 3.6439 6.6685 0.0 0
M  V30 16 C 7.6211 7.1865 0.0 0
M  V30 17 O 7.4602 5.6550 0.0 0
M  V30 18 C 5.1839 4.0011 0.0 0
M  V30 19 C 2.8738 5.3348 0.0 0
M  V30 20 C 3.6439 4.0011 0.0 0
M  V30 21 C 8.9549 7.9565 0.0 0
M  V30 22 C 10.2886 7.1865 0.0 0
M  V30 23 C 8.9549 9.4966 0.0 0
M  V30 24 C 11.6223 7.9565 0.0 0
M  V30 25 C 10.2886 10.2666 0.0 0
M  V30 26 C 11.6223 9.4966 0.0 0
M  V30 27 C 1.3338 5.3348 0.0 0
M  V30 28 C 0.0000 6.1048 0.0 0
M  V30 29 C 0.0000 4.5648 0.0 0
M  V30 30 C 14.2897 9.4966 0.0 0
M  V30 31 C 14.2897 7.9565 0.0 0
M  V30 32 C 15.6234 10.2666 0.0 0
M  V30 33 C 15.6234 7.1865 0.0 0
M  V30 34 C 16.9571 9.4966 0.0 0
M  V30 35 C 16.9571 7.9565 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 26
M  V30 11 1 10 30
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 16 21
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 19 27
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1179986-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1179985-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5148366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 11:
5-cyclopropyl-2-(4-(4-fluorophenoxy)phenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
A solution of
5-cyclopropyl-2-(4-(4-fluorophenoxy)phenyl)-6-(methylsulfonamido)benzofuran-3-carboxylic
acid (9.9 g, 20.56 mmol) in dry DMF (50 mL) was treated with DIPEA (5.86
g, 45.23 mmol) and HATU (9.42 g, 24.67 mmol) at 20 °C. After 15 minutes,
2 M methylamine in THF (41.12 mL, 82.24 mmol) was added drop wise and the
mixture was stirred for another 2 hours and then diluted with water
(200ml). The mixture was extracted with EA (3×250 mL), washed with water
(2×200 mL), dried and concentrated. a reddish brown thick oil (10 g, 98
%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Benzofuranyl)aminoalkyl-substituted boronic acid derivatives and their
preparation and use for the treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad; Haigh, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067663 A1 2012-05-24

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
5-Cyclopropyl-2-[4-(4-fluorophenoxy)phenyl]-6-[(methylsulfonyl)amino]-3-benzo...
C25H20FNO6S
1179986-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8940 9.3192 0.0 0
M  V30 2 O 4.4293 9.7952 0.0 0
M  V30 3 O 7.0384 10.3497 0.0 0
M  V30 4 N 2.8738 2.6674 0.0 0
M  V30 5 S 3.6438 1.3336 0.0 0 VAL=6
M  V30 6 C 4.4138 0.0000 0.0 0
M  V30 7 O 4.9774 2.1038 0.0 0
M  V30 8 O 2.3100 0.5636 0.0 0
M  V30 9 O 12.9557 10.2666 0.0 0
M  V30 10 F 18.2906 7.1866 0.0 0
M  V30 11 C 5.1838 6.6685 0.0 0
M  V30 12 C 5.9538 5.3347 0.0 0
M  V30 13 C 6.2142 7.8129 0.0 0
M  V30 14 C 3.6438 6.6685 0.0 0
M  V30 15 O 7.4601 5.6549 0.0 0
M  V30 16 C 5.1838 4.0011 0.0 0
M  V30 17 C 7.6210 7.1866 0.0 0
M  V30 18 C 2.8738 5.3347 0.0 0
M  V30 19 C 3.6438 4.0011 0.0 0
M  V30 20 C 8.9548 7.9566 0.0 0
M  V30 21 C 10.2884 7.1866 0.0 0
M  V30 22 C 8.9548 9.4966 0.0 0
M  V30 23 C 11.6221 7.9566 0.0 0
M  V30 24 C 10.2884 10.2666 0.0 0
M  V30 25 C 11.6221 9.4966 0.0 0
M  V30 26 C 1.3338 5.3347 0.0 0
M  V30 27 C 0.0000 6.1047 0.0 0
M  V30 28 C 0.0000 4.5647 0.0 0
M  V30 29 C 14.2895 9.4966 0.0 0
M  V30 30 C 14.2895 7.9566 0.0 0
M  V30 31 C 15.6231 10.2666 0.0 0
M  V30 32 C 15.6231 7.1866 0.0 0
M  V30 33 C 16.9568 9.4966 0.0 0
M  V30 34 C 16.9568 7.9566 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 25
M  V30 10 1 9 29
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 18 26
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyclopropyl-2-[4-(4-fluorophenoxy)phenyl]-N-methyl-6-[(methylsulfonyl)amino...
C26H23FN2O5S
1179985-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8941 9.3193 0.0 0
M  V30 2 N 4.4294 9.7952 0.0 0
M  V30 3 O 7.0385 10.3499 0.0 0
M  V30 4 C 4.1092 11.3016 0.0 0
M  V30 5 N 2.8738 2.6675 0.0 0
M  V30 6 S 3.6439 1.3337 0.0 0 VAL=6
M  V30 7 C 4.4139 0.0000 0.0 0
M  V30 8 O 2.3100 0.5636 0.0 0
M  V30 9 O 4.9775 2.1037 0.0 0
M  V30 10 O 12.9561 10.2666 0.0 0
M  V30 11 F 18.2909 7.1865 0.0 0
M  V30 12 C 5.1839 6.6685 0.0 0
M  V30 13 C 6.2143 7.8130 0.0 0
M  V30 14 C 5.9539 5.3348 0.0 0
M  V30 15 C 3.6439 6.6685 0.0 0
M  V30 16 C 7.6211 7.1865 0.0 0
M  V30 17 O 7.4602 5.6550 0.0 0
M  V30 18 C 5.1839 4.0011 0.0 0
M  V30 19 C 2.8738 5.3348 0.0 0
M  V30 20 C 3.6439 4.0011 0.0 0
M  V30 21 C 8.9549 7.9565 0.0 0
M  V30 22 C 10.2886 7.1865 0.0 0
M  V30 23 C 8.9549 9.4966 0.0 0
M  V30 24 C 11.6223 7.9565 0.0 0
M  V30 25 C 10.2886 10.2666 0.0 0
M  V30 26 C 11.6223 9.4966 0.0 0
M  V30 27 C 1.3338 5.3348 0.0 0
M  V30 28 C 0.0000 6.1048 0.0 0
M  V30 29 C 0.0000 4.5648 0.0 0
M  V30 30 C 14.2897 9.4966 0.0 0
M  V30 31 C 14.2897 7.9565 0.0 0
M  V30 32 C 15.6234 10.2666 0.0 0
M  V30 33 C 15.6234 7.1865 0.0 0
M  V30 34 C 16.9571 9.4966 0.0 0
M  V30 35 C 16.9571 7.9565 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 26
M  V30 11 1 10 30
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 16 21
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 19 27
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1179986-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1179985-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11793959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 12:
5-cyclopropyl-2-(4-(4-fluorophenoxy)phenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
To a solution of 5-cyclopropyl-2-(4-(4-fluorophenoxy)phenyl)-6-
(methylsulfonamido)benzofuran-3-carboxylic acid (9.9 g, 20.56 mmol) in
dry DMF (50 mL) was added DIPEA (5.86 g, 45.23 mmol), and HATU (9.42 g,
24.67 mmol) at 20 °C. After 15 minutes, 2 M Methylamine in THF (41.12 mL,
82.24 mmol) was added dropwise and the mixture was stirred for another 2
hours, and then water as added(200ml). The mixture was extracted with EA
(3× 250 mL), washed with water (2× 200 mL), dried and concentrated to
afford
5-cyclopropyl-2-(4-(4-fluorophenoxy)phenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide
as a reddish brown thick oil (10 g, 98 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuranylaminoalkyl boronic acid derivatives
therapeutic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011103063 A1 2011-08-25

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-2-nitrobenzene
C10H12BrNO3
118327-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 C 9.2400 6.6685 0.0 0
M  V30 6 Br 10.7800 6.6685 0.0 0
M  V30 7 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 O 2.3100 5.3347 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 1.5400 1.3338 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(2-nitrophenoxy)-1-butanamine
C11H16N2O3
1195950-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 9 O 0.0000 5.3901 0.0 0
M  V30 10 O 2.6673 5.3901 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 12
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118327-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10440972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxyacetophenone
C8H8O2
118-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-1-(Methylimino)ethyl]phenol
C9H11NO
365276-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 365276-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1798407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved solvent-free preparation of 2-imidoylphenols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cimarelli, Cristina; Palmieri, Gianni; Volpini, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2001), 33(4), 369-371

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(2S,3S)-1-(3-Chloro-4-cyanophenyl)-3-hydroxy-2-methyl-3-pyrrolidinyl]-3-py...
C18H16ClN3O3
1192603-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.9721 5.3780 0.0 0
M  V30 2 O 6.7114 4.9437 0.0 0
M  V30 3 Cl 14.0215 0.0000 0.0 0
M  V30 4 C 15.5615 2.6674 0.0 0
M  V30 5 N 17.1015 2.6674 0.0 0
M  V30 6 C 0.9052 2.7936 0.0 0
M  V30 7 O 0.0000 4.0394 0.0 0
M  V30 8 O 0.2789 1.3866 0.0 0
M  V30 9 N 9.4014 2.6674 0.0 0
M  V30 10 C 8.4962 3.9133 0.0 0 CFG=1
M  V30 11 C 8.4962 1.4216 0.0 0
M  V30 12 C 7.0315 3.4375 0.0 0 CFG=1
M  V30 13 C 7.0315 1.8974 0.0 0
M  V30 14 C 10.9414 2.6674 0.0 0
M  V30 15 C 11.7115 1.3338 0.0 0
M  V30 16 C 11.7115 4.0011 0.0 0
M  V30 17 C 13.2515 1.3338 0.0 0
M  V30 18 C 13.2515 4.0011 0.0 0
M  V30 19 C 14.0215 2.6674 0.0 0
M  V30 20 C 5.5000 3.2765 0.0 0
M  V30 21 C 4.5948 4.5224 0.0 0
M  V30 22 N 4.8737 1.8696 0.0 0
M  V30 23 C 3.0632 4.3613 0.0 0
M  V30 24 C 3.3420 1.7086 0.0 0
M  V30 25 C 2.4368 2.9545 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 12 2 CFG=3
M  V30 3 1 3 17
M  V30 4 3 4 5
M  V30 5 1 4 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 25
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 12 20 CFG=1
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-[(2S,3S)-1-(3-Chloro-4-cyanophenyl)-3-hydroxy-2-methyl-3-pyrrolidinyl]-N-me...
C19H19ClN4O2
1192603-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6029 5.8764 0.0 0
M  V30 2 O 8.3092 5.6808 0.0 0
M  V30 3 Cl 15.0625 0.0000 0.0 0
M  V30 4 C 16.8729 2.4919 0.0 0
M  V30 5 N 18.4045 2.3308 0.0 0
M  V30 6 C 2.3100 4.1493 0.0 0
M  V30 7 N 1.5400 5.4829 0.0 0
M  V30 8 O 1.5400 2.8156 0.0 0
M  V30 9 C 0.0000 5.4829 0.0 0
M  V30 10 N 10.7466 3.1358 0.0 0
M  V30 11 C 9.9766 4.4695 0.0 0 CFG=1
M  V30 12 C 9.7160 1.9912 0.0 0
M  V30 13 C 8.4701 4.1493 0.0 0 CFG=1
M  V30 14 C 8.3092 2.6177 0.0 0
M  V30 15 C 12.2781 2.9749 0.0 0
M  V30 16 C 12.9045 1.5679 0.0 0
M  V30 17 C 13.1834 4.2207 0.0 0
M  V30 18 C 14.4360 1.4070 0.0 0
M  V30 19 C 14.7149 4.0597 0.0 0
M  V30 20 C 15.3412 2.6528 0.0 0
M  V30 21 C 6.9301 4.1493 0.0 0
M  V30 22 C 6.1601 2.8156 0.0 0
M  V30 23 N 6.1601 5.4829 0.0 0
M  V30 24 C 4.6201 2.8156 0.0 0
M  V30 25 C 4.6201 5.4829 0.0 0
M  V30 26 C 3.8501 4.1493 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=3
M  V30 2 1 13 2 CFG=3
M  V30 3 1 3 18
M  V30 4 3 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 1 13 21 CFG=1
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192603-29-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192603-33-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1273860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 63307-62-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamamoto, Satoshi; Kobayashi, Hiromi; Kaku, Tomohiro; Aikawa, Katsuji;
Hara, Takahito; Yamaoka, Masuo; Kanzaki, Naoyuki; Hasuoka, Atsushi; Baba,
Atsuo; Ito, Mitsuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(1), 70-83

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-(trifluoromethoxy)benzene
C11H12BrF3O2
1195950-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 F 0.0000 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 C 9.3358 2.3101 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 C 12.0033 2.3101 0.0 0
M  V30 10 C 13.3370 3.0801 0.0 0
M  V30 11 Br 14.6707 2.3101 0.0 0
M  V30 12 C 4.0010 0.7700 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-(trifluoromethoxy)phenoxy]-1-butanamine
C12H16F3NO2
1195950-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 F 0.0000 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 1.3338 2.3100 0.0 0
M  V30 6 O 8.0022 3.0800 0.0 0
M  V30 7 C 9.3359 2.3100 0.0 0
M  V30 8 C 10.6697 3.0800 0.0 0
M  V30 9 C 12.0034 2.3100 0.0 0
M  V30 10 C 13.3370 3.0800 0.0 0
M  V30 11 N 14.6707 2.3100 0.0 0
M  V30 12 C 16.0045 3.0800 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 6.6686 0.7700 0.0 0
M  V30 17 C 5.3348 3.0800 0.0 0
M  V30 18 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1195950-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4051461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (1α,3α,5α)-spiro[8-azabicyclo[3.2.1]octane-3,2′-oxirane]-8-...
C13H21NO3
1196118-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7087 3.6412 0.0 0
M  V30 2 O 8.0425 2.8712 0.0 0
M  V30 3 O 6.7087 5.1812 0.0 0
M  V30 4 C 9.3761 3.6412 0.0 0
M  V30 5 C 10.1461 2.3075 0.0 0
M  V30 6 C 10.7098 4.4112 0.0 0
M  V30 7 C 8.6061 4.9750 0.0 0
M  V30 8 C 1.5398 2.3214 0.0 0 CFG=2
M  V30 9 C 2.7885 2.5535 0.0 0
M  V30 10 C 2.5224 3.5445 0.0 0
M  V30 11 C 0.7902 0.9761 0.0 0
M  V30 12 O 0.0000 2.2978 0.0 0
M  V30 13 C 4.3939 1.6567 0.0 0 CFG=2
M  V30 14 C 4.0428 2.6617 0.0 0 CFG=1
M  V30 15 N 5.3751 2.8712 0.0 0
M  V30 16 C 4.5955 0.0000 0.0 0
M  V30 17 C 3.9185 1.1952 0.0 0
M  V30 18 H 5.8743 1.2323 0.0 0
M  V30 19 H 4.3260 4.1754 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9 CFG=1
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 18 CFG=3
M  V30 18 1 14 15
M  V30 19 1 14 17
M  V30 20 1 14 19 CFG=1
M  V30 21 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 8 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3-endo)-3-hydroxy-3-[(methylamino)methyl]-8-azabicyclo[3.2...
C14H26N2O3
1899919-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.6412 0.0 0
M  V30 2 O 2.6673 2.8712 0.0 0
M  V30 3 O 4.0010 5.1812 0.0 0
M  V30 4 C 1.3337 3.6412 0.0 0
M  V30 5 C 2.1037 4.9749 0.0 0
M  V30 6 C 0.0000 4.4112 0.0 0
M  V30 7 C 0.5636 2.3076 0.0 0
M  V30 8 C 10.5944 2.9068 0.0 0
M  V30 9 N 11.8137 1.9660 0.0 0
M  V30 10 C 13.2380 2.5515 0.0 0
M  V30 11 O 9.3285 0.7896 0.0 0
M  V30 12 N 5.3348 2.8712 0.0 0
M  V30 13 C 6.3159 1.6568 0.0 0 CFG=2
M  V30 14 C 6.6671 2.6618 0.0 0 CFG=1
M  V30 15 C 7.9214 2.5534 0.0 0
M  V30 16 C 6.1143 0.0000 0.0 0
M  V30 17 C 8.1875 3.5445 0.0 0
M  V30 18 C 6.7913 1.1952 0.0 0
M  V30 19 C 9.1701 2.3214 0.0 0 CFG=1
M  V30 20 H 4.8355 1.2323 0.0 0
M  V30 21 H 6.3837 4.1755 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 19 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 19 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 20 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 21 CFG=1
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196118-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1899919-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-15899343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of
4'-alkyl-8-azaspiro[bicyclo[3.2.1]octane-3,2'-morpholin]-5'-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mandzhulo, A. Yu.; Mel'nichuk, N. A.; Fetyukhin, V. N.; Vovk, M. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2016), 52(1), 87-91

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Diethyl 2,2′-(1,2-phenylenediimino)bis[2-oxoacetate]
C14H16N2O6
119935-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 O 3.8500 2.6674 0.0 0
M  V30 5 O 2.3100 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 C 1.5400 6.6685 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 N 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 4.0011 0.0 0
M  V30 11 C 11.5500 5.3347 0.0 0
M  V30 12 O 11.5500 2.6674 0.0 0
M  V30 13 O 13.0900 5.3347 0.0 0
M  V30 14 O 10.7800 6.6685 0.0 0
M  V30 15 C 13.8600 6.6685 0.0 0
M  V30 16 C 15.4000 6.6685 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 6.1600 1.3338 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 6.9300 0.0000 0.0 0
M  V30 22 C 8.4700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanediamide, N,N′′-1,2-phenylenebis[N′-methyl-
C12H14N4O4
188727-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 2.3100 5.3347 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 N 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.0100 5.3347 0.0 0
M  V30 11 O 10.0100 2.6674 0.0 0
M  V30 12 N 11.5500 5.3347 0.0 0
M  V30 13 O 9.2400 6.6685 0.0 0
M  V30 14 C 12.3200 6.6685 0.0 0
M  V30 15 C 5.3900 2.6674 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 4.6200 1.3338 0.0 0
M  V30 18 C 7.7000 1.3338 0.0 0
M  V30 19 C 5.3900 0.0000 0.0 0
M  V30 20 C 6.9300 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119935-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 188727-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5368483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Formation of the ligand 358: A methanolic solution (150 cm**3) of diethyl
o-phenylenebis(oxamate) 357 (9.0 g, 29 mmol) was treated with 3
equivalents of methylamine (33 % in ethanol) (8.14 g, 87.5 mmol) at room
temperature. The mixture was heated to 65 degC for 30 min with vigorous
stirring and after cooling, the white precipitate was filtered off,
washed with methanol and ether and dried under vacuum to give a white
powder (8.0 g, 98 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Synthetic Uses for Chiral 1,3-Dioxolan-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Power, Lynn A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2008), (20140701), No pp.

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Ethyl 2-[(1S)-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]butyl]-1,3-dithiolane...
C14H27NO3S3
1203455-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 5.3348 0.0 0 CFG=2
M  V30 2 N 4.6201 4.0010 0.0 0
M  V30 3 C 2.3100 5.3348 0.0 0
M  V30 4 S 3.8501 2.6673 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 C 3.2864 0.5636 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 C 5.9539 2.1037 0.0 0
M  V30 12 C 5.8661 5.7632 0.0 0
M  V30 13 O 7.2729 6.3896 0.0 0
M  V30 14 O 5.7050 4.2317 0.0 0
M  V30 15 C 8.5188 5.4843 0.0 0
M  V30 16 C 9.9257 6.1108 0.0 0
M  V30 17 C 4.6201 6.6684 0.0 0
M  V30 18 S 5.6506 7.8128 0.0 0
M  V30 19 S 3.2133 7.2948 0.0 0
M  V30 20 C 4.8806 9.1465 0.0 0
M  V30 21 C 3.3742 8.8263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1S)-1-[[(S)-(1,1-Dimethylethyl)sulfinyl]amino]butyl]-N-methyl-1,3-dithiol...
C13H26N2O2S3
1203455-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8117 3.8501 0.0 0 CFG=2
M  V30 2 N 5.1456 4.6201 0.0 0
M  V30 3 C 3.8117 2.3101 0.0 0
M  V30 4 S 6.4792 3.8501 0.0 0 CFG=1 VAL=4
M  V30 5 C 2.4781 1.5400 0.0 0
M  V30 6 C 7.8129 4.6201 0.0 0
M  V30 7 O 6.4792 2.3101 0.0 0
M  V30 8 C 2.4781 0.0000 0.0 0
M  V30 9 C 8.5829 3.2864 0.0 0
M  V30 10 C 9.1466 5.3901 0.0 0
M  V30 11 C 7.0429 5.9538 0.0 0
M  V30 12 C 3.3833 5.8660 0.0 0
M  V30 13 N 2.7570 7.2730 0.0 0
M  V30 14 O 4.9149 5.7051 0.0 0
M  V30 15 C 3.6622 8.5189 0.0 0
M  V30 16 C 2.4781 4.6201 0.0 0
M  V30 17 S 1.3337 5.6505 0.0 0
M  V30 18 S 1.8517 3.2133 0.0 0
M  V30 19 C 0.0000 4.8805 0.0 0
M  V30 20 C 0.3202 3.3742 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 16
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1203455-73-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1203455-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11021073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Beyond the chiral pool: a general approach to β-amino-α-keto amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Cristian L.; Krawiec, Mariusz; Forslund, Raymond E.; Nugent,
William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(1), 41-47

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]butyl]-1,3-dithiolane...
C14H27NO3S3
1203455-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 5.3348 0.0 0 CFG=2
M  V30 2 N 4.6201 4.0010 0.0 0
M  V30 3 C 2.3100 5.3348 0.0 0
M  V30 4 S 3.8501 2.6673 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 C 3.2864 0.5636 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 C 5.9539 2.1037 0.0 0
M  V30 12 C 5.8661 5.7632 0.0 0
M  V30 13 O 7.2729 6.3896 0.0 0
M  V30 14 O 5.7050 4.2317 0.0 0
M  V30 15 C 8.5188 5.4843 0.0 0
M  V30 16 C 9.9257 6.1108 0.0 0
M  V30 17 C 4.6201 6.6684 0.0 0
M  V30 18 S 5.6506 7.8128 0.0 0
M  V30 19 S 3.2133 7.2948 0.0 0
M  V30 20 C 4.8806 9.1465 0.0 0
M  V30 21 C 3.3742 8.8263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[(1S)-1-[[(S)-(1,1-Dimethylethyl)sulfinyl]amino]butyl]-N-methyl-1,3-dithiol...
C13H26N2O2S3
1203455-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8117 3.8501 0.0 0 CFG=2
M  V30 2 N 5.1456 4.6201 0.0 0
M  V30 3 C 3.8117 2.3101 0.0 0
M  V30 4 S 6.4792 3.8501 0.0 0 CFG=1 VAL=4
M  V30 5 C 2.4781 1.5400 0.0 0
M  V30 6 C 7.8129 4.6201 0.0 0
M  V30 7 O 6.4792 2.3101 0.0 0
M  V30 8 C 2.4781 0.0000 0.0 0
M  V30 9 C 8.5829 3.2864 0.0 0
M  V30 10 C 9.1466 5.3901 0.0 0
M  V30 11 C 7.0429 5.9538 0.0 0
M  V30 12 C 3.3833 5.8660 0.0 0
M  V30 13 N 2.7570 7.2730 0.0 0
M  V30 14 O 4.9149 5.7051 0.0 0
M  V30 15 C 3.6622 8.5189 0.0 0
M  V30 16 C 2.4781 4.6201 0.0 0
M  V30 17 S 1.3337 5.6505 0.0 0
M  V30 18 S 1.8517 3.2133 0.0 0
M  V30 19 C 0.0000 4.8805 0.0 0
M  V30 20 C 0.3202 3.3742 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6 CFG=3
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 16
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1203455-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1203455-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1275057
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 7: Preparation of
(S,Ss)-2-[1-(tert-butylsulfinylamino)butyl]-N-methyl-1,3-dithiolane-2-carboxamide.
A heavy-walled glass tube was charged with ethyl
(S,Ss)-2-[1-(tert-butylsulfinylamino)butyl]-1,3-dithiolane-2-carboxylate
(0.50 g, 1.4 mmol) and a chilled 8.0 M solution of methylamine in ethanol
(5 mL, 40 mmol). The mixture was allowed to warm to room temperature and
was allowed to stand for 72 hours. Distillation of the solvent at reduced
pressure afforded
(S,Ss)-2-[1-(tert-butylsulfinylamino)butyl]-N-methyl-1,3-dithiolane-2-carboxamide
(0.47 g, 98%) as a viscous amber-colored oil. 1H NMR (500 MHz, CD3OD): δ
0.89 (t, J= 7 Hz, 3H), 1.22 (s, 9H), 1.34 (m, 1H), 1.50 (m, 1H), 1.59 (m,
1H), 2.75 (s, 3H), 3.19 (m, 2H), 3.40 (m, 2H), 3.91 (m, 1H). 13C NMR (125
MHz, CD3OD): δ 14.2, 21.3, 24.7, 27.4, 37.8, 41.0, 41.2, 58.4, 64.7,
78.7, 174.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for the preparation of protected α-keto-β-amino ester and amide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nugent, William A.; Looker, Adam R.; Forslund, Raymond E.; Martinot,
Theodore A.; Harrison, Cristian L.; Ibrahim, Sheree
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010002474 A1 2010-01-07

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,10bR)-4-Ethyl-3,3a,4,5,10,10b-hexahydro-2H-furo[2,3-a]carbazol-2-one
C16H17NO2
1204823-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0010 1.3337 0.0 0
M  V30 2 C 3.7711 0.0000 0.0 0
M  V30 3 O 0.0000 6.6229 0.0 0
M  V30 4 C 5.3111 5.3348 0.0 0
M  V30 5 C 6.0811 4.0011 0.0 0
M  V30 6 C 3.7711 5.3348 0.0 0 CFG=1
M  V30 7 N 6.3417 6.4792 0.0 0
M  V30 8 C 7.5875 4.3213 0.0 0
M  V30 9 C 5.3111 2.6673 0.0 0
M  V30 10 C 3.0010 4.0011 0.0 0 CFG=1
M  V30 11 O 2.7406 6.4792 0.0 0
M  V30 12 C 7.7485 5.8529 0.0 0
M  V30 13 C 8.8334 3.4161 0.0 0
M  V30 14 C 3.7711 2.6673 0.0 0 CFG=1
M  V30 15 C 1.4947 4.3213 0.0 0
M  V30 16 C 1.3338 5.8529 0.0 0
M  V30 17 C 9.1554 6.4792 0.0 0
M  V30 18 C 10.2402 4.0424 0.0 0
M  V30 19 C 10.4013 5.5740 0.0 0
M  V30 20 H 4.3975 6.7416 0.0 0
M  V30 21 H 2.0958 2.7551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 2 3 16
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 6 20 CFG=1
M  V30 12 1 7 12
M  V30 13 1 8 12
M  V30 14 2 8 13
M  V30 15 1 9 14
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 1 10 21 CFG=1
M  V30 19 1 11 16
M  V30 20 2 12 17
M  V30 21 1 13 18
M  V30 22 1 15 16
M  V30 23 1 17 19
M  V30 24 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 10 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,3S)-3-Ethyl-2,3,4,9-tetrahydro-1-hydroxy-N-methyl-1H-carbazole-2-a...
C17H22N2O2
1992033-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.4000 6.6685 0.0 0
M  V30 2 C 7.4000 1.3338 0.0 0
M  V30 3 C 6.6300 0.0000 0.0 0
M  V30 4 C 8.9401 4.0011 0.0 0
M  V30 5 C 9.7101 5.3347 0.0 0
M  V30 6 N 11.2501 5.3347 0.0 0
M  V30 7 O 8.9401 6.6685 0.0 0
M  V30 8 C 12.0201 6.6685 0.0 0
M  V30 9 C 4.3200 4.0011 0.0 0
M  V30 10 C 5.0900 5.3347 0.0 0
M  V30 11 C 2.8137 4.3213 0.0 0
M  V30 12 C 5.0900 2.6674 0.0 0
M  V30 13 C 6.6300 5.3347 0.0 0 CFG=1
M  V30 14 N 4.0596 6.4793 0.0 0
M  V30 15 C 2.6527 5.8528 0.0 0
M  V30 16 C 1.5679 3.4160 0.0 0
M  V30 17 C 6.6300 2.6674 0.0 0 CFG=1
M  V30 18 C 7.4000 4.0011 0.0 0 CFG=1
M  V30 19 C 1.2459 6.4793 0.0 0
M  V30 20 C 0.1609 4.0425 0.0 0
M  V30 21 C 0.0000 5.5741 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 18 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 15
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1204823-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1992033-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16387800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective Total Synthesis of (±)-Dasycarpidol and (±)-Dasycarpidone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patir, Suleyman; Tezeren, Mustafa A.; Salih, Bekir; Erturk, Erkan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(23), 4175-4180

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-bromo-1-propanone
C11H9BrO2
1207259-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 Br 7.7047 3.8500 0.0 0
M  V30 5 C 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-(methylamino)-1-propanone
C12H13NO2
2855950-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 N 9.0383 1.5400 0.0 0
M  V30 5 C 7.7045 3.8500 0.0 0
M  V30 6 C 10.3720 2.3100 0.0 0
M  V30 7 C 2.3698 2.3100 0.0 0
M  V30 8 C 2.3698 3.8500 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 C 0.9052 1.8341 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 O 0.9052 4.3259 0.0 0
M  V30 13 C 5.0372 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207259-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855950-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37132005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzofuran salt morphic forms and mixtures for the treatment of mental
disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Lofthus, Sean Jeffrey; De Leon, Xanthe Marie
Renomeron; Singh, Aniruddh; Hudgins, Connor James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107653 A2 2023-06-15

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-bromo-6-chloro-, methyl ester
C7H5BrClNO2
1214353-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 Cl 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide, 5-bromo-6-chloro-N-methyl-
C7H6BrClN2O
2918937-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 Cl 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214353-79-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2918937-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37025155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused 1,2,3,4-tetrahydropyridine-2,4-dione multicyclic compounds as PARP1
inhibitors and their preparation, pharmaceutical compositions and use in
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paliwal, Sunil; Samatar, Ahmed Abdi; Cripe, Lawrence Saunders
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023096915 A1 2023-06-01

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(trifluoromethyl)benzaldehyde
C9H7F3O2
1214384-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 F 2.4611 1.5400 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 5.5411 1.5400 0.0 0
M  V30 5 C 1.3336 3.0800 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 6.6685 3.0800 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 5.3347 5.3900 0.0 0
M  V30 14 C 4.0011 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 3-methoxy-N-methyl-2-(trifluoromethyl)-
C10H12F3NO
3040200-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 F 5.5411 1.5400 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 2.4611 1.5400 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 N 8.0021 3.8500 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 O 1.3336 3.0800 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 5.3347 5.3900 0.0 0
M  V30 14 C 2.6674 5.3900 0.0 0
M  V30 15 C 4.0011 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214384-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-82-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Triethylamine
C6H15N
121-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6676 0.7700 0.0 0
M  V30 2 C 1.3340 0.0000 0.0 0
M  V30 3 C 4.0013 0.0000 0.0 0
M  V30 4 C 2.6676 2.3101 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3350 0.7700 0.0 0
M  V30 7 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sulfamic acid, N-methyl-, compd. with N,N-diethylethanamine (1:1)
C6H15N.CH5NO3S
2141977-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.0007 5.9537 0.0 0 VAL=6
M  V30 2 N 3.3343 6.7238 0.0 0
M  V30 3 O 2.7707 4.6201 0.0 0
M  V30 4 O 1.2306 7.2874 0.0 0
M  V30 5 O 0.6670 5.1837 0.0 0
M  V30 6 C 4.6680 5.9537 0.0 0
M  V30 7 N 2.6676 0.7700 0.0 0
M  V30 8 C 1.3340 0.0000 0.0 0
M  V30 9 C 4.0013 0.0000 0.0 0
M  V30 10 C 2.6676 2.3101 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 12 C 5.3350 0.7700 0.0 0
M  V30 13 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 7 8
M  V30 7 1 7 9
M  V30 8 1 7 10
M  V30 9 1 8 11
M  V30 10 1 9 12
M  V30 11 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2141977-81-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29729435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 26412-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-substituted sulfamate esters from sulfamic acid salts by
activation with triphenylphosphine ditriflate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blackburn, J. Miles; Short, Melanie A.; Castanheiro, Thomas; Ayer, Suraj
K.; Muellers, Tobias D.; Roizen, Jennifer L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(21), 6012-6015

$RFMT $RIREG SCHEME236 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethyl phosphite
C3H9O3P
121-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.6676 0.7700 0.0 0
M  V30 2 O 1.3340 0.0000 0.0 0
M  V30 3 O 4.0013 0.0000 0.0 0
M  V30 4 O 2.6676 2.3101 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3350 0.7700 0.0 0
M  V30 7 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Euparin
C13H12O3
532-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2447 3.0800 0.0 0
M  V30 2 C 10.0147 4.4137 0.0 0
M  V30 3 C 10.0147 1.7464 0.0 0
M  V30 4 O 1.3338 4.6200 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 O 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 6.7994 1.8341 0.0 0
M  V30 14 C 7.7047 3.0800 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H22NO5P
2283382-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 2.6673 0.0 0
M  V30 2 P 2.3100 3.4373 0.0 0 VAL=5
M  V30 3 N 3.6437 4.2074 0.0 0
M  V30 4 C 2.8737 1.3337 0.0 0
M  V30 5 O 0.9764 4.2074 0.0 0
M  V30 6 O 1.5400 2.1037 0.0 0
M  V30 7 O 3.0801 4.7710 0.0 0
M  V30 8 C 4.9775 4.9774 0.0 0
M  V30 9 C 0.9764 5.7474 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 O 5.1837 0.0000 0.0 0
M  V30 12 C 11.2650 5.2891 0.0 0
M  V30 13 C 12.5987 4.5191 0.0 0
M  V30 14 C 11.2650 6.8291 0.0 0
M  V30 15 C 5.1837 2.6673 0.0 0
M  V30 16 C 5.9538 4.0010 0.0 0
M  V30 17 C 5.9538 1.3337 0.0 0
M  V30 18 C 7.4938 4.0010 0.0 0
M  V30 19 C 7.4938 1.3337 0.0 0
M  V30 20 C 8.2638 2.6673 0.0 0
M  V30 21 C 8.5244 5.1455 0.0 0
M  V30 22 O 9.7703 2.9875 0.0 0
M  V30 23 C 9.9312 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 2 7
M  V30 8 1 3 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 23
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 2 19 20
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-45-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2283382-46-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27874777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, Kabachnik-Fields reaction, ZnO
nanoparticles used as catalyst, optimization study, optimized on
catalyst, optimized on solvent, optimized on temperature, optimized on
time, optimized on stoichiometry of catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of α-aminophosphonates using ZnO nanoparticles as an
efficient catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ezzatzadeh, Elham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2018), 73(3-4), 179-184

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(2,2-difluoroethoxy)-5-nitro-N-[trans-4-(trifluoromethyl)cyclohexy...
C15H15ClF5N3O4
1218944-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 6.9300 8.0021 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 O 4.6200 4.0011 0.0 0
M  V30 5 C 3.8500 2.6673 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 F 3.8500 0.0000 0.0 0
M  V30 8 F 6.1600 1.3336 0.0 0
M  V30 9 N 1.5400 9.3358 0.0 0 VAL=5
M  V30 10 O 2.3100 10.6694 0.0 0
M  V30 11 O 0.0000 9.3358 0.0 0
M  V30 12 Cl 0.0000 6.6684 0.0 0
M  V30 13 C 13.0900 8.0021 0.0 0
M  V30 14 F 13.0900 6.4621 0.0 0
M  V30 15 F 14.6300 8.0021 0.0 0
M  V30 16 F 13.0900 9.5421 0.0 0
M  V30 17 C 4.6200 6.6684 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 3.8500 8.0021 0.0 0
M  V30 20 N 2.3100 5.3347 0.0 0
M  V30 21 C 2.3100 8.0021 0.0 0
M  V30 22 C 1.5400 6.6684 0.0 0
M  V30 23 C 8.4700 8.0021 0.0 0 CFG=2
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 9.2400 9.3358 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 10.7800 9.3358 0.0 0
M  V30 28 C 11.5500 8.0021 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 23 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 1 12 22
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 28 13 CFG=1
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-(2,2-Difluoroethoxy)-6-(methylamino)-5-nitro-N-[trans-4-(trifluoromethyl)cy...
C16H19F5N4O4
1218944-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 8.0021 0.0 0
M  V30 3 O 7.7000 5.3347 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 5.3900 1.3336 0.0 0
M  V30 7 F 4.6200 0.0000 0.0 0
M  V30 8 F 6.9300 1.3336 0.0 0
M  V30 9 N 2.3100 9.3358 0.0 0 VAL=5
M  V30 10 O 3.0800 10.6694 0.0 0
M  V30 11 O 0.7700 9.3358 0.0 0
M  V30 12 N 0.7700 6.6684 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 13.8600 8.0021 0.0 0
M  V30 15 F 13.8600 9.5421 0.0 0
M  V30 16 F 15.4000 8.0021 0.0 0
M  V30 17 F 13.8600 6.4621 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 4.6200 8.0021 0.0 0
M  V30 21 N 3.0800 5.3347 0.0 0
M  V30 22 C 3.0800 8.0021 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 9.2400 8.0021 0.0 0 CFG=2
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 27 C 11.5500 6.6684 0.0 0
M  V30 28 C 11.5500 9.3358 0.0 0
M  V30 29 C 12.3200 8.0021 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 24 2 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 12 13
M  V30 14 1 12 23
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 29 14 CFG=1
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1218944-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1218944-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9513846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (d)
2-(2,2-Difluoro-ethoxy)-6-methylamino-5-nitro-nicotinic acid methyl ester
Methylamine (2 M in THF; 32.0 mL, 64.0 mmol) is added at 10° C. to
6-chloro-2-(2,2-difluoro-ethoxy)-5-nitro-nicotinic acid methyl ester (9.1
g, 30.7 mmol) in THF (50 mL). After 1 h at rt the reaction mixture is
concentrated, treated with water and filtered. The filtercake is washed
with water and dried to give the sub-title compound. (g)
2-(2,2-Difluoro-ethoxy)-6-methylamino-5-nitro-N-(trans-4-trifluoromethyl-cyclohexyl)-nicotinamide
The subtitle compound is prepared from
6-chloro-2-(2,2-difluoro-ethoxy)-5-nitro-N-(trans-4-trifluoromethyl-cyclohexyl)-nicotinamide
(2.5 g, 5.8 mmol) and CH3NH2 (2 M in THF; 6.0 mL, 12.0 mmol) in THF (25
mL) in analogy with example 1d. Yield: 2.4 g (98%). Rf(TLC): 0.58 (silica
gel, PE:EtOAc 1:1). MS m/z: 472 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylaminoimidazopyridinecarboxamide derivatives for use as
mPGES-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Doods, Henri; Kuelzer, Raimund; Pfau, Roland; Stenkamp,
Dirk; Pelcman, Benjamin; Roenn, Robert; Lubriks, Dimitrijs; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012022792 A1 2012-02-23

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40148185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective synthesis of isoquinolinonediones through remote
unactivated C(sp3)-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Lei; Sun, Jun; Sun, Boxuan; Song, Shengjie; Li, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(36),
4818-4821

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,1′′,1′′′,1′′′′,1′′′′′,1′′′′′′,1′′′′′′′-Octakis(1,1-dimethylethyl) 4,4′,4...
C216H242O33S
1228438-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  250 271 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 40.0408 45.3461 0.0 0
M  V30 2 C 40.8109 44.0124 0.0 0
M  V30 3 C 38.7072 44.5761 0.0 0
M  V30 4 C 40.0408 42.6786 0.0 0
M  V30 5 C 40.8109 41.3449 0.0 0
M  V30 6 O 40.0408 40.0113 0.0 0
M  V30 7 O 36.9608 50.6809 0.0 0
M  V30 8 C 37.7308 52.0146 0.0 0
M  V30 9 O 45.3757 48.4262 0.0 0
M  V30 10 C 46.7093 47.6561 0.0 0
M  V30 11 C 43.1209 34.6764 0.0 0
M  V30 12 C 42.3509 33.3426 0.0 0
M  V30 13 C 41.5809 34.6764 0.0 0
M  V30 14 C 40.8109 33.3426 0.0 0
M  V30 15 C 40.0408 32.0090 0.0 0
M  V30 16 O 38.5008 32.0090 0.0 0
M  V30 17 C 34.6507 57.3494 0.0 0
M  V30 18 O 35.4207 58.6831 0.0 0
M  V30 19 O 33.1107 57.3494 0.0 0
M  V30 20 C 34.6507 60.0169 0.0 0
M  V30 21 C 35.9844 60.7869 0.0 0
M  V30 22 C 33.8807 61.3506 0.0 0
M  V30 23 C 33.3171 59.2469 0.0 0
M  V30 24 C 52.0442 50.7362 0.0 0
M  V30 25 O 53.3778 49.9662 0.0 0
M  V30 26 O 52.0442 52.2762 0.0 0
M  V30 27 C 54.7117 50.7362 0.0 0
M  V30 28 C 53.9416 52.0699 0.0 0
M  V30 29 C 56.0453 51.5062 0.0 0
M  V30 30 C 55.4817 49.4025 0.0 0
M  V30 31 O 49.2810 34.6764 0.0 0
M  V30 32 C 50.0511 33.3428 0.0 0
M  V30 33 C 51.5911 33.3428 0.0 0
M  V30 34 C 52.3611 32.0090 0.0 0
M  V30 35 C 53.9011 32.0090 0.0 0
M  V30 36 C 53.9011 33.5490 0.0 0
M  V30 37 C 35.4207 26.6741 0.0 0
M  V30 38 C 36.1908 25.3405 0.0 0
M  V30 39 C 36.9608 26.6741 0.0 0
M  V30 40 C 35.4207 24.0068 0.0 0
M  V30 41 C 36.1908 22.6730 0.0 0
M  V30 42 O 35.4207 21.3393 0.0 0
M  V30 43 S 36.1908 20.0056 0.0 0 VAL=6
M  V30 44 C 34.8571 19.2356 0.0 0
M  V30 45 O 36.9608 18.6720 0.0 0
M  V30 46 O 37.5244 20.7757 0.0 0
M  V30 47 O 60.0613 32.0090 0.0 0
M  V30 48 C 60.8313 30.6753 0.0 0
M  V30 49 O 53.9011 25.8488 0.0 0
M  V30 50 C 52.5675 25.0788 0.0 0
M  V30 51 O 29.2606 26.6741 0.0 0
M  V30 52 C 28.4906 25.3405 0.0 0
M  V30 53 C 26.9506 25.3405 0.0 0
M  V30 54 C 26.1806 24.0068 0.0 0
M  V30 55 C 24.6405 24.0068 0.0 0
M  V30 56 C 25.4105 25.3405 0.0 0
M  V30 57 C 66.9914 30.6753 0.0 0
M  V30 58 O 67.7614 32.0090 0.0 0
M  V30 59 O 67.7614 29.3416 0.0 0
M  V30 60 C 69.3015 32.0090 0.0 0
M  V30 61 C 69.3015 30.4689 0.0 0
M  V30 62 C 70.8415 32.0090 0.0 0
M  V30 63 C 69.3015 33.5490 0.0 0
M  V30 64 C 52.5675 18.9187 0.0 0
M  V30 65 O 51.2336 18.1487 0.0 0
M  V30 66 O 53.9011 18.1487 0.0 0
M  V30 67 C 51.2336 16.6086 0.0 0
M  V30 68 C 52.7737 16.6086 0.0 0
M  V30 69 C 51.2336 15.0686 0.0 0
M  V30 70 C 49.6936 16.6086 0.0 0
M  V30 71 O 21.5605 29.3416 0.0 0
M  V30 72 C 22.3305 30.6753 0.0 0
M  V30 73 C 21.5605 32.0090 0.0 0
M  V30 74 C 22.3305 33.3426 0.0 0
M  V30 75 C 21.5605 34.6764 0.0 0
M  V30 76 C 23.1005 34.6764 0.0 0
M  V30 77 O 21.5605 18.6720 0.0 0
M  V30 78 C 20.0204 18.6720 0.0 0
M  V30 79 C 19.2504 17.3381 0.0 0
M  V30 80 C 17.7104 17.3381 0.0 0
M  V30 81 C 16.9404 16.0045 0.0 0
M  V30 82 C 16.1703 17.3381 0.0 0
M  V30 83 O 24.6405 40.0113 0.0 0
M  V30 84 C 23.8705 41.3449 0.0 0
M  V30 85 O 15.4003 34.6764 0.0 0
M  V30 86 C 14.6303 36.0101 0.0 0
M  V30 87 O 10.7802 16.0045 0.0 0
M  V30 88 C 10.0102 14.6708 0.0 0
M  V30 89 O 20.0204 10.6697 0.0 0
M  V30 90 C 19.2504 9.3360 0.0 0
M  V30 91 C 26.9506 46.6798 0.0 0
M  V30 92 O 26.1806 48.0134 0.0 0
M  V30 93 O 28.4906 46.6798 0.0 0
M  V30 94 C 26.9506 49.3473 0.0 0
M  V30 95 C 25.6169 50.1173 0.0 0
M  V30 96 C 27.7206 50.6809 0.0 0
M  V30 97 C 28.2842 48.5772 0.0 0
M  V30 98 C 8.4702 36.0101 0.0 0
M  V30 99 O 7.7002 34.6764 0.0 0
M  V30 100 O 7.7002 37.3438 0.0 0
M  V30 101 C 6.1601 34.6764 0.0 0
M  V30 102 C 6.1601 33.1364 0.0 0
M  V30 103 C 4.6201 34.6764 0.0 0
M  V30 104 C 6.1601 36.2165 0.0 0
M  V30 105 C 3.8501 14.6708 0.0 0
M  V30 106 O 3.0801 13.3371 0.0 0
M  V30 107 O 3.0801 16.0045 0.0 0
M  V30 108 C 1.5400 13.3371 0.0 0
M  V30 109 C 1.5400 11.7971 0.0 0
M  V30 110 C 0.0000 13.3371 0.0 0
M  V30 111 C 1.5400 14.8772 0.0 0
M  V30 112 C 22.3305 4.0012 0.0 0
M  V30 113 O 21.5605 2.6675 0.0 0
M  V30 114 O 23.8705 4.0012 0.0 0
M  V30 115 C 22.3305 1.3337 0.0 0
M  V30 116 C 23.6641 2.1037 0.0 0
M  V30 117 C 23.1005 0.0000 0.0 0
M  V30 118 C 20.9968 0.5637 0.0 0
M  V30 119 C 39.2708 46.6798 0.0 0
M  V30 120 C 40.0408 48.0134 0.0 0
M  V30 121 C 37.7308 46.6798 0.0 0
M  V30 122 C 39.2708 49.3473 0.0 0
M  V30 123 C 36.9608 48.0134 0.0 0
M  V30 124 C 37.7308 49.3473 0.0 0
M  V30 125 C 41.3745 46.1161 0.0 0
M  V30 126 C 42.7082 45.3461 0.0 0
M  V30 127 C 41.3745 47.6561 0.0 0
M  V30 128 C 44.0420 46.1161 0.0 0
M  V30 129 C 42.7082 48.4262 0.0 0
M  V30 130 C 44.0420 47.6561 0.0 0
M  V30 131 C 40.8109 38.6776 0.0 0
M  V30 132 C 42.3509 38.6776 0.0 0
M  V30 133 C 40.0408 37.3438 0.0 0
M  V30 134 C 43.1209 37.3438 0.0 0
M  V30 135 C 40.8109 36.0101 0.0 0
M  V30 136 C 42.3509 36.0101 0.0 0
M  V30 137 C 36.9608 53.3483 0.0 0
M  V30 138 C 35.4207 53.3483 0.0 0
M  V30 139 C 37.7308 54.6821 0.0 0
M  V30 140 C 34.6507 54.6821 0.0 0
M  V30 141 C 36.9608 56.0158 0.0 0
M  V30 142 C 35.4207 56.0158 0.0 0
M  V30 143 C 48.0430 48.4262 0.0 0
M  V30 144 C 48.0430 49.9662 0.0 0
M  V30 145 C 49.3768 47.6561 0.0 0
M  V30 146 C 49.3768 50.7362 0.0 0
M  V30 147 C 50.7105 48.4262 0.0 0
M  V30 148 C 50.7105 49.9662 0.0 0
M  V30 149 C 44.6609 34.6764 0.0 0
M  V30 150 C 45.4310 33.3426 0.0 0
M  V30 151 C 45.4310 36.0101 0.0 0
M  V30 152 C 46.9710 33.3426 0.0 0
M  V30 153 C 46.9710 36.0101 0.0 0
M  V30 154 C 47.7410 34.6764 0.0 0
M  V30 155 C 37.7308 30.6753 0.0 0
M  V30 156 C 38.5008 29.3416 0.0 0
M  V30 157 C 36.1908 30.6753 0.0 0
M  V30 158 C 37.7308 28.0078 0.0 0
M  V30 159 C 35.4207 29.3416 0.0 0
M  V30 160 C 36.1908 28.0078 0.0 0
M  V30 161 C 55.4412 32.0090 0.0 0
M  V30 162 C 56.2112 30.6753 0.0 0
M  V30 163 C 56.2112 33.3428 0.0 0
M  V30 164 C 57.7512 30.6753 0.0 0
M  V30 165 C 57.7512 33.3426 0.0 0
M  V30 166 C 58.5212 32.0090 0.0 0
M  V30 167 C 53.9011 30.4689 0.0 0
M  V30 168 C 52.5675 29.6989 0.0 0
M  V30 169 C 55.2348 29.6989 0.0 0
M  V30 170 C 52.5675 28.1589 0.0 0
M  V30 171 C 55.2348 28.1589 0.0 0
M  V30 172 C 53.9011 27.3889 0.0 0
M  V30 173 C 33.8807 26.6741 0.0 0
M  V30 174 C 33.1107 28.0078 0.0 0
M  V30 175 C 33.1107 25.3405 0.0 0
M  V30 176 C 31.5707 28.0078 0.0 0
M  V30 177 C 31.5707 25.3405 0.0 0
M  V30 178 C 30.8006 26.6741 0.0 0
M  V30 179 C 62.3713 30.6753 0.0 0
M  V30 180 C 63.1413 29.3416 0.0 0
M  V30 181 C 63.1413 32.0090 0.0 0
M  V30 182 C 64.6814 29.3416 0.0 0
M  V30 183 C 64.6814 32.0090 0.0 0
M  V30 184 C 65.4514 30.6753 0.0 0
M  V30 185 C 52.5675 23.5388 0.0 0
M  V30 186 C 53.9011 22.7688 0.0 0
M  V30 187 C 51.2336 22.7688 0.0 0
M  V30 188 C 53.9011 21.2287 0.0 0
M  V30 189 C 51.2336 21.2287 0.0 0
M  V30 190 C 52.5675 20.4587 0.0 0
M  V30 191 C 23.8705 25.3405 0.0 0
M  V30 192 C 22.3305 25.3405 0.0 0
M  V30 193 C 24.6405 26.6741 0.0 0
M  V30 194 C 21.5605 26.6741 0.0 0
M  V30 195 C 23.8705 28.0078 0.0 0
M  V30 196 C 22.3305 28.0078 0.0 0
M  V30 197 C 23.8705 22.6730 0.0 0
M  V30 198 C 22.3305 22.6730 0.0 0
M  V30 199 C 24.6405 21.3393 0.0 0
M  V30 200 C 21.5605 21.3393 0.0 0
M  V30 201 C 23.8705 20.0056 0.0 0
M  V30 202 C 22.3305 20.0056 0.0 0
M  V30 203 C 22.3305 36.0101 0.0 0
M  V30 204 C 21.5605 37.3438 0.0 0
M  V30 205 C 23.8705 36.0101 0.0 0
M  V30 206 C 22.3305 38.6775 0.0 0
M  V30 207 C 24.6405 37.3438 0.0 0
M  V30 208 C 23.8705 38.6776 0.0 0
M  V30 209 C 20.0204 34.6764 0.0 0
M  V30 210 C 19.2504 36.0101 0.0 0
M  V30 211 C 19.2504 33.3426 0.0 0
M  V30 212 C 17.7104 36.0101 0.0 0
M  V30 213 C 17.7104 33.3426 0.0 0
M  V30 214 C 16.9404 34.6764 0.0 0
M  V30 215 C 15.4003 16.0045 0.0 0
M  V30 216 C 14.6303 17.3381 0.0 0
M  V30 217 C 14.6303 14.6708 0.0 0
M  V30 218 C 13.0903 17.3381 0.0 0
M  V30 219 C 13.0903 14.6708 0.0 0
M  V30 220 C 12.3203 16.0045 0.0 0
M  V30 221 C 17.7104 14.6708 0.0 0
M  V30 222 C 19.2504 14.6708 0.0 0
M  V30 223 C 16.9404 13.3371 0.0 0
M  V30 224 C 20.0204 13.3371 0.0 0
M  V30 225 C 17.7104 12.0033 0.0 0
M  V30 226 C 19.2504 12.0033 0.0 0
M  V30 227 C 24.6405 42.6786 0.0 0
M  V30 228 C 26.1806 42.6786 0.0 0
M  V30 229 C 23.8705 44.0124 0.0 0
M  V30 230 C 26.9506 44.0124 0.0 0
M  V30 231 C 24.6405 45.3461 0.0 0
M  V30 232 C 26.1806 45.3461 0.0 0
M  V30 233 C 13.0903 36.0101 0.0 0
M  V30 234 C 12.3203 34.6764 0.0 0
M  V30 235 C 12.3203 37.3438 0.0 0
M  V30 236 C 10.7802 34.6764 0.0 0
M  V30 237 C 10.7802 37.3438 0.0 0
M  V30 238 C 10.0102 36.0101 0.0 0
M  V30 239 C 8.4702 14.6708 0.0 0
M  V30 240 C 7.7002 13.3371 0.0 0
M  V30 241 C 7.7002 16.0045 0.0 0
M  V30 242 C 6.1601 13.3371 0.0 0
M  V30 243 C 6.1601 16.0045 0.0 0
M  V30 244 C 5.3901 14.6708 0.0 0
M  V30 245 C 20.0204 8.0023 0.0 0
M  V30 246 C 19.2504 6.6685 0.0 0
M  V30 247 C 21.5605 8.0023 0.0 0
M  V30 248 C 20.0204 5.3348 0.0 0
M  V30 249 C 22.3305 6.6685 0.0 0
M  V30 250 C 21.5605 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 119
M  V30 4 1 1 125
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 131
M  V30 9 1 7 8
M  V30 10 1 7 124
M  V30 11 1 8 137
M  V30 12 1 9 10
M  V30 13 1 9 130
M  V30 14 1 10 143
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 136
M  V30 18 1 11 149
M  V30 19 1 12 14
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 16 155
M  V30 23 1 17 18
M  V30 24 2 17 19
M  V30 25 1 17 142
M  V30 26 1 18 20
M  V30 27 1 20 21
M  V30 28 1 20 22
M  V30 29 1 20 23
M  V30 30 1 24 25
M  V30 31 2 24 26
M  V30 32 1 24 148
M  V30 33 1 25 27
M  V30 34 1 27 28
M  V30 35 1 27 29
M  V30 36 1 27 30
M  V30 37 1 31 32
M  V30 38 1 31 154
M  V30 39 1 32 33
M  V30 40 1 33 34
M  V30 41 1 34 35
M  V30 42 1 35 36
M  V30 43 1 35 161
M  V30 44 1 35 167
M  V30 45 1 37 38
M  V30 46 1 37 39
M  V30 47 1 37 160
M  V30 48 1 37 173
M  V30 49 1 38 40
M  V30 50 1 40 41
M  V30 51 1 41 42
M  V30 52 1 42 43
M  V30 53 1 43 44
M  V30 54 2 43 45
M  V30 55 2 43 46
M  V30 56 1 47 48
M  V30 57 1 47 166
M  V30 58 1 48 179
M  V30 59 1 49 50
M  V30 60 1 49 172
M  V30 61 1 50 185
M  V30 62 1 51 52
M  V30 63 1 51 178
M  V30 64 1 52 53
M  V30 65 1 53 54
M  V30 66 1 54 55
M  V30 67 1 55 56
M  V30 68 1 55 191
M  V30 69 1 55 197
M  V30 70 1 57 58
M  V30 71 2 57 59
M  V30 72 1 57 184
M  V30 73 1 58 60
M  V30 74 1 60 61
M  V30 75 1 60 62
M  V30 76 1 60 63
M  V30 77 1 64 65
M  V30 78 2 64 66
M  V30 79 1 64 190
M  V30 80 1 65 67
M  V30 81 1 67 68
M  V30 82 1 67 69
M  V30 83 1 67 70
M  V30 84 1 71 72
M  V30 85 1 71 196
M  V30 86 1 72 73
M  V30 87 1 73 74
M  V30 88 1 74 75
M  V30 89 1 75 76
M  V30 90 1 75 203
M  V30 91 1 75 209
M  V30 92 1 77 78
M  V30 93 1 77 202
M  V30 94 1 78 79
M  V30 95 1 79 80
M  V30 96 1 80 81
M  V30 97 1 81 82
M  V30 98 1 81 215
M  V30 99 1 81 221
M  V30 100 1 83 84
M  V30 101 1 83 208
M  V30 102 1 84 227
M  V30 103 1 85 86
M  V30 104 1 85 214
M  V30 105 1 86 233
M  V30 106 1 87 88
M  V30 107 1 87 220
M  V30 108 1 88 239
M  V30 109 1 89 90
M  V30 110 1 89 226
M  V30 111 1 90 245
M  V30 112 1 91 92
M  V30 113 2 91 93
M  V30 114 1 91 232
M  V30 115 1 92 94
M  V30 116 1 94 95
M  V30 117 1 94 96
M  V30 118 1 94 97
M  V30 119 1 98 99
M  V30 120 2 98 100
M  V30 121 1 98 238
M  V30 122 1 99 101
M  V30 123 1 101 102
M  V30 124 1 101 103
M  V30 125 1 101 104
M  V30 126 1 105 106
M  V30 127 2 105 107
M  V30 128 1 105 244
M  V30 129 1 106 108
M  V30 130 1 108 109
M  V30 131 1 108 110
M  V30 132 1 108 111
M  V30 133 1 112 113
M  V30 134 2 112 114
M  V30 135 1 112 250
M  V30 136 1 113 115
M  V30 137 1 115 116
M  V30 138 1 115 117
M  V30 139 1 115 118
M  V30 140 2 119 120
M  V30 141 1 119 121
M  V30 142 1 120 122
M  V30 143 2 121 123
M  V30 144 2 122 124
M  V30 145 1 123 124
M  V30 146 2 125 126
M  V30 147 1 125 127
M  V30 148 1 126 128
M  V30 149 2 127 129
M  V30 150 2 128 130
M  V30 151 1 129 130
M  V30 152 2 131 132
M  V30 153 1 131 133
M  V30 154 1 132 134
M  V30 155 2 133 135
M  V30 156 2 134 136
M  V30 157 1 135 136
M  V30 158 2 137 138
M  V30 159 1 137 139
M  V30 160 1 138 140
M  V30 161 2 139 141
M  V30 162 2 140 142
M  V30 163 1 141 142
M  V30 164 2 143 144
M  V30 165 1 143 145
M  V30 166 1 144 146
M  V30 167 2 145 147
M  V30 168 2 146 148
M  V30 169 1 147 148
M  V30 170 2 149 150
M  V30 171 1 149 151
M  V30 172 1 150 152
M  V30 173 2 151 153
M  V30 174 2 152 154
M  V30 175 1 153 154
M  V30 176 2 155 156
M  V30 177 1 155 157
M  V30 178 1 156 158
M  V30 179 2 157 159
M  V30 180 2 158 160
M  V30 181 1 159 160
M  V30 182 2 161 162
M  V30 183 1 161 163
M  V30 184 1 162 164
M  V30 185 2 163 165
M  V30 186 2 164 166
M  V30 187 1 165 166
M  V30 188 2 167 168
M  V30 189 1 167 169
M  V30 190 1 168 170
M  V30 191 2 169 171
M  V30 192 2 170 172
M  V30 193 1 171 172
M  V30 194 2 173 174
M  V30 195 1 173 175
M  V30 196 1 174 176
M  V30 197 2 175 177
M  V30 198 2 176 178
M  V30 199 1 177 178
M  V30 200 2 179 180
M  V30 201 1 179 181
M  V30 202 1 180 182
M  V30 203 2 181 183
M  V30 204 2 182 184
M  V30 205 1 183 184
M  V30 206 2 185 186
M  V30 207 1 185 187
M  V30 208 1 186 188
M  V30 209 2 187 189
M  V30 210 2 188 190
M  V30 211 1 189 190
M  V30 212 2 191 192
M  V30 213 1 191 193
M  V30 214 1 192 194
M  V30 215 2 193 195
M  V30 216 2 194 196
M  V30 217 1 195 196
M  V30 218 2 197 198
M  V30 219 1 197 199
M  V30 220 1 198 200
M  V30 221 2 199 201
M  V30 222 2 200 202
M  V30 223 1 201 202
M  V30 224 2 203 204
M  V30 225 1 203 205
M  V30 226 1 204 206
M  V30 227 2 205 207
M  V30 228 2 206 208
M  V30 229 1 207 208
M  V30 230 2 209 210
M  V30 231 1 209 211
M  V30 232 1 210 212
M  V30 233 2 211 213
M  V30 234 2 212 214
M  V30 235 1 213 214
M  V30 236 2 215 216
M  V30 237 1 215 217
M  V30 238 1 216 218
M  V30 239 2 217 219
M  V30 240 2 218 220
M  V30 241 1 219 220
M  V30 242 2 221 222
M  V30 243 1 221 223
M  V30 244 1 222 224
M  V30 245 2 223 225
M  V30 246 2 224 226
M  V30 247 1 225 226
M  V30 248 2 227 228
M  V30 249 1 227 229
M  V30 250 1 228 230
M  V30 251 2 229 231
M  V30 252 2 230 232
M  V30 253 1 231 232
M  V30 254 2 233 234
M  V30 255 1 233 235
M  V30 256 1 234 236
M  V30 257 2 235 237
M  V30 258 2 236 238
M  V30 259 1 237 238
M  V30 260 2 239 240
M  V30 261 1 239 241
M  V30 262 1 240 242
M  V30 263 2 241 243
M  V30 264 2 242 244
M  V30 265 1 243 244
M  V30 266 2 245 246
M  V30 267 1 245 247
M  V30 268 1 246 248
M  V30 269 2 247 249
M  V30 270 2 248 250
M  V30 271 1 249 250
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,1′′,1′′′,1′′′′,1′′′′′,1′′′′′′,1′′′′′′′-Octakis(1,1-dimethylethyl) 4,4′,4...
C216H243NO30
1228438-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  247 268 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3369 33.3164 0.0 0
M  V30 2 C 14.6705 32.5464 0.0 0
M  V30 3 C 14.1069 34.6500 0.0 0
M  V30 4 C 16.0043 33.3164 0.0 0
M  V30 5 C 17.3379 32.5464 0.0 0
M  V30 6 O 18.6716 33.3164 0.0 0
M  V30 7 O 8.0021 36.3964 0.0 0
M  V30 8 C 8.0021 37.9364 0.0 0
M  V30 9 O 10.2569 27.9816 0.0 0
M  V30 10 C 11.0269 26.6479 0.0 0
M  V30 11 C 24.0063 30.2364 0.0 0
M  V30 12 C 24.0063 28.6964 0.0 0
M  V30 13 C 22.6727 29.4664 0.0 0
M  V30 14 C 25.3399 27.9264 0.0 0
M  V30 15 C 25.3399 26.3864 0.0 0
M  V30 16 O 26.6737 25.6164 0.0 0
M  V30 17 C 2.6674 41.0164 0.0 0
M  V30 18 O 2.6674 42.5564 0.0 0
M  V30 19 O 1.3338 40.2464 0.0 0
M  V30 20 C 1.3338 43.3264 0.0 0
M  V30 21 C 2.1038 44.6600 0.0 0
M  V30 22 C 0.0000 44.0964 0.0 0
M  V30 23 C 0.5638 41.9926 0.0 0
M  V30 24 C 7.9469 21.3131 0.0 0
M  V30 25 O 6.4069 21.3131 0.0 0
M  V30 26 O 8.7169 19.9795 0.0 0
M  V30 27 C 5.6369 19.9795 0.0 0
M  V30 28 C 4.3032 20.7495 0.0 0
M  V30 29 C 4.8669 18.6459 0.0 0
M  V30 30 C 6.9705 19.2095 0.0 0
M  V30 31 O 29.3410 33.3164 0.0 0
M  V30 32 C 29.3410 34.8564 0.0 0
M  V30 33 C 28.0074 35.6264 0.0 0
M  V30 34 C 28.0074 37.1664 0.0 0
M  V30 35 C 26.6737 37.9364 0.0 0
M  V30 36 C 25.9037 36.6026 0.0 0
M  V30 37 C 26.6737 19.4564 0.0 0
M  V30 38 C 26.6737 17.9164 0.0 0
M  V30 39 C 25.1337 19.4564 0.0 0
M  V30 40 C 25.3399 17.1464 0.0 0
M  V30 41 C 25.3399 15.6064 0.0 0
M  V30 42 N 24.0063 14.8364 0.0 0
M  V30 43 C 24.0063 13.2964 0.0 0
M  V30 44 O 21.3390 41.0164 0.0 0
M  V30 45 C 20.0052 40.2464 0.0 0
M  V30 46 O 29.7537 43.2711 0.0 0
M  V30 47 C 31.2937 43.2711 0.0 0
M  V30 48 O 32.8337 19.4564 0.0 0
M  V30 49 C 33.6037 20.7900 0.0 0
M  V30 50 C 35.1437 20.7900 0.0 0
M  V30 51 C 35.9137 22.1236 0.0 0
M  V30 52 C 37.4537 22.1236 0.0 0
M  V30 53 C 37.4537 23.6636 0.0 0
M  V30 54 C 14.6705 43.3264 0.0 0
M  V30 55 O 14.6705 44.8664 0.0 0
M  V30 56 O 13.3369 42.5564 0.0 0
M  V30 57 C 13.3369 45.6364 0.0 0
M  V30 58 C 14.1069 46.9700 0.0 0
M  V30 59 C 12.0032 46.4064 0.0 0
M  V30 60 C 12.5669 44.3026 0.0 0
M  V30 61 C 34.3737 48.6058 0.0 0
M  V30 62 O 35.9137 48.6058 0.0 0
M  V30 63 O 33.6037 49.9394 0.0 0
M  V30 64 C 36.6837 49.9394 0.0 0
M  V30 65 C 35.3499 50.7094 0.0 0
M  V30 66 C 37.4537 51.2731 0.0 0
M  V30 67 C 38.0174 49.1694 0.0 0
M  V30 68 O 43.6137 22.1236 0.0 0
M  V30 69 C 44.3837 23.4573 0.0 0
M  V30 70 C 45.9237 23.4573 0.0 0
M  V30 71 C 46.6937 24.7911 0.0 0
M  V30 72 C 48.2337 24.7911 0.0 0
M  V30 73 C 48.2337 23.2511 0.0 0
M  V30 74 O 37.4537 15.9636 0.0 0
M  V30 75 C 36.1199 15.1936 0.0 0
M  V30 76 C 36.1199 13.6536 0.0 0
M  V30 77 C 34.7863 12.8836 0.0 0
M  V30 78 C 34.7863 11.3436 0.0 0
M  V30 79 C 36.1199 12.1136 0.0 0
M  V30 80 O 54.3937 24.7911 0.0 0
M  V30 81 C 55.1637 26.1247 0.0 0
M  V30 82 O 48.2337 30.9511 0.0 0
M  V30 83 C 46.8999 31.7211 0.0 0
M  V30 84 O 40.1210 8.2636 0.0 0
M  V30 85 C 40.1210 6.7236 0.0 0
M  V30 86 O 29.4516 8.2636 0.0 0
M  V30 87 C 29.4516 6.7236 0.0 0
M  V30 88 C 61.3237 26.1247 0.0 0
M  V30 89 O 62.0937 27.4584 0.0 0
M  V30 90 O 62.0937 24.7911 0.0 0
M  V30 91 C 63.6337 27.4584 0.0 0
M  V30 92 C 63.6337 25.9184 0.0 0
M  V30 93 C 65.1737 27.4584 0.0 0
M  V30 94 C 63.6337 28.9984 0.0 0
M  V30 95 C 46.8999 37.8811 0.0 0
M  V30 96 O 48.2337 38.6511 0.0 0
M  V30 97 O 45.5663 38.6511 0.0 0
M  V30 98 C 48.2337 40.1911 0.0 0
M  V30 99 C 46.6937 40.1911 0.0 0
M  V30 100 C 48.2337 41.7311 0.0 0
M  V30 101 C 49.7737 40.1911 0.0 0
M  V30 102 C 45.4557 3.6436 0.0 0
M  V30 103 O 45.4557 2.1036 0.0 0
M  V30 104 O 46.7894 4.4136 0.0 0
M  V30 105 C 46.7894 1.3336 0.0 0
M  V30 106 C 47.5594 2.6673 0.0 0
M  V30 107 C 48.1232 0.5636 0.0 0
M  V30 108 C 46.0194 0.0000 0.0 0
M  V30 109 C 24.1169 3.6436 0.0 0
M  V30 110 O 24.1169 2.1036 0.0 0
M  V30 111 O 22.7832 4.4136 0.0 0
M  V30 112 C 22.7832 1.3336 0.0 0
M  V30 113 C 23.5532 0.0000 0.0 0
M  V30 114 C 21.4496 0.5636 0.0 0
M  V30 115 C 22.0132 2.6673 0.0 0
M  V30 116 C 12.0032 34.0864 0.0 0
M  V30 117 C 12.0032 35.6264 0.0 0
M  V30 118 C 10.6696 33.3164 0.0 0
M  V30 119 C 10.6696 36.3964 0.0 0
M  V30 120 C 9.3358 34.0864 0.0 0
M  V30 121 C 9.3358 35.6264 0.0 0
M  V30 122 C 12.5669 31.9826 0.0 0
M  V30 123 C 13.3369 30.6489 0.0 0
M  V30 124 C 11.0269 31.9826 0.0 0
M  V30 125 C 12.5669 29.3153 0.0 0
M  V30 126 C 10.2569 30.6489 0.0 0
M  V30 127 C 11.0269 29.3153 0.0 0
M  V30 128 C 20.0052 32.5464 0.0 0
M  V30 129 C 21.3390 33.3164 0.0 0
M  V30 130 C 20.0052 31.0064 0.0 0
M  V30 131 C 22.6727 32.5464 0.0 0
M  V30 132 C 21.3390 30.2364 0.0 0
M  V30 133 C 22.6727 31.0064 0.0 0
M  V30 134 C 6.6685 38.7064 0.0 0
M  V30 135 C 5.3349 37.9364 0.0 0
M  V30 136 C 6.6685 40.2464 0.0 0
M  V30 137 C 4.0011 38.7064 0.0 0
M  V30 138 C 5.3349 41.0164 0.0 0
M  V30 139 C 4.0011 40.2464 0.0 0
M  V30 140 C 10.2569 25.3142 0.0 0
M  V30 141 C 8.7169 25.3142 0.0 0
M  V30 142 C 11.0269 23.9806 0.0 0
M  V30 143 C 7.9469 23.9806 0.0 0
M  V30 144 C 10.2569 22.6469 0.0 0
M  V30 145 C 8.7169 22.6469 0.0 0
M  V30 146 C 25.3399 31.0064 0.0 0
M  V30 147 C 26.6737 30.2364 0.0 0
M  V30 148 C 25.3399 32.5464 0.0 0
M  V30 149 C 28.0074 31.0064 0.0 0
M  V30 150 C 26.6737 33.3164 0.0 0
M  V30 151 C 28.0074 32.5464 0.0 0
M  V30 152 C 26.6737 24.0764 0.0 0
M  V30 153 C 25.3399 23.3064 0.0 0
M  V30 154 C 28.0074 23.3064 0.0 0
M  V30 155 C 25.3399 21.7664 0.0 0
M  V30 156 C 28.0074 21.7664 0.0 0
M  V30 157 C 26.6737 20.9964 0.0 0
M  V30 158 C 25.3399 38.7064 0.0 0
M  V30 159 C 25.3399 40.2464 0.0 0
M  V30 160 C 24.0063 37.9364 0.0 0
M  V30 161 C 24.0063 41.0164 0.0 0
M  V30 162 C 22.6727 38.7064 0.0 0
M  V30 163 C 22.6727 40.2464 0.0 0
M  V30 164 C 27.4437 39.2700 0.0 0
M  V30 165 C 26.6737 40.6036 0.0 0
M  V30 166 C 28.9837 39.2700 0.0 0
M  V30 167 C 27.4437 41.9373 0.0 0
M  V30 168 C 29.7537 40.6036 0.0 0
M  V30 169 C 28.9837 41.9373 0.0 0
M  V30 170 C 28.2137 19.4564 0.0 0
M  V30 171 C 28.9837 20.7900 0.0 0
M  V30 172 C 28.9837 18.1226 0.0 0
M  V30 173 C 30.5237 20.7900 0.0 0
M  V30 174 C 30.5237 18.1226 0.0 0
M  V30 175 C 31.2937 19.4564 0.0 0
M  V30 176 C 18.6716 41.0164 0.0 0
M  V30 177 C 18.6716 42.5564 0.0 0
M  V30 178 C 17.3379 40.2464 0.0 0
M  V30 179 C 17.3379 43.3264 0.0 0
M  V30 180 C 16.0043 41.0164 0.0 0
M  V30 181 C 16.0043 42.5564 0.0 0
M  V30 182 C 32.0637 44.6047 0.0 0
M  V30 183 C 31.2937 45.9384 0.0 0
M  V30 184 C 33.6037 44.6047 0.0 0
M  V30 185 C 32.0637 47.2720 0.0 0
M  V30 186 C 34.3737 45.9384 0.0 0
M  V30 187 C 33.6037 47.2720 0.0 0
M  V30 188 C 38.9937 22.1236 0.0 0
M  V30 189 C 39.7637 23.4573 0.0 0
M  V30 190 C 39.7637 20.7900 0.0 0
M  V30 191 C 41.3037 23.4573 0.0 0
M  V30 192 C 41.3037 20.7900 0.0 0
M  V30 193 C 42.0737 22.1236 0.0 0
M  V30 194 C 37.4537 20.5836 0.0 0
M  V30 195 C 36.1199 19.8136 0.0 0
M  V30 196 C 38.7874 19.8136 0.0 0
M  V30 197 C 36.1199 18.2736 0.0 0
M  V30 198 C 38.7874 18.2736 0.0 0
M  V30 199 C 37.4537 17.5036 0.0 0
M  V30 200 C 49.7737 24.7911 0.0 0
M  V30 201 C 50.5437 23.4573 0.0 0
M  V30 202 C 50.5437 26.1247 0.0 0
M  V30 203 C 52.0837 23.4573 0.0 0
M  V30 204 C 52.0837 26.1247 0.0 0
M  V30 205 C 52.8537 24.7911 0.0 0
M  V30 206 C 48.2337 26.3311 0.0 0
M  V30 207 C 49.5674 27.1011 0.0 0
M  V30 208 C 46.8999 27.1011 0.0 0
M  V30 209 C 49.5674 28.6411 0.0 0
M  V30 210 C 46.8999 28.6411 0.0 0
M  V30 211 C 48.2337 29.4111 0.0 0
M  V30 212 C 36.1199 10.5736 0.0 0
M  V30 213 C 36.1199 9.0336 0.0 0
M  V30 214 C 37.4537 11.3436 0.0 0
M  V30 215 C 37.4537 8.2636 0.0 0
M  V30 216 C 38.7874 10.5736 0.0 0
M  V30 217 C 38.7874 9.0336 0.0 0
M  V30 218 C 33.4527 10.5736 0.0 0
M  V30 219 C 33.4527 9.0336 0.0 0
M  V30 220 C 32.1190 11.3436 0.0 0
M  V30 221 C 32.1190 8.2636 0.0 0
M  V30 222 C 30.7852 10.5736 0.0 0
M  V30 223 C 30.7852 9.0336 0.0 0
M  V30 224 C 56.7037 26.1247 0.0 0
M  V30 225 C 57.4737 27.4584 0.0 0
M  V30 226 C 57.4737 24.7911 0.0 0
M  V30 227 C 59.0137 27.4584 0.0 0
M  V30 228 C 59.0137 24.7911 0.0 0
M  V30 229 C 59.7837 26.1247 0.0 0
M  V30 230 C 46.8999 33.2611 0.0 0
M  V30 231 C 45.5663 34.0311 0.0 0
M  V30 232 C 48.2337 34.0311 0.0 0
M  V30 233 C 45.5663 35.5711 0.0 0
M  V30 234 C 48.2337 35.5711 0.0 0
M  V30 235 C 46.8999 36.3411 0.0 0
M  V30 236 C 41.4546 5.9536 0.0 0
M  V30 237 C 41.4546 4.4136 0.0 0
M  V30 238 C 42.7884 6.7236 0.0 0
M  V30 239 C 42.7884 3.6436 0.0 0
M  V30 240 C 44.1221 5.9536 0.0 0
M  V30 241 C 44.1221 4.4136 0.0 0
M  V30 242 C 28.1179 5.9536 0.0 0
M  V30 243 C 26.7843 6.7236 0.0 0
M  V30 244 C 28.1179 4.4136 0.0 0
M  V30 245 C 25.4505 5.9536 0.0 0
M  V30 246 C 26.7843 3.6436 0.0 0
M  V30 247 C 25.4505 4.4136 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 116
M  V30 4 1 1 122
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 128
M  V30 9 1 7 8
M  V30 10 1 7 121
M  V30 11 1 8 134
M  V30 12 1 9 10
M  V30 13 1 9 127
M  V30 14 1 10 140
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 133
M  V30 18 1 11 146
M  V30 19 1 12 14
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 16 152
M  V30 23 1 17 18
M  V30 24 2 17 19
M  V30 25 1 17 139
M  V30 26 1 18 20
M  V30 27 1 20 21
M  V30 28 1 20 22
M  V30 29 1 20 23
M  V30 30 1 24 25
M  V30 31 2 24 26
M  V30 32 1 24 145
M  V30 33 1 25 27
M  V30 34 1 27 28
M  V30 35 1 27 29
M  V30 36 1 27 30
M  V30 37 1 31 32
M  V30 38 1 31 151
M  V30 39 1 32 33
M  V30 40 1 33 34
M  V30 41 1 34 35
M  V30 42 1 35 36
M  V30 43 1 35 158
M  V30 44 1 35 164
M  V30 45 1 37 38
M  V30 46 1 37 39
M  V30 47 1 37 157
M  V30 48 1 37 170
M  V30 49 1 38 40
M  V30 50 1 40 41
M  V30 51 1 41 42
M  V30 52 1 42 43
M  V30 53 1 44 45
M  V30 54 1 44 163
M  V30 55 1 45 176
M  V30 56 1 46 47
M  V30 57 1 46 169
M  V30 58 1 47 182
M  V30 59 1 48 49
M  V30 60 1 48 175
M  V30 61 1 49 50
M  V30 62 1 50 51
M  V30 63 1 51 52
M  V30 64 1 52 53
M  V30 65 1 52 188
M  V30 66 1 52 194
M  V30 67 1 54 55
M  V30 68 2 54 56
M  V30 69 1 54 181
M  V30 70 1 55 57
M  V30 71 1 57 58
M  V30 72 1 57 59
M  V30 73 1 57 60
M  V30 74 1 61 62
M  V30 75 2 61 63
M  V30 76 1 61 187
M  V30 77 1 62 64
M  V30 78 1 64 65
M  V30 79 1 64 66
M  V30 80 1 64 67
M  V30 81 1 68 69
M  V30 82 1 68 193
M  V30 83 1 69 70
M  V30 84 1 70 71
M  V30 85 1 71 72
M  V30 86 1 72 73
M  V30 87 1 72 200
M  V30 88 1 72 206
M  V30 89 1 74 75
M  V30 90 1 74 199
M  V30 91 1 75 76
M  V30 92 1 76 77
M  V30 93 1 77 78
M  V30 94 1 78 79
M  V30 95 1 78 212
M  V30 96 1 78 218
M  V30 97 1 80 81
M  V30 98 1 80 205
M  V30 99 1 81 224
M  V30 100 1 82 83
M  V30 101 1 82 211
M  V30 102 1 83 230
M  V30 103 1 84 85
M  V30 104 1 84 217
M  V30 105 1 85 236
M  V30 106 1 86 87
M  V30 107 1 86 223
M  V30 108 1 87 242
M  V30 109 1 88 89
M  V30 110 2 88 90
M  V30 111 1 88 229
M  V30 112 1 89 91
M  V30 113 1 91 92
M  V30 114 1 91 93
M  V30 115 1 91 94
M  V30 116 1 95 96
M  V30 117 2 95 97
M  V30 118 1 95 235
M  V30 119 1 96 98
M  V30 120 1 98 99
M  V30 121 1 98 100
M  V30 122 1 98 101
M  V30 123 1 102 103
M  V30 124 2 102 104
M  V30 125 1 102 241
M  V30 126 1 103 105
M  V30 127 1 105 106
M  V30 128 1 105 107
M  V30 129 1 105 108
M  V30 130 1 109 110
M  V30 131 2 109 111
M  V30 132 1 109 247
M  V30 133 1 110 112
M  V30 134 1 112 113
M  V30 135 1 112 114
M  V30 136 1 112 115
M  V30 137 2 116 117
M  V30 138 1 116 118
M  V30 139 1 117 119
M  V30 140 2 118 120
M  V30 141 2 119 121
M  V30 142 1 120 121
M  V30 143 2 122 123
M  V30 144 1 122 124
M  V30 145 1 123 125
M  V30 146 2 124 126
M  V30 147 2 125 127
M  V30 148 1 126 127
M  V30 149 2 128 129
M  V30 150 1 128 130
M  V30 151 1 129 131
M  V30 152 2 130 132
M  V30 153 2 131 133
M  V30 154 1 132 133
M  V30 155 2 134 135
M  V30 156 1 134 136
M  V30 157 1 135 137
M  V30 158 2 136 138
M  V30 159 2 137 139
M  V30 160 1 138 139
M  V30 161 2 140 141
M  V30 162 1 140 142
M  V30 163 1 141 143
M  V30 164 2 142 144
M  V30 165 2 143 145
M  V30 166 1 144 145
M  V30 167 2 146 147
M  V30 168 1 146 148
M  V30 169 1 147 149
M  V30 170 2 148 150
M  V30 171 2 149 151
M  V30 172 1 150 151
M  V30 173 2 152 153
M  V30 174 1 152 154
M  V30 175 1 153 155
M  V30 176 2 154 156
M  V30 177 2 155 157
M  V30 178 1 156 157
M  V30 179 2 158 159
M  V30 180 1 158 160
M  V30 181 1 159 161
M  V30 182 2 160 162
M  V30 183 2 161 163
M  V30 184 1 162 163
M  V30 185 2 164 165
M  V30 186 1 164 166
M  V30 187 1 165 167
M  V30 188 2 166 168
M  V30 189 2 167 169
M  V30 190 1 168 169
M  V30 191 2 170 171
M  V30 192 1 170 172
M  V30 193 1 171 173
M  V30 194 2 172 174
M  V30 195 2 173 175
M  V30 196 1 174 175
M  V30 197 2 176 177
M  V30 198 1 176 178
M  V30 199 1 177 179
M  V30 200 2 178 180
M  V30 201 2 179 181
M  V30 202 1 180 181
M  V30 203 2 182 183
M  V30 204 1 182 184
M  V30 205 1 183 185
M  V30 206 2 184 186
M  V30 207 2 185 187
M  V30 208 1 186 187
M  V30 209 2 188 189
M  V30 210 1 188 190
M  V30 211 1 189 191
M  V30 212 2 190 192
M  V30 213 2 191 193
M  V30 214 1 192 193
M  V30 215 2 194 195
M  V30 216 1 194 196
M  V30 217 1 195 197
M  V30 218 2 196 198
M  V30 219 2 197 199
M  V30 220 1 198 199
M  V30 221 2 200 201
M  V30 222 1 200 202
M  V30 223 1 201 203
M  V30 224 2 202 204
M  V30 225 2 203 205
M  V30 226 1 204 205
M  V30 227 2 206 207
M  V30 228 1 206 208
M  V30 229 1 207 209
M  V30 230 2 208 210
M  V30 231 2 209 211
M  V30 232 1 210 211
M  V30 233 2 212 213
M  V30 234 1 212 214
M  V30 235 1 213 215
M  V30 236 2 214 216
M  V30 237 2 215 217
M  V30 238 1 216 217
M  V30 239 2 218 219
M  V30 240 1 218 220
M  V30 241 1 219 221
M  V30 242 2 220 222
M  V30 243 2 221 223
M  V30 244 1 222 223
M  V30 245 2 224 225
M  V30 246 1 224 226
M  V30 247 1 225 227
M  V30 248 2 226 228
M  V30 249 2 227 229
M  V30 250 1 228 229
M  V30 251 2 230 231
M  V30 252 1 230 232
M  V30 253 1 231 233
M  V30 254 2 232 234
M  V30 255 2 233 235
M  V30 256 1 234 235
M  V30 257 2 236 237
M  V30 258 1 236 238
M  V30 259 1 237 239
M  V30 260 2 238 240
M  V30 261 2 239 241
M  V30 262 1 240 241
M  V30 263 2 242 243
M  V30 264 1 242 244
M  V30 265 1 243 245
M  V30 266 2 244 246
M  V30 267 2 245 247
M  V30 268 1 246 247
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1228438-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228438-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8955083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Into a sealed tube with a solution of
Gn-OMs-benzoic acid tert-butyl ester (10-12), ca. 0.5-1.0 g in 6 mL of
THF, was added methyl amine (40 wt % solution in H2O) (6 mL). The
reaction mixture was then heated to 60-70 °C for 5 h.At the end of the
reaction as shown by TLC the mixture was cooled to room temperature, and
20 mL of water was added to quench the reaction. The solution was
extracted with 2 x 20 mL of dichloromethane. The combined organic layers
were dried over Na2SO4. Dichloromethane was removed under reduced
pressure.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dendritically Encapsulated, Water-Soluble Fe4S4: Synthesis and
Electrochemical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Anil K.; Kim, Namjin; Cameron, Christopher S.; Lyndon, Matthew;
Gorman, Christopher B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2010), 49(11), 5072-5078

$RFMT $RIREG SCHEME240 STEP1
$RXN



  3  1
$MOL
Phenyl chloroformate
C7H5ClO2
1885-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,3-Dimethyl-4-nitrophenoxy)-2-pyridinamine
C13H13N3O3
1229607-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 4.0011 6.1601 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 9.3359 4.6201 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 10.6695 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 N 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 9
M  V30 4 1 3 11
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(2,3-Dimethyl-4-nitrophenoxy)-2-pyridinyl]-N′-methylurea
C15H16N4O4
1338815-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6686 4.6201 0.0 0
M  V30 2 C 4.0011 6.1601 0.0 0
M  V30 3 C 1.3338 4.6201 0.0 0
M  V30 4 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 N 12.0034 4.6201 0.0 0
M  V30 8 C 13.3370 3.8500 0.0 0
M  V30 9 N 14.6707 4.6201 0.0 0
M  V30 10 O 13.3370 2.3100 0.0 0
M  V30 11 C 16.0045 3.8500 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 18 C 8.0022 3.8500 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 8.0022 2.3100 0.0 0
M  V30 21 C 10.6697 3.8500 0.0 0
M  V30 22 C 9.3359 1.5400 0.0 0
M  V30 23 N 10.6697 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 13
M  V30 4 1 3 15
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 17
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1885-14-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1229607-67-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338815-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-15287154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a suspension of Intermediate C2 (160 mg, 0.62 mmol) in DCM (3.0 mL)
containing DIPEA (330 μL, 230 mg, 1.9 mmol) was added phenyl
carbonochloridate (160 μL, 190 mg, 1.20 mmol) and the resulting mixture
maintained at RT for 1 hr and then treated with a solution of methylamine
(2M in THF, 1.20 mL, 2.40 mmol). After 1 hr an additional aliquot of
methylamine solution (800 μL, 1.60 mmol) was added and after a further 16
hr the mixture was partitioned between DCM (40 mL) and water (20 mL). The
organic layer was separated and was washed with sat. aq NaHCO3 (20 mL)
and water (20 mL) and then dried and evaporated in vacuo to afford
1-(4-(2,3-dimethyl-4-nitrophenoxy)pyridin-2-yl)-3-methylurea. Pale orange
solid, yield 200 mg, 98% Rt 1.73 min (Method 2); m/z 317 (M+H)+ (ES+).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolyl naphthyl ureas as p38 MAP kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM King-Underwood, John; Murray, Peter John; Williams, Jonathan Gareth;
Buck, Ildiko; Onions, Stuart Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011124930 A1 2011-10-13

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-4-(3,4-Dichlorophenyl)-1-tetralone
C16H12Cl2O
124379-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14 CFG=1
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(4S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
312620-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0 CFG=2
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=1
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124379-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 312620-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11550988
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 3: Preparation of cis-racemate sertraline hydrochloride To a
mixture of tetralone (25 g) and toluene (350 ml), activated molecular
sieves (100 g) were added. A solution of methylamine gas (16 g) in
toluene (50 ml) was charged to the above mixture. The reaction mixture
was heated to 90 -95°C gradually in 3-4 hrs and cooled to 25-30°C. The
molecular sieves were filtered, washed with toluene (50 ml x 2) and the
filtrate was combined with the washings. This combined solution was then
concentrated under vacuum at ~50°C to get a residue which was dissolved
in toluene (350 ml) and used as such in the next step. Example 3:
Preparation of cis-racemate sertraline hydrochloride A mixture of Schiff
base in toluene and palladium on carbon catalyst was hy-drogenated for
3-4 hours under 3-4 psi hydrogen pressure. The catalyst was filtered and
washed with toluene (75 ml x 2) under nitrogen atmosphere and
concentrated under vacuum at 50 to 60 °C to obtain a residue which was
again diluted with toluene (175 ml) and warmed to 35-40°C. Concentrated
hydrochloric acid (11 ml) was added to adjust pH to 1-2 to obtain the
precipitate. The reaction mass was cooled to 25 °C. It was filtered and
washed with toluene (50 ml x 2 ) and dried under vacuum at 35 to 40 °C to
obtain the product (Yield 97.6 %). Dehalo-impurity: 0.65 % w/w (by HPLC).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes for the preparation of sertraline hydrochloride from
4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone by methylimine
formation with methylamine, hydrogenation and resolution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramana, Kintali Venkata; Singh, Kaptan; Prasad, Mohan; Deo, Keshav;
Kumar, Yatendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005121074 A2 2005-12-22

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(2-cyanoethyl)-1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxylate
C15H14N2O4
1252873-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 N 12.3200 5.3347 0.0 0
M  V30 5 O 2.3100 4.0011 0.0 0
M  V30 6 O 6.9300 6.6685 0.0 0
M  V30 7 C 3.8500 6.6685 0.0 0
M  V30 8 O 2.3100 6.6685 0.0 0
M  V30 9 O 4.6200 8.0021 0.0 0
M  V30 10 C 1.5400 8.0021 0.0 0
M  V30 11 C 0.0000 8.0021 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 N 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 1.3336 0.0 0
M  V30 16 C 3.8500 4.0011 0.0 0
M  V30 17 C 3.8500 1.3336 0.0 0
M  V30 18 C 6.1600 5.3347 0.0 0
M  V30 19 C 6.1600 0.0000 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 16
M  V30 6 2 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Cyanoethyl)-1,2-dihydro-4-hydroxy-N-methyl-2-oxo-3-quinolinecarboxamide
C14H13N3O3
1430061-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 N 10.7800 5.3347 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 O 5.3900 6.6685 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0
M  V30 9 O 3.0800 8.0021 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.0800 2.6674 0.0 0
M  V30 13 N 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 4.6200 5.3347 0.0 0
M  V30 18 C 4.6200 0.0000 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 15
M  V30 6 2 6 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1252873-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1430061-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12491882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Unsubstituted amide 2a and alkylamides 2b-l were obtained by the
amidation of ester 3 using ammonia and alkylamines, respectively,
according to our previous methods [7, 13]. 2b, yield 98%. Mp 174-176 °С
(EtOH), Empirical formula C14H13N3O3, Found C 62.08%, H 4.7%, N 15.41%,
Calculated C 61.99%, H 4.83%, N 15.49%.
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Hydroxy-2-quinolones. 221.* Synthesis, structure, and biological
activity of
3-(3-(alkylcarbamoyl-4-hydroxy-2-oxo-1,2-dihydroquinolin-1-yl)propanoic
acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Andreeva, K. V.; Gorokhova, O. V.; Kravchenko, V. N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2013),
48(12), 1809-1816

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[(2-Chloro-3-pyridinyl)sulfonyl]-2-[4-(trifluoromethoxy)phenyl]-2,8-diazasp...
C20H19ClF3N3O4S
1255713-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.6694 5.3779 0.0 0
M  V30 2 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 O 16.5934 7.0582 0.0 0
M  V30 6 C 18.0004 6.4317 0.0 0
M  V30 7 F 18.1613 4.9002 0.0 0
M  V30 8 F 19.4072 5.8054 0.0 0
M  V30 9 F 19.2462 7.3369 0.0 0
M  V30 10 Cl 3.0800 0.0000 0.0 0
M  V30 11 C 9.2400 2.6673 0.0 0
M  V30 12 C 10.1453 3.9132 0.0 0
M  V30 13 C 10.1453 1.4214 0.0 0
M  V30 14 C 8.4700 1.3336 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 N 11.6098 3.4373 0.0 0
M  V30 17 C 11.6098 1.8973 0.0 0
M  V30 18 C 6.9300 1.3336 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 N 6.1600 2.6673 0.0 0
M  V30 21 C 12.8558 4.3425 0.0 0
M  V30 22 C 12.6947 5.8741 0.0 0
M  V30 23 C 14.2626 3.7162 0.0 0
M  V30 24 C 13.9406 6.7793 0.0 0
M  V30 25 C 15.5085 4.6214 0.0 0
M  V30 26 C 15.3476 6.1529 0.0 0
M  V30 27 C 3.0800 2.6673 0.0 0
M  V30 28 C 2.3100 1.3336 0.0 0
M  V30 29 C 2.3100 4.0011 0.0 0
M  V30 30 N 0.7700 1.3336 0.0 0
M  V30 31 C 0.7700 4.0011 0.0 0
M  V30 32 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 2 27
M  V30 6 1 5 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 16 21
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[[2-(Methylamino)-3-pyridinyl]sulfonyl]-2-[4-(trifluoromethoxy)phenyl]-2,8-...
C21H23F3N4O4S
1255713-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.6694 6.7115 0.0 0
M  V30 2 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 3 O 4.6200 5.5409 0.0 0
M  V30 4 O 4.6200 2.4609 0.0 0
M  V30 5 O 16.5934 8.3918 0.0 0
M  V30 6 C 18.0003 7.7653 0.0 0
M  V30 7 F 19.2462 8.6705 0.0 0
M  V30 8 F 19.4071 7.1390 0.0 0
M  V30 9 F 18.1613 6.2338 0.0 0
M  V30 10 N 3.0800 1.3336 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 9.2400 4.0009 0.0 0
M  V30 13 C 10.1452 5.2469 0.0 0
M  V30 14 C 10.1452 2.7551 0.0 0
M  V30 15 C 8.4700 2.6673 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 N 11.6098 4.7709 0.0 0
M  V30 18 C 11.6098 3.2309 0.0 0
M  V30 19 C 6.9300 2.6673 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 N 6.1600 4.0009 0.0 0
M  V30 22 C 12.8558 5.6761 0.0 0
M  V30 23 C 12.6947 7.2078 0.0 0
M  V30 24 C 14.2626 5.0498 0.0 0
M  V30 25 C 13.9406 8.1129 0.0 0
M  V30 26 C 15.5085 5.9550 0.0 0
M  V30 27 C 15.3475 7.4866 0.0 0
M  V30 28 C 3.0800 4.0009 0.0 0
M  V30 29 C 2.3100 2.6673 0.0 0
M  V30 30 C 2.3100 5.3347 0.0 0
M  V30 31 N 0.7700 2.6673 0.0 0
M  V30 32 C 0.7700 5.3347 0.0 0
M  V30 33 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 2 28
M  V30 6 1 5 6
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 17 22
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1255713-93-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1255713-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4150756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 189:
8-(2-Methylamino-pyridine-3-sulfonyl)-2-(4-trifluoromethoxy-phenyl)-2,8-diaza-spiro[4.5]decan-1-one
A mixture of
8-(2-chloro-pyridine-3-sulfonyl)-2-(4-trifluoromethoxy-phenyl)-2,8-diaza-spiro[4.5]decan-1-one
(described in example 188, 40 mg, 0.08 mmol)and 8M methyl amine solution
in ethanol (408 uL, 3.26 mmol) and was heated to 90°C in a sealed tube
for 48h. The reaction mixture was transferred to a round bottom flask and
concentrated in vacuo to give a crude residue which was diluted with
ethyl acetate and washed with water, sat. NaHCO3 and brine. The organic
layer was dried (Na2SO4), filtered and evaporated under reduced pressure
to give a crude residue which was purified by flash column chromatography
using Amine-Silica. A white solid (39 mg, 98%). MS (ESI): 485.2 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azacyclic spiro derivatives as HSL inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ackermann, Jean; Conte, Aurelia; Hunziker, Daniel; Neidhart, Werner;
Nettekoven, Matthias; Schulz-Gasch, Tanja; Wertheimer, Stanley
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010130665 A1 2010-11-18

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-10-methyl-2-nitro-9(10H)-acridinone
C14H9ClN2O3
126491-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1601 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 N 9.3359 4.6201 0.0 0 VAL=5
M  V30 4 O 9.3359 6.1601 0.0 0
M  V30 5 O 10.6695 3.8500 0.0 0
M  V30 6 Cl 9.3359 1.5400 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 6.6684 4.6201 0.0 0
M  V30 11 N 4.0011 1.5400 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 8.0022 3.8500 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 8.0022 2.3100 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 2 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9(10H)-Acridinone, 10-methyl-3-(methylamino)-2-nitro-
C15H13N3O3
1237443-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 C 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0 VAL=5
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 N 9.3358 1.5400 0.0 0
M  V30 7 C 9.3358 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 N 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 2 15 17
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126491-45-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1237443-41-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13945817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acridone-Benzimidazole Ring-Fused Ligands: A New Class of Sensitizers of
Lanthanide Luminescence via Low-Energy Excitation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deiters, Emmanuel; Gumy, Frederic; Bunzli, Jean-Claude G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2010), (18), 2723-2734

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-(2-Iodoethyl)benzenemethanol
C9H11IO
127073-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 I 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[2-(Methylamino)ethyl]benzenemethanol
C10H15NO
115290-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 127073-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 115290-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5194850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-catalyzed enantioselective hydrosilylation of halo-substituted
alkyl aryl and heteroaryl ketones: asymmetric synthesis of (R)-fluoxetine
and (S)-duloxetine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Ji-Ning; Fang, Qiang; Hu, Yi-Hu; Yang, Li-Yao; Wu, Fei-Fei; Xie,
Lin-Jie; Wu, Jing; Li, Shijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(6), 1009-1017

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl)-4-pentenal
C9H16O
129031-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 1.3338 3.0801 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 2.1038 4.4137 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 0.5638 1.7464 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 O 4.0012 0.0000 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(1,1-Dimethylethyl)-4-penten-1-ylidene]methanamine
C10H19N
2389014-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0009 0.0 0
M  V30 2 C 1.5400 4.0009 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0
M  V30 5 C 1.5400 2.4609 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 C 1.5400 5.5409 0.0 0
M  V30 8 C 3.0800 1.3336 0.0 0
M  V30 9 N 5.3900 5.3347 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 6.1600 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 2 4 9 CFG=2
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 129031-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2389014-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21006183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modulation of Pharmacologically Relevant Properties of Piperidine
Derivatives by Functional Groups in an Equatorial or Axial β-Position to
the Amino Group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schnider, Patrick; Dolente, Cosimo; Stalder, Henri; Martin, Rainer E.;
Reinmueller, Viktoria; Marty, Roman; Wyss Gramberg, Caroline; Wagner,
Bjoern; Fischer, Holger; Alker, Andre M.; Mueller, Klaus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemBioChem (2020), 21(1-2), 212-234

$RFMT $RIREG SCHEME247 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-nitrobutyrate
C5H9NO4
13013-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl hexahydro-1,3-dimethyl-5-nitro-5-pyrimidinepropanoate
C10H19N3O4
910324-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5827 5.5175 0.0 0 VAL=5
M  V30 2 O 2.1355 6.0443 0.0 0
M  V30 3 O 4.7623 6.5074 0.0 0
M  V30 4 C 5.2971 4.5278 0.0 0
M  V30 5 C 6.4769 3.5378 0.0 0
M  V30 6 C 7.9239 4.0645 0.0 0
M  V30 7 O 9.1037 3.0746 0.0 0
M  V30 8 O 8.1914 5.5811 0.0 0
M  V30 9 C 10.5508 3.6013 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 3.8500 4.0009 0.0 0
M  V30 13 C 2.3100 4.0009 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 N 1.5400 2.6673 0.0 0
M  V30 16 N 3.8500 1.3336 0.0 0
M  V30 17 C 2.3100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 16
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13013-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910324-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26527494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1,3-Dimethyl-5-[2-(methoxycarbonyl)ethyl]-5-nitrohexahydropyrimidine
(4a). A mixture of 26% formalin (2.33 mL, ∼22 mmol of CH2O) and a 24%
aqueous solution of MeNH2 (1.40 g, ∼11 mmol) was added at 0-10 °C to a
stirred solution of methyl 4-nitrobutanoate (1d) (0.32 g, 2.17 mmol) in
MeOH (15 mL). The mixture was refluxed for 4 h, MeOH was evaporated under
reduced pressure, and CHCl3 (10 mL) was added. The reaction mixture was
washed with water (3×5 mL) and dried with anhydrous Na2SO4, and the
solvent was removed under reduced pressure. For analytical purposes, the
product was additionally chromatographed on SiO2 (CHCl3-PriOH, 9 : 1).
Yield: 0.52 g (98%). Oil. Found (%): C, 49.05; H, 7.74; N, 16.92.
C10H19N3O4. Calculated (%): C, 48.97; H, 7.81; N, 17.13. MS, m/z: 245
[M+]. 1H NMR (CDCl3), 50 °C, δ: 2.20-2.36 (m, 4 H, CH2CH2CO2); 2.26 (s, 6
H, 2 NMe); 2.44 (d, 2 HOq, CH2N, 2J= 12.2 Hz); 2.79 (d, 1 Heq, NCH2N, 2J=
8.6 Hz); 3.20 (d, 2 Hax, CH2N, 2J= 12.2 Hz); 3.26 (d, 1 Hax, NCH2N, 2J=
8.6 Hz); 3.65 (s, 3 H, OMe). 1H NMR (CDCl3, δ): Simulation NO2(ax):
(3.20-3.48, OMe), (1.57-2.14, CH2CH2CO2), (1.57-2.14, CH2CO2),
(1.73-2.24, NMe), (1.53, 1.64 (HOq); 3.53, 3.53 (Hax), CH2N), (2.07
(HOq); 3.21 (Hax), NCH2N); NO2(eq) (3.18-3.48, OMe), (1.83-2.75,
CH2CH2CO2), (1.83-2.75, CH2CO2), (1.81-2.27, NMe), (1.68, 1.80 (HOq);
3.09, 3.13 (Hax), CH2N), (1.96 (HOq); 3.19 (Hax), NCH2N). 13C NMR (CDCl3,
δ): Experiment (51.76, OMe), (31.29, CH2CH2CO2), (27.71, CH2CO2), (42.25,
NMe), (58.96, CH2N), (78.13, NCH2N), (86.48, CNO2), (171.99, CO2). 13C
NMR (CDCl3, δ): Simulation NO2(ax) (51.26, OMe), (33.58, CH2CH2CO2),
(28.20, CH2CO2), (40.88; 40.88, NmO), (55.88; 59.53, CH2N), (75.58,
NCH2N), (87.50, CNO2), (172.75, CO2); NO2(eq) (51.07, OMe), (32.33,
CH2CH2CO2), (27.91, CH2CO2), (41.17; 41.46, NMe), (55.49; 59.05, CH2N),
(75.77, NCH2N), (86.15, CNO2), (172.65, CO2).
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich conditions, alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reaction of γ-nitro ketones and methyl 4-nitrobutanoates with
formaldehyde and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shakirov, R. R.; Vlasova, L. I.; Shishkin, D. V.; Yarmukhamedov, N. N.;
Baybulatova, N. Z.; Semesko, D. G.; Dokichev, V. A.; Tomilov, Yu. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2005), 54(7), 1737-1743

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-nitrobutyrate
C5H9NO4
13013-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobutanamide
C5H10N2O3
791074-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13013-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 791074-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-676626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-METHYL-4-NITRO-BUTYRAMIDETo a sealed reaction vessel was added methyl
4-nitrobutyrate (1.00 g, 6.80 mmol) and methylamine (2.0 M methylamine in
MeOH, 50.0 mL, 100 mmol). The resulting yellow solution was stirred at
room temperature for 20 h. The solvent was evaporated and the residue was
purified by flash chromatography (silica gel, load: CH2Cl2, elution with
EtOAc:Hexanes, 1:1) to give the title product. White solid, yield (0.97
g, 98%). 1H NMR (CDCl3): 5.84 (br s, NH, 1H), 4.54-4.48 (m, 2H), 2.82 (d,
J= 4.7 Hz, 3H), 2.36-2.32 (m, 4H).
$DTYPE RXN:VAR(1):NOTES
$DATUM Dess-Martin oxidation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptidyl protease inhibitors for coronaviruses and
SARS-CoV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Sui Xiong; Kemnitzer, William E.; Zhang, Hong; Zhang, Han-Zhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004101742 A2 2004-11-25

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-nitrobenzene
C9H10BrNO3
13094-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 Br 12.0033 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(4-nitrophenoxy)-1-propanamine
C10H14N2O3
141770-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 N 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13094-50-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 141770-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6845571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-3a,8-bis(phenylmethyl)-2H-furo[2,3-b]indol...
C24H21NO2
1312132-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.2477 0.0 0
M  V30 2 C 8.8109 5.6252 0.0 0
M  V30 3 O 2.3890 6.2031 0.0 0
M  V30 4 C 5.3901 3.5813 0.0 0 CFG=2
M  V30 5 C 6.1601 4.9150 0.0 0 CFG=2
M  V30 6 C 6.4205 2.4369 0.0 0
M  V30 7 C 3.8836 3.9015 0.0 0
M  V30 8 N 7.6664 4.5948 0.0 0
M  V30 9 O 5.1295 6.0595 0.0 0
M  V30 10 C 7.8273 3.0633 0.0 0
M  V30 11 C 6.2596 0.9052 0.0 0
M  V30 12 C 3.7227 5.4331 0.0 0
M  V30 13 C 9.0734 2.1580 0.0 0
M  V30 14 C 7.5055 0.0000 0.0 0
M  V30 15 C 8.9123 0.6265 0.0 0
M  V30 16 C 3.0800 2.2477 0.0 0
M  V30 17 C 2.3100 3.5813 0.0 0
M  V30 18 C 2.3100 0.9139 0.0 0
M  V30 19 C 0.7700 3.5813 0.0 0
M  V30 20 C 0.7700 0.9139 0.0 0
M  V30 21 C 0.0000 2.2477 0.0 0
M  V30 22 C 10.2755 5.1494 0.0 0
M  V30 23 C 10.5957 3.6431 0.0 0
M  V30 24 C 11.4200 6.1800 0.0 0
M  V30 25 C 12.0604 3.1672 0.0 0
M  V30 26 C 12.8846 5.7039 0.0 0
M  V30 27 C 13.2048 4.1976 0.0 0
M  V30 28 H 6.9301 6.2488 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 1 1 16
M  V30 3 1 2 8
M  V30 4 1 2 22
M  V30 5 2 3 12
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 28 CFG=1
M  V30 12 1 6 10
M  V30 13 2 6 11
M  V30 14 1 7 12
M  V30 15 1 8 10
M  V30 16 1 9 12
M  V30 17 2 10 13
M  V30 18 1 11 14
M  V30 19 1 13 15
M  V30 20 2 14 15
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a,8-bis(phenylmethyl)pyrrolo[2,3...
C25H24N2O
1312132-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3183 0.0 0
M  V30 2 C 8.8108 1.9406 0.0 0
M  V30 3 C 5.4498 0.0000 0.0 0
M  V30 4 O 2.3890 1.3628 0.0 0
M  V30 5 C 5.3900 3.9845 0.0 0 CFG=2
M  V30 6 C 6.1600 2.6508 0.0 0 CFG=2
M  V30 7 C 6.4204 5.1290 0.0 0
M  V30 8 C 3.8836 3.6643 0.0 0
M  V30 9 N 7.6663 2.9710 0.0 0
M  V30 10 N 5.1295 1.5064 0.0 0
M  V30 11 C 7.8272 4.5025 0.0 0
M  V30 12 C 6.2595 6.6605 0.0 0
M  V30 13 C 3.7227 2.1328 0.0 0
M  V30 14 C 9.0733 5.4077 0.0 0
M  V30 15 C 7.5054 7.5658 0.0 0
M  V30 16 C 8.9122 6.9393 0.0 0
M  V30 17 C 3.0800 5.3183 0.0 0
M  V30 18 C 2.3100 3.9845 0.0 0
M  V30 19 C 2.3100 6.6519 0.0 0
M  V30 20 C 0.7700 3.9845 0.0 0
M  V30 21 C 0.7700 6.6519 0.0 0
M  V30 22 C 0.0000 5.3183 0.0 0
M  V30 23 C 10.2754 2.4164 0.0 0
M  V30 24 C 10.5956 3.9229 0.0 0
M  V30 25 C 11.4199 1.3860 0.0 0
M  V30 26 C 12.0603 4.3987 0.0 0
M  V30 27 C 12.8845 1.8619 0.0 0
M  V30 28 C 13.2046 3.3682 0.0 0
M  V30 29 H 6.9300 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 9
M  V30 4 1 2 23
M  V30 5 1 3 10
M  V30 6 2 4 13
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 29 CFG=3
M  V30 13 1 7 11
M  V30 14 2 7 12
M  V30 15 1 8 13
M  V30 16 1 9 11
M  V30 17 1 10 13
M  V30 18 2 11 14
M  V30 19 1 12 15
M  V30 20 1 14 16
M  V30 21 2 15 16
M  V30 22 2 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312132-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11161217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME251 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dioxolane-4-ethanol, 2,2-dimethyl-, 4-methanesulfonate
C8H16O5S
76099-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0170 2.6218 0.0 0
M  V30 2 C 6.3506 1.8517 0.0 0
M  V30 3 O 7.6845 2.6218 0.0 0
M  V30 4 S 9.0181 1.8517 0.0 0 VAL=6
M  V30 5 C 8.2481 0.5181 0.0 0
M  V30 6 O 10.3518 1.0817 0.0 0
M  V30 7 O 9.7881 3.1854 0.0 0
M  V30 8 C 0.0000 0.4284 0.0 0
M  V30 9 C 0.2155 2.4781 0.0 0
M  V30 10 C 3.6833 1.8517 0.0 0
M  V30 11 O 2.2763 2.4781 0.0 0
M  V30 12 C 3.5224 0.3202 0.0 0
M  V30 13 C 1.2459 1.3337 0.0 0
M  V30 14 O 2.0159 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 13
M  V30 9 1 9 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Benzyloxycarbonyloxy)succinimide
C12H11NO5
13139-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7711 3.3320 0.0 0
M  V30 2 C 5.1047 2.5620 0.0 0
M  V30 3 O 6.4384 3.3320 0.0 0
M  V30 4 O 5.1047 1.0220 0.0 0
M  V30 5 C 7.7722 2.5620 0.0 0
M  V30 6 O 3.4209 0.0000 0.0 0
M  V30 7 O 0.7103 4.6948 0.0 0
M  V30 8 N 2.4373 2.5620 0.0 0
M  V30 9 C 2.2763 1.0304 0.0 0
M  V30 10 C 1.0304 3.1885 0.0 0
M  V30 11 C 0.7700 0.7103 0.0 0
M  V30 12 C 0.0000 2.0439 0.0 0
M  V30 13 C 9.1059 3.3320 0.0 0
M  V30 14 C 10.4396 2.5620 0.0 0
M  V30 15 C 9.1059 4.8721 0.0 0
M  V30 16 C 11.7732 3.3320 0.0 0
M  V30 17 C 10.4396 5.6421 0.0 0
M  V30 18 C 11.7732 4.8721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 13
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethyl]-N-methylcarbamate
C16H23NO4
1224373-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 2.3100 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 N 8.0022 2.3100 0.0 0
M  V30 4 C 6.6686 3.0800 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 O 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 4.6200 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 15.6866 4.5033 0.0 0
M  V30 10 C 15.4711 2.4535 0.0 0
M  V30 11 C 12.0033 3.0800 0.0 0
M  V30 12 O 13.4101 2.4535 0.0 0
M  V30 13 C 12.1642 4.6116 0.0 0
M  V30 14 C 14.4405 3.5981 0.0 0
M  V30 15 O 13.6705 4.9317 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 1.3338 3.0800 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 20 C 1.3338 0.0000 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 14
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76099-47-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13139-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224373-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4607839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3b: Preparation of Compound 37 Compound 36 (3.9 g, 17.4 mmol) was
stirred with ethanolic methylamine (33 %, 100 mL) over 72 h. Removal of
solvent gave a residue which was treated with Cbz-OSu (1.2 eq) and NEt3
(3 eq) for 18 h. Aqueous workup then column chromatography gave compound
37 (5.2 g, 98 %). Electrospray MS (+ve): Molecular weight for C16H23NO4
(M + H)+ Calc. 294.2, Found 294.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved lipid formulation for gene targeting
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akinc, Akin; Querbes, William; Wong, Frances; Dorkin, Joseph Robert; Qin,
Xiaojun; Cantley, William; Borodovsky, Anna; De, Soma; Manoharan,
Muthiah; Jayaraman, Muthusamy; Rajeev, Kallanthottathil G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010088537 A2 2010-08-05

$RFMT $RIREG SCHEME251 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dioxolane-4-ethanol, 2,2-dimethyl-, 4-methanesulfonate
C8H16O5S
76099-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0170 2.6218 0.0 0
M  V30 2 C 6.3506 1.8517 0.0 0
M  V30 3 O 7.6845 2.6218 0.0 0
M  V30 4 S 9.0181 1.8517 0.0 0 VAL=6
M  V30 5 C 8.2481 0.5181 0.0 0
M  V30 6 O 10.3518 1.0817 0.0 0
M  V30 7 O 9.7881 3.1854 0.0 0
M  V30 8 C 0.0000 0.4284 0.0 0
M  V30 9 C 0.2155 2.4781 0.0 0
M  V30 10 C 3.6833 1.8517 0.0 0
M  V30 11 O 2.2763 2.4781 0.0 0
M  V30 12 C 3.5224 0.3202 0.0 0
M  V30 13 C 1.2459 1.3337 0.0 0
M  V30 14 O 2.0159 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 13
M  V30 9 1 9 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Benzyloxycarbonyloxy)succinimide
C12H11NO5
13139-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7711 3.3320 0.0 0
M  V30 2 C 5.1047 2.5620 0.0 0
M  V30 3 O 6.4384 3.3320 0.0 0
M  V30 4 O 5.1047 1.0220 0.0 0
M  V30 5 C 7.7722 2.5620 0.0 0
M  V30 6 O 3.4209 0.0000 0.0 0
M  V30 7 O 0.7103 4.6948 0.0 0
M  V30 8 N 2.4373 2.5620 0.0 0
M  V30 9 C 2.2763 1.0304 0.0 0
M  V30 10 C 1.0304 3.1885 0.0 0
M  V30 11 C 0.7700 0.7103 0.0 0
M  V30 12 C 0.0000 2.0439 0.0 0
M  V30 13 C 9.1059 3.3320 0.0 0
M  V30 14 C 10.4396 2.5620 0.0 0
M  V30 15 C 9.1059 4.8721 0.0 0
M  V30 16 C 11.7732 3.3320 0.0 0
M  V30 17 C 10.4396 5.6421 0.0 0
M  V30 18 C 11.7732 4.8721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 13
M  V30 7 2 6 9
M  V30 8 2 7 10
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethyl]-N-methylcarbamate
C16H23NO4
1224373-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 2.3100 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 N 8.0022 2.3100 0.0 0
M  V30 4 C 6.6686 3.0800 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 O 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 4.6200 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 15.6866 4.5033 0.0 0
M  V30 10 C 15.4711 2.4535 0.0 0
M  V30 11 C 12.0033 3.0800 0.0 0
M  V30 12 O 13.4101 2.4535 0.0 0
M  V30 13 C 12.1642 4.6116 0.0 0
M  V30 14 C 14.4405 3.5981 0.0 0
M  V30 15 O 13.6705 4.9317 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 1.3338 3.0800 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 20 C 1.3338 0.0000 0.0 0
M  V30 21 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 16
M  V30 10 1 9 14
M  V30 11 1 10 14
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76099-47-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13139-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1224373-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4899384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 15b: Preparation of Compound 37 Compound 36 (3.9 g. 17.4 mmol) was
stirred with ethanolic methylamine (33 %, 100 mL) over 72 h. Removal of
solvent gave a residue which was treated with Cbz-OSu (1.2 eq) and NEt3
(3 eq) for 18 h. Aqueous workup then column chromatography gave compound
37 (5.2 g, 98 %). Electrospray MS (+ve): Molecular weight for C16H23NO4
(M + H)+ Calc. 294.2. Found 294.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes for preparing lipids for use in delivery of therapeutic agents
into cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Jayaraman, Muthusamy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010048536 A2 2010-04-29

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-[(1R)-1-(2-Bromophenyl)ethyl]-1H-pyrrol-2-yl]-2,2,2-trichloroethanone
C14H11BrCl3NO
1333169-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0 CFG=2
M  V30 2 C 5.3900 5.1048 0.0 0
M  V30 3 C 7.9521 3.4208 0.0 0
M  V30 4 C 9.4584 3.1006 0.0 0
M  V30 5 O 7.4762 4.8855 0.0 0
M  V30 6 Cl 9.7785 4.6071 0.0 0
M  V30 7 Cl 10.9648 2.7805 0.0 0
M  V30 8 Cl 9.1382 1.5944 0.0 0
M  V30 9 Br 3.0800 6.4384 0.0 0
M  V30 10 N 5.3900 2.4374 0.0 0
M  V30 11 C 6.9215 2.2764 0.0 0
M  V30 12 C 4.7637 1.0306 0.0 0
M  V30 13 C 7.2418 0.7700 0.0 0
M  V30 14 C 5.9081 0.0000 0.0 0
M  V30 15 C 3.0800 3.7710 0.0 0
M  V30 16 C 2.3100 5.1048 0.0 0
M  V30 17 C 2.3100 2.4374 0.0 0
M  V30 18 C 0.7700 5.1048 0.0 0
M  V30 19 C 0.7700 2.4374 0.0 0
M  V30 20 C 0.0000 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 10
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1R)-1-(2-Bromophenyl)ethyl]-N-methyl-1H-pyrrole-2-carboxamide
C14H15BrN2O
1333169-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0 CFG=2
M  V30 2 C 5.3900 5.1048 0.0 0
M  V30 3 C 7.9521 3.4208 0.0 0
M  V30 4 N 9.4584 3.1006 0.0 0
M  V30 5 O 7.4762 4.8855 0.0 0
M  V30 6 C 10.4889 4.2450 0.0 0
M  V30 7 Br 3.0800 6.4384 0.0 0
M  V30 8 N 5.3900 2.4374 0.0 0
M  V30 9 C 6.9217 2.2764 0.0 0
M  V30 10 C 4.7637 1.0306 0.0 0
M  V30 11 C 7.2418 0.7700 0.0 0
M  V30 12 C 5.9081 0.0000 0.0 0
M  V30 13 C 3.0800 3.7710 0.0 0
M  V30 14 C 2.3100 5.1048 0.0 0
M  V30 15 C 2.3100 2.4374 0.0 0
M  V30 16 C 0.7700 5.1048 0.0 0
M  V30 17 C 0.7700 2.4374 0.0 0
M  V30 18 C 0.0000 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 8
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333169-28-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333169-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-1661115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for Conversion of Trichloroacetyl to Amide. The
substrate (0.2 mmol) was treated with 2 M MeNH2 in THF (0.5 mL) at room
temperature for 3-5 h. The reaction mixture was then concentrated
followed by column chromatography purification on silica gel
(hexanes/ethyl acetate) to give the title compound.
(R)-1-(2-Bromophenylethyl)-1H-pyrrol-N-methyl-2-carboxamide (1o): viscous
liquid; 98% yield. 1H NMR (500 MHz, CDCl3) δ 1.81 (d, J = 7.0 Hz, 3H),
2.86 (d, J = 5.5 Hz, 3H), 5.78 (br, 1H), 6.13-6.15 (m, 1H), 6.54 (dd, J =
4.0, 1.5 Hz, 1H), 6.78 (q, J = 7.0 Hz, 1H), 6.85-6.86 (m, 1H), 6.89 (dd,
J = 8.0, 1.5 Hz, 1H), 7.10 (dt, J = 7.0, 1.5 Hz, 1H), 7.23 (dt, J = 7.0,
1.5 Hz, 1H), 7.55 (dd, J = 8.0, 1.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ
20.9, 26.2, 55.8, 107.5, 111.9, 123.5, 123.7, 126.3, 126.6, 127.7, 128.8,
133.3, 142.6, 162.4; HRMS obsd 307.0440, calcd 307.0444 for C14H16N2OBr,
M + H.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused imidazoles, pyrroles, and indoles with a defined
stereocenter α to nitrogen utilizing Mitsunobu alkylation followed by
palladium-catalyzed cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Cuny, Gregory D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(20), 8477-8482

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(1E)-1-(2-chloro-4-fluorobenzoyl)-2-(dimethylamino)ethenyl]phospho...
C15H20ClFNO4P
1350374-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 4.4139 0.0 0
M  V30 2 P 4.6201 3.0801 0.0 0 VAL=5
M  V30 3 C 4.6201 5.7476 0.0 0
M  V30 4 C 2.3101 4.4139 0.0 0
M  V30 5 O 5.3901 1.7464 0.0 0
M  V30 6 O 3.2864 2.3101 0.0 0
M  V30 7 O 5.9538 3.8501 0.0 0
M  V30 8 O 3.8501 7.0812 0.0 0
M  V30 9 N 1.5400 5.7476 0.0 0
M  V30 10 C 6.9302 1.7464 0.0 0
M  V30 11 C 3.2864 0.7700 0.0 0
M  V30 12 C 2.3101 7.0812 0.0 0
M  V30 13 C 0.0000 5.7476 0.0 0
M  V30 14 C 7.7002 0.4127 0.0 0
M  V30 15 C 1.9526 0.0000 0.0 0
M  V30 16 Cl 6.1601 8.4151 0.0 0
M  V30 17 F 10.7802 5.7476 0.0 0
M  V30 18 C 6.1601 5.7476 0.0 0
M  V30 19 C 6.9302 7.0812 0.0 0
M  V30 20 C 6.9302 4.4139 0.0 0
M  V30 21 C 8.4702 7.0812 0.0 0
M  V30 22 C 8.4702 4.4139 0.0 0
M  V30 23 C 9.2402 5.7476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 2 3 8
M  V30 8 1 3 18
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 16 19
M  V30 17 1 17 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[(1E)-1-(2-chloro-4-fluorobenzoyl)-2-(methylamino)ethenyl]phosphonate
C14H18ClFNO4P
1350374-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 3.8500 0.0 0
M  V30 2 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 3 C 6.1600 5.1836 0.0 0
M  V30 4 C 6.1600 2.5162 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 O 3.8500 2.3100 0.0 0
M  V30 7 O 3.8500 5.3900 0.0 0
M  V30 8 O 5.3900 6.5173 0.0 0
M  V30 9 N 7.7000 2.5162 0.0 0
M  V30 10 C 1.5400 5.1836 0.0 0
M  V30 11 C 2.5164 1.5400 0.0 0
M  V30 12 C 8.4700 1.1826 0.0 0
M  V30 13 C 0.0000 5.1836 0.0 0
M  V30 14 C 2.5164 0.0000 0.0 0
M  V30 15 Cl 7.7000 7.8509 0.0 0
M  V30 16 F 12.3200 5.1836 0.0 0
M  V30 17 C 7.7000 5.1836 0.0 0
M  V30 18 C 8.4700 6.5173 0.0 0
M  V30 19 C 8.4700 3.8500 0.0 0
M  V30 20 C 10.0100 6.5173 0.0 0
M  V30 21 C 10.0100 3.8500 0.0 0
M  V30 22 C 10.7800 5.1836 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 2 3 8
M  V30 8 1 3 17
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 15 18
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350374-68-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350374-76-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8411823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM isomer mix.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient syntheses of 3-phosphorylquinolin-4-ones and
3-phosphoryl-1,8-naphthyridin-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kedzia, Jacek; Modranka, Jakub; Janecki, Tomasz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(49), 6623-6626

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-(1,1-Dimethylethyl) 6-methyl 3′,6′-dihydro[3,4′-bipyridine]-1′,6(2′H)-dica...
C17H22N2O4
1351522-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 C 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3′,6′-dihydro-6-[(methylamino)carbonyl][3,4′-bipyridine]-1′...
C17H23N3O3
2855981-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 C 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1351522-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855981-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37025148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused 1,2,3,4-tetrahydropyridine-2,4-dione multicyclic compounds as PARP1
inhibitors and their preparation, pharmaceutical compositions and use in
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paliwal, Sunil; Samatar, Ahmed Abdi; Cripe, Lawrence Saunders
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023096915 A1 2023-06-01

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2R,3R,4R,5S)-4-(6-Chloro-9H-purin-9-yl)-2,3-dihydroxybicyclo[3.1.0]hexane...
C13H15ClN4O4
1355670-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.7888 3.5811 0.0 0
M  V30 2 O 10.8192 4.7257 0.0 0
M  V30 3 O 8.7117 1.1907 0.0 0
M  V30 4 C 6.4274 0.9051 0.0 0
M  V30 5 O 5.1815 0.0000 0.0 0
M  V30 6 O 4.7600 2.1166 0.0 0
M  V30 7 Cl 0.0000 7.1755 0.0 0
M  V30 8 C 8.2823 3.9013 0.0 0 CFG=1
M  V30 9 C 7.0364 4.8065 0.0 0 CFG=1
M  V30 10 C 8.4432 5.4328 0.0 0
M  V30 11 C 7.8065 2.4368 0.0 0 CFG=1
M  V30 12 C 5.7906 3.9013 0.0 0 CFG=1
M  V30 13 C 6.2664 2.4368 0.0 0 CFG=2
M  V30 14 N 4.3259 4.3772 0.0 0
M  V30 15 C 3.8500 5.8419 0.0 0
M  V30 16 C 3.0800 3.4721 0.0 0
M  V30 17 C 2.3100 5.8419 0.0 0
M  V30 18 N 4.6200 7.1755 0.0 0
M  V30 19 N 1.8341 4.3772 0.0 0
M  V30 20 C 1.5400 7.1755 0.0 0
M  V30 21 C 3.8500 8.5092 0.0 0
M  V30 22 N 2.3100 8.5092 0.0 0
M  V30 23 H 6.2664 6.1402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 11 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 13 4 CFG=3
M  V30 6 1 13 6 CFG=1
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 1 9 12
M  V30 13 1 9 23 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 12 14 CFG=3
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2R,3R,4R,5S)-2,3-Dihydroxy-4-[6-(methylamino)-9H-purin-9-yl]bicyclo[3.1.0...
C14H19N5O4
1355670-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.3202 5.4051 0.0 0
M  V30 2 O 0.0000 6.9114 0.0 0
M  V30 3 O 0.0578 2.7964 0.0 0
M  V30 4 C 1.8932 1.4068 0.0 0
M  V30 5 O 2.5195 0.0000 0.0 0
M  V30 6 O 3.9428 1.6223 0.0 0
M  V30 7 N 10.5948 3.6235 0.0 0
M  V30 8 C 11.9285 4.3936 0.0 0
M  V30 9 C 1.7849 4.9292 0.0 0 CFG=1
M  V30 10 C 3.3165 5.0901 0.0 0 CFG=1
M  V30 11 C 2.4112 6.3360 0.0 0
M  V30 12 C 1.4646 3.4227 0.0 0 CFG=1
M  V30 13 C 3.9428 3.6833 0.0 0 CFG=1
M  V30 14 C 2.7984 2.6527 0.0 0 CFG=2
M  V30 15 N 5.4493 3.3630 0.0 0
M  V30 16 C 6.5937 4.3936 0.0 0
M  V30 17 C 6.0756 1.9562 0.0 0
M  V30 18 C 7.9273 3.6235 0.0 0
M  V30 19 N 6.5937 5.9336 0.0 0
M  V30 20 N 7.6072 2.1171 0.0 0
M  V30 21 C 9.2611 4.3936 0.0 0
M  V30 22 C 7.9273 6.7036 0.0 0
M  V30 23 N 9.2611 5.9336 0.0 0
M  V30 24 H 4.6501 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 12 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 14 4 CFG=1
M  V30 6 1 14 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 11
M  V30 13 1 10 13
M  V30 14 1 10 24 CFG=1
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 13 15 CFG=1
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 2 17 20
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1355670-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1355670-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2007018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective synthesis and anti-HCV activity of conformationally
restricted 2'-C-substituted carbanucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Won Jun; Ko, Yun Jung; Chandra, Girish; Lee, Hyuk Woo; Kim, Hea Ok;
Koh, Hyo Jung; Moon, Hyung Ryong; Jung, Young Hoon; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(4), 1253-1261

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl N-[1-(4-C-azido-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-1,2-dihyd...
C16H21FN6O8
1360459-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.8104 5.9438 0.0 0
M  V30 2 N 0.9052 7.1897 0.0 0 CHG=1 VAL=4
M  V30 3 N 0.0000 8.4355 0.0 0 CHG=-1
M  V30 4 C 3.0218 7.6112 0.0 0
M  V30 5 O 4.1663 8.6416 0.0 0
M  V30 6 O 2.0961 3.6595 0.0 0
M  V30 7 F 5.2825 2.6242 0.0 0
M  V30 8 O 7.2519 8.0022 0.0 0
M  V30 9 N 11.8719 5.3347 0.0 0
M  V30 10 C 12.6419 4.0011 0.0 0 CFG=2
M  V30 11 C 14.1819 4.0011 0.0 0
M  V30 12 C 11.8719 2.6674 0.0 0
M  V30 13 C 14.9519 5.3347 0.0 0
M  V30 14 O 12.6419 1.3336 0.0 0
M  V30 15 O 10.3319 2.6674 0.0 0
M  V30 16 C 16.4919 5.3347 0.0 0
M  V30 17 C 11.8719 0.0000 0.0 0
M  V30 18 O 17.2619 6.6684 0.0 0
M  V30 19 O 17.2619 4.0011 0.0 0
M  V30 20 C 18.8019 6.6684 0.0 0
M  V30 21 C 3.3420 6.1047 0.0 0 CFG=1
M  V30 22 O 4.8067 6.5806 0.0 0
M  V30 23 C 3.3420 4.5647 0.0 0 CFG=1
M  V30 24 C 5.7119 5.3347 0.0 0 CFG=1
M  V30 25 C 4.8067 4.0889 0.0 0 CFG=2
M  V30 26 N 7.2519 5.3347 0.0 0
M  V30 27 C 8.0219 6.6684 0.0 0
M  V30 28 C 8.0219 4.0011 0.0 0
M  V30 29 N 9.5619 6.6684 0.0 0
M  V30 30 C 9.5619 4.0011 0.0 0
M  V30 31 C 10.3319 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 21 4 CFG=1
M  V30 6 1 23 6 CFG=3
M  V30 7 1 25 7 CFG=1
M  V30 8 2 8 27
M  V30 9 1 9 10
M  V30 10 1 9 31
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 25
M  V30 26 1 24 26 CFG=1
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 21 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pentanediamide, 2-[[1-(4-C-azido-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-1,2-d...
C16H23FN8O6
2395907-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.8104 5.9438 0.0 0
M  V30 2 N 0.9052 7.1897 0.0 0 CHG=1 VAL=4
M  V30 3 N 0.0000 8.4355 0.0 0 CHG=-1
M  V30 4 C 3.0218 7.6112 0.0 0
M  V30 5 O 4.1663 8.6416 0.0 0
M  V30 6 O 2.0961 3.6595 0.0 0
M  V30 7 F 5.2825 2.6242 0.0 0
M  V30 8 O 7.2519 8.0022 0.0 0
M  V30 9 N 11.8719 5.3347 0.0 0
M  V30 10 C 12.6419 4.0011 0.0 0 CFG=2
M  V30 11 C 14.1819 4.0011 0.0 0
M  V30 12 C 11.8719 2.6674 0.0 0
M  V30 13 C 14.9519 5.3347 0.0 0
M  V30 14 N 12.6419 1.3336 0.0 0
M  V30 15 O 10.3319 2.6674 0.0 0
M  V30 16 C 16.4919 5.3347 0.0 0
M  V30 17 C 11.8719 0.0000 0.0 0
M  V30 18 N 17.2619 6.6684 0.0 0
M  V30 19 O 17.2619 4.0011 0.0 0
M  V30 20 C 18.8019 6.6684 0.0 0
M  V30 21 C 3.3420 6.1047 0.0 0 CFG=1
M  V30 22 O 4.8067 6.5806 0.0 0
M  V30 23 C 3.3420 4.5647 0.0 0 CFG=1
M  V30 24 C 5.7119 5.3347 0.0 0 CFG=1
M  V30 25 C 4.8067 4.0889 0.0 0 CFG=2
M  V30 26 N 7.2519 5.3347 0.0 0
M  V30 27 C 8.0219 6.6684 0.0 0
M  V30 28 C 8.0219 4.0011 0.0 0
M  V30 29 N 9.5619 6.6684 0.0 0
M  V30 30 C 9.5619 4.0011 0.0 0
M  V30 31 C 10.3319 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 21 4 CFG=1
M  V30 6 1 23 6 CFG=3
M  V30 7 1 25 7 CFG=1
M  V30 8 2 8 27
M  V30 9 1 9 10
M  V30 10 1 9 31
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 25
M  V30 26 1 24 26 CFG=1
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 21 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1360459-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2395907-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22591627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anti-CVB3 activity of 4-amino acid derivative substituted
pyrimidine nucleoside analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Le; Li, Yujiang; Guo, Xiaohe; Dong, Lihong; Liu, Luping; Wang,
Qiang; Yu, Xuejun; Song, Chuanjun; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126770

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-[1-(4-hydroxybutyl)-1H-pyrazol-4-yl]-2-pyridinecarboxylate
C15H20N4O3
1380304-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 13.3050 3.4372 0.0 0
M  V30 7 C 14.2102 4.6831 0.0 0
M  V30 8 C 15.7418 4.5222 0.0 0
M  V30 9 C 16.6470 5.7680 0.0 0
M  V30 10 O 18.1786 5.6071 0.0 0
M  V30 11 N 4.0012 0.0000 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 N 6.6685 3.0801 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 6.6685 0.0000 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 9.3360 3.0801 0.0 0
M  V30 19 C 10.7428 2.4537 0.0 0
M  V30 20 C 9.4969 4.6116 0.0 0
M  V30 21 N 11.7734 3.5981 0.0 0
M  V30 22 N 11.0034 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-[1-(4-hydroxybutyl)-1H-pyrazol-4-yl]-N-methyl-2-pyridinecarboxamide
C14H19N5O2
1380304-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 1.3338 4.6201 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 0.0000 5.3901 0.0 0
M  V30 5 C 10.6376 3.4372 0.0 0
M  V30 6 C 11.5427 4.6831 0.0 0
M  V30 7 C 13.0744 4.5222 0.0 0
M  V30 8 C 13.9795 5.7680 0.0 0
M  V30 9 O 15.5112 5.6071 0.0 0
M  V30 10 N 1.3338 0.0000 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 N 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 17 C 6.6687 3.0801 0.0 0
M  V30 18 C 8.0755 2.4537 0.0 0
M  V30 19 C 6.8296 4.6116 0.0 0
M  V30 20 N 9.1059 3.5981 0.0 0
M  V30 21 N 8.3359 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1380304-24-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380304-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Compound 6D:
3-Amino-6-bromo-N-methylpyridine-2-carboxamide. A 10M solution of
Methylamine in H2O (30.0 mL, 386 mmol) was added to a stainless steel
reactor containing 3-amino-6-bromopyridine-2-carboxylic acid ethyl ester
(Compound 6E, 7.614 g, 31.07 mmol) in MeOH (20.0 mL). The reactor was
sealed and heated to 100°C for 16 hours. The cooled reaction mixture was
transferred to a round bottom flask and concentrated in vacuo forming a
yellow precipitate which was collected by filtration. Further precipitate
formed in the filtrate which was also collected. The combined
precipitates were dried in vacuo to afford the title compound. Compound
15C:
3-amino-6-[1-(4-hydroxybutyl)-1H-pyrazol-4-yl]-N-methylpyridine-2-carboxamide.
Prepared analogously to Compound 6D using ethyl
3-amino-6-[1-(4-hydroxybutyl)-1H-pyrazol-4-yl]pyridine-2-carboxylate
(Compound 15D, 0.211 g, 0.69 mmol) to afford 196 mg of the title compound
(98%). 1H NMR (400 MHz, CDCl3) δ 8.12 (br. s., 1H), 7.87 (s, 1H), 7.81
(s, 1H), 7.36 (d, J = 8.6 Hz, 1H), 7.03 (d, J = 8.6 Hz, 1H), 5.94 (br.
s., 2H), 4.23 (t, J = 6.9 Hz, 2H), 3.70 (q, J = 5.9 Hz, 2H), 3.03 (d, J =
5.1 Hz, 3H), 2.03 (quin, J = 7.3 Hz, 2H), 1.60-1.67 (m, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed reactor used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic phosphonates and phosphinates, fused with five- and
six-membered nitrogen heterocycles as specific focal adhesion kinase
inhibitors in cancer therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crew, Andrew P.; Dong, Hanqing; Ferraro, Caterina; Sherman, Dan; Siu, Kam
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012074951 A1 2012-06-07

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-(ethoxycarbonyl)-4-benzofuranyl]-1-piperazinecarboxylate
C20H26N2O5
1383842-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.2913 6.0811 0.0 0
M  V30 2 O 14.8314 6.0811 0.0 0
M  V30 3 O 12.5213 7.4149 0.0 0
M  V30 4 C 15.6014 7.4149 0.0 0
M  V30 5 C 17.1414 7.4149 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 O 2.6673 4.6201 0.0 0
M  V30 8 O 4.0011 6.9301 0.0 0
M  V30 9 C 1.3337 5.3901 0.0 0
M  V30 10 C 0.5636 4.0564 0.0 0
M  V30 11 C 0.0000 6.1601 0.0 0
M  V30 12 C 2.1037 6.7239 0.0 0
M  V30 13 C 10.6696 3.0800 0.0 0
M  V30 14 C 9.3359 2.3100 0.0 0
M  V30 15 C 12.0033 2.3100 0.0 0
M  V30 16 C 10.9898 4.5865 0.0 0
M  V30 17 C 9.3359 0.7700 0.0 0
M  V30 18 O 13.1478 3.3406 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 20 C 12.5213 4.7474 0.0 0
M  V30 21 C 10.6696 0.0000 0.0 0
M  V30 22 N 8.0021 3.0800 0.0 0
M  V30 23 C 8.0021 4.6201 0.0 0
M  V30 24 C 6.6685 2.3100 0.0 0
M  V30 25 C 6.6685 5.3901 0.0 0
M  V30 26 C 5.3348 3.0800 0.0 0
M  V30 27 N 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 27
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 22
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-[(methylamino)carbonyl]-4-benzofuranyl]-1-piperazineca...
C19H25N3O4
1383842-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 6.0811 0.0 0
M  V30 2 N 0.7700 6.0811 0.0 0
M  V30 3 O 3.0801 7.4149 0.0 0
M  V30 4 C 0.0000 7.4149 0.0 0
M  V30 5 C 11.6003 5.3901 0.0 0
M  V30 6 O 12.9341 4.6201 0.0 0
M  V30 7 O 11.6003 6.9301 0.0 0
M  V30 8 C 14.2678 5.3901 0.0 0
M  V30 9 C 15.0378 4.0564 0.0 0
M  V30 10 C 15.6014 6.1601 0.0 0
M  V30 11 C 13.4977 6.7239 0.0 0
M  V30 12 C 4.9318 3.0801 0.0 0
M  V30 13 C 6.2655 2.3100 0.0 0
M  V30 14 C 3.5981 2.3100 0.0 0
M  V30 15 C 4.6116 4.5865 0.0 0
M  V30 16 C 6.2655 0.7700 0.0 0
M  V30 17 O 2.4536 3.3406 0.0 0
M  V30 18 C 3.5981 0.7700 0.0 0
M  V30 19 C 3.0801 4.7474 0.0 0
M  V30 20 C 4.9318 0.0000 0.0 0
M  V30 21 N 7.5993 3.0801 0.0 0
M  V30 22 C 8.9329 2.3100 0.0 0
M  V30 23 C 7.5993 4.6201 0.0 0
M  V30 24 C 10.2666 3.0801 0.0 0
M  V30 25 C 8.9329 5.3901 0.0 0
M  V30 26 N 10.2666 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 26
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 21
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383842-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383842-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7758195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM ii) tert-Butyl
4-(2-(methylcarbamoyl)benzofuran-4-yl)piperazine-1-carboxylate tert-Butyl
4-(2-(ethoxycarbonyl)benzofuran-4-yl)piperazine-1-carboxylate (6.17 g,
16.5 mmol) and sodium cyanide (0.081 g, 1.6 mmol) were stirred overnight
at rt in methyl amine (8 M in ethanol) (62 mL, 490 mmol). The solvent was
removed by rotary evaporation, the residue was dissolved in
dichloromethane and transferred to a separatory funnel. The mixture was
washed with 2 M sodium hydroxide and water. The organic phase was
separated, dried over potassium carbonate, filtered and the solvent was
removed by rotary evaporation to give the title compound. Yield 5.8 g,
98%. 1H NMR (500 MHz, CDCl3) δ ppm 1.51 (s, 9 H)3.06 (d, 3 H) 3.15-3.23
(m, 4 H) 3.61 - 3.70 (m, 4H) 6.59- 6.66 (m, 1 H) 6.71 (d, 1 H) 7.13 (d, 1
H) 7.29- 7.35 (m, 1 H) 7.51 (d, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydroquinolinylethylpiperazinylbenzofurancarboxamide
derivative for use in treatment of cognitive disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gybaeck, Helena; Malmstroem, Jonas; Terp, Elgaard Gitte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012087229 A1 2012-06-28

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methoxy-O-methyl-L-tyrosine methyl ester
C17H25NO6
138908-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 3 N 9.2402 4.0012 0.0 0
M  V30 4 C 6.9302 2.6675 0.0 0
M  V30 5 C 10.0102 5.3348 0.0 0
M  V30 6 O 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 2.6675 0.0 0
M  V30 8 O 11.5503 5.3348 0.0 0
M  V30 9 O 9.2402 6.6685 0.0 0
M  V30 10 C 6.9302 0.0000 0.0 0
M  V30 11 C 12.3203 6.6685 0.0 0
M  V30 12 C 13.6539 5.8985 0.0 0
M  V30 13 C 13.0903 8.0023 0.0 0
M  V30 14 C 10.9866 7.4385 0.0 0
M  V30 15 O 2.3101 8.0023 0.0 0
M  V30 16 C 3.0801 9.3360 0.0 0
M  V30 17 O 0.7700 5.3348 0.0 0
M  V30 18 C 0.0000 4.0012 0.0 0
M  V30 19 C 5.3901 5.3348 0.0 0
M  V30 20 C 4.6201 6.6685 0.0 0
M  V30 21 C 4.6201 4.0012 0.0 0
M  V30 22 C 3.0801 6.6685 0.0 0
M  V30 23 C 3.0801 4.0012 0.0 0
M  V30 24 C 2.3101 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 17 18
M  V30 18 1 17 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[(3,4-dimethoxyphenyl)methyl]-2-(methylamino)-2-o...
C17H26N2O5
944416-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 3 N 9.2402 4.0012 0.0 0
M  V30 4 C 6.9302 2.6675 0.0 0
M  V30 5 C 10.0102 5.3348 0.0 0
M  V30 6 N 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 2.6675 0.0 0
M  V30 8 O 11.5503 5.3348 0.0 0
M  V30 9 O 9.2402 6.6685 0.0 0
M  V30 10 C 6.9302 0.0000 0.0 0
M  V30 11 C 12.3203 6.6685 0.0 0
M  V30 12 C 13.6539 5.8985 0.0 0
M  V30 13 C 13.0903 8.0023 0.0 0
M  V30 14 C 10.9866 7.4385 0.0 0
M  V30 15 O 2.3101 8.0023 0.0 0
M  V30 16 C 3.0801 9.3360 0.0 0
M  V30 17 O 0.7700 5.3348 0.0 0
M  V30 18 C 0.0000 4.0012 0.0 0
M  V30 19 C 5.3901 5.3348 0.0 0
M  V30 20 C 4.6201 6.6685 0.0 0
M  V30 21 C 4.6201 4.0012 0.0 0
M  V30 22 C 3.0801 6.6685 0.0 0
M  V30 23 C 3.0801 4.0012 0.0 0
M  V30 24 C 2.3101 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 17 18
M  V30 18 1 17 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 138908-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944416-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-766736
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of tetrahydroisoquinoline-based pseudopeptides and their
characterization as suitable reverse turn mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Meschini, Elisa; Recca, Teresa; Sacchetti, Alessandro;
Silvani, Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2007), 63(25), 5567-5578

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
trans-Cinnamic acid
C9H8O2
140-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-phenyl-2-propenamide
C10H11NO
25695-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 140-10-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 25695-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3703369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem superelectrophilic hydroarylation of C=C bond and carbonyl
reduction in cinnamides: synthetic route to 3,3-diarylpropylamines,
valuable pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zakusilo, Dmitry N.; Ryabukhin, Dmitry S.; Boyarskaya, Irina A.;
Yuzikhin, Oleg S.; Vasilyev, Aleksander V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(1), 102-108

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
(5R,7R)-7-Hydroxy-5,8,8-trimethylnonanoic acid
C12H24O3
1403236-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.1037 0.0 0 CFG=1
M  V30 2 C 4.0012 1.3337 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 O 2.6673 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0 CFG=2
M  V30 6 C 0.5637 2.6673 0.0 0
M  V30 7 C 0.0000 0.5637 0.0 0
M  V30 8 C 2.1037 0.0000 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 C 5.3348 3.6437 0.0 0
M  V30 11 C 8.0022 2.1037 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.6697 2.1037 0.0 0
M  V30 14 O 10.6697 3.6437 0.0 0
M  V30 15 O 12.0033 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=3
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5R,7R)-7-Hydroxy-N,5,8,8-tetramethylnonanamide
C13H27NO2
2004694-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.1037 0.0 0 CFG=2
M  V30 2 C 4.0010 1.3337 0.0 0
M  V30 3 C 6.6685 1.3337 0.0 0
M  V30 4 C 5.3348 3.6437 0.0 0
M  V30 5 C 2.6673 2.1037 0.0 0 CFG=1
M  V30 6 C 8.0022 2.1037 0.0 0
M  V30 7 C 1.3337 1.3337 0.0 0
M  V30 8 O 2.6673 3.6437 0.0 0
M  V30 9 C 9.3360 1.3337 0.0 0
M  V30 10 C 2.1037 0.0000 0.0 0
M  V30 11 C 0.0000 0.5637 0.0 0
M  V30 12 C 0.5637 2.6673 0.0 0
M  V30 13 C 10.6697 2.1037 0.0 0
M  V30 14 N 12.0033 1.3337 0.0 0
M  V30 15 O 10.6697 3.6437 0.0 0
M  V30 16 C 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8 CFG=3
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1403236-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2004694-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16324555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective total synthesis of palmyrolide A via intramolecular trans
N-methyl enamide formation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borra, Suresh; Amrutapu, Sravanth Kumar; Pabbaraja, Srihari; Singh, Yadav
Jhillu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(40), 4456-4459

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[(2-Nitrobenzoyl)amino]benzoyl]-L-proline methyl ester
C20H19N3O6
1404368-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 C 1.9406 2.6091 0.0 0
M  V30 4 O 0.9100 1.4647 0.0 0
M  V30 5 O 3.4468 2.2889 0.0 0
M  V30 6 C 1.3859 0.0000 0.0 0
M  V30 7 N 6.9898 5.3196 0.0 0
M  V30 8 C 8.5298 5.3196 0.0 0
M  V30 9 O 9.2998 6.6533 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0 VAL=5
M  V30 11 O 13.1498 5.3196 0.0 0
M  V30 12 O 10.8398 6.6533 0.0 0
M  V30 13 N 2.3698 5.3196 0.0 0
M  V30 14 C 1.4645 4.0738 0.0 0 CFG=2
M  V30 15 C 1.4645 6.5655 0.0 0
M  V30 16 C 0.0000 4.5496 0.0 0
M  V30 17 C 0.0000 6.0897 0.0 0
M  V30 18 C 4.6798 6.6533 0.0 0
M  V30 19 C 6.2198 6.6533 0.0 0
M  V30 20 C 3.9098 7.9871 0.0 0
M  V30 21 C 6.9898 7.9871 0.0 0
M  V30 22 C 4.6798 9.3207 0.0 0
M  V30 23 C 6.2198 9.3207 0.0 0
M  V30 24 C 9.2998 3.9860 0.0 0
M  V30 25 C 10.8398 3.9860 0.0 0
M  V30 26 C 8.5298 2.6522 0.0 0
M  V30 27 C 11.6098 2.6522 0.0 0
M  V30 28 C 9.2998 1.3186 0.0 0
M  V30 29 C 10.8398 1.3186 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 14 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 2 8 9
M  V30 11 1 8 24
M  V30 12 2 10 11
M  V30 13 2 10 12
M  V30 14 1 10 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-N-Methyl-1-[2-[(2-nitrobenzoyl)amino]benzoyl]-2-pyrrolidinecarboxamide
C20H20N4O5
1404368-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 C 1.9406 2.6091 0.0 0
M  V30 4 N 0.9100 1.4647 0.0 0
M  V30 5 O 3.4468 2.2889 0.0 0
M  V30 6 C 1.3859 0.0000 0.0 0
M  V30 7 N 6.9898 5.3196 0.0 0
M  V30 8 C 8.5298 5.3196 0.0 0
M  V30 9 O 9.2998 6.6533 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0 VAL=5
M  V30 11 O 13.1498 5.3196 0.0 0
M  V30 12 O 10.8398 6.6533 0.0 0
M  V30 13 N 2.3698 5.3196 0.0 0
M  V30 14 C 1.4645 4.0738 0.0 0 CFG=2
M  V30 15 C 1.4645 6.5655 0.0 0
M  V30 16 C 0.0000 4.5496 0.0 0
M  V30 17 C 0.0000 6.0897 0.0 0
M  V30 18 C 4.6798 6.6533 0.0 0
M  V30 19 C 6.2198 6.6533 0.0 0
M  V30 20 C 3.9098 7.9871 0.0 0
M  V30 21 C 6.9898 7.9871 0.0 0
M  V30 22 C 4.6798 9.3207 0.0 0
M  V30 23 C 6.2198 9.3207 0.0 0
M  V30 24 C 9.2998 3.9860 0.0 0
M  V30 25 C 10.8398 3.9860 0.0 0
M  V30 26 C 8.5298 2.6522 0.0 0
M  V30 27 C 11.6098 2.6522 0.0 0
M  V30 28 C 9.2998 1.3186 0.0 0
M  V30 29 C 10.8398 1.3186 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 14 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 2 8 9
M  V30 11 1 8 24
M  V30 12 2 10 11
M  V30 13 2 10 12
M  V30 14 1 10 25
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1404368-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1404368-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9820985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multifaceted folding in a foldamer featuring highly cooperative folds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Priya, Gowri; Kotmale, Amol S.; Gonnade, Rajesh G.;
Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(91),
11205-11207

$RFMT $RIREG SCHEME263 STEP1
$RXN



  3  1
$MOL
4-Fluorobenzylamine
C7H8FN
140-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[2,3-Bis(phenylmethoxy)-1,4-phenylene]bis[1-(2-thioxo-3-thiazolidinyl)me...
C28H24N2O4S4
492454-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 5.3901 0.0 0
M  V30 2 C 6.6686 4.6201 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 C 4.0011 7.7001 0.0 0
M  V30 5 C 10.6698 6.9301 0.0 0
M  V30 6 O 10.6698 5.3901 0.0 0
M  V30 7 C 5.3348 10.0102 0.0 0
M  V30 8 O 4.0011 9.2402 0.0 0
M  V30 9 S 13.7304 5.5674 0.0 0
M  V30 10 S 2.6244 11.9794 0.0 0
M  V30 11 C 8.0023 6.9301 0.0 0
M  V30 12 C 6.6686 7.7001 0.0 0
M  V30 13 C 9.3360 7.7001 0.0 0
M  V30 14 C 6.6686 9.2402 0.0 0
M  V30 15 C 9.3360 9.2402 0.0 0
M  V30 16 C 8.0023 10.0102 0.0 0
M  V30 17 N 12.0034 7.7001 0.0 0
M  V30 18 C 13.4103 7.0737 0.0 0
M  V30 19 C 12.1644 9.2317 0.0 0
M  V30 20 S 14.4409 8.2182 0.0 0
M  V30 21 C 13.6708 9.5519 0.0 0
M  V30 22 C 6.6686 3.0801 0.0 0
M  V30 23 C 5.3350 2.3100 0.0 0
M  V30 24 C 8.0023 2.3100 0.0 0
M  V30 25 C 5.3350 0.7700 0.0 0
M  V30 26 C 8.0023 0.7700 0.0 0
M  V30 27 C 6.6686 0.0000 0.0 0
M  V30 28 N 5.3348 11.5502 0.0 0
M  V30 29 C 4.0889 12.4554 0.0 0
M  V30 30 C 6.5809 12.4554 0.0 0
M  V30 31 S 4.5648 13.9200 0.0 0
M  V30 32 C 6.1048 13.9200 0.0 0
M  V30 33 C 2.6675 6.9301 0.0 0
M  V30 34 C 1.3338 7.7001 0.0 0
M  V30 35 C 2.6675 5.3901 0.0 0
M  V30 36 C 0.0000 6.9301 0.0 0
M  V30 37 C 1.3338 4.6201 0.0 0
M  V30 38 C 0.0000 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 33
M  V30 7 2 5 6
M  V30 8 1 5 13
M  V30 9 1 5 17
M  V30 10 2 7 8
M  V30 11 1 7 14
M  V30 12 1 7 28
M  V30 13 2 9 18
M  V30 14 2 10 29
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[(4-Fluorophenyl)methyl]-N4-methyl-2,3-bis(phenylmethoxy)-1,4-benzenedicar...
C30H27FN2O4
1392440-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 10.6694 6.9300 0.0 0
M  V30 6 N 12.0032 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 13.3369 6.9300 0.0 0
M  V30 9 C 5.3347 10.0100 0.0 0
M  V30 10 N 5.3347 11.5500 0.0 0
M  V30 11 O 4.0011 9.2400 0.0 0
M  V30 12 C 4.0011 12.3200 0.0 0
M  V30 13 F 18.6716 10.0100 0.0 0
M  V30 14 C 8.0021 6.9300 0.0 0
M  V30 15 C 6.6684 7.7000 0.0 0
M  V30 16 C 9.3358 7.7000 0.0 0
M  V30 17 C 6.6684 9.2400 0.0 0
M  V30 18 C 9.3358 9.2400 0.0 0
M  V30 19 C 8.0021 10.0100 0.0 0
M  V30 20 C 6.6684 3.0800 0.0 0
M  V30 21 C 8.0021 2.3100 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0
M  V30 23 C 8.0021 0.7700 0.0 0
M  V30 24 C 5.3347 0.7700 0.0 0
M  V30 25 C 6.6684 0.0000 0.0 0
M  V30 26 C 2.6674 6.9300 0.0 0
M  V30 27 C 1.3336 7.7000 0.0 0
M  V30 28 C 2.6674 5.3900 0.0 0
M  V30 29 C 0.0000 6.9300 0.0 0
M  V30 30 C 1.3336 4.6200 0.0 0
M  V30 31 C 0.0000 5.3900 0.0 0
M  V30 32 C 14.6705 7.7000 0.0 0
M  V30 33 C 16.0041 6.9300 0.0 0
M  V30 34 C 14.6705 9.2400 0.0 0
M  V30 35 C 17.3379 7.7000 0.0 0
M  V30 36 C 16.0041 10.0100 0.0 0
M  V30 37 C 17.3379 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 26
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 5 16
M  V30 10 1 6 8
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 17
M  V30 15 1 10 12
M  V30 16 1 13 37
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 140-75-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 492454-84-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1392440-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12934191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0208] 2,3-Bis(benzyloxy)-N1-(4-fluorobenzyl)-N4-methylterephthalamide
(16).Compound 15 (1.1 g, 1.9 mmol) was combined with FPMA (80 μL, 0.7
mmol) in 120 mL of CH2Cl2. After 3 h, the reaction mixture was evaporated
to dryness and partially purified by passage through a silica plug using
5% MeOH/CH2Cl2 as eluant. The semi-purified material was dissolved in 12
mL of CH2Cl2 to which 800 mL of CH3NH2 (40% aqueous solution) was added.
After 30 min, the reaction mixture was evaporated to dryness and purified
by silica column chromatography using 0-5% MeOH/CH2Cl2 as eluant. After
removal of solvent the desired product was isolated as a solid. White
solid (343 mg, 0.69 mmol), Yield = 98%. 1H NMR (400 MHz, CDCl3, 25 °C): δ
= 2.82 (d, J=4.0 Hz, 3H), 4.44 (d, J= 8.0 Hz, 2H), 5.08 (d, i=4.0 Hz,
4H), 6.93 (t, J=8.0 Hz, 2H; ArH), 7.20 (m, 12H; ArH), 7.66 (brt, J=8.0
Hz, 1H; NH), 7.93 (q, J=8.0 Hz, 2H; ArH), 8.10 (brt, J=8.0 Hz, 1H; NH).
ESI-MS (+) m/z 498.90 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of raltegravir-chelator derivatives as HIV integrase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cohen, Seth M.; Agrawal, Arpita; Desoto, Jamie; Pommier, Yves; Maddali,
Kasthuraiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012106534 A2 2012-08-09

$RFMT $RIREG SCHEME263 STEP1
$RXN



  3  1
$MOL
4-Fluorobenzylamine
C7H8FN
140-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[2,3-Bis(phenylmethoxy)-1,4-phenylene]bis[1-(2-thioxo-3-thiazolidinyl)me...
C28H24N2O4S4
492454-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 5.3901 0.0 0
M  V30 2 C 6.6686 4.6201 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 C 4.0011 7.7001 0.0 0
M  V30 5 C 10.6698 6.9301 0.0 0
M  V30 6 O 10.6698 5.3901 0.0 0
M  V30 7 C 5.3348 10.0102 0.0 0
M  V30 8 O 4.0011 9.2402 0.0 0
M  V30 9 S 13.7304 5.5674 0.0 0
M  V30 10 S 2.6244 11.9794 0.0 0
M  V30 11 C 8.0023 6.9301 0.0 0
M  V30 12 C 6.6686 7.7001 0.0 0
M  V30 13 C 9.3360 7.7001 0.0 0
M  V30 14 C 6.6686 9.2402 0.0 0
M  V30 15 C 9.3360 9.2402 0.0 0
M  V30 16 C 8.0023 10.0102 0.0 0
M  V30 17 N 12.0034 7.7001 0.0 0
M  V30 18 C 13.4103 7.0737 0.0 0
M  V30 19 C 12.1644 9.2317 0.0 0
M  V30 20 S 14.4409 8.2182 0.0 0
M  V30 21 C 13.6708 9.5519 0.0 0
M  V30 22 C 6.6686 3.0801 0.0 0
M  V30 23 C 5.3350 2.3100 0.0 0
M  V30 24 C 8.0023 2.3100 0.0 0
M  V30 25 C 5.3350 0.7700 0.0 0
M  V30 26 C 8.0023 0.7700 0.0 0
M  V30 27 C 6.6686 0.0000 0.0 0
M  V30 28 N 5.3348 11.5502 0.0 0
M  V30 29 C 4.0889 12.4554 0.0 0
M  V30 30 C 6.5809 12.4554 0.0 0
M  V30 31 S 4.5648 13.9200 0.0 0
M  V30 32 C 6.1048 13.9200 0.0 0
M  V30 33 C 2.6675 6.9301 0.0 0
M  V30 34 C 1.3338 7.7001 0.0 0
M  V30 35 C 2.6675 5.3901 0.0 0
M  V30 36 C 0.0000 6.9301 0.0 0
M  V30 37 C 1.3338 4.6201 0.0 0
M  V30 38 C 0.0000 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 33
M  V30 7 2 5 6
M  V30 8 1 5 13
M  V30 9 1 5 17
M  V30 10 2 7 8
M  V30 11 1 7 14
M  V30 12 1 7 28
M  V30 13 2 9 18
M  V30 14 2 10 29
M  V30 15 2 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-[(4-Fluorophenyl)methyl]-N4-methyl-2,3-bis(phenylmethoxy)-1,4-benzenedicar...
C30H27FN2O4
1392440-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 C 4.0011 7.7000 0.0 0
M  V30 5 C 10.6694 6.9300 0.0 0
M  V30 6 N 12.0032 7.7000 0.0 0
M  V30 7 O 10.6694 5.3900 0.0 0
M  V30 8 C 13.3369 6.9300 0.0 0
M  V30 9 C 5.3347 10.0100 0.0 0
M  V30 10 N 5.3347 11.5500 0.0 0
M  V30 11 O 4.0011 9.2400 0.0 0
M  V30 12 C 4.0011 12.3200 0.0 0
M  V30 13 F 18.6716 10.0100 0.0 0
M  V30 14 C 8.0021 6.9300 0.0 0
M  V30 15 C 6.6684 7.7000 0.0 0
M  V30 16 C 9.3358 7.7000 0.0 0
M  V30 17 C 6.6684 9.2400 0.0 0
M  V30 18 C 9.3358 9.2400 0.0 0
M  V30 19 C 8.0021 10.0100 0.0 0
M  V30 20 C 6.6684 3.0800 0.0 0
M  V30 21 C 8.0021 2.3100 0.0 0
M  V30 22 C 5.3347 2.3100 0.0 0
M  V30 23 C 8.0021 0.7700 0.0 0
M  V30 24 C 5.3347 0.7700 0.0 0
M  V30 25 C 6.6684 0.0000 0.0 0
M  V30 26 C 2.6674 6.9300 0.0 0
M  V30 27 C 1.3336 7.7000 0.0 0
M  V30 28 C 2.6674 5.3900 0.0 0
M  V30 29 C 0.0000 6.9300 0.0 0
M  V30 30 C 1.3336 4.6200 0.0 0
M  V30 31 C 0.0000 5.3900 0.0 0
M  V30 32 C 14.6705 7.7000 0.0 0
M  V30 33 C 16.0041 6.9300 0.0 0
M  V30 34 C 14.6705 9.2400 0.0 0
M  V30 35 C 17.3379 7.7000 0.0 0
M  V30 36 C 16.0041 10.0100 0.0 0
M  V30 37 C 17.3379 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 26
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 5 16
M  V30 10 1 6 8
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 17
M  V30 15 1 10 12
M  V30 16 1 13 37
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 140-75-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 492454-84-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1392440-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-6926042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Probing chelation motifs in HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Agrawal, Arpita; DeSoto, Jamie; Fullagar, Jessica L.; Maddali,
Kasthuraiah; Rostami, Shahrzad; Richman, Douglas D.; Pommier, Yves;
Cohen, Seth M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2012), 109(7), 2251-2256, S2251/1-S2251/32

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-6-isothiocyanato-1,4-benzodioxin
C9H7NO2S
141492-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 S 9.3360 1.5400 0.0 0
M  V30 4 C 2.6675 2.3101 0.0 0
M  V30 5 C 2.6675 0.7700 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N′-methylthiourea
C10H12N2O2S
77991-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 S 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 O 1.3337 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141492-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 77991-99-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-8254462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships of 1,2,4-triazoles as a
novel class of potent tubulin polymerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ouyang, Xiaohu; Chen, Xiaoling; Piatnitski, Evgueni L.; Kiselyov,
Alexander S.; He, Hai-Ying; Mao, Yunyu; Pattaropong, Vatee; Yu, Yang;
Kim, Ki H.; Kincaid, John; Smith, Leon; Wong, Wai C.; Lee, Sui Ping;
Milligan, Daniel L.; Malikzay, Asra; Fleming, James; Gerlak, Jason;
Deevi, Dhanvanthri; Doody, Jacqueline F.; Chiang, Hui-Hsien; Patel,
Sheetal N.; Wang, Ying; Rolser, Robin L.; Kussie, Paul; Labelle, Marc;
Tuma, M. Carolina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(23), 5154-5159

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[[[[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]amino]carbonyl...
C24H25N5O3
1415484-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.5626 7.1045 0.0 0
M  V30 2 C 7.3326 8.4381 0.0 0
M  V30 3 N 8.8726 8.4381 0.0 0
M  V30 4 O 6.5626 9.7718 0.0 0
M  V30 5 C 1.4069 8.7797 0.0 0
M  V30 6 C 0.0000 8.1532 0.0 0
M  V30 7 C 0.1611 9.6848 0.0 0
M  V30 8 C 1.5679 10.3112 0.0 0
M  V30 9 C 6.0209 0.0000 0.0 0
M  V30 10 C 14.9536 8.4837 0.0 0
M  V30 11 O 14.9536 6.9437 0.0 0
M  V30 12 O 16.2873 9.2537 0.0 0
M  V30 13 N 4.1175 5.8586 0.0 0
M  V30 14 C 5.0226 7.1045 0.0 0
M  V30 15 N 2.6528 6.3345 0.0 0
M  V30 16 C 4.1175 8.3503 0.0 0
M  V30 17 C 2.6528 7.8745 0.0 0
M  V30 18 C 4.5934 4.3939 0.0 0
M  V30 19 C 6.0996 4.0738 0.0 0
M  V30 20 C 3.5628 3.2496 0.0 0
M  V30 21 C 6.5755 2.6091 0.0 0
M  V30 22 C 4.0388 1.7849 0.0 0
M  V30 23 C 5.5451 1.4647 0.0 0
M  V30 24 C 9.6426 9.7718 0.0 0
M  V30 25 C 11.1826 9.7718 0.0 0
M  V30 26 C 8.8726 11.1054 0.0 0
M  V30 27 C 11.9526 11.1054 0.0 0
M  V30 28 N 12.2131 8.6274 0.0 0
M  V30 29 C 9.6426 12.4392 0.0 0
M  V30 30 C 13.4590 10.7852 0.0 0
M  V30 31 C 11.1826 12.4392 0.0 0
M  V30 32 C 13.6199 9.2537 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 24
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 17
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 32
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 27 31
M  V30 33 1 28 32
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[[[[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]amino]carbonyl...
C25H28N6O2
1415484-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4017 7.1045 0.0 0
M  V30 2 C 7.1717 8.4382 0.0 0
M  V30 3 N 8.7117 8.4382 0.0 0
M  V30 4 O 6.4017 9.7718 0.0 0
M  V30 5 C 1.2459 8.7797 0.0 0
M  V30 6 C 0.3406 7.5337 0.0 0
M  V30 7 C 0.0000 9.6848 0.0 0
M  V30 8 C 2.1511 10.0256 0.0 0
M  V30 9 C 5.8599 0.0000 0.0 0
M  V30 10 C 14.7927 8.4837 0.0 0
M  V30 11 N 16.1263 9.2538 0.0 0
M  V30 12 O 14.7927 6.9437 0.0 0
M  V30 13 C 17.4600 8.4837 0.0 0
M  V30 14 N 3.9564 5.8587 0.0 0
M  V30 15 C 4.8617 7.1045 0.0 0
M  V30 16 N 2.4917 6.3345 0.0 0
M  V30 17 C 3.9564 8.3504 0.0 0
M  V30 18 C 2.4917 7.8745 0.0 0
M  V30 19 C 4.4323 4.3940 0.0 0
M  V30 20 C 5.9386 4.0738 0.0 0
M  V30 21 C 3.4019 3.2496 0.0 0
M  V30 22 C 6.4146 2.6091 0.0 0
M  V30 23 C 3.8777 1.7849 0.0 0
M  V30 24 C 5.3840 1.4647 0.0 0
M  V30 25 C 9.4817 9.7718 0.0 0
M  V30 26 C 11.0217 9.7718 0.0 0
M  V30 27 C 8.7117 11.1055 0.0 0
M  V30 28 C 11.7917 11.1055 0.0 0
M  V30 29 N 12.0521 8.6274 0.0 0
M  V30 30 C 9.4817 12.4393 0.0 0
M  V30 31 C 13.2980 10.7853 0.0 0
M  V30 32 C 11.0217 12.4393 0.0 0
M  V30 33 C 13.4589 9.2538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 18
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 33
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 26 29
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 28 32
M  V30 34 1 29 33
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1415484-16-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1415484-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7470546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of novel series of pyrazole and indole-urea based DFG-out
PYK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattacharya, Samit K.; Aspnes, Gary E.; Bagley, Scott W.; Boehm, Markus;
Brosius, Arthur D.; Buckbinder, Leonard; Chang, Jeanne S.; Dibrino,
Joseph; Eng, Heather; Frederick, Kosea S.; Griffith, David A.; Griffor,
Matthew C.; Guimaraes, Cristiano R. W.; Guzman-Perez, Angel; Han,
Seungil; Kalgutkar, Amit S.; Klug-McLeod, Jacquelyn; Garcia-Irizarry,
Carmen; Li, Jianke; Lippa, Blaise; Price, David A.; Southers, James A.;
Walker, Daniel P.; Wei, Liuqing; Xiao, Jun; Zawistoski, Michael P.; Zhao,
Xumiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(24), 7523-7529

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-1,2,4,9-tetrahydro-α-methyl-2′-oxospiro[3H-pyrido[3,4-b]indole...
C18H21N3O3
1422538-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.1797 5.3779 0.0 0
M  V30 2 C 11.1490 2.6674 0.0 0 CFG=1
M  V30 3 C 11.9190 1.3336 0.0 0
M  V30 4 C 11.9190 4.0011 0.0 0
M  V30 5 O 13.4591 1.3336 0.0 0
M  V30 6 O 11.1490 0.0000 0.0 0
M  V30 7 C 14.2291 0.0000 0.0 0
M  V30 8 C 7.2391 3.4375 0.0 0 CFG=2
M  V30 9 C 5.8323 2.8110 0.0 0
M  V30 10 C 8.7038 3.9133 0.0 0
M  V30 11 C 7.2391 1.8974 0.0 0
M  V30 12 N 7.4002 4.9690 0.0 0
M  V30 13 C 4.5865 3.7162 0.0 0
M  V30 14 N 9.6090 2.6674 0.0 0
M  V30 15 C 8.7038 1.4216 0.0 0
M  V30 16 C 6.1542 5.8742 0.0 0
M  V30 17 C 3.0800 3.3960 0.0 0
M  V30 18 C 4.7474 5.2477 0.0 0
M  V30 19 C 2.3100 4.7297 0.0 0
M  V30 20 C 2.3100 2.0624 0.0 0
M  V30 21 N 3.3406 5.8742 0.0 0
M  V30 22 C 0.7700 4.7297 0.0 0
M  V30 23 C 0.7700 2.0624 0.0 0
M  V30 24 C 0.0000 3.3960 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS,3S)-1,2,4,9-Tetrahydro-N,α-dimethyl-2′-oxospiro[3H-pyrido[3,4-b]indole-3,...
C18H22N4O2
1422538-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.1797 5.3779 0.0 0
M  V30 2 C 11.1490 2.6674 0.0 0 CFG=1
M  V30 3 C 11.9190 1.3336 0.0 0
M  V30 4 C 11.9190 4.0011 0.0 0
M  V30 5 N 13.4591 1.3336 0.0 0
M  V30 6 O 11.1490 0.0000 0.0 0
M  V30 7 C 14.2291 0.0000 0.0 0
M  V30 8 C 7.2391 3.4375 0.0 0 CFG=2
M  V30 9 C 5.8323 2.8110 0.0 0
M  V30 10 C 8.7038 3.9133 0.0 0
M  V30 11 C 7.2391 1.8974 0.0 0
M  V30 12 N 7.4002 4.9690 0.0 0
M  V30 13 C 4.5865 3.7162 0.0 0
M  V30 14 N 9.6090 2.6674 0.0 0
M  V30 15 C 8.7038 1.4216 0.0 0
M  V30 16 C 6.1542 5.8742 0.0 0
M  V30 17 C 3.0800 3.3960 0.0 0
M  V30 18 C 4.7474 5.2477 0.0 0
M  V30 19 C 2.3100 4.7297 0.0 0
M  V30 20 C 2.3100 2.0624 0.0 0
M  V30 21 N 3.3406 5.8742 0.0 0
M  V30 22 C 0.7700 4.7297 0.0 0
M  V30 23 C 0.7700 2.0624 0.0 0
M  V30 24 C 0.0000 3.3960 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=1
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=3
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1422538-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422538-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5851195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-N-Methyl-2-((S)-2'-oxo-1,2,4,9-tetrahydrospiro[pyrido[3,4-b]-indole-3,3'-pyrrolidin]-1'-yl)propanamide,
14. To a solution of 13 (0.305 g 0.93 mmol) in THF (20 mL) was added
methanamine (2 M in THF, 3.73 mL, 7.45 mmol). After 6 h under stirring,
the mixture was concentrated in vacuo to afford pure 14. Product 14 as a
yellow foam, yield 0.300 g, 98%. Rf 0.31 (3:1, EtOAc/MeOH); [α]20D -7.5
(c 0.2 MeOH); 1H NMR (400 MHz, DMSO-d6) δ 10.69 (s, br, 1H), 7.82 (q, br,
J = 4.5 Hz, 1H), 7.35 (d, br, J = 7.8 Hz, 1H), 7.27 (d, J = 7.8 Hz, 1H),
7.01 (ddd, J = 7.8, 7.3, and 1.3 Hz, 1H), 6.93 (ddd, J = 7.8, 7.3, and
1.0 Hz, 1H), 4.53 (q, J = 7.3 Hz, 1H), 4.00 (d, J = 16.9 Hz, 1H), 3.88
(d, br, J = 16.9 Hz, 1H), 3.49 (td, J = 9.3 and 3.5 Hz, 1H), 3.40-3.25
(m, br, 1H), 3.36 (dt, J = 9.3 and 7.3 Hz, 1H), 2.68 (d, br, J = 15.2 Hz,
1H), 2.62 (d, J = 15.2 Hz, 1H), 2.61 (d, J = 4.5 Hz, 3H), 2.03 (ddd, J =
12.2, 9.3, and 7.3 Hz, 1H), 1.81 (ddd, J = 12.2, 7.3, and 3.5 Hz, 1H),
1.30 (d, J = 7.3 Hz, 3H); 13C NMR (100 MHz, DMSO-d6) δ 175.9, 171.3,
136.3, 133.5, 127.9, 120.8, 118.6, 117.6, 111.3, 105.4, 59.3, 50.2, 40.8,
39.3, 30.5, 28.1, 26.07, 15.5; HRMS (EI) calcd for C18H22N4O2 326.1743,
found 326.1736.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydro-β-carboline-Based Spirocyclic Lactam as Type II' β-Turn:
Application to the Synthesis and Biological Evaluation of Somatostatin
Mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Cecchi, Roberto; Cagnotto, Alfredo; Gobbi, Marco;
Meneghetti, Fiorella; Musolino, Manuele; Sacchetti, Alessandro; Silvani,
Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(6), 2600-2610

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylium, tris(2,6-dimethoxyphenyl)-, tetrafluoroborate(1-) (1:1)
C25H27O6.BF4
142467-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7750 10.6215 0.0 0
M  V30 2 O 1.9250 11.9552 0.0 0
M  V30 3 C 0.3850 11.9552 0.0 0
M  V30 4 O 6.5450 14.6226 0.0 0
M  V30 5 C 7.3150 15.9562 0.0 0
M  V30 6 O 1.5400 8.6211 0.0 0
M  V30 7 C 0.0000 8.6211 0.0 0
M  V30 8 O 6.1600 5.9536 0.0 0
M  V30 9 C 6.9300 4.6200 0.0 0
M  V30 10 O 9.6250 7.9543 0.0 0 CHG=1 VAL=3
M  V30 11 C 8.8550 6.6205 0.0 0
M  V30 12 O 9.6250 13.2890 0.0 0
M  V30 13 C 10.3950 14.6226 0.0 0
M  V30 14 C 4.2350 13.2890 0.0 0
M  V30 15 C 2.6950 13.2890 0.0 0
M  V30 16 C 5.0050 14.6226 0.0 0
M  V30 17 C 1.9250 14.6226 0.0 0
M  V30 18 C 4.2350 15.9562 0.0 0
M  V30 19 C 2.6950 15.9562 0.0 0
M  V30 20 C 3.8500 7.2873 0.0 0
M  V30 21 C 2.3100 7.2873 0.0 0
M  V30 22 C 4.6200 5.9536 0.0 0
M  V30 23 C 1.5400 5.9536 0.0 0
M  V30 24 C 3.8500 4.6200 0.0 0
M  V30 25 C 2.3100 4.6200 0.0 0
M  V30 26 C 9.6250 10.6215 0.0 0
M  V30 27 C 10.3950 9.2879 0.0 0
M  V30 28 C 10.3950 11.9552 0.0 0
M  V30 29 C 11.9350 9.2879 0.0 0
M  V30 30 C 11.9350 11.9552 0.0 0
M  V30 31 C 12.7050 10.6215 0.0 0
M  V30 32 B 6.3525 1.5400 0.0 0 CHG=3 VAL=4
M  V30 33 F 4.8125 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 34 F 7.8925 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 35 F 6.3525 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 36 F 6.3525 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 2 1 26
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 4 5
M  V30 7 1 4 16
M  V30 8 1 6 7
M  V30 9 1 6 21
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 2 10 27 CFG=2
M  V30 14 1 12 13
M  V30 15 1 12 28
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 32 35
M  V30 37 1 32 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acridinium, 9-(2,6-dimethoxyphenyl)-1,8-dimethoxy-10-methyl-, hexafluorophosp...
C24H24NO4.F6P
321679-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 5.5410 0.0 0
M  V30 2 C 6.9301 4.2073 0.0 0
M  V30 3 O 6.1601 10.8759 0.0 0
M  V30 4 C 6.9301 12.2096 0.0 0
M  V30 5 O 8.4701 5.5410 0.0 0
M  V30 6 C 9.2401 4.2073 0.0 0
M  V30 7 O 8.4701 10.8759 0.0 0
M  V30 8 C 9.2401 12.2096 0.0 0
M  V30 9 C 0.0000 8.2085 0.0 0
M  V30 10 C 4.6201 8.2085 0.0 0
M  V30 11 C 3.8500 6.8748 0.0 0
M  V30 12 C 3.8500 9.5421 0.0 0
M  V30 13 C 2.3100 6.8748 0.0 0
M  V30 14 C 4.6201 5.5410 0.0 0
M  V30 15 C 2.3100 9.5421 0.0 0
M  V30 16 C 4.6201 10.8759 0.0 0
M  V30 17 N 1.5400 8.2085 0.0 0 CHG=1 VAL=4
M  V30 18 C 1.5400 5.5410 0.0 0
M  V30 19 C 3.8500 4.2073 0.0 0
M  V30 20 C 1.5400 10.8759 0.0 0
M  V30 21 C 3.8500 12.2096 0.0 0
M  V30 22 C 2.3100 4.2073 0.0 0
M  V30 23 C 2.3100 12.2096 0.0 0
M  V30 24 C 8.4701 8.2085 0.0 0
M  V30 25 C 9.2401 6.8748 0.0 0
M  V30 26 C 9.2401 9.5421 0.0 0
M  V30 27 C 10.7801 6.8748 0.0 0
M  V30 28 C 10.7801 9.5421 0.0 0
M  V30 29 C 11.5501 8.2085 0.0 0
M  V30 30 P 5.7751 1.3337 0.0 0 CHG=5 VAL=6
M  V30 31 F 4.2350 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 32 F 7.3151 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 33 F 5.0050 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 34 F 6.5451 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 35 F 6.5451 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 36 F 5.0050 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 24
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 15 20
M  V30 22 2 16 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 34
M  V30 37 1 30 35
M  V30 38 1 30 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 142467-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 321679-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16670458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 17084-13-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Structures of N-Alkyl-1,13-dimethoxychromeno-
[2,3,4-kl]acridinium Salts: The Missing Azaoxa[4]helicenium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorensen, Thomas Just; Madsen, Anders O.; Laursen, Bo W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(21), 6391-6400

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 4-cyanobenzenesulfonate
C17H10ClNO5S
1427203-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 C 14.5750 2.2548 0.0 0
M  V30 9 N 15.9089 1.4847 0.0 0
M  V30 10 C 3.8501 4.0012 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 6.1601 2.6675 0.0 0
M  V30 15 O 3.8501 1.3338 0.0 0
M  V30 16 C 1.5400 2.6675 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 2.3101 1.3338 0.0 0
M  V30 20 C 10.5740 4.5648 0.0 0
M  V30 21 C 10.5740 3.0248 0.0 0
M  V30 22 C 11.9077 5.3348 0.0 0
M  V30 23 C 11.9077 2.2548 0.0 0
M  V30 24 C 13.2414 4.5648 0.0 0
M  V30 25 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 2 7 19
M  V30 9 3 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 4-cyanobe...
C18H14N2O5S
1427203-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0127 1.7270 0.0 0
M  V30 2 C 2.5367 3.1917 0.0 0
M  V30 3 N 1.0304 3.5118 0.0 0
M  V30 4 O 3.5673 4.3360 0.0 0
M  V30 5 C 0.0000 2.3673 0.0 0
M  V30 6 O 9.6644 4.7472 0.0 0
M  V30 7 S 9.6644 6.2872 0.0 0 VAL=6
M  V30 8 O 9.6644 7.8272 0.0 0
M  V30 9 O 8.1244 6.2872 0.0 0
M  V30 10 C 15.8244 6.2872 0.0 0
M  V30 11 N 17.3644 6.2872 0.0 0
M  V30 12 C 5.6635 2.4372 0.0 0
M  V30 13 C 6.9971 1.6672 0.0 0
M  V30 14 C 4.5190 1.4068 0.0 0
M  V30 15 C 5.6635 3.9772 0.0 0
M  V30 16 C 8.3308 2.4372 0.0 0
M  V30 17 O 6.6770 0.1609 0.0 0
M  V30 18 C 5.1453 0.0000 0.0 0
M  V30 19 C 6.9971 4.7472 0.0 0
M  V30 20 C 8.3308 3.9772 0.0 0
M  V30 21 C 11.2044 6.2872 0.0 0
M  V30 22 C 11.9744 7.6210 0.0 0
M  V30 23 C 11.9744 4.9536 0.0 0
M  V30 24 C 13.5144 7.6210 0.0 0
M  V30 25 C 13.5144 4.9536 0.0 0
M  V30 26 C 14.2844 6.2872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 3 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-82-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5235279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Cyanobenzenesulfonate (25). 25 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 20% → 90%). Yield: 98%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.64 (d, J = 4.7 Hz, 3H), 5.22 (d, J = 2.5 Hz,
2H), 5.86 (t, J = 2.5 Hz, 1H), 6.56 (dd, J1 = 2.2 Hz, J2 = 8.8 Hz, 1H),
6.71 (d, J = 2.2 Hz, 1H), 8.03-8.08 (m, 3H, 1 proton disappears with
D2O), 8.15 (d, J = 8.5 Hz, 2H), 8.85 (d, J = 8.8 Hz, 1H). IC50 ± SD (nM),
MAO-A: 45 ± 3.5; MAO-B: 10 ± 2.1%. Calculated: C 58.37, H 3.81, N 7.56;
Found: C 58.55, H 3.86, N 7.68.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-8-methyl-2-oxo-2H-1-benzopyran-7-yl 3,3,3-trifluoro-1-propan...
C14H12ClF3O5S
1427203-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 C 6.9302 1.3338 0.0 0
M  V30 4 O 8.4702 4.0012 0.0 0
M  V30 5 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 6 C 10.5740 4.5648 0.0 0
M  V30 7 O 10.0102 6.6687 0.0 0
M  V30 8 O 7.9065 6.1048 0.0 0
M  V30 9 C 11.9077 5.3348 0.0 0
M  V30 10 C 13.2414 4.5648 0.0 0
M  V30 11 F 12.4713 3.2311 0.0 0
M  V30 12 F 14.5752 3.7948 0.0 0
M  V30 13 F 14.0114 5.8986 0.0 0
M  V30 14 O 1.5400 0.0000 0.0 0
M  V30 15 C 3.8501 4.0012 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 4.6201 5.3348 0.0 0
M  V30 19 C 6.1601 2.6675 0.0 0
M  V30 20 O 3.8501 1.3338 0.0 0
M  V30 21 C 1.5400 2.6675 0.0 0
M  V30 22 C 6.1601 5.3348 0.0 0
M  V30 23 C 6.9302 4.0012 0.0 0
M  V30 24 C 2.3101 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 24
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 24
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-7-methyl-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl ...
C15H16F3NO5S
1427203-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2888 3.3778 0.0 0
M  V30 2 C 2.6091 4.8841 0.0 0
M  V30 3 N 1.4646 5.9147 0.0 0
M  V30 4 O 4.0737 5.3601 0.0 0
M  V30 5 C 0.0000 5.4388 0.0 0
M  V30 6 C 8.0197 0.0000 0.0 0
M  V30 7 O 9.5598 2.6675 0.0 0
M  V30 8 S 10.3298 4.0012 0.0 0 VAL=6
M  V30 9 C 11.6636 3.2311 0.0 0
M  V30 10 O 11.0998 5.3348 0.0 0
M  V30 11 O 8.9961 4.7712 0.0 0
M  V30 12 C 12.9973 4.0012 0.0 0
M  V30 13 C 14.3309 3.2311 0.0 0
M  V30 14 F 15.1010 4.5648 0.0 0
M  V30 15 F 15.6646 2.4611 0.0 0
M  V30 16 F 13.5609 1.8975 0.0 0
M  V30 17 C 4.9397 2.6675 0.0 0
M  V30 18 C 5.7097 1.3338 0.0 0
M  V30 19 C 3.4334 2.3473 0.0 0
M  V30 20 C 5.7097 4.0012 0.0 0
M  V30 21 C 7.2497 1.3338 0.0 0
M  V30 22 O 4.6792 0.1893 0.0 0
M  V30 23 C 3.2724 0.8156 0.0 0
M  V30 24 C 7.2497 4.0012 0.0 0
M  V30 25 C 8.0197 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 2 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12199264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-7-Methyl-3-[2-(methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
3,3,3-Trifluoropropane-1-sulfonate (36). 36 was purified by flash
chromatography (gradient eluent ethyl acetate in n-hexane 20% → 90%).
Yield: 98%. 1H NMR (300 MHz, DMSO-d6) δ: 2.12 (s, 3H), 2.66 (d, J = 4.7
Hz, 3H), 2.89-3.01 (m, 2H), 3.95-4.01 (m, 2H), 5.28 (d, J = 2.5 Hz, 2H),
5.87 (t, J = 2.5 Hz, 1H), 6.92 (d, J = 8.5 Hz, 1H), 8.03 (br q, J = 4.7
Hz, 1H, disappears with D2O), 8.79 (d, J = 8.5 Hz, 1H). IC50 ± SD (nM),
MAO-A: 11 ± 2.8; MAO-B: 5 ± 0.8%. Calculated: C 47.49, H 4.25, N 3.69;
Found: C 47.84, H 4.28, N 3.71.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1R,3S)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-phenyl-1H-pyrido[3,4-b]...
C22H21ClN2O3
1447959-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 8.9401 0.0 0
M  V30 2 C 6.6685 9.7102 0.0 0
M  V30 3 O 4.0011 9.7102 0.0 0
M  V30 4 Cl 6.6685 11.2502 0.0 0
M  V30 5 C 8.0021 7.4001 0.0 0
M  V30 6 O 9.3359 6.6301 0.0 0
M  V30 7 O 8.0021 8.9401 0.0 0
M  V30 8 C 10.6696 7.4001 0.0 0
M  V30 9 C 12.0033 6.6301 0.0 0
M  V30 10 C 4.0011 6.6301 0.0 0 CFG=1
M  V30 11 C 4.0011 5.0901 0.0 0
M  V30 12 N 5.3348 7.4001 0.0 0
M  V30 13 C 5.3348 4.3201 0.0 0
M  V30 14 N 2.8566 4.0597 0.0 0
M  V30 15 C 6.6685 6.6301 0.0 0 CFG=2
M  V30 16 C 5.0146 2.8138 0.0 0
M  V30 17 C 6.6685 5.0901 0.0 0
M  V30 18 C 3.4831 2.6527 0.0 0
M  V30 19 C 5.9199 1.5679 0.0 0
M  V30 20 C 2.8566 1.2459 0.0 0
M  V30 21 C 5.2934 0.1609 0.0 0
M  V30 22 C 3.7618 0.0000 0.0 0
M  V30 23 C 2.6673 7.4001 0.0 0
M  V30 24 C 1.3337 6.6301 0.0 0
M  V30 25 C 2.6673 8.9401 0.0 0
M  V30 26 C 0.0000 7.4001 0.0 0
M  V30 27 C 1.3337 9.7102 0.0 0
M  V30 28 C 0.0000 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 15 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 23 CFG=1
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6R,12aS)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-phenylpyrazino[1′,2′:1,6]pyrido...
C21H19N3O2
1447959-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.0800 0.0 0
M  V30 2 O 2.6673 9.2400 0.0 0
M  V30 3 C 0.0000 7.7000 0.0 0
M  V30 4 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 5 C 6.6684 5.3900 0.0 0
M  V30 6 N 4.0011 5.3900 0.0 0
M  V30 7 C 6.6684 6.9300 0.0 0
M  V30 8 N 8.1331 4.9142 0.0 0
M  V30 9 C 4.0011 6.9300 0.0 0 CFG=2
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 8.1331 7.4059 0.0 0
M  V30 12 C 5.3347 7.7000 0.0 0
M  V30 13 C 9.0383 6.1600 0.0 0
M  V30 14 C 2.6673 7.7000 0.0 0
M  V30 15 C 1.3336 5.3900 0.0 0
M  V30 16 C 8.7594 8.8128 0.0 0
M  V30 17 C 10.5698 6.3210 0.0 0
M  V30 18 N 1.3336 6.9300 0.0 0
M  V30 19 C 10.2909 8.9738 0.0 0
M  V30 20 C 11.1962 7.7279 0.0 0
M  V30 21 C 5.3347 3.0800 0.0 0
M  V30 22 C 4.0011 2.3100 0.0 0
M  V30 23 C 6.6684 2.3100 0.0 0
M  V30 24 C 4.0011 0.7700 0.0 0
M  V30 25 C 6.6684 0.7700 0.0 0
M  V30 26 C 5.3347 0.0000 0.0 0
M  V30 27 H 4.0011 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=1
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 27 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447959-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447959-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1731946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5. General procedure for the synthesis of
compounds 13. A mixture of 12 (100 mg, 0.25 mmol) and the appropriate
amine (1.25 mmol) in dry EtOH (10 ml) was stirred for 24 h at room
temperature. Then, the solvent was evaporated and the residue extracted
with EtOAc. The combined organic phases were washed with saturated
NaHCO3, dried (MgSO4) and evaporated in vacuo. Purification by means of
column chromatography on silicagel (hexane/EtOAc) gave pure compound.
Diketopiperazine 10a, Yield: 98%. Reactant:
trans-Ethyl-2-(2-chloroacetyl)-1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate
8a.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of functionalized diketopiperazines as Cyclotryprostatin and
Tryprostatin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van, Tuyen Nguyen; Claes, Pieter; De Kimpe, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(8), 1006-1010

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C44H46N6O8
1448441-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0462 3.5673 0.0 0
M  V30 2 O 12.3664 5.0737 0.0 0
M  V30 3 C 9.3356 5.5366 0.0 0
M  V30 4 N 8.0020 6.3066 0.0 0
M  V30 5 O 10.6694 6.3066 0.0 0
M  V30 6 N 14.9754 4.5191 0.0 0
M  V30 7 C 16.4401 4.9950 0.0 0
M  V30 8 O 17.5845 3.9644 0.0 0
M  V30 9 C 5.3347 7.8466 0.0 0
M  V30 10 N 4.0009 8.6166 0.0 0
M  V30 11 O 5.3347 6.3066 0.0 0
M  V30 12 N 19.3693 5.9467 0.0 0
M  V30 13 C 20.8340 6.4226 0.0 0
M  V30 14 O 21.1542 7.9290 0.0 0
M  V30 15 C 1.3336 10.1566 0.0 0
M  V30 16 O 0.0000 10.9266 0.0 0
M  V30 17 O 2.6673 10.9266 0.0 0
M  V30 18 C 0.0000 12.4666 0.0 0
M  V30 19 C 24.1112 7.1193 0.0 0
M  V30 20 C 25.6427 7.2802 0.0 0
M  V30 21 O 23.2060 8.3651 0.0 0
M  V30 22 C 25.8036 5.7487 0.0 0
M  V30 23 C 27.1742 7.4411 0.0 0
M  V30 24 C 25.4818 8.8117 0.0 0
M  V30 25 N 10.5816 3.0914 0.0 0
M  V30 26 C 9.3358 3.9966 0.0 0 CFG=2
M  V30 27 C 10.1058 1.6267 0.0 0
M  V30 28 C 8.0898 3.0914 0.0 0
M  V30 29 C 8.5658 1.6267 0.0 0
M  V30 30 C 13.1907 2.5368 0.0 0
M  V30 31 C 14.6553 3.0127 0.0 0
M  V30 32 C 12.8705 1.0304 0.0 0
M  V30 33 C 15.7998 1.9823 0.0 0
M  V30 34 C 14.0149 0.0000 0.0 0
M  V30 35 C 15.4796 0.4759 0.0 0
M  V30 36 C 8.0020 7.8466 0.0 0
M  V30 37 C 6.6684 8.6166 0.0 0
M  V30 38 C 9.3356 8.6166 0.0 0
M  V30 39 C 6.6684 10.1566 0.0 0
M  V30 40 C 9.3356 10.1566 0.0 0
M  V30 41 C 8.0020 10.9266 0.0 0
M  V30 42 C 16.7603 6.5013 0.0 0
M  V30 43 C 18.2250 6.9771 0.0 0
M  V30 44 C 15.6159 7.5318 0.0 0
M  V30 45 C 18.5451 8.4836 0.0 0
M  V30 46 C 15.9361 9.0381 0.0 0
M  V30 47 C 17.4006 9.5140 0.0 0
M  V30 48 C 2.6673 7.8466 0.0 0
M  V30 49 C 1.3336 8.6166 0.0 0
M  V30 50 C 2.6673 6.3066 0.0 0
M  V30 51 C 0.0000 7.8466 0.0 0
M  V30 52 C 1.3336 5.5366 0.0 0
M  V30 53 C 0.0000 6.3066 0.0 0
M  V30 54 C 21.9784 5.3922 0.0 0 CFG=2
M  V30 55 N 23.4848 5.7123 0.0 0
M  V30 56 C 21.8175 3.8606 0.0 0
M  V30 57 C 24.2548 4.3787 0.0 0
M  V30 58 C 23.2243 3.2342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 25
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 26 3 CFG=1
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 31
M  V30 10 2 7 8
M  V30 11 1 7 42
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 37
M  V30 15 1 10 48
M  V30 16 1 12 13
M  V30 17 1 12 43
M  V30 18 2 13 14
M  V30 19 1 54 13 CFG=1
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 15 49
M  V30 23 1 16 18
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 1 19 55
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 59 1 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C44H47N7O7
1448441-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0462 3.5673 0.0 0
M  V30 2 O 12.3664 5.0737 0.0 0
M  V30 3 C 9.3356 5.5366 0.0 0
M  V30 4 N 8.0020 6.3066 0.0 0
M  V30 5 O 10.6694 6.3066 0.0 0
M  V30 6 N 14.9754 4.5191 0.0 0
M  V30 7 C 16.4401 4.9950 0.0 0
M  V30 8 O 17.5845 3.9644 0.0 0
M  V30 9 C 5.3347 7.8466 0.0 0
M  V30 10 N 4.0009 8.6166 0.0 0
M  V30 11 O 5.3347 6.3066 0.0 0
M  V30 12 N 19.3694 5.9467 0.0 0
M  V30 13 C 20.8340 6.4226 0.0 0
M  V30 14 O 21.1542 7.9290 0.0 0
M  V30 15 C 1.3336 10.1566 0.0 0
M  V30 16 N 0.0000 10.9266 0.0 0
M  V30 17 O 2.6673 10.9266 0.0 0
M  V30 18 C 0.0000 12.4666 0.0 0
M  V30 19 C 24.1112 7.1193 0.0 0
M  V30 20 C 25.6427 7.2802 0.0 0
M  V30 21 O 23.2060 8.3651 0.0 0
M  V30 22 C 25.8036 5.7487 0.0 0
M  V30 23 C 27.1742 7.4411 0.0 0
M  V30 24 C 25.4818 8.8117 0.0 0
M  V30 25 N 10.5816 3.0914 0.0 0
M  V30 26 C 9.3356 3.9966 0.0 0 CFG=2
M  V30 27 C 10.1056 1.6267 0.0 0
M  V30 28 C 8.0898 3.0914 0.0 0
M  V30 29 C 8.5656 1.6267 0.0 0
M  V30 30 C 13.1907 2.5368 0.0 0
M  V30 31 C 14.6553 3.0127 0.0 0
M  V30 32 C 12.8705 1.0304 0.0 0
M  V30 33 C 15.7998 1.9823 0.0 0
M  V30 34 C 14.0149 0.0000 0.0 0
M  V30 35 C 15.4796 0.4759 0.0 0
M  V30 36 C 8.0020 7.8466 0.0 0
M  V30 37 C 6.6684 8.6166 0.0 0
M  V30 38 C 9.3356 8.6166 0.0 0
M  V30 39 C 6.6684 10.1566 0.0 0
M  V30 40 C 9.3356 10.1566 0.0 0
M  V30 41 C 8.0020 10.9266 0.0 0
M  V30 42 C 16.7603 6.5013 0.0 0
M  V30 43 C 18.2250 6.9771 0.0 0
M  V30 44 C 15.6159 7.5318 0.0 0
M  V30 45 C 18.5451 8.4836 0.0 0
M  V30 46 C 15.9361 9.0381 0.0 0
M  V30 47 C 17.4006 9.5140 0.0 0
M  V30 48 C 2.6673 7.8466 0.0 0
M  V30 49 C 1.3336 8.6166 0.0 0
M  V30 50 C 2.6673 6.3066 0.0 0
M  V30 51 C 0.0000 7.8466 0.0 0
M  V30 52 C 1.3336 5.5366 0.0 0
M  V30 53 C 0.0000 6.3066 0.0 0
M  V30 54 C 21.9784 5.3922 0.0 0 CFG=2
M  V30 55 N 23.4848 5.7123 0.0 0
M  V30 56 C 21.8175 3.8606 0.0 0
M  V30 57 C 24.2548 4.3787 0.0 0
M  V30 58 C 23.2243 3.2342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 25
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 26 3 CFG=1
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 31
M  V30 10 2 7 8
M  V30 11 1 7 42
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 37
M  V30 15 1 10 48
M  V30 16 1 12 13
M  V30 17 1 12 43
M  V30 18 2 13 14
M  V30 19 1 54 13 CFG=1
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 15 49
M  V30 23 1 16 18
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 1 19 55
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 59 1 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448441-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448441-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14329775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-N-(2-((2-(methylcarbamoyl)phenyl)carbamoyl)phenyl)-1-(2-(2-((S)-1-pivaloyl
pyrrolidine-2-carboxamido)benzamido)benzoyl)pyrrolidine-2-carboxamide 5:
The ester 5a (0.2g, 0.25 mmol) was taken in saturated
methanolicmethylamine solution (2 mL) and stirred at room temperature for
2 h. Thesolvent was removed under reduced pressure, and the residue was
purified by column chromatography (eluent: 60% AcOEt/pet. Ether, Rf :
0.2) to afford 5. White solid, yield 0.19 g, 98%. mp: 147-149 °C; [α ]
26.38 D : -15.148° (c 1, CHCl3); IR (CHCl3) ν (cm-1): 3300, 3268, 3019,
2400, 1694, 1659, 1626, 1586, 1520, 1447, 1435, 1271; 1H NMR (200 MHz,
CDCl3) δ: 12.25 (s, 1H, amide), 12.16 (s, 1H, amide), 11.21 (s, 1H,
amide),10.38 (s, 1H, amide), 8.80-8.77 (d, J = 7.96 Hz, 1H), 8.57-8.53
(d, J = 8.08 Hz, 1H ), 8.33-8.29 (d, J = 8.08 Hz, 1H ), 8.23-8.19 (d, J =
8.21 Hz, 1H ), 8.45-8.43 (d, J = 8.55 Hz, 1H ), 7.82-7.78 (d, J = 7.83
Hz, 1H ), 7.76-7.72 (d, J = 7.58 Hz, 1H ), 7.58-7.54 (d, J = 7.83 Hz, 1H
), 7.51-7.01 (m, 10H), 6.57-6.49 (m, 1H), 4.93-4.86 (dd, J = 7.96 Hz, J =
5.31 Hz, 1H), 4.62-4.56 (m, 1H), 3.96-3.67 (m, 4H), 2.86-2.84 (d, J =
4.67 Hz, 3H), 2.46-2.25 (m, 2H), 2.16-1.89 (m, 8H), 2.12-2.04 (m, 2H),
1.33 (s, 9H); 13C NMR (50 MHz, CDCl3) δ: 177.8, 171.4, 170.3, 170.2,
169.5, 167.6, 167.6, 166.7, 140.1, 139.5, 138.4, 136.7, 133.1, 132.5,
131.6, 130.9, 128.5, 127.4, 127.2, 127.15, 124.6, 123.6, 123.4, 123.3,
123.0, 122.1, 121.2, 121.1, 120.0, 64.1, 62.8, 50.7, 48.5, 39.0, 29.6,
28.8, 27.5, 26.8, 25.5, 25.2; MALDI-TOF/TOF: 808.6611 (M+Na)+, 824.6780
(M+K)+; Elemental analysis calculated for C44H47N7O7: C, 67.25; H, 6.03;
N, 12.48. Found: C, 67.09; H, 6.04; N, 12.37. Crystal data of 5: Single
crystals of the complex were grown by slow evaporation of the solution of
DCM and MeOH. Colourless plate like crystal of approximate size 0.45 x
0.19 x 0.09 mm3 , was used for data collection. Hemisphere data
acquisition. Total scans = 3, total frames = 1271, exposure / frame =
10.0 sec / frame, θ range = 1.90 to 25.00 °, completeness to θ of 25.00 °
is 100 %. C 44H51N7O9, M = 821.92. Crystals belong to orthorhombic, space
group P2 1 2 1 2 1, a= 10.2506(5) b= 19.2039(9) c = 21.485(1) Å , V =
4229.4(3) Å 3 , Z= 4, Dc = 1.291 g /cc, μ (Mo-K α) = 0.092 mm-1 , 1744,
reflections measured, 21448 unique [I>2σ(I)], R value 0.0857, wR2 =
0.1797. Largest diff. peak and hole 0.308 and -0.208 e. Å -3 .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Synthetic Zipper Peptide Motif Orchestrated via Co-operative Interplay
of Hydrogen Bonding, Aromatic Stacking, and Backbone Chirality
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nair, Roshna V.; Kheria, Sanjeev; Rayavarapu, Suresh; Kotmale, Amol S.;
Jagadeesh, Bharatam; Gonnade, Rajesh G.; Puranik, Vedavati G.;
Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(31), 11477-11480

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (αR)-α-[2-[(methylsulfonyl)oxy]ethyl]-α-[[(methylsulfonyl)o...
C18H28O8S2
1467777-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3348 0.0 0 CFG=2
M  V30 2 C 4.0012 4.5648 0.0 0
M  V30 3 C 6.1048 4.0012 0.0 0
M  V30 4 C 6.6685 6.1048 0.0 0
M  V30 5 C 4.5648 6.6685 0.0 0
M  V30 6 O 5.3348 2.6673 0.0 0
M  V30 7 O 7.6449 4.0012 0.0 0
M  V30 8 C 8.0022 5.3348 0.0 0
M  V30 9 O 5.3348 8.0023 0.0 0
M  V30 10 C 6.1048 1.3337 0.0 0
M  V30 11 O 9.3360 6.1048 0.0 0
M  V30 12 S 4.5648 9.3360 0.0 0 VAL=6
M  V30 13 C 4.7712 0.5637 0.0 0
M  V30 14 C 6.8749 0.0000 0.0 0
M  V30 15 C 7.4385 2.1037 0.0 0
M  V30 16 S 10.6697 5.3348 0.0 0 VAL=6
M  V30 17 C 3.2311 8.5660 0.0 0
M  V30 18 O 3.7948 10.6697 0.0 0
M  V30 19 O 5.8985 10.1060 0.0 0
M  V30 20 C 9.8996 4.0012 0.0 0
M  V30 21 O 12.0033 4.5648 0.0 0
M  V30 22 O 11.4397 6.6685 0.0 0
M  V30 23 C 2.6673 5.3348 0.0 0
M  V30 24 C 2.6673 6.8749 0.0 0
M  V30 25 C 1.3337 4.5648 0.0 0
M  V30 26 C 1.3337 7.6449 0.0 0
M  V30 27 C 0.0000 5.3348 0.0 0
M  V30 28 C 0.0000 6.8749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 23
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 2 12 19
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 2 16 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-1-methyl-3-(phenylmethyl)-3-pyrrolidinecarboxylate
C17H25NO2
1467776-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6359 4.7902 0.0 0
M  V30 2 O 8.0428 4.1639 0.0 0
M  V30 3 O 6.4750 6.3217 0.0 0
M  V30 4 C 9.2887 5.0691 0.0 0
M  V30 5 C 8.3835 6.3150 0.0 0
M  V30 6 C 10.5346 5.9743 0.0 0
M  V30 7 C 10.1939 3.8231 0.0 0
M  V30 8 C 4.6200 5.2188 0.0 0
M  V30 9 C 6.2769 0.0000 0.0 0
M  V30 10 C 5.3900 3.8850 0.0 0 CFG=2
M  V30 11 C 6.4204 2.7406 0.0 0
M  V30 12 C 3.9832 3.2587 0.0 0
M  V30 13 N 5.6504 1.4070 0.0 0
M  V30 14 C 4.1442 1.7271 0.0 0
M  V30 15 C 3.0800 5.2188 0.0 0
M  V30 16 C 2.3100 6.5524 0.0 0
M  V30 17 C 2.3100 3.8850 0.0 0
M  V30 18 C 0.7700 6.5524 0.0 0
M  V30 19 C 0.7700 3.8850 0.0 0
M  V30 20 C 0.0000 5.2188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 10 8 CFG=3
M  V30 9 1 8 15
M  V30 10 1 9 13
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1467777-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467776-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15326572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Phase-Transfer Catalytic α-Benzylation and α-Allylation
of α-tert-Butoxycarbonyllactones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ha, Min Woo; Lee, Heejin; Yi, Hye Yeong; Park, Yohan; Kim, Sori; Hong,
Suckchang; Lee, Myungmo; Kim, Mi-hyun; Kim, Taek-Soo; Park, Hyeung-geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2013), 355(4), 637-642

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
2-Methyl 3-carboxy-2-furanacetate
C8H8O5
1479004-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 3.4208 0.0 0
M  V30 2 O 0.0000 3.1006 0.0 0
M  V30 3 O 1.9823 4.8855 0.0 0
M  V30 4 C 4.8384 3.7710 0.0 0
M  V30 5 C 6.3784 3.7710 0.0 0
M  V30 6 O 7.1484 5.1048 0.0 0
M  V30 7 O 7.1484 2.4374 0.0 0
M  V30 8 C 8.6884 5.1048 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0
M  V30 10 C 4.0684 2.4374 0.0 0
M  V30 11 C 2.2167 0.7700 0.0 0
M  V30 12 O 4.6947 1.0306 0.0 0
M  V30 13 C 3.5503 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)carbonyl]-2-furanacetate
C9H11NO4
1479004-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1821 3.4208 0.0 0
M  V30 2 N 8.6883 3.1006 0.0 0
M  V30 3 O 6.7062 4.8855 0.0 0
M  V30 4 C 9.7189 4.2451 0.0 0
M  V30 5 C 3.8500 3.7710 0.0 0
M  V30 6 C 2.3100 3.7710 0.0 0
M  V30 7 O 1.5400 5.1048 0.0 0
M  V30 8 O 1.5400 2.4373 0.0 0
M  V30 9 C 0.0000 5.1048 0.0 0
M  V30 10 C 6.1516 2.2764 0.0 0
M  V30 11 C 4.6200 2.4373 0.0 0
M  V30 12 C 6.4718 0.7700 0.0 0
M  V30 13 O 3.9937 1.0306 0.0 0
M  V30 14 C 5.1380 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1479004-17-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1479004-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4473883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Furo- and thieno-fused 1,3-diazepine-4,6-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ozer, Merve Sinem; Koza, Gani; Sahin, Ertan; Balci, Metin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(48), 6553-6556

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[[4-(Dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-meth...
C17H21N2
14844-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 N 12.0032 1.5400 0.0 0 CHG=1 VAL=4
M  V30 6 C 13.3369 2.3100 0.0 0
M  V30 7 C 12.0032 0.0000 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 9.3359 4.6201 0.0 0
M  V30 17 C 9.3359 1.5400 0.0 0
M  V30 18 C 10.6695 3.8500 0.0 0
M  V30 19 C 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)-α-[4-(dimethylamino)phenyl]-N-methylbenzenemethanamine
C18H25N3
1397751-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 2.3100 0.0 0
M  V30 2 N 6.6684 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 N 1.3337 5.3901 0.0 0
M  V30 5 C 1.3337 6.9301 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 N 12.0032 5.3901 0.0 0
M  V30 8 C 12.0032 6.9301 0.0 0
M  V30 9 C 13.3369 4.6201 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 4.0010 2.3100 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 3.0800 0.0 0
M  V30 14 C 4.0010 5.3901 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 8.0021 3.0800 0.0 0
M  V30 17 C 9.3359 2.3100 0.0 0
M  V30 18 C 8.0021 4.6201 0.0 0
M  V30 19 C 10.6695 3.0800 0.0 0
M  V30 20 C 9.3359 5.3901 0.0 0
M  V30 21 C 10.6695 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14844-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1397751-34-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-478-CAS-6728079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Bis(4-(dimethylamino)phenyl)methyl)-methylamine (28). Methylamine (13, 1
mL, 33% in ethanol, 0.2 g, 8 mmol) was added to a solution of
(dma)2CH+BF4- (16i, 100 mg, 0.294 mmol) in acetonitrile (10 mL) and
stirred for 5 min at rt. Then 2 M NaOH (10 mL) was added, and the
solution was extracted with diethyl ether (15 mL). The ethereal phase was
dried (MgSO4) and filtered, and the volatile compounds were evaporated
under reduced pressure: 28. Colorless crystals, yield (82 mg, 0.29 mmol,
98%). mp 125-126 °C (pentane). 1H NMR (300 MHz, CDCl3): δ 2.39 (s, 3 H,
NH(CH3)), 2.90 (s, 12 H, N(CH3)2), 4.54 (s, 1 H, Ar2CH), 6.68 (d, J = 8.8
Hz, 4 H, Har), 7.23 (d, J = 8.7 Hz, 4 H, Har). 13C NMR (75 MHz, CDCl3): δ
35.2 (q), 40.9 (q), 68.4 (d, Ar2CH), 112.9 (d), 128.0 (d), 132.9 (s),
149.7 (s). HRMS (EI, positive) m/z calcd for C18H25N3+: 283.2048, found
283.2038.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleophilic Reactivities of Hydrazines and Amines: The Futile Search for
the α-Effect in Hydrazine Reactivities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nigst, Tobias A.; Antipova, Anna; Mayr, Herbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(18), 8142-8155

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
2-Chloro-4-pyrimidinecarboxylic acid
C5H3ClN2O2
149849-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 N 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-pyrimidinecarboxamide
C6H6ClN3O
1201657-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 N 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 149849-92-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1201657-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14897567
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted piperazine compounds as selective serotonin
reuptake inhibitors and/or 5-HT1a receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yingjun; Jin, Chuanfei; Cheng, Changchung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015169180 A1 2015-11-12

$RFMT $RIREG SCHEME276 STEP1
$RXN



  3  1
$MOL
Dehydroepiandrosterone
C19H28O2
53-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6026 3.7975 0.0 0
M  V30 2 C 8.1632 6.1516 0.0 0
M  V30 3 O 9.9426 6.5605 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 6 C 5.3348 3.0800 0.0 0 CFG=2
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=2
M  V30 8 C 6.6684 0.7700 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 10 C 5.3348 4.6200 0.0 0
M  V30 11 C 8.0022 4.6200 0.0 0 CFG=2
M  V30 12 C 9.4668 2.6040 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 6.6684 5.3901 0.0 0
M  V30 17 C 9.4668 5.0959 0.0 0
M  V30 18 C 10.3720 3.8500 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0 CFG=1
M  V30 22 H 7.5518 1.0484 0.0 0
M  V30 23 H 4.2458 4.1690 0.0 0
M  V30 24 H 8.5540 1.6423 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=1
M  V30 3 2 3 17
M  V30 4 1 21 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 23 CFG=3
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 24 CFG=3
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 2 13 14
M  V30 23 1 14 19
M  V30 24 1 15 20
M  V30 25 1 17 18
M  V30 26 1 19 21
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 5 6 7 9 11 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Potassium cyanide
CKN
151-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 K 0.0000 0.0000 0.0 0
M  V30 3 N 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β,17α)-3-Hydroxy-17-(methylamino)androst-5-ene-17-carbonitrile
C21H32N2O
1032682-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.1631 6.1516 0.0 0
M  V30 2 C 10.8004 5.8659 0.0 0
M  V30 3 N 12.1341 6.6359 0.0 0
M  V30 4 N 8.8403 6.5029 0.0 0
M  V30 5 C 9.7455 7.7487 0.0 0
M  V30 6 C 3.6024 3.7975 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 9 C 8.0021 3.0800 0.0 0 CFG=1
M  V30 10 C 9.4668 5.0959 0.0 0 CFG=1
M  V30 11 C 6.6684 5.3900 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0 CFG=2
M  V30 13 C 9.4668 2.6042 0.0 0
M  V30 14 C 10.3720 3.8500 0.0 0
M  V30 15 C 5.3348 4.6200 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0 CFG=1
M  V30 17 C 6.6684 0.7700 0.0 0
M  V30 18 C 4.0009 2.3100 0.0 0 CFG=2
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 4.0009 0.7700 0.0 0
M  V30 21 C 2.6673 3.0800 0.0 0
M  V30 22 C 2.6673 0.0000 0.0 0
M  V30 23 C 1.3336 2.3100 0.0 0
M  V30 24 C 1.3336 0.7700 0.0 0 CFG=1
M  V30 25 H 8.5540 1.6423 0.0 0
M  V30 26 H 7.7573 1.2211 0.0 0
M  V30 27 H 4.4514 4.3416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 3 2 3
M  V30 3 1 10 2 CFG=1
M  V30 4 1 4 5
M  V30 5 1 10 4 CFG=3
M  V30 6 1 18 6 CFG=1
M  V30 7 1 24 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 25 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 26 CFG=1
M  V30 19 1 13 14
M  V30 20 1 15 16
M  V30 21 1 16 18
M  V30 22 1 16 27 CFG=3
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 2 19 20
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 8 9 10 12 16 18 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53-43-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 151-50-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032682-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-7917614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New steroidal derivatives synthesized using 3β-hydroxyandrosten-17-one as
starting material
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abd El-Latif, Nehad A.; Abdulla, Mohamed M.; Amr, Abd El-Galil E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Pharmaceutica (Zagreb, Croatia) (2008), 58(1), 43-59

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichloro-4-pyridinecarbonitrile
C6H2Cl2N2
153463-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 Cl 3.0800 5.3349 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 N 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-5-(dimethylamino)-4-pyridinecarbonitrile
C8H8ClN3
211571-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 N 2.6674 0.0000 0.0 0
M  V30 3 N 5.3347 3.0800 0.0 0
M  V30 4 C 5.3347 1.5400 0.0 0
M  V30 5 C 6.6685 3.8500 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 1.3338 5.3900 0.0 0
M  V30 12 N 2.6674 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 153463-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 211571-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29454315
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method W: A sealed tube containing 6-8 mL of dimethylamine and 4.18 g
(24.2 mmol) of compound 32 was warmed from -78°C to room temperature over
1 h and then heated at 50°C for an additional 1 h. The reaction mixture
was cooled to 0°C and partitioned between 20 mL of water and 50 mL of
ethyl acetate. The organic layer was washed with 10 mL of water, 20 mL of
brine, and dried over sodium sulfate. It was filtered and the filtrate
was concentrated to give 4.37 g (98%) of compound 33. MS calcd for
C8H9ClN3 =182.1; found 182.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic compounds as mGluR1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matasi, Julius J.; Tulshian, Deen; Burnett, Duane A.; Wu, Wen-Lian;
Korakas, Peter; Silverman, Lisa S.; Sasikumar, Thavalakulamgara K.;
Qiang, Li; Domalski, Martin S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006002051 A1 2006-01-05

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Boc-L-alanine
C8H15NO4
15761-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 4 O 2.6675 1.5400 0.0 0
M  V30 5 O 4.0012 3.8501 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 O 9.3360 2.3101 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 2.1037 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-methyl-2-(methylamino)-2-oxoethyl]carbamate
C9H18N2O3
84851-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 8.0023 1.5400 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 O 2.6673 1.5400 0.0 0
M  V30 7 O 4.0012 3.8501 0.0 0
M  V30 8 N 9.3360 2.3101 0.0 0
M  V30 9 O 8.0023 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 0.5637 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-38-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84851-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6751174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure III (GP-III). N-Alkyl Amidation of PG-Xaa-OH N-Methyl
morpholine (10 mmol) and isobutyl chloroformate (10 mmol) were
successively added to a solution of Boc-Xaa-OH 2a-g (10 mmol) or
PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at -20°C. After an activation
period of 3 min, 40 % aqueous methylamine (12-50 mmol) or N-alkyl amine
(13 mmol) in THF (5 mL) was added to above solution, and the resulting
solution was stirred for 1 h at -20°C prior to the addition of 5 % NaHCO3
(20 mL). After 30 min at room temperature, the aqueous phase was
extracted with CH2Cl2 (3×50 mL). The combined organic layer was washed
with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4). Evaporation of solvents
under reduced pressure gave Boc-Xaa-NHMe 3a-g or PhtN-Xaa-NHR.3h-n The
crude products were purified by flash chromatography (EtOAc/cyclohexane,
1:2) or by crystallization (EtOAc/pentane or CH2Cl2/pentane). tert-Butyl
(S)-1-(methylcarbamoyl)ethylcarbamate (3a) [Boc-L-Ala-NHMe]. Following
GP-III, from Boc-L-Ala-OH 2a (9.46 g, 50 mmol), title compound 3a was
isolated as a white crystalline solid (9.92 g, > 98 %) mp 148°C
(CH2Cl2/pentane); [α]D -12.9 (c 1.03, MeOH); δH (300.14 MHz, CDCl3): 1.35
(d, 3 H, 3JHH = 6.9 Hz), 1.44 (3×s, 9 H), 2.81 (d, 3 H, 3JHH = 4.5 Hz),
4.19 (dq, 1 H, 3JHH = 7.3 Hz, 3JHH = 7.0 Hz), 5.26 (d, 1 H, 3JHH = 7.3
Hz), 6.58 (bs, 1 H); δC (75.48 MHz, CDCl3): 18.68 (q), 26.08 (q), 28.28
(3×q), 50.10 (d), 79.93 (s), 155.52 (s), 173.36 (s); MS-ES, m/z: 203.2
[M+H], 225.2 [M+Na]. Analytical and spectral data agree with literature.5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(phenylmethyl)-4-quinazolinamine
C15H12ClN3
157864-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 Cl 2.6673 0.0000 0.0 0
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 C 2.6673 6.1601 0.0 0
M  V30 8 N 4.0012 2.3101 0.0 0
M  V30 9 N 1.3337 2.3101 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 0.0000 6.1601 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 8.0023 6.1601 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 14
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-N4-(phenylmethyl)-2,4-quinazolinediamine
C16H16N4
681475-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 1.5400 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 N 3.8500 5.3347 0.0 0
M  V30 10 N 1.5400 4.0011 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 10.7800 4.0011 0.0 0
M  V30 19 C 10.7800 6.6685 0.0 0
M  V30 20 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 157864-32-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 681475-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8496849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure D: Amine Substitution of
4-Aminosubstituted-2-chloroquinazolines to Yield 2,4-Diamino-Substituted
Quinazolines. 1.5 equiv of amine was mixed with 1 equiv of
4-amino-substituted 2-chloroquinazoline at 0.2 M concentration in ethanol
in a sealed tube and heated to 150 °C. When the reaction was finished as
observed by TLC, the compound was purified by either method Da:
Purification Method Da. The compound crystallized out of the cool
solution and was filtered and rinsed with cold ethanol to yield pure
product. N4-BenzyN2-methylquinazoline-2,4-diamine (12). 0.088 g (0.326
mmol) of 10d was reacted with 2.0 M methylamine in methanol and purified
according to method Da to furnish 0.085 g (0.321 mmol) of the title
compound as a cream colored solid in 98% yield. 1H NMR (400 MHz, CDCl3) δ
8.29 (s, 1H), 7.42 (d, J = 7.7 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.27
(d, J = 9.0 Hz, 1H), 7.20−7.11 (m, 3H), 7.06 (t, J = 7.6 Hz, 1H), 4.80
(s, 2H), 2.93 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 160.11, 156.03, 142.69,
138.07, 133.96, 128.35, 127.94, 127.26, 123.74, 123.10, 119.20, 110.28,
45.06, 28.01. HRMS: m/z calcd for C16H17N4 [M + H]+ 265.1448; found
265.1454. Rf = 0.47 (dichloromethane to methanol 9:1).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antileishmanial Activity of a Series of N2,N4-Disubstituted
Quinazoline-2,4-diamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Horn, Kurt S.; Zhu, Xiaohua; Pandharkar, Trupti; Yang, Sihyung;
Vesely, Brian; Vanaerschot, Manu; Dujardin, Jean-Claude; Rijal, Suman;
Kyle, Dennis E.; Wang, Michael Zhuo; Werbovetz, Karl A.; Manetsch, Roman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(12), 5141-5156

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3R,4R)-4-[[(4-Methylphenyl)sulfonyl]amino]-1-(phenylmethyl)-3-piperidinyl...
C25H33N3O4S
1579997-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1789 9.3358 0.0 0
M  V30 2 S 9.7189 9.3358 0.0 0 VAL=6
M  V30 3 O 9.7189 10.8758 0.0 0
M  V30 4 O 9.7189 7.7958 0.0 0
M  V30 5 C 2.5368 8.3522 0.0 0
M  V30 6 O 1.0306 8.6724 0.0 0
M  V30 7 O 3.0127 6.8877 0.0 0
M  V30 8 C 0.0000 7.5280 0.0 0
M  V30 9 C 5.0989 4.0009 0.0 0
M  V30 10 C 15.8789 9.3358 0.0 0
M  V30 11 C 5.8689 8.0020 0.0 0 CFG=2
M  V30 12 C 7.4089 8.0020 0.0 0 CFG=2
M  V30 13 C 5.0989 6.6684 0.0 0
M  V30 14 C 8.1789 6.6684 0.0 0
M  V30 15 N 5.8689 5.3347 0.0 0
M  V30 16 C 7.4089 5.3347 0.0 0
M  V30 17 N 5.0989 9.3358 0.0 0
M  V30 18 C 3.5673 9.4967 0.0 0 CFG=2
M  V30 19 C 5.7253 10.7426 0.0 0
M  V30 20 C 3.2471 11.0030 0.0 0
M  V30 21 C 4.5809 11.7730 0.0 0
M  V30 22 C 11.2589 9.3358 0.0 0
M  V30 23 C 12.0289 8.0020 0.0 0
M  V30 24 C 12.0289 10.6694 0.0 0
M  V30 25 C 13.5689 8.0020 0.0 0
M  V30 26 C 13.5689 10.6694 0.0 0
M  V30 27 C 14.3389 9.3358 0.0 0
M  V30 28 C 5.8689 2.6673 0.0 0
M  V30 29 C 5.0989 1.3336 0.0 0
M  V30 30 C 7.4089 2.6673 0.0 0
M  V30 31 C 5.8689 0.0000 0.0 0
M  V30 32 C 8.1789 1.3336 0.0 0
M  V30 33 C 7.4089 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 18 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 9 15
M  V30 11 1 9 28
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 17 CFG=1
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-N-Methyl-1-[(3R,4R)-4-[[(4-methylphenyl)sulfonyl]amino]-1-(phenylmethyl)...
C25H34N4O3S
1579997-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1789 9.3358 0.0 0
M  V30 2 S 9.7189 9.3358 0.0 0 VAL=6
M  V30 3 O 9.7189 10.8758 0.0 0
M  V30 4 O 9.7189 7.7958 0.0 0
M  V30 5 C 2.5368 8.3522 0.0 0
M  V30 6 N 1.0306 8.6724 0.0 0
M  V30 7 O 3.0127 6.8877 0.0 0
M  V30 8 C 0.0000 7.5280 0.0 0
M  V30 9 C 5.0989 4.0009 0.0 0
M  V30 10 C 15.8789 9.3358 0.0 0
M  V30 11 C 5.8689 8.0020 0.0 0 CFG=2
M  V30 12 C 7.4089 8.0020 0.0 0 CFG=2
M  V30 13 C 5.0989 6.6684 0.0 0
M  V30 14 C 8.1789 6.6684 0.0 0
M  V30 15 N 5.8689 5.3347 0.0 0
M  V30 16 C 7.4089 5.3347 0.0 0
M  V30 17 N 5.0989 9.3358 0.0 0
M  V30 18 C 3.5673 9.4967 0.0 0 CFG=2
M  V30 19 C 5.7253 10.7426 0.0 0
M  V30 20 C 3.2471 11.0030 0.0 0
M  V30 21 C 4.5809 11.7730 0.0 0
M  V30 22 C 11.2589 9.3358 0.0 0
M  V30 23 C 12.0289 10.6694 0.0 0
M  V30 24 C 12.0289 8.0020 0.0 0
M  V30 25 C 13.5689 10.6694 0.0 0
M  V30 26 C 13.5689 8.0020 0.0 0
M  V30 27 C 14.3389 9.3358 0.0 0
M  V30 28 C 5.8689 2.6673 0.0 0
M  V30 29 C 7.4089 2.6673 0.0 0
M  V30 30 C 5.0989 1.3336 0.0 0
M  V30 31 C 8.1789 1.3336 0.0 0
M  V30 32 C 5.8689 0.0000 0.0 0
M  V30 33 C 7.4089 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 18 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 9 15
M  V30 11 1 9 28
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 17 CFG=1
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1579997-45-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1579997-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4682055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM S-N-Methyl1-[(3R,4R)-1-Benzyl-4-tosylamidopiperidin-3-yl]-pyrrolidine-2-carboxamide
(8). Pure isomer 5a (0.4 g, 0.85 mmol) was dissolved in CHCl3 (2 mL).
Methylamine (8 M in EtOH, 15 mL) was added at 0 °C and under N2
atmosphere. After 1 h, the ice bath was removed and the stirring
continued overnight. The solvent was evaporated. Pure compound 8 (0.38g,
98%) as a yellow powder after crystallization from Et2O; IR (KBr) 3307,
3087, 1655 cm-1; [α]D =-75.0 (c 0.4, 20 °C); mp 80-82 °C (Et2O); 1H NMR
(CDCl3, 200 MHz) δ 1.37-2.25 (m, 7H), 2.40 (s, 3H), 2.42-2.95 (m, 5H),
2.8 (d, J 5.14 Hz, 3H), 3.00-3.22 (m, 1H), 3.41 (d, J 11.0 Hz, 1H), 3.47
(d, J 11.0 Hz, 1H), 5.28 (bs, 1H), 7.18-7.38 (m, 7H), 7.62 (bs, 1H,
exch), 7.77 (d, J 8.1 Hz, 2H); 13C NMR (CDCl3, 50 MHz) δ 21.7, 25.1,
26.1, 31.4, 32.5, 45.4, 51.9, 52.1, 54.2, 60.5, 62.9, 64.4, 127.1, 127.5,
128.5, 129.1, 129.8, 137.7, 138.7, 143.4, 176.2 MS (ESI) M+ 471. Anal.
Calcd for C25H32N4O4S: C, 61.96; H, 6.66; N, 11.56. Found: C, 61.81; H,
6.89; N, 11.32.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric modular synthesis of a semirigid dipeptide mimetic by cascade
cycloaddition/ring rearrangement and borohydride reduction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pellegrino, Sara; Contini, Alessandro; Gelmi, Maria Luisa; Lo Presti,
Leonardo; Soave, Raffaella; Erba, Emanuela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(7), 3094-3102

$RFMT $RIREG SCHEME281 STEP1
$RXN



  3  1
$MOL
3-Trifluoromethoxybenzyl bromide
C8H6BrF3O
159689-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 1.3337 0.7700 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 Br 9.3360 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-threo-L-galacto-Octonic acid, 3,7-anhydro-5-deoxy-6,8-O-[(S)-phenylmethylen...
C24H22F3N3O7
2445854-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.6506 5.9393 0.0 0
M  V30 2 C 11.5009 8.5168 0.0 0 CFG=2
M  V30 3 C 12.4908 7.3370 0.0 0
M  V30 4 O 12.0277 9.9638 0.0 0
M  V30 5 O 14.0074 7.6045 0.0 0
M  V30 6 O 11.9641 5.8898 0.0 0
M  V30 7 C 14.9974 6.4247 0.0 0
M  V30 8 F 4.8736 0.3219 0.0 0
M  V30 9 F 0.0000 2.4918 0.0 0
M  V30 10 F 1.8103 0.0000 0.0 0
M  V30 11 C 7.3170 9.7893 0.0 0 CFG=1
M  V30 12 C 7.3170 8.2493 0.0 0 CFG=2
M  V30 13 C 8.6506 10.5593 0.0 0 CFG=1
M  V30 14 O 5.9833 10.5593 0.0 0
M  V30 15 C 8.6506 7.4793 0.0 0 CFG=1
M  V30 16 O 9.9843 9.7893 0.0 0
M  V30 17 C 8.6506 12.0993 0.0 0
M  V30 18 C 5.9833 12.0993 0.0 0 CFG=1
M  V30 19 C 9.9843 8.2493 0.0 0 CFG=2
M  V30 20 O 7.3170 12.8694 0.0 0
M  V30 21 N 5.9833 7.4793 0.0 0
M  V30 22 C 5.8222 5.9477 0.0 0
M  V30 23 N 4.5763 8.1056 0.0 0
M  V30 24 C 4.3159 5.6276 0.0 0
M  V30 25 N 3.5459 6.9612 0.0 0
M  V30 26 C 4.6495 12.8694 0.0 0
M  V30 27 C 3.3158 12.0993 0.0 0
M  V30 28 C 4.6495 14.4094 0.0 0
M  V30 29 C 1.9822 12.8694 0.0 0
M  V30 30 C 3.3158 15.1794 0.0 0
M  V30 31 C 1.9822 14.4094 0.0 0
M  V30 32 C 3.6896 4.2206 0.0 0
M  V30 33 C 4.5947 2.9747 0.0 0
M  V30 34 C 2.1579 4.0597 0.0 0
M  V30 35 C 3.9683 1.5679 0.0 0
M  V30 36 C 1.5316 2.6528 0.0 0
M  V30 37 C 2.4368 1.4068 0.0 0
M  V30 38 H 5.9833 9.0193 0.0 0
M  V30 39 H 9.9843 11.3293 0.0 0
M  V30 40 H 10.5111 6.8021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 35
M  V30 9 1 9 36
M  V30 10 1 10 37
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 38 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 21 CFG=1
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 39 CFG=3
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 18 20
M  V30 25 1 18 26 CFG=1
M  V30 26 1 19 40 CFG=3
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 2 22 24
M  V30 30 2 23 25
M  V30 31 1 24 25
M  V30 32 1 24 32
M  V30 33 2 26 27
M  V30 34 1 26 28
M  V30 35 1 27 29
M  V30 36 2 28 30
M  V30 37 2 29 31
M  V30 38 1 30 31
M  V30 39 2 32 33
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 2 34 36
M  V30 43 2 35 37
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 2 11 12 13 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-threo-L-galacto-Octonamide, 3,7-anhydro-5-deoxy-N-methyl-2-O-[[3-(trifluoro...
C25H24F6N4O7
2446506-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5323 9.4966 0.0 0
M  V30 2 O 8.9614 13.5833 0.0 0
M  V30 3 C 3.8500 10.6694 0.0 0 CFG=1
M  V30 4 O 4.6200 9.3358 0.0 0
M  V30 5 C 2.3100 10.6694 0.0 0
M  V30 6 C 3.8500 8.0020 0.0 0
M  V30 7 N 1.5400 12.0031 0.0 0
M  V30 8 O 1.5400 9.3358 0.0 0
M  V30 9 C 0.0000 12.0031 0.0 0
M  V30 10 C 6.6020 15.5629 0.0 0
M  V30 11 O 5.4222 16.5528 0.0 0
M  V30 12 F 15.5317 11.9552 0.0 0
M  V30 13 F 15.1595 6.6334 0.0 0
M  V30 14 F 16.8818 9.1869 0.0 0
M  V30 15 O 3.8500 2.6673 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 F 6.1600 1.3336 0.0 0
M  V30 18 F 5.3900 0.0000 0.0 0
M  V30 19 F 3.8500 0.0000 0.0 0
M  V30 20 C 7.2468 11.5398 0.0 0 CFG=1
M  V30 21 C 5.7996 11.0132 0.0 0 CFG=1
M  V30 22 C 7.5143 13.0564 0.0 0 CFG=1
M  V30 23 C 4.6200 12.0031 0.0 0 CFG=2
M  V30 24 C 6.3345 14.0463 0.0 0 CFG=1
M  V30 25 O 4.8873 13.5197 0.0 0
M  V30 26 N 8.4266 10.5499 0.0 0
M  V30 27 C 9.9208 10.9226 0.0 0
M  V30 28 N 8.3191 9.0138 0.0 0
M  V30 29 C 10.7369 9.6165 0.0 0
M  V30 30 N 9.7470 8.4369 0.0 0
M  V30 31 C 12.2730 9.5092 0.0 0
M  V30 32 C 13.1342 10.7859 0.0 0
M  V30 33 C 12.9482 8.1250 0.0 0
M  V30 34 C 14.6705 10.6784 0.0 0
M  V30 35 C 14.4845 8.0175 0.0 0
M  V30 36 C 15.3456 9.2944 0.0 0
M  V30 37 C 4.6200 6.6684 0.0 0
M  V30 38 C 3.8500 5.3347 0.0 0
M  V30 39 C 6.1600 6.6684 0.0 0
M  V30 40 C 4.6200 4.0011 0.0 0
M  V30 41 C 6.9300 5.3347 0.0 0
M  V30 42 C 6.1600 4.0011 0.0 0
M  V30 43 H 3.1729 12.5297 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=1
M  V30 2 1 22 2 CFG=3
M  V30 3 1 3 4 CFG=3
M  V30 4 1 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 37
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 24 10 CFG=3
M  V30 13 1 12 34
M  V30 14 1 13 35
M  V30 15 1 14 36
M  V30 16 1 15 16
M  V30 17 1 15 40
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 26 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 43 CFG=1
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 3 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159689-88-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445854-48-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446506-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-23796675
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 5872-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (CSA) (stage 3), screw cap scintillation vial (stage
3 and 7), unspecified acid resin used for neutralization (stage 4)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of galectin-3 inhibiting C-glycosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Magnani, John L.; Peterson, John M.; Sarkar, Arun K.; Vohra, Yusufbhai
U.; Gosh, Indranath; Noguiera, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021086816 A1 2021-05-06

$RFMT $RIREG SCHEME281 STEP1
$RXN



  3  1
$MOL
3-Trifluoromethoxybenzyl bromide
C8H6BrF3O
159689-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 1.3337 0.7700 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 Br 9.3360 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-threo-L-galacto-Octonic acid, 3,7-anhydro-5-deoxy-6,8-O-[(S)-phenylmethylen...
C24H22F3N3O7
2445854-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.6506 5.9393 0.0 0
M  V30 2 C 11.5009 8.5168 0.0 0 CFG=2
M  V30 3 C 12.4908 7.3370 0.0 0
M  V30 4 O 12.0277 9.9638 0.0 0
M  V30 5 O 14.0074 7.6045 0.0 0
M  V30 6 O 11.9641 5.8898 0.0 0
M  V30 7 C 14.9974 6.4247 0.0 0
M  V30 8 F 4.8736 0.3219 0.0 0
M  V30 9 F 0.0000 2.4918 0.0 0
M  V30 10 F 1.8103 0.0000 0.0 0
M  V30 11 C 7.3170 9.7893 0.0 0 CFG=1
M  V30 12 C 7.3170 8.2493 0.0 0 CFG=2
M  V30 13 C 8.6506 10.5593 0.0 0 CFG=1
M  V30 14 O 5.9833 10.5593 0.0 0
M  V30 15 C 8.6506 7.4793 0.0 0 CFG=1
M  V30 16 O 9.9843 9.7893 0.0 0
M  V30 17 C 8.6506 12.0993 0.0 0
M  V30 18 C 5.9833 12.0993 0.0 0 CFG=1
M  V30 19 C 9.9843 8.2493 0.0 0 CFG=2
M  V30 20 O 7.3170 12.8694 0.0 0
M  V30 21 N 5.9833 7.4793 0.0 0
M  V30 22 C 5.8222 5.9477 0.0 0
M  V30 23 N 4.5763 8.1056 0.0 0
M  V30 24 C 4.3159 5.6276 0.0 0
M  V30 25 N 3.5459 6.9612 0.0 0
M  V30 26 C 4.6495 12.8694 0.0 0
M  V30 27 C 3.3158 12.0993 0.0 0
M  V30 28 C 4.6495 14.4094 0.0 0
M  V30 29 C 1.9822 12.8694 0.0 0
M  V30 30 C 3.3158 15.1794 0.0 0
M  V30 31 C 1.9822 14.4094 0.0 0
M  V30 32 C 3.6896 4.2206 0.0 0
M  V30 33 C 4.5947 2.9747 0.0 0
M  V30 34 C 2.1579 4.0597 0.0 0
M  V30 35 C 3.9683 1.5679 0.0 0
M  V30 36 C 1.5316 2.6528 0.0 0
M  V30 37 C 2.4368 1.4068 0.0 0
M  V30 38 H 5.9833 9.0193 0.0 0
M  V30 39 H 9.9843 11.3293 0.0 0
M  V30 40 H 10.5111 6.8021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 35
M  V30 9 1 9 36
M  V30 10 1 10 37
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 38 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 21 CFG=1
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 39 CFG=3
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 18 20
M  V30 25 1 18 26 CFG=1
M  V30 26 1 19 40 CFG=3
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 2 22 24
M  V30 30 2 23 25
M  V30 31 1 24 25
M  V30 32 1 24 32
M  V30 33 2 26 27
M  V30 34 1 26 28
M  V30 35 1 27 29
M  V30 36 2 28 30
M  V30 37 2 29 31
M  V30 38 1 30 31
M  V30 39 2 32 33
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 2 34 36
M  V30 43 2 35 37
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 2 11 12 13 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-threo-L-galacto-Octonamide, 3,7-anhydro-5-deoxy-N-methyl-2-O-[[3-(trifluoro...
C25H24F6N4O7
2446506-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5323 9.4966 0.0 0
M  V30 2 O 8.9614 13.5833 0.0 0
M  V30 3 C 3.8500 10.6694 0.0 0 CFG=1
M  V30 4 O 4.6200 9.3358 0.0 0
M  V30 5 C 2.3100 10.6694 0.0 0
M  V30 6 C 3.8500 8.0020 0.0 0
M  V30 7 N 1.5400 12.0031 0.0 0
M  V30 8 O 1.5400 9.3358 0.0 0
M  V30 9 C 0.0000 12.0031 0.0 0
M  V30 10 C 6.6020 15.5629 0.0 0
M  V30 11 O 5.4222 16.5528 0.0 0
M  V30 12 F 15.5317 11.9552 0.0 0
M  V30 13 F 15.1595 6.6334 0.0 0
M  V30 14 F 16.8818 9.1869 0.0 0
M  V30 15 O 3.8500 2.6673 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 F 6.1600 1.3336 0.0 0
M  V30 18 F 5.3900 0.0000 0.0 0
M  V30 19 F 3.8500 0.0000 0.0 0
M  V30 20 C 7.2468 11.5398 0.0 0 CFG=1
M  V30 21 C 5.7996 11.0132 0.0 0 CFG=1
M  V30 22 C 7.5143 13.0564 0.0 0 CFG=1
M  V30 23 C 4.6200 12.0031 0.0 0 CFG=2
M  V30 24 C 6.3345 14.0463 0.0 0 CFG=1
M  V30 25 O 4.8873 13.5197 0.0 0
M  V30 26 N 8.4266 10.5499 0.0 0
M  V30 27 C 9.9208 10.9226 0.0 0
M  V30 28 N 8.3191 9.0138 0.0 0
M  V30 29 C 10.7369 9.6165 0.0 0
M  V30 30 N 9.7470 8.4369 0.0 0
M  V30 31 C 12.2730 9.5092 0.0 0
M  V30 32 C 13.1342 10.7859 0.0 0
M  V30 33 C 12.9482 8.1250 0.0 0
M  V30 34 C 14.6705 10.6784 0.0 0
M  V30 35 C 14.4845 8.0175 0.0 0
M  V30 36 C 15.3456 9.2944 0.0 0
M  V30 37 C 4.6200 6.6684 0.0 0
M  V30 38 C 3.8500 5.3347 0.0 0
M  V30 39 C 6.1600 6.6684 0.0 0
M  V30 40 C 4.6200 4.0011 0.0 0
M  V30 41 C 6.9300 5.3347 0.0 0
M  V30 42 C 6.1600 4.0011 0.0 0
M  V30 43 H 3.1729 12.5297 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=1
M  V30 2 1 22 2 CFG=3
M  V30 3 1 3 4 CFG=3
M  V30 4 1 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 37
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 24 10 CFG=3
M  V30 13 1 12 34
M  V30 14 1 13 35
M  V30 15 1 14 36
M  V30 16 1 15 16
M  V30 17 1 15 40
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 26 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 43 CFG=1
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 3 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 159689-88-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445854-48-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446506-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-22953198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 5872-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (CSA) (stage 3), screw cap scintillation vial (stage
3 and 7), unspecified acid resin used for neutralization (stage 4)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of galectin-3 inhibiting C-glycosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Magnani, John L.; Peterson, John M.; Sarkar, Arun K.; Vohra, Yusufbhai
U.; Ghosh, Indranath; Noguiera, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020139960 A1 2020-07-02

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Dimethyl 2,2′-sulfonylbis[acetate]
C6H10O6S
16002-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.7700 0.0 0
M  V30 2 S 5.3348 1.5400 0.0 0 VAL=6
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 O 4.5648 0.2064 0.0 0
M  V30 6 O 6.1048 2.8737 0.0 0
M  V30 7 O 9.3360 0.7700 0.0 0
M  V30 8 O 8.0023 3.0801 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 11 O 1.3337 2.3101 0.0 0
M  V30 12 O 2.6673 0.0000 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1,3,5-Thiadiazine, tetrahydro-3,5-dimethyl-, 1,1-dioxide
C5H12N2O2S
1450627-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.5826 0.0 0
M  V30 2 O 0.9898 5.2971 0.0 0
M  V30 3 C 2.8503 0.0000 0.0 0
M  V30 4 C 5.5176 4.6201 0.0 0
M  V30 5 S 1.5166 3.8501 0.0 0 VAL=6
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 N 2.8503 1.5400 0.0 0
M  V30 9 N 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16002-30-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1450627-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27513450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reactions of sulfurcontaining CH acids with formaldehyde and primary
amines (general proceure). To a solution of the cor responding amine (9.6
mmol) in a mixture of water (15 mL) and MeOH (30 mL), a 33% aqueous
formaldehyde solution (1.75 g, 19.2 mmol) and dimethyl sulfonyldiacetate
(1) (for 3a-c and 4) (4.8 mmol) or
N-methyl-2r,6c-di(methoxycarbonyl)3t,5t-di-phenyltetrahydro-1,4thiazine
1,1dioxide (5) (for 6) were added. Then ~5 mL of a 20% aqueous NaOH (for
3a-c and 4) or KOH (for 6) solution were added to the reaction mixture
until pH 7.5-8.0, and the mixture was refluxed for 4 h. The solvent was
removed in vacuo, 1 M HCl was added to the residue to pH 1, and the
mixture was washed with CHCl3 (3×25 mL). Acidic aqueous solution obtained
after extraction was neutralized with 20% aqueous NaOH and extracted with
CHCl3 (3×25 mL). The combined organic layers were dried with anhydrous
Na2SO4, the solvent was removed in vacuo, the products were isolated by
column chromatography (SiO2, elution with CHCl3-PriOH, 9 : 1).
3,5-Dimethyl2H-tetrahydro-1,3,5-thiadiazine 1,1dioxide (4), yield 98%.
Found (%): C, 36.59; H, 7.38; N, 17.02; S, 19.50. C5H12N2O2S. Calculated
(%): C, 36.57; H, 7.36; N, 17.06; S, 19.53. MS, m/z: 164 [M]+. IR, ν/cm-1
1136, 1308 (SO2). 1H NMR (CDCl3), δ : 2.09 (s, 6 H, 2 Me); 2.55 (d, 1 Hax
NCH2N, 2J = 8.8 Hz); 2.60 (d, 2 Hax CH2N, 2J = 11.6 Hz); 2.96 (d, 1 Heq,
NCH2N, 2J = 8.8 Hz); 3.09 (d, 2 Heq, CH2N, 2J = 11.6 Hz). 13C NMR
(CDCl3), δ : 42.67 (MeN), 69.30 (C(2), C(6)); 77.94 (C(4)).
$DTYPE RXN:VAR(1):NOTES
$DATUM product depends on type of hydroxide used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Mannich-type interaction of sulfur-containing CH acids with
formaldehyde and primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vlasova, L. I.; Baibulatova, N. Z.; Dokichev, V. A.; Tomilov, Yu. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2012), 61(11), 2129-2132

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinesulfonyl chloride
C5H4ClNO2S
16133-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 N 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-pyridinesulfonamide
C6H8N2O2S
4847-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 2.3100 0.2064 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 0.7700 0.2064 0.0 0
M  V30 10 N 0.7700 2.8736 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16133-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4847-34-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20442016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity and Structure-Conformation Relationships of Aryl
Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein
1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2)
Protein-Protein Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heightman, Tom D.; Callahan, James F.; Chiarparin, Elisabetta; Coyle,
Joseph E.; Griffiths-Jones, Charlotte; Lakdawala, Ami S.; McMenamin,
Rachel; Mortenson, Paul N.; Norton, David; Peakman, Torren M.; Rich,
Sharna J.; Richardson, Caroline; Rumsey, William L.; Sanchez, Yolanda;
Saxty, Gordon; Willems, Henriette M. G.; Wolfe, Lawrence; Woolford,
Alison J.-A.; Wu, Zining; Yan, Hongxing; Kerns, Jeffrey K.; Davies,
Thomas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(9), 4683-4702

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1-Bromocyclopentyl)(2-fluorophenyl)methanone
C12H12BrFO
1616657-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 O 2.4917 1.3338 0.0 0
M  V30 3 F 4.8017 0.0000 0.0 0
M  V30 4 Br 3.8987 4.6274 0.0 0
M  V30 5 C 4.8017 2.6674 0.0 0
M  V30 6 C 5.5717 1.3338 0.0 0
M  V30 7 C 5.5717 4.0011 0.0 0
M  V30 8 C 7.1117 1.3338 0.0 0
M  V30 9 C 7.1117 4.0011 0.0 0
M  V30 10 C 7.8817 2.6674 0.0 0
M  V30 11 C 2.4917 4.0011 0.0 0
M  V30 12 C 1.2459 3.0959 0.0 0
M  V30 13 C 2.0159 5.4658 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 6
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Fluorophenyl)(methylimino)methyl]cyclopentanol
C13H16FNO
111982-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2617 2.6674 0.0 0
M  V30 2 N 2.4917 1.3338 0.0 0
M  V30 3 C 0.9517 1.3338 0.0 0
M  V30 4 O 3.8987 4.6274 0.0 0
M  V30 5 F 4.8017 0.0000 0.0 0
M  V30 6 C 4.8017 2.6674 0.0 0
M  V30 7 C 5.5717 1.3338 0.0 0
M  V30 8 C 5.5717 4.0011 0.0 0
M  V30 9 C 7.1117 1.3338 0.0 0
M  V30 10 C 7.1117 4.0011 0.0 0
M  V30 11 C 7.8817 2.6674 0.0 0
M  V30 12 C 2.4917 4.0011 0.0 0
M  V30 13 C 1.2459 3.0959 0.0 0
M  V30 14 C 2.0159 5.4658 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 0.4759 5.4658 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 12
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616657-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 111982-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24336047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylcyclohexylamine derivatives and their use in the
treatment of psychiatric disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kruegel, Andrew Carry; Sames, Dalibor; Hashimoto, Kenji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021134086 A1 2021-07-01

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(1R,3R)-4-methyl-3-[[(2S,3S)-3-methyl-2-[[[(2R)-1-methyl-2-piperidi...
C34H49N5O9S
1621880-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.5502 7.7394 0.0 0 CFG=2
M  V30 2 C 10.0101 7.7394 0.0 0
M  V30 3 O 12.3202 9.0730 0.0 0
M  V30 4 C 9.2401 9.0730 0.0 0 CFG=2
M  V30 5 C 13.8602 9.0730 0.0 0
M  V30 6 N 7.7001 9.0730 0.0 0
M  V30 7 C 10.0101 10.4069 0.0 0
M  V30 8 O 14.6302 10.4069 0.0 0
M  V30 9 O 14.6302 7.7394 0.0 0
M  V30 10 C 6.9301 10.4069 0.0 0
M  V30 11 C 6.9301 7.7394 0.0 0
M  V30 12 C 9.2401 11.7405 0.0 0
M  V30 13 C 11.5502 10.4069 0.0 0
M  V30 14 C 5.3901 10.4069 0.0 0 CFG=2
M  V30 15 O 7.7001 11.7405 0.0 0
M  V30 16 C 7.7001 6.4057 0.0 0
M  V30 17 N 4.6201 9.0730 0.0 0
M  V30 18 C 4.6201 11.7405 0.0 0 CFG=1
M  V30 19 C 6.9301 5.0719 0.0 0
M  V30 20 C 3.0800 9.0730 0.0 0
M  V30 21 C 5.3901 13.0742 0.0 0
M  V30 22 C 3.0800 11.7405 0.0 0
M  V30 23 O 2.3100 10.4069 0.0 0
M  V30 24 C 4.6201 14.4078 0.0 0
M  V30 25 C 12.6773 2.4368 0.0 0
M  V30 26 O 13.9232 1.5316 0.0 0
M  V30 27 O 11.2703 1.8103 0.0 0
M  V30 28 C 13.7623 0.0000 0.0 0
M  V30 29 N 20.7903 10.4069 0.0 0 VAL=5
M  V30 30 O 21.5603 9.0730 0.0 0
M  V30 31 O 21.5603 11.7405 0.0 0
M  V30 32 C 0.0000 9.0730 0.0 0
M  V30 33 C 12.3202 6.4057 0.0 0
M  V30 34 N 11.6938 4.9988 0.0 0
M  V30 35 S 13.8517 6.2446 0.0 0
M  V30 36 C 12.8382 3.9683 0.0 0
M  V30 37 C 14.1719 4.7383 0.0 0
M  V30 38 C 16.1702 10.4069 0.0 0
M  V30 39 C 16.9402 11.7405 0.0 0
M  V30 40 C 16.9402 9.0730 0.0 0
M  V30 41 C 18.4803 11.7405 0.0 0
M  V30 42 C 18.4803 9.0730 0.0 0
M  V30 43 C 19.2503 10.4069 0.0 0
M  V30 44 C 2.3100 7.7394 0.0 0 CFG=1
M  V30 45 N 0.7700 7.7394 0.0 0
M  V30 46 C 3.0800 6.4057 0.0 0
M  V30 47 C 0.0000 6.4057 0.0 0
M  V30 48 C 2.3100 5.0721 0.0 0
M  V30 49 C 0.7700 5.0721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 33
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 8 38
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 14 17 CFG=1
M  V30 19 1 14 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22 CFG=1
M  V30 24 2 20 23
M  V30 25 1 44 20 CFG=1
M  V30 26 1 21 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 25 36
M  V30 30 1 26 28
M  V30 31 2 29 30
M  V30 32 2 29 31
M  V30 33 1 29 43
M  V30 34 1 32 45
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 46 1 44 45
M  V30 47 1 44 46
M  V30 48 1 45 47
M  V30 49 1 46 48
M  V30 50 1 47 49
M  V30 51 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 4 14 18 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(1R,3R)-4-methyl-1-[[(methylamino)carbonyl]oxy]-3-[[(2S,3S)-3-methy...
C29H49N5O6S
1621880-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=2
M  V30 2 C 8.4700 6.6685 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 6.9300 6.6685 0.0 0 CFG=2
M  V30 5 C 9.2400 2.6674 0.0 0
M  V30 6 N 6.1600 8.0021 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 N 8.4700 1.3338 0.0 0
M  V30 9 O 10.7800 2.6674 0.0 0
M  V30 10 C 4.6200 8.0021 0.0 0
M  V30 11 C 6.9300 9.3358 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 9.2400 0.0000 0.0 0
M  V30 15 C 3.8500 9.3358 0.0 0 CFG=2
M  V30 16 O 3.8500 6.6685 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 N 4.6200 10.6694 0.0 0
M  V30 19 C 2.3100 9.3358 0.0 0 CFG=1
M  V30 20 C 9.2400 10.6694 0.0 0
M  V30 21 C 3.8500 12.0032 0.0 0
M  V30 22 C 1.5400 8.0021 0.0 0
M  V30 23 C 1.5400 10.6694 0.0 0
M  V30 24 O 2.3100 12.0032 0.0 0
M  V30 25 C 0.0000 8.0021 0.0 0
M  V30 26 C 14.3956 7.0099 0.0 0
M  V30 27 O 15.8026 6.3836 0.0 0
M  V30 28 O 14.2347 8.5416 0.0 0
M  V30 29 C 17.0484 7.2888 0.0 0
M  V30 30 C 2.3100 14.6705 0.0 0
M  V30 31 C 10.7800 5.3347 0.0 0
M  V30 32 N 11.6852 6.5807 0.0 0
M  V30 33 S 11.6852 4.0889 0.0 0
M  V30 34 C 13.1498 6.1047 0.0 0
M  V30 35 C 13.1498 4.5647 0.0 0
M  V30 36 C 4.6200 13.3369 0.0 0 CFG=1
M  V30 37 N 3.8500 14.6705 0.0 0
M  V30 38 C 6.1600 13.3369 0.0 0
M  V30 39 C 4.6200 16.0043 0.0 0
M  V30 40 C 6.9300 14.6705 0.0 0
M  V30 41 C 6.1600 16.0043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 31
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=3
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 1 15 18 CFG=3
M  V30 19 1 15 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23 CFG=3
M  V30 24 2 21 24
M  V30 25 1 36 21 CFG=3
M  V30 26 1 22 25
M  V30 27 1 26 27
M  V30 28 2 26 28
M  V30 29 1 26 34
M  V30 30 1 27 29
M  V30 31 1 30 37
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 4 15 19 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1621880-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1621880-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13816339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of antimitotic compounds structurally related to tubulysins
and their conjugates for targeted delivery and their use for treating
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cong, Qiang; Cheng, Heng; Gangwar, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20140227295 A1 2014-08-14

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4bR,7R,8aS)-4b,5,6,7,8,8a,9,10-Octahydro-7-hydroxy-3-methoxy-4b,8,8-trim...
C19H26O4
1638501-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 2.3100 1.3338 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 C 8.9727 6.8515 0.0 0
M  V30 5 C 10.6871 5.8615 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 O 0.0000 2.6674 0.0 0
M  V30 9 O 11.5500 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 6.9300 6.6685 0.0 0
M  V30 21 C 9.2400 2.6674 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 10.0100 4.0011 0.0 0 CFG=1
M  V30 24 H 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 22
M  V30 9 1 23 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 14 24 CFG=3
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 17 20
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 11 14 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4bR,7R,8aS)-4b,5,6,7,8,8a,9,10-Octahydro-7-hydroxy-3-methoxy-N,4b,8,8-te...
C20H29NO3
1709781-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 O 9.2400 1.3338 0.0 0
M  V30 3 C 8.4700 0.0000 0.0 0
M  V30 4 C 2.5773 6.8515 0.0 0
M  V30 5 C 0.8629 5.8615 0.0 0
M  V30 6 C 10.7800 4.0011 0.0 0
M  V30 7 N 11.5500 5.3347 0.0 0
M  V30 8 O 11.5500 2.6674 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 O 0.0000 4.0011 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 6.1600 6.6685 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 4.6200 6.6685 0.0 0
M  V30 22 C 2.3100 2.6674 0.0 0
M  V30 23 C 9.2400 4.0011 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0 CFG=1
M  V30 25 H 3.0800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 4 20
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 23
M  V30 9 1 7 9
M  V30 10 1 24 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 15 21
M  V30 21 1 15 25 CFG=1
M  V30 22 1 16 22
M  V30 23 1 17 23
M  V30 24 1 18 21
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 15 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1638501-11-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1709781-52-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12414612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of tricyclic diterpene
derivatives as novel neuroprotective agents against ischemic brain injury
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ying-Ying; Gao, Yuan-Xue; Gao, Wei; Xu, Yuan; Xu, Ya-Zhou; Wang,
Yun-Jie; Chang, Sai; Yu, Li-Gang; Zhang, Lu-Yong; Liao, Hong; Yang,
Lian-Fang; Pang, Tao; Qiu, Wen-Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2015), 103396-408

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
164353-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-3-methanamine
C12H16N2
335032-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164353-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7052175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole c)
1,7-Dimethyl-3-(methylaminomethyl)-1H-indole [0748] According to the
procedure of Preparation 13 (c), except substituting
1,7-dimethyl-1H-indole-3-carboxylate for the
1,3-dimethyl-1H-indole-2-carboxylate, the title compound (0.74 g, 98%)
was obtained as an amber oil. MS (ES) m/e 189.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
164353-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-3-methanamine
C12H16N2
335032-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164353-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14157585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
164353-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-3-methanamine
C12H16N2
335032-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164353-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7881309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
164353-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 C 1.9572 5.7308 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 5.1457 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-3-methanamine
C12H16N2
335032-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 C 1.9571 5.7308 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.1456 3.3405 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 4.5192 4.7473 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164353-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1091680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole. To
1,3-dimethyl-1H-indole-2-carboxaldehyde (13.0 g, 75 mmole) was added a
solution of 2.0 M methylamine in methanol (150 mL, 300 mmole) and HOAc
(4.3 mL, 75 mmole). The solution was stirred at RT for 4 hr, then was
cooled to 0 °C, and sodium cyanoborohydride (5.0 g, 80 mmole) was added
portionwise over 5 min. The reaction was then allowed to warm to RT.
After 16 hr, the reaction was concentrated under vacuum and the residue
was taken up in Et2O. The solution was washed with 1.0 N NaOH then with
brine, dried (Na2SO4), and concentrated to dryness. Flash chromatography
on silica gel (95:5 CHCl3/methanol containing 5% NH4OH) gave the title
compound.. 1,7-Dimethyl-3-(methylaminomethyl)-1H-indole. According to the
procedure of Preparation 40 (c), except substituting
1,7-dimethyl-1H-indole-3-carboxaldehyde for
1,3-dimethyl-1H-indole-1-carboxaldehyde, the title compound (98%) was
prepared as a white, crystalline solid. MS (ES) m/e 189.2 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-2-[(1-methyl-1H-indol-3-yl)methyl]-9-[(4-methylphenyl)sulfonyl]-4-ox...
C26H31N3O4S
1646908-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3683 3.7571 0.0 0
M  V30 2 C 4.3784 2.0427 0.0 0
M  V30 3 O 4.5613 0.0000 0.0 0
M  V30 4 S 12.5635 4.6200 0.0 0 VAL=6
M  V30 5 O 13.3335 3.2864 0.0 0
M  V30 6 O 11.7935 5.9538 0.0 0
M  V30 7 C 0.0000 3.0027 0.0 0
M  V30 8 C 17.8982 7.7000 0.0 0
M  V30 9 C 8.5624 2.3100 0.0 0
M  V30 10 N 7.2288 3.0800 0.0 0
M  V30 11 C 9.8960 1.5400 0.0 0
M  V30 12 C 8.5624 3.8500 0.0 0
M  V30 13 C 8.5624 0.7700 0.0 0
M  V30 14 C 5.8950 2.3100 0.0 0
M  V30 15 C 11.2297 2.3100 0.0 0
M  V30 16 C 9.8960 4.6200 0.0 0
M  V30 17 O 7.2288 0.0000 0.0 0
M  V30 18 C 5.8950 0.7700 0.0 0
M  V30 19 N 11.2297 3.8500 0.0 0
M  V30 20 C 3.8517 4.0246 0.0 0
M  V30 21 C 3.1766 5.4088 0.0 0
M  V30 22 C 2.7440 2.9548 0.0 0
M  V30 23 C 1.6517 5.1944 0.0 0
M  V30 24 C 3.7534 6.8367 0.0 0
M  V30 25 N 1.3842 3.6778 0.0 0
M  V30 26 C 0.7035 6.4079 0.0 0
M  V30 27 C 2.8054 8.0502 0.0 0
M  V30 28 C 1.2804 7.8358 0.0 0
M  V30 29 C 13.8971 5.3900 0.0 0
M  V30 30 C 15.2308 4.6200 0.0 0
M  V30 31 C 13.8971 6.9300 0.0 0
M  V30 32 C 16.5644 5.3900 0.0 0
M  V30 33 C 15.2308 7.7000 0.0 0
M  V30 34 C 16.5644 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 14
M  V30 4 2 3 18
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 1 4 29
M  V30 9 1 7 25
M  V30 10 1 8 34
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 1 17 18
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 23 25
M  V30 29 2 23 26
M  V30 30 1 24 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[4-(Hydroxymethyl)-1-[(4-methylphenyl)sulfonyl]-4-piperidinyl]amino]-N,α,1...
C27H36N4O4S
1646908-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5760 3.7558 0.0 0
M  V30 2 C 7.0928 4.0231 0.0 0
M  V30 3 N 6.8253 5.5397 0.0 0
M  V30 4 C 7.3601 2.5065 0.0 0
M  V30 5 C 8.6094 4.2906 0.0 0
M  V30 6 N 6.1805 1.5166 0.0 0
M  V30 7 O 8.8073 1.9798 0.0 0
M  V30 8 C 6.4478 0.0000 0.0 0
M  V30 9 C 3.5454 8.7820 0.0 0
M  V30 10 C 6.8253 7.5195 0.0 0
M  V30 11 O 7.0926 9.0361 0.0 0
M  V30 12 S 12.6249 6.5296 0.0 0 VAL=6
M  V30 13 O 12.6249 4.9896 0.0 0
M  V30 14 O 12.6249 8.0696 0.0 0
M  V30 15 C 18.7849 6.5296 0.0 0
M  V30 16 C 3.0500 4.8279 0.0 0
M  V30 17 C 4.5863 4.9354 0.0 0
M  V30 18 C 2.4731 6.2558 0.0 0
M  V30 19 C 2.1018 3.6144 0.0 0
M  V30 20 C 4.9588 6.4297 0.0 0
M  V30 21 N 3.6527 7.2457 0.0 0
M  V30 22 C 0.9480 6.4702 0.0 0
M  V30 23 C 0.5769 3.8287 0.0 0
M  V30 24 C 0.0000 5.2566 0.0 0
M  V30 25 C 8.0049 6.5296 0.0 0
M  V30 26 C 8.7749 5.1960 0.0 0
M  V30 27 C 8.7749 7.8632 0.0 0
M  V30 28 C 10.3149 5.1960 0.0 0
M  V30 29 C 10.3149 7.8632 0.0 0
M  V30 30 N 11.0849 6.5296 0.0 0
M  V30 31 C 14.1649 6.5296 0.0 0
M  V30 32 C 14.9349 7.8632 0.0 0
M  V30 33 C 14.9349 5.1960 0.0 0
M  V30 34 C 16.4749 7.8632 0.0 0
M  V30 35 C 16.4749 5.1960 0.0 0
M  V30 36 C 17.2449 6.5296 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 25
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 30
M  V30 16 1 12 31
M  V30 17 1 15 36
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1646908-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1646908-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12861850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-catalysed C-H activation of aliphatic amines to give strained
nitrogen heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McNally, Andrew; Haffemayer, Benjamin; Collins, Beatrice S. L.; Gaunt,
Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature (London, United Kingdom) (2014), 510(7503), 129-133

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(2-Azidoethoxy)ethoxy]ethanamine
C6H14N4O2
166388-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 O 6.6685 0.7700 0.0 0
M  V30 3 C 9.3358 0.7700 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 O 10.6697 1.5400 0.0 0
M  V30 6 C 4.0010 0.7700 0.0 0
M  V30 7 C 12.0033 0.7700 0.0 0
M  V30 8 N 2.6673 1.5400 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 11 N 14.6707 0.7700 0.0 0
M  V30 12 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(2-Azidoethoxy)ethoxy]-N-methylethanamine
C7H16N4O2
1072920-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 1.5400 0.0 0
M  V30 2 C 9.3360 0.7700 0.0 0
M  V30 3 O 6.6687 0.7700 0.0 0
M  V30 4 O 10.6698 1.5400 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 12.0035 0.7700 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 13.3372 1.5400 0.0 0
M  V30 9 N 2.6675 1.5400 0.0 0
M  V30 10 N 14.6708 0.7700 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0 CHG=1 VAL=4
M  V30 12 C 16.0046 1.5400 0.0 0
M  V30 13 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 166388-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072920-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41617105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Insertion of Chemical Handles into the Backbone of DNA during Solid-Phase
Synthesis by Oxidative Coupling of Amines to Phosphites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hansen, Rikke A.; Marcher, Anders; Pedersen, Kristian Noergaard; Gothelf,
Kurt V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(26), e202305373

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dihydro-4(5H)-benzofuranone
C8H8O2
16806-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 C 1.1444 0.7700 0.0 0
M  V30 7 O 0.0000 3.3405 0.0 0
M  V30 8 C 3.8119 0.7700 0.0 0
M  V30 9 C 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7-Tetrahydro-1-methyl-4H-indol-4-one
C9H11NO
51471-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 C 6.6520 3.0203 0.0 0
M  V30 3 C 2.6675 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 2.9877 4.5864 0.0 0
M  V30 7 N 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16806-93-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51471-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39516553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivity and Stability of (Hetero)Benzylic Alkenes via the Wittig
Olefination Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khan, Ajmir; Sarwar, Mohammed G.; Ali, Sher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2024), 29(2), 501

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl thiooxamate
C4H7NO2S
16982-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 S 1.3338 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(methylamino)-2-thioxoacetamide
C4H8N2OS
38762-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 1.3338 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 N 5.3347 2.3100 0.0 0
M  V30 6 S 4.0011 0.0000 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16982-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38762-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-2134325
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-2-methylamino-2-thioxoacetamide (21). To a mixture cooled in ice
of 4.95 g (37.2 mmol) of ethyl thiooxamate in 5 mL of dry tetrahydrofuran
was added over a 1-2 min period 41 mL (82 mmol) of a 2.0 M solution of
methylamine in tetrahydrofuran. The contents were then heated at 40 °C
for 1 h and then stirred at room temperature for 2 h. The solution was
concentrated to dryness to afford 4.8 g (98%) of 21 as a solid.
Recrystallization of 167 mg of 21 from methanol afforded 100 mg
N-Methyl-2-methylamino-2-thioxoacetamide (21), Yield 4.8 g (98%) mp
129-131 °C [lit. 122-4 °C (22)]; 1H NMR δ 9.61 (br s, 1H), 8.21 (br s,
1H), 3.25 (d, 3H, J = 5.2 Hz), 2.94 (d, 3H, J = 4.8 Hz); IR (KBr) cm-1
3303, 3247, 1678; MS (EI-DIP), m/z 133 ([M + H]+,1), 65 (100). Anal.
Calcd for C4H8N2OS: C, 36.34; H, 6.10; N, 21.20. Found: C, 36.53; H,
6.13; N, 21.03.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydropiperazine Neonicotinoid Compounds. Synthesis and Insecticidal
Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Samaritoni, Jack G.; Demeter, David A.; Gifford, James M.; Watson, Gerald
B.; Kempe, Margaret S.; Bruce, Timothy J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2003), 51(10), 3035-3042

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7559278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple process for preparation of tadalafil
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Killol; Deo, Keshav; Prasad, Mohan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2005DE02969 A 2009-07-31

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14596784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple process for preparation of tadalafil
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anonymous
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM IP.com Journal (2007), 7(2A), 6

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-1-naphthaldehyde
C11H7FO
172033-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3349 0.0 0
M  V30 3 F 0.0000 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-1-naphthalenemethanamine
C12H12FN
101846-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 F 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172033-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101846-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1350218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine b)
(4-Fluoro-naphthalen-1-ylmethyl)methylamine [0813] According to the
procedure of Preparation 67, except substituting
4-fluoro-naphthalene-1-carbaldehyde for the
1-propyl-naphthalene-2-carbaldehyde, the title compound (3.18 g, 98%) was
prepared as a golden oil. MS (ESI) m/e 190 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-1-naphthaldehyde
C11H7FO
172033-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3349 0.0 0
M  V30 3 F 0.0000 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-1-naphthalenemethanamine
C12H12FN
101846-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 F 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172033-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101846-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-193404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-1-naphthaldehyde
C11H7FO
172033-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 5.3349 0.0 0
M  V30 3 F 0.0000 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-1-naphthalenemethanamine
C12H12FN
101846-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 F 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172033-73-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 101846-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3905157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. b) (4-Fluoro-naphthalen-1-ylmethyl)methylamine
According to the procedure of Preparation 1, except substituting
4-fluoronaphthalene-1-carbaldehyde for the
1-propyl-naphthalene-2-carbaldehyde, the title compound (3.18 g, 98%) was
prepared as a golden oil. MS (ESI) m/e 190 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
1-(2-Iodophenyl)-3-isoquinolinecarboxylic acid
C16H10INO2
175235-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.0012 7.7002 0.0 0
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 O 8.0023 6.9302 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 4.0012 4.6201 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 N 5.3348 5.3901 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 2.6675 6.9302 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 7.7002 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 11
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Iodophenyl)-N-methyl-3-isoquinolinecarboxamide
C17H13IN2O
215922-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.0011 7.7000 0.0 0
M  V30 2 C 8.0021 5.3900 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 O 8.0021 6.9300 0.0 0
M  V30 5 C 10.6694 5.3900 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 N 5.3347 5.3900 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 4.0011 0.0000 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 12
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 175235-99-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 215922-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2118055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, fluorine-18 radiolabeling, and in vitro characterization of
1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinolinecarboxamide derivatives
as potential PET radioligands for imaging peripheral benzodiazepine
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Weiping; Wang, Eric; Voll, Ronald J.; Miller, Andrew H.; Goodman,
Mark M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(11), 6145-6155

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C6H3Cl2NO2
1777794-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0 MASS=13
M  V30 7 C 3.0801 1.3337 0.0 0 MASS=13
M  V30 8 C 3.0801 4.0010 0.0 0 MASS=13
M  V30 9 C 4.6201 1.3337 0.0 0 MASS=13
M  V30 10 C 4.6201 4.0010 0.0 0 MASS=13
M  V30 11 C 5.3901 2.6673 0.0 0 MASS=13
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C7H7ClN2O2
1777794-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0 MASS=13
M  V30 8 C 2.3100 4.0011 0.0 0 MASS=13
M  V30 9 C 4.6200 2.6674 0.0 0 MASS=13
M  V30 10 C 3.0800 5.3349 0.0 0 MASS=13
M  V30 11 C 5.3900 4.0011 0.0 0 MASS=13
M  V30 12 C 4.6200 5.3349 0.0 0 MASS=13
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1777794-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1777794-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6761748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor,
and its major metabolites labeled with carbon-13 and carbon-14
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Latli, Bachir; Hrapchak, Matt; Chevliakov, Maxim; Li, Guisheng; Campbell,
Scot; Busacca, Carl A.; Senanayake, Chris H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Labelled Compounds and Radiopharmaceuticals (2015), 58(6),
250-260

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-iodo-5-benzoxazolecarboxylate
C9H6INO3
1803887-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9109 1.5400 0.0 0
M  V30 2 O 9.2447 2.3100 0.0 0
M  V30 3 O 7.9109 0.0000 0.0 0
M  V30 4 C 10.5783 1.5400 0.0 0
M  V30 5 I 0.0000 3.0800 0.0 0
M  V30 6 C 3.9099 2.3100 0.0 0
M  V30 7 C 3.9099 3.8500 0.0 0
M  V30 8 C 5.2436 1.5400 0.0 0
M  V30 9 N 2.4452 1.8341 0.0 0
M  V30 10 O 2.4452 4.3259 0.0 0
M  V30 11 C 5.2436 4.6200 0.0 0
M  V30 12 C 6.5772 2.3100 0.0 0
M  V30 13 C 1.5400 3.0800 0.0 0
M  V30 14 C 6.5772 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(methylamino)-5-benzoxazolecarboxylate
C10H10N2O3
2091202-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6809 1.5400 0.0 0
M  V30 2 O 10.0147 2.3100 0.0 0
M  V30 3 O 8.6809 0.0000 0.0 0
M  V30 4 C 11.3483 1.5400 0.0 0
M  V30 5 N 0.7700 3.0800 0.0 0
M  V30 6 C 0.0000 4.4137 0.0 0
M  V30 7 C 4.6799 2.3100 0.0 0
M  V30 8 C 4.6799 3.8500 0.0 0
M  V30 9 C 6.0136 1.5400 0.0 0
M  V30 10 N 3.2152 1.8341 0.0 0
M  V30 11 O 3.2152 4.3259 0.0 0
M  V30 12 C 6.0136 4.6200 0.0 0
M  V30 13 C 7.3472 2.3100 0.0 0
M  V30 14 C 2.3100 3.0800 0.0 0
M  V30 15 C 7.3472 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1803887-57-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2091202-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41578152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of benzimidazole derivatives for pharmaceutical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clark, Ryan; Gallovic, Matthew; Junkins, Robert David; Duraiswamy,
Athisayamani Jeyaraj; Hallur, Mahanandeesha S.; Babu, Polina Sai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024130173 A1 2024-06-20

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(2R,5S,7S)-7-Methoxy-2-methyl-5-[(2S)-3-methyl-1-oxo-2-[1-oxo-4-(phenylmethox...
C30H48O8
1808266-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 6.6685 0.0 0 CFG=1
M  V30 2 O 9.2402 6.6685 0.0 0
M  V30 3 C 6.9302 8.0022 0.0 0
M  V30 4 C 6.9302 5.3348 0.0 0
M  V30 5 C 10.0102 8.0022 0.0 0
M  V30 6 C 5.3901 8.0022 0.0 0 CFG=1
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 11.5503 8.0022 0.0 0 CFG=2
M  V30 9 O 9.2402 9.3358 0.0 0
M  V30 10 C 4.6201 9.3358 0.0 0
M  V30 11 O 4.6201 6.6685 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0 CFG=1
M  V30 13 O 12.3203 9.3358 0.0 0
M  V30 14 C 12.3203 6.6685 0.0 0
M  V30 15 C 3.0801 9.3358 0.0 0
M  V30 16 C 3.0801 6.6685 0.0 0
M  V30 17 C 7.7002 1.3337 0.0 0
M  V30 18 C 5.3901 2.6673 0.0 0
M  V30 19 C 13.8603 9.3358 0.0 0
M  V30 20 C 11.5503 5.3348 0.0 0
M  V30 21 C 13.8603 6.6685 0.0 0
M  V30 22 C 2.3101 10.6697 0.0 0
M  V30 23 O 6.9302 0.0000 0.0 0
M  V30 24 O 9.2402 1.3337 0.0 0
M  V30 25 C 14.6303 10.6697 0.0 0
M  V30 26 O 14.6303 8.0022 0.0 0
M  V30 27 C 0.7700 10.6697 0.0 0
M  V30 28 C 16.1704 10.6697 0.0 0
M  V30 29 C 0.0000 12.0033 0.0 0
M  V30 30 C 16.9404 12.0033 0.0 0
M  V30 31 O 18.4804 12.0033 0.0 0
M  V30 32 C 19.2504 13.3370 0.0 0
M  V30 33 C 20.7905 13.3370 0.0 0
M  V30 34 C 21.5605 12.0033 0.0 0
M  V30 35 C 21.5605 14.6707 0.0 0
M  V30 36 C 23.1005 12.0033 0.0 0
M  V30 37 C 23.1005 14.6707 0.0 0
M  V30 38 C 23.8705 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11 CFG=1
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14 CFG=1
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18 CFG=3
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 17 23
M  V30 23 2 17 24
M  V30 24 1 19 25
M  V30 25 2 19 26
M  V30 26 1 22 27
M  V30 27 1 25 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 30 31
M  V30 31 1 31 32
M  V30 32 1 32 33
M  V30 33 2 33 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 2 35 37
M  V30 37 2 36 38
M  V30 38 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 6 8 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanoic acid, 3-methyl-2-[1-oxo-4-(phenylmethoxy)butoxy]-, (1S,3S)-3-methoxy...
C31H51NO7
1808266-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 8.0020 0.0 0 CFG=1
M  V30 2 O 9.2400 8.0020 0.0 0
M  V30 3 C 6.9300 9.3356 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0
M  V30 5 C 10.0100 9.3356 0.0 0
M  V30 6 C 5.3900 9.3356 0.0 0 CFG=1
M  V30 7 C 7.7000 5.3347 0.0 0
M  V30 8 C 11.5500 9.3356 0.0 0 CFG=2
M  V30 9 O 9.2400 10.6694 0.0 0
M  V30 10 C 4.6200 10.6694 0.0 0
M  V30 11 O 4.6200 8.0020 0.0 0
M  V30 12 C 6.9300 4.0009 0.0 0 CFG=1
M  V30 13 O 12.3200 10.6694 0.0 0
M  V30 14 C 12.3200 8.0020 0.0 0
M  V30 15 C 3.0800 10.6694 0.0 0
M  V30 16 C 3.0800 8.0020 0.0 0
M  V30 17 C 7.7000 2.6673 0.0 0
M  V30 18 C 5.3900 4.0009 0.0 0
M  V30 19 C 13.8600 10.6694 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 13.8600 8.0020 0.0 0
M  V30 22 C 2.3100 12.0031 0.0 0
M  V30 23 N 6.9300 1.3336 0.0 0
M  V30 24 O 9.2400 2.6673 0.0 0
M  V30 25 C 14.6300 12.0031 0.0 0
M  V30 26 O 14.6300 9.3356 0.0 0
M  V30 27 C 0.7700 12.0031 0.0 0
M  V30 28 C 7.7000 0.0000 0.0 0
M  V30 29 C 16.1700 12.0031 0.0 0
M  V30 30 C 0.0000 13.3367 0.0 0
M  V30 31 C 16.9400 13.3367 0.0 0
M  V30 32 O 18.4800 13.3367 0.0 0
M  V30 33 C 19.2500 14.6703 0.0 0
M  V30 34 C 20.7900 14.6703 0.0 0
M  V30 35 C 21.5600 13.3367 0.0 0
M  V30 36 C 21.5600 16.0040 0.0 0
M  V30 37 C 23.1000 13.3367 0.0 0
M  V30 38 C 23.1000 16.0040 0.0 0
M  V30 39 C 23.8700 14.6703 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11 CFG=1
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14 CFG=1
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18 CFG=3
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 15 22
M  V30 22 1 17 23
M  V30 23 2 17 24
M  V30 24 1 19 25
M  V30 25 2 19 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 1 25 29
M  V30 29 1 27 30
M  V30 30 1 29 31
M  V30 31 1 31 32
M  V30 32 1 32 33
M  V30 33 1 33 34
M  V30 34 2 34 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 2 36 38
M  V30 38 2 37 39
M  V30 39 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 6 8 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1808266-74-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1808266-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7444329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of amine/H2O (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective Total Synthesis of the Marine Macrolide Sanctolide A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yadav, Jhillu Singh; Suresh, Borra; Srihari, Pabbaraja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(26), 5856-5863

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[4-Chloro-5-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]...
C30H23ClN2O5
1818317-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 O 11.5500 6.6684 0.0 0
M  V30 4 Cl 10.0100 4.0011 0.0 0
M  V30 5 O 16.1700 4.0011 0.0 0
M  V30 6 C 16.9400 5.3347 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 O 13.8600 0.0000 0.0 0
M  V30 9 C 21.5600 8.0020 0.0 0
M  V30 10 N 22.3300 9.3358 0.0 0
M  V30 11 C 5.3900 9.3358 0.0 0
M  V30 12 C 4.6200 10.6694 0.0 0
M  V30 13 C 4.6200 8.0020 0.0 0
M  V30 14 C 3.0800 10.6694 0.0 0
M  V30 15 C 3.0800 8.0020 0.0 0
M  V30 16 C 2.3100 9.3358 0.0 0
M  V30 17 O 2.3100 12.0031 0.0 0
M  V30 18 O 0.7700 9.3358 0.0 0
M  V30 19 C 0.7700 12.0031 0.0 0
M  V30 20 C 0.0000 10.6694 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 7.7000 8.0020 0.0 0
M  V30 23 C 7.7000 10.6694 0.0 0
M  V30 24 C 9.2400 8.0020 0.0 0
M  V30 25 C 9.2400 10.6694 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 27 C 12.3200 5.3347 0.0 0
M  V30 28 C 13.8600 5.3347 0.0 0
M  V30 29 C 11.5500 4.0011 0.0 0
M  V30 30 C 14.6300 4.0011 0.0 0
M  V30 31 C 12.3200 2.6673 0.0 0
M  V30 32 C 13.8600 2.6673 0.0 0
M  V30 33 C 18.4800 5.3347 0.0 0
M  V30 34 C 19.2500 6.6684 0.0 0
M  V30 35 C 19.2500 4.0011 0.0 0
M  V30 36 C 20.7900 6.6684 0.0 0
M  V30 37 N 20.7900 4.0011 0.0 0
M  V30 38 C 21.5600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 1 3 27
M  V30 5 1 4 29
M  V30 6 1 5 6
M  V30 7 1 5 30
M  V30 8 1 6 33
M  V30 9 2 7 8
M  V30 10 1 7 32
M  V30 11 3 9 10
M  V30 12 1 9 36
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 21
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 15 16
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[4-Chloro-5-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]...
C31H28ClN3O4
2566711-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 8.0022 0.0 0
M  V30 2 C 10.0102 8.0022 0.0 0
M  V30 3 O 11.5503 8.0022 0.0 0
M  V30 4 Cl 10.0102 5.3348 0.0 0
M  V30 5 O 16.1704 5.3348 0.0 0
M  V30 6 C 16.9404 6.6685 0.0 0
M  V30 7 C 14.6303 2.6673 0.0 0
M  V30 8 N 13.8603 1.3337 0.0 0
M  V30 9 C 14.6303 0.0000 0.0 0
M  V30 10 C 21.5605 9.3358 0.0 0
M  V30 11 N 22.3305 10.6697 0.0 0
M  V30 12 C 5.3901 10.6697 0.0 0
M  V30 13 C 4.6201 12.0033 0.0 0
M  V30 14 C 4.6201 9.3360 0.0 0
M  V30 15 C 3.0801 12.0033 0.0 0
M  V30 16 C 3.0801 9.3360 0.0 0
M  V30 17 C 2.3101 10.6697 0.0 0
M  V30 18 O 2.3101 13.3370 0.0 0
M  V30 19 O 0.7700 10.6697 0.0 0
M  V30 20 C 0.7700 13.3370 0.0 0
M  V30 21 C 0.0000 12.0033 0.0 0
M  V30 22 C 6.9302 10.6697 0.0 0
M  V30 23 C 7.7002 9.3360 0.0 0
M  V30 24 C 7.7002 12.0033 0.0 0
M  V30 25 C 9.2402 9.3360 0.0 0
M  V30 26 C 9.2402 12.0033 0.0 0
M  V30 27 C 10.0102 10.6697 0.0 0
M  V30 28 C 12.3203 6.6685 0.0 0
M  V30 29 C 13.8603 6.6685 0.0 0
M  V30 30 C 11.5503 5.3348 0.0 0
M  V30 31 C 14.6303 5.3348 0.0 0
M  V30 32 C 12.3203 4.0010 0.0 0
M  V30 33 C 13.8603 4.0010 0.0 0
M  V30 34 C 18.4804 6.6685 0.0 0
M  V30 35 C 19.2504 8.0022 0.0 0
M  V30 36 C 19.2504 5.3348 0.0 0
M  V30 37 C 20.7905 8.0022 0.0 0
M  V30 38 N 20.7905 5.3348 0.0 0
M  V30 39 C 21.5605 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 28
M  V30 5 1 4 30
M  V30 6 1 5 6
M  V30 7 1 5 31
M  V30 8 1 6 34
M  V30 9 1 7 8
M  V30 10 1 7 33
M  V30 11 1 8 9
M  V30 12 3 10 11
M  V30 13 1 10 37
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 22
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 2 16 17
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818317-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2566711-78-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25252593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel, potent and selective small-molecule inhibitor of
PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Chenglong; Zhou, Feilong; Yan, Ziqin; Shen, Lian; Zhang, Xichen; He,
Fenglian; Wang, Heng; Lu, Xiaojie; Yu, Ker; Zhao, Yujun; Zhu, Di
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM British Journal of Pharmacology (2021), 178(13), 2651-2670

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Chloro-3-ethyl-7-methyl-3H-pyrrolo[3,2-f]quinoline
C14H13ClN2
1818405-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6200 0.0000 0.0 0
M  V30 2 C 9.5808 4.7113 0.0 0
M  V30 3 C 11.0455 4.2355 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 6.1600 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 7.1906 1.5231 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 N 8.4364 3.6809 0.0 0
M  V30 12 C 6.1600 5.3349 0.0 0
M  V30 13 C 8.5974 2.1494 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 15 N 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 1.3338 0.0 0
M  V30 17 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 13
M  V30 17 2 12 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethyl-N,7-dimethyl-3H-pyrrolo[3,2-f]quinolin-9-amine
C15H17N3
1818405-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 9.5808 6.0451 0.0 0
M  V30 4 C 11.0455 5.5691 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 7.1906 2.8567 0.0 0
M  V30 12 N 2.3100 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 N 8.4364 5.0145 0.0 0
M  V30 16 C 6.1600 6.6685 0.0 0
M  V30 17 C 8.5974 3.4830 0.0 0
M  V30 18 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 2 13 16
M  V30 19 2 14 18
M  V30 20 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818405-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1818405-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8939340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Photophysical Properties of Pyrroloquinoline-Based
Compounds Showing Strong Blue Fluorescence as Potential Dyes for
Biomedical Applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carta, Davide; Balasso, Anna; Caliceti, Paolo; Ferlin, Maria Grazia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2015), 10(11), 1846-1862

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-chloro-4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dih...
C21H19ClN2O6
1850386-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 C 10.0100 6.6684 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 O 12.3200 8.0021 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 C 14.6300 9.3358 0.0 0
M  V30 9 Cl 4.6200 0.0000 0.0 0
M  V30 10 O 0.0000 10.6694 0.0 0
M  V30 11 N 7.7000 5.3347 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6673 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 O 9.2400 2.6673 0.0 0
M  V30 18 C 6.9300 1.3336 0.0 0
M  V30 19 C 4.6200 2.6673 0.0 0
M  V30 20 C 5.3900 1.3336 0.0 0
M  V30 21 C 5.3900 6.6684 0.0 0
M  V30 22 C 4.6200 8.0021 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 3.0800 8.0021 0.0 0
M  V30 25 C 3.0800 5.3347 0.0 0
M  V30 26 C 2.3100 6.6684 0.0 0
M  V30 27 N 2.3100 9.3358 0.0 0
M  V30 28 O 0.7700 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 20
M  V30 11 2 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 26
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-N...
C20H18ClN3O5
1850385-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 C 10.0100 6.6684 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 N 12.3200 8.0021 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 Cl 4.6200 0.0000 0.0 0
M  V30 9 O 0.0000 10.6694 0.0 0
M  V30 10 N 7.7000 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 7.7000 2.6673 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 O 9.2400 2.6673 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 4.6200 2.6673 0.0 0
M  V30 19 C 5.3900 1.3336 0.0 0
M  V30 20 C 5.3900 6.6684 0.0 0
M  V30 21 C 4.6200 8.0021 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 3.0800 5.3347 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 N 2.3100 9.3358 0.0 0
M  V30 27 O 0.7700 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 19
M  V30 10 2 9 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1850386-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1850385-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20407641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Mineralocorticoid Receptor Modulators with Low Impact
on Electrolyte Homeostasis but Maintained Organ Protection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Granberg, Kenneth L.; Yuan, Zhong-Qing; Lindmark, Bo; Edman, Karl;
Kajanus, Johan; Hogner, Anders; Malmgren, Marcus; OMahony, Gavin;
Nordqvist, Anneli; Lindberg, Jan; Taangefjord, Stefan; Kossenjans,
Michael; Loefberg, Christian; Braanalt, Jonas; Liu, Dongmei; Selmi,
Nidhal; Nikitidis, Grigorios; Nordberg, Peter; Hayen, Ahlke; Aagaard,
Anna; Hansson, Eva; Hermansson, Majlis; Ivarsson, Ida; Jansson-Loefmark,
Rasmus; Karlsson, Ulla; Johansson, Ulrika; William-Olsson, Lena;
Hartleib-Geschwindner, Judith; Bamberg, Krister
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(3), 1385-1406

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-chloro-4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dih...
C21H19ClN2O6
1850386-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 C 10.0100 6.6684 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 O 12.3200 8.0021 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 C 14.6300 9.3358 0.0 0
M  V30 9 Cl 4.6200 0.0000 0.0 0
M  V30 10 O 0.0000 10.6694 0.0 0
M  V30 11 N 7.7000 5.3347 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6673 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 O 9.2400 2.6673 0.0 0
M  V30 18 C 6.9300 1.3336 0.0 0
M  V30 19 C 4.6200 2.6673 0.0 0
M  V30 20 C 5.3900 1.3336 0.0 0
M  V30 21 C 5.3900 6.6684 0.0 0
M  V30 22 C 4.6200 8.0021 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 3.0800 8.0021 0.0 0
M  V30 25 C 3.0800 5.3347 0.0 0
M  V30 26 C 2.3100 6.6684 0.0 0
M  V30 27 N 2.3100 9.3358 0.0 0
M  V30 28 O 0.7700 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 20
M  V30 11 2 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 26
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-N...
C20H18ClN3O5
1850385-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 C 10.0100 6.6684 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 N 12.3200 8.0021 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 Cl 4.6200 0.0000 0.0 0
M  V30 9 O 0.0000 10.6694 0.0 0
M  V30 10 N 7.7000 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 7.7000 2.6673 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 O 9.2400 2.6673 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 4.6200 2.6673 0.0 0
M  V30 19 C 5.3900 1.3336 0.0 0
M  V30 20 C 5.3900 6.6684 0.0 0
M  V30 21 C 4.6200 8.0021 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 3.0800 5.3347 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 N 2.3100 9.3358 0.0 0
M  V30 27 O 0.7700 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 19
M  V30 10 2 9 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1850386-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1850385-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15236785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoxazinone amides as mineralocorticoid receptor
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM O'Mahony, Gavin; Kossenjans, Michael; Edman, Karl; Kajanus, Johan;
Hogner, Karl Anders; Cornwall, Philip; Turner, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150376170 A1 2015-12-31

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzenepropanamine
C9H12ClN
18655-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 N 9.3360 2.3101 0.0 0
M  V30 5 Cl 0.0000 0.0000 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenepropanamine
C10H14ClN
90944-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 N 9.2401 4.0010 0.0 0
M  V30 5 C 10.7801 4.0010 0.0 0
M  V30 6 Cl 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18655-50-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90944-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-7625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the synthesis of phenylpropylamines. A stirred
solution of the appropriately substituted phenylpropionic acid in 20 mL
of DCM (ca. 0.5-1.0 M total cone.) was reacted with 1.2 equiv. of
1,1’-carbonyldiimidazole by addition of 500 mg portions over a 15 min
period, during which time significant evolution of CO was observed. The
resulting solution was stirred 90 min at RT, then cooled to 0 °C and
treated with 8 mL of a cold (0 °C) 40% aqueous solution of methylamine.
The resulting mixture was allowed to warm to RT and stirred vigorously
for 14 h. The reaction mixture was then acidified to pH =1 by careful
addition of cone. HCl, diluted with 70 mL of chloroform and extracted
with H2O (1 x 100 mL). The organic layer was separated, dried (MgSO4),
and concentrated in vacuo to afford a white solid. This material was
immediately dissolved in 80 mL of THF, and 1.2 equiv. (assuming 100%
conversion) of a 1.0 M solution of LiAlH4 in THF was added dropwise over
10 min. After the addition was complete, the resulting solution was
stirred 10 min at RT and then was heated to 60 °C for 6 h. The reaction
mixture was then cooled to 0 °C and the reaction was quenched by careful
addition of 0.76 mL of H2O, followed by 0.76 mL of 15% NaOH and then 2.7
mL of H2O. The resulting slurry was stirred vigorously for 10 min. and
then filtered through a pad of Celite to remove the salts. The salts were
isolated, triturated with EtOAc, and refiltered through a pad of Celite.
The filtrates were combined, dried (MgSO4), and concentrated in vacuo.
The material was used without further purification unless otherwise
noted. N-[3-(4-chlorophenyl)propyl]-N-methylamine. Concentration in vacuo
afforded 98% of the title compound as a clear yellow oil, which was used
without further purification. 1H NMR (CDCl3, 400 MHz) δ 7.27 (d, 2 H, J =
8.4), 7.14 (d, 2 H, J= 8.4), 2.53 (m, 4 H), 2.45 (s, 3 H), 1.81 (m, 2 H),
1.57 (s, br, 1 H); TLC (chloroform/MeOH 9:1) Rf = 0.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new series of estrogen receptor modulators that display selectivity for
estrogen receptor β
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henke, Brad R.; Consler, Thomas G.; Go, Ning; Hale, Ron L.; Hohman, Dana
R.; Jones, Stacey A.; Lu, Amy T.; Moore, Linda B.; Moore, John T.;
Orband-Miller, Lisa A.; Robinett, R. Graham; Shearin, Jean; Spearing,
Paul K.; Stewart, Eugene L.; Turnbull, Philip S.; Weaver, Susan L.;
Williams, Shawn P.; Wisely, G. Bruce; Lambert, Millard H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(25), 5492-5505

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-thiophenecarboxaldehyde
C5H3BrOS
18791-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 Br 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 C 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-thiophenemethanamine
C6H8BrNS
814255-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 Br 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 C 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18791-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 814255-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10979575
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 166 1-(4-bromothiophen-2-yl)-N-methylmethanamine To a
solution of 4-bromothiophene-2-carbaldehyde (5.1 g) in a mixed solvent of
tetrahydrofuran (30 mL) and methanol (30 mL) was added 40%
methylamine-methanol solution (27 mL) at 0&#x00B0; C., and the mixture
was stirred at room temperature for 16 hr, and concentrated under reduced
pressure. The residue was dissolved in methanol (50 mL), sodium
borohydride (6.9 g) was added at 0&#x00B0; C., and the mixture was
stirred at room temperature for 6 hr, and concentrated under reduced
pressure. Water was added to the residue, and the mixture was extracted
with ethyl acetate. The extract was washed successively with saturated
aqueous sodium hydrogen carbonate solution, water and saturated brine,
dried over anhydrous sodium sulfate, and concentrated under reduced
pressure to give the title compound as a yellow oil (5.4 g, yield 98%).
1H-NMR (CDCl3) &#x03B4; : 2.47 (3H, s), 3.90 (2H, s), 6.83-6.84 (1H, m),
7.10-7.11 (1H, m), 1H: not detected.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
(2E)-3-(2-Fluorophenyl)-2-propenoic acid
C9H7FO2
18944-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 F 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(2-Fluorophenyl)-N-methyl-2-propenamide
C10H10FNO
1639887-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 O 6.6684 4.6200 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 F 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18944-77-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639887-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5451758
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem superelectrophilic hydroarylation of C=C bond and carbonyl
reduction in cinnamides: synthetic route to 3,3-diarylpropylamines,
valuable pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zakusilo, Dmitry N.; Ryabukhin, Dmitry S.; Boyarskaya, Irina A.;
Yuzikhin, Oleg S.; Vasilyev, Aleksander V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(1), 102-108

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridyl ketone
C11H8N2O
19437-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 N 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Di-2-pyridinylmethylene)methanamine
C12H11N3
868592-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 N 4.0011 0.7700 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 N 1.3336 2.3100 0.0 0
M  V30 7 C 1.3336 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 0.0000 4.6200 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 N 6.6685 2.3100 0.0 0
M  V30 13 C 6.6685 5.3900 0.0 0
M  V30 14 C 8.0021 3.0800 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 2 3
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19437-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868592-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7700186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 2,2'-dipyridyl-N-metilimine (dpNmei). A solution of
2,2'-dipyridyl ketone (dpk) (0.100 g, 0.540 mmol) in 5 mL of dry methanol
was added to a solution of methylamine 2.0 M (1.0 mL, 0.062 g, 2.00
mmol). The mixture was refluxed for 24 h using a Dean-Stark trap. The
excess of solvent and methylamine were evaporated to dryness in vacuum to
give a moisture sensitivity yellow solid. Yield: (0.105 g) 98%. mp.:
67-68°C. Microanalysis: Found (Calc.): C, 72.93 (73.07); H, 5.81 (5.62);
N, 20.93 (21.30)%; 1H NMR: δ 8.52 (d, H-3, J= 4.40 Hz), 8.30 (d, H-8, J=
4.40 Hz), 7.85 (d, 1H, H-11, J= 8.10 Hz), 7.56 (td, H-5, J= 7.70, 1.83
Hz), 7.49 (td, H-10, J= 7.70, 1.46 Hz), 7.08 (m, 2H, H-6 and H-4), 7.00
(td, H-9, J= 6.0, 1.10 Hz), 3.14 (s, Me-12); 13C 1H NMR: δ 167.9 (C-1),
156.7 (C-7), 154.7 (C-2), 149.7 (C-3), 148.7 (C-8), 136.3 (C-10), 136.0
(C-5), 124.0 (C-9), 123.6 (C-4), 123.0 (C-6), 122.1 (C-11), 41.3 (Me-12).
IR data (CH2Cl2): (C═N) 1683 cm-1 ; MS: 197 m/z[M]+. Formula: C12H11N3,
Crystal size (mm) 0.55 × 0.50 × 0.45, Crystal system: Monoclinic, Space
group P21/n, a ( Å) 6.3887(6), b (Å) 10.1709(10), c (Å) 16.7594(17), α
90°, β 100.918(2)°, γ 90°, Z: 4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and crystal structures of
dipyridyl-N-methylimine and chloro-bis
(N,N'-2,2'-dipyridyl-N-methylimine)lithium complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flores-Chavez, Benito; Martinez-Ortega, Bernat Abeit; Alvarado-Rodriguez,
Jose Guadalupe; Andrade-Lopez, Noemi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Crystallography (2005), 35(6), 451-456

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]benzaldehyde
C14H10Cl2O2
1961201-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 O 13.3370 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 8.0022 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]-N-methylbenzenemethanamine
C15H15Cl2NO
1933393-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 N 13.3370 3.0801 0.0 0
M  V30 7 C 14.6707 2.3101 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 9.3358 5.3901 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 9
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1961201-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1933393-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35848932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and In Vitro Antimicrobial SAR of Benzyl and Phenyl Guanidine
and Aminoguanidine Hydrazone Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dohle, Wolfgang; Su, Xiangdong; Nigam, Yamni; Dudley, Edward; Potter,
Barry V. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2023), 28(1), 5

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]benzaldehyde
C14H10Cl2O2
1961201-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 O 13.3370 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 8.0022 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]-N-methylbenzenemethanamine
C15H15Cl2NO
1933393-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 N 13.3370 3.0801 0.0 0
M  V30 7 C 14.6707 2.3101 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 9.3358 5.3901 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 9
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1961201-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1933393-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16111244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl and benzylguanidine compounds as antimicrobial
compounds, compositions and methods
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Potter, Barry Victor Lloyd; Nigam, Yamni; Dudley, Edward; Su, Xiangdong;
Dohle, Wolfgang; Normanton, John Raymond
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2533925 A 2016-07-13

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]benzaldehyde
C14H10Cl2O2
1961201-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 O 13.3370 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 8.0022 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 8
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(2,3-Dichlorophenyl)methoxy]-N-methylbenzenemethanamine
C15H15Cl2NO
1933393-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6685 2.3101 0.0 0
M  V30 3 Cl 2.6673 4.6201 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 N 13.3370 3.0801 0.0 0
M  V30 7 C 14.6707 2.3101 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 9.3358 5.3901 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 9
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1961201-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1933393-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16478634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl and benzylguanidine compounds as antimicrobial
agents and compositions thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Potter, Barry Victor Lloyd; Dohle, Wolfgang; Su, Xiangdong; Normanton,
John; Dudley, Edward; Nigam, Yamni
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016108045 A2 2016-07-07

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-L-tyrosine methyl ester
C20H28N2O6
19669-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 N 6.6687 2.3101 0.0 0
M  V30 3 O 8.0023 4.6201 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0 CFG=2
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 O 2.6675 3.0801 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 11.0631 4.4428 0.0 0
M  V30 11 O 12.5277 4.9187 0.0 0
M  V30 12 O 9.9186 5.4733 0.0 0
M  V30 13 C 12.8479 6.4252 0.0 0
M  V30 14 C 11.3416 6.7453 0.0 0
M  V30 15 C 13.1681 7.9315 0.0 0
M  V30 16 C 14.3543 6.1048 0.0 0
M  V30 17 O 0.0000 7.7002 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0 CFG=2
M  V30 19 N 10.7428 2.9364 0.0 0
M  V30 20 C 9.4969 0.7785 0.0 0
M  V30 21 C 11.7734 1.7920 0.0 0
M  V30 22 C 11.0034 0.4583 0.0 0
M  V30 23 C 4.0012 5.3901 0.0 0
M  V30 24 C 4.0012 6.9302 0.0 0
M  V30 25 C 2.6675 4.6201 0.0 0
M  V30 26 C 2.6675 7.7002 0.0 0
M  V30 27 C 1.3337 5.3901 0.0 0
M  V30 28 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 23
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 19
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Tyrosinamide, 1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl-N-methyl-
C20H29N3O5
411242-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 N 6.6687 2.3101 0.0 0
M  V30 3 O 8.0023 4.6201 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0 CFG=2
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 N 4.0012 0.7700 0.0 0
M  V30 8 O 2.6675 3.0801 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 11.0631 4.4428 0.0 0
M  V30 11 O 12.5277 4.9187 0.0 0
M  V30 12 O 9.9186 5.4733 0.0 0
M  V30 13 C 12.8479 6.4252 0.0 0
M  V30 14 C 14.3543 6.1048 0.0 0
M  V30 15 C 13.1681 7.9315 0.0 0
M  V30 16 C 11.3416 6.7453 0.0 0
M  V30 17 O 0.0000 7.7002 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0 CFG=2
M  V30 19 N 10.7428 2.9364 0.0 0
M  V30 20 C 9.4969 0.7785 0.0 0
M  V30 21 C 11.7734 1.7920 0.0 0
M  V30 22 C 11.0034 0.4583 0.0 0
M  V30 23 C 4.0012 5.3901 0.0 0
M  V30 24 C 2.6675 4.6201 0.0 0
M  V30 25 C 4.0012 6.9302 0.0 0
M  V30 26 C 1.3337 5.3901 0.0 0
M  V30 27 C 2.6675 7.7002 0.0 0
M  V30 28 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 23
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 19
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19669-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 411242-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5812634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the synthesis of
N-acylprolyltyrosinamides (I-III). A solution of 5 mmole of
N-acyldipeptide ester in 50 ml of anhydrous methanol was saturated with
ammonia (or methylamine) at 0°C and allowed to stand for two days at room
temperature. Then the solvent was evaporated in vacuum and the product
was purified by column chromatography (eluent, chloroform-ethanol, 9:1
v/v) and crystallized by triturating with diethyl ether.
tert-Butyloxycarbonyl-L-prolyl-L-tyrosine methylamide:
Boc-L-Pro-L-Tyr-NHCH3 (H) was obtained from Boc-L-Pro-L-Tyr-OMe with a
yield of 98%; white crystalline substance. m.p., 90-93°C;[α]20D, -90° (c,
0.3; chloroform); Rf, 0.4 (Kieselgel, chloroform-ethanol, 9:1);
C20H39N3O5. Proton Chemical Shifts (ppm) 1H NMR in DMSO-d6: (CβH2-CγH2Pro
m): 1.53-2.14, (CβH2Tyr 2dd): 2.65-3.10, (CδH2 Pro m): 3.10-3.30, (CαH
Pro dd): 3.95,4.01, (CαHTyr m): 4.30; 4.36 , (C6H4 Tyr m): 6.62;6.99,
(NHTyr d): 7.81, 7.85, (NH22sNHCH3 q): 7.58,7.82, (OHTyr S): 9.13,9.15 ,
Other signals: 1.22, 1.40 (2s, 9H, (CH3)3C), 2.50, 2.56 (2d, 3H, NHCH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The conformational features of some biologically active
N-acylprolyltyrosinamides studied by H NMR spectroscopy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zaitseva, N. I.; Lezina, V. P.; Ignashin, A. N.; Briling, V. K.;
Gudasheva, T. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (Translation of
Khimiko-Farmatsevticheskii Zhurnal) (2001), 35(7), 382-385

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylsulfony...
C28H35Cl2N5O7S
1970121-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.2637 8.0021 0.0 0
M  V30 2 Cl 9.0337 6.6684 0.0 0
M  V30 3 Cl 4.4137 4.0010 0.0 0
M  V30 4 C 6.7237 10.6695 0.0 0
M  V30 5 C 8.2637 10.6695 0.0 0
M  V30 6 C 9.0337 12.0032 0.0 0
M  V30 7 O 10.5738 4.0010 0.0 0
M  V30 8 C 11.3438 2.6673 0.0 0
M  V30 9 O 5.9537 1.3337 0.0 0
M  V30 10 C 6.7237 0.0000 0.0 0
M  V30 11 S 1.3337 12.0032 0.0 0 VAL=6
M  V30 12 C 0.5636 13.3369 0.0 0
M  V30 13 O 0.0000 11.2332 0.0 0
M  V30 14 O 2.6673 12.7732 0.0 0
M  V30 15 C 15.1938 12.0032 0.0 0
M  V30 16 O 15.9638 13.3369 0.0 0
M  V30 17 O 15.9638 10.6695 0.0 0
M  V30 18 C 17.5038 13.3369 0.0 0
M  V30 19 C 17.5038 14.8769 0.0 0
M  V30 20 C 19.0438 13.3369 0.0 0
M  V30 21 C 17.5038 11.7968 0.0 0
M  V30 22 C 5.9537 6.6684 0.0 0
M  V30 23 C 4.4137 6.6684 0.0 0
M  V30 24 C 6.7237 8.0021 0.0 0
M  V30 25 C 3.6437 8.0021 0.0 0
M  V30 26 N 5.9537 9.3359 0.0 0
M  V30 27 C 4.4137 9.3359 0.0 0
M  V30 28 C 2.1037 8.0021 0.0 0
M  V30 29 N 3.6437 10.6695 0.0 0
M  V30 30 N 1.3337 9.3359 0.0 0
M  V30 31 C 2.1037 10.6695 0.0 0
M  V30 32 C 6.7237 5.3348 0.0 0
M  V30 33 C 8.2637 5.3348 0.0 0
M  V30 34 C 5.9537 4.0010 0.0 0
M  V30 35 C 9.0337 4.0010 0.0 0
M  V30 36 C 6.7237 2.6673 0.0 0
M  V30 37 C 8.2637 2.6673 0.0 0
M  V30 38 N 10.5738 12.0032 0.0 0
M  V30 39 C 11.3438 10.6695 0.0 0
M  V30 40 C 11.3438 13.3369 0.0 0
M  V30 41 C 12.8838 10.6695 0.0 0
M  V30 42 C 12.8838 13.3369 0.0 0
M  V30 43 N 13.6538 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 33
M  V30 3 1 3 34
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 6 38
M  V30 8 1 7 8
M  V30 9 1 7 35
M  V30 10 1 9 10
M  V30 11 1 9 36
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 31
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 43
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 32
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 25 28
M  V30 30 1 26 27
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-...
C28H36Cl2N6O5
1802932-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 Cl 4.0012 6.9302 0.0 0
M  V30 3 Cl 6.6685 2.3101 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 C 13.3370 4.6201 0.0 0
M  V30 7 O 1.3337 5.3901 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 O 4.0012 0.7700 0.0 0
M  V30 10 C 2.6673 0.0000 0.0 0
M  V30 11 N 12.0033 10.0102 0.0 0
M  V30 12 C 12.0033 11.5503 0.0 0
M  V30 13 C 18.6718 7.7002 0.0 0
M  V30 14 O 20.0057 6.9302 0.0 0
M  V30 15 O 18.6718 9.2402 0.0 0
M  V30 16 C 21.3393 7.7002 0.0 0
M  V30 17 C 22.1093 6.3665 0.0 0
M  V30 18 C 22.6730 8.4702 0.0 0
M  V30 19 C 20.5693 9.0338 0.0 0
M  V30 20 C 6.6685 5.3901 0.0 0
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 6.6685 6.9302 0.0 0
M  V30 23 N 9.3360 5.3901 0.0 0
M  V30 24 C 8.0022 7.7002 0.0 0
M  V30 25 C 9.3360 6.9302 0.0 0
M  V30 26 C 8.0022 9.2402 0.0 0
M  V30 27 N 10.6697 7.7002 0.0 0
M  V30 28 N 9.3360 10.0102 0.0 0
M  V30 29 C 10.6697 9.2402 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 4.0012 5.3901 0.0 0
M  V30 32 C 5.3348 3.0801 0.0 0
M  V30 33 C 2.6673 4.6201 0.0 0
M  V30 34 C 4.0012 2.3101 0.0 0
M  V30 35 C 2.6673 3.0801 0.0 0
M  V30 36 N 14.6708 5.3901 0.0 0
M  V30 37 C 16.0045 4.6201 0.0 0
M  V30 38 C 14.6708 6.9302 0.0 0
M  V30 39 C 17.3382 5.3901 0.0 0
M  V30 40 C 16.0045 7.7002 0.0 0
M  V30 41 N 17.3382 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 31
M  V30 3 1 3 32
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 6 36
M  V30 8 1 7 8
M  V30 9 1 7 33
M  V30 10 1 9 10
M  V30 11 1 9 34
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 41
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 30
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1970121-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802932-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30766260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the Irreversible Covalent FGFR Inhibitor
8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
(PRN1371) for the Treatment of Solid Tumors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brameld, Ken A.; Owens, Timothy D.; Verner, Erik; Venetsanakos, Eleni;
Bradshaw, J. Michael; Phan, Vernon T.; Tam, Danny; Leung, Kwan; Shu, Jin;
LaStant, Jacob; Loughhead, David G.; Ton, Tony; Karr, Dane E.; Gerritsen,
Mary E.; Goldstein, David M.; Funk, Jens Oliver
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(15), 6516-6527

$RFMT $RIREG SCHEME308 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dichloro-4-fluoro-5-nitrobenzene
C6H2Cl2FNO2
2339-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon(isothiocyanatidic) acid, 9H-fluoren-9-ylmethyl ester
C16H11NO2S
199915-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 S 12.4218 6.0010 0.0 0
M  V30 8 C 4.4195 4.4610 0.0 0
M  V30 9 C 3.0127 5.0873 0.0 0
M  V30 10 C 4.2586 2.9293 0.0 0
M  V30 11 C 1.9823 3.9429 0.0 0
M  V30 12 C 2.5369 6.5520 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 0.4759 4.2631 0.0 0
M  V30 16 C 1.0304 6.8722 0.0 0
M  V30 17 C 2.2765 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.0000 5.7276 0.0 0
M  V30 20 C 3.3069 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, (5,6-dichloro-1-methyl-1H-benzimidazol-2-yl)-, 9H-fluoren-9-yl...
C23H17Cl2N3O2
496838-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 5.2310 0.0 0
M  V30 2 O 7.0871 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7544 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 12.8152 3.0982 0.0 0
M  V30 7 Cl 15.8355 9.7502 0.0 0
M  V30 8 Cl 17.3755 7.0827 0.0 0
M  V30 9 C 4.4196 4.4610 0.0 0
M  V30 10 C 4.2586 2.9294 0.0 0
M  V30 11 C 3.0128 5.0873 0.0 0
M  V30 12 C 2.7522 2.6091 0.0 0
M  V30 13 C 5.2891 1.7849 0.0 0
M  V30 14 C 1.9822 3.9429 0.0 0
M  V30 15 C 2.5369 6.5520 0.0 0
M  V30 16 C 2.2763 1.1445 0.0 0
M  V30 17 C 4.8132 0.3203 0.0 0
M  V30 18 C 0.4759 4.2631 0.0 0
M  V30 19 C 1.0304 6.8722 0.0 0
M  V30 20 C 3.3069 0.0000 0.0 0
M  V30 21 C 0.0000 5.7277 0.0 0
M  V30 22 C 11.0880 5.2310 0.0 0
M  V30 23 N 11.2491 6.7626 0.0 0
M  V30 24 N 12.4950 4.6045 0.0 0
M  V30 25 C 12.7554 7.0827 0.0 0
M  V30 26 C 13.5254 5.7491 0.0 0
M  V30 27 C 13.5254 8.4164 0.0 0
M  V30 28 C 15.0655 5.7491 0.0 0
M  V30 29 C 15.0655 8.4164 0.0 0
M  V30 30 C 15.8355 7.0827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 22
M  V30 7 1 6 24
M  V30 8 1 7 29
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2339-78-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 199915-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496838-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11706645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
3-(4-Chlorophenyl)propionic acid
C9H9ClO2
2019-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenepropanamine
C10H14ClN
90944-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 N 9.2401 4.0010 0.0 0
M  V30 5 C 10.7801 4.0010 0.0 0
M  V30 6 Cl 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2019-34-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90944-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2195660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 4: N-[3-(4-chlorophenyl)propyl]-N-methylamine. A stirred
solution of 3.0 g (16.2 mmol) of 4-chlorophenylpropionic acid in 20 mL of
DCM was reacted with 3.1 g (19.4 mmol, 1.2 equiv.) of
1.1'-carbonyldiimidazole by addition of 500 mg portions over a 15 min
period, during which time significant evolution of CO was observed. The
resulting solution was stirred 90 min at RT, then cooled to 0 °C and
treated with 8 mL of a cold (0 °C) 40% aqueous solution of methylamine.
The resulting mixture was allowed to warm to RT and stirred vigorously
for 14 h. The reaction mixture was then acidified to a pH of 1 by careful
addition of conc. HCl, diluted with 70 mL of chloroform and extracted
with H2O (1 x 100 mL). The organic layer was separated, dried (MgSO4),
and concentrated in vacuo to afford 3.1 g of a white solid. This material
was immediately dissolved in 80 mL of THF, and 19.4 mL of a 1.0 M
solution of LiA4 in THF was added dropwise over 10 min. After the
addition was complete, the resulting solution was stirred 10 min at RT
and then was heated to 60 °C for 6 h. The reaction mixture was then
cooled to 0 °C and the reaction was quenched by careful addition of 0.76
mL of H2O, followed by 0.76 mL of 15% NaOH and then 2.7 mL of H2O. The
resulting slurry was stirred vigorously for 10 min. and then filtered
through a pad of Celite to remove the salts. The salts were isolated,
triturated with EtOAc, and refiltered through a pad of Celite. The
filtrates were combined, dried (MgSO4), and concentrated in vacuo to
afford of the title compound, which was used without further
purification: Cear yellow oil, 3.01 g, %. 1H NMR (CDCl3, 400 MHz) δ 7.27
(d, 2 H, J = 8.4), 7.14 (d, 2 H, J= 8.4), 2.53 (m, 4 H), 2.45 (s, 3 H),
1.81 (m, 2 H), 1.57 (s, br, 1 H);TLC (chloroform/MeOH 9:1) Rf = 0.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyltriazines as estrogen receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hale, Ronnie Lee; Henke, Brad Richard; Lambert, Millard Hurst, III; Lu,
Amy Tsai; Spearing, Paul Kenneth; Turnbull, Philip Stewart
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002072561 A1 2002-09-19

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-fluorobenzene
C10H12BrFO
2033-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 F 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Fluorophenoxy)-N-methyl-1-butanamine
C11H16FNO
1195950-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 F 0.0000 0.0000 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2033-80-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-20-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15024550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-chlorobenzene
C10H12BrClO
2033-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 Cl 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Chlorophenoxy)-N-methyl-1-butanamine
C11H16ClNO
1195950-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 Cl 0.0000 0.0000 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2033-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6508250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-2-methylbenzene
C11H15BrO
2033-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 Br 10.6697 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(2-methylphenoxy)-1-butanamine
C12H19NO
1195950-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2033-82-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4367386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-methoxybenzene
C11H15BrO2
2033-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 Br 13.3370 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenoxy)-N-methyl-1-butanamine
C12H19NO2
776245-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 3.0801 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2033-83-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 776245-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8916490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-1-[(1,1-Dimethylethoxy)carbonyl]-α-[[(9H-fluoren-9-ylmethoxy)carbonyl]am...
C28H34N2O6
204058-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=2
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 O 11.9843 7.7838 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 C 16.6043 5.1163 0.0 0
M  V30 12 O 17.3743 3.7827 0.0 0
M  V30 13 O 17.3743 6.4500 0.0 0
M  V30 14 C 18.9143 3.7827 0.0 0
M  V30 15 C 18.9143 2.2427 0.0 0
M  V30 16 C 20.4543 3.7827 0.0 0
M  V30 17 C 18.9143 5.3227 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 31 C 11.9843 5.1163 0.0 0
M  V30 32 C 12.7543 3.7827 0.0 0
M  V30 33 C 12.7543 6.4500 0.0 0
M  V30 34 C 14.2943 3.7827 0.0 0
M  V30 35 C 14.2943 6.4500 0.0 0
M  V30 36 N 15.0643 5.1163 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 36
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 23
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[(2S)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]ami...
C29H37N3O5
2994671-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 O 5.8243 5.3347 0.0 0
M  V30 3 C 7.3643 5.3347 0.0 0
M  V30 4 N 8.1343 4.0011 0.0 0
M  V30 5 O 8.1343 6.6684 0.0 0
M  V30 6 C 9.6743 4.0011 0.0 0 CFG=2
M  V30 7 C 10.4443 5.3347 0.0 0
M  V30 8 C 10.4443 2.6673 0.0 0
M  V30 9 N 9.6743 1.3336 0.0 0
M  V30 10 O 11.9843 2.6673 0.0 0
M  V30 11 C 10.4443 0.0000 0.0 0
M  V30 12 C 16.6043 5.3347 0.0 0
M  V30 13 O 17.3743 6.6684 0.0 0
M  V30 14 O 17.3743 4.0011 0.0 0
M  V30 15 C 18.9143 6.6684 0.0 0
M  V30 16 C 18.9143 5.1284 0.0 0
M  V30 17 C 20.4543 6.6684 0.0 0
M  V30 18 C 18.9143 8.2084 0.0 0
M  V30 19 C 3.5143 6.6684 0.0 0
M  V30 20 C 2.6091 5.4225 0.0 0
M  V30 21 C 2.6091 7.9142 0.0 0
M  V30 22 C 1.1445 5.8984 0.0 0
M  V30 23 C 2.9292 3.9162 0.0 0
M  V30 24 C 1.1445 7.4384 0.0 0
M  V30 25 C 2.9292 9.4206 0.0 0
M  V30 26 C 0.0000 4.8679 0.0 0
M  V30 27 C 1.7849 2.8857 0.0 0
M  V30 28 C 0.0000 8.4688 0.0 0
M  V30 29 C 1.7849 10.4511 0.0 0
M  V30 30 C 0.3202 3.3615 0.0 0
M  V30 31 C 0.3202 9.9752 0.0 0
M  V30 32 C 11.9843 5.3347 0.0 0
M  V30 33 C 12.7543 6.6684 0.0 0
M  V30 34 C 12.7543 4.0011 0.0 0
M  V30 35 C 14.2943 6.6684 0.0 0
M  V30 36 C 14.2943 4.0011 0.0 0
M  V30 37 N 15.0643 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 37
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 22 24
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 2 29 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 204058-25-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2994671-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38231050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bromodomain and Extra-Terminal (BET) Subfamily Bromodomain 1 (BD1)
selective inhibitors and methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matzuk, Martin; Yu, Zhifeng; Modukuri, Ramkumar; Li, Feng; Young, Damian;
Ucisik, Melek Nihan; Faver, John; Tan, Zhi; Jin, Zhuang; Anglin, Justin;
Teng, Mingxing; Kim, Choel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023196455 A1 2023-10-12

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (βR)-α-methylene-β-(2-methylpropyl)-γ-oxo-1-piperidinebutanoate
C21H29NO3
206553-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0 CFG=2
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 5.3901 5.3348 0.0 0
M  V30 4 C 5.3901 2.6673 0.0 0
M  V30 5 O 2.3100 2.6673 0.0 0
M  V30 6 C 6.9301 5.3348 0.0 0
M  V30 7 C 4.6201 6.6684 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 O 7.7001 6.6684 0.0 0
M  V30 10 O 7.7001 4.0011 0.0 0
M  V30 11 C 5.3901 0.0000 0.0 0
M  V30 12 C 3.0800 1.3337 0.0 0
M  V30 13 C 9.2401 6.6684 0.0 0
M  V30 14 N 2.3100 5.3348 0.0 0
M  V30 15 C 0.7700 5.3348 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 0.0000 6.6684 0.0 0
M  V30 18 C 2.3100 8.0022 0.0 0
M  V30 19 C 0.7700 8.0022 0.0 0
M  V30 20 C 10.0101 8.0022 0.0 0
M  V30 21 C 11.5501 8.0022 0.0 0
M  V30 22 C 9.2401 9.3359 0.0 0
M  V30 23 C 12.3201 9.3359 0.0 0
M  V30 24 C 10.0101 10.6695 0.0 0
M  V30 25 C 11.5501 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 20
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (αR,βR)-α-[(methylamino)methyl]-β-(2-methylpropyl)-γ-oxo-1-piper...
C22H34N2O3
206553-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 5.3900 2.6673 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 4.6200 6.6684 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 O 7.7000 6.6684 0.0 0
M  V30 10 O 7.7000 4.0011 0.0 0
M  V30 11 N 5.3900 8.0021 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 4.6200 9.3358 0.0 0
M  V30 16 N 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6684 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 10.0100 8.0021 0.0 0
M  V30 23 C 9.2400 9.3358 0.0 0
M  V30 24 C 11.5500 8.0020 0.0 0
M  V30 25 C 10.0100 10.6694 0.0 0
M  V30 26 C 12.3200 9.3358 0.0 0
M  V30 27 C 11.5500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 2 3 7
M  V30 7 1 3 16
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 11 15
M  V30 16 1 14 22
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 206553-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 206553-94-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8083521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step F: 5-Methyl-2S-methylaminomethyl-3R-(piperidine-1-carbonyl)-hexanoic
acid benzyl ester Methylamine (33% in methanol; 6.21 ml, 50 mmol) was
added to a stirred solution of
2-[3-Methyl-1R-(piperidine-1-carbonyl)-butyl]-acrylic acid benzyl ester
(8.3 g, 25 mmol) in methanol (50 ml) and the mixture was stirred at room
temperature for 90 minutes. The solvent was removed in vacuo, The title
compound as a yellow oil (15:1 mixture of diastereoisomers by 1H-NMR)
(8.865 g, 98%). 1H-NMR: δ (CDCl3, major diastereoisomer), 7.43-7.28 (5H,
m), 5.25-5.12 (2H, m), 3.53-3.50 (4H, m), 3.18 (1H, m), 2.93 (1H, m),
2.71 (1H, d, J=11.9 Hz), 2.63 (1H, dd, J-11.9, 5.0 Hz), 2.35 (3H, s),
1.81-1.30 (9H, m), 1.94 (1H, m) and 0.83-0.75 (6H, m).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 15:1 mixture of diastereomers obtained, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonylaminoalkanediamides and related compounds as
matrix metalloproteinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beckett, Raymond Paul; Martin, Fionna Mitchell; Miller, Andrew; Todd,
Richard Simon; Whittaker, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6022873 A 2000-02-08

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenebutanol, 4-chloro-3-[[[1-[4-[2-(cyclopropyloxy)phenyl]-3-pyridinyl]cyc...
C30H35ClN2O4S
2102056-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.8371 4.1990 0.0 0
M  V30 2 C 11.1709 3.4290 0.0 0
M  V30 3 O 2.9637 3.8066 0.0 0
M  V30 4 Cl 11.1709 6.5090 0.0 0
M  V30 5 C 16.5056 3.4290 0.0 0
M  V30 6 C 17.8392 4.1990 0.0 0
M  V30 7 C 16.5056 1.8890 0.0 0
M  V30 8 C 19.1728 3.4290 0.0 0
M  V30 9 C 20.5065 4.1990 0.0 0
M  V30 10 O 21.8403 3.4290 0.0 0
M  V30 11 S 23.1739 4.1990 0.0 0 VAL=6
M  V30 12 C 22.4039 5.5328 0.0 0
M  V30 13 O 24.5076 4.9690 0.0 0
M  V30 14 O 23.9439 2.8653 0.0 0
M  V30 15 C 8.5034 3.4291 0.0 0
M  V30 16 C 7.5135 2.2493 0.0 0
M  V30 17 C 9.0301 1.9820 0.0 0
M  V30 18 C 7.5135 4.6088 0.0 0
M  V30 19 C 5.9969 4.3413 0.0 0
M  V30 20 C 8.0402 6.0559 0.0 0
M  V30 21 C 5.0070 5.5211 0.0 0
M  V30 22 N 7.0503 7.2355 0.0 0
M  V30 23 C 5.5337 6.9682 0.0 0
M  V30 24 C 5.4702 2.8943 0.0 0
M  V30 25 C 3.9536 2.6268 0.0 0
M  V30 26 C 6.4601 1.7145 0.0 0
M  V30 27 C 3.4270 1.1796 0.0 0
M  V30 28 C 5.9335 0.2673 0.0 0
M  V30 29 C 4.4167 0.0000 0.0 0
M  V30 30 C 12.5045 4.1990 0.0 0
M  V30 31 C 13.8381 3.4290 0.0 0
M  V30 32 C 12.5045 5.7390 0.0 0
M  V30 33 C 15.1718 4.1990 0.0 0
M  V30 34 C 13.8381 6.5090 0.0 0
M  V30 35 C 15.1718 5.7390 0.0 0
M  V30 36 C 1.4471 3.5391 0.0 0
M  V30 37 C 0.0000 4.0658 0.0 0
M  V30 38 C 0.2673 2.5492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 30
M  V30 4 1 3 25
M  V30 5 1 3 36
M  V30 6 1 4 32
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 33
M  V30 10 1 6 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 11 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 19 24
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[1-[4-[2-(cyclopropyloxy)phenyl]-3-pyridinyl]cyclopropyl]-5-[1-met...
C30H36ClN3O
2102056-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3915 4.3414 0.0 0
M  V30 2 C 8.9181 2.8943 0.0 0
M  V30 3 O 2.8738 8.4588 0.0 0
M  V30 4 Cl 9.9715 0.0000 0.0 0
M  V30 5 C 13.9311 4.7189 0.0 0
M  V30 6 C 15.4477 4.4515 0.0 0
M  V30 7 C 13.4043 6.1660 0.0 0
M  V30 8 C 16.4377 5.6312 0.0 0
M  V30 9 C 17.9542 5.3638 0.0 0
M  V30 10 N 18.9442 6.5435 0.0 0
M  V30 11 C 20.4607 6.2760 0.0 0
M  V30 12 C 6.8747 4.6089 0.0 0
M  V30 13 C 6.3480 3.1618 0.0 0
M  V30 14 C 5.3581 4.3414 0.0 0
M  V30 15 C 6.8747 6.1489 0.0 0
M  V30 16 C 5.5411 6.9189 0.0 0
M  V30 17 C 8.2085 6.9189 0.0 0
M  V30 18 C 5.5411 8.4589 0.0 0
M  V30 19 N 8.2085 8.4589 0.0 0
M  V30 20 C 6.8747 9.2289 0.0 0
M  V30 21 C 4.2074 6.1489 0.0 0
M  V30 22 C 2.8738 6.9189 0.0 0
M  V30 23 C 4.2074 4.6089 0.0 0
M  V30 24 C 1.5400 6.1488 0.0 0
M  V30 25 C 2.8738 3.8389 0.0 0
M  V30 26 C 1.5400 4.6088 0.0 0
M  V30 27 C 10.4347 2.6269 0.0 0
M  V30 28 C 11.4246 3.8066 0.0 0
M  V30 29 C 10.9614 1.1798 0.0 0
M  V30 30 C 12.9412 3.5392 0.0 0
M  V30 31 C 12.4780 0.9123 0.0 0
M  V30 32 C 13.4679 2.0921 0.0 0
M  V30 33 C 1.5400 9.2288 0.0 0
M  V30 34 C 0.7700 10.5626 0.0 0
M  V30 35 C 0.0000 9.2288 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 27
M  V30 4 1 3 22
M  V30 5 1 3 33
M  V30 6 1 4 29
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 30
M  V30 10 1 6 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2102056-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102056-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34795492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 4-phenyl pyridine compounds as non-systemic
TGR5 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lewis, Jason G.; Leadbetter, Michael Robert; Caldwell, Jeremy; Dragoli,
Dean; Bell, Noah; Jacobs, Jeffrey W.; Finn, Patricia; Jain, Rakesh; Chen,
Tao; Siegel, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20220306672 A1 2022-09-29

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenebutanol, 4-chloro-3-[[[1-[4-[2-(cyclopropyloxy)phenyl]-3-pyridinyl]cyc...
C30H35ClN2O4S
2102056-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.8371 4.1990 0.0 0
M  V30 2 C 11.1709 3.4290 0.0 0
M  V30 3 O 2.9637 3.8066 0.0 0
M  V30 4 Cl 11.1709 6.5090 0.0 0
M  V30 5 C 16.5056 3.4290 0.0 0
M  V30 6 C 17.8392 4.1990 0.0 0
M  V30 7 C 16.5056 1.8890 0.0 0
M  V30 8 C 19.1728 3.4290 0.0 0
M  V30 9 C 20.5065 4.1990 0.0 0
M  V30 10 O 21.8403 3.4290 0.0 0
M  V30 11 S 23.1739 4.1990 0.0 0 VAL=6
M  V30 12 C 22.4039 5.5328 0.0 0
M  V30 13 O 24.5076 4.9690 0.0 0
M  V30 14 O 23.9439 2.8653 0.0 0
M  V30 15 C 8.5034 3.4291 0.0 0
M  V30 16 C 7.5135 2.2493 0.0 0
M  V30 17 C 9.0301 1.9820 0.0 0
M  V30 18 C 7.5135 4.6088 0.0 0
M  V30 19 C 5.9969 4.3413 0.0 0
M  V30 20 C 8.0402 6.0559 0.0 0
M  V30 21 C 5.0070 5.5211 0.0 0
M  V30 22 N 7.0503 7.2355 0.0 0
M  V30 23 C 5.5337 6.9682 0.0 0
M  V30 24 C 5.4702 2.8943 0.0 0
M  V30 25 C 3.9536 2.6268 0.0 0
M  V30 26 C 6.4601 1.7145 0.0 0
M  V30 27 C 3.4270 1.1796 0.0 0
M  V30 28 C 5.9335 0.2673 0.0 0
M  V30 29 C 4.4167 0.0000 0.0 0
M  V30 30 C 12.5045 4.1990 0.0 0
M  V30 31 C 13.8381 3.4290 0.0 0
M  V30 32 C 12.5045 5.7390 0.0 0
M  V30 33 C 15.1718 4.1990 0.0 0
M  V30 34 C 13.8381 6.5090 0.0 0
M  V30 35 C 15.1718 5.7390 0.0 0
M  V30 36 C 1.4471 3.5391 0.0 0
M  V30 37 C 0.0000 4.0658 0.0 0
M  V30 38 C 0.2673 2.5492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 30
M  V30 4 1 3 25
M  V30 5 1 3 36
M  V30 6 1 4 32
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 33
M  V30 10 1 6 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 11 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 19 24
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[1-[4-[2-(cyclopropyloxy)phenyl]-3-pyridinyl]cyclopropyl]-5-[1-met...
C30H36ClN3O
2102056-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3915 4.3414 0.0 0
M  V30 2 C 8.9181 2.8943 0.0 0
M  V30 3 O 2.8738 8.4588 0.0 0
M  V30 4 Cl 9.9715 0.0000 0.0 0
M  V30 5 C 13.9311 4.7189 0.0 0
M  V30 6 C 15.4477 4.4515 0.0 0
M  V30 7 C 13.4043 6.1660 0.0 0
M  V30 8 C 16.4377 5.6312 0.0 0
M  V30 9 C 17.9542 5.3638 0.0 0
M  V30 10 N 18.9442 6.5435 0.0 0
M  V30 11 C 20.4607 6.2760 0.0 0
M  V30 12 C 6.8747 4.6089 0.0 0
M  V30 13 C 6.3480 3.1618 0.0 0
M  V30 14 C 5.3581 4.3414 0.0 0
M  V30 15 C 6.8747 6.1489 0.0 0
M  V30 16 C 5.5411 6.9189 0.0 0
M  V30 17 C 8.2085 6.9189 0.0 0
M  V30 18 C 5.5411 8.4589 0.0 0
M  V30 19 N 8.2085 8.4589 0.0 0
M  V30 20 C 6.8747 9.2289 0.0 0
M  V30 21 C 4.2074 6.1489 0.0 0
M  V30 22 C 2.8738 6.9189 0.0 0
M  V30 23 C 4.2074 4.6089 0.0 0
M  V30 24 C 1.5400 6.1488 0.0 0
M  V30 25 C 2.8738 3.8389 0.0 0
M  V30 26 C 1.5400 4.6088 0.0 0
M  V30 27 C 10.4347 2.6269 0.0 0
M  V30 28 C 11.4246 3.8066 0.0 0
M  V30 29 C 10.9614 1.1798 0.0 0
M  V30 30 C 12.9412 3.5392 0.0 0
M  V30 31 C 12.4780 0.9123 0.0 0
M  V30 32 C 13.4679 2.0921 0.0 0
M  V30 33 C 1.5400 9.2288 0.0 0
M  V30 34 C 0.7700 10.5626 0.0 0
M  V30 35 C 0.0000 9.2288 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 27
M  V30 4 1 3 22
M  V30 5 1 3 33
M  V30 6 1 4 29
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 30
M  V30 10 1 6 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2102056-31-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102056-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18872651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 4-phenyl pyridine compounds as non-systemic
TGR5 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lewis, Jason G.; Leadbetter, Michael Robert; Caldwell, Jeremy; Dragoli,
Dean; Bell, Noah; Jacobs, Jeffrey W.; Finn, Patricia; Jain, Rakesh; Chen,
Tao; Siegel, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017106818 A1 2017-06-22

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5H-Indolo[2,3-c]pyrrolo[3,4-a]carbazole-6,8(7H,9H)-dione
C20H11N3O2
211233-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 5.7249 0.0 0
M  V30 2 O 3.1864 10.1105 0.0 0
M  V30 3 C 4.8685 4.5864 0.0 0
M  V30 4 C 5.7735 5.8322 0.0 0
M  V30 5 C 3.3368 4.7473 0.0 0
M  V30 6 C 5.1886 3.0799 0.0 0
M  V30 7 C 5.1472 7.2391 0.0 0
M  V30 8 C 7.3052 5.9931 0.0 0
M  V30 9 C 2.7105 6.1542 0.0 0
M  V30 10 N 2.7105 3.3405 0.0 0
M  V30 11 C 3.8549 2.3100 0.0 0
M  V30 12 C 6.5223 2.3100 0.0 0
M  V30 13 C 3.6157 7.4000 0.0 0
M  V30 14 N 6.2916 8.2695 0.0 0
M  V30 15 C 7.6253 7.4995 0.0 0
M  V30 16 C 8.4495 4.9627 0.0 0
M  V30 17 C 1.2458 6.6301 0.0 0
M  V30 18 C 3.8549 0.7700 0.0 0
M  V30 19 C 6.5223 0.7700 0.0 0
M  V30 20 C 2.7105 8.6459 0.0 0
M  V30 21 C 9.0899 7.9754 0.0 0
M  V30 22 C 9.9142 5.4386 0.0 0
M  V30 23 N 1.2458 8.1700 0.0 0
M  V30 24 C 5.1886 0.0000 0.0 0
M  V30 25 C 10.2344 6.9450 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 2 8 16
M  V30 16 2 9 13
M  V30 17 1 9 17
M  V30 18 1 10 11
M  V30 19 2 11 18
M  V30 20 1 12 19
M  V30 21 1 13 20
M  V30 22 1 14 15
M  V30 23 2 15 21
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 2 19 24
M  V30 28 1 20 23
M  V30 29 1 21 25
M  V30 30 2 22 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methyl-5H-indolo[2,3-c]pyrrolo[3,4-a]carbazole-6,8(7H,9H)-dione
C21H13N3O2
211233-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.5524 9.4736 0.0 0
M  V30 2 O 9.7573 4.5210 0.0 0
M  V30 3 C 10.4540 7.7984 0.0 0
M  V30 4 C 4.1320 5.8265 0.0 0
M  V30 5 C 4.7585 4.4197 0.0 0
M  V30 6 C 5.0373 7.0724 0.0 0
M  V30 7 C 2.6675 6.3024 0.0 0
M  V30 8 C 6.2901 4.2586 0.0 0
M  V30 9 C 4.1320 3.0127 0.0 0
M  V30 10 C 6.5688 6.9115 0.0 0
M  V30 11 N 4.1320 8.3184 0.0 0
M  V30 12 C 2.6675 7.8424 0.0 0
M  V30 13 C 1.3338 5.5324 0.0 0
M  V30 14 C 7.1953 5.5047 0.0 0
M  V30 15 N 6.6102 2.7523 0.0 0
M  V30 16 C 5.2766 1.9823 0.0 0
M  V30 17 C 2.6675 2.5369 0.0 0
M  V30 18 C 7.7134 7.9419 0.0 0
M  V30 19 C 1.3338 8.6124 0.0 0
M  V30 20 C 0.0000 6.3024 0.0 0
M  V30 21 C 8.7268 5.6656 0.0 0
M  V30 22 C 4.9564 0.4760 0.0 0
M  V30 23 C 2.3473 1.0306 0.0 0
M  V30 24 N 9.0470 7.1719 0.0 0
M  V30 25 C 0.0000 7.8424 0.0 0
M  V30 26 C 3.4917 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 21
M  V30 3 1 3 24
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 1 8 15
M  V30 15 1 9 16
M  V30 16 2 9 17
M  V30 17 2 10 14
M  V30 18 1 10 18
M  V30 19 1 11 12
M  V30 20 2 12 19
M  V30 21 1 13 20
M  V30 22 1 14 21
M  V30 23 1 15 16
M  V30 24 2 16 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 2 20 25
M  V30 29 1 21 24
M  V30 30 1 22 26
M  V30 31 2 23 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 211233-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 211233-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-2420276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rebeccamycin analogues from Indolo[2,3-c]carbazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Voldoire, A.; Sancelme, M.; Prudhomme, M.; Colson, P.; Houssier, C.;
Bailly, C.; Leonce, S.; Lambel, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2001), 9(2), 357-365

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-Cyclohexyl-1-[(2S,4R)-tetrahydro-4-(2-methyl-2-propen-1-yl)-5-oxo-2...
C26H32N2O3
212790-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 2 C 10.0100 4.0011 0.0 0
M  V30 3 N 7.7000 5.3347 0.0 0
M  V30 4 C 6.9300 6.6684 0.0 0
M  V30 5 O 7.7000 8.0021 0.0 0
M  V30 6 C 13.9663 6.1925 0.0 0
M  V30 7 C 15.1108 7.2229 0.0 0
M  V30 8 C 14.7906 8.7293 0.0 0
M  V30 9 C 16.5753 6.7470 0.0 0
M  V30 10 O 12.9311 9.3789 0.0 0
M  V30 11 C 10.0100 6.6684 0.0 0 CFG=1
M  V30 12 C 11.2559 5.7631 0.0 0
M  V30 13 O 10.4859 8.1330 0.0 0
M  V30 14 C 12.5017 6.6684 0.0 0 CFG=1
M  V30 15 C 12.0259 8.1330 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 10.0100 1.3336 0.0 0
M  V30 18 C 7.7000 2.6674 0.0 0
M  V30 19 C 9.2400 0.0000 0.0 0
M  V30 20 C 6.9300 1.3336 0.0 0
M  V30 21 C 7.7000 0.0000 0.0 0
M  V30 22 C 5.3900 6.6684 0.0 0
M  V30 23 C 4.6200 8.0021 0.0 0
M  V30 24 C 4.6200 5.3347 0.0 0
M  V30 25 C 3.0800 8.0021 0.0 0
M  V30 26 N 3.0800 5.3347 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 0.7700 6.6684 0.0 0
M  V30 30 C 0.7700 9.3358 0.0 0
M  V30 31 C 0.0000 8.0021 0.0 0
M  V30 32 H 8.6031 7.2948 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 4 22
M  V30 8 1 6 7
M  V30 9 1 14 6 CFG=3
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 2 10 15
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 32 CFG=3
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2S,4R)-1-(Cyclohexylmethyl)-2-hydroxy-6-methyl-4-[(methylamino)carbony...
C27H37N3O3
212787-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 6.9300 0.0 0
M  V30 2 N 8.0021 6.1600 0.0 0
M  V30 3 O 9.3358 8.4700 0.0 0
M  V30 4 C 6.6685 6.9300 0.0 0 CFG=1
M  V30 5 C 5.3347 6.1600 0.0 0 CFG=1
M  V30 6 C 6.6685 8.4700 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 O 4.0011 6.9300 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 N 5.3349 1.5400 0.0 0
M  V30 13 O 2.6674 1.5400 0.0 0
M  V30 14 C 1.3338 3.8500 0.0 0
M  V30 15 C 5.3349 0.0000 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 17 C 1.3338 2.3100 0.0 0
M  V30 18 C 13.3369 6.1600 0.0 0
M  V30 19 C 13.3369 4.6200 0.0 0
M  V30 20 C 12.0032 6.9300 0.0 0
M  V30 21 C 14.6705 6.9300 0.0 0
M  V30 22 N 12.0032 3.8500 0.0 0
M  V30 23 C 14.6705 3.8500 0.0 0
M  V30 24 C 10.6696 6.1600 0.0 0
M  V30 25 C 16.0043 6.1600 0.0 0
M  V30 26 C 10.6696 4.6200 0.0 0
M  V30 27 C 16.0043 4.6200 0.0 0
M  V30 28 C 5.3347 9.2400 0.0 0
M  V30 29 C 5.3347 10.7800 0.0 0
M  V30 30 C 4.0011 8.4700 0.0 0
M  V30 31 C 4.0011 11.5500 0.0 0
M  V30 32 C 2.6674 9.2400 0.0 0
M  V30 33 C 2.6674 10.7800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=3
M  V30 9 1 6 28
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=3
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 25
M  V30 26 2 22 26
M  V30 27 2 23 27
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 212790-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 212787-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8067016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl-hexanoic acid amides which are CCR1 antagonists
useful as immunomodulatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Matthew F.; Gaweco, Anderson S.; Gladue, Ronald P.; Kath, John C.;
Poss, Christopher S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040087571 A1 2004-05-06

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H21ClN6O7S
2135821-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1135 0.0 0
M  V30 2 N 5.3347 7.6535 0.0 0
M  V30 3 S 4.0011 8.4235 0.0 0 VAL=6
M  V30 4 C 6.6685 8.4235 0.0 0
M  V30 5 O 3.2311 7.0897 0.0 0
M  V30 6 O 4.7711 9.7571 0.0 0
M  V30 7 C 5.8440 0.4286 0.0 0
M  V30 8 C 7.8599 0.0000 0.0 0
M  V30 9 Cl 15.4505 6.8240 0.0 0
M  V30 10 N 4.0011 11.5035 0.0 0 VAL=5
M  V30 11 O 5.3347 10.7335 0.0 0
M  V30 12 O 4.0011 13.0435 0.0 0
M  V30 13 C 9.1057 4.8254 0.0 0 CFG=2
M  V30 14 C 8.3357 3.4916 0.0 0 CFG=2
M  V30 15 O 8.0753 5.9698 0.0 0
M  V30 16 C 6.8294 3.8118 0.0 0 CFG=2
M  V30 17 O 8.4968 1.9601 0.0 0
M  V30 18 C 6.6685 5.3435 0.0 0 CFG=2
M  V30 19 O 6.0594 2.4782 0.0 0
M  V30 20 C 7.0899 1.3338 0.0 0
M  V30 21 N 10.6372 4.9864 0.0 0
M  V30 22 C 11.4072 6.3200 0.0 0
M  V30 23 C 11.6678 3.8418 0.0 0
M  V30 24 C 12.9137 5.9998 0.0 0
M  V30 25 N 10.9314 7.7847 0.0 0
M  V30 26 N 13.0746 4.4683 0.0 0
M  V30 27 C 13.9441 7.1442 0.0 0
M  V30 28 C 11.9619 8.9291 0.0 0
M  V30 29 N 13.4682 8.6089 0.0 0
M  V30 30 C 2.6674 9.1935 0.0 0
M  V30 31 C 2.6674 10.7335 0.0 0
M  V30 32 C 1.3338 8.4235 0.0 0
M  V30 33 C 1.3338 11.5035 0.0 0
M  V30 34 C 0.0000 9.1935 0.0 0
M  V30 35 C 0.0000 10.7335 0.0 0
M  V30 36 H 9.8421 3.1715 0.0 0
M  V30 37 H 5.3230 4.1320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 3 30
M  V30 8 1 7 20
M  V30 9 1 8 20
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 31
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 21 CFG=1
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 36 CFG=1
M  V30 20 1 15 18
M  V30 21 1 16 18
M  V30 22 1 16 19
M  V30 23 1 16 37 CFG=1
M  V30 24 1 17 20
M  V30 25 1 19 20
M  V30 26 1 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 22 25
M  V30 30 2 23 26
M  V30 31 1 24 26
M  V30 32 2 24 27
M  V30 33 1 25 28
M  V30 34 1 27 29
M  V30 35 2 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C21H25N7O7S
2135822-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1136 0.0 0
M  V30 2 N 5.3348 7.6536 0.0 0
M  V30 3 S 4.0010 8.4236 0.0 0 VAL=6
M  V30 4 C 6.6685 8.4236 0.0 0
M  V30 5 O 4.7710 9.7573 0.0 0
M  V30 6 O 3.2310 7.0898 0.0 0
M  V30 7 C 5.8439 0.4286 0.0 0
M  V30 8 C 7.8598 0.0000 0.0 0
M  V30 9 N 15.4506 6.8242 0.0 0
M  V30 10 C 16.4811 7.9687 0.0 0
M  V30 11 N 4.0010 11.5037 0.0 0 VAL=5
M  V30 12 O 5.3348 10.7337 0.0 0
M  V30 13 O 4.0010 13.0437 0.0 0
M  V30 14 C 9.1059 4.8255 0.0 0 CFG=2
M  V30 15 C 8.3359 3.4917 0.0 0 CFG=2
M  V30 16 O 8.0753 5.9699 0.0 0
M  V30 17 C 6.8294 3.8119 0.0 0 CFG=2
M  V30 18 O 8.4968 1.9601 0.0 0
M  V30 19 C 6.6685 5.3436 0.0 0 CFG=2
M  V30 20 O 6.0594 2.4782 0.0 0
M  V30 21 C 7.0898 1.3338 0.0 0
M  V30 22 N 10.6374 4.9865 0.0 0
M  V30 23 C 11.4074 6.3201 0.0 0
M  V30 24 C 11.6679 3.8419 0.0 0
M  V30 25 C 12.9137 5.9999 0.0 0
M  V30 26 N 10.9316 7.7848 0.0 0
M  V30 27 N 13.0748 4.4684 0.0 0
M  V30 28 C 13.9443 7.1443 0.0 0
M  V30 29 C 11.9620 8.9292 0.0 0
M  V30 30 N 13.4683 8.6091 0.0 0
M  V30 31 C 2.6673 9.1937 0.0 0
M  V30 32 C 2.6673 10.7337 0.0 0
M  V30 33 C 1.3337 8.4236 0.0 0
M  V30 34 C 1.3337 11.5037 0.0 0
M  V30 35 C 0.0000 9.1937 0.0 0
M  V30 36 C 0.0000 10.7337 0.0 0
M  V30 37 H 9.8422 3.1715 0.0 0
M  V30 38 H 5.3231 4.1320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 3 31
M  V30 8 1 7 21
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 9 28
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 32
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 22 CFG=1
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 37 CFG=1
M  V30 21 1 16 19
M  V30 22 1 17 19
M  V30 23 1 17 20
M  V30 24 1 17 38 CFG=1
M  V30 25 1 18 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 23 26
M  V30 31 2 24 27
M  V30 32 1 25 27
M  V30 33 2 25 28
M  V30 34 1 26 29
M  V30 35 1 28 30
M  V30 36 2 29 30
M  V30 37 2 31 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 2 33 35
M  V30 41 2 34 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2135821-75-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2135822-05-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18008680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of analogs of
5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or
AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with
antitrypanosomal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brockway, Anthony J.; Volkov, Oleg A.; Cosner, Casey C.; MacMillan, Karen
S.; Wring, Stephen A.; Richardson, Thomas E.; Peel, Michael; Phillips,
Margaret A.; De Brabander, Jef K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(20), 5433-5440

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[2-deoxy-2-fluoro-4-C-(fluoromethyl)-β-D-arabinofuranosyl]-9H-puri...
C11H12ClF2N5O3
2171104-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 3.3325 7.1223 0.0 0
M  V30 2 C 0.6263 3.1534 0.0 0
M  V30 3 F 0.0000 1.7465 0.0 0
M  V30 4 C 2.1579 1.7744 0.0 0
M  V30 5 O 3.4916 1.0044 0.0 0
M  V30 6 O 0.4309 5.4472 0.0 0
M  V30 7 Cl 10.9678 4.6201 0.0 0
M  V30 8 N 8.3004 0.0000 0.0 0
M  V30 9 N 5.8222 4.8805 0.0 0
M  V30 10 C 6.9668 3.8501 0.0 0
M  V30 11 C 6.4487 6.2873 0.0 0
M  V30 12 C 8.3004 4.6201 0.0 0
M  V30 13 N 6.9668 2.3100 0.0 0
M  V30 14 N 7.9803 6.1264 0.0 0
M  V30 15 C 9.6341 3.8501 0.0 0
M  V30 16 C 8.3004 1.5400 0.0 0
M  V30 17 N 9.6341 2.3100 0.0 0
M  V30 18 C 4.3159 4.5603 0.0 0 CFG=1
M  V30 19 O 3.6894 3.1534 0.0 0
M  V30 20 C 3.1714 5.5908 0.0 0 CFG=1
M  V30 21 C 2.1579 3.3145 0.0 0 CFG=1
M  V30 22 C 1.8377 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 21 2 CFG=1
M  V30 4 1 4 5
M  V30 5 1 21 4 CFG=3
M  V30 6 1 22 6 CFG=1
M  V30 7 1 7 15
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[2-Deoxy-2-fluoro-4-C-(fluoromethyl)-β-D-arabinofuranosyl]-N6-methyl-9H-pur...
C12H16F2N6O3
2171104-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.9679 4.6201 0.0 0
M  V30 2 C 12.3017 3.8501 0.0 0
M  V30 3 N 8.3006 0.0000 0.0 0
M  V30 4 F 3.3325 7.1223 0.0 0
M  V30 5 C 0.6265 3.1534 0.0 0
M  V30 6 F 0.0000 1.7465 0.0 0
M  V30 7 C 2.1580 1.7744 0.0 0
M  V30 8 O 3.4917 1.0044 0.0 0
M  V30 9 O 0.4309 5.4472 0.0 0
M  V30 10 C 6.9669 3.8501 0.0 0
M  V30 11 N 5.8224 4.8805 0.0 0
M  V30 12 C 8.3006 4.6201 0.0 0
M  V30 13 N 6.9669 2.3100 0.0 0
M  V30 14 C 6.4487 6.2873 0.0 0
M  V30 15 C 9.6342 3.8501 0.0 0
M  V30 16 N 7.9804 6.1264 0.0 0
M  V30 17 C 8.3006 1.5400 0.0 0
M  V30 18 N 9.6342 2.3100 0.0 0
M  V30 19 C 4.3161 4.5603 0.0 0 CFG=1
M  V30 20 O 3.6896 3.1534 0.0 0
M  V30 21 C 3.1715 5.5908 0.0 0 CFG=1
M  V30 22 C 2.1580 3.3144 0.0 0 CFG=1
M  V30 23 C 1.8379 4.8207 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 17
M  V30 4 1 21 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=3
M  V30 9 1 23 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 19 11 CFG=3
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2171104-64-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171104-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18786987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed container used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 6-aminopurine nucleotides for the treatment of
paramyxovirus and orthomyxovirus infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018009623 A1 2018-01-11

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-[6-(dimethylamino)-2-naphthalenyl]-3-pyridinecarbonitrile
C18H14ClN3
219968-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 N 2.6673 6.1601 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 N 12.0033 5.3901 0.0 0
M  V30 5 C 13.3370 4.6201 0.0 0
M  V30 6 C 12.0033 6.9302 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 N 1.3337 0.7700 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-(Dimethylamino)-2-naphthalenyl]-2-(methylamino)-3-pyridinecarbonitrile
C19H18N4
219968-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 N 4.0010 6.1601 0.0 0
M  V30 3 N 1.3337 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 13.3370 5.3901 0.0 0
M  V30 6 C 13.3370 6.9302 0.0 0
M  V30 7 C 14.6707 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 N 2.6673 0.7700 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 9.3358 3.0801 0.0 0
M  V30 18 C 8.0022 5.3901 0.0 0
M  V30 19 C 9.3358 4.6201 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 21 C 10.6697 5.3901 0.0 0
M  V30 22 C 12.0033 3.0801 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 219968-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 219968-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-311270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1 (s)-Preparation of
4-[6-(dimethylamino)-2-naphthyl]-2-(methylamino)nicotinonitrle
2-chloro-4-[6-(dimethylamino)-2-naphthyl]nicotinonitrile (194.5 mg, 0.63
mmol), prepared as described in Example 1(j) above, was suspended in
ethanolic solution of methylamine (5 mL of 33% solution) and heated under
reflux for 1 h. Additional 5 mL of methanolic methylamine was added and
heating was continued for 9 h. After cooling,
4-[6-(dimethylamino)-2-naphthyl]-2-(methylamino)nicotinonitrile was
filtered off (147 mg, 77%). Additional amount of product (40 mg), leading
to a total yield of 98%, was isolated from the mother liquor by radial
chromatography (1 mm silica, 1% of MeOH in dichloromethane). mp
193-194°C.; Elemental analysis calculated for C19H18N4: C, 75.470; H,
6.00; N, 18.53. Pound: C, 75.28; H, 5.99; N, 18.48; IR (KBr pellet): 2210
cm−1 (CN), 3270 cm−1 (NH); 1H NMR (300 MHz, CDCl3) δ : 3.1 (s, 6H, NMe2),
3.12 (d, 3H, MeNH, J=4.8 Hz), 5.38 (bs, 1H, NH), 6.76 (d, 1H, H-5′, J=5.3
Hz), 6.92 (d, 1H, H-5, J=2.5 Hz), 7.20 (dd, 1H, H-7, J=2.5 and 9.1 Hz),
7.56 (dd, 1H, H-3, J=1.9 and 8.6 Hz), 7.73 (d, 1H, H-4, J=8.6 Hz), 7.78
(d, 1H, H-8, J=9.1 Hz), 7.94 (d, 1H, H-1, J=1.9 Hz), 8.29 (d, 1H, H-6′,
J=5.3 Hz).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methanolic methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for binding agents to β-amyloid plaques
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrio, Jorge R.; Petric, Andre J.; Satyamurthy, Nagichettiar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005040337 A2 2005-05-06

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-[6-(dimethylamino)-2-naphthalenyl]-3-pyridinecarbonitrile
C18H14ClN3
219968-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 N 2.6673 6.1601 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 N 12.0033 5.3901 0.0 0
M  V30 5 C 13.3370 4.6201 0.0 0
M  V30 6 C 12.0033 6.9302 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 N 1.3337 0.7700 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-(Dimethylamino)-2-naphthalenyl]-2-(methylamino)-3-pyridinecarbonitrile
C19H18N4
219968-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 N 4.0010 6.1601 0.0 0
M  V30 3 N 1.3337 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 13.3370 5.3901 0.0 0
M  V30 6 C 13.3370 6.9302 0.0 0
M  V30 7 C 14.6707 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 N 2.6673 0.7700 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 9.3358 3.0801 0.0 0
M  V30 18 C 8.0022 5.3901 0.0 0
M  V30 19 C 9.3358 4.6201 0.0 0
M  V30 20 C 10.6697 2.3101 0.0 0
M  V30 21 C 10.6697 5.3901 0.0 0
M  V30 22 C 12.0033 3.0801 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 23
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 219968-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 219968-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14259140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of 4-(2-naphthyl)pyridine derivatives from DDNP
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skofic, Primoz; Dambrot, Cheryl; Kozelj, Matjaz; Golobic, Amalija;
Barrio, Jorge R.; Petric, Andrej
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Chimica Slovenica (2005), 52(4), 391-397

$RFMT $RIREG SCHEME322 STEP1
$RXN



  1  1
$MOL
Methanamine, nitrate (1:1)
CH5N.HNO3
22113-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8501 0.0 0
M  V30 3 O 2.6673 3.8501 0.0 0
M  V30 4 O 1.3337 1.5400 0.0 0
M  V30 5 C 0.5637 0.0000 0.0 0
M  V30 6 N 2.1037 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, compd. with nitronitramide (1:1)
CH5N.HN3O4
165603-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 3.8500 0.0 0
M  V30 2 N 4.0011 3.0800 0.0 0 VAL=5
M  V30 3 N 1.3338 3.0800 0.0 0 VAL=5
M  V30 4 O 4.0011 1.5400 0.0 0
M  V30 5 O 5.3349 3.8500 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 1.3338 1.5400 0.0 0
M  V30 8 C 1.8974 0.0000 0.0 0
M  V30 9 N 3.4374 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22113-87-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 165603-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41063143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 140456-79-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM ionic liquid formed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Replacement of Toxic Hydrazines in Satellite Propulsion with Greener
Dinitramide-Based Energetic Ionic Liquid Candidates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le, Duc-Minh; Renault, Anne; Delage, Arthur; Ducos, Paul; Miro-Sabate,
Carlos; Pelletier, Nicolas; Lacote, Emmanuel; Jacob, Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2024), 30(31), e202303965

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
rel-Methyl (3aR,8aR)-2,3,3a,8a-tetrahydro-3a-(3-methyl-2-buten-1-yl)-2-oxo-8H...
C17H19NO4
221230-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.5411 0.0 0
M  V30 2 C 2.6673 3.7711 0.0 0
M  V30 3 C 1.3337 4.5411 0.0 0
M  V30 4 C 1.3337 6.0811 0.0 0
M  V30 5 C 0.0000 3.7711 0.0 0
M  V30 6 C 9.3193 3.7115 0.0 0
M  V30 7 O 10.3497 4.8558 0.0 0
M  V30 8 O 9.7952 2.2467 0.0 0
M  V30 9 C 11.8560 4.5357 0.0 0
M  V30 10 O 4.0466 0.0000 0.0 0
M  V30 11 C 5.3348 3.7711 0.0 0 CFG=2
M  V30 12 C 6.6684 3.0010 0.0 0 CFG=2
M  V30 13 C 5.6550 5.2775 0.0 0
M  V30 14 C 4.1902 2.7406 0.0 0
M  V30 15 N 7.8128 4.0316 0.0 0
M  V30 16 O 6.3483 1.4947 0.0 0
M  V30 17 C 7.1865 5.4384 0.0 0
M  V30 18 C 4.7497 6.5234 0.0 0
M  V30 19 C 4.8166 1.3338 0.0 0
M  V30 20 C 7.8128 6.8454 0.0 0
M  V30 21 C 5.3761 7.9302 0.0 0
M  V30 22 C 6.9076 8.0913 0.0 0
M  V30 23 H 8.0021 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=3
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a-(3-methyl-2-buten-1-yl)pyrrolo...
C16H20N2O
161991-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9099 3.0800 0.0 0
M  V30 2 C 2.5761 2.3100 0.0 0
M  V30 3 C 2.5761 0.7700 0.0 0
M  V30 4 C 1.2425 0.0000 0.0 0
M  V30 5 C 3.9099 0.0000 0.0 0
M  V30 6 C 1.9694 8.1004 0.0 0
M  V30 7 O 0.0000 5.3900 0.0 0
M  V30 8 C 3.9099 4.6200 0.0 0 CFG=2
M  V30 9 C 5.3745 4.1440 0.0 0
M  V30 10 C 3.9099 6.1600 0.0 0 CFG=1
M  V30 11 C 2.4452 4.1440 0.0 0
M  V30 12 C 6.2797 5.3900 0.0 0
M  V30 13 C 6.0009 2.7372 0.0 0
M  V30 14 N 5.3745 6.6359 0.0 0
M  V30 15 N 2.4452 6.6359 0.0 0
M  V30 16 C 1.5400 5.3900 0.0 0
M  V30 17 C 7.8112 5.2289 0.0 0
M  V30 18 C 7.5325 2.5763 0.0 0
M  V30 19 C 8.4377 3.8221 0.0 0
M  V30 20 H 3.9099 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 2 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 20 CFG=3
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 221230-12-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 161991-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-2719628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First total syntheses of dihydroflustramine C and flustramine E,
alkaloids from the marine bryozoan Flustra foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(8), 1479-1484

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-3a-(1,1-Dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-8-(3-methy...
C20H25NO2
221230-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.5411 0.0 0
M  V30 2 C 1.3337 3.7711 0.0 0
M  V30 3 C 1.3337 5.3111 0.0 0
M  V30 4 C 2.6673 6.0811 0.0 0
M  V30 5 C 0.0000 4.5411 0.0 0
M  V30 6 C 7.9857 3.7115 0.0 0
M  V30 7 C 9.0161 4.8559 0.0 0
M  V30 8 C 10.5226 4.5357 0.0 0
M  V30 9 C 10.9984 3.0710 0.0 0
M  V30 10 C 11.5530 5.6801 0.0 0
M  V30 11 O 2.7131 0.0000 0.0 0
M  V30 12 C 4.0011 3.7711 0.0 0 CFG=2
M  V30 13 C 5.3348 3.0011 0.0 0 CFG=2
M  V30 14 C 4.3213 5.2775 0.0 0
M  V30 15 C 2.8566 2.7406 0.0 0
M  V30 16 N 6.4792 4.0316 0.0 0
M  V30 17 O 5.0146 1.4948 0.0 0
M  V30 18 C 5.8529 5.4385 0.0 0
M  V30 19 C 3.4161 6.5234 0.0 0
M  V30 20 C 3.4831 1.3338 0.0 0
M  V30 21 C 6.4792 6.8454 0.0 0
M  V30 22 C 4.0424 7.9302 0.0 0
M  V30 23 C 5.5741 8.0913 0.0 0
M  V30 24 H 6.6685 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 12 1 CFG=3
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 24 CFG=3
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-3a-(1,1-Dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-1-methyl-8...
C21H28N2O
221230-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.5411 0.0 0
M  V30 2 C 1.3337 3.7711 0.0 0
M  V30 3 C 1.3337 5.3111 0.0 0
M  V30 4 C 2.6673 6.0811 0.0 0
M  V30 5 C 0.0000 4.5411 0.0 0
M  V30 6 C 7.9856 3.7115 0.0 0
M  V30 7 C 9.0161 4.8559 0.0 0
M  V30 8 C 10.5225 4.5357 0.0 0
M  V30 9 C 10.9984 3.0710 0.0 0
M  V30 10 C 11.5530 5.6801 0.0 0
M  V30 11 C 6.0451 0.3502 0.0 0
M  V30 12 O 2.7131 0.0000 0.0 0
M  V30 13 C 4.0011 3.7711 0.0 0 CFG=2
M  V30 14 C 5.3348 3.0010 0.0 0 CFG=2
M  V30 15 C 4.3213 5.2775 0.0 0
M  V30 16 C 2.8566 2.7406 0.0 0
M  V30 17 N 6.4792 4.0316 0.0 0
M  V30 18 N 5.0146 1.4947 0.0 0
M  V30 19 C 5.8529 5.4384 0.0 0
M  V30 20 C 3.4161 6.5234 0.0 0
M  V30 21 C 3.4831 1.3338 0.0 0
M  V30 22 C 6.4792 6.8454 0.0 0
M  V30 23 C 4.0424 7.9302 0.0 0
M  V30 24 C 5.5741 8.0913 0.0 0
M  V30 25 H 6.6685 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 13 1 CFG=3
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 18
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 25 CFG=3
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221230-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 221230-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9643486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for Lactamization. To a solution of the appropriate
lactone 16a (0.32 mmol), 17a (0.32 mmol), 16b (0.23 mmol), or 17b (0.23
mmol) in MeOH (10 mL) was added NH2Me (2 mL of a 2.0 M solution in MeOH,
4 mmol). The reaction mixture was stirred for 5, 2, 24, or 15 h,
respectively, at rt. The mixture was evaporated, and the resultant crude
lactam 18, 3, 19, or 4 was purified by silica gel flash column
chromatography (1:1 EtOAc/hexane).
1-Methyl-3a-(2-methyl-3-buten-2-yl)-8-(3-methyl-2-buten-1-yl)-2-oxo-2,3,3a,8a-tetrahydro-8H-pyrrolo[2,3-b]indole,
Debromoflustramide A (18). Prepared from 16a as a colorless oil (102 mg,
98% yield): Rf 0.45 (1:1 EtOAc/hexane); IR (CHCl3) νmax 2934, 1678, 1602,
1492 cm-1; 1H NMR (DMSO-d6) δ 7.13 (1H, br d, J = 7.4 Hz), 7.12 (1H, br
t, J = 7.6 Hz), 6.93 (1H, br t, J = 7.4 Hz), 6.51 (1H, br d, J = 7.8 Hz),
5.92 (1H, dd, J = 17.3, 10.9 Hz), 5.33 (1H, br t, J = 6.6 Hz), 5.13 (1H,
dd, J = 10.9, 1.2 Hz), 5.08 (1H, dd, J = 17.3, 1.5 Hz), 5.05 (1H, s),
4.09 (1H, dd, J = 15.9, 6.7 Hz), 3.97 (1H, dd, J = 15.9, 6.7 Hz), 2.82
(1H, d, J = 17.1 Hz), 2.79 (3H, s), 2.44 (1H, d, J = 17.1 Hz), 1.78 (3H,
s), 1.76 (3H, s), 1.02 (3H, s), 0.92 (3H, s); 13C NMR (DMSO-d6) δ 171.5,
149.5, 143.9, 134.0, 132.4, 128.6, 124.9, 121.5, 117.5, 114.0, 107.6,
84.7, 55.2, 45.7, 40.9, 39.1, 27.2, 25.4, 22.5, 21.5, 17.9; EIMS m/z
(relative intensity) 324 (M+, 22); HRMS (FAB) m/e 324.2199 (M+, C21H28N2O
requires 324.2202).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total syntheses of five indole alkaloids from the marine bryozoan Flustra
foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Trujillo-Serrato,
Joel J.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(4), 1186-1192

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(4-cyanophenyl)-5-(3-phenanthrenyl)-1H-pyrazole-3-carboxylate
C26H17N3O2
2225885-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3269 2.4369 0.0 0
M  V30 2 O 5.0810 1.5317 0.0 0
M  V30 3 O 7.7338 1.8105 0.0 0
M  V30 4 C 5.2419 0.0000 0.0 0
M  V30 5 C 1.0304 10.8227 0.0 0
M  V30 6 N 0.0000 11.9672 0.0 0
M  V30 7 C 6.6840 6.4059 0.0 0
M  V30 8 N 5.1525 6.2448 0.0 0
M  V30 9 C 7.3103 4.9989 0.0 0
M  V30 10 N 4.8323 4.7385 0.0 0
M  V30 11 C 6.1659 3.9685 0.0 0
M  V30 12 C 7.4540 7.7395 0.0 0
M  V30 13 C 8.9940 7.7395 0.0 0
M  V30 14 C 6.6840 9.0732 0.0 0
M  V30 15 C 9.7640 9.0732 0.0 0
M  V30 16 C 7.4540 10.4069 0.0 0
M  V30 17 C 11.3041 9.0732 0.0 0
M  V30 18 C 8.9940 10.4069 0.0 0
M  V30 19 C 12.0741 10.4069 0.0 0
M  V30 20 C 12.0741 7.7395 0.0 0
M  V30 21 C 9.7640 11.7407 0.0 0
M  V30 22 C 11.3041 11.7407 0.0 0
M  V30 23 C 13.6141 10.4069 0.0 0
M  V30 24 C 13.6141 7.7395 0.0 0
M  V30 25 C 14.3841 9.0732 0.0 0
M  V30 26 C 4.1219 7.3893 0.0 0
M  V30 27 C 4.5979 8.8539 0.0 0
M  V30 28 C 2.6156 7.0692 0.0 0
M  V30 29 C 3.5673 9.9984 0.0 0
M  V30 30 C 1.5851 8.2136 0.0 0
M  V30 31 C 2.0610 9.6783 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 31
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 2 19 22
M  V30 25 1 19 23
M  V30 26 2 20 24
M  V30 27 1 21 22
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Cyanophenyl)-N-methyl-5-(3-phenanthrenyl)-1H-pyrazole-3-carboxamide
C26H18N4O
2225887-85-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3269 2.4369 0.0 0
M  V30 2 N 5.0810 1.5317 0.0 0
M  V30 3 O 7.7338 1.8105 0.0 0
M  V30 4 C 5.2419 0.0000 0.0 0
M  V30 5 C 1.0304 10.8227 0.0 0
M  V30 6 N 0.0000 11.9672 0.0 0
M  V30 7 C 6.6840 6.4059 0.0 0
M  V30 8 N 5.1525 6.2448 0.0 0
M  V30 9 C 7.3103 4.9989 0.0 0
M  V30 10 N 4.8323 4.7385 0.0 0
M  V30 11 C 6.1659 3.9685 0.0 0
M  V30 12 C 7.4540 7.7395 0.0 0
M  V30 13 C 8.9940 7.7395 0.0 0
M  V30 14 C 6.6840 9.0732 0.0 0
M  V30 15 C 9.7640 9.0732 0.0 0
M  V30 16 C 7.4540 10.4069 0.0 0
M  V30 17 C 11.3041 9.0732 0.0 0
M  V30 18 C 8.9940 10.4069 0.0 0
M  V30 19 C 12.0741 10.4069 0.0 0
M  V30 20 C 12.0741 7.7395 0.0 0
M  V30 21 C 9.7640 11.7407 0.0 0
M  V30 22 C 11.3041 11.7407 0.0 0
M  V30 23 C 13.6141 10.4069 0.0 0
M  V30 24 C 13.6141 7.7395 0.0 0
M  V30 25 C 14.3841 9.0732 0.0 0
M  V30 26 C 4.1219 7.3893 0.0 0
M  V30 27 C 4.5979 8.8539 0.0 0
M  V30 28 C 2.6156 7.0692 0.0 0
M  V30 29 C 3.5673 9.9984 0.0 0
M  V30 30 C 1.5851 8.2136 0.0 0
M  V30 31 C 2.0610 9.6783 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 31
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 2 18 21
M  V30 24 2 19 22
M  V30 25 1 19 23
M  V30 26 2 20 24
M  V30 27 1 21 22
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2225885-41-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2225887-85-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19129307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of anti-fungal pesticides from protein kinase inhibitor-based
anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Yihui; Liang, Shen; Zhang, Yongchao; Yang, Dangwei; Wang, Ruofei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 148349-358

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[4-(aminosulfonyl)phenyl]-5-(3-phenanthrenyl)-1H-pyrazole-3-carboxylate
C25H19N3O4S
2225892-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4409 2.4369 0.0 0
M  V30 2 O 5.1950 1.5317 0.0 0
M  V30 3 O 7.8479 1.8105 0.0 0
M  V30 4 C 5.3559 0.0000 0.0 0
M  V30 5 S 1.1446 10.8227 0.0 0 VAL=6
M  V30 6 N 0.1140 11.9673 0.0 0
M  V30 7 O 2.2890 11.8532 0.0 0
M  V30 8 O 0.0000 9.7923 0.0 0
M  V30 9 C 6.7980 6.4059 0.0 0
M  V30 10 N 5.2665 6.2448 0.0 0
M  V30 11 C 7.4243 4.9989 0.0 0
M  V30 12 N 4.9463 4.7385 0.0 0
M  V30 13 C 6.2799 3.9685 0.0 0
M  V30 14 C 7.5680 7.7396 0.0 0
M  V30 15 C 9.1081 7.7396 0.0 0
M  V30 16 C 6.7980 9.0733 0.0 0
M  V30 17 C 9.8781 9.0733 0.0 0
M  V30 18 C 7.5680 10.4069 0.0 0
M  V30 19 C 11.4181 9.0733 0.0 0
M  V30 20 C 9.1081 10.4069 0.0 0
M  V30 21 C 12.1881 10.4069 0.0 0
M  V30 22 C 12.1881 7.7396 0.0 0
M  V30 23 C 9.8781 11.7408 0.0 0
M  V30 24 C 11.4181 11.7408 0.0 0
M  V30 25 C 13.7282 10.4069 0.0 0
M  V30 26 C 13.7282 7.7396 0.0 0
M  V30 27 C 14.4982 9.0733 0.0 0
M  V30 28 C 4.2359 7.3894 0.0 0
M  V30 29 C 4.7119 8.8540 0.0 0
M  V30 30 C 2.7296 7.0692 0.0 0
M  V30 31 C 3.6813 9.9985 0.0 0
M  V30 32 C 1.6991 8.2136 0.0 0
M  V30 33 C 2.1750 9.6783 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 33
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 24
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Aminosulfonyl)phenyl]-N-methyl-5-(3-phenanthrenyl)-1H-pyrazole-3-carbox...
C25H20N4O3S
2225888-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4409 2.4369 0.0 0
M  V30 2 N 5.1950 1.5317 0.0 0
M  V30 3 O 7.8479 1.8105 0.0 0
M  V30 4 C 5.3559 0.0000 0.0 0
M  V30 5 S 1.1446 10.8227 0.0 0 VAL=6
M  V30 6 N 0.1140 11.9673 0.0 0
M  V30 7 O 0.0000 9.7923 0.0 0
M  V30 8 O 2.2890 11.8532 0.0 0
M  V30 9 C 6.7980 6.4059 0.0 0
M  V30 10 N 5.2665 6.2448 0.0 0
M  V30 11 C 7.4243 4.9989 0.0 0
M  V30 12 N 4.9463 4.7385 0.0 0
M  V30 13 C 6.2799 3.9685 0.0 0
M  V30 14 C 7.5680 7.7396 0.0 0
M  V30 15 C 9.1081 7.7396 0.0 0
M  V30 16 C 6.7980 9.0733 0.0 0
M  V30 17 C 9.8781 9.0733 0.0 0
M  V30 18 C 7.5680 10.4069 0.0 0
M  V30 19 C 11.4181 9.0733 0.0 0
M  V30 20 C 9.1081 10.4069 0.0 0
M  V30 21 C 12.1881 10.4069 0.0 0
M  V30 22 C 12.1881 7.7396 0.0 0
M  V30 23 C 9.8781 11.7408 0.0 0
M  V30 24 C 11.4181 11.7408 0.0 0
M  V30 25 C 13.7282 10.4069 0.0 0
M  V30 26 C 13.7282 7.7396 0.0 0
M  V30 27 C 14.4982 9.0733 0.0 0
M  V30 28 C 4.2359 7.3894 0.0 0
M  V30 29 C 4.7119 8.8540 0.0 0
M  V30 30 C 2.7296 7.0692 0.0 0
M  V30 31 C 3.6813 9.9985 0.0 0
M  V30 32 C 1.6991 8.2136 0.0 0
M  V30 33 C 2.1750 9.6783 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 33
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 24
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2225892-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2225888-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19129306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of anti-fungal pesticides from protein kinase inhibitor-based
anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Yihui; Liang, Shen; Zhang, Yongchao; Yang, Dangwei; Wang, Ruofei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 148349-358

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[7-[(methylsulfonyl)oxy]heptyl]-, 1,1-dimethylethyl ester
C13H27NO5S
2243093-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 0.5637 2.8737 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 N 5.3348 2.3101 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 13.3372 2.3101 0.0 0
M  V30 15 C 14.6708 1.5400 0.0 0
M  V30 16 O 16.0045 2.3101 0.0 0
M  V30 17 S 17.3383 1.5400 0.0 0 VAL=6
M  V30 18 C 18.1083 2.8737 0.0 0
M  V30 19 O 18.6720 0.7700 0.0 0
M  V30 20 O 16.5683 0.2064 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 2 17 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[7-(methylamino)heptyl]-, 1,1-dimethylethyl ester
C13H28N2O2
2352661-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3338 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 C 2.1038 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5638 2.8737 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 12.0035 1.5400 0.0 0
M  V30 14 C 13.3372 2.3101 0.0 0
M  V30 15 C 14.6708 1.5400 0.0 0
M  V30 16 N 16.0045 2.3101 0.0 0
M  V30 17 C 17.3383 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2243093-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2352661-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22611262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-hydroxybenzaldehyde
C7H5BrO2
22532-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 2.3101 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methylamino)-2-[(methylimino)methyl]phenol
C9H12N2O
2763215-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 N 7.7002 4.0010 0.0 0
M  V30 3 C 9.2402 4.0010 0.0 0
M  V30 4 O 5.3901 0.0000 0.0 0
M  V30 5 N 0.7700 2.6673 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 3.0801 4.0010 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22532-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763215-07-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31721021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann reaction, sealed vessel used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugates including a detectable moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lefever, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022043491 A2 2022-03-03

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
(3R)-1′-[(1,1-Dimethylethoxy)carbonyl]-2-oxo[1,4′-bipiperidine]-3-acetic acid
C17H28N2O5
226917-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6696 4.6200 0.0 0
M  V30 2 C 13.3369 3.0800 0.0 0
M  V30 3 C 14.6705 2.3100 0.0 0
M  V30 4 O 14.6705 0.7700 0.0 0
M  V30 5 O 16.0043 3.0800 0.0 0
M  V30 6 C 4.0011 5.3900 0.0 0
M  V30 7 O 2.6674 4.6200 0.0 0
M  V30 8 O 4.0011 6.9300 0.0 0
M  V30 9 C 1.3338 5.3900 0.0 0
M  V30 10 C 2.1038 6.7236 0.0 0
M  V30 11 C 0.0000 6.1600 0.0 0
M  V30 12 C 0.5638 4.0564 0.0 0
M  V30 13 N 9.3358 2.3100 0.0 0
M  V30 14 C 10.6696 3.0800 0.0 0
M  V30 15 C 9.3358 0.7700 0.0 0
M  V30 16 C 12.0032 2.3100 0.0 0 CFG=1
M  V30 17 C 10.6696 0.0000 0.0 0
M  V30 18 C 12.0032 0.7700 0.0 0
M  V30 19 C 8.0021 3.0800 0.0 0
M  V30 20 C 8.0021 4.6200 0.0 0
M  V30 21 C 6.6685 2.3100 0.0 0
M  V30 22 C 6.6685 5.3900 0.0 0
M  V30 23 C 5.3347 3.0800 0.0 0
M  V30 24 N 5.3347 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-[2-(methylamino)-2-oxoethyl]-2-oxo[1,4′-bipiperidine...
C18H31N3O4
474310-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 4.6201 0.0 0
M  V30 2 C 13.3370 3.0800 0.0 0
M  V30 3 C 14.6707 2.3100 0.0 0
M  V30 4 N 16.0043 3.0800 0.0 0
M  V30 5 O 14.6707 0.7700 0.0 0
M  V30 6 C 17.3381 2.3100 0.0 0
M  V30 7 C 4.0011 5.3901 0.0 0
M  V30 8 O 2.6675 4.6201 0.0 0
M  V30 9 O 4.0011 6.9301 0.0 0
M  V30 10 C 1.3338 5.3901 0.0 0
M  V30 11 C 0.5638 4.0564 0.0 0
M  V30 12 C 0.0000 6.1601 0.0 0
M  V30 13 C 2.1038 6.7237 0.0 0
M  V30 14 N 9.3359 2.3100 0.0 0
M  V30 15 C 10.6695 3.0800 0.0 0
M  V30 16 C 9.3359 0.7700 0.0 0
M  V30 17 C 12.0034 2.3100 0.0 0 CFG=1
M  V30 18 C 10.6695 0.0000 0.0 0
M  V30 19 C 12.0034 0.7700 0.0 0
M  V30 20 C 8.0022 3.0800 0.0 0
M  V30 21 C 6.6686 2.3100 0.0 0
M  V30 22 C 8.0022 4.6201 0.0 0
M  V30 23 C 5.3348 3.0800 0.0 0
M  V30 24 C 6.6686 5.3901 0.0 0
M  V30 25 N 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 226917-24-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 474310-39-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-682392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The asymmetric synthesis of
(3R)-N-methyl-2-oxo-[1,4'-bipiperidine]-3-acetamide in quantity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reichard, Gregory A.; Spitler, James; Mergelsberg, Ingrid; Miller, Alan;
Wong, George; Raghavan, Ramani; Jenkins, John; Gan, Tong; McPhail, Andrew
T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2002), 13(9), 939-943

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-[[(4-Methoxyphenyl)methyl]methylamino]-2-oxo-2-[[4-[1-(tetrahydro-2H-pyr...
C32H34N4O5
2269472-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 C 8.4700 6.6684 0.0 0
M  V30 3 N 6.1600 8.0020 0.0 0
M  V30 4 N 9.2400 8.0020 0.0 0
M  V30 5 O 9.2400 5.3347 0.0 0
M  V30 6 C 4.6200 8.0020 0.0 0
M  V30 7 C 6.9300 9.3358 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 O 2.3100 1.3336 0.0 0
M  V30 10 O 4.6200 0.0000 0.0 0
M  V30 11 O 1.5400 13.3368 0.0 0
M  V30 12 C 0.0000 13.3368 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.9300 4.0009 0.0 0
M  V30 16 C 3.8500 4.0009 0.0 0
M  V30 17 C 6.1600 2.6673 0.0 0
M  V30 18 C 4.6200 2.6673 0.0 0
M  V30 19 C 10.7801 8.0020 0.0 0
M  V30 20 C 11.5501 6.6684 0.0 0
M  V30 21 C 11.5501 9.3358 0.0 0
M  V30 22 C 13.0901 6.6684 0.0 0
M  V30 23 C 13.0901 9.3358 0.0 0
M  V30 24 C 13.8601 8.0020 0.0 0
M  V30 25 C 3.8500 9.3358 0.0 0
M  V30 26 C 4.6200 10.6695 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 3.8500 12.0031 0.0 0
M  V30 29 C 1.5400 10.6695 0.0 0
M  V30 30 C 2.3100 12.0031 0.0 0
M  V30 31 C 15.4001 8.0020 0.0 0
M  V30 32 C 16.3053 9.2479 0.0 0
M  V30 33 C 16.3053 6.7562 0.0 0
M  V30 34 N 17.7698 8.7720 0.0 0
M  V30 35 N 17.7698 7.2320 0.0 0
M  V30 36 C 19.0157 9.6773 0.0 0
M  V30 37 C 18.8548 11.2088 0.0 0
M  V30 38 O 20.4227 9.0509 0.0 0
M  V30 39 C 20.1006 12.1140 0.0 0
M  V30 40 C 21.6685 9.9562 0.0 0
M  V30 41 C 21.5076 11.4877 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 19
M  V30 9 1 6 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 18
M  V30 13 1 11 12
M  V30 14 1 11 30
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 31
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[(4-Methoxyphenyl)methyl]methylamino]-4-[(methylamino)carbonyl]-N-[4-[1-(t...
C33H37N5O4
2269472-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0020 0.0 0
M  V30 2 C 8.4700 8.0020 0.0 0
M  V30 3 N 6.1600 9.3357 0.0 0
M  V30 4 N 9.2400 9.3357 0.0 0
M  V30 5 O 9.2400 6.6684 0.0 0
M  V30 6 C 4.6200 9.3357 0.0 0
M  V30 7 C 6.9300 10.6695 0.0 0
M  V30 8 C 3.8500 2.6673 0.0 0
M  V30 9 N 4.6200 1.3336 0.0 0
M  V30 10 O 2.3100 2.6673 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 O 1.5400 14.6704 0.0 0
M  V30 13 C 0.0000 14.6704 0.0 0
M  V30 14 C 6.1600 6.6684 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 6.1600 4.0009 0.0 0
M  V30 19 C 4.6200 4.0009 0.0 0
M  V30 20 C 10.7801 9.3357 0.0 0
M  V30 21 C 11.5501 10.6695 0.0 0
M  V30 22 C 11.5501 8.0020 0.0 0
M  V30 23 C 13.0901 10.6695 0.0 0
M  V30 24 C 13.0901 8.0020 0.0 0
M  V30 25 C 13.8601 9.3357 0.0 0
M  V30 26 C 3.8500 10.6695 0.0 0
M  V30 27 C 2.3100 10.6695 0.0 0
M  V30 28 C 4.6200 12.0031 0.0 0
M  V30 29 C 1.5400 12.0031 0.0 0
M  V30 30 C 3.8500 13.3368 0.0 0
M  V30 31 C 2.3100 13.3368 0.0 0
M  V30 32 C 15.4001 9.3357 0.0 0
M  V30 33 C 16.3053 10.5817 0.0 0
M  V30 34 C 16.3053 8.0898 0.0 0
M  V30 35 N 17.7698 10.1057 0.0 0
M  V30 36 N 17.7698 8.5657 0.0 0
M  V30 37 C 19.0157 11.0109 0.0 0
M  V30 38 C 18.8548 12.5424 0.0 0
M  V30 39 O 20.4227 10.3846 0.0 0
M  V30 40 C 20.1006 13.4477 0.0 0
M  V30 41 C 21.6685 11.2898 0.0 0
M  V30 42 C 21.5076 12.8213 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 20
M  V30 9 1 6 26
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 19
M  V30 13 1 9 11
M  V30 14 1 12 13
M  V30 15 1 12 31
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 25 32
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2269472-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2269472-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21017080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of rho associated coiled-coil containing protein kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skucas, Eduardas; Liu, Kevin G.; Kim, Ji-In; Poyurovsky, Masha V.; Mo,
Rigen; Zhang, Jingya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019018855 A1 2019-01-24

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butoxycarbonyl-D-valine
C10H19NO4
22838-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=1
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R)-2-methyl-1-[(methylamino)carbonyl]propyl]-, 1,1-dimethyl...
C11H22N2O3
122902-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.2074 0.0 0 CFG=1
M  V30 2 C 7.7000 4.2074 0.0 0
M  V30 3 N 5.3900 2.8738 0.0 0
M  V30 4 C 5.3900 5.5411 0.0 0
M  V30 5 N 8.4700 2.8738 0.0 0
M  V30 6 O 8.4700 5.5411 0.0 0
M  V30 7 C 3.8500 2.8738 0.0 0
M  V30 8 C 3.8500 5.5411 0.0 0
M  V30 9 C 6.1600 6.8749 0.0 0
M  V30 10 C 10.0100 2.8738 0.0 0
M  V30 11 O 3.0800 1.5400 0.0 0
M  V30 12 O 3.0800 4.2074 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 C 1.5400 0.0000 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 11 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22838-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122902-99-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33341882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridazine derivatives as IL-17 modulators for
treatment and prevention of inflammatory and autoimmune disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brace, Gareth Neil; Chu, Shuyu; Foley, Anne Marie; Johnson, James Andrew;
Norman, Timothy John; Quincey, Joanna Rachel; Reuberson, James Thomas;
Straker, Robert; Townsend, Robert James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022128584 A1 2022-06-23

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(5-Bromopentyl)oxy]benzene
C11H15BrO
22921-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-phenoxy-1-pentanamine
C12H19NO
361395-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 N 12.0033 3.0801 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22921-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361395-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12036071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Antifungal Activity of Novel Conformationally
Restricted Triazole Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Miao, Zhenyuan;
Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2009), 342(12), 732-739

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Diazaspiro[4.5]decane-2,4-dithione
C8H12N2S2
23000-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.5092 0.0000 0.0 0
M  V30 2 S 6.6956 4.3856 0.0 0
M  V30 3 C 3.0800 2.7104 0.0 0
M  V30 4 N 3.9852 3.9564 0.0 0
M  V30 5 C 3.9852 1.4645 0.0 0
M  V30 6 C 2.3100 1.3768 0.0 0
M  V30 7 C 2.3100 4.0442 0.0 0
M  V30 8 C 5.4498 3.4804 0.0 0
M  V30 9 N 5.4498 1.9404 0.0 0
M  V30 10 C 0.7700 1.3768 0.0 0
M  V30 11 C 0.7700 4.0442 0.0 0
M  V30 12 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-1,3-diazaspiro[4.5]dec-3-ene-2-thione
C9H15N3S
364606-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5092 1.1444 0.0 0
M  V30 2 C 4.5398 0.0000 0.0 0
M  V30 3 S 6.6956 5.5302 0.0 0
M  V30 4 C 3.0800 3.8549 0.0 0
M  V30 5 C 3.9852 2.6091 0.0 0
M  V30 6 N 3.9852 5.1008 0.0 0
M  V30 7 C 2.3100 2.5213 0.0 0
M  V30 8 C 2.3100 5.1886 0.0 0
M  V30 9 N 5.4498 3.0849 0.0 0
M  V30 10 C 5.4498 4.6250 0.0 0
M  V30 11 C 0.7700 2.5213 0.0 0
M  V30 12 C 0.7700 5.1886 0.0 0
M  V30 13 C 0.0000 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23000-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 364606-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1168947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Et,propyl and benzylamine have similar reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New method for preparing novel
3-alkyl-2-thioxo-1,3-diazaspiro[4.5]decan-4-one and
4-alkylimino-3-oxa-1-azaspiro[4.5]decane-2-thione derivatives having
potential biological activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ismail, M. A. H.; El-Meligie, Salwa; El-Ansary, Afaf K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Egyptian Journal of Pharmaceutical Sciences (2000), 40(1), 79-92

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-2-chlorobenzene
C10H12BrClO
23468-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 Br 10.6697 2.3101 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Chlorophenoxy)-N-methyl-1-butanamine
C11H16ClNO
91428-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23468-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91428-60-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8643287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)pyrido[3′,2′:5,6]pyrazino...
C19H19ClN6
2378730-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 5.8614 0.0 0
M  V30 2 C 13.2311 8.6333 0.0 0
M  V30 3 N 3.8500 4.5278 0.0 0
M  V30 4 C 4.6200 5.8614 0.0 0
M  V30 5 C 4.3259 3.0631 0.0 0
M  V30 6 C 2.3100 4.5278 0.0 0
M  V30 7 C 3.8500 7.1951 0.0 0
M  V30 8 N 6.1600 5.8614 0.0 0
M  V30 9 C 3.0800 2.1579 0.0 0
M  V30 10 C 5.7328 2.4367 0.0 0
M  V30 11 N 1.8341 3.0631 0.0 0
M  V30 12 C 1.5400 5.8614 0.0 0
M  V30 13 N 2.3100 7.1951 0.0 0
M  V30 14 C 4.6200 8.5288 0.0 0
M  V30 15 C 6.9300 7.1951 0.0 0
M  V30 16 C 3.2409 0.6263 0.0 0
M  V30 17 C 5.8937 0.9052 0.0 0
M  V30 18 C 6.1600 8.5288 0.0 0
M  V30 19 C 4.6479 0.0000 0.0 0
M  V30 20 N 8.4700 7.1951 0.0 0
M  V30 21 C 9.1382 8.5826 0.0 0
M  V30 22 C 9.1382 5.8077 0.0 0
M  V30 23 C 10.6396 8.9252 0.0 0
M  V30 24 C 10.6396 5.4649 0.0 0
M  V30 25 N 11.8436 7.9651 0.0 0
M  V30 26 C 11.8436 6.4251 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 8 15
M  V30 15 1 9 11
M  V30 16 2 9 16
M  V30 17 1 10 17
M  V30 18 2 12 13
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 15 20
M  V30 22 1 16 19
M  V30 23 2 17 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-methylpyrido[3′,2′:5,6]pyrazino...
C20H23N7
2378730-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 5.8614 0.0 0
M  V30 2 C 0.0000 7.1951 0.0 0
M  V30 3 C 14.0011 8.6333 0.0 0
M  V30 4 N 4.6200 4.5278 0.0 0
M  V30 5 C 5.3900 5.8614 0.0 0
M  V30 6 C 3.0800 4.5278 0.0 0
M  V30 7 C 5.0959 3.0631 0.0 0
M  V30 8 C 4.6200 7.1951 0.0 0
M  V30 9 N 6.9300 5.8614 0.0 0
M  V30 10 C 2.3100 5.8614 0.0 0
M  V30 11 N 2.6042 3.0631 0.0 0
M  V30 12 C 3.8500 2.1579 0.0 0
M  V30 13 C 6.5028 2.4368 0.0 0
M  V30 14 N 3.0800 7.1951 0.0 0
M  V30 15 C 5.3900 8.5289 0.0 0
M  V30 16 C 7.7000 7.1951 0.0 0
M  V30 17 C 4.0110 0.6263 0.0 0
M  V30 18 C 6.6638 0.9052 0.0 0
M  V30 19 C 6.9300 8.5289 0.0 0
M  V30 20 C 5.4179 0.0000 0.0 0
M  V30 21 N 9.2400 7.1951 0.0 0
M  V30 22 C 9.9083 5.8077 0.0 0
M  V30 23 C 9.9083 8.5826 0.0 0
M  V30 24 C 11.4096 5.4649 0.0 0
M  V30 25 C 11.4096 8.9253 0.0 0
M  V30 26 C 12.6136 6.4251 0.0 0
M  V30 27 N 12.6136 7.9651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 27
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 2 8 15
M  V30 15 1 9 16
M  V30 16 2 10 14
M  V30 17 1 11 12
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 2 16 19
M  V30 22 1 16 21
M  V30 23 1 17 20
M  V30 24 2 18 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378730-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378730-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21522830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinoline derivatives and related compounds as anticancer
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haddach, Mustapha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016141042 A2 2016-09-09

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 4-(hydroxymethyl)-6-methoxy-, methyl ester
C9H11NO4
2422198-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 O 1.3337 5.3901 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 N 4.0012 5.3901 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide, 4-(hydroxymethyl)-6-methoxy-N-methyl-
C9H12N2O3
2422197-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2422198-21-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2422197-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22305699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Class of Potent and Selective Non-competitive
Sentrin-Specific Protease 1 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lindenmann, Urs; Brand, Michael; Gall, Flavio; Frasson, David; Hunziker,
Lukas; Kroslakova, Ivana; Sievers, Martin; Riedl, Rainer
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2020), 15(8), 675-679

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C33H25Cl2F5N6O6
2437212-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.0890 10.6696 0.0 0
M  V30 2 C 8.3190 12.0032 0.0 0
M  V30 3 C 9.0890 13.3369 0.0 0
M  V30 4 O 10.6291 13.3369 0.0 0
M  V30 5 O 8.3190 14.6705 0.0 0
M  V30 6 C 5.6519 14.6385 0.0 0
M  V30 7 C 1.4646 11.4708 0.0 0
M  V30 8 F 0.0000 10.9950 0.0 0
M  V30 9 F 0.9887 12.9356 0.0 0
M  V30 10 F 2.9293 11.9467 0.0 0
M  V30 11 F 18.3044 9.3298 0.0 0
M  V30 12 F 15.1687 13.6457 0.0 0
M  V30 13 Cl 3.3682 5.6123 0.0 0
M  V30 14 Cl 17.9825 12.3930 0.0 0
M  V30 15 C 9.0890 8.0021 0.0 0 CFG=1
M  V30 16 C 8.3190 9.3358 0.0 0 CFG=1
M  V30 17 C 8.3190 6.6684 0.0 0 CFG=1
M  V30 18 C 6.7790 9.3358 0.0 0 CFG=2
M  V30 19 C 6.7790 6.6684 0.0 0 CFG=1
M  V30 20 O 9.0890 5.3348 0.0 0
M  V30 21 O 6.0090 8.0021 0.0 0
M  V30 22 C 6.0090 5.3348 0.0 0
M  V30 23 C 8.3190 4.0010 0.0 0 CFG=1
M  V30 24 O 6.7790 4.0010 0.0 0
M  V30 25 N 10.6291 8.0021 0.0 0
M  V30 26 C 11.5341 9.2480 0.0 0
M  V30 27 N 11.5341 6.7562 0.0 0
M  V30 28 C 12.9989 8.7721 0.0 0
M  V30 29 N 12.9989 7.2321 0.0 0
M  V30 30 C 6.0090 10.6696 0.0 0
M  V30 31 N 4.4773 10.8305 0.0 0
M  V30 32 N 6.6353 12.0764 0.0 0
M  V30 33 N 4.1571 12.3368 0.0 0
M  V30 34 C 5.4908 13.1068 0.0 0
M  V30 35 C 9.0890 2.6673 0.0 0
M  V30 36 C 10.6291 2.6673 0.0 0
M  V30 37 C 8.3190 1.3337 0.0 0
M  V30 38 C 11.3991 1.3337 0.0 0
M  V30 39 C 9.0890 0.0000 0.0 0
M  V30 40 C 10.6291 0.0000 0.0 0
M  V30 41 C 14.2447 9.6773 0.0 0
M  V30 42 C 15.6517 9.0510 0.0 0
M  V30 43 C 14.0838 11.2089 0.0 0
M  V30 44 C 16.8976 9.9561 0.0 0
M  V30 45 C 15.3297 12.1141 0.0 0
M  V30 46 C 16.7365 11.4878 0.0 0
M  V30 47 C 3.4469 9.6860 0.0 0
M  V30 48 C 1.9406 10.0063 0.0 0
M  V30 49 C 3.9227 8.2214 0.0 0
M  V30 50 C 0.9100 8.8617 0.0 0
M  V30 51 C 2.8923 7.0769 0.0 0
M  V30 52 C 1.3859 7.3972 0.0 0
M  V30 53 H 9.8591 6.6684 0.0 0
M  V30 54 H 5.2390 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 34
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 48
M  V30 11 1 11 44
M  V30 12 1 12 45
M  V30 13 1 13 51
M  V30 14 1 14 46
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 25 CFG=1
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 17 53 CFG=3
M  V30 22 1 18 21
M  V30 23 1 18 30 CFG=1
M  V30 24 1 19 21
M  V30 25 1 19 22
M  V30 26 1 19 54 CFG=3
M  V30 27 1 20 23
M  V30 28 1 22 24
M  V30 29 1 23 24
M  V30 30 1 23 35 CFG=1
M  V30 31 1 25 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 1 28 41
M  V30 37 1 30 31
M  V30 38 2 30 32
M  V30 39 1 31 33
M  V30 40 1 31 47
M  V30 41 1 32 34
M  V30 42 2 33 34
M  V30 43 2 35 36
M  V30 44 1 35 37
M  V30 45 1 36 38
M  V30 46 2 37 39
M  V30 47 2 38 40
M  V30 48 1 39 40
M  V30 49 2 41 42
M  V30 50 1 41 43
M  V30 51 1 42 44
M  V30 52 2 43 45
M  V30 53 2 44 46
M  V30 54 1 45 46
M  V30 55 2 47 48
M  V30 56 1 47 49
M  V30 57 1 48 50
M  V30 58 2 49 51
M  V30 59 2 50 52
M  V30 60 1 51 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 15 16 17 18 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C34H28Cl2F5N7O5
2491661-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.0889 10.6696 0.0 0
M  V30 2 C 8.3189 12.0032 0.0 0
M  V30 3 C 9.0889 13.3369 0.0 0
M  V30 4 N 8.3189 14.6705 0.0 0
M  V30 5 O 10.6289 13.3369 0.0 0
M  V30 6 C 9.0889 16.0043 0.0 0
M  V30 7 C 5.6518 14.6383 0.0 0
M  V30 8 C 1.4645 11.4708 0.0 0
M  V30 9 F 2.9292 11.9467 0.0 0
M  V30 10 F 0.9887 12.9355 0.0 0
M  V30 11 F 0.0000 10.9950 0.0 0
M  V30 12 F 18.3041 9.3298 0.0 0
M  V30 13 F 15.1685 13.6456 0.0 0
M  V30 14 Cl 3.3681 5.6124 0.0 0
M  V30 15 Cl 17.9823 12.3928 0.0 0
M  V30 16 C 9.0889 8.0021 0.0 0 CFG=1
M  V30 17 C 8.3189 9.3358 0.0 0 CFG=1
M  V30 18 C 8.3189 6.6685 0.0 0 CFG=1
M  V30 19 C 6.7789 9.3358 0.0 0 CFG=2
M  V30 20 C 6.7789 6.6685 0.0 0 CFG=1
M  V30 21 O 9.0889 5.3347 0.0 0
M  V30 22 O 6.0089 8.0021 0.0 0
M  V30 23 C 6.0089 5.3349 0.0 0
M  V30 24 C 8.3189 4.0011 0.0 0 CFG=1
M  V30 25 O 6.7789 4.0011 0.0 0
M  V30 26 N 10.6289 8.0021 0.0 0
M  V30 27 C 11.5340 9.2480 0.0 0
M  V30 28 N 11.5340 6.7563 0.0 0
M  V30 29 C 12.9987 8.7721 0.0 0
M  V30 30 N 12.9987 7.2321 0.0 0
M  V30 31 C 6.0089 10.6696 0.0 0
M  V30 32 N 4.4772 10.8305 0.0 0
M  V30 33 N 6.6352 12.0764 0.0 0
M  V30 34 N 4.1571 12.3368 0.0 0
M  V30 35 C 5.4907 13.1068 0.0 0
M  V30 36 C 9.0889 2.6674 0.0 0
M  V30 37 C 10.6289 2.6674 0.0 0
M  V30 38 C 8.3189 1.3338 0.0 0
M  V30 39 C 11.3989 1.3338 0.0 0
M  V30 40 C 9.0889 0.0000 0.0 0
M  V30 41 C 10.6289 0.0000 0.0 0
M  V30 42 C 14.2445 9.6774 0.0 0
M  V30 43 C 15.6515 9.0509 0.0 0
M  V30 44 C 14.0836 11.2089 0.0 0
M  V30 45 C 16.8973 9.9561 0.0 0
M  V30 46 C 15.3295 12.1141 0.0 0
M  V30 47 C 16.7363 11.4878 0.0 0
M  V30 48 C 3.4468 9.6860 0.0 0
M  V30 49 C 1.9406 10.0061 0.0 0
M  V30 50 C 3.9227 8.2214 0.0 0
M  V30 51 C 0.9100 8.8618 0.0 0
M  V30 52 C 2.8923 7.0769 0.0 0
M  V30 53 C 1.3858 7.3971 0.0 0
M  V30 54 H 9.8589 6.6685 0.0 0
M  V30 55 H 5.2389 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 35
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 49
M  V30 12 1 12 45
M  V30 13 1 13 46
M  V30 14 1 14 52
M  V30 15 1 15 47
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 26 CFG=1
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 18 54 CFG=3
M  V30 23 1 19 22
M  V30 24 1 19 31 CFG=1
M  V30 25 1 20 22
M  V30 26 1 20 23
M  V30 27 1 20 55 CFG=3
M  V30 28 1 21 24
M  V30 29 1 23 25
M  V30 30 1 24 25
M  V30 31 1 24 36 CFG=1
M  V30 32 1 26 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 37 1 29 42
M  V30 38 1 31 32
M  V30 39 2 31 33
M  V30 40 1 32 34
M  V30 41 1 32 48
M  V30 42 1 33 35
M  V30 43 2 34 35
M  V30 44 2 36 37
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 2 38 40
M  V30 48 2 39 41
M  V30 49 1 40 41
M  V30 50 2 42 43
M  V30 51 1 42 44
M  V30 52 1 43 45
M  V30 53 2 44 46
M  V30 54 2 45 47
M  V30 55 1 46 47
M  V30 56 2 48 49
M  V30 57 1 48 50
M  V30 58 1 49 51
M  V30 59 2 50 52
M  V30 60 2 51 53
M  V30 61 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 16 17 18 19 20 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2437212-70-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2491661-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23254055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolyl glycoside as galectin-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Chunjian; Yoon, David S.; Wang, Wei; Feng, Jianxin; Ellsworth, Bruce
A.; Regueiro-Ren, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020198266 A1 2020-10-01

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-4-hydroxy-6,7-dimethoxy-2-oxo-3-quinolinecarboxylate
C13H13NO6
243841-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 O 0.7700 4.0011 0.0 0
M  V30 3 C 0.0000 5.3347 0.0 0
M  V30 4 O 7.7000 8.0021 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 O 10.0100 6.6685 0.0 0
M  V30 7 O 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 6.6685 0.0 0
M  V30 9 O 2.3100 1.3336 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 N 5.3900 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 2 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-4-hydroxy-6,7-dimethoxy-N-methyl-2-oxo-3-quinolinecarboxamide
C13H14N2O5
799253-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 2.6674 0.0 0
M  V30 2 O 0.7700 4.0011 0.0 0
M  V30 3 C 0.0000 5.3347 0.0 0
M  V30 4 O 7.7000 8.0021 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 N 10.0100 6.6685 0.0 0
M  V30 7 O 10.0100 4.0011 0.0 0
M  V30 8 C 11.5500 6.6685 0.0 0
M  V30 9 O 2.3100 1.3336 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 N 5.3900 6.6685 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 2 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 243841-56-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 799253-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-279266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid
Methylamide (6a). A suspension of methyl ester 1 (2.79 g, 0.01 mol) in
DMF (20 ml) was saturated with gaseous methylamine (the precipitate was
rapidly dissolved) and left at room temperature for 3 h. The reaction
mixture was diluted with cold water and acidified with dilute HCl (1:1)
to pH 4.5-5.0. The precipitatedwas filtered off, washed with water, and
dried. Yield 98%. Mp,°С (DMF): 323-325; Empirical formula: C13H14N2O5;
Chemical shifts, δ, ppm (J, Hz): 2.87 (3Н, d, J= 4.8, СН3)
$DTYPE RXN:VAR(1):NOTES
$DATUM gaseous methylamine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Hydroxy-2-quinolones. 202. Synthesis, chemical and biological
properties of
4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid
alkylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Bevz, O. V.; Mospanova, E. V.; Savchenkova, L. V.;
Yankovich, S. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2012),
48(2), 320-326

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-(2,7-dichloro-8-fluoropyrido[4,3-d]pyrimidin-4-yl)-3,8-di...
C18H20Cl2FN5O2
2454397-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0010 0.0000 0.0 0
M  V30 2 F 0.0000 3.8501 0.0 0
M  V30 3 Cl 0.0000 6.9302 0.0 0
M  V30 4 C 11.8570 5.8609 0.0 0
M  V30 5 O 13.1788 5.0707 0.0 0
M  V30 6 O 11.8806 7.4008 0.0 0
M  V30 7 C 14.5242 5.8202 0.0 0
M  V30 8 C 15.2737 4.4749 0.0 0
M  V30 9 C 15.8694 6.5698 0.0 0
M  V30 10 C 13.7747 7.1655 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 4.0010 6.1601 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 N 2.6673 2.3101 0.0 0
M  V30 19 N 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 N 6.6685 4.6201 0.0 0
M  V30 22 C 7.6697 5.8281 0.0 0
M  V30 23 C 7.9205 4.8331 0.0 0
M  V30 24 C 9.1764 4.9223 0.0 0
M  V30 25 C 9.5122 3.9120 0.0 0
M  V30 26 N 10.5118 5.1114 0.0 0
M  V30 27 C 9.0297 3.4577 0.0 0
M  V30 28 C 9.6885 2.2523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 17
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 26
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 21
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 2 17 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 25 26
M  V30 30 1 25 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[7-chloro-8-fluoro-2-(methylamino)pyrido[4,3-d]pyrimidin-...
C19H24ClFN6O2
2621933-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 F 0.0000 4.6201 0.0 0
M  V30 4 Cl 0.0000 7.7002 0.0 0
M  V30 5 C 11.8570 6.6309 0.0 0
M  V30 6 O 13.1788 5.8407 0.0 0
M  V30 7 O 11.8806 8.1708 0.0 0
M  V30 8 C 14.5242 6.5903 0.0 0
M  V30 9 C 13.7747 7.9355 0.0 0
M  V30 10 C 15.8694 7.3398 0.0 0
M  V30 11 C 15.2737 5.2449 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0010 5.3901 0.0 0
M  V30 14 N 5.3348 3.0801 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 4.0010 6.9302 0.0 0
M  V30 17 C 4.0010 2.3101 0.0 0
M  V30 18 N 2.6673 3.0801 0.0 0
M  V30 19 C 1.3337 5.3901 0.0 0
M  V30 20 N 2.6673 7.7002 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 N 6.6685 5.3901 0.0 0
M  V30 23 C 7.6697 6.5981 0.0 0
M  V30 24 C 7.9205 5.6031 0.0 0
M  V30 25 C 9.1764 5.6923 0.0 0
M  V30 26 C 9.5122 4.6820 0.0 0
M  V30 27 N 10.5118 5.8814 0.0 0
M  V30 28 C 9.0297 4.2277 0.0 0
M  V30 29 C 9.6885 3.0223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 19
M  V30 4 1 4 21
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 22
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 18
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 26 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454397-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2621933-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23823768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(3,8-Diazabicyclo[3.2.1]octan-3-yl)pyrido[4,3-d]pyrimidines as KRas
G12D inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaolun; Burns, Aaron Craig; Christensen, James Gail; Ketcham, John
Michael; Lawson, John David; Marx, Matthew Arnold; Smith, Christopher
Ronald; Allen, Shelley; Blake, James Francis; Chicarelli, Mark Joseph;
Dahlke, Joshua Ryan; Dai, Donghua; Fell, Jay Bradford; Fischer, John
Peter; Mejia, Macedonio J.; Newhouse, Brad; Nguyen, Phong; O'Leary, Jacob
Matthew; Pajk, Spencer; Rodriguez, Martha E.; Savechenkov, Pavel; Tang,
Tony P.; Vigers, Guy P. A.; Zhao, Qian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021041671 A1 2021-03-04

$RFMT $RIREG SCHEME340 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-nitroacetate
C3H5NO4
2483-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl hexahydro-1,3-dimethyl-5-nitro-5-pyrimidinecarboxylate
C8H15N3O4
1132093-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2971 4.5278 0.0 0
M  V30 2 O 6.4768 3.5378 0.0 0
M  V30 3 O 5.5645 6.0443 0.0 0
M  V30 4 C 7.9239 4.0645 0.0 0
M  V30 5 N 3.5825 5.5175 0.0 0 VAL=5
M  V30 6 O 4.7623 6.5074 0.0 0
M  V30 7 O 2.1354 6.0443 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 3.8500 4.0009 0.0 0
M  V30 11 C 4.6200 2.6673 0.0 0
M  V30 12 C 2.3100 4.0009 0.0 0
M  V30 13 N 3.8500 1.3336 0.0 0
M  V30 14 N 1.5400 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2483-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132093-74-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-15283556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reaction of Methyl Nitroacetate and 3-Nitropropionate with Formaldehyde
and Primary Amines (General Method). Formalin (2.93 ml, 35%, 37.6 mmol of
CH2O) and the primary amine (18.8 mmol) were added to a solution of the
methyl nitrocarboxylate (3.76 mmol) in MeOH (27 ml) which was stirred
with a magnetic stirrer and the product was refluxed with a reflux
condenser for 4 h. Methanol was distilled off under reduced pressure and
chloroform (18 ml) was added. The reaction mixture was washed with water
(3×10 ml), dried over anhydrous Na2SO4 and the solvent was removed under
reduced pressure. The residue was chromatographed on a silica gel column
(eluent CHCl3-2-PrOH, 9:1).
5-Methoxycarbonyl-1,3-dimethyl-5-nitrohexahydropyrimidine (6) was
obtained at 65 °C from methyl nitroacetate 1, (10 g, 8.4 mmol), aqueous
formalin (35%, 6.99 ml, 84 mmol) and aqueous methylamine (25.2%, 5.17 g,
42 mmol). Oil (1.81 g, 98%). IR spectrum, ν, cm-1: 1384, 1552 (NO2),
1284, 1712 (CO2). 1H NMR spectrum, δ, ppm (J, Hz): 2.28 (6H, s, 2CH3);
2.72 (1Hax, d, 2J = 9.2, NCH2N); 2.77 (2Hax, d, 2J = 12.6, 2CH2N); 3.35
(1Heq, d, 2J = 9.2, NCH2N); 3.56 (2Heq, d, 2J = 12.6, 2CH2N); 3.77 (3H,
s, OCH3). 13C NMR spectrum, δ, ppm: 42.2 (NCH3); 53.79 (OCH3); 56.8
(CH2N); 77.4 (NCH2N); 89.0 (CNO2); 164.9 (CO2). Mass spectrum, m/z: 217
[M]+. Found, %: C 44.35; H 7.00; N 19.20. C8H15N3O4. Calculated, %: C
44.23; H 6.96; N 19.34.
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methyl nitroacetate and 3-nitropropionate in the synthesis of
hexahydropyrimidines and piperidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shakirov, R. R.; Dokichev, T. V.; Biglova, R. Z.; Vlasova, N. M.;
Baibulatova, N. Z.; Talipov, R. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2008),
44(1), 43-49

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Octyl acrylate
C11H20O2
2499-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6673 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 O 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 9.3358 2.3101 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 13.3370 1.5400 0.0 0
M  V30 13 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[3-(octyloxy)-3-oxopropyl]-β-alanine octyl ester
C23H45NO4
1123109-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 16.0045 1.5400 0.0 0
M  V30 2 C 14.6708 2.3101 0.0 0
M  V30 3 C 17.3382 2.3101 0.0 0
M  V30 4 C 16.0045 0.0000 0.0 0
M  V30 5 C 13.3370 1.5400 0.0 0
M  V30 6 C 18.6718 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 C 20.0057 2.3101 0.0 0
M  V30 9 O 10.6697 1.5400 0.0 0
M  V30 10 O 12.0033 3.8501 0.0 0
M  V30 11 O 21.3393 1.5400 0.0 0
M  V30 12 O 20.0057 3.8501 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0
M  V30 14 C 22.6730 2.3101 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 C 24.0067 1.5400 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 25.3405 2.3101 0.0 0
M  V30 19 C 5.3348 1.5400 0.0 0
M  V30 20 C 26.6742 1.5400 0.0 0
M  V30 21 C 4.0012 2.3101 0.0 0
M  V30 22 C 28.0078 2.3101 0.0 0
M  V30 23 C 2.6673 1.5400 0.0 0
M  V30 24 C 29.3416 1.5400 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 30.6753 2.3101 0.0 0
M  V30 27 C 0.0000 1.5400 0.0 0
M  V30 28 C 32.0090 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2499-59-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-56-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7326591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound 4e
Product CH3N(CH2CH2COOC8H17)2 Yield 98.4 %. Refractive index nD20 1.4490
Molecular formula C23H45NO4 Elemental analysis calcd. (wt%): C, 69.13; H,
11.35; N, 3.51. found (wt%): C, 69.16; H, 11.34; N, 3.52.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-c]pyridine-2-carboxylic acid, 4-(4-bromophenoxy)-, methyl ester
C15H10BrNO3S
251993-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 O 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 Br 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenoxy)-N-methylthieno[2,3-c]pyridine-2-carboxamide
C15H11BrN2O2S
251994-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 N 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 Br 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 2.6673 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 2.6673 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251993-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251994-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17637462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stewart, Andrew O.; Boyd, Steven A.; Arendsen, David L.; Bhatia, Pramila;
Condroski, Kevin R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Zhu,
Gui-dong; Lartey, Kraig; Mccarty, Catherine M.; Mort, Nicholas A.; Patel,
Meena V.; Staeger, Michael A.; Stout, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6232320 B1 2001-05-15

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-c]pyridine-2-carboxylic acid, 4-(4-bromophenoxy)-, methyl ester
C15H10BrNO3S
251993-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 O 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 Br 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Bromophenoxy)-N-methylthieno[2,3-c]pyridine-2-carboxamide
C15H11BrN2O2S
251994-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 N 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 Br 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 2.6673 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 2.6673 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251993-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251994-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10151953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 171. Methyl
4-(4-Bromophenoxy)thieno[2,3-c]pyridine-2-carboxamide. Example 73A (2 g,
5.5 mmol) was suspended in a solution of methylamine in methanol (2 M
solution, 15 mL) and refluxed for 1 hour under nitrogen atmosphere. Then
the solvent was removed and the residue was purified by flash
chromatography on silica gel eluting with 30% acetone in hexane to obtain
the title compound. Yield: (1.96 g, 98%). mp 78-80°C; MS (DCI/NH3) m/e:
363, 365 (M+H)+; 1HNMR (300 MHz, DMSO-d6) δ 2.79 (d, 3H, J = 4.8 Hz),
7.06 (d, 2H, J = 8.8 Hz), 7.59 (d, 2H, J = 8.8 Hz), 8.06 (s, 1H), 8.20
(s, 1H), 8.96 (q, 1H, J = 4.8 Hz), 9.17 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arendsen, David L.; Bhatia, Pramila; Boyd, Steven A.; Condroski, Kevin
R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Lartey, Kraig;
McCarty, Catherine M.; Mort, Nicholas A.; Patel, Meena V.; Staeger,
Michael A.; Stewart, Andrew O.; Stout, David M.; Zhu, Gui-Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000075145 A1 2000-12-14

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-isoxazolecarboxylate
C12H18N2O5
253196-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.3158 5.8826 0.0 0
M  V30 2 O 12.7226 5.2562 0.0 0
M  V30 3 O 11.1547 7.4142 0.0 0
M  V30 4 C 13.9684 6.1614 0.0 0
M  V30 5 C 15.3754 5.5351 0.0 0
M  V30 6 C 6.1600 4.2074 0.0 0
M  V30 7 N 5.3900 2.8736 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 O 3.0800 1.5400 0.0 0
M  V30 10 O 3.0800 4.2074 0.0 0
M  V30 11 C 1.5400 1.5400 0.0 0
M  V30 12 C 1.5400 0.0000 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 1.5400 3.0800 0.0 0
M  V30 15 C 10.0699 4.9774 0.0 0
M  V30 16 C 8.6052 5.4533 0.0 0
M  V30 17 N 10.0699 3.4374 0.0 0
M  V30 18 C 7.7000 4.2074 0.0 0
M  V30 19 O 8.6052 2.9616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-[(methylamino)carbonyl]-5-isoxazolyl]methyl]carbamate
C11H17N3O4
1000895-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 O 2.6673 2.3101 0.0 0
M  V30 5 O 4.0010 0.0000 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 0.0000 0.7700 0.0 0
M  V30 9 C 2.1037 0.2064 0.0 0
M  V30 10 C 11.9711 2.6672 0.0 0
M  V30 11 N 12.8764 3.9131 0.0 0
M  V30 12 O 12.5976 1.2602 0.0 0
M  V30 13 C 14.4079 3.7521 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 9.4091 1.6836 0.0 0
M  V30 16 O 8.1633 3.8416 0.0 0
M  V30 17 C 10.4396 2.8281 0.0 0
M  V30 18 N 9.6696 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 253196-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000895-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10929044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl N-[[3-(methylcarbamoyl)-1,2-oxazol-5-yl]methyl]carbamate, used
as starting material was prepared as follows:-Ethyl
5-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,2-oxazole-3-carboxylate
(1g,3.7mmol, 1eq) was dissolved in 2M methylamine in THF (5mL) and
stirred at room temperature overnight. The mixture was evaporated to
dryness, triturated with diethyl ether and dried to give the product as a
white solid (929mg, 98%). Ethyl
5-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,2-oxazole-3-carboxylate
used as starting material was prepared as shown in Example 61. 1H NMR
(CDCl3 400.13MHz) δ 1.43 (9H, s), 2.99 (3H, d), 4.45 (2H, d), 4.98 (1H,
s), 6.6 (1H, s), 6.75 (1H, s). MS m/z 254 (M-H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidine derivatives useful in the treatment of cancer and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buttar, David; Foote, Kevin Michael; Nowak, Thorsten; Rudge, David Alan;
Theoclitou, Maria-Elena; Thomas, Andrew Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008001070 A1 2008-01-03

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
2-[[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl][1,1′-biphenyl]-4-yl]meth...
C27H28N4O5S
254739-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.5503 8.0022 0.0 0 VAL=6
M  V30 2 N 12.3203 6.6685 0.0 0
M  V30 3 O 10.2164 7.2322 0.0 0
M  V30 4 O 12.8839 8.7722 0.0 0
M  V30 5 C 6.1601 4.0012 0.0 0
M  V30 6 N 4.6201 4.0012 0.0 0
M  V30 7 C 3.8501 5.3348 0.0 0
M  V30 8 C 4.6201 6.6685 0.0 0
M  V30 9 C 3.8501 8.0022 0.0 0
M  V30 10 C 14.2895 3.9579 0.0 0
M  V30 11 C 17.4760 4.9933 0.0 0
M  V30 12 C 1.5400 4.0012 0.0 0
M  V30 13 O 2.3101 5.3348 0.0 0
M  V30 14 O 0.0000 4.0012 0.0 0
M  V30 15 C 9.2402 9.3360 0.0 0
M  V30 16 C 10.7802 9.3360 0.0 0
M  V30 17 C 8.4702 10.6697 0.0 0
M  V30 18 C 11.5503 10.6697 0.0 0
M  V30 19 C 9.2402 12.0033 0.0 0
M  V30 20 C 10.7802 12.0033 0.0 0
M  V30 21 C 8.4702 8.0022 0.0 0
M  V30 22 C 6.9302 8.0022 0.0 0
M  V30 23 C 9.2402 6.6685 0.0 0
M  V30 24 C 6.1601 6.6685 0.0 0
M  V30 25 C 8.4702 5.3348 0.0 0
M  V30 26 C 6.9302 5.3348 0.0 0
M  V30 27 C 13.8603 6.6685 0.0 0
M  V30 28 C 14.7655 5.4226 0.0 0
M  V30 29 O 14.7655 7.9144 0.0 0
M  V30 30 C 16.2301 5.8985 0.0 0
M  V30 31 N 16.2301 7.4385 0.0 0
M  V30 32 C 3.8501 2.6673 0.0 0
M  V30 33 C 2.3101 2.6673 0.0 0
M  V30 34 N 4.6201 1.3337 0.0 0
M  V30 35 C 1.5400 1.3337 0.0 0
M  V30 36 C 3.8501 0.0000 0.0 0
M  V30 37 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 27
M  V30 6 1 5 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 1 6 32
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 28
M  V30 13 1 11 30
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 33
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 21
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl][1,1′-biphenyl]-4-yl]meth...
C28H31N5O4S
254739-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 12.3203 8.0022 0.0 0 VAL=6
M  V30 2 N 13.0903 6.6685 0.0 0
M  V30 3 O 13.6539 8.7722 0.0 0
M  V30 4 O 10.9864 7.2322 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 N 5.3901 4.0012 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 C 4.6201 8.0022 0.0 0
M  V30 10 C 15.0595 3.9579 0.0 0
M  V30 11 C 18.2460 4.9933 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 N 0.7700 4.0012 0.0 0
M  V30 14 O 3.0801 5.3348 0.0 0
M  V30 15 C 0.0000 5.3348 0.0 0
M  V30 16 C 10.0102 9.3360 0.0 0
M  V30 17 C 11.5503 9.3360 0.0 0
M  V30 18 C 9.2402 10.6697 0.0 0
M  V30 19 C 12.3203 10.6697 0.0 0
M  V30 20 C 10.0102 12.0033 0.0 0
M  V30 21 C 11.5503 12.0033 0.0 0
M  V30 22 C 9.2402 8.0022 0.0 0
M  V30 23 C 7.7002 8.0022 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 6.9302 6.6685 0.0 0
M  V30 26 C 9.2402 5.3348 0.0 0
M  V30 27 C 7.7002 5.3348 0.0 0
M  V30 28 C 14.6303 6.6685 0.0 0
M  V30 29 C 15.5356 5.4226 0.0 0
M  V30 30 O 15.5356 7.9144 0.0 0
M  V30 31 C 17.0001 5.8985 0.0 0
M  V30 32 N 17.0001 7.4385 0.0 0
M  V30 33 C 4.6201 2.6673 0.0 0
M  V30 34 C 3.0801 2.6673 0.0 0
M  V30 35 N 5.3901 1.3337 0.0 0
M  V30 36 C 2.3101 1.3337 0.0 0
M  V30 37 C 4.6201 0.0000 0.0 0
M  V30 38 C 3.0801 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 28
M  V30 6 1 5 6
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 33
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 29
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 34
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 22
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 254739-85-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 254739-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13697999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Method 12: Amide Formation using
1,1′-Carbonyldiimidazole 1,1′-Carbonyldiimidazole (2.0 eq) was added to a
0.1 M solution or suspension of an appropriate carboxylic acid (1.0 eq)
in THF. The mixture was heated at 50° C. for 1 h, and was then cooled to
RT. An appropriate amine (5-10 eq) was then added, and the mixture was
stirred at RT for 12 h. Ethyl acetate and aqueous sodium bicarbonate
solution were added and the aqueous layer was extracted with ethyl
acetate. The combined organic layers were dried over sodium sulfate and
concentrated. The residue was purified by reverse-phase preparative HPLC
or by silica gel chromatography.
2′-[(3,3-Dimethyl-2-oxopyrrolidin-1-yl)methyl]-4′-[(2-ethoxy-7-(N-methylcarbamoyl)benzimidazol-1-yl)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-[1,1′-biphenyl]-2-sulfonamide
33 (80 mg) was subjected to amide formation according to General Method
12 using methylamine as the amine component. The product was purified by
reverse-phase preparative HPLC. * A. Linear gradient of 0 to 100% solvent
B over 4 min, with 1 min hold at 100% B; * UV visualization at 220 nm *
Column: YMC S5 ODS Ballistic 4.6×50 mm * Flowrate: 4 ml/min * Solvent A:
0.1% trifluoroacetic acid, 90% water, 10% methanol * Solvent B: 0.1%
trifluoroacetic acid, 90% methanol, 10% water. STARTING EXAMPLE 204 * B.
Linear gradient of 0 to 100% solvent B over 30 min, with 5 min hold at
100% B; * UV visualization at 254 nm * Column: YMC S3 ODS 6×150 mm *
Flowrate: 1.5 m/min * Solvent A: 0.2% phosphoric acid, 90% water, 10%
methanol * Solvent B: 0.2% phosphoric acid, 90% methanol, 10% water.
2-[[[2′-[[(3,4- Dimethyl-5-isoxazolyl)amino] sulfonyl][1,1′-biphenyl]-4-
yl]methyl]propylamino]-N- methyl-3-pyridinecarboxamide (MH)- 534; HPLC
23.8 (B)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as
dual angiotensin II and endothelin receptor antagonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Tellew, John E.; Macor, Jhon E.; Gu, Zhengxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020143024 A1 2002-10-03

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
2-[[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl][1,1′-biphenyl]-4-yl]meth...
C27H28N4O5S
254739-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.5503 8.0022 0.0 0 VAL=6
M  V30 2 N 12.3203 6.6685 0.0 0
M  V30 3 O 10.2164 7.2322 0.0 0
M  V30 4 O 12.8839 8.7722 0.0 0
M  V30 5 C 6.1601 4.0012 0.0 0
M  V30 6 N 4.6201 4.0012 0.0 0
M  V30 7 C 3.8501 5.3348 0.0 0
M  V30 8 C 4.6201 6.6685 0.0 0
M  V30 9 C 3.8501 8.0022 0.0 0
M  V30 10 C 14.2895 3.9579 0.0 0
M  V30 11 C 17.4760 4.9933 0.0 0
M  V30 12 C 1.5400 4.0012 0.0 0
M  V30 13 O 2.3101 5.3348 0.0 0
M  V30 14 O 0.0000 4.0012 0.0 0
M  V30 15 C 9.2402 9.3360 0.0 0
M  V30 16 C 10.7802 9.3360 0.0 0
M  V30 17 C 8.4702 10.6697 0.0 0
M  V30 18 C 11.5503 10.6697 0.0 0
M  V30 19 C 9.2402 12.0033 0.0 0
M  V30 20 C 10.7802 12.0033 0.0 0
M  V30 21 C 8.4702 8.0022 0.0 0
M  V30 22 C 6.9302 8.0022 0.0 0
M  V30 23 C 9.2402 6.6685 0.0 0
M  V30 24 C 6.1601 6.6685 0.0 0
M  V30 25 C 8.4702 5.3348 0.0 0
M  V30 26 C 6.9302 5.3348 0.0 0
M  V30 27 C 13.8603 6.6685 0.0 0
M  V30 28 C 14.7655 5.4226 0.0 0
M  V30 29 O 14.7655 7.9144 0.0 0
M  V30 30 C 16.2301 5.8985 0.0 0
M  V30 31 N 16.2301 7.4385 0.0 0
M  V30 32 C 3.8501 2.6673 0.0 0
M  V30 33 C 2.3101 2.6673 0.0 0
M  V30 34 N 4.6201 1.3337 0.0 0
M  V30 35 C 1.5400 1.3337 0.0 0
M  V30 36 C 3.8501 0.0000 0.0 0
M  V30 37 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 27
M  V30 6 1 5 6
M  V30 7 1 5 26
M  V30 8 1 6 7
M  V30 9 1 6 32
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 28
M  V30 13 1 11 30
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 33
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 21
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl][1,1′-biphenyl]-4-yl]meth...
C28H31N5O4S
254739-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 12.3203 8.0022 0.0 0 VAL=6
M  V30 2 N 13.0903 6.6685 0.0 0
M  V30 3 O 13.6539 8.7722 0.0 0
M  V30 4 O 10.9864 7.2322 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 N 5.3901 4.0012 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 C 4.6201 8.0022 0.0 0
M  V30 10 C 15.0595 3.9579 0.0 0
M  V30 11 C 18.2460 4.9933 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 N 0.7700 4.0012 0.0 0
M  V30 14 O 3.0801 5.3348 0.0 0
M  V30 15 C 0.0000 5.3348 0.0 0
M  V30 16 C 10.0102 9.3360 0.0 0
M  V30 17 C 11.5503 9.3360 0.0 0
M  V30 18 C 9.2402 10.6697 0.0 0
M  V30 19 C 12.3203 10.6697 0.0 0
M  V30 20 C 10.0102 12.0033 0.0 0
M  V30 21 C 11.5503 12.0033 0.0 0
M  V30 22 C 9.2402 8.0022 0.0 0
M  V30 23 C 7.7002 8.0022 0.0 0
M  V30 24 C 10.0102 6.6685 0.0 0
M  V30 25 C 6.9302 6.6685 0.0 0
M  V30 26 C 9.2402 5.3348 0.0 0
M  V30 27 C 7.7002 5.3348 0.0 0
M  V30 28 C 14.6303 6.6685 0.0 0
M  V30 29 C 15.5356 5.4226 0.0 0
M  V30 30 O 15.5356 7.9144 0.0 0
M  V30 31 C 17.0001 5.8985 0.0 0
M  V30 32 N 17.0001 7.4385 0.0 0
M  V30 33 C 4.6201 2.6673 0.0 0
M  V30 34 C 3.0801 2.6673 0.0 0
M  V30 35 N 5.3901 1.3337 0.0 0
M  V30 36 C 2.3101 1.3337 0.0 0
M  V30 37 C 4.6201 0.0000 0.0 0
M  V30 38 C 3.0801 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 28
M  V30 6 1 5 6
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 33
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 29
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 34
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 22
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 254739-85-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 254739-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12924733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Method 12: Amide Formation using
1,1'-Carbonyldiimidazole 1,1'-Carbonyldiimidazole (2.0 eq) was added to a
0.1 M solution or suspension of an appropriate carboxylic acid (1.0 eq)
in THF. The mixture was heated at 50 °C for 1h, and was then cooled to
RT. An appropriate amine (5-10 eq) was then added, and the miture was
stirred at RT for 12 h. Ethyl acetate and aqueous sodium bicarbonate
solution were added and the aqueous layer was extracted with ethyl
acetate. The combined organic layers were dried over sodium sulfate and
concentrated. The residue was purified by reverse-phase preparative HPLC
or by silica gel chromatography. Example: 204,
2-[[[2'-[[(3,4-Dimethy5-isoxazolyl)amino]sulfonyl] [1,1'-biphenyl]-4-yl]
methyl]propylamino]-N-methy3-pyridinecarboxamide, yield 98%. M/z (MH)-
534 HPLC % Purity: 99 HPLC ret time, (method) 23.8(B).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as
dual angiotensin II and endothelin receptor antagonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Tellew, John E.; Macor, John E.; Gu, Zhengxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001044239 A2 2001-06-21

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2,N4-bis[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine
C17H10ClF6N5
2571594-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0035 4.6201 0.0 0
M  V30 2 N 6.6685 4.6201 0.0 0
M  V30 3 Cl 9.3360 0.0000 0.0 0
M  V30 4 C 17.3383 4.6201 0.0 0
M  V30 5 F 18.1083 3.2864 0.0 0
M  V30 6 F 18.6720 5.3901 0.0 0
M  V30 7 F 16.5683 5.9538 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 F 2.1037 5.9538 0.0 0
M  V30 10 F 0.0000 5.3901 0.0 0
M  V30 11 F 0.5637 3.2864 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 N 9.3360 4.6201 0.0 0
M  V30 14 N 10.6697 2.3101 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 9.3360 1.5400 0.0 0
M  V30 17 N 8.0023 2.3101 0.0 0
M  V30 18 C 13.3372 3.8501 0.0 0
M  V30 19 C 14.6708 4.6201 0.0 0
M  V30 20 C 13.3372 2.3101 0.0 0
M  V30 21 C 16.0045 3.8501 0.0 0
M  V30 22 C 14.6708 1.5400 0.0 0
M  V30 23 C 16.0045 2.3101 0.0 0
M  V30 24 C 5.3348 3.8501 0.0 0
M  V30 25 C 4.0012 4.6201 0.0 0
M  V30 26 C 5.3348 2.3101 0.0 0
M  V30 27 C 2.6675 3.8501 0.0 0
M  V30 28 C 4.0012 1.5400 0.0 0
M  V30 29 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 15
M  V30 4 1 2 24
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 21
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 27
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-N4,N6-bis[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4,6-triamine
C18H14F6N6
2571592-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0035 5.3901 0.0 0
M  V30 2 N 6.6685 5.3901 0.0 0
M  V30 3 N 9.3360 0.7700 0.0 0
M  V30 4 C 8.0023 0.0000 0.0 0
M  V30 5 C 17.3383 5.3901 0.0 0
M  V30 6 F 16.5683 6.7238 0.0 0
M  V30 7 F 18.6720 6.1601 0.0 0
M  V30 8 F 18.1083 4.0564 0.0 0
M  V30 9 C 1.3337 5.3901 0.0 0
M  V30 10 F 0.5637 4.0564 0.0 0
M  V30 11 F 0.0000 6.1601 0.0 0
M  V30 12 F 2.1037 6.7238 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 N 9.3360 5.3901 0.0 0
M  V30 15 N 10.6697 3.0801 0.0 0
M  V30 16 C 8.0023 4.6201 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 N 8.0023 3.0801 0.0 0
M  V30 19 C 13.3372 4.6201 0.0 0
M  V30 20 C 14.6708 5.3901 0.0 0
M  V30 21 C 13.3372 3.0801 0.0 0
M  V30 22 C 16.0045 4.6201 0.0 0
M  V30 23 C 14.6708 2.3101 0.0 0
M  V30 24 C 16.0045 3.0801 0.0 0
M  V30 25 C 5.3348 4.6201 0.0 0
M  V30 26 C 4.0012 5.3901 0.0 0
M  V30 27 C 5.3348 3.0801 0.0 0
M  V30 28 C 2.6675 4.6201 0.0 0
M  V30 29 C 4.0012 2.3101 0.0 0
M  V30 30 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 16
M  V30 4 1 2 25
M  V30 5 1 3 4
M  V30 6 1 3 17
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 22
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 28
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2571594-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2571592-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37767196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Drug Design of Novel Triaminotriazine Derivatives as
Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and
Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid
Leukemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Qingyun; Yao, Kun; Yang, Jie; Zhou, Qian; Liu, Pengyu; Chen, Jiao;
Liu, Haipeng; Lai, Yisheng; Cao, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(18), 12894-12910

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-Dimethyl (3S,3′S)-1,1′,2,2′-tetrahydro-1,1′-dimethyl-2,2′-dioxo[3,3′-bi-...
C24H24N2O6
2599109-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6643 3.0800 0.0 0
M  V30 2 C 4.9981 2.3100 0.0 0
M  V30 3 O 4.9981 0.7700 0.0 0
M  V30 4 O 6.3317 3.0800 0.0 0
M  V30 5 C 3.6643 0.0000 0.0 0
M  V30 6 C 8.3790 4.6237 0.0 0
M  V30 7 C 7.2528 3.5734 0.0 0
M  V30 8 O 7.5991 2.0728 0.0 0
M  V30 9 O 5.7801 4.0236 0.0 0
M  V30 10 C 9.0718 1.6225 0.0 0
M  V30 11 O 1.3627 3.1254 0.0 0
M  V30 12 O 5.8700 7.8137 0.0 0
M  V30 13 C 0.0000 6.1862 0.0 0
M  V30 14 C 8.3205 10.0987 0.0 0
M  V30 15 C 3.6643 4.6200 0.0 0 CFG=2
M  V30 16 C 3.9844 6.1264 0.0 0
M  V30 17 C 2.1327 4.4591 0.0 0
M  V30 18 C 2.6508 6.8964 0.0 0
M  V30 19 C 5.3182 6.8964 0.0 0
M  V30 20 N 1.5064 5.8659 0.0 0
M  V30 21 C 2.6508 8.4364 0.0 0
M  V30 22 C 5.3182 8.4364 0.0 0
M  V30 23 C 3.9844 9.2064 0.0 0
M  V30 24 C 8.0326 6.1241 0.0 0 CFG=2
M  V30 25 C 9.5611 6.3118 0.0 0
M  V30 26 C 7.3818 7.5198 0.0 0
M  V30 27 C 9.8549 7.8235 0.0 0
M  V30 28 C 10.7233 5.3015 0.0 0
M  V30 29 N 8.5080 8.5701 0.0 0
M  V30 30 C 11.3111 8.3249 0.0 0
M  V30 31 C 12.1796 5.8029 0.0 0
M  V30 32 C 12.4734 7.3145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 17
M  V30 12 2 12 26
M  V30 13 1 13 20
M  V30 14 1 14 29
M  V30 15 1 15 16 CFG=3
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[3,3′-Bi-3H-indole]-3,3′-diacetamide, 1,1′,2,2′-tetrahydro-N3,N3′,1,1′-tetram...
C24H26N4O4
2241963-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6054 3.0010 0.0 0
M  V30 2 C 7.4792 1.9507 0.0 0
M  V30 3 N 7.8255 0.4501 0.0 0
M  V30 4 O 6.0065 2.4010 0.0 0
M  V30 5 C 9.2982 0.0000 0.0 0
M  V30 6 C 3.6643 3.4445 0.0 0
M  V30 7 C 4.9981 2.6745 0.0 0
M  V30 8 N 4.9981 1.1345 0.0 0
M  V30 9 O 6.3317 3.4445 0.0 0
M  V30 10 C 3.6643 0.3645 0.0 0
M  V30 11 O 6.0964 6.1911 0.0 0
M  V30 12 O 1.3627 3.4898 0.0 0
M  V30 13 C 8.5468 8.4760 0.0 0
M  V30 14 C 0.0000 6.5505 0.0 0
M  V30 15 C 8.2590 4.5016 0.0 0 CFG=2
M  V30 16 C 9.7875 4.6893 0.0 0
M  V30 17 C 7.6082 5.8973 0.0 0
M  V30 18 C 10.0813 6.2010 0.0 0
M  V30 19 C 10.9497 3.6789 0.0 0
M  V30 20 N 8.7344 6.9476 0.0 0
M  V30 21 C 11.5375 6.7024 0.0 0
M  V30 22 C 12.4059 4.1803 0.0 0
M  V30 23 C 12.6998 5.6920 0.0 0
M  V30 24 C 3.6643 4.9845 0.0 0 CFG=2
M  V30 25 C 3.9844 6.4908 0.0 0
M  V30 26 C 2.1327 4.8234 0.0 0
M  V30 27 C 2.6508 7.2608 0.0 0
M  V30 28 C 5.3182 7.2608 0.0 0
M  V30 29 N 1.5064 6.2304 0.0 0
M  V30 30 C 2.6508 8.8008 0.0 0
M  V30 31 C 5.3182 8.8008 0.0 0
M  V30 32 C 3.9844 9.5708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 17
M  V30 12 2 12 26
M  V30 13 1 13 20
M  V30 14 1 14 29
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=3
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2599109-26-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241963-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23503329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dielectrophilic allenic ketone-enabled [4 + 2] annulation with
3,3'-bisoxindoles: enantioselective creation of two contiguous quaternary
stereogenic centers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Xiaodong; Tan, Chuan Xiang Alvin; Chan, Wai-Lun; Zhang, Fuhao;
Zheng, Wenrui; Lu, Yixin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2021), 11(3), 1361-1367

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[(2,3-dihydro-2,2-dimethyl-7-benzofuranyl)oxy]methyl]-α-(metho...
C21H23NO5
2640797-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 C 0.0000 5.1369 0.0 0
M  V30 4 C 1.0304 3.3522 0.0 0
M  V30 5 C 10.8738 4.0011 0.0 0
M  V30 6 C 10.1038 5.3348 0.0 0
M  V30 7 N 12.4138 4.0011 0.0 0
M  V30 8 O 10.8738 6.6686 0.0 0
M  V30 9 O 8.5638 5.3348 0.0 0
M  V30 10 O 13.1838 2.6675 0.0 0
M  V30 11 C 10.1038 8.0023 0.0 0
M  V30 12 C 14.7238 2.6675 0.0 0
M  V30 13 C 3.9437 5.3348 0.0 0
M  V30 14 C 3.1737 6.6686 0.0 0
M  V30 15 C 5.4837 5.3348 0.0 0
M  V30 16 O 2.9133 4.1904 0.0 0
M  V30 17 C 1.6674 6.3483 0.0 0
M  V30 18 C 3.9437 8.0023 0.0 0
M  V30 19 C 6.2537 6.6686 0.0 0
M  V30 20 C 1.5063 4.8167 0.0 0
M  V30 21 C 5.4837 8.0023 0.0 0
M  V30 22 C 8.5638 2.6675 0.0 0
M  V30 23 C 10.1038 2.6675 0.0 0
M  V30 24 C 7.7937 1.3337 0.0 0
M  V30 25 C 10.8738 1.3337 0.0 0
M  V30 26 C 8.5638 0.0000 0.0 0
M  V30 27 C 10.1038 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 22
M  V30 4 1 3 20
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[(2,3-Dihydro-2,2-dimethyl-7-benzofuranyl)oxy]methyl]-α-(methoxyimino...
C21H24N2O4
2640797-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 C 0.0000 5.1369 0.0 0
M  V30 4 C 1.0304 3.3522 0.0 0
M  V30 5 C 10.8738 4.0011 0.0 0
M  V30 6 C 10.1038 5.3348 0.0 0
M  V30 7 N 12.4138 4.0011 0.0 0
M  V30 8 N 10.8738 6.6686 0.0 0
M  V30 9 O 8.5638 5.3348 0.0 0
M  V30 10 O 13.1838 2.6675 0.0 0
M  V30 11 C 10.1038 8.0023 0.0 0
M  V30 12 C 14.7238 2.6675 0.0 0
M  V30 13 C 3.9437 5.3348 0.0 0
M  V30 14 C 3.1737 6.6686 0.0 0
M  V30 15 C 5.4837 5.3348 0.0 0
M  V30 16 O 2.9133 4.1904 0.0 0
M  V30 17 C 1.6674 6.3483 0.0 0
M  V30 18 C 3.9437 8.0023 0.0 0
M  V30 19 C 6.2537 6.6686 0.0 0
M  V30 20 C 1.5063 4.8167 0.0 0
M  V30 21 C 5.4837 8.0023 0.0 0
M  V30 22 C 8.5638 2.6675 0.0 0
M  V30 23 C 10.1038 2.6675 0.0 0
M  V30 24 C 7.7937 1.3337 0.0 0
M  V30 25 C 10.8738 1.3337 0.0 0
M  V30 26 C 8.5638 0.0000 0.0 0
M  V30 27 C 10.1038 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 22
M  V30 4 1 3 20
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640797-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2640797-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[4-(1,3-dimethyl-1H-pyrazol-4-yl)phenoxy]methyl]-α-(methoxyimi...
C22H23N3O4
2648657-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.7731 4.0286 0.0 0
M  V30 2 C 10.4395 3.2586 0.0 0
M  V30 3 N 13.1068 3.2586 0.0 0
M  V30 4 O 10.4395 1.7186 0.0 0
M  V30 5 O 9.1057 4.0286 0.0 0
M  V30 6 O 14.4404 4.0286 0.0 0
M  V30 7 C 9.1057 0.9486 0.0 0
M  V30 8 C 15.7742 3.2586 0.0 0
M  V30 9 C 9.1057 5.5686 0.0 0
M  V30 10 O 7.7721 6.3386 0.0 0
M  V30 11 C 0.7104 5.3914 0.0 0
M  V30 12 C 0.1437 0.0000 0.0 0
M  V30 13 C 11.7731 5.5686 0.0 0
M  V30 14 C 10.4395 6.3386 0.0 0
M  V30 15 C 13.1068 6.3386 0.0 0
M  V30 16 C 10.4395 7.8786 0.0 0
M  V30 17 C 13.1068 7.8786 0.0 0
M  V30 18 C 11.7731 8.6486 0.0 0
M  V30 19 C 6.4384 5.5686 0.0 0
M  V30 20 C 5.1048 6.3386 0.0 0
M  V30 21 C 6.4384 4.0286 0.0 0
M  V30 22 C 3.7710 5.5686 0.0 0
M  V30 23 C 5.1048 3.2586 0.0 0
M  V30 24 C 3.7710 4.0286 0.0 0
M  V30 25 C 2.4374 3.2586 0.0 0
M  V30 26 C 1.0306 3.8850 0.0 0
M  V30 27 C 2.2764 1.7271 0.0 0
M  V30 28 N 0.0000 2.7406 0.0 0
M  V30 29 N 0.7700 1.4069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 26
M  V30 13 1 12 29
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[4-(1,3-Dimethyl-1H-pyrazol-4-yl)phenoxy]methyl]-α-(methoxyimino)-N-m...
C22H24N4O3
2648657-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.7731 4.0286 0.0 0
M  V30 2 C 10.4395 3.2586 0.0 0
M  V30 3 N 13.1068 3.2586 0.0 0
M  V30 4 N 10.4395 1.7186 0.0 0
M  V30 5 O 9.1057 4.0286 0.0 0
M  V30 6 O 14.4404 4.0286 0.0 0
M  V30 7 C 9.1057 0.9486 0.0 0
M  V30 8 C 15.7742 3.2586 0.0 0
M  V30 9 C 9.1057 5.5686 0.0 0
M  V30 10 O 7.7721 6.3386 0.0 0
M  V30 11 C 0.7104 5.3914 0.0 0
M  V30 12 C 0.1437 0.0000 0.0 0
M  V30 13 C 11.7731 5.5686 0.0 0
M  V30 14 C 10.4395 6.3386 0.0 0
M  V30 15 C 13.1068 6.3386 0.0 0
M  V30 16 C 10.4395 7.8786 0.0 0
M  V30 17 C 13.1068 7.8786 0.0 0
M  V30 18 C 11.7731 8.6486 0.0 0
M  V30 19 C 6.4384 5.5686 0.0 0
M  V30 20 C 5.1048 6.3386 0.0 0
M  V30 21 C 6.4384 4.0286 0.0 0
M  V30 22 C 3.7710 5.5686 0.0 0
M  V30 23 C 5.1048 3.2586 0.0 0
M  V30 24 C 3.7710 4.0286 0.0 0
M  V30 25 C 2.4374 3.2586 0.0 0
M  V30 26 C 1.0306 3.8850 0.0 0
M  V30 27 C 2.2764 1.7271 0.0 0
M  V30 28 N 0.0000 2.7406 0.0 0
M  V30 29 N 0.7700 1.4069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 26
M  V30 13 1 12 29
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2648657-84-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648657-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23615463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Fungicidal Activity of Novel
Pyrazole-Containing Strobilurin Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hao, Zesheng; Wang, Weibo; Yu, Bin; Qi, Xin; Lv, You; Liu, Xiaoyu; Chen,
Haoyin; Kalinina, Tatiana A.; Glukhareva, Tatiana V.; Fan, Zhijin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2021), 39(6), 1531-1537

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
1-(4-Fluorophenyl)-3-[4-(methoxycarbonyl)phenyl]-α,α-dimethyl-4-(phenylmethox...
C33H28FNO5
2721390-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6238 5.6923 0.0 0
M  V30 2 C 12.1638 5.6923 0.0 0
M  V30 3 C 11.3938 4.3585 0.0 0
M  V30 4 C 9.8538 4.3585 0.0 0
M  V30 5 O 12.9338 7.0259 0.0 0
M  V30 6 O 12.9338 4.3585 0.0 0
M  V30 7 O 5.3347 8.6933 0.0 0
M  V30 8 C 4.0011 9.4633 0.0 0
M  V30 9 C 4.2005 2.6091 0.0 0
M  V30 10 O 4.6764 1.1445 0.0 0
M  V30 11 O 2.6941 2.9292 0.0 0
M  V30 12 C 3.6460 0.0000 0.0 0
M  V30 13 F 16.5057 9.7135 0.0 0
M  V30 14 C 8.3223 7.1869 0.0 0
M  V30 15 C 8.0021 8.6933 0.0 0
M  V30 16 C 9.8538 7.0259 0.0 0
M  V30 17 C 9.3358 9.4633 0.0 0
M  V30 18 C 6.6685 9.4633 0.0 0
M  V30 19 N 10.4803 8.4327 0.0 0
M  V30 20 C 9.3358 11.0033 0.0 0
M  V30 21 C 6.6685 11.0033 0.0 0
M  V30 22 C 8.0021 11.7733 0.0 0
M  V30 23 C 7.2919 6.0425 0.0 0
M  V30 24 C 5.7855 6.3627 0.0 0
M  V30 25 C 7.7678 4.5778 0.0 0
M  V30 26 C 4.7551 5.2181 0.0 0
M  V30 27 C 6.7373 3.4334 0.0 0
M  V30 28 C 5.2309 3.7536 0.0 0
M  V30 29 C 11.9866 8.7529 0.0 0
M  V30 30 C 13.0170 7.6085 0.0 0
M  V30 31 C 12.4625 10.2176 0.0 0
M  V30 32 C 14.5234 7.9287 0.0 0
M  V30 33 C 13.9689 10.5378 0.0 0
M  V30 34 C 14.9993 9.3934 0.0 0
M  V30 35 C 2.6674 8.6933 0.0 0
M  V30 36 C 2.6674 7.1533 0.0 0
M  V30 37 C 1.3338 9.4633 0.0 0
M  V30 38 C 1.3338 6.3833 0.0 0
M  V30 39 C 0.0000 8.6933 0.0 0
M  V30 40 C 0.0000 7.1533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 8 35
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 28
M  V30 13 1 10 12
M  V30 14 1 13 34
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 23
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 29
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[2-[1,1-dimethyl-2-(methylamino)-2-oxoethyl]-1-(4-fluorophenyl)-4-(p...
C34H31FN2O4
2721390-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6238 5.6923 0.0 0
M  V30 2 C 12.1638 5.6923 0.0 0
M  V30 3 C 11.3938 4.3585 0.0 0
M  V30 4 C 9.8538 4.3585 0.0 0
M  V30 5 N 12.9338 4.3585 0.0 0
M  V30 6 O 12.9338 7.0259 0.0 0
M  V30 7 C 14.4738 4.3585 0.0 0
M  V30 8 O 5.3347 8.6933 0.0 0
M  V30 9 C 4.0011 9.4633 0.0 0
M  V30 10 C 4.2005 2.6091 0.0 0
M  V30 11 O 4.6764 1.1445 0.0 0
M  V30 12 O 2.6941 2.9292 0.0 0
M  V30 13 C 3.6460 0.0000 0.0 0
M  V30 14 F 16.5057 9.7135 0.0 0
M  V30 15 C 8.3223 7.1869 0.0 0
M  V30 16 C 8.0021 8.6933 0.0 0
M  V30 17 C 9.8538 7.0259 0.0 0
M  V30 18 C 9.3358 9.4633 0.0 0
M  V30 19 C 6.6685 9.4633 0.0 0
M  V30 20 N 10.4803 8.4327 0.0 0
M  V30 21 C 9.3358 11.0033 0.0 0
M  V30 22 C 6.6685 11.0033 0.0 0
M  V30 23 C 8.0021 11.7733 0.0 0
M  V30 24 C 7.2919 6.0425 0.0 0
M  V30 25 C 5.7855 6.3627 0.0 0
M  V30 26 C 7.7678 4.5778 0.0 0
M  V30 27 C 4.7551 5.2181 0.0 0
M  V30 28 C 6.7373 3.4334 0.0 0
M  V30 29 C 5.2309 3.7536 0.0 0
M  V30 30 C 11.9866 8.7529 0.0 0
M  V30 31 C 13.0170 7.6085 0.0 0
M  V30 32 C 12.4625 10.2176 0.0 0
M  V30 33 C 14.5234 7.9287 0.0 0
M  V30 34 C 13.9689 10.5378 0.0 0
M  V30 35 C 14.9993 9.3934 0.0 0
M  V30 36 C 2.6674 8.6933 0.0 0
M  V30 37 C 2.6674 7.1533 0.0 0
M  V30 38 C 1.3338 9.4633 0.0 0
M  V30 39 C 1.3338 6.3833 0.0 0
M  V30 40 C 0.0000 8.6933 0.0 0
M  V30 41 C 0.0000 7.1533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 19
M  V30 10 1 9 36
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 29
M  V30 14 1 11 13
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 24
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 20 30
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2721390-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2721390-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24595220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole derivatives as alpha-1-antitrypsin modulators for
treating alpha-1-antitrypsin deficiency (AATD)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giroux, Simon; Clark, Michael Philip; Brodney, Michael Aaron; Nuhant,
Philippe Marcel; Allen, Emily Elizabeth; Fimognari, Robert Francis, Jr.;
Zaky, Mariam; Boyd, Michael John; Deininger, David D.; Zhang, Hu; Deng,
Hongbo; Collier, Philip Noel; Maxwell, Brad; Waal, Nathan D.; Ronkin,
Steven M.; Wang, Jian; Tang, Qing; Fleming, Gabrielle Simone; Jones,
Peter; Boucher, Diane Marie; Fanning, Lev T.D.; Hall, Amy B.; Hurley,
Dennis James; Johnson, Mac Arthur, Jr.; Maxwell, John Patrick; Swett,
Rebecca Jane; Tapley, Timothy Lewis; Thomson, Stephen A.; Damagnez,
Veronique; Cottrell, Kevin Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021203023 A1 2021-10-07

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole-2-carboxaldehyde
C10H9NO
27421-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 6.0810 1.3627 0.0 0
M  V30 3 O 7.4148 2.1327 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 4.5864 3.6643 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 N 3.3406 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7474 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl[(1-methyl-1H-indol-2-yl)methyl]amine
C11H14N2
3514-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 C 8.8870 4.0442 0.0 0
M  V30 5 C 2.6673 3.4804 0.0 0
M  V30 6 C 2.6673 1.9404 0.0 0
M  V30 7 C 4.1320 3.9564 0.0 0
M  V30 8 C 1.3336 4.2504 0.0 0
M  V30 9 N 4.1320 1.4645 0.0 0
M  V30 10 C 1.3336 1.1704 0.0 0
M  V30 11 C 5.0370 2.7104 0.0 0
M  V30 12 C 0.0000 3.4804 0.0 0
M  V30 13 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27421-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3514-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9501044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methyl-2-(methylaminomethyl)-1H-indole (23). A suspension of
1-methylindole-2-carboxaldehyde (5.0 g, 31.4 mmol) in 2.0 M
methylamine/methanol (150 mL) was stirred for 24 h at room temperature
and then was concentrated to dryness in vacuo. The remaining solid
residue was taken up in ethanol (150 mL), and NaBH4 (1.19 g, 31.4 mmol)
was added with stirring at room temperature. Vigorous gas evolution was
observed, which subsided after 15 min. The reaction mixture was stirred
for 4 h, then was concentrated to dryness. The residue was treated with
1.0 N NaOH (150 mL) and extracted with Et2O (150 mL). The combined
organic layers were washed with brine, dried (Na2SO4), and concentrated
to dryness to give 23 (5.39 g, 98%) as a yellow oil. 1H NMR (400 MHz,
CDCl3) δ 7.56 (d, J = 7.8 Hz, 1H), 7.29 (d, J = 8.2 Hz, 1H), 7.19 (app t,
1H), 7.08 (app t, 1H), 6.39 (s, 1H), 3.90 (s, 2H), 3.77 (s, 3H), 2.50 (s,
3H), 1.44 (br s, 1H); MS (ES) m/e 175.0 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP
Reductase (FabI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Seefeld, Mark A.; Newlander, Kenneth A.; Uzinskas,
Irene N.; Burgess, Walter J.; Heerding, Dirk A.; Yuan, Catherine C. K.;
Head, Martha S.; Payne, David J.; Rittenhouse, Stephen F.; Moore,
Terrance D.; Pearson, Stewart C.; Berry, Valerie; DeWolf, Walter E. Jr.;
Keller, Paul M.; Polizzi, Brian J.; Qiu, Xiayang; Janson, Cheryl A.;
Huffman, William F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(15), 3246-3256

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2S)-1-Acetyl-1,2,3,4-tetrahydro-2-methyl-6-quinolinyl]benzaldehyde
C19H19NO2
2750360-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 0.0000 1.3338 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 0.0000 4.0011 0.0 0
M  V30 5 C 13.0900 2.6674 0.0 0
M  V30 6 O 13.8600 1.3338 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0 CFG=1
M  V30 14 C 6.1600 1.3338 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 13 4 CFG=1
M  V30 5 2 5 6
M  V30 6 1 5 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 18 1 15 17
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(2S)-3,4-Dihydro-2-methyl-6-[4-[(methylamino)methyl]phenyl]-1(2H)-quinolin...
C20H24N2O
2750362-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 C 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 0.0000 1.3338 0.0 0
M  V30 5 C 13.0900 2.6674 0.0 0
M  V30 6 N 13.8600 4.0011 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 1.5400 1.3338 0.0 0 CFG=1
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 2.3100 0.0000 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 9.2400 1.3338 0.0 0
M  V30 21 C 10.7800 4.0011 0.0 0
M  V30 22 C 10.7800 1.3338 0.0 0
M  V30 23 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 14 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2750360-57-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2750362-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27658524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual kinase-bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thompson, Philip; Shortt, Jake; Johnstone, Ricky; Ma, Xiao; Oh, Danielle;
Jennings, Ian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021243421 A1 2021-12-09

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Benzofuranyl)-2-bromo-1-propanone
C11H9BrO2
2755454-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 Br 7.7047 3.8500 0.0 0
M  V30 5 C 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 O 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 C 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Benzofuranyl)-2-(methylamino)-1-propanone
C12H13NO2
2855974-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 N 9.0383 1.5400 0.0 0
M  V30 5 C 7.7045 3.8500 0.0 0
M  V30 6 C 10.3720 2.3100 0.0 0
M  V30 7 C 2.3698 2.3100 0.0 0
M  V30 8 C 2.3698 3.8500 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 O 0.9052 1.8341 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 C 0.9052 4.3259 0.0 0
M  V30 13 C 5.0372 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755454-43-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855974-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37063928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specialized combinations for mental disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Dalziel, Sean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107715 A1 2023-06-15

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Benzofuranyl)-2-bromo-1-propanone
C11H9BrO2
2755454-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 Br 7.7047 3.8500 0.0 0
M  V30 5 C 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 O 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 C 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Benzofuranyl)-2-(methylamino)-1-propanone
C12H13NO2
2855974-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 N 9.0383 1.5400 0.0 0
M  V30 5 C 7.7045 3.8500 0.0 0
M  V30 6 C 10.3720 2.3100 0.0 0
M  V30 7 C 2.3698 2.3100 0.0 0
M  V30 8 C 2.3698 3.8500 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 O 0.9052 1.8341 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 C 0.9052 4.3259 0.0 0
M  V30 13 C 5.0372 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755454-43-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855974-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31073444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advantageous enantiomerically enriched mixtures of benzofurans and
compositions for mental disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252538 A2 2021-12-16

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N′-[3-[[1-(2,6-Dichlorobenzoyl)-5-[6-(4-oxo-1-piperidinyl)-3-pyridinyl]-1H-py...
C34H28Cl2F2N6O5S
2756317-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9593 8.3504 0.0 0
M  V30 2 O 9.9899 9.4948 0.0 0
M  V30 3 C 8.9593 2.9292 0.0 0
M  V30 4 O 9.9899 1.7849 0.0 0
M  V30 5 F 8.0076 11.2796 0.0 0
M  V30 6 F 6.8985 6.0615 0.0 0
M  V30 7 Cl 8.0076 0.0000 0.0 0
M  V30 8 Cl 6.8985 5.2182 0.0 0
M  V30 9 N 4.9949 11.9200 0.0 0
M  V30 10 S 3.4886 12.2401 0.0 0 VAL=6
M  V30 11 N 1.9821 12.5603 0.0 0
M  V30 12 O 3.1684 10.7339 0.0 0
M  V30 13 O 3.8087 13.7466 0.0 0
M  V30 14 C 1.5063 14.0250 0.0 0
M  V30 15 C 0.9517 11.4159 0.0 0
M  V30 16 C 0.0000 14.3452 0.0 0
M  V30 17 O 22.9030 11.7998 0.0 0
M  V30 18 C 10.8999 6.4098 0.0 0
M  V30 19 C 10.8999 4.8698 0.0 0
M  V30 20 C 9.4353 6.8857 0.0 0
M  V30 21 C 12.2335 7.1798 0.0 0
M  V30 22 N 9.4353 4.3940 0.0 0
M  V30 23 N 12.2335 4.0998 0.0 0
M  V30 24 C 8.5301 5.6398 0.0 0
M  V30 25 C 13.5673 6.4098 0.0 0
M  V30 26 C 13.5673 4.8698 0.0 0
M  V30 27 C 7.4530 8.6706 0.0 0
M  V30 28 C 6.9772 10.1351 0.0 0
M  V30 29 C 6.4226 7.5260 0.0 0
M  V30 30 C 5.4707 10.4553 0.0 0
M  V30 31 C 4.9162 7.8462 0.0 0
M  V30 32 C 4.4403 9.3109 0.0 0
M  V30 33 C 14.9010 7.1798 0.0 0
M  V30 34 C 14.9010 8.7198 0.0 0
M  V30 35 C 16.2346 6.4098 0.0 0
M  V30 36 C 16.2346 9.4898 0.0 0
M  V30 37 N 17.5683 7.1798 0.0 0
M  V30 38 C 17.5683 8.7198 0.0 0
M  V30 39 C 7.4530 2.6091 0.0 0
M  V30 40 C 6.9772 1.1445 0.0 0
M  V30 41 C 6.4226 3.7536 0.0 0
M  V30 42 C 5.4707 0.8242 0.0 0
M  V30 43 C 4.9162 3.4333 0.0 0
M  V30 44 C 4.4403 1.9687 0.0 0
M  V30 45 N 18.9021 9.4898 0.0 0
M  V30 46 C 20.2357 8.7198 0.0 0
M  V30 47 C 18.9021 11.0298 0.0 0
M  V30 48 C 21.5694 9.4898 0.0 0
M  V30 49 C 20.2357 11.7998 0.0 0
M  V30 50 C 21.5694 11.0298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 27
M  V30 4 2 3 4
M  V30 5 1 3 22
M  V30 6 1 3 39
M  V30 7 1 5 28
M  V30 8 1 6 29
M  V30 9 1 7 40
M  V30 10 1 8 41
M  V30 11 1 9 10
M  V30 12 1 9 30
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 11 15
M  V30 18 1 14 16
M  V30 19 2 17 50
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 1 22 24
M  V30 28 1 23 26
M  V30 29 2 25 26
M  V30 30 1 25 33
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 43 1 38 45
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 50 1 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N′-[3-[[1-(2,6-Dichlorobenzoyl)-5-[6-[4-(methylamino)-1-piperidinyl]-3-pyridi...
C35H33Cl2F2N7O4S
2756317-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9594 8.3503 0.0 0
M  V30 2 O 9.9900 9.4947 0.0 0
M  V30 3 C 8.9594 2.9292 0.0 0
M  V30 4 O 9.9900 1.7849 0.0 0
M  V30 5 F 8.0077 11.2796 0.0 0
M  V30 6 F 6.8986 6.0614 0.0 0
M  V30 7 Cl 6.8986 5.2181 0.0 0
M  V30 8 Cl 8.0077 0.0000 0.0 0
M  V30 9 N 4.9950 11.9199 0.0 0
M  V30 10 S 3.4887 12.2401 0.0 0 VAL=6
M  V30 11 N 1.9823 12.5602 0.0 0
M  V30 12 O 3.1684 10.7338 0.0 0
M  V30 13 O 3.8089 13.7465 0.0 0
M  V30 14 C 1.5064 14.0249 0.0 0
M  V30 15 C 0.9519 11.4159 0.0 0
M  V30 16 C 0.0000 14.3451 0.0 0
M  V30 17 N 22.9030 11.7998 0.0 0
M  V30 18 C 24.2368 11.0298 0.0 0
M  V30 19 C 10.9000 6.4098 0.0 0
M  V30 20 C 10.9000 4.8698 0.0 0
M  V30 21 C 9.4353 6.8856 0.0 0
M  V30 22 C 12.2336 7.1798 0.0 0
M  V30 23 N 9.4353 4.3939 0.0 0
M  V30 24 N 12.2336 4.0998 0.0 0
M  V30 25 C 8.5302 5.6398 0.0 0
M  V30 26 C 13.5674 6.4098 0.0 0
M  V30 27 C 13.5674 4.8698 0.0 0
M  V30 28 C 7.4531 8.6705 0.0 0
M  V30 29 C 6.9773 10.1350 0.0 0
M  V30 30 C 6.4227 7.5260 0.0 0
M  V30 31 C 5.4709 10.4552 0.0 0
M  V30 32 C 4.9163 7.8461 0.0 0
M  V30 33 C 4.4404 9.3108 0.0 0
M  V30 34 C 14.9010 7.1798 0.0 0
M  V30 35 C 16.2347 6.4098 0.0 0
M  V30 36 C 14.9010 8.7198 0.0 0
M  V30 37 C 17.5683 7.1798 0.0 0
M  V30 38 N 16.2347 9.4898 0.0 0
M  V30 39 C 17.5683 8.7198 0.0 0
M  V30 40 C 7.4531 2.6091 0.0 0
M  V30 41 C 6.4227 3.7536 0.0 0
M  V30 42 C 6.9773 1.1445 0.0 0
M  V30 43 C 4.9163 3.4333 0.0 0
M  V30 44 C 5.4709 0.8242 0.0 0
M  V30 45 C 4.4404 1.9687 0.0 0
M  V30 46 N 18.9021 9.4898 0.0 0
M  V30 47 C 18.9021 11.0298 0.0 0
M  V30 48 C 20.2358 8.7198 0.0 0
M  V30 49 C 20.2358 11.7998 0.0 0
M  V30 50 C 21.5694 9.4898 0.0 0
M  V30 51 C 21.5694 11.0298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 21
M  V30 3 1 1 28
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 3 40
M  V30 7 1 5 29
M  V30 8 1 6 30
M  V30 9 1 7 41
M  V30 10 1 8 42
M  V30 11 1 9 10
M  V30 12 1 9 31
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 11 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 51
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 1 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 1 26 34
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 39
M  V30 44 1 39 46
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 51 1 46 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 1 50 51
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756317-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756317-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31094866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as BRAF degraders for treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolente, Cosimo; Duplessis, Martin; Fitzgerald, Mark E.; Garza, Victoria;
Good, Andrew Charles; Hewings, David Stephen; Hunziker, Daniel; Jackson,
Katrina L.; Kuhn, Bernd; Liang, Yanke; Moustakim, Moses; Nasveschuk,
Christopher G.; O'Shea, Morgan Welzel; Pettazzoni, Piergiorgio Francesco
Tommaso; Ricklin, Fabienne; Riemer, Claus; Veits, Gesine Kerstin;
Wichmann, Juergen; Yap, Jeremy L.; Yu, Robert T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021255212 A1 2021-12-23

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, 2,5-dioxo-1-p...
C25H28N2O7
27601-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 6.4384 0.0 0 CFG=2
M  V30 2 C 6.7238 7.7722 0.0 0
M  V30 3 C 6.7238 5.1047 0.0 0
M  V30 4 N 4.4137 6.4384 0.0 0
M  V30 5 O 5.9537 3.7711 0.0 0
M  V30 6 O 8.2638 5.1047 0.0 0
M  V30 7 C 3.6437 7.7722 0.0 0
M  V30 8 O 2.1037 7.7722 0.0 0
M  V30 9 O 4.4137 9.1059 0.0 0
M  V30 10 C 1.3337 9.1059 0.0 0
M  V30 11 C 0.0000 8.3359 0.0 0
M  V30 12 C 0.5637 10.4395 0.0 0
M  V30 13 C 2.6673 9.8759 0.0 0
M  V30 14 O 4.5910 0.7103 0.0 0
M  V30 15 O 9.2859 3.4209 0.0 0
M  V30 16 O 12.8839 7.7722 0.0 0
M  V30 17 C 13.6539 9.1059 0.0 0
M  V30 18 C 8.2638 7.7722 0.0 0
M  V30 19 C 9.0338 6.4384 0.0 0
M  V30 20 C 9.0338 9.1059 0.0 0
M  V30 21 C 10.5738 6.4384 0.0 0
M  V30 22 C 10.5738 9.1059 0.0 0
M  V30 23 C 11.3438 7.7722 0.0 0
M  V30 24 N 6.7238 2.4374 0.0 0
M  V30 25 C 6.0974 1.0304 0.0 0
M  V30 26 C 8.2553 2.2763 0.0 0
M  V30 27 C 7.2418 0.0000 0.0 0
M  V30 28 C 8.5755 0.7700 0.0 0
M  V30 29 C 15.1939 9.1059 0.0 0
M  V30 30 C 15.9639 10.4395 0.0 0
M  V30 31 C 15.9639 7.7722 0.0 0
M  V30 32 C 17.5040 10.4395 0.0 0
M  V30 33 C 17.5040 7.7722 0.0 0
M  V30 34 C 18.2740 9.1059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 24
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 14 25
M  V30 16 2 15 26
M  V30 17 1 16 17
M  V30 18 1 16 23
M  V30 19 1 17 29
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-(methylamino)-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]ethy...
C22H28N2O4
96136-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 5.3347 0.0 0
M  V30 2 C 5.9536 4.0011 0.0 0 CFG=1
M  V30 3 N 4.4136 4.0011 0.0 0
M  V30 4 C 6.7236 2.6674 0.0 0
M  V30 5 C 3.6436 5.3347 0.0 0
M  V30 6 N 5.9536 1.3336 0.0 0
M  V30 7 O 8.2636 2.6674 0.0 0
M  V30 8 O 2.1036 5.3347 0.0 0
M  V30 9 O 4.4136 6.6685 0.0 0
M  V30 10 C 6.7236 0.0000 0.0 0
M  V30 11 C 1.3336 6.6685 0.0 0
M  V30 12 C 0.0000 5.8985 0.0 0
M  V30 13 C 0.5636 8.0021 0.0 0
M  V30 14 C 2.6673 7.4385 0.0 0
M  V30 15 O 12.8836 5.3347 0.0 0
M  V30 16 C 13.6536 6.6685 0.0 0
M  V30 17 C 8.2636 5.3347 0.0 0
M  V30 18 C 9.0336 4.0011 0.0 0
M  V30 19 C 9.0336 6.6685 0.0 0
M  V30 20 C 10.5736 4.0011 0.0 0
M  V30 21 C 10.5736 6.6685 0.0 0
M  V30 22 C 11.3436 5.3347 0.0 0
M  V30 23 C 15.1936 6.6685 0.0 0
M  V30 24 C 15.9636 8.0021 0.0 0
M  V30 25 C 15.9636 5.3347 0.0 0
M  V30 26 C 17.5036 8.0021 0.0 0
M  V30 27 C 17.5036 5.3347 0.0 0
M  V30 28 C 18.2736 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 16 23
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27601-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96136-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19706576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric α-arylation of amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel J.; Ward, John W.; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature (London, United Kingdom) (2018), 562(7725), 105-109

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, 2,5-dioxo-1-p...
C25H28N2O7
27601-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 6.4384 0.0 0 CFG=2
M  V30 2 C 6.7238 7.7722 0.0 0
M  V30 3 C 6.7238 5.1047 0.0 0
M  V30 4 N 4.4137 6.4384 0.0 0
M  V30 5 O 5.9537 3.7711 0.0 0
M  V30 6 O 8.2638 5.1047 0.0 0
M  V30 7 C 3.6437 7.7722 0.0 0
M  V30 8 O 2.1037 7.7722 0.0 0
M  V30 9 O 4.4137 9.1059 0.0 0
M  V30 10 C 1.3337 9.1059 0.0 0
M  V30 11 C 0.0000 8.3359 0.0 0
M  V30 12 C 0.5637 10.4395 0.0 0
M  V30 13 C 2.6673 9.8759 0.0 0
M  V30 14 O 4.5910 0.7103 0.0 0
M  V30 15 O 9.2859 3.4209 0.0 0
M  V30 16 O 12.8839 7.7722 0.0 0
M  V30 17 C 13.6539 9.1059 0.0 0
M  V30 18 C 8.2638 7.7722 0.0 0
M  V30 19 C 9.0338 6.4384 0.0 0
M  V30 20 C 9.0338 9.1059 0.0 0
M  V30 21 C 10.5738 6.4384 0.0 0
M  V30 22 C 10.5738 9.1059 0.0 0
M  V30 23 C 11.3438 7.7722 0.0 0
M  V30 24 N 6.7238 2.4374 0.0 0
M  V30 25 C 6.0974 1.0304 0.0 0
M  V30 26 C 8.2553 2.2763 0.0 0
M  V30 27 C 7.2418 0.0000 0.0 0
M  V30 28 C 8.5755 0.7700 0.0 0
M  V30 29 C 15.1939 9.1059 0.0 0
M  V30 30 C 15.9639 10.4395 0.0 0
M  V30 31 C 15.9639 7.7722 0.0 0
M  V30 32 C 17.5040 10.4395 0.0 0
M  V30 33 C 17.5040 7.7722 0.0 0
M  V30 34 C 18.2740 9.1059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 24
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 14 25
M  V30 16 2 15 26
M  V30 17 1 16 17
M  V30 18 1 16 23
M  V30 19 1 17 29
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-(methylamino)-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]ethy...
C22H28N2O4
96136-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 5.3347 0.0 0
M  V30 2 C 5.9536 4.0011 0.0 0 CFG=1
M  V30 3 N 4.4136 4.0011 0.0 0
M  V30 4 C 6.7236 2.6674 0.0 0
M  V30 5 C 3.6436 5.3347 0.0 0
M  V30 6 N 5.9536 1.3336 0.0 0
M  V30 7 O 8.2636 2.6674 0.0 0
M  V30 8 O 2.1036 5.3347 0.0 0
M  V30 9 O 4.4136 6.6685 0.0 0
M  V30 10 C 6.7236 0.0000 0.0 0
M  V30 11 C 1.3336 6.6685 0.0 0
M  V30 12 C 0.0000 5.8985 0.0 0
M  V30 13 C 0.5636 8.0021 0.0 0
M  V30 14 C 2.6673 7.4385 0.0 0
M  V30 15 O 12.8836 5.3347 0.0 0
M  V30 16 C 13.6536 6.6685 0.0 0
M  V30 17 C 8.2636 5.3347 0.0 0
M  V30 18 C 9.0336 4.0011 0.0 0
M  V30 19 C 9.0336 6.6685 0.0 0
M  V30 20 C 10.5736 4.0011 0.0 0
M  V30 21 C 10.5736 6.6685 0.0 0
M  V30 22 C 11.3436 5.3347 0.0 0
M  V30 23 C 15.1936 6.6685 0.0 0
M  V30 24 C 15.9636 8.0021 0.0 0
M  V30 25 C 15.9636 5.3347 0.0 0
M  V30 26 C 17.5036 8.0021 0.0 0
M  V30 27 C 17.5036 5.3347 0.0 0
M  V30 28 C 18.2736 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 16 23
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27601-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96136-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20359324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quaternary unnatural amino acids and hydantoins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel Jamie; Ward, John William; Clayden, Jonathan Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2557931 A 2018-07-04

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, 2,5-dioxo-1-p...
C25H28N2O7
27601-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 6.4384 0.0 0 CFG=2
M  V30 2 C 6.7238 7.7722 0.0 0
M  V30 3 C 6.7238 5.1047 0.0 0
M  V30 4 N 4.4137 6.4384 0.0 0
M  V30 5 O 5.9537 3.7711 0.0 0
M  V30 6 O 8.2638 5.1047 0.0 0
M  V30 7 C 3.6437 7.7722 0.0 0
M  V30 8 O 2.1037 7.7722 0.0 0
M  V30 9 O 4.4137 9.1059 0.0 0
M  V30 10 C 1.3337 9.1059 0.0 0
M  V30 11 C 0.0000 8.3359 0.0 0
M  V30 12 C 0.5637 10.4395 0.0 0
M  V30 13 C 2.6673 9.8759 0.0 0
M  V30 14 O 4.5910 0.7103 0.0 0
M  V30 15 O 9.2859 3.4209 0.0 0
M  V30 16 O 12.8839 7.7722 0.0 0
M  V30 17 C 13.6539 9.1059 0.0 0
M  V30 18 C 8.2638 7.7722 0.0 0
M  V30 19 C 9.0338 6.4384 0.0 0
M  V30 20 C 9.0338 9.1059 0.0 0
M  V30 21 C 10.5738 6.4384 0.0 0
M  V30 22 C 10.5738 9.1059 0.0 0
M  V30 23 C 11.3438 7.7722 0.0 0
M  V30 24 N 6.7238 2.4374 0.0 0
M  V30 25 C 6.0974 1.0304 0.0 0
M  V30 26 C 8.2553 2.2763 0.0 0
M  V30 27 C 7.2418 0.0000 0.0 0
M  V30 28 C 8.5755 0.7700 0.0 0
M  V30 29 C 15.1939 9.1059 0.0 0
M  V30 30 C 15.9639 10.4395 0.0 0
M  V30 31 C 15.9639 7.7722 0.0 0
M  V30 32 C 17.5040 10.4395 0.0 0
M  V30 33 C 17.5040 7.7722 0.0 0
M  V30 34 C 18.2740 9.1059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 24
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 14 25
M  V30 16 2 15 26
M  V30 17 1 16 17
M  V30 18 1 16 23
M  V30 19 1 17 29
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-(methylamino)-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]ethy...
C22H28N2O4
96136-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7236 5.3347 0.0 0
M  V30 2 C 5.9536 4.0011 0.0 0 CFG=1
M  V30 3 N 4.4136 4.0011 0.0 0
M  V30 4 C 6.7236 2.6674 0.0 0
M  V30 5 C 3.6436 5.3347 0.0 0
M  V30 6 N 5.9536 1.3336 0.0 0
M  V30 7 O 8.2636 2.6674 0.0 0
M  V30 8 O 2.1036 5.3347 0.0 0
M  V30 9 O 4.4136 6.6685 0.0 0
M  V30 10 C 6.7236 0.0000 0.0 0
M  V30 11 C 1.3336 6.6685 0.0 0
M  V30 12 C 0.0000 5.8985 0.0 0
M  V30 13 C 0.5636 8.0021 0.0 0
M  V30 14 C 2.6673 7.4385 0.0 0
M  V30 15 O 12.8836 5.3347 0.0 0
M  V30 16 C 13.6536 6.6685 0.0 0
M  V30 17 C 8.2636 5.3347 0.0 0
M  V30 18 C 9.0336 4.0011 0.0 0
M  V30 19 C 9.0336 6.6685 0.0 0
M  V30 20 C 10.5736 4.0011 0.0 0
M  V30 21 C 10.5736 6.6685 0.0 0
M  V30 22 C 11.3436 5.3347 0.0 0
M  V30 23 C 15.1936 6.6685 0.0 0
M  V30 24 C 15.9636 8.0021 0.0 0
M  V30 25 C 15.9636 5.3347 0.0 0
M  V30 26 C 17.5036 8.0021 0.0 0
M  V30 27 C 17.5036 5.3347 0.0 0
M  V30 28 C 18.2736 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 16 23
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27601-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96136-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19299333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quaternary unnatural amino acids and hydantoins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel Jamie; Ward, John William; Clayden, Jonathan Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018109496 A2 2018-06-21

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-3-methyl-2-[[[(E)-[1-[6-(trifluoromethyl)-2-pyra...
C19H19F3N4O4
2761371-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 16.7745 4.0564 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 15.2345 6.7238 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 N 13.3372 5.3901 0.0 0
M  V30 27 C 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 N 13.3372 2.3101 0.0 0
M  V30 30 C 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H20F3N5O3
2761370-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 16.7745 4.0564 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 15.2345 6.7238 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 N 13.3372 5.3901 0.0 0
M  V30 27 C 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 N 13.3372 2.3101 0.0 0
M  V30 30 C 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761371-38-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761370-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Amino-5-bromo-3-methylphenyl)-2,2,2-trichloroethanone
C9H7BrCl3NO
2763629-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 C 1.3336 3.8500 0.0 0
M  V30 3 O 2.6674 6.1600 0.0 0
M  V30 4 Cl 0.5636 5.1836 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 Cl 2.1036 2.5164 0.0 0
M  V30 7 N 5.3347 6.1600 0.0 0
M  V30 8 C 8.0021 4.6200 0.0 0
M  V30 9 Br 5.3347 0.0000 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 6.6685 3.8500 0.0 0
M  V30 14 C 5.3347 1.5400 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 11
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromo-N,3-dimethylbenzamide
C9H11BrN2O
890707-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Br 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2763629-93-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890707-30-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31838563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of anthranilic acid or amide compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mahapatra, Tridib; Patra, Pranab Kumar; Klausener, Alexander G. M.; Mal,
Sanjib; Sharma, Raju
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022058916 A1 2022-03-24

$RFMT $RIREG SCHEME357 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methoxypropylidene)glycine ethyl ester
C8H15NO3
2781061-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 N 2.6675 3.0801 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 O 1.3337 0.7700 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 O 6.6685 2.3101 0.0 0
M  V30 10 O 5.3348 4.6201 0.0 0
M  V30 11 C 8.0023 3.0801 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Imidazol-4-one, 5-[(2,5-dimethoxyphenyl)methylene]-2-ethyl-3,5-dihydro-3-m...
C15H18N2O3
2914210-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0
M  V30 2 O 1.5400 6.6684 0.0 0
M  V30 3 C 0.0000 6.6684 0.0 0
M  V30 4 O 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 O 6.5894 9.3790 0.0 0
M  V30 7 C 9.7758 4.9932 0.0 0
M  V30 8 C 11.1826 5.6196 0.0 0
M  V30 9 C 9.7758 8.3436 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 3.8500 2.6674 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 6.1600 6.6684 0.0 0
M  V30 17 N 7.0652 5.4225 0.0 0
M  V30 18 C 7.0652 7.9143 0.0 0
M  V30 19 C 8.5298 5.8984 0.0 0
M  V30 20 N 8.5298 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 2 6 18
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 1 9 20
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2781061-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2914210-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35773039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Keto-Analogs of Arylidene-Imidazolones as Fluorogenic Dyes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sokolov, A. I.; Gorshkova, A. A.; Baleeva, N. S.; Baranov, M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Bioorganic Chemistry (2022), 48(6), 1367-1371

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-chlorobenzene
C9H10BrClO
27983-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 C 9.2401 4.0010 0.0 0
M  V30 5 Br 10.7801 4.0010 0.0 0
M  V30 6 Cl 0.0000 1.3337 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenoxy)-N-methyl-1-propanamine
C10H14ClNO
90945-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 Cl 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27983-04-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90945-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4439695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(2-chloro-4-pyridinyl)-8-[[[4-cyano-1-[(1,1-dimethylethoxy)carbonyl]-...
C27H32ClN7O4
2827007-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1391 7.7000 0.0 0
M  V30 2 C 10.4728 6.9300 0.0 0
M  V30 3 C 2.4873 7.6404 0.0 0
M  V30 4 C 3.8500 10.7010 0.0 0
M  V30 5 O 2.3100 10.7010 0.0 0
M  V30 6 O 4.6200 12.0348 0.0 0
M  V30 7 C 1.5400 12.0348 0.0 0
M  V30 8 C 0.0000 12.0348 0.0 0
M  V30 9 C 10.8167 8.8798 0.0 0
M  V30 10 N 9.8267 10.0594 0.0 0
M  V30 11 Cl 3.8044 0.0000 0.0 0
M  V30 12 C 16.3563 6.8978 0.0 0
M  V30 13 O 17.3463 8.0775 0.0 0
M  V30 14 O 16.8830 5.4507 0.0 0
M  V30 15 C 18.8628 7.8101 0.0 0
M  V30 16 C 19.1302 9.3267 0.0 0
M  V30 17 C 20.3794 7.5426 0.0 0
M  V30 18 C 18.5953 6.2935 0.0 0
M  V30 19 C 6.4719 7.7000 0.0 0
M  V30 20 N 5.1381 6.9300 0.0 0
M  V30 21 C 7.8055 6.9300 0.0 0
M  V30 22 N 6.1515 9.2064 0.0 0
M  V30 23 C 5.1381 5.3900 0.0 0
M  V30 24 C 3.9937 7.9606 0.0 0
M  V30 25 N 7.8055 5.3900 0.0 0
M  V30 26 C 4.6200 9.3674 0.0 0
M  V30 27 C 6.4719 4.6200 0.0 0
M  V30 28 C 6.4719 3.0800 0.0 0
M  V30 29 C 5.1381 2.3100 0.0 0
M  V30 30 C 7.8055 2.3100 0.0 0
M  V30 31 C 5.1381 0.7700 0.0 0
M  V30 32 C 7.8055 0.7700 0.0 0
M  V30 33 N 6.4719 0.0000 0.0 0
M  V30 34 C 11.8066 7.7000 0.0 0
M  V30 35 C 12.3332 6.2529 0.0 0
M  V30 36 C 12.7963 8.8798 0.0 0
M  V30 37 C 13.8498 5.9855 0.0 0
M  V30 38 C 14.3129 8.6123 0.0 0
M  V30 39 N 14.8397 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 34
M  V30 4 1 3 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 26
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 3 9 10
M  V30 11 1 9 34
M  V30 12 1 11 31
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 39
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 27 28
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(2-chloro-4-pyridinyl)-3-methyl-2-[(methylamino)carb...
C26H31ClN8O3
2827007-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7000 0.0 0
M  V30 2 C 8.9328 6.9300 0.0 0
M  V30 3 C 0.9473 7.6404 0.0 0
M  V30 4 C 2.3100 10.7010 0.0 0
M  V30 5 N 0.7700 10.7010 0.0 0
M  V30 6 O 3.0800 12.0348 0.0 0
M  V30 7 C 0.0000 12.0348 0.0 0
M  V30 8 C 9.2767 8.8798 0.0 0
M  V30 9 N 8.2867 10.0594 0.0 0
M  V30 10 Cl 2.2644 0.0000 0.0 0
M  V30 11 C 14.8163 6.8978 0.0 0
M  V30 12 O 15.8063 8.0775 0.0 0
M  V30 13 O 15.3430 5.4507 0.0 0
M  V30 14 C 17.3228 7.8101 0.0 0
M  V30 15 C 17.5902 9.3267 0.0 0
M  V30 16 C 18.8394 7.5426 0.0 0
M  V30 17 C 17.0553 6.2935 0.0 0
M  V30 18 C 4.9319 7.7000 0.0 0
M  V30 19 N 3.5981 6.9300 0.0 0
M  V30 20 C 6.2655 6.9300 0.0 0
M  V30 21 N 4.6115 9.2064 0.0 0
M  V30 22 C 3.5981 5.3900 0.0 0
M  V30 23 C 2.4537 7.9606 0.0 0
M  V30 24 N 6.2655 5.3900 0.0 0
M  V30 25 C 3.0800 9.3674 0.0 0
M  V30 26 C 4.9319 4.6200 0.0 0
M  V30 27 C 4.9319 3.0800 0.0 0
M  V30 28 C 3.5981 2.3100 0.0 0
M  V30 29 C 6.2655 2.3100 0.0 0
M  V30 30 C 3.5981 0.7700 0.0 0
M  V30 31 C 6.2655 0.7700 0.0 0
M  V30 32 N 4.9319 0.0000 0.0 0
M  V30 33 C 10.2666 7.7000 0.0 0
M  V30 34 C 10.7932 6.2529 0.0 0
M  V30 35 C 11.2563 8.8798 0.0 0
M  V30 36 C 12.3098 5.9855 0.0 0
M  V30 37 C 12.7729 8.6123 0.0 0
M  V30 38 N 13.2997 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 33
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 5 7
M  V30 9 3 8 9
M  V30 10 1 8 33
M  V30 11 1 10 30
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 38
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C31H27BrF3N3O7
2861902-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.2304 10.0102 0.0 0
M  V30 2 C 12.2304 11.5502 0.0 0
M  V30 3 C 8.5730 11.1900 0.0 0 CFG=1
M  V30 4 O 7.0564 10.9225 0.0 0
M  V30 5 C 9.0997 12.6370 0.0 0
M  V30 6 C 6.0665 12.1021 0.0 0
M  V30 7 O 10.6163 12.9045 0.0 0
M  V30 8 O 8.1098 13.8168 0.0 0
M  V30 9 F 19.5412 4.2422 0.0 0
M  V30 10 F 18.9836 9.5478 0.0 0
M  V30 11 F 20.7940 7.0559 0.0 0
M  V30 12 Br 0.0000 11.0326 0.0 0
M  V30 13 C 10.8966 7.7001 0.0 0 CFG=2
M  V30 14 C 9.5629 6.9301 0.0 0 CFG=1
M  V30 15 C 10.8966 9.2401 0.0 0 CFG=1
M  V30 16 C 8.2293 7.7001 0.0 0 CFG=1
M  V30 17 O 9.5629 5.3901 0.0 0
M  V30 18 C 9.5629 10.0102 0.0 0 CFG=2
M  V30 19 O 8.2293 9.2401 0.0 0
M  V30 20 C 6.8956 6.9301 0.0 0
M  V30 21 C 8.2293 4.6201 0.0 0 CFG=1
M  V30 22 O 6.8955 5.3901 0.0 0
M  V30 23 N 12.2304 6.9301 0.0 0
M  V30 24 C 13.6372 7.5564 0.0 0
M  V30 25 N 12.3913 5.3986 0.0 0
M  V30 26 C 14.6677 6.4120 0.0 0
M  V30 27 N 13.8976 5.0784 0.0 0
M  V30 28 C 8.2293 3.0800 0.0 0
M  V30 29 C 6.8956 2.3100 0.0 0
M  V30 30 C 9.5629 2.3100 0.0 0
M  V30 31 C 6.8956 0.7700 0.0 0
M  V30 32 C 9.5629 0.7700 0.0 0
M  V30 33 C 8.2293 0.0000 0.0 0
M  V30 34 C 16.1992 6.5730 0.0 0
M  V30 35 C 17.1044 5.3271 0.0 0
M  V30 36 C 16.8257 7.9799 0.0 0
M  V30 37 C 18.6361 5.4880 0.0 0
M  V30 38 C 18.3572 8.1409 0.0 0
M  V30 39 C 19.2625 6.8950 0.0 0
M  V30 40 C 4.5498 11.8348 0.0 0
M  V30 41 C 3.5599 13.0144 0.0 0
M  V30 42 C 4.0232 10.3876 0.0 0
M  V30 43 C 2.0433 12.7471 0.0 0
M  V30 44 C 2.5065 10.1203 0.0 0
M  V30 45 C 1.5166 11.2999 0.0 0
M  V30 46 H 10.8966 6.1601 0.0 0
M  V30 47 H 6.8955 8.4701 0.0 0
M  V30 48 H 10.5529 11.1900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 3 4 CFG=3
M  V30 4 1 3 5
M  V30 5 1 3 18
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 40
M  V30 10 1 9 37
M  V30 11 1 10 38
M  V30 12 1 11 39
M  V30 13 1 12 45
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 23 CFG=1
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 46 CFG=3
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 16 20
M  V30 23 1 16 47 CFG=3
M  V30 24 1 17 21
M  V30 25 1 18 19
M  V30 26 1 18 48 CFG=3
M  V30 27 1 20 22
M  V30 28 1 21 22
M  V30 29 1 21 28 CFG=1
M  V30 30 1 23 24
M  V30 31 1 23 25
M  V30 32 2 24 26
M  V30 33 2 25 27
M  V30 34 1 26 27
M  V30 35 1 26 34
M  V30 36 2 28 29
M  V30 37 1 28 30
M  V30 38 1 29 31
M  V30 39 2 30 32
M  V30 40 2 31 33
M  V30 41 1 32 33
M  V30 42 2 34 35
M  V30 43 1 34 36
M  V30 44 1 35 37
M  V30 45 2 36 38
M  V30 46 2 37 39
M  V30 47 1 38 39
M  V30 48 2 40 41
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 2 42 44
M  V30 52 2 43 45
M  V30 53 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 3 13 14 15 16 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C32H30BrF3N4O6
2861902-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.2304 10.0101 0.0 0
M  V30 2 C 12.2304 11.5502 0.0 0
M  V30 3 C 8.5730 11.1898 0.0 0 CFG=1
M  V30 4 O 7.0564 10.9225 0.0 0
M  V30 5 C 9.0997 12.6370 0.0 0
M  V30 6 C 6.0665 12.1021 0.0 0
M  V30 7 N 8.1098 13.8166 0.0 0
M  V30 8 O 10.6163 12.9043 0.0 0
M  V30 9 C 8.6366 15.2638 0.0 0
M  V30 10 F 19.5412 4.2421 0.0 0
M  V30 11 F 18.9835 9.5477 0.0 0
M  V30 12 F 20.7940 7.0559 0.0 0
M  V30 13 Br 0.0000 11.0324 0.0 0
M  V30 14 C 10.8966 7.7001 0.0 0 CFG=2
M  V30 15 C 9.5629 6.9301 0.0 0 CFG=1
M  V30 16 C 10.8966 9.2401 0.0 0 CFG=1
M  V30 17 C 8.2293 7.7001 0.0 0 CFG=1
M  V30 18 O 9.5629 5.3901 0.0 0
M  V30 19 C 9.5629 10.0101 0.0 0 CFG=2
M  V30 20 O 8.2293 9.2401 0.0 0
M  V30 21 C 6.8956 6.9301 0.0 0
M  V30 22 C 8.2293 4.6201 0.0 0 CFG=1
M  V30 23 O 6.8954 5.3901 0.0 0
M  V30 24 N 12.2304 6.9301 0.0 0
M  V30 25 C 13.6372 7.5564 0.0 0
M  V30 26 N 12.3913 5.3984 0.0 0
M  V30 27 C 14.6676 6.4120 0.0 0
M  V30 28 N 13.8976 5.0782 0.0 0
M  V30 29 C 8.2293 3.0800 0.0 0
M  V30 30 C 9.5629 2.3100 0.0 0
M  V30 31 C 6.8954 2.3100 0.0 0
M  V30 32 C 9.5629 0.7700 0.0 0
M  V30 33 C 6.8954 0.7700 0.0 0
M  V30 34 C 8.2293 0.0000 0.0 0
M  V30 35 C 16.1992 6.5730 0.0 0
M  V30 36 C 17.1044 5.3271 0.0 0
M  V30 37 C 16.8257 7.9798 0.0 0
M  V30 38 C 18.6361 5.4880 0.0 0
M  V30 39 C 18.3572 8.1409 0.0 0
M  V30 40 C 19.2624 6.8948 0.0 0
M  V30 41 C 4.5498 11.8348 0.0 0
M  V30 42 C 4.0232 10.3876 0.0 0
M  V30 43 C 3.5599 13.0144 0.0 0
M  V30 44 C 2.5065 10.1201 0.0 0
M  V30 45 C 2.0433 12.7471 0.0 0
M  V30 46 C 1.5166 11.2999 0.0 0
M  V30 47 H 10.8966 6.1601 0.0 0
M  V30 48 H 6.8954 8.4701 0.0 0
M  V30 49 H 10.5528 11.1898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 1 3 4 CFG=3
M  V30 4 1 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 41
M  V30 10 1 7 9
M  V30 11 1 10 38
M  V30 12 1 11 39
M  V30 13 1 12 40
M  V30 14 1 13 46
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 24 CFG=1
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 47 CFG=3
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 17 21
M  V30 24 1 17 48 CFG=3
M  V30 25 1 18 22
M  V30 26 1 19 20
M  V30 27 1 19 49 CFG=3
M  V30 28 1 21 23
M  V30 29 1 22 23
M  V30 30 1 22 29 CFG=1
M  V30 31 1 24 25
M  V30 32 1 24 26
M  V30 33 2 25 27
M  V30 34 2 26 28
M  V30 35 1 27 28
M  V30 36 1 27 35
M  V30 37 2 29 30
M  V30 38 1 29 31
M  V30 39 1 30 32
M  V30 40 2 31 33
M  V30 41 2 32 34
M  V30 42 1 33 34
M  V30 43 2 35 36
M  V30 44 1 35 37
M  V30 45 1 36 38
M  V30 46 2 37 39
M  V30 47 2 38 40
M  V30 48 1 39 40
M  V30 49 2 41 42
M  V30 50 1 41 43
M  V30 51 1 42 44
M  V30 52 2 43 45
M  V30 53 2 44 46
M  V30 54 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 3 14 15 16 17 19 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2861902-52-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2861902-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35223073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of galectin-3 inhibiting C-glycosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Magnani, John L.; Peterson, John M.; Sarkar, Arun K.; Vohra, Yusuf U.;
Ghosh, Indranath; Nogueira, Jason; Majumdar, Debatosh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022241183 A1 2022-11-17

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2,4-Dichloro-3-[7,8-dihydro-8-methyl-2-(methylsulfonyl)-7-oxopyrido[2,3-d]...
C23H14Cl2N4O5S
2891866-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.0200 3.3918 0.0 0
M  V30 2 O 13.7305 8.0866 0.0 0
M  V30 3 Cl 9.3360 4.4137 0.0 0
M  V30 4 Cl 6.6687 9.0338 0.0 0
M  V30 5 O 5.3348 8.2638 0.0 0
M  V30 6 C 2.6675 6.7238 0.0 0
M  V30 7 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 O 0.5638 2.6673 0.0 0
M  V30 10 O 2.1038 0.0000 0.0 0
M  V30 11 N 12.0035 5.9538 0.0 0
M  V30 12 C 12.1644 4.4222 0.0 0
M  V30 13 C 13.4103 6.5803 0.0 0
M  V30 14 C 13.6709 4.1020 0.0 0
M  V30 15 C 14.4409 5.4357 0.0 0
M  V30 16 C 14.4409 2.7684 0.0 0
M  V30 17 C 15.9809 5.4357 0.0 0
M  V30 18 C 15.9809 2.7684 0.0 0
M  V30 19 C 16.7509 4.1020 0.0 0
M  V30 20 C 10.6698 6.7238 0.0 0
M  V30 21 C 9.3360 5.9538 0.0 0
M  V30 22 C 10.6698 8.2638 0.0 0
M  V30 23 C 8.0023 6.7238 0.0 0
M  V30 24 C 9.3360 9.0338 0.0 0
M  V30 25 C 8.0023 8.2638 0.0 0
M  V30 26 C 6.6687 5.9538 0.0 0
M  V30 27 C 6.6687 4.4137 0.0 0
M  V30 28 C 5.3348 6.7238 0.0 0
M  V30 29 C 5.3348 3.6437 0.0 0
M  V30 30 N 4.0012 5.9538 0.0 0
M  V30 31 C 4.0012 4.4137 0.0 0
M  V30 32 C 5.3348 2.1037 0.0 0
M  V30 33 N 2.6675 3.6437 0.0 0
M  V30 34 N 4.0012 1.3337 0.0 0
M  V30 35 C 2.6675 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 13
M  V30 3 1 3 21
M  V30 4 1 4 25
M  V30 5 2 5 28
M  V30 6 1 6 30
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 35
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 23 26
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 29 32
M  V30 35 1 30 31
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Amino-2,6-dichlorophenyl)-8-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin...
C15H13Cl2N5O
2891866-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 5.3349 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 N 0.0000 5.3349 0.0 0
M  V30 5 C 7.7000 0.0000 0.0 0
M  V30 6 N 11.5500 4.0011 0.0 0
M  V30 7 C 12.3200 5.3347 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 5.3900 1.3338 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 N 6.9300 1.3338 0.0 0
M  V30 19 C 7.7000 2.6674 0.0 0
M  V30 20 C 7.7000 5.3349 0.0 0
M  V30 21 N 9.2400 2.6674 0.0 0
M  V30 22 N 9.2400 5.3349 0.0 0
M  V30 23 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 16
M  V30 4 1 4 11
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 19
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891866-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2891866-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35624402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1-(4-fluorophenyl)-1H-pyrazole-3-carboxamides
as modulators of protein kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Gary A.; Galatsis, Paul; Huntsman, Andrew C.; Huynh, Khoi; Werner,
Doug
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023283369 A1 2023-01-12

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[6-fluoro-7-[[(8-fluoro-2-methylimidazo[1,2-a]...
C26H29F2N7O3
2916879-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2435 0.0 0
M  V30 2 N 7.6212 6.5772 0.0 0
M  V30 3 O 7.6212 3.9099 0.0 0
M  V30 4 F 9.9312 7.9110 0.0 0
M  V30 5 C 11.4712 0.0000 0.0 0
M  V30 6 C 19.1712 5.2435 0.0 0
M  V30 7 O 19.9412 6.5772 0.0 0
M  V30 8 O 19.9412 3.9099 0.0 0
M  V30 9 C 21.4810 6.5772 0.0 0
M  V30 10 C 21.4812 8.1172 0.0 0
M  V30 11 C 23.0212 6.5772 0.0 0
M  V30 12 C 21.4812 5.0372 0.0 0
M  V30 13 F 3.0012 3.9099 0.0 0
M  V30 14 C 0.0000 9.1990 0.0 0
M  V30 15 C 10.7012 3.9099 0.0 0
M  V30 16 C 12.2412 3.9099 0.0 0
M  V30 17 C 9.9312 5.2435 0.0 0
M  V30 18 N 10.2251 2.4452 0.0 0
M  V30 19 C 13.0112 5.2435 0.0 0
M  V30 20 C 12.7170 2.4452 0.0 0
M  V30 21 C 10.7012 6.5772 0.0 0
M  V30 22 N 11.4712 1.5400 0.0 0
M  V30 23 C 12.2412 6.5772 0.0 0
M  V30 24 N 14.5512 5.2435 0.0 0
M  V30 25 C 15.3212 3.9099 0.0 0
M  V30 26 C 15.3212 6.5772 0.0 0
M  V30 27 C 16.8612 3.9099 0.0 0
M  V30 28 C 16.8612 6.5772 0.0 0
M  V30 29 N 17.6312 5.2435 0.0 0
M  V30 30 C 6.0812 6.5772 0.0 0
M  V30 31 C 5.3112 7.9110 0.0 0
M  V30 32 C 5.3112 5.2435 0.0 0
M  V30 33 N 3.7712 7.9110 0.0 0
M  V30 34 C 3.7712 5.2435 0.0 0
M  V30 35 C 3.0012 6.5772 0.0 0
M  V30 36 C 2.7406 9.0554 0.0 0
M  V30 37 N 1.4947 6.8974 0.0 0
M  V30 38 C 1.3338 8.4290 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 30
M  V30 5 1 4 21
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 29
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 34
M  V30 15 1 14 38
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 19 24
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 1 34 35
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[7-[[(8-fluoro-2-methylimidazo[1,2-a]pyridin-6...
C27H33FN8O3
2916879-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2435 0.0 0
M  V30 2 N 7.6212 6.5772 0.0 0
M  V30 3 O 7.6212 3.9099 0.0 0
M  V30 4 C 11.4710 0.0000 0.0 0
M  V30 5 N 9.9312 7.9108 0.0 0
M  V30 6 C 10.7012 9.2446 0.0 0
M  V30 7 C 19.1710 5.2435 0.0 0
M  V30 8 O 19.9410 6.5772 0.0 0
M  V30 9 O 19.9410 3.9099 0.0 0
M  V30 10 C 21.4810 6.5772 0.0 0
M  V30 11 C 21.4810 8.1172 0.0 0
M  V30 12 C 23.0212 6.5772 0.0 0
M  V30 13 C 21.4810 5.0372 0.0 0
M  V30 14 F 3.0010 3.9099 0.0 0
M  V30 15 C 0.0000 9.1990 0.0 0
M  V30 16 C 12.2412 3.9099 0.0 0
M  V30 17 C 10.7012 3.9099 0.0 0
M  V30 18 C 13.0110 5.2435 0.0 0
M  V30 19 C 12.7170 2.4452 0.0 0
M  V30 20 C 9.9312 5.2435 0.0 0
M  V30 21 N 10.2251 2.4452 0.0 0
M  V30 22 C 12.2412 6.5772 0.0 0
M  V30 23 N 11.4712 1.5400 0.0 0
M  V30 24 C 10.7012 6.5772 0.0 0
M  V30 25 N 14.5510 5.2435 0.0 0
M  V30 26 C 15.3210 3.9099 0.0 0
M  V30 27 C 15.3210 6.5772 0.0 0
M  V30 28 C 16.8612 3.9099 0.0 0
M  V30 29 C 16.8610 6.5772 0.0 0
M  V30 30 N 17.6310 5.2435 0.0 0
M  V30 31 C 6.0812 6.5772 0.0 0
M  V30 32 C 5.3112 7.9108 0.0 0
M  V30 33 C 5.3112 5.2435 0.0 0
M  V30 34 N 3.7710 7.9108 0.0 0
M  V30 35 C 3.7710 5.2435 0.0 0
M  V30 36 C 3.0012 6.5772 0.0 0
M  V30 37 C 2.7406 9.0554 0.0 0
M  V30 38 N 1.4947 6.8974 0.0 0
M  V30 39 C 1.3338 8.4290 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 31
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 30
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 35
M  V30 16 1 15 39
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 18 25
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 34 37
M  V30 40 1 35 36
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2916879-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2916879-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36290140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaromatic compounds and methods for modulating
splicing
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reynolds, Dominic; Seiler, Michael W.; Agrawal, Anant A.; Vaillancourt,
Frederic; Smith, Peter; Prajapati, Sudeep; Hopper, Allen T.; Vyskocil,
Stepan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023034812 A1 2023-03-09

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[(methylsulfonyl)oxy]propyl]-1-piperazinecarboxylate
C13H26N2O5S
295330-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.2073 0.0 0
M  V30 2 O 3.0800 5.5409 0.0 0
M  V30 3 O 3.0800 2.8736 0.0 0
M  V30 4 C 1.5400 5.5409 0.0 0
M  V30 5 C 1.5400 7.0809 0.0 0
M  V30 6 C 0.0000 5.5409 0.0 0
M  V30 7 C 1.5400 4.0009 0.0 0
M  V30 8 C 10.0100 4.2073 0.0 0
M  V30 9 C 10.7800 2.8736 0.0 0
M  V30 10 C 12.3200 2.8736 0.0 0
M  V30 11 O 13.0900 1.5400 0.0 0
M  V30 12 S 14.6300 1.5400 0.0 0 VAL=6
M  V30 13 C 14.6300 3.0800 0.0 0
M  V30 14 O 16.1700 1.5400 0.0 0
M  V30 15 O 14.6300 0.0000 0.0 0
M  V30 16 N 5.3900 4.2073 0.0 0
M  V30 17 C 6.1600 5.5409 0.0 0
M  V30 18 C 6.1600 2.8736 0.0 0
M  V30 19 C 7.7000 5.5409 0.0 0
M  V30 20 C 7.7000 2.8736 0.0 0
M  V30 21 N 8.4700 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-(methylamino)propyl]-1-piperazinecarboxylate
C13H27N3O2
1782254-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.5637 2.8737 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 2.1037 0.2064 0.0 0
M  V30 8 C 9.3358 4.6201 0.0 0
M  V30 9 C 10.6697 3.8501 0.0 0
M  V30 10 C 12.0033 4.6201 0.0 0
M  V30 11 N 13.3370 3.8501 0.0 0
M  V30 12 C 14.6707 4.6201 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 N 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 295330-86-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1782254-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22611504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone, 4-(5-bromo-6-methoxy-2H-indazol-2-yl)-3-methyl-, (3R,4S)-rel-
C15H17BrN2O2
2967595-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.5400 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 Br 0.0000 4.6200 0.0 0
M  V30 4 C 7.9110 5.7473 0.0 0
M  V30 5 O 12.5310 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 N 5.4658 1.8341 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 5.4658 4.3259 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 N 6.3710 3.0800 0.0 0
M  V30 13 C 1.3338 2.3100 0.0 0
M  V30 14 C 1.3338 3.8500 0.0 0
M  V30 15 C 7.9110 3.0800 0.0 0 CFG=1
M  V30 16 C 8.6810 4.4136 0.0 0 CFG=2
M  V30 17 C 8.6810 1.7462 0.0 0
M  V30 18 C 10.2210 4.4136 0.0 0
M  V30 19 C 10.2210 1.7462 0.0 0
M  V30 20 C 10.9910 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 14
M  V30 4 1 16 4 CFG=3
M  V30 5 2 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 2 11 14
M  V30 15 1 15 12 CFG=3
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclohexanamine, 4-(5-bromo-6-methoxy-2H-indazol-2-yl)-N,3-dimethyl-, (3R,4S)...
C16H22BrN3O
2967595-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.5400 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 Br 0.0000 4.6200 0.0 0
M  V30 4 C 7.9110 5.7473 0.0 0
M  V30 5 N 12.5310 3.0800 0.0 0
M  V30 6 C 13.3010 1.7462 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 5.4658 1.8341 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 5.4658 4.3259 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 N 6.3710 3.0800 0.0 0
M  V30 14 C 1.3338 2.3100 0.0 0
M  V30 15 C 1.3338 3.8500 0.0 0
M  V30 16 C 7.9110 3.0800 0.0 0 CFG=1
M  V30 17 C 8.6810 4.4136 0.0 0 CFG=2
M  V30 18 C 8.6810 1.7462 0.0 0
M  V30 19 C 10.2210 4.4136 0.0 0
M  V30 20 C 10.2210 1.7462 0.0 0
M  V30 21 C 10.9910 3.0800 0.0 0 CFG=3
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 15
M  V30 4 1 17 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 2 12 15
M  V30 16 1 16 13 CFG=3
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2967595-24-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2967595-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37367999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of IRAK4 inhibitors comprises pharmaceutically acceptable
salts to inhibit IRAK4 for treatment of respiratory diseases in human
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Terstiege, Ina; Schiesser, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023152349 A1 2023-08-17

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzenesulfonyl chloride
C7H4ClF3O2S
2991-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 6 Cl 9.2400 1.5400 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 O 7.7000 3.0800 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenesulfonamide
C8H8F3NO2S
873002-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 2 N 9.2400 1.5400 0.0 0
M  V30 3 O 7.7000 0.0000 0.0 0
M  V30 4 O 7.7000 3.0800 0.0 0
M  V30 5 C 10.0100 2.8736 0.0 0
M  V30 6 C 1.5400 1.5400 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 F 0.0000 1.5400 0.0 0
M  V30 9 F 1.5400 3.0800 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 3.8500 0.2064 0.0 0
M  V30 14 C 3.8500 2.8736 0.0 0
M  V30 15 C 3.0800 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2991-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 873002-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-3-methyl-2-nitrobenzene
C7H6FNO2
3013-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 C 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzenamine
C8H10N2O2
70254-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3013-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70254-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34248168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclic SHP2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ciammaichella, Alina; Di Fabio, Romano; Ferrigno, Federica; Fezzardi,
Paola; Montalbetti, Christian; Petrocchi, Alessia; Relitti, Nicola;
Rossetti, Ilaria; Sferrazza, Alessio; Torrente, Esther; Ferrante, Luca;
Grillo, Alessandro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022167682 A1 2022-08-11

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, N-[1′-[6-(chloromethyl)-2-(1,1-difluoroethyl)-4-pyrimidinyl]-1′,2′...
C18H18ClF2N5O
3024866-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.2388 5.2444 0.0 0
M  V30 2 C 12.7035 5.7204 0.0 0
M  V30 3 C 13.0237 7.2267 0.0 0
M  V30 4 O 13.8479 4.6898 0.0 0
M  V30 5 C 1.3337 4.0011 0.0 0
M  V30 6 C 0.5636 5.3348 0.0 0
M  V30 7 F 1.3337 2.4611 0.0 0
M  V30 8 F 0.0000 3.2311 0.0 0
M  V30 9 C 5.9537 1.3338 0.0 0
M  V30 10 Cl 5.1837 0.0000 0.0 0
M  V30 11 C 6.4718 9.1058 0.0 0
M  V30 12 C 7.8055 8.3358 0.0 0
M  V30 13 C 5.3272 8.0754 0.0 0
M  V30 14 C 5.5666 10.3517 0.0 0
M  V30 15 C 7.0981 10.5128 0.0 0
M  V30 16 C 7.4853 6.8295 0.0 0
M  V30 17 C 9.2702 8.8117 0.0 0
M  V30 18 N 5.9537 6.6686 0.0 0
M  V30 19 C 8.6297 5.7991 0.0 0
M  V30 20 N 10.4146 7.7813 0.0 0
M  V30 21 C 10.0944 6.2750 0.0 0
M  V30 22 C 5.1837 5.3348 0.0 0
M  V30 23 N 3.6437 5.3348 0.0 0
M  V30 24 C 5.9537 4.0011 0.0 0
M  V30 25 C 2.8737 4.0011 0.0 0
M  V30 26 C 5.1837 2.6675 0.0 0
M  V30 27 N 3.6437 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 25
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, N-[1′-[2-(1,1-difluoroethyl)-6-[(methylamino)methyl]-4-pyrimidinyl...
C19H22F2N6O
3024863-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.2388 6.5781 0.0 0
M  V30 2 C 12.7035 7.0541 0.0 0
M  V30 3 C 13.0237 8.5604 0.0 0
M  V30 4 O 13.8479 6.0235 0.0 0
M  V30 5 C 1.3337 5.3348 0.0 0
M  V30 6 C 0.5636 6.6685 0.0 0
M  V30 7 F 1.3337 3.7948 0.0 0
M  V30 8 F 0.0000 4.5648 0.0 0
M  V30 9 C 5.9537 2.6675 0.0 0
M  V30 10 N 5.1837 1.3337 0.0 0
M  V30 11 C 5.9537 0.0000 0.0 0
M  V30 12 C 6.4718 10.4395 0.0 0
M  V30 13 C 7.8055 9.6695 0.0 0
M  V30 14 C 5.3273 9.4091 0.0 0
M  V30 15 C 7.0981 11.8465 0.0 0
M  V30 16 C 5.5666 11.6856 0.0 0
M  V30 17 C 7.4853 8.1632 0.0 0
M  V30 18 C 9.2702 10.1455 0.0 0
M  V30 19 N 5.9537 8.0023 0.0 0
M  V30 20 C 8.6297 7.1328 0.0 0
M  V30 21 N 10.4146 9.1149 0.0 0
M  V30 22 C 10.0944 7.6086 0.0 0
M  V30 23 C 5.1837 6.6685 0.0 0
M  V30 24 N 3.6437 6.6685 0.0 0
M  V30 25 C 5.9537 5.3348 0.0 0
M  V30 26 C 2.8737 5.3348 0.0 0
M  V30 27 C 5.1837 4.0011 0.0 0
M  V30 28 N 3.6437 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 26
M  V30 9 1 9 10
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3024866-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3024863-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39697007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolopyridines as tyrosine kinase 2 inhibitors and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vessels, Jeffrey; Zhang, Lei; Van Vloten, Kurt; Sciabola, Simone;
Vandeveer, Harold George; Lopez de Turiso, Felix Gonzalez; Chen, Teyu;
Xin, Zhili; Lin, Edward Yin Shiang; Levin, Tamara Halkina; Helal,
Christopher; Maitra, Soma; Guckian, Kevin M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023250064 A1 2023-12-28

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Pyran-6-carboxylic acid, 3,4-dihydro-2-(3-methyl-1H-indol-2-yl)-3,4-diphen...
C28H25NO3
3028339-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 10.2622 0.0 0
M  V30 2 C 10.0823 7.7002 0.0 0
M  V30 3 O 11.4160 6.9302 0.0 0
M  V30 4 O 10.0823 9.2402 0.0 0
M  V30 5 C 12.7496 7.7002 0.0 0
M  V30 6 C 6.0811 5.3901 0.0 0 CFG=1
M  V30 7 C 6.0811 6.9302 0.0 0 CFG=1
M  V30 8 C 7.4148 4.6201 0.0 0 CFG=2
M  V30 9 O 7.4148 7.7002 0.0 0
M  V30 10 C 8.7485 5.3901 0.0 0
M  V30 11 C 8.7485 6.9302 0.0 0
M  V30 12 C 4.7475 4.6201 0.0 0
M  V30 13 C 3.4136 5.3901 0.0 0
M  V30 14 C 4.7475 3.0801 0.0 0
M  V30 15 C 2.0800 4.6201 0.0 0
M  V30 16 C 3.4136 2.3101 0.0 0
M  V30 17 C 2.0800 3.0801 0.0 0
M  V30 18 C 4.7475 7.7002 0.0 0
M  V30 19 C 4.5864 9.2317 0.0 0
M  V30 20 N 3.3405 7.0737 0.0 0
M  V30 21 C 3.0801 9.5519 0.0 0
M  V30 22 C 2.3101 8.2182 0.0 0
M  V30 23 C 2.3101 10.8856 0.0 0
M  V30 24 C 0.7700 8.2182 0.0 0
M  V30 25 C 0.7700 10.8856 0.0 0
M  V30 26 C 0.0000 9.5519 0.0 0
M  V30 27 C 7.4148 3.0801 0.0 0
M  V30 28 C 6.0811 2.3101 0.0 0
M  V30 29 C 8.7485 2.3101 0.0 0
M  V30 30 C 6.0811 0.7700 0.0 0
M  V30 31 C 8.7485 0.7700 0.0 0
M  V30 32 C 7.4148 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12 CFG=3
M  V30 9 1 7 9
M  V30 10 1 7 18 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 27 CFG=1
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Pyran-6-carboxamide, 3,4-dihydro-N-methyl-2-(3-methyl-1H-indol-2-yl)-3,4-d...
C28H26N2O2
3028340-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 10.2622 0.0 0
M  V30 2 C 10.0823 7.7002 0.0 0
M  V30 3 N 11.4160 6.9302 0.0 0
M  V30 4 O 10.0823 9.2402 0.0 0
M  V30 5 C 12.7496 7.7002 0.0 0
M  V30 6 C 6.0811 5.3901 0.0 0 CFG=1
M  V30 7 C 6.0811 6.9302 0.0 0 CFG=1
M  V30 8 C 7.4148 4.6201 0.0 0 CFG=2
M  V30 9 O 7.4148 7.7002 0.0 0
M  V30 10 C 8.7485 5.3901 0.0 0
M  V30 11 C 8.7485 6.9302 0.0 0
M  V30 12 C 4.7475 4.6201 0.0 0
M  V30 13 C 4.7475 3.0801 0.0 0
M  V30 14 C 3.4136 5.3901 0.0 0
M  V30 15 C 3.4136 2.3101 0.0 0
M  V30 16 C 2.0800 4.6201 0.0 0
M  V30 17 C 2.0800 3.0801 0.0 0
M  V30 18 C 4.7475 7.7002 0.0 0
M  V30 19 C 4.5864 9.2317 0.0 0
M  V30 20 N 3.3405 7.0737 0.0 0
M  V30 21 C 3.0801 9.5519 0.0 0
M  V30 22 C 2.3101 8.2182 0.0 0
M  V30 23 C 2.3101 10.8856 0.0 0
M  V30 24 C 0.7700 8.2182 0.0 0
M  V30 25 C 0.7700 10.8856 0.0 0
M  V30 26 C 0.0000 9.5519 0.0 0
M  V30 27 C 7.4148 3.0801 0.0 0
M  V30 28 C 8.7485 2.3101 0.0 0
M  V30 29 C 6.0811 2.3101 0.0 0
M  V30 30 C 8.7485 0.7700 0.0 0
M  V30 31 C 6.0811 0.7700 0.0 0
M  V30 32 C 7.4148 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12 CFG=3
M  V30 9 1 7 9
M  V30 10 1 7 18 CFG=1
M  V30 11 1 8 10
M  V30 12 1 8 27 CFG=1
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3028339-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3028340-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39206561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lewis acid-catalyzed [4 + 2] cycloaddition of 3-alkyl-2-vinylindoles with
β,γ-unsaturated α-ketoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Yuwen; Wang, Zhaoshan; Wu, Shufang; Zhang, Yuchen; Shi, Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Synthesis and Catalysis (2022), 3(1), 84-88

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[6-(methoxycarbonyl)-2-(trifluoromethyl)-3-pyr...
C17H22F3N3O4
3031772-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 F 8.6764 2.1038 0.0 0
M  V30 3 F 9.2400 0.0000 0.0 0
M  V30 4 F 11.3436 0.5638 0.0 0
M  V30 5 C 14.6300 4.0011 0.0 0
M  V30 6 O 15.4000 5.3349 0.0 0
M  V30 7 O 15.4000 2.6674 0.0 0
M  V30 8 C 16.9400 5.3349 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 3.0800 5.3347 0.0 0
M  V30 11 O 3.0800 2.6674 0.0 0
M  V30 12 C 1.5400 5.3349 0.0 0
M  V30 13 C 1.5400 6.8749 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 1.5400 3.7949 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 N 12.3200 2.6674 0.0 0
M  V30 20 C 12.3200 5.3349 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 N 8.4700 4.0011 0.0 0
M  V30 23 C 7.7000 2.6674 0.0 0
M  V30 24 C 7.7000 5.3349 0.0 0
M  V30 25 C 6.1600 2.6674 0.0 0
M  V30 26 C 6.1600 5.3349 0.0 0
M  V30 27 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-2-(trifluoromethyl)-3-pyridiny...
C17H23F3N4O3
2589532-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 F 8.6764 2.1038 0.0 0
M  V30 3 F 9.2400 0.0000 0.0 0
M  V30 4 F 11.3436 0.5638 0.0 0
M  V30 5 C 14.6300 4.0011 0.0 0
M  V30 6 N 15.4000 5.3349 0.0 0
M  V30 7 O 15.4000 2.6674 0.0 0
M  V30 8 C 16.9400 5.3349 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 3.0800 5.3349 0.0 0
M  V30 11 O 3.0800 2.6674 0.0 0
M  V30 12 C 1.5400 5.3349 0.0 0
M  V30 13 C 1.5400 6.8749 0.0 0
M  V30 14 C 0.0000 5.3349 0.0 0
M  V30 15 C 1.5400 3.7949 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 N 12.3200 2.6674 0.0 0
M  V30 20 C 12.3200 5.3349 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 N 8.4700 4.0011 0.0 0
M  V30 23 C 7.7000 5.3349 0.0 0
M  V30 24 C 7.7000 2.6674 0.0 0
M  V30 25 C 6.1600 5.3349 0.0 0
M  V30 26 C 6.1600 2.6674 0.0 0
M  V30 27 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3031772-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[6-(methoxycarbonyl)-2-(trifluoromethyl)-3-pyr...
C17H22F3N3O4
3031772-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 F 8.6764 2.1038 0.0 0
M  V30 3 F 9.2400 0.0000 0.0 0
M  V30 4 F 11.3436 0.5638 0.0 0
M  V30 5 C 14.6300 4.0011 0.0 0
M  V30 6 O 15.4000 5.3349 0.0 0
M  V30 7 O 15.4000 2.6674 0.0 0
M  V30 8 C 16.9400 5.3349 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 3.0800 5.3347 0.0 0
M  V30 11 O 3.0800 2.6674 0.0 0
M  V30 12 C 1.5400 5.3349 0.0 0
M  V30 13 C 1.5400 6.8749 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 1.5400 3.7949 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 N 12.3200 2.6674 0.0 0
M  V30 20 C 12.3200 5.3349 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 N 8.4700 4.0011 0.0 0
M  V30 23 C 7.7000 2.6674 0.0 0
M  V30 24 C 7.7000 5.3349 0.0 0
M  V30 25 C 6.1600 2.6674 0.0 0
M  V30 26 C 6.1600 5.3349 0.0 0
M  V30 27 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-2-(trifluoromethyl)-3-pyridiny...
C17H23F3N4O3
2589532-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 F 8.6764 2.1038 0.0 0
M  V30 3 F 9.2400 0.0000 0.0 0
M  V30 4 F 11.3436 0.5638 0.0 0
M  V30 5 C 14.6300 4.0011 0.0 0
M  V30 6 N 15.4000 5.3349 0.0 0
M  V30 7 O 15.4000 2.6674 0.0 0
M  V30 8 C 16.9400 5.3349 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 3.0800 5.3349 0.0 0
M  V30 11 O 3.0800 2.6674 0.0 0
M  V30 12 C 1.5400 5.3349 0.0 0
M  V30 13 C 1.5400 6.8749 0.0 0
M  V30 14 C 0.0000 5.3349 0.0 0
M  V30 15 C 1.5400 3.7949 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 N 12.3200 2.6674 0.0 0
M  V30 20 C 12.3200 5.3349 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 N 8.4700 4.0011 0.0 0
M  V30 23 C 7.7000 5.3349 0.0 0
M  V30 24 C 7.7000 2.6674 0.0 0
M  V30 25 C 6.1600 5.3349 0.0 0
M  V30 26 C 6.1600 2.6674 0.0 0
M  V30 27 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3031772-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C42H39F3O6
3040200-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0102 0.0 0
M  V30 2 C 4.0012 9.2402 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 C 5.3348 5.3901 0.0 0
M  V30 5 O 8.0023 5.3901 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 6.9302 0.0 0
M  V30 8 O 12.0035 7.7002 0.0 0
M  V30 9 C 13.3372 6.9302 0.0 0
M  V30 10 C 10.6697 14.6303 0.0 0
M  V30 11 F 11.4397 13.2967 0.0 0
M  V30 12 F 12.0035 15.4003 0.0 0
M  V30 13 F 9.8996 15.9640 0.0 0
M  V30 14 C 8.0023 16.1704 0.0 0
M  V30 15 O 6.6687 16.9404 0.0 0
M  V30 16 C 6.6687 9.2402 0.0 0 CFG=2
M  V30 17 C 8.0023 10.0102 0.0 0 CFG=2
M  V30 18 C 6.6687 7.7002 0.0 0 CFG=1
M  V30 19 O 9.3360 9.2402 0.0 0
M  V30 20 C 8.0023 6.9302 0.0 0 CFG=2
M  V30 21 C 9.3360 7.7002 0.0 0 CFG=2
M  V30 22 C 8.0023 11.5503 0.0 0
M  V30 23 C 9.3360 12.3203 0.0 0
M  V30 24 C 6.6687 12.3203 0.0 0
M  V30 25 C 9.3360 13.8603 0.0 0
M  V30 26 C 6.6687 13.8603 0.0 0
M  V30 27 C 8.0023 14.6303 0.0 0
M  V30 28 C 2.6675 10.0102 0.0 0
M  V30 29 C 2.6675 11.5503 0.0 0
M  V30 30 C 1.3338 9.2402 0.0 0
M  V30 31 C 1.3338 12.3203 0.0 0
M  V30 32 C 0.0000 10.0102 0.0 0
M  V30 33 C 0.0000 11.5503 0.0 0
M  V30 34 C 4.0012 4.6201 0.0 0
M  V30 35 C 2.6675 5.3901 0.0 0
M  V30 36 C 4.0012 3.0801 0.0 0
M  V30 37 C 1.3338 4.6201 0.0 0
M  V30 38 C 2.6675 2.3101 0.0 0
M  V30 39 C 1.3338 3.0801 0.0 0
M  V30 40 C 9.3360 3.0801 0.0 0
M  V30 41 C 10.6697 2.3101 0.0 0
M  V30 42 C 8.0023 2.3101 0.0 0
M  V30 43 C 10.6697 0.7700 0.0 0
M  V30 44 C 8.0023 0.7700 0.0 0
M  V30 45 C 9.3360 0.0000 0.0 0
M  V30 46 C 14.6708 7.7002 0.0 0
M  V30 47 C 14.6708 9.2402 0.0 0
M  V30 48 C 16.0045 6.9302 0.0 0
M  V30 49 C 16.0045 10.0102 0.0 0
M  V30 50 C 17.3383 7.7002 0.0 0
M  V30 51 C 17.3383 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 1 18 3 CFG=3
M  V30 6 1 4 34
M  V30 7 1 5 6
M  V30 8 1 20 5 CFG=1
M  V30 9 1 6 40
M  V30 10 1 7 8
M  V30 11 1 21 7 CFG=3
M  V30 12 1 8 9
M  V30 13 1 9 46
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 1 10 13
M  V30 17 1 10 25
M  V30 18 2 14 15
M  V30 19 1 14 27
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 17 22 CFG=3
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 51 2 46 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 2 48 50
M  V30 55 2 49 51
M  V30 56 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 16 17 18 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C43H44F3NO5
3040200-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.0102 12.0035 0.0 0
M  V30 2 C 9.2402 13.3372 0.0 0
M  V30 3 O 6.9302 12.0035 0.0 0
M  V30 4 C 5.3901 12.0035 0.0 0
M  V30 5 O 5.3901 9.3360 0.0 0
M  V30 6 C 4.6201 8.0023 0.0 0
M  V30 7 C 6.9302 6.6687 0.0 0
M  V30 8 O 7.7002 5.3348 0.0 0
M  V30 9 C 6.9302 4.0012 0.0 0
M  V30 10 C 14.6303 6.6687 0.0 0
M  V30 11 F 13.2967 5.8986 0.0 0
M  V30 12 F 15.4003 5.3348 0.0 0
M  V30 13 F 15.9640 7.4387 0.0 0
M  V30 14 C 16.1704 9.3360 0.0 0
M  V30 15 N 16.9404 10.6697 0.0 0
M  V30 16 C 18.4804 10.6697 0.0 0
M  V30 17 C 9.2402 10.6697 0.0 0 CFG=2
M  V30 18 C 10.0102 9.3360 0.0 0 CFG=2
M  V30 19 C 7.7002 10.6697 0.0 0 CFG=1
M  V30 20 O 9.2402 8.0023 0.0 0
M  V30 21 C 6.9302 9.3360 0.0 0 CFG=2
M  V30 22 C 7.7002 8.0023 0.0 0 CFG=2
M  V30 23 C 11.5503 9.3360 0.0 0
M  V30 24 C 12.3203 8.0023 0.0 0
M  V30 25 C 12.3203 10.6697 0.0 0
M  V30 26 C 13.8603 8.0023 0.0 0
M  V30 27 C 13.8603 10.6697 0.0 0
M  V30 28 C 14.6303 9.3360 0.0 0
M  V30 29 C 10.0102 14.6708 0.0 0
M  V30 30 C 11.5503 14.6708 0.0 0
M  V30 31 C 9.2402 16.0045 0.0 0
M  V30 32 C 12.3203 16.0045 0.0 0
M  V30 33 C 10.0102 17.3383 0.0 0
M  V30 34 C 11.5503 17.3383 0.0 0
M  V30 35 C 4.6201 13.3372 0.0 0
M  V30 36 C 5.3901 14.6708 0.0 0
M  V30 37 C 3.0801 13.3372 0.0 0
M  V30 38 C 4.6201 16.0045 0.0 0
M  V30 39 C 2.3101 14.6708 0.0 0
M  V30 40 C 3.0801 16.0045 0.0 0
M  V30 41 C 3.0801 8.0023 0.0 0
M  V30 42 C 2.3101 6.6687 0.0 0
M  V30 43 C 2.3101 9.3360 0.0 0
M  V30 44 C 0.7700 6.6687 0.0 0
M  V30 45 C 0.7700 9.3360 0.0 0
M  V30 46 C 0.0000 8.0023 0.0 0
M  V30 47 C 7.7002 2.6675 0.0 0
M  V30 48 C 9.2402 2.6675 0.0 0
M  V30 49 C 6.9302 1.3338 0.0 0
M  V30 50 C 10.0102 1.3338 0.0 0
M  V30 51 C 7.7002 0.0000 0.0 0
M  V30 52 C 9.2402 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 29
M  V30 4 1 3 4
M  V30 5 1 19 3 CFG=3
M  V30 6 1 4 35
M  V30 7 1 5 6
M  V30 8 1 21 5 CFG=1
M  V30 9 1 6 41
M  V30 10 1 7 8
M  V30 11 1 22 7 CFG=3
M  V30 12 1 8 9
M  V30 13 1 9 47
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 1 10 13
M  V30 17 1 10 26
M  V30 18 1 14 15
M  V30 19 1 14 28
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 18 23 CFG=3
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 52 2 47 48
M  V30 53 1 47 49
M  V30 54 1 48 50
M  V30 55 2 49 51
M  V30 56 2 50 52
M  V30 57 1 51 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 17 18 19 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3040200-93-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7H-Purine, 2,6-dichloro-7-(2-naphthalenylmethyl)-
C16H10Cl2N4
3052383-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 2.4656 0.0 0
M  V30 2 Cl 8.8545 0.0000 0.0 0
M  V30 3 Cl 13.9283 1.6486 0.0 0
M  V30 4 N 8.0023 3.2356 0.0 0
M  V30 5 C 9.4091 2.6091 0.0 0
M  V30 6 C 8.1632 4.7671 0.0 0
M  V30 7 C 10.4397 3.7537 0.0 0
M  V30 8 C 9.8850 1.1445 0.0 0
M  V30 9 N 9.6697 5.0873 0.0 0
M  V30 10 N 11.9460 3.4335 0.0 0
M  V30 11 N 11.3914 0.8244 0.0 0
M  V30 12 C 12.4218 1.9688 0.0 0
M  V30 13 C 5.3348 3.2356 0.0 0
M  V30 14 C 4.0011 2.4656 0.0 0
M  V30 15 C 5.3348 4.7756 0.0 0
M  V30 16 C 2.6675 3.2356 0.0 0
M  V30 17 C 4.0011 5.5456 0.0 0
M  V30 18 C 2.6675 4.7756 0.0 0
M  V30 19 C 1.3338 2.4656 0.0 0
M  V30 20 C 1.3338 5.5456 0.0 0
M  V30 21 C 0.0000 3.2356 0.0 0
M  V30 22 C 0.0000 4.7756 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7H-Purin-6-amine, 2-chloro-N-methyl-7-(2-naphthalenylmethyl)-
C17H14ClN5
3052383-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 3.9301 0.0 0
M  V30 2 N 8.8545 1.4647 0.0 0
M  V30 3 C 9.3303 0.0000 0.0 0
M  V30 4 Cl 13.9282 3.1131 0.0 0
M  V30 5 C 9.4090 4.0738 0.0 0
M  V30 6 N 8.0022 4.7001 0.0 0
M  V30 7 C 10.4396 5.2182 0.0 0
M  V30 8 C 9.8849 2.6091 0.0 0
M  V30 9 C 8.1632 6.2317 0.0 0
M  V30 10 N 9.6696 6.5518 0.0 0
M  V30 11 N 11.9459 4.8980 0.0 0
M  V30 12 N 11.3914 2.2889 0.0 0
M  V30 13 C 12.4218 3.4333 0.0 0
M  V30 14 C 5.3348 4.7001 0.0 0
M  V30 15 C 4.0011 3.9301 0.0 0
M  V30 16 C 5.3348 6.2401 0.0 0
M  V30 17 C 2.6675 4.7001 0.0 0
M  V30 18 C 4.0011 7.0102 0.0 0
M  V30 19 C 2.6675 6.2401 0.0 0
M  V30 20 C 1.3338 3.9301 0.0 0
M  V30 21 C 1.3338 7.0102 0.0 0
M  V30 22 C 0.0000 4.7001 0.0 0
M  V30 23 C 0.0000 6.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052383-47-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052383-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37258107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of
potent antitubercular agents inhibiting DprE1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Finger, Vladimir; Kucera, Tomas; Kafkova, Radka; Muckova, Lubica;
Dolezal, Rafael; Kubes, Jan; Novak, Martin; Prchal, Lukas; Lakatos,
Levente; Andrs, Martin; Hympanova, Michaela; Marek, Jan; Kufa, Martin;
Spiwok, Vojtech; Soukup, Ondrej; Mezeiova, Eva; Janousek, Jiri;
Nevosadova, Lenka; Benkova, Marketa; Kitson, Russell R. A.; Kratky,
Martin; Bosze, Szilvia; Mikusova, Katarina; Hartkoorn, Ruben; Roh,
Jaroslav; Korabecny, Jan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 258115611

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-3-nitrobenzene
C9H10BrNO3
31191-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 Br 12.0033 3.0801 0.0 0
M  V30 6 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(3-nitrophenoxy)-1-propanamine
C10H14N2O3
68157-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 N 12.0033 3.0801 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31191-43-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68157-92-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8981613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-3-nitrobenzene
C10H12BrNO3
31191-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 Br 13.3370 2.3101 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(3-nitrophenoxy)-1-butanamine
C11H16N2O3
1195950-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 3.0801 0.0 0
M  V30 8 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 0.0000 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31191-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195950-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8308847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-1-[(1,1-Dimethylethoxy)carbonyl]-α-[[(9H-fluoren-9-ylmethoxy)carbonyl]am...
C28H34N2O6
313052-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0 CFG=1
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 O 11.9843 7.7838 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 C 16.6043 5.1163 0.0 0
M  V30 12 O 17.3743 3.7827 0.0 0
M  V30 13 O 17.3743 6.4500 0.0 0
M  V30 14 C 18.9143 3.7827 0.0 0
M  V30 15 C 18.9143 2.2427 0.0 0
M  V30 16 C 20.4543 3.7827 0.0 0
M  V30 17 C 18.9143 5.3227 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 31 C 11.9843 5.1163 0.0 0
M  V30 32 C 12.7543 3.7827 0.0 0
M  V30 33 C 12.7543 6.4500 0.0 0
M  V30 34 C 14.2943 3.7827 0.0 0
M  V30 35 C 14.2943 6.4500 0.0 0
M  V30 36 N 15.0643 5.1163 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 36
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 23
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[(2R)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]ami...
C29H37N3O5
2994671-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 O 5.8243 5.3347 0.0 0
M  V30 3 C 7.3643 5.3347 0.0 0
M  V30 4 N 8.1343 4.0011 0.0 0
M  V30 5 O 8.1343 6.6684 0.0 0
M  V30 6 C 9.6743 4.0011 0.0 0 CFG=1
M  V30 7 C 10.4443 5.3347 0.0 0
M  V30 8 C 10.4443 2.6673 0.0 0
M  V30 9 N 9.6743 1.3336 0.0 0
M  V30 10 O 11.9843 2.6673 0.0 0
M  V30 11 C 10.4443 0.0000 0.0 0
M  V30 12 C 16.6043 5.3347 0.0 0
M  V30 13 O 17.3743 6.6684 0.0 0
M  V30 14 O 17.3743 4.0011 0.0 0
M  V30 15 C 18.9143 6.6684 0.0 0
M  V30 16 C 18.9143 8.2084 0.0 0
M  V30 17 C 20.4543 6.6684 0.0 0
M  V30 18 C 18.9143 5.1284 0.0 0
M  V30 19 C 3.5143 6.6684 0.0 0
M  V30 20 C 2.6091 5.4225 0.0 0
M  V30 21 C 2.6091 7.9142 0.0 0
M  V30 22 C 1.1445 5.8984 0.0 0
M  V30 23 C 2.9292 3.9162 0.0 0
M  V30 24 C 1.1445 7.4384 0.0 0
M  V30 25 C 2.9292 9.4206 0.0 0
M  V30 26 C 0.0000 4.8679 0.0 0
M  V30 27 C 1.7849 2.8857 0.0 0
M  V30 28 C 0.0000 8.4688 0.0 0
M  V30 29 C 1.7849 10.4511 0.0 0
M  V30 30 C 0.3202 3.3615 0.0 0
M  V30 31 C 0.3202 9.9752 0.0 0
M  V30 32 C 11.9843 5.3347 0.0 0
M  V30 33 C 12.7543 6.6684 0.0 0
M  V30 34 C 12.7543 4.0011 0.0 0
M  V30 35 C 14.2943 6.6684 0.0 0
M  V30 36 C 14.2943 4.0011 0.0 0
M  V30 37 N 15.0643 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 37
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 22 24
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 2 29 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313052-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2994671-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38231044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bromodomain and Extra-Terminal (BET) Subfamily Bromodomain 1 (BD1)
selective inhibitors and methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matzuk, Martin; Yu, Zhifeng; Modukuri, Ramkumar; Li, Feng; Young, Damian;
Ucisik, Melek Nihan; Faver, John; Tan, Zhi; Jin, Zhuang; Anglin, Justin;
Teng, Mingxing; Kim, Choel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023196455 A1 2023-10-12

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-...
C28H34N2O6
313052-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 3.7827 0.0 0
M  V30 2 O 5.8243 5.1163 0.0 0
M  V30 3 C 7.3643 5.1163 0.0 0
M  V30 4 N 8.1343 6.4500 0.0 0
M  V30 5 O 8.1343 3.7827 0.0 0
M  V30 6 C 9.6743 6.4500 0.0 0
M  V30 7 C 10.4443 5.1163 0.0 0
M  V30 8 C 10.4443 7.7838 0.0 0
M  V30 9 O 11.9843 7.7838 0.0 0
M  V30 10 O 9.6743 9.1174 0.0 0
M  V30 11 C 16.6043 5.1163 0.0 0
M  V30 12 O 17.3743 3.7827 0.0 0
M  V30 13 O 17.3743 6.4500 0.0 0
M  V30 14 C 18.9143 3.7827 0.0 0
M  V30 15 C 18.9143 2.2427 0.0 0
M  V30 16 C 20.4543 3.7827 0.0 0
M  V30 17 C 18.9143 5.3227 0.0 0
M  V30 18 C 3.5143 3.7827 0.0 0
M  V30 19 C 2.6091 5.0286 0.0 0
M  V30 20 C 2.6091 2.5368 0.0 0
M  V30 21 C 1.1445 4.5527 0.0 0
M  V30 22 C 2.9292 6.5350 0.0 0
M  V30 23 C 1.1445 3.0127 0.0 0
M  V30 24 C 2.9292 1.0304 0.0 0
M  V30 25 C 0.0000 5.5831 0.0 0
M  V30 26 C 1.7849 7.5654 0.0 0
M  V30 27 C 0.0000 1.9823 0.0 0
M  V30 28 C 1.7849 0.0000 0.0 0
M  V30 29 C 0.3202 7.0895 0.0 0
M  V30 30 C 0.3202 0.4759 0.0 0
M  V30 31 C 11.9843 5.1163 0.0 0
M  V30 32 C 12.7543 3.7827 0.0 0
M  V30 33 C 12.7543 6.4500 0.0 0
M  V30 34 C 14.2943 3.7827 0.0 0
M  V30 35 C 14.2943 6.4500 0.0 0
M  V30 36 N 15.0643 5.1163 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 36
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 23
M  V30 26 2 21 25
M  V30 27 1 22 26
M  V30 28 2 23 27
M  V30 29 1 24 28
M  V30 30 1 25 29
M  V30 31 2 26 29
M  V30 32 1 27 30
M  V30 33 2 28 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3...
C29H37N3O5
2994671-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 O 5.8243 5.3347 0.0 0
M  V30 3 C 7.3643 5.3347 0.0 0
M  V30 4 N 8.1343 4.0011 0.0 0
M  V30 5 O 8.1343 6.6684 0.0 0
M  V30 6 C 9.6743 4.0011 0.0 0
M  V30 7 C 10.4443 5.3347 0.0 0
M  V30 8 C 10.4443 2.6673 0.0 0
M  V30 9 N 9.6743 1.3336 0.0 0
M  V30 10 O 11.9843 2.6673 0.0 0
M  V30 11 C 10.4443 0.0000 0.0 0
M  V30 12 C 16.6043 5.3347 0.0 0
M  V30 13 O 17.3743 6.6684 0.0 0
M  V30 14 O 17.3743 4.0011 0.0 0
M  V30 15 C 18.9143 6.6684 0.0 0
M  V30 16 C 18.9143 5.1284 0.0 0
M  V30 17 C 20.4543 6.6684 0.0 0
M  V30 18 C 18.9143 8.2084 0.0 0
M  V30 19 C 3.5143 6.6684 0.0 0
M  V30 20 C 2.6091 5.4225 0.0 0
M  V30 21 C 2.6091 7.9142 0.0 0
M  V30 22 C 1.1445 5.8984 0.0 0
M  V30 23 C 2.9292 3.9162 0.0 0
M  V30 24 C 1.1445 7.4384 0.0 0
M  V30 25 C 2.9292 9.4206 0.0 0
M  V30 26 C 0.0000 4.8679 0.0 0
M  V30 27 C 1.7849 2.8857 0.0 0
M  V30 28 C 0.0000 8.4688 0.0 0
M  V30 29 C 1.7849 10.4511 0.0 0
M  V30 30 C 0.3202 3.3615 0.0 0
M  V30 31 C 0.3202 9.9752 0.0 0
M  V30 32 C 11.9843 5.3347 0.0 0
M  V30 33 C 12.7543 4.0011 0.0 0
M  V30 34 C 12.7543 6.6684 0.0 0
M  V30 35 C 14.2943 4.0011 0.0 0
M  V30 36 C 14.2943 6.6684 0.0 0
M  V30 37 N 15.0643 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 37
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 22 24
M  V30 27 2 22 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 2 29 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313052-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2994671-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38231045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bromodomain and Extra-Terminal (BET) Subfamily Bromodomain 1 (BD1)
selective inhibitors and methods using same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matzuk, Martin; Yu, Zhifeng; Modukuri, Ramkumar; Li, Feng; Young, Damian;
Ucisik, Melek Nihan; Faver, John; Tan, Zhi; Jin, Zhuang; Anglin, Justin;
Teng, Mingxing; Kim, Choel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023196455 A1 2023-10-12

$RFMT $RIREG SCHEME376 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzaldehyde
C7H5BrO
3132-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[[(3-Bromophenyl)methyl]methylamino]methyl]benzenemethanol
C16H18BrNO
338998-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 N 6.6685 3.0801 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 Br 13.3370 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 14
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3132-99-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338998-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13986195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Methylamine (40 wt % aqueous, 2.6 mL, 30 mmol) was added
to a stirred solution of 3-bromobenzaldehyde (5.44 g, 29.4 mmol) in MeOH
(30 mL) under N2. After stirring 1 h, the colorless solution was cooled
to 0°C. and then NaBH4 (0.60 g, 16 mmol) was added portionwise. After
stirring 1 h, the cooling bath was removed. After stirring for 90 min,
the reaction was cooled to 0°C. and then phenacyl bromide (5.90 g, 29.6
mmol) was added portionwise over 30 min. The reaction was allowed to warm
to room temperature. After stirring for 2 h at room temperature, the
solution was cooled to °C. and then NaBH4 (1.20 g, 31.7 mmol) was added
portionwise over 10 min. The solution was stirred for 24 h, during which
time the temperature rose from 0°C to 25°C. The solution was diluted with
H2O (400 mL), extracted (4×) with ether. The ether extracts were dried
over Na2SO4, filtered, and the solvent removed in vacuo to give the
product (9.21 g, 98%) as a yellow oil. 1H NMR (300 MHz, CDCl3) δ
7.47-7.21 (m, 9H), 4.77 (dd, J = 10.0, 4.0 Hz, 1H), 3.71 (d, J = 13.3 Hz,
1H), 3.51 (d, J = 13.3 Hz, 1H), 2.61-2.49 (m, 2H), 2.32 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenyl substituted tetrahydroisoquinolines and their use
to block reuptake of norepinephrine, dopamine, and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Berkowitz, Barry; Cohen, Marlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060111393 A1 2006-05-25

$RFMT $RIREG SCHEME376 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzaldehyde
C7H5BrO
3132-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[[(3-Bromophenyl)methyl]methylamino]methyl]benzenemethanol
C16H18BrNO
338998-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 N 6.6685 3.0801 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 Br 13.3370 2.3101 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 14
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3132-99-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338998-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9893460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: Methylamine (40 wt% aqueous, 2.6 mL, 30 mmol) was added to a
stirred solution of 3-bromobenzaldehyde (5.44 g, 29.4 mmol) in MeOH (30
mL) under N2. After stirring 1 h, the colorless solution was cooled to
0°C and then NaBH4 (0.60 g, 16 mmol) was added portionwise. After
stirring 1 h, the cooling bath was removed. After stirring for 90 min,
the reaction was cooled to 0°C and then phenacyl bromide (5.90 g, 29.6
mmol) was added portionwise over 30 min. The reaction was allowed to warm
to room temperature. After stirring for 2 h at room temperature, the
solution was cooled to 0°C and then NaBH4 (1.20 g, 31.7 mmol) was added
portionwise over 10 min. The solution was stirred for 24 h, during which
time the temperature rose from 0° to 25 °C. The solution was diluted with
H2O (400 mL), extracted (4×) with ether. The ether extracts were dried
over Na2SO4, filtered, and the solvent removed in vacuo to give the
product. Intermediate compound, Yield: (9.21 g, 98%), yellow oil. 1H NMR
(300 MHz, CDCl3) δ 7.47- 7.21 (m, 9H), 4.77 (dd, J= 10.0, 4.0 Hz, 1H),
3.71 (d ,J= 13.3 Hz, 1H), 3.51 (d, J= 13.3 Hz, 1H), 2.61- 2.49 (m, 2H),
2.32 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic (stage 4)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Phenyltetrahydroisoquinolines and use thereof to block reuptake of
norepinephrine, dopamine and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beck, James P.; Smith, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001032624 A1 2001-05-10

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinebutanol, 1-(phenylmethyl)-, 4-methanesulfonate
C17H27NO3S
316362-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0
M  V30 3 C 10.6697 2.3101 0.0 0
M  V30 4 C 12.0035 3.0801 0.0 0
M  V30 5 C 13.3372 2.3101 0.0 0
M  V30 6 O 14.6708 3.0801 0.0 0
M  V30 7 S 16.0045 2.3101 0.0 0 VAL=6
M  V30 8 C 15.2345 0.9764 0.0 0
M  V30 9 O 17.3383 1.5400 0.0 0
M  V30 10 O 16.7745 3.6437 0.0 0
M  V30 11 N 5.3348 0.7700 0.0 0
M  V30 12 C 6.6687 0.0000 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 C 6.6687 3.0801 0.0 0
M  V30 16 C 8.0023 2.3101 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 1.3338 0.0000 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 21 C 1.3338 3.0801 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(phenylmethyl)-4-piperidinebutanamine
C17H28N2
316363-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.0000 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 C 10.6697 2.3100 0.0 0
M  V30 4 C 12.0034 3.0800 0.0 0
M  V30 5 C 13.3370 2.3100 0.0 0
M  V30 6 N 14.6707 3.0800 0.0 0
M  V30 7 C 16.0045 2.3100 0.0 0
M  V30 8 N 5.3348 0.7700 0.0 0
M  V30 9 C 6.6686 0.0000 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 8.0022 0.7700 0.0 0
M  V30 12 C 6.6686 3.0800 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 1.3338 0.0000 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 18 C 1.3338 3.0800 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 316362-90-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 316363-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9187884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 2, a) 4-[4-(Methylamino) butyl]-N-benzylpiperidine (XVI) To a
stirred solution of methanesulfonate derivative (XIII) (1.65 g, 5.1 mmol)
in acetonitrile (7 mL) was added methylamine 40% in water (102 mmol) and
the mixture was stirred for 15 h at room temperature. The reaction was
poured into brine (80 mL), extracted with diethyl ether (3×50 mL), dried
over Na2SO4 and the solvent was removed in vacuo. 1.35 g of (XVI) as a
yellow oil. Yield 98%. IR (neat) cm-1: 3250 (NH), 2900,2830,2780,1440.
1H-NMR (CDCl3)δ (ppm): 1.14-1.70 (11H, m), 1.90 (2H, t br, J=11.5 Hz,
NCHax), 2.41 (3H, s), 2.54 (2H, J=7.1 Hz, t), 2.85 (2H, d br, J=11.4 Hz,
NCHeq), 3.46 (2H, s, CH2Ph), 7.20-7.35 (5H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5H-dibenz[b,f]azepines for pharmaceutical use as selective
M2 muscarinic receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Terni, Patrizia Maria Luisa; Mandelli, Giacomina Roberta; Maiorana,
Stefano; Imbimbo, Bruno Pietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001002386 A1 2001-01-11

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Piperidinebutanol, 1-(phenylmethyl)-, 4-methanesulfonate
C17H27NO3S
316362-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0
M  V30 3 C 10.6697 2.3101 0.0 0
M  V30 4 C 12.0035 3.0801 0.0 0
M  V30 5 C 13.3372 2.3101 0.0 0
M  V30 6 O 14.6708 3.0801 0.0 0
M  V30 7 S 16.0045 2.3101 0.0 0 VAL=6
M  V30 8 C 15.2345 0.9764 0.0 0
M  V30 9 O 17.3383 1.5400 0.0 0
M  V30 10 O 16.7745 3.6437 0.0 0
M  V30 11 N 5.3348 0.7700 0.0 0
M  V30 12 C 6.6687 0.0000 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 8.0023 0.7700 0.0 0
M  V30 15 C 6.6687 3.0801 0.0 0
M  V30 16 C 8.0023 2.3101 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 1.3338 0.0000 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 0.0000 0.7700 0.0 0
M  V30 21 C 1.3338 3.0801 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(phenylmethyl)-4-piperidinebutanamine
C17H28N2
316363-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.0000 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 C 10.6697 2.3100 0.0 0
M  V30 4 C 12.0034 3.0800 0.0 0
M  V30 5 C 13.3370 2.3100 0.0 0
M  V30 6 N 14.6707 3.0800 0.0 0
M  V30 7 C 16.0045 2.3100 0.0 0
M  V30 8 N 5.3348 0.7700 0.0 0
M  V30 9 C 6.6686 0.0000 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 8.0022 0.7700 0.0 0
M  V30 12 C 6.6686 3.0800 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 1.3338 0.0000 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 18 C 1.3338 3.0800 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 316362-90-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 316363-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1390960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new cardioselective M2 muscarinic receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mandelli, Giacomina R.; Maiorana, Stefano; Terni, Patrizia; Lamperti,
Giuseppina; Colibretti, Maria Luisa; Imbimbo, Bruno P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2000), 48(11), 1611-1622

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-methylpiperidin-3-one
C13H17NO
32018-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 O 0.0000 3.0800 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 N 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 3.0800 0.0 0
M  V30 6 C 4.0011 0.7700 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 8.0022 3.0800 0.0 0
M  V30 12 C 6.6684 0.7700 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 8.0022 0.0000 0.0 0
M  V30 15 C 9.3359 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Methyl-1-(phenylmethyl)-3-piperidinylidene]methanamine
C14H20N2
2106832-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 9.2400 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 C 5.3900 1.3338 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 8 CFG=2
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32018-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2106832-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19124946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of chiral amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Vries, Andre; Lefort, Laurent; Verzijl, Gerard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018060512 A1 2018-04-05

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-4-(1,1-dimethylethyl)benzene
C13H19BrO
3245-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 C 1.5400 1.1273 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 C 1.5400 4.2073 0.0 0
M  V30 5 O 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 C 10.7800 0.0000 0.0 0
M  V30 9 Br 12.3200 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-(1,1-Dimethylethyl)phenoxy]-N-methyl-1-propanamine
C14H23NO
1040065-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.1037 0.0000 0.0 0
M  V30 3 C 0.0000 0.5637 0.0 0
M  V30 4 C 0.5637 2.6673 0.0 0
M  V30 5 O 6.6685 4.4137 0.0 0
M  V30 6 C 8.0022 3.6437 0.0 0
M  V30 7 C 9.3360 4.4137 0.0 0
M  V30 8 C 10.6697 3.6437 0.0 0
M  V30 9 N 12.0033 4.4137 0.0 0
M  V30 10 C 13.3370 3.6437 0.0 0
M  V30 11 C 2.6673 2.1037 0.0 0
M  V30 12 C 4.0010 1.3337 0.0 0
M  V30 13 C 2.6673 3.6437 0.0 0
M  V30 14 C 5.3348 2.1037 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3245-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1040065-77-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6576086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromobutoxy)-4-methylbenzene
C11H15BrO
3257-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 Br 12.0033 2.3101 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(4-methylphenoxy)-1-butanamine
C12H19NO
361395-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 N 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 0.0000 0.0000 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3257-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361395-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2251335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent novel antifungal azoles by structure-based
rational design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing;
Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(20), 5965-5969

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloropyrimidine
C4H2BrClN2
32779-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 N 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(methylamino)pyrimidine
C5H6BrN3
31402-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32779-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31402-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1562820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5-Bromo-N-cyclohexylpyrimidin-2-amine (13j). A
solution of 5-bromo-2-chloropyrimidine 12 (1.93 g, 10.0 mmol) and
cyclohexylamine (2.29 mL, 20 mmol) in ethanol (15.0 mL) was heated at 80
°C with stirring in a sealed tube overnight. The reaction mixture was
cooled to room temperature. After evaporation of the solvent, the
off-white solid was disssolved in ethyl acetate. Then the organic phase
was washed with water, dried over anhydrous sodium sulfate, and
concentrated to give desired product. Compound 13f. Yield 98%.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of
3-(1H-1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl
Inhibitors Including the Threonine315→Isoleucine315 Mutant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yupeng; Shen, Mengjie; Zhang, Zhang; Luo, Jinfeng; Pan, Xiaofen; Lu,
Xiaoyun; Long, Huoyou; Wen, Donghai; Zhang, Fengxiang; Leng, Fang; Li,
Yingjun; Tu, Zhengchao; Ren, Xiaomei; Ding, Ke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(22), 10033-10046

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
329-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-methyl-4-(trifluoromethyl)-
C9H8F3NO
65017-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65017-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40148188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective synthesis of isoquinolinonediones through remote
unactivated C(sp3)-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Lei; Sun, Jun; Sun, Boxuan; Song, Shengjie; Li, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(36),
4818-4821

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
rel-Methyl (3aR,8aR)-6-bromo-2,3,3a,8a-tetrahydro-3a-(3-methyl-2-buten-1-yl)-...
C17H18BrNO4
331716-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8551 4.9569 0.0 0
M  V30 2 C 9.1888 5.7269 0.0 0
M  V30 3 C 10.5224 4.9569 0.0 0
M  V30 4 C 10.5224 3.4169 0.0 0
M  V30 5 C 11.8561 5.7269 0.0 0
M  V30 6 C 2.5367 5.7867 0.0 0
M  V30 7 O 1.5063 4.6423 0.0 0
M  V30 8 O 2.0609 7.2514 0.0 0
M  V30 9 C 0.0000 4.9625 0.0 0
M  V30 10 O 7.8095 9.4980 0.0 0
M  V30 11 Br 4.3220 0.0000 0.0 0
M  V30 12 C 6.5213 5.7269 0.0 0 CFG=1
M  V30 13 C 6.2011 4.2206 0.0 0
M  V30 14 C 5.1876 6.4969 0.0 0 CFG=2
M  V30 15 C 7.6658 6.7575 0.0 0
M  V30 16 C 4.6695 4.0597 0.0 0
M  V30 17 C 7.1063 2.9747 0.0 0
M  V30 18 N 4.0432 5.4665 0.0 0
M  V30 19 O 5.5078 8.0034 0.0 0
M  V30 20 C 7.0395 8.1643 0.0 0
M  V30 21 C 4.0432 2.6527 0.0 0
M  V30 22 C 6.4800 1.5678 0.0 0
M  V30 23 C 4.9484 1.4068 0.0 0
M  V30 24 H 3.8539 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 2 10 20
M  V30 11 1 11 23
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 24 CFG=3
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-6-Bromo-3,3a,8,8a-tetrahydro-1-methyl-3a-(3-methyl-2-buten-1-yl...
C16H19BrN2O
440327-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 3.0800 0.0 0
M  V30 2 C 2.5761 2.3100 0.0 0
M  V30 3 C 2.5761 0.7700 0.0 0
M  V30 4 C 3.9098 0.0000 0.0 0
M  V30 5 C 1.2425 0.0000 0.0 0
M  V30 6 C 1.9692 8.1004 0.0 0
M  V30 7 O 0.0000 5.3900 0.0 0
M  V30 8 Br 9.9691 3.6612 0.0 0
M  V30 9 C 3.9098 4.6200 0.0 0 CFG=2
M  V30 10 C 3.9098 6.1600 0.0 0 CFG=2
M  V30 11 C 5.3745 4.1440 0.0 0
M  V30 12 C 2.4452 4.1440 0.0 0
M  V30 13 N 5.3745 6.6359 0.0 0
M  V30 14 N 2.4452 6.6359 0.0 0
M  V30 15 C 6.2797 5.3900 0.0 0
M  V30 16 C 6.0008 2.7372 0.0 0
M  V30 17 C 1.5400 5.3900 0.0 0
M  V30 18 C 7.8112 5.2289 0.0 0
M  V30 19 C 7.5323 2.5763 0.0 0
M  V30 20 C 8.4375 3.8221 0.0 0
M  V30 21 H 3.9098 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 2 7 17
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 21 CFG=1
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 331716-92-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440327-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-4563435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First total syntheses of dihydroflustramine C and flustramine E,
alkaloids from the marine bryozoan Flustra foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(8), 1479-1484

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-6-Bromo-3a-(1,1-dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-8-...
C20H24BrNO2
331716-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.9569 0.0 0
M  V30 2 C 1.3337 5.7269 0.0 0
M  V30 3 C 1.3337 4.1869 0.0 0
M  V30 4 C 2.6673 3.4169 0.0 0
M  V30 5 C 0.0000 4.9569 0.0 0
M  V30 6 C 7.9857 5.7867 0.0 0
M  V30 7 C 9.0161 4.6423 0.0 0
M  V30 8 C 10.5226 4.9625 0.0 0
M  V30 9 C 10.9985 6.4270 0.0 0
M  V30 10 C 11.5530 3.8179 0.0 0
M  V30 11 O 2.7131 9.4980 0.0 0
M  V30 12 Br 6.2005 0.0000 0.0 0
M  V30 13 C 4.0012 5.7269 0.0 0 CFG=2
M  V30 14 C 5.3348 6.4969 0.0 0 CFG=2
M  V30 15 C 4.3213 4.2206 0.0 0
M  V30 16 C 2.8566 6.7575 0.0 0
M  V30 17 N 6.4792 5.4665 0.0 0
M  V30 18 O 5.0147 8.0034 0.0 0
M  V30 19 C 5.8529 4.0597 0.0 0
M  V30 20 C 3.4161 2.9747 0.0 0
M  V30 21 C 3.4831 8.1643 0.0 0
M  V30 22 C 6.4792 2.6527 0.0 0
M  V30 23 C 4.0424 1.5678 0.0 0
M  V30 24 C 5.5742 1.4068 0.0 0
M  V30 25 H 6.6685 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 13 1 CFG=1
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 21
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 25 CFG=1
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-6-Bromo-3a-(1,1-dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-1-...
C21H27BrN2O
878626-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.9569 0.0 0
M  V30 2 C 1.3337 5.7269 0.0 0
M  V30 3 C 1.3337 4.1869 0.0 0
M  V30 4 C 2.6673 3.4169 0.0 0
M  V30 5 C 0.0000 4.9569 0.0 0
M  V30 6 C 7.9857 5.7867 0.0 0
M  V30 7 C 9.0161 4.6423 0.0 0
M  V30 8 C 10.5226 4.9625 0.0 0
M  V30 9 C 10.9985 6.4270 0.0 0
M  V30 10 C 11.5530 3.8179 0.0 0
M  V30 11 C 6.0451 9.1478 0.0 0
M  V30 12 O 2.7131 9.4980 0.0 0
M  V30 13 Br 6.2005 0.0000 0.0 0
M  V30 14 C 4.0012 5.7269 0.0 0 CFG=2
M  V30 15 C 5.3348 6.4969 0.0 0 CFG=2
M  V30 16 C 4.3213 4.2206 0.0 0
M  V30 17 C 2.8566 6.7575 0.0 0
M  V30 18 N 6.4792 5.4665 0.0 0
M  V30 19 N 5.0147 8.0034 0.0 0
M  V30 20 C 5.8529 4.0597 0.0 0
M  V30 21 C 3.4161 2.9747 0.0 0
M  V30 22 C 3.4831 8.1643 0.0 0
M  V30 23 C 6.4792 2.6527 0.0 0
M  V30 24 C 4.0424 1.5678 0.0 0
M  V30 25 C 5.5742 1.4068 0.0 0
M  V30 26 H 6.6685 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 14 1 CFG=1
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 2 12 22
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 26 CFG=1
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 331716-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878626-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9594773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Lactamization. To a
solution of the appropriate lactone 16a (0.32 mmol), 17a (0.32 mmol), 16b
(0.23 mmol), or 17b (0.23 mmol) in MeOH (10 mL) was added NH2Me (2 mL of
a 2.0 M solution in MeOH, 4 mmol). The reaction mixture was stirred for
5, 2, 24, or 15 h, respectively, at rt. The mixture was evaporated, and
the resultant crude lactam 18, 3, 19, or 4 was purified by silica gel
flash column chromatography (1:1 EtOAc/hexane).
6-Bromo-3a-(2-methyl-3-buten-2-yl)-8-(3-methyl-2-buten-1-yl)-2-oxo-2,3,3a,8a-tetrahydro-8H-pyrrolo[2,3-b]indole,
Flustramide A (3). Prepared from 16b as a colorless oil (91 mg, 98%
yield): Rf 0.35 (1:1 EtOAc/hexane); IR (CHCl3) νmax 3006, 1680, 1594,
1492 cm-1; 1H NMR (CDCl3) δ 6.92 (1H, d, J = 8.0 Hz), 6.81 (1H, dd, J =
8.0, 1.8 Hz), 6.57 (1H, d, J = 1.8 Hz), 5.78 (1H, dd, J = 17.3, 10.9 Hz),
5.26 (1H, br t, J = 6.7 Hz), 5.12 (1H, dd, J = 10.9, 1.1 Hz), 5.05 (1H,
dd, J = 17.3, 1.1 Hz), 4.83 (1H, s), 3.93 (2H, d, J = 6.7 Hz), 2.85 (3H,
s), 2.84 (1H, d, J = 17.6 Hz), 2.55 (1H, d, J = 17.6 Hz), 1.77 (3H, s),
1.75 (3H, s), 1.03 (3H, s), 0.93 (3H, s); 13C NMR (CDCl3) δ 172.6, 151.1,
143.3, 135.7, 131.7, 126.2, 122.5, 120.7, 120.3, 114.6, 110.9, 85.9,
55.4, 46.3, 41.2, 39.4, 27.9, 25.6, 22.6, 21.8, 18.1; EIMS m/z (relative
intensity) 402/404 (M+, 6/6), 333/335 (20/20), 265/267 (63/61), 208/210
(16/16), 69 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total syntheses of five indole alkaloids from the marine bryozoan Flustra
foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Trujillo-Serrato,
Joel J.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(4), 1186-1192

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-6-Bromo-3,3a,8,8a-tetrahydro-3a,8-bis(3-methyl-2-buten-1-yl)-2H...
C20H24BrNO2
331716-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.9569 0.0 0
M  V30 2 C 2.6673 5.7269 0.0 0
M  V30 3 C 1.3337 4.9569 0.0 0
M  V30 4 C 1.3337 3.4169 0.0 0
M  V30 5 C 0.0000 5.7269 0.0 0
M  V30 6 C 9.3194 5.7867 0.0 0
M  V30 7 C 10.3498 4.6423 0.0 0
M  V30 8 C 11.8563 4.9625 0.0 0
M  V30 9 C 12.8867 3.8179 0.0 0
M  V30 10 C 12.3321 6.4270 0.0 0
M  V30 11 O 4.0467 9.4980 0.0 0
M  V30 12 Br 7.5342 0.0000 0.0 0
M  V30 13 C 5.3348 5.7269 0.0 0 CFG=1
M  V30 14 C 5.6550 4.2206 0.0 0
M  V30 15 C 6.6685 6.4969 0.0 0 CFG=2
M  V30 16 C 4.1903 6.7575 0.0 0
M  V30 17 C 7.1866 4.0597 0.0 0
M  V30 18 C 4.7498 2.9747 0.0 0
M  V30 19 N 7.8131 5.4665 0.0 0
M  V30 20 O 6.3483 8.0034 0.0 0
M  V30 21 C 4.8168 8.1643 0.0 0
M  V30 22 C 7.8131 2.6527 0.0 0
M  V30 23 C 5.3763 1.5678 0.0 0
M  V30 24 C 6.9078 1.4068 0.0 0
M  V30 25 H 8.0022 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 21
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 15 20
M  V30 20 1 15 25 CFG=1
M  V30 21 1 16 21
M  V30 22 1 17 19
M  V30 23 2 17 22
M  V30 24 1 18 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-6-Bromo-3,3a,8,8a-tetrahydro-1-methyl-3a,8-bis(3-methyl-2-buten...
C21H27BrN2O
331716-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.9569 0.0 0
M  V30 2 C 2.6673 5.7269 0.0 0
M  V30 3 C 1.3337 4.9569 0.0 0
M  V30 4 C 1.3337 3.4169 0.0 0
M  V30 5 C 0.0000 5.7269 0.0 0
M  V30 6 C 9.3194 5.7867 0.0 0
M  V30 7 C 10.3498 4.6423 0.0 0
M  V30 8 C 11.8563 4.9625 0.0 0
M  V30 9 C 12.8867 3.8179 0.0 0
M  V30 10 C 12.3321 6.4270 0.0 0
M  V30 11 C 7.3788 9.1478 0.0 0
M  V30 12 O 4.0467 9.4980 0.0 0
M  V30 13 Br 7.5342 0.0000 0.0 0
M  V30 14 C 5.3348 5.7269 0.0 0 CFG=2
M  V30 15 C 6.6685 6.4969 0.0 0 CFG=2
M  V30 16 C 5.6550 4.2206 0.0 0
M  V30 17 C 4.1903 6.7575 0.0 0
M  V30 18 N 7.8131 5.4665 0.0 0
M  V30 19 N 6.3483 8.0034 0.0 0
M  V30 20 C 7.1866 4.0597 0.0 0
M  V30 21 C 4.7498 2.9747 0.0 0
M  V30 22 C 4.8168 8.1643 0.0 0
M  V30 23 C 7.8131 2.6527 0.0 0
M  V30 24 C 5.3763 1.5678 0.0 0
M  V30 25 C 6.9078 1.4068 0.0 0
M  V30 26 H 8.0022 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 19
M  V30 12 2 12 22
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 26 CFG=1
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 18 20
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 331716-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331716-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11724399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Lactamization. To a
solution of the appropriate lactone 16a (0.32 mmol), 17a (0.32 mmol), 16b
(0.23 mmol), or 17b (0.23 mmol) in MeOH (10 mL) was added NH2Me (2 mL of
a 2.0 M solution in MeOH, 4 mmol). The reaction mixture was stirred for
5, 2, 24, or 15 h, respectively, at rt. The mixture was evaporated, and
the resultant crude lactam 18, 3, 19, or 4 was purified by silica gel
flash column chromatography (1:1 EtOAc/hexane).
6-Bromo-3a,8-bis(3-methyl-2-buten-1-yl)-2-oxo-2,3,3a,-8a-tetrahydro-8H-pyrrolo[2,3-b]indole,
Flustramide B (4). Prepared from 17b as a colorless oil (91 mg, 98%
yield): Rf 0.32 (1:1 EtOAc/hexane); IR (CHCl3) νmax 3026, 1682, 1596,
1488 cm-1; 1H NMR (CDCl3) δ 6.87 (1H, d, J = 7.2 Hz), 6.83 (1H, dd, J =
7.2, 1.4 Hz), 6.60 (1H, d, J = 1.5 Hz), 5.18 (1H, br t, J = 6.7 Hz), 4.95
(1H, br t, J = 7.4 Hz), 4.73 (1H, s), 3.96 (1H, dd, J = 16.4, 6.6 Hz),
3.88 (1H, dd, J = 16.3, 7.4 Hz), 2.87 (3H, s), 2.64 (2H, s), 2.38 (1H,
dd, J = 14.4, 7.7 Hz), 2.30 (1H, dd, J = 14.4, 6.8 Hz), 1.75 (3H, s),
1.74 (3H, s), 1.70 (3H, s), 1.56 (3H, s); 13C NMR (CDCl3) δ 172.8, 150.6,
136.0 (2C), 134.3, 124.4, 122.2, 121.5, 120.1, 118.2, 111.7, 87.4, 49.5,
46.6, 41.7, 37.4, 28.0, 26.0, 25.7, 18.1 (2C); EIMS m/z (relative
intensity) 402/404 (M+, 36/35), 333/335 (24/22), 265/267 (100/ 97); HRMS
(FAB) m/e 403.1398 (M+ + H, C21H27BrN2O requires 403.1385).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total syntheses of five indole alkaloids from the marine bryozoan Flustra
foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Trujillo-Serrato,
Joel J.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(4), 1186-1192

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzenesulfonamide
C7H8FNO2S
433-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 F 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 433-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, α-methyl-3,5-bis(trifluoromethyl)-, 1-methanesulfonate, (αS)-
C11H10F6O3S
367922-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.1601 0.0 0 CFG=2
M  V30 2 O 8.0023 5.3901 0.0 0
M  V30 3 C 6.6685 7.7002 0.0 0
M  V30 4 S 9.3360 6.1601 0.0 0 VAL=6
M  V30 5 C 8.5660 7.4938 0.0 0
M  V30 6 O 10.6697 6.9302 0.0 0
M  V30 7 O 10.1060 4.8265 0.0 0
M  V30 8 C 1.3337 6.1601 0.0 0
M  V30 9 F 2.1037 7.4938 0.0 0
M  V30 10 F 0.0000 6.9302 0.0 0
M  V30 11 F 0.5637 4.8265 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 F 2.4611 1.5400 0.0 0
M  V30 14 F 4.0012 0.0000 0.0 0
M  V30 15 F 5.5412 1.5400 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 4.0012 3.0801 0.0 0
M  V30 21 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 20
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[(1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethyl]methylamine
C11H11F6N
334477-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4937 0.0 0
M  V30 3 F 0.0000 6.9301 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 5.5411 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 2.4611 1.5400 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0 CFG=1
M  V30 10 N 8.0022 5.3901 0.0 0
M  V30 11 C 6.6684 7.7001 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 4.0011 6.1601 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=1
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 367922-41-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 334477-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-516329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Stage 3: METHOD The stage 2 toluene solution and the aqueous methylamine
(40 wt% solution) was charged to a Parr reactor. The vessel was sealed
and warmed to 50°C (1.8 bar max). The reaction was completed after 48
hrs. The two layers were transferred to a separating funnel and
separated. The organic layer was washed twice with water and once with
brine (1/3 volume each). (Yield: >98%; 79% ee).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 79% ee, Parr reactor used, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of N-(arylmethyl)amine by stereoselective
reduction of aryl ketone to chiral arylmethanol derivative
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hodges, George Robert; Martin, Juliette; Hammil, Noel Anthony; Houson,
Ian Nicholas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006067395 A1 2006-06-29

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-5-methyl-3-pyridinesulfonyl chloride
C6H5Cl2NO2S
37105-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 C 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,5-dimethyl-3-pyridinesulfonamide
C7H9ClN2O2S
1683534-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37105-10-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1683534-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-11309443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinoline compounds and their use as pyruvate
dehydrogenase kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brough, Paul Andrew; Macias, Alba; Roughley, Stephen David; Stokes,
Stephen; Davies, Nicholas Gareth Morse
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015040424 A1 2015-03-26

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Ethyl 4,4,4-trifluoroacetoacetate
C6H7F3O3
372-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.3337 0.0 0
M  V30 2 C 2.6675 2.1037 0.0 0
M  V30 3 C 5.3348 2.1037 0.0 0
M  V30 4 C 1.3337 1.3337 0.0 0
M  V30 5 O 2.6675 3.6437 0.0 0
M  V30 6 O 6.6685 1.3337 0.0 0
M  V30 7 O 5.3348 3.6437 0.0 0
M  V30 8 F 0.0000 0.5637 0.0 0
M  V30 9 F 2.1037 0.0000 0.0 0
M  V30 10 F 0.5637 2.6673 0.0 0
M  V30 11 C 8.0023 2.1037 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4,4,4-trifluoro-3-(methylamino)-, ethyl ester
C7H10F3NO2
121303-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 N 2.6675 0.7700 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 F 0.0000 3.8501 0.0 0
M  V30 7 F 2.1037 4.4137 0.0 0
M  V30 8 F 0.5637 1.7464 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 O 6.6685 3.0801 0.0 0
M  V30 11 O 5.3348 0.7700 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 372-31-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121303-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14895639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-87-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4.4.4-trifluoro-3-methylamino-crotonic Acid Ethyl Ester 32 g (0.53 mol)
of acetic acid are added to a solution of 400 g (2.17 mol) of
trifluoroacetoacetic acid ethyl ester in 420 g of methylcyclohexane and
240 g of ethanol, and the mixture is heated to a temperature of 80-85°C.
Then 71 g (2.29 mol) of gaseous methylamine are introduced within a
period of 3 to 4 hours, with stirring, in such a manner that the ammonium
salt that forms goes continuously into solution without precipitating.
During the addition of the methylamine, the water that forms is removed
continuously from the reaction mixture by azeotropic distillation under
atmospheric pressure. If the reaction temperature exceeds 90°C. during
the distillation, additional ethanol may be added. The organic phase of
the distillate is returned to the reaction vessel. When the addition of
methylamine is complete, the distillation is continued until no further
water is formed. Then the alcohol is removed by fractional distillation
under reduced pressure, the pressure being so selected that the
temperature does not exceed 90°C. After cooling the reaction mixture to
room temperature, the lower phase, which has a small volume, is separated
off. If the concentration of 4,4,4-trifluoro-3-methylaminocrotonic acid
ethyl ester in the solution is high, phase inversion may occur and the
undesired phase is located in the upper region of the reaction vessel.
After separating off the methylcyclohexane by fractional distillation of
the organic phase in vacuo, 4,4,4-trifluoro-3-methylamino-crotonic acid
ethyl ester is obtained in a yield of 98% of the theoretical yield.
4,4,4-trifluoro-3-methylamino-crotonic acid ethyl ester, yield 98%
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of substituted crotonic acid esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hanreich, Reinhard Georg; Wu, Herng-tay; Oliver, Michael Allen; Hoglen,
Dean Kent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030216594 A1 2003-11-20

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-1H-pyrido[3,4-b]indole-...
C20H20N2O3
380895-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 O 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=1
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 7.5823 8.4701 0.0 0
M  V30 22 C 8.9160 6.1601 0.0 0
M  V30 23 C 8.9160 9.2401 0.0 0
M  V30 24 C 10.2498 6.9301 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-2,3,4,9-Tetrahydro-1-(4-methoxyphenyl)-N-methyl-1H-pyrido[3,4-b]indol...
C20H21N3O2
2254177-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 N 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=1
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 8.9160 6.1601 0.0 0
M  V30 22 C 7.5823 8.4701 0.0 0
M  V30 23 C 10.2498 6.9301 0.0 0
M  V30 24 C 8.9160 9.2401 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 380895-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254177-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19425564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of all stereoisomers of
1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Onda, Momoko; Higashida, Ayaka; Hirano, Takako; Nishio, Toshiyuki;
Hakamata, Wataru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molbank (2018), (1), M973/1-M973/6

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,5S)-5-(6-Chloro-9H-purin-9-yl)tetrahydro-3-thiophenemethanol
C10H11ClN4OS
381211-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0801 0.0 0
M  V30 2 C 10.5371 3.9071 0.0 0
M  V30 3 O 11.7831 3.0020 0.0 0
M  V30 4 N 5.1457 3.3405 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.5192 4.7473 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 N 1.3338 0.7700 0.0 0
M  V30 13 C 6.6520 3.0203 0.0 0 CFG=1
M  V30 14 C 7.7966 4.0508 0.0 0
M  V30 15 S 7.2785 1.6133 0.0 0
M  V30 16 C 9.1302 3.2807 0.0 0 CFG=2
M  V30 17 C 8.8101 1.7744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 13 4 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3R,5S)-Tetrahydro-5-[6-(methylamino)-9H-purin-9-yl]-3-thiophenemethanol
C11H15N5OS
381211-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 11.8707 3.9071 0.0 0
M  V30 4 O 13.1168 3.0020 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 N 6.4794 3.3405 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 N 5.3348 0.7700 0.0 0
M  V30 9 C 5.8529 4.7473 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.3213 4.5864 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 N 2.6675 0.7700 0.0 0
M  V30 14 C 7.9857 3.0203 0.0 0 CFG=1
M  V30 15 C 9.1302 4.0508 0.0 0
M  V30 16 S 8.6122 1.6133 0.0 0
M  V30 17 C 10.4639 3.2807 0.0 0 CFG=2
M  V30 18 C 10.1437 1.7744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 17 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 14 6 CFG=3
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 381211-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 381211-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9874862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of novel thioapio dideoxynucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moon, Hyung Ryong; Kim, Hea Ok; Lee, Sang Kook; Choi, Won Jun; Chun, Moon
Woo; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2002), 10(5), 1499-1507

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(1E)-3-Bromo-1-methyl-1-propen-1-yl]benzene
C10H11Br
39171-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 Br 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Buten-1-amine, N-methyl-3-phenyl-, (2E)-
C11H15N
2958626-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 4.0011 4.6201 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 1.3337 3.0800 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39171-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2958626-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37763621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective congested β-amido ketone synthesis via NHC-catalyzed
radical-radical coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sato, Yukiya; Miyamoto, Yusuke; Matsui, Takanori; Sumida, Yuto; Ohmiya,
Hirohisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chem Catalysis (2023), 3(9), 100736

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(1E)-3-Bromo-1-methyl-1-propen-1-yl]benzene
C10H11Br
39171-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 Br 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Buten-1-amine, N-methyl-3-phenyl-, (2E)-
C11H15N
2958626-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 4.0011 4.6201 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 1.3337 3.0800 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39171-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2958626-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37395023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective congested β-amido ketone synthesis via NHC-catalyzed
radical-radical coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sato, Yukiya; Miyamoto, Yusuke; Matsui, Takanori; Sumida, Yuto; Ohmiya,
Hirohisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2023), 1-9

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrophenol
C6H4FNO3
394-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-4-nitrophenol
C7H8N2O3
14703-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14703-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7681056
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 8: Trifluoromethanesulfonic acid
3-methyl-3H-benzoimidazol-5-yl ester. Step 1:
3-Methylamino-4-nitro-phenol. To a pressure vessel was added
3-fluoro-4-nitro-phenol (5.0 g, 31.82 mmol) and a 40% aqueous solution of
methylamine (10 mL). The reaction mixture was stirred at 85°C for 5h,
then it was cooled to room temperature, poured on water, and acidified to
pH 1 with 1N aqueous HCl. The resulting precipitate was filtered, washed
with water, and dried in vacuo to give 5.23 g of
3-methylamino-4-nitro-phenol as an orange solid (98% yield):. 1H NMR
(DMSO-d6) δ 2.88 (d, 3H), 6.14 (dd, 1H), 6.17 (d, 1H), 7.96 (d, 1H), 8.25
(q, 1H), 10.8 (broad s, 1H); MS (m/z) 167 [M-H]-.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic triazoles as protein kinase modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bounaud, Pierre-Yves; Smith, Christopher Ronald; Jefferson, Elizabeth
Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051808 A2 2008-05-02

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-(Acetyloxy)-3-methoxyphenyl]methylene]-2-methyl-5(4H)-oxazolone
C14H13NO5
39600-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3319 4.0011 0.0 0
M  V30 2 O 7.9519 1.3338 0.0 0
M  V30 3 C 7.1819 0.0000 0.0 0
M  V30 4 O 0.0000 4.3513 0.0 0
M  V30 5 O 9.4919 4.0011 0.0 0
M  V30 6 C 10.2619 5.3349 0.0 0
M  V30 7 C 11.8019 5.3349 0.0 0
M  V30 8 O 9.4919 6.6685 0.0 0
M  V30 9 C 2.2048 9.3038 0.0 0
M  V30 10 C 4.8719 4.0011 0.0 0
M  V30 11 C 5.6419 2.6674 0.0 0
M  V30 12 C 5.6419 5.3349 0.0 0
M  V30 13 C 7.1819 2.6674 0.0 0
M  V30 14 C 7.1819 5.3349 0.0 0
M  V30 15 C 7.9519 4.0011 0.0 0
M  V30 16 C 2.5619 5.3349 0.0 0
M  V30 17 N 3.1884 6.7417 0.0 0
M  V30 18 C 1.0304 5.4958 0.0 0
M  V30 19 C 2.0439 7.7721 0.0 0
M  V30 20 O 0.7102 7.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 1 16 CFG=2
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 2 4 18
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-3-(4-hydroxy-3-methoxyphenyl)-N-methyl-2-propenamide
C13H16N2O4
1384247-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.3348 0.0 0
M  V30 2 C 6.9302 4.0012 0.0 0
M  V30 3 C 6.1601 2.6675 0.0 0
M  V30 4 N 8.4702 4.0012 0.0 0
M  V30 5 N 6.9302 1.3337 0.0 0
M  V30 6 O 4.6201 2.6675 0.0 0
M  V30 7 C 9.2402 5.3348 0.0 0
M  V30 8 C 6.1601 0.0000 0.0 0
M  V30 9 C 8.4702 6.6685 0.0 0
M  V30 10 O 10.7802 5.3348 0.0 0
M  V30 11 O 1.5400 8.0023 0.0 0
M  V30 12 C 2.3101 9.3360 0.0 0
M  V30 13 O 0.0000 5.3348 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 3.8501 6.6685 0.0 0
M  V30 16 C 3.8501 4.0012 0.0 0
M  V30 17 C 2.3101 6.6685 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 1.5400 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39600-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1384247-73-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7912378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-arylidene-5-imidazolinones as synthetic analogs of
fluorescent protein chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng-Yu; Chen, Yun-Chung; Lin, Hao-Chun; Jhong, Yuandong; Chang,
Chih-Wei; Tsai, Ching-Hua; Kao, Chai-Lin; Chien, Tun-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(29), 5898-5907

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzo[b]thiophene-2-carbonyl chloride
C9H5ClOS
39827-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 Cl 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 S 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylbenzo[b]thiophene-2-carboxamide
C10H9NOS
335032-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 O 7.3472 0.2064 0.0 0
M  V30 4 C 8.8872 2.8737 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 4.1321 2.7859 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 S 4.1321 0.2941 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 5.0371 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39827-11-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-3537207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 43. Preparation of 2-(methylaminomethyl)benzothiophene. a)
N-methyl benzothiophene-2-carboxamide. To a stirred solution of 2.0 M
methylamine in THF (60 mL) and THF (60 mL) was added dropwise at 0 °C a
solution of benzothiophene-2-carbonyl chloride (10.8 g, 55 mmole) in THF
(50 mL) over 15 minutes. After the addition the reaction was allowed to
warm to RT then was concentrated under vacuum. Trituration with a cold
solution of 4:1 H2O/methanol (50 mL), filtration, and drying under vacuum
gave the title compound. Yield: (10.35 g, 98%) as a white solid. MS (ES)
m/e 191.9 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
39974-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 5.4210 0.0 0
M  V30 2 O 0.0000 5.7411 0.0 0
M  V30 3 C 1.5064 0.0000 0.0 0
M  V30 4 O 7.4479 4.2504 0.0 0
M  V30 5 C 8.7817 3.4804 0.0 0
M  V30 6 C 3.4470 3.4804 0.0 0
M  V30 7 C 3.4470 1.9404 0.0 0
M  V30 8 C 1.9823 3.9564 0.0 0
M  V30 9 C 4.7806 4.2504 0.0 0
M  V30 10 N 1.9823 1.4645 0.0 0
M  V30 11 C 4.7806 1.1704 0.0 0
M  V30 12 C 1.0771 2.7104 0.0 0
M  V30 13 C 6.1143 3.4804 0.0 0
M  V30 14 C 6.1143 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
149685-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 O 1.5400 6.6519 0.0 0
M  V30 6 C 0.0000 6.6519 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 3.8500 2.6508 0.0 0
M  V30 9 C 6.1263 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 N 4.8804 1.5064 0.0 0
M  V30 12 C 2.3100 2.6508 0.0 0
M  V30 13 C 6.2872 2.1327 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 15 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39974-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149685-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4285840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole b)
5-Methoxy-1-methyl-3-(methylaminomethyl)-1H-indole [0752] According to
the procedure of Preparation 13 (c), except substituting
5-methoxy-1-methyl-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (0.85 g, 98%)
was obtained as a light yellow oil. MS (ES) m/e 205.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
39974-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 5.4210 0.0 0
M  V30 2 O 0.0000 5.7411 0.0 0
M  V30 3 C 1.5064 0.0000 0.0 0
M  V30 4 O 7.4479 4.2504 0.0 0
M  V30 5 C 8.7817 3.4804 0.0 0
M  V30 6 C 3.4470 3.4804 0.0 0
M  V30 7 C 3.4470 1.9404 0.0 0
M  V30 8 C 1.9823 3.9564 0.0 0
M  V30 9 C 4.7806 4.2504 0.0 0
M  V30 10 N 1.9823 1.4645 0.0 0
M  V30 11 C 4.7806 1.1704 0.0 0
M  V30 12 C 1.0771 2.7104 0.0 0
M  V30 13 C 6.1143 3.4804 0.0 0
M  V30 14 C 6.1143 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
149685-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 O 1.5400 6.6519 0.0 0
M  V30 6 C 0.0000 6.6519 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 3.8500 2.6508 0.0 0
M  V30 9 C 6.1263 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 N 4.8804 1.5064 0.0 0
M  V30 12 C 2.3100 2.6508 0.0 0
M  V30 13 C 6.2872 2.1327 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 15 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39974-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149685-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3286767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
39974-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 5.4210 0.0 0
M  V30 2 O 0.0000 5.7411 0.0 0
M  V30 3 C 1.5064 0.0000 0.0 0
M  V30 4 O 7.4479 4.2504 0.0 0
M  V30 5 C 8.7817 3.4804 0.0 0
M  V30 6 C 3.4470 3.4804 0.0 0
M  V30 7 C 3.4470 1.9404 0.0 0
M  V30 8 C 1.9823 3.9564 0.0 0
M  V30 9 C 4.7806 4.2504 0.0 0
M  V30 10 N 1.9823 1.4645 0.0 0
M  V30 11 C 4.7806 1.1704 0.0 0
M  V30 12 C 1.0771 2.7104 0.0 0
M  V30 13 C 6.1143 3.4804 0.0 0
M  V30 14 C 6.1143 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
149685-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 O 1.5400 6.6519 0.0 0
M  V30 6 C 0.0000 6.6519 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 3.8500 2.6508 0.0 0
M  V30 9 C 6.1263 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 N 4.8804 1.5064 0.0 0
M  V30 12 C 2.3100 2.6508 0.0 0
M  V30 13 C 6.2872 2.1327 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 15 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39974-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149685-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-885911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Proline, N-(5-carboxy-1-oxopentyl)-L-valyl-L-valyl-4-[[(3,4-dihydro-2(1H)-i...
C32H46N4O9
402958-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.1141 5.3195 0.0 0
M  V30 2 C 13.8841 6.6533 0.0 0 CFG=2
M  V30 3 O 13.8841 3.9858 0.0 0
M  V30 4 N 15.4241 6.6533 0.0 0
M  V30 5 C 13.1141 7.9869 0.0 0
M  V30 6 C 16.1941 7.9869 0.0 0
M  V30 7 C 11.5741 7.9869 0.0 0
M  V30 8 C 13.8841 9.3206 0.0 0
M  V30 9 C 17.7341 7.9869 0.0 0 CFG=2
M  V30 10 O 15.4241 9.3206 0.0 0
M  V30 11 N 18.5041 9.3206 0.0 0
M  V30 12 C 18.5041 6.6533 0.0 0
M  V30 13 C 20.0441 9.3206 0.0 0
M  V30 14 C 20.0441 6.6533 0.0 0
M  V30 15 C 17.7341 5.3195 0.0 0
M  V30 16 C 20.8141 10.6542 0.0 0
M  V30 17 O 20.8141 7.9869 0.0 0
M  V30 18 C 22.3541 10.6542 0.0 0
M  V30 19 C 23.1241 11.9880 0.0 0
M  V30 20 C 24.6641 11.9880 0.0 0
M  V30 21 C 25.4342 13.3217 0.0 0
M  V30 22 O 26.9742 13.3217 0.0 0
M  V30 23 O 24.6641 14.6553 0.0 0
M  V30 24 C 11.1447 2.6091 0.0 0
M  V30 25 O 10.1143 1.4645 0.0 0
M  V30 26 O 12.6512 2.2889 0.0 0
M  V30 27 C 10.5902 0.0000 0.0 0
M  V30 28 O 7.9583 6.9947 0.0 0
M  V30 29 C 6.5515 6.3684 0.0 0
M  V30 30 O 6.3904 4.8369 0.0 0
M  V30 31 N 11.5741 5.3195 0.0 0
M  V30 32 C 10.6689 4.0736 0.0 0 CFG=2
M  V30 33 C 10.6689 6.5655 0.0 0
M  V30 34 C 9.2042 4.5495 0.0 0
M  V30 35 C 9.2042 6.0895 0.0 0 CFG=2
M  V30 36 N 5.3056 7.2736 0.0 0
M  V30 37 C 3.8987 6.6471 0.0 0
M  V30 38 C 5.4666 8.8051 0.0 0
M  V30 39 C 2.6528 7.5524 0.0 0
M  V30 40 C 4.2207 9.7104 0.0 0
M  V30 41 C 2.8137 9.0840 0.0 0
M  V30 42 C 1.2459 6.9260 0.0 0
M  V30 43 C 1.5679 9.9891 0.0 0
M  V30 44 C 0.0000 7.8312 0.0 0
M  V30 45 C 0.1611 9.3628 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 31
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 32 24 CFG=3
M  V30 27 1 25 27
M  V30 28 1 28 29
M  V30 29 1 35 28 CFG=1
M  V30 30 2 29 30
M  V30 31 1 29 36
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 34 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 2 39 42
M  V30 43 1 40 41
M  V30 44 2 41 43
M  V30 45 1 42 44
M  V30 46 1 43 45
M  V30 47 2 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 9 32 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Proline, N-[6-(methylamino)-1,6-dioxohexyl]-L-valyl-L-valyl-4-[[(3,4-dihydr...
C33H49N5O8
402958-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.1141 5.3195 0.0 0
M  V30 2 C 13.8841 6.6533 0.0 0 CFG=2
M  V30 3 O 13.8841 3.9858 0.0 0
M  V30 4 N 15.4241 6.6533 0.0 0
M  V30 5 C 13.1141 7.9869 0.0 0
M  V30 6 C 16.1941 7.9869 0.0 0
M  V30 7 C 11.5741 7.9869 0.0 0
M  V30 8 C 13.8841 9.3206 0.0 0
M  V30 9 C 17.7341 7.9869 0.0 0 CFG=2
M  V30 10 O 15.4241 9.3206 0.0 0
M  V30 11 N 18.5041 9.3206 0.0 0
M  V30 12 C 18.5041 6.6533 0.0 0
M  V30 13 C 20.0441 9.3206 0.0 0
M  V30 14 C 20.0441 6.6533 0.0 0
M  V30 15 C 17.7341 5.3195 0.0 0
M  V30 16 C 20.8141 10.6544 0.0 0
M  V30 17 O 20.8141 7.9869 0.0 0
M  V30 18 C 22.3541 10.6542 0.0 0
M  V30 19 C 23.1241 11.9880 0.0 0
M  V30 20 C 24.6641 11.9880 0.0 0
M  V30 21 C 25.4342 13.3217 0.0 0
M  V30 22 N 26.9742 13.3217 0.0 0
M  V30 23 O 24.6641 14.6553 0.0 0
M  V30 24 C 27.7442 14.6553 0.0 0
M  V30 25 C 11.1447 2.6091 0.0 0
M  V30 26 O 10.1143 1.4645 0.0 0
M  V30 27 O 12.6512 2.2889 0.0 0
M  V30 28 C 10.5902 0.0000 0.0 0
M  V30 29 O 7.9583 6.9947 0.0 0
M  V30 30 C 6.5515 6.3684 0.0 0
M  V30 31 O 6.3904 4.8369 0.0 0
M  V30 32 N 11.5741 5.3195 0.0 0
M  V30 33 C 10.6689 4.0736 0.0 0 CFG=2
M  V30 34 C 10.6689 6.5655 0.0 0
M  V30 35 C 9.2042 4.5495 0.0 0
M  V30 36 C 9.2042 6.0895 0.0 0 CFG=2
M  V30 37 N 5.3056 7.2736 0.0 0
M  V30 38 C 3.8987 6.6471 0.0 0
M  V30 39 C 5.4666 8.8051 0.0 0
M  V30 40 C 2.6528 7.5524 0.0 0
M  V30 41 C 4.2207 9.7104 0.0 0
M  V30 42 C 2.8137 9.0840 0.0 0
M  V30 43 C 1.2459 6.9260 0.0 0
M  V30 44 C 1.5679 9.9891 0.0 0
M  V30 45 C 0.0000 7.8312 0.0 0
M  V30 46 C 0.1611 9.3628 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 32
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 9 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 25 26
M  V30 26 2 25 27
M  V30 27 1 33 25 CFG=3
M  V30 28 1 26 28
M  V30 29 1 29 30
M  V30 30 1 36 29 CFG=1
M  V30 31 2 30 31
M  V30 32 1 30 37
M  V30 33 1 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 1 35 36
M  V30 38 1 37 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 2 40 43
M  V30 44 1 41 42
M  V30 45 2 42 44
M  V30 46 1 43 45
M  V30 47 1 44 46
M  V30 48 2 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 9 33 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402958-65-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402958-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12619146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound xxxxvii (1 g, 1.59 mmol) and 990 mg (2.28 mmol) of PyBop is
dissolved in 20 mL DCM and 1.6 mL of 1 M methylamine in THF is added. The
mixture is stirred at about room temperature for 4 hours. The reaction
mixture is diluted to 100 mL with EtOAc and washed with 1 N HCl, NaHCO3
and brine. The residue is purified by flash column chromatography (10%
EtOH/EtOAc) Yield 1 g (98%), compound xxxxviii
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptidomimetic protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babine, Robert Edward; Chen, Shu Hui; Lamar, Jason Eric; Snyder, Nancy
June; Sun, Xicheng David; Tebbe, Mark Joseph; Victor, Frantz; Wang, Q.
May; Yip, Yvonne Yee Mai; Collado, Ivan; Garcia-Paredes, Cristina;
Parker, Raymond Samuel, III; Jin, Ling; Guo, Deqi; Glass, John Irvin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002018369 A2 2002-03-07

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40148184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective synthesis of isoquinolinonediones through remote
unactivated C(sp3)-H bonds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Lei; Sun, Jun; Sun, Boxuan; Song, Shengjie; Li, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(36),
4818-4821

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-(3,4-Dimethoxyphenyl)-9H-purine-6-carbonitrile
C14H11N5O2
403796-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.9090 5.3256 0.0 0
M  V30 2 N 13.3737 4.8498 0.0 0
M  V30 3 O 2.3102 1.3336 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 O 0.7702 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 N 6.9302 4.0011 0.0 0
M  V30 8 C 7.8352 5.2469 0.0 0
M  V30 9 C 7.8352 2.7552 0.0 0
M  V30 10 C 9.2999 4.7711 0.0 0
M  V30 11 N 7.5150 6.7534 0.0 0
M  V30 12 N 9.2999 3.2311 0.0 0
M  V30 13 C 10.4443 5.8015 0.0 0
M  V30 14 C 8.6596 7.7838 0.0 0
M  V30 15 N 10.1241 7.3079 0.0 0
M  V30 16 C 5.3902 4.0011 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 4.6202 5.3347 0.0 0
M  V30 19 C 3.0802 2.6674 0.0 0
M  V30 20 C 3.0802 5.3347 0.0 0
M  V30 21 C 2.3102 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethoxyphenyl)-7,8-dihydro-8-imino-7-methylpyrimido[5,4-d]pyrimidin-...
C15H16N6O2
403796-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 N 12.3200 8.0021 0.0 0
M  V30 3 C 13.8600 5.3347 0.0 0
M  V30 4 O 2.3100 1.3336 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 7.7000 5.3347 0.0 0
M  V30 10 C 10.0100 6.6685 0.0 0
M  V30 11 N 10.0100 4.0011 0.0 0
M  V30 12 N 6.9300 6.6685 0.0 0
M  V30 13 C 11.5500 6.6685 0.0 0
M  V30 14 N 9.2400 8.0021 0.0 0
M  V30 15 C 11.5500 4.0011 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 N 12.3200 5.3347 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 3.0800 5.3347 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 2 2 13
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403796-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 403796-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25947427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 6-cyano-9-substituted-9H-purines and their ring
expansion to 8-(arylamino)-4-imino-3-methylpyrimidino[5,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Azini, Amal; Booth, Brian L.; Carpenter, Robert A.; Carvalho, Alice;
Marrelec, Elodie; Pritchard, Robin G.; Proenca, M. Fernanda J. R. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chemical Society, Perkin Transactions 1 (2001), (20),
2532-2537

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Methylthio)-2-phenyl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5(1H)-one
C11H9N5OS
40597-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 3.0800 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 N 5.4658 2.6042 0.0 0
M  V30 8 N 5.4658 5.0959 0.0 0
M  V30 9 N 2.6674 5.3900 0.0 0
M  V30 10 N 1.3338 3.0800 0.0 0
M  V30 11 C 6.3710 3.8500 0.0 0
M  V30 12 C 1.3338 4.6200 0.0 0
M  V30 13 C 7.9110 3.8500 0.0 0
M  V30 14 C 8.6810 5.1837 0.0 0
M  V30 15 C 8.6810 2.5164 0.0 0
M  V30 16 C 10.2210 5.1837 0.0 0
M  V30 17 C 10.2210 2.5164 0.0 0
M  V30 18 C 10.9910 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Methylamino)-2-phenyl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5(1H)-one
C11H10N6O
2335876-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 3.0800 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 N 5.4658 2.6042 0.0 0
M  V30 8 N 5.4658 5.0959 0.0 0
M  V30 9 N 2.6674 5.3900 0.0 0
M  V30 10 N 1.3338 3.0800 0.0 0
M  V30 11 C 6.3710 3.8500 0.0 0
M  V30 12 C 1.3338 4.6200 0.0 0
M  V30 13 C 7.9110 3.8500 0.0 0
M  V30 14 C 8.6810 2.5164 0.0 0
M  V30 15 C 8.6810 5.1837 0.0 0
M  V30 16 C 10.2210 2.5164 0.0 0
M  V30 17 C 10.2210 5.1837 0.0 0
M  V30 18 C 10.9910 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40597-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2335876-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30130144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic systems with an s-triazine ring. 34. Development of a
practical approach for the synthesis of 5-aza-isoguanines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Junaid, Ahmad; Lim, Felicia Phei Lin; Zhou, Yvonne Peijun; Chui, Wai
Keung; Dolzhenko, Anton V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(8), 1453pp.

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-methyl-5-(2-phenylethynyl)-3(2H)-pyridazinone
C13H9ClN2O
407577-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 7.7002 2.6673 0.0 0
M  V30 3 Cl 4.6201 0.0000 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 N 2.3101 4.0010 0.0 0
M  V30 11 N 1.5400 2.6673 0.0 0
M  V30 12 C 9.2402 2.6673 0.0 0
M  V30 13 C 10.0102 4.0010 0.0 0
M  V30 14 C 10.0102 1.3337 0.0 0
M  V30 15 C 11.5503 4.0010 0.0 0
M  V30 16 C 11.5503 1.3337 0.0 0
M  V30 17 C 12.3203 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 7
M  V30 5 2 4 9
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-1,5-dimethyl-2-phenyl-4H-pyrrolo[2,3-d]pyridazin-4-one
C14H13N3O
637772-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 C 5.9416 5.7904 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 5.4658 1.8340 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 5.4658 4.3259 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 6.3710 3.0800 0.0 0
M  V30 11 N 1.3338 2.3100 0.0 0
M  V30 12 N 1.3338 3.8500 0.0 0
M  V30 13 C 7.9110 3.0800 0.0 0
M  V30 14 C 8.6810 1.7462 0.0 0
M  V30 15 C 8.6810 4.4136 0.0 0
M  V30 16 C 10.2210 1.7462 0.0 0
M  V30 17 C 10.2210 4.4136 0.0 0
M  V30 18 C 10.9910 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 407577-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 637772-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31022735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Alkynyl-4-chloro- and 4-alkynyl-5-chloro-2-methylpyridazin-3(2H)-ones:
Convenient precursors for the preparation of 2-substituted
pyrrolo[2,3-d]pyridazinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM R'kyek, Omar; Maes, Bert U. W.; Lemiere, Guy L. F.; Dommisse, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2003), 60(11), 2471-2483

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methylbenzo[g]pyrazolo[1,5-c]quinazoline
C15H10ClN3
409369-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3778 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.7308 0.0 0
M  V30 3 C 4.0012 3.4207 0.0 0
M  V30 4 C 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 4.9608 0.0 0
M  V30 6 C 5.3348 2.6507 0.0 0
M  V30 7 N 1.3337 3.4207 0.0 0
M  V30 8 C 2.3472 1.1444 0.0 0
M  V30 9 C 5.3348 5.7308 0.0 0
M  V30 10 N 2.6675 5.7308 0.0 0
M  V30 11 C 6.6685 3.4207 0.0 0
M  V30 12 C 1.3337 4.9608 0.0 0
M  V30 13 N 0.1893 2.3903 0.0 0
M  V30 14 C 0.8156 0.9835 0.0 0
M  V30 15 C 6.6685 4.9608 0.0 0
M  V30 16 C 8.0023 2.6507 0.0 0
M  V30 17 C 8.0023 5.7308 0.0 0
M  V30 18 C 9.3360 3.4207 0.0 0
M  V30 19 C 9.3360 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 12
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 2 13 14
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethylbenzo[g]pyrazolo[1,5-c]quinazolin-5-amine
C16H14N4
409369-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4494 0.4294 0.0 0
M  V30 2 N 9.2400 3.7035 0.0 0
M  V30 3 C 10.0100 5.0372 0.0 0
M  V30 4 C 5.3900 2.3699 0.0 0
M  V30 5 C 4.6200 3.7035 0.0 0
M  V30 6 N 6.9300 2.3699 0.0 0
M  V30 7 C 4.9141 0.9052 0.0 0
M  V30 8 C 5.3900 5.0372 0.0 0
M  V30 9 C 3.0800 3.7035 0.0 0
M  V30 10 C 7.7000 3.7035 0.0 0
M  V30 11 N 7.4059 0.9052 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 4.6200 6.3708 0.0 0
M  V30 14 N 6.9300 5.0372 0.0 0
M  V30 15 C 2.3100 5.0372 0.0 0
M  V30 16 C 3.0800 6.3708 0.0 0
M  V30 17 C 0.7700 5.0372 0.0 0
M  V30 18 C 2.3100 7.7046 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 14
M  V30 16 2 11 12
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 409369-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 409369-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3896525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 4-amino derivatives of
benzimidazoquinoxaline, benzimidazoquinoline, and
benzopyrazoloquinazoline as potent IKK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beaulieu, Francis; Ouellet, Carl; Ruediger, Edward H.; Belema, Makonen;
Qiu, Yuping; Yang, Xuejie; Banville, Jacques; Burke, James R.; Gregor,
Kurt R.; MacMaster, John F.; Martel, Alain; McIntyre, Kim W.; Pattoli,
Mark A.; Zusi, F. Christopher; Vyas, Dolatrai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(5), 1233-1237

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methylbenzo[g]pyrazolo[1,5-c]quinazoline
C15H10ClN3
409369-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3778 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.7308 0.0 0
M  V30 3 C 4.0012 3.4207 0.0 0
M  V30 4 C 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 4.9608 0.0 0
M  V30 6 C 5.3348 2.6507 0.0 0
M  V30 7 N 1.3337 3.4207 0.0 0
M  V30 8 C 2.3472 1.1444 0.0 0
M  V30 9 C 5.3348 5.7308 0.0 0
M  V30 10 N 2.6675 5.7308 0.0 0
M  V30 11 C 6.6685 3.4207 0.0 0
M  V30 12 C 1.3337 4.9608 0.0 0
M  V30 13 N 0.1893 2.3903 0.0 0
M  V30 14 C 0.8156 0.9835 0.0 0
M  V30 15 C 6.6685 4.9608 0.0 0
M  V30 16 C 8.0023 2.6507 0.0 0
M  V30 17 C 8.0023 5.7308 0.0 0
M  V30 18 C 9.3360 3.4207 0.0 0
M  V30 19 C 9.3360 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 12
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 2 13 14
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethylbenzo[g]pyrazolo[1,5-c]quinazolin-5-amine
C16H14N4
409369-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4494 0.4294 0.0 0
M  V30 2 N 9.2400 3.7035 0.0 0
M  V30 3 C 10.0100 5.0372 0.0 0
M  V30 4 C 5.3900 2.3699 0.0 0
M  V30 5 C 4.6200 3.7035 0.0 0
M  V30 6 N 6.9300 2.3699 0.0 0
M  V30 7 C 4.9141 0.9052 0.0 0
M  V30 8 C 5.3900 5.0372 0.0 0
M  V30 9 C 3.0800 3.7035 0.0 0
M  V30 10 C 7.7000 3.7035 0.0 0
M  V30 11 N 7.4059 0.9052 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 4.6200 6.3708 0.0 0
M  V30 14 N 6.9300 5.0372 0.0 0
M  V30 15 C 2.3100 5.0372 0.0 0
M  V30 16 C 3.0800 6.3708 0.0 0
M  V30 17 C 0.7700 5.0372 0.0 0
M  V30 18 C 2.3100 7.7046 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 14
M  V30 16 2 11 12
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 409369-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 409369-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4420989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods of treating inflammatory and immune diseases using inhibitors of
IκB kinase (IKK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burke, James R.; Townsend, Robert M.; Qiu, Yuping; Zusi, Fred
Christopher; Nadler, Steven G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030022898 A1 2003-01-30

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methylbenzo[g]pyrazolo[1,5-c]quinazoline
C15H10ClN3
409369-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3778 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.7308 0.0 0
M  V30 3 C 4.0012 3.4207 0.0 0
M  V30 4 C 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 4.9608 0.0 0
M  V30 6 C 5.3348 2.6507 0.0 0
M  V30 7 N 1.3337 3.4207 0.0 0
M  V30 8 C 2.3472 1.1444 0.0 0
M  V30 9 C 5.3348 5.7308 0.0 0
M  V30 10 N 2.6675 5.7308 0.0 0
M  V30 11 C 6.6685 3.4207 0.0 0
M  V30 12 C 1.3337 4.9608 0.0 0
M  V30 13 N 0.1893 2.3903 0.0 0
M  V30 14 C 0.8156 0.9835 0.0 0
M  V30 15 C 6.6685 4.9608 0.0 0
M  V30 16 C 8.0023 2.6507 0.0 0
M  V30 17 C 8.0023 5.7308 0.0 0
M  V30 18 C 9.3360 3.4207 0.0 0
M  V30 19 C 9.3360 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 12
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 2 13 14
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethylbenzo[g]pyrazolo[1,5-c]quinazolin-5-amine
C16H14N4
409369-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4494 0.4294 0.0 0
M  V30 2 N 9.2400 3.7035 0.0 0
M  V30 3 C 10.0100 5.0372 0.0 0
M  V30 4 C 5.3900 2.3699 0.0 0
M  V30 5 C 4.6200 3.7035 0.0 0
M  V30 6 N 6.9300 2.3699 0.0 0
M  V30 7 C 4.9141 0.9052 0.0 0
M  V30 8 C 5.3900 5.0372 0.0 0
M  V30 9 C 3.0800 3.7035 0.0 0
M  V30 10 C 7.7000 3.7035 0.0 0
M  V30 11 N 7.4059 0.9052 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 4.6200 6.3708 0.0 0
M  V30 14 N 6.9300 5.0372 0.0 0
M  V30 15 C 2.3100 5.0372 0.0 0
M  V30 16 C 3.0800 6.3708 0.0 0
M  V30 17 C 0.7700 5.0372 0.0 0
M  V30 18 C 2.3100 7.7046 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 14
M  V30 16 2 11 12
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 409369-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 409369-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7153909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 14. 1-METHYL-4-METHYLAMINOBENZO[G]PYRAZOLO[1,5-C]QUINAZOLINE. A
mixture of 4-methyl-1-(4-tolunesulfonyl)-5-trimethylstannylpyrazole
(Preparation 8 in Example 11) (24.0 mg, 0.0896 mmol) and MeNH2 (3.0 mL of
2.0 M/THF, 6.0 mmol) in a pressure tube was heated at 60°C for 5 hr.
After the reaction mixture was cooled to RT, it was treated with NaHCO3
(57 mg) and water (2 pipet-drops) and stirred for 5 min. Silica gel was
added and the volatile component was removed in vacuo. The resulting
silica gel mesh was submitted to flash chromatography (20% EtOAc/hexanes)
to afford the title compound. Yield: (23.0 mg, 98%), light yellow solid.
1H NMR (DMSO, δ = 2.50): 8.60 (s, 1H), 8.10 (s, d, J = 8.3, 1H), 8.03 (s,
1H), 8.01 (s, 1H), 7.95 (d, J = 8.01, 1H), 7.92 (q, J = 4.7, 1H), 7.50
(t, J = 7.5, 1H), 7.44 (t, J = 7.4, 1H), 3.09 (d, J = 4.7, 3H), 2.66 (s,
3H). (ESI) m/z (M+H)+ = 263.02. IKK-1, IC50: 0.67 μM.
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of treating inflammatory and immune diseases using 4-amino
substituted imidazoquinoxaline, benzopyrazoloquinazoline,
benzoimidazoquinoxaline and benzoimidazoquinoline inhibitors of Iκb
kinase (IKK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burke, James R.; Nadler, Steven; Qiu, Yuping; Townsend, Robert M.; Zusi,
Fred Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002060386 A2 2002-08-08

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methylbenzo[g]pyrazolo[1,5-c]quinazoline
C15H10ClN3
409369-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3778 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.7308 0.0 0
M  V30 3 C 4.0012 3.4207 0.0 0
M  V30 4 C 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 4.9608 0.0 0
M  V30 6 C 5.3348 2.6507 0.0 0
M  V30 7 N 1.3337 3.4207 0.0 0
M  V30 8 C 2.3472 1.1444 0.0 0
M  V30 9 C 5.3348 5.7308 0.0 0
M  V30 10 N 2.6675 5.7308 0.0 0
M  V30 11 C 6.6685 3.4207 0.0 0
M  V30 12 C 1.3337 4.9608 0.0 0
M  V30 13 N 0.1893 2.3903 0.0 0
M  V30 14 C 0.8156 0.9835 0.0 0
M  V30 15 C 6.6685 4.9608 0.0 0
M  V30 16 C 8.0023 2.6507 0.0 0
M  V30 17 C 8.0023 5.7308 0.0 0
M  V30 18 C 9.3360 3.4207 0.0 0
M  V30 19 C 9.3360 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 12
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 2 13 14
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethylbenzo[g]pyrazolo[1,5-c]quinazolin-5-amine
C16H14N4
409369-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4494 0.4294 0.0 0
M  V30 2 N 9.2400 3.7035 0.0 0
M  V30 3 C 10.0100 5.0372 0.0 0
M  V30 4 C 5.3900 2.3699 0.0 0
M  V30 5 C 4.6200 3.7035 0.0 0
M  V30 6 N 6.9300 2.3699 0.0 0
M  V30 7 C 4.9141 0.9052 0.0 0
M  V30 8 C 5.3900 5.0372 0.0 0
M  V30 9 C 3.0800 3.7035 0.0 0
M  V30 10 C 7.7000 3.7035 0.0 0
M  V30 11 N 7.4059 0.9052 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 4.6200 6.3708 0.0 0
M  V30 14 N 6.9300 5.0372 0.0 0
M  V30 15 C 2.3100 5.0372 0.0 0
M  V30 16 C 3.0800 6.3708 0.0 0
M  V30 17 C 0.7700 5.0372 0.0 0
M  V30 18 C 2.3100 7.7046 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 14
M  V30 16 2 11 12
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 409369-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 409369-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7101868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methy4-methylaminobenzo[g]pyrazolo[1,5-c]quinazoline A mixture of
4-methyl-(4-toIunesulfonyl)-5-trimethylstannylpyrazole (Preparation 8)
(24.0 mg, 0.0896 mmol) and MeNH2 (3.0 mL of 2.0 M/THF, 6.0 mmol) in a
pressure tube was heated at 60°C for 5 hr. After the reaction mixture was
cooled to RT, it was treated with NaHCO3 (57 mg) and water (2
pipet-drops) and stirred for 5 min. Silica gel was added and the volatile
component was removed in vacuo. The resulting silica gel mesh was
submitted to flash chromatography (20% EtOAc/hexanes) to afford the title
compound. Light yellow solid, yield (23.0 mg, 98%). 1H NMR (DMSO, δ=
2.50): 8.60 (s, 1H), 8.10 (s, d, J = 8.3, 1H), 8.03 (s, 1H), 8.01 (s,
1H), 7.95 (d, J = 8.01, 1H), 7.92 (q, J = 4.7, 1H), 7.50 (t, J = 7.5,
1H), 7.44 (t, J = 7.4, 1H), 3.09 (d, J = 4.7, 3H), 2.66 (s, 3H). (ESI)
m/z (M+H)+ = 263.02.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino-substituted tetracyclic compounds as
antiinflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beaulieu, Francis; Ouellet, Carl; Belema, Makonen; Qiu, Yuping; Yang,
Xuejie; Zusi, Fred C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002028860 A2 2002-04-11

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Leucine, N-[[[3-[carboxy[2-[(2-cyanoethyl)amino]ethyl]amino]propyl]phenylam...
C41H60N8O8
416898-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 7.7002 0.0 0
M  V30 2 C 6.6685 8.4702 0.0 0
M  V30 3 C 9.3358 8.4702 0.0 0
M  V30 4 N 6.6685 10.0102 0.0 0
M  V30 5 O 5.3348 7.7002 0.0 0
M  V30 6 C 10.6697 7.7002 0.0 0
M  V30 7 C 5.3348 10.7802 0.0 0 CFG=2
M  V30 8 C 12.0033 8.4702 0.0 0
M  V30 9 C 4.0010 10.0102 0.0 0
M  V30 10 C 5.3348 12.3203 0.0 0
M  V30 11 N 13.3370 7.7002 0.0 0
M  V30 12 N 6.6685 13.0903 0.0 0
M  V30 13 O 4.0010 13.0903 0.0 0
M  V30 14 C 14.6707 8.4702 0.0 0
M  V30 15 C 13.3370 6.1601 0.0 0
M  V30 16 C 6.6685 14.6303 0.0 0 CFG=1
M  V30 17 N 16.0045 7.7002 0.0 0
M  V30 18 O 14.6707 10.0102 0.0 0
M  V30 19 C 14.6707 5.3901 0.0 0
M  V30 20 C 8.0022 15.4003 0.0 0
M  V30 21 C 5.3348 15.4003 0.0 0
M  V30 22 C 17.3382 8.4702 0.0 0 CFG=1
M  V30 23 N 14.6707 3.8501 0.0 0
M  V30 24 O 8.0022 16.9404 0.0 0
M  V30 25 O 9.3358 14.6303 0.0 0
M  V30 26 C 5.3348 16.9404 0.0 0
M  V30 27 C 18.6718 7.7002 0.0 0
M  V30 28 C 17.3382 10.0102 0.0 0
M  V30 29 C 16.0045 3.0801 0.0 0
M  V30 30 C 9.3358 17.7104 0.0 0
M  V30 31 C 6.6685 17.7104 0.0 0
M  V30 32 C 4.0010 17.7104 0.0 0
M  V30 33 N 20.0055 8.4702 0.0 0
M  V30 34 O 18.6718 6.1601 0.0 0
M  V30 35 C 16.0045 10.7802 0.0 0
M  V30 36 C 18.6718 10.7802 0.0 0
M  V30 37 C 16.0045 1.5400 0.0 0
M  V30 38 C 21.3393 7.7002 0.0 0 CFG=1
M  V30 39 C 17.3382 0.7700 0.0 0
M  V30 40 C 22.6730 8.4702 0.0 0
M  V30 41 C 21.3393 6.1601 0.0 0
M  V30 42 N 18.6718 0.0000 0.0 0
M  V30 43 O 24.0067 7.7002 0.0 0
M  V30 44 O 22.6730 10.0102 0.0 0
M  V30 45 C 25.3403 8.4702 0.0 0
M  V30 46 C 8.0022 6.1601 0.0 0
M  V30 47 C 9.3358 5.3901 0.0 0
M  V30 48 C 6.6685 5.3901 0.0 0
M  V30 49 C 9.3358 3.8501 0.0 0
M  V30 50 C 6.6685 3.8501 0.0 0
M  V30 51 C 8.0022 3.0801 0.0 0
M  V30 52 C 2.6673 10.7802 0.0 0
M  V30 53 C 1.3337 10.0102 0.0 0
M  V30 54 C 2.6673 12.3203 0.0 0
M  V30 55 C 0.0000 10.7802 0.0 0
M  V30 56 C 1.3337 13.0903 0.0 0
M  V30 57 C 0.0000 12.3203 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 46
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 52
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 16 21 CFG=1
M  V30 23 1 17 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 1 22 27
M  V30 29 1 22 28 CFG=1
M  V30 30 1 23 29
M  V30 31 1 24 30
M  V30 32 1 26 31
M  V30 33 1 26 32
M  V30 34 1 27 33
M  V30 35 2 27 34
M  V30 36 1 28 35
M  V30 37 1 28 36
M  V30 38 1 29 37
M  V30 39 1 33 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 38 41 CFG=3
M  V30 43 3 39 42
M  V30 44 1 40 43
M  V30 45 2 40 44
M  V30 46 1 43 45
M  V30 47 2 46 47
M  V30 48 1 46 48
M  V30 49 1 47 49
M  V30 50 2 48 50
M  V30 51 2 49 51
M  V30 52 1 50 51
M  V30 53 2 52 53
M  V30 54 1 52 54
M  V30 55 1 53 55
M  V30 56 2 54 56
M  V30 57 2 55 57
M  V30 58 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 16 22 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Leucinamide, N-[[[3-[carboxy[2-[(2-cyanoethyl)amino]ethyl]amino]propyl]phen...
C41H62N10O6
416898-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 7.7002 0.0 0
M  V30 2 C 6.6685 8.4702 0.0 0
M  V30 3 C 9.3358 8.4702 0.0 0
M  V30 4 N 6.6685 10.0102 0.0 0
M  V30 5 O 5.3348 7.7002 0.0 0
M  V30 6 C 10.6697 7.7002 0.0 0
M  V30 7 C 5.3348 10.7802 0.0 0 CFG=2
M  V30 8 C 12.0033 8.4702 0.0 0
M  V30 9 C 4.0010 10.0102 0.0 0
M  V30 10 C 5.3348 12.3203 0.0 0
M  V30 11 N 13.3370 7.7002 0.0 0
M  V30 12 N 6.6685 13.0903 0.0 0
M  V30 13 O 4.0010 13.0903 0.0 0
M  V30 14 C 14.6707 8.4702 0.0 0
M  V30 15 C 13.3370 6.1601 0.0 0
M  V30 16 C 6.6685 14.6303 0.0 0 CFG=1
M  V30 17 N 16.0045 7.7002 0.0 0
M  V30 18 O 14.6707 10.0102 0.0 0
M  V30 19 C 14.6707 5.3901 0.0 0
M  V30 20 C 8.0022 15.4003 0.0 0
M  V30 21 C 5.3348 15.4003 0.0 0
M  V30 22 C 17.3382 8.4702 0.0 0 CFG=1
M  V30 23 N 14.6707 3.8501 0.0 0
M  V30 24 N 8.0022 16.9404 0.0 0
M  V30 25 O 9.3358 14.6303 0.0 0
M  V30 26 C 5.3348 16.9404 0.0 0
M  V30 27 C 18.6718 7.7002 0.0 0
M  V30 28 C 17.3382 10.0102 0.0 0
M  V30 29 C 16.0045 3.0801 0.0 0
M  V30 30 C 9.3358 17.7104 0.0 0
M  V30 31 C 6.6685 17.7104 0.0 0
M  V30 32 C 4.0010 17.7104 0.0 0
M  V30 33 N 20.0055 8.4702 0.0 0
M  V30 34 O 18.6718 6.1601 0.0 0
M  V30 35 C 16.0045 10.7802 0.0 0
M  V30 36 C 18.6718 10.7802 0.0 0
M  V30 37 C 16.0045 1.5400 0.0 0
M  V30 38 C 21.3393 7.7002 0.0 0 CFG=1
M  V30 39 C 17.3382 0.7700 0.0 0
M  V30 40 C 22.6730 8.4702 0.0 0
M  V30 41 C 21.3393 6.1601 0.0 0
M  V30 42 N 18.6718 0.0000 0.0 0
M  V30 43 N 24.0067 7.7002 0.0 0
M  V30 44 O 22.6730 10.0102 0.0 0
M  V30 45 C 25.3403 8.4702 0.0 0
M  V30 46 C 8.0022 6.1601 0.0 0
M  V30 47 C 6.6685 5.3901 0.0 0
M  V30 48 C 9.3358 5.3901 0.0 0
M  V30 49 C 6.6685 3.8501 0.0 0
M  V30 50 C 9.3358 3.8501 0.0 0
M  V30 51 C 8.0022 3.0801 0.0 0
M  V30 52 C 2.6673 10.7802 0.0 0
M  V30 53 C 1.3337 10.0102 0.0 0
M  V30 54 C 2.6673 12.3203 0.0 0
M  V30 55 C 0.0000 10.7802 0.0 0
M  V30 56 C 1.3337 13.0903 0.0 0
M  V30 57 C 0.0000 12.3203 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 46
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 52
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 16 21 CFG=1
M  V30 23 1 17 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 2 20 25
M  V30 27 1 21 26
M  V30 28 1 22 27
M  V30 29 1 22 28 CFG=1
M  V30 30 1 23 29
M  V30 31 1 24 30
M  V30 32 1 26 31
M  V30 33 1 26 32
M  V30 34 1 27 33
M  V30 35 2 27 34
M  V30 36 1 28 35
M  V30 37 1 28 36
M  V30 38 1 29 37
M  V30 39 1 33 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 38 41 CFG=3
M  V30 43 3 39 42
M  V30 44 1 40 43
M  V30 45 2 40 44
M  V30 46 1 43 45
M  V30 47 2 46 47
M  V30 48 1 46 48
M  V30 49 1 47 49
M  V30 50 2 48 50
M  V30 51 2 49 51
M  V30 52 1 50 51
M  V30 53 2 52 53
M  V30 54 1 52 54
M  V30 55 1 53 55
M  V30 56 2 54 56
M  V30 57 2 55 57
M  V30 58 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 16 22 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 416898-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 416898-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4698589
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-stranded mixed artificial β-sheets
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowick, James S.; Smith, Eric M.; Ziller, Joseph W.; Shaka, A. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(4), 727-739

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-iodo-3-nitropyridine
C5H2ClIN2O2
426463-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 I 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Iodo-N-methyl-3-nitro-2-pyridinamine
C6H6IN3O2
1338652-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 I 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 426463-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338652-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30636214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolecarboxamides as inhibitors of fibroblast growth factor receptor
kinases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaldor, Stephen W.; Tyhonas, John; Murphy, Eric A.; Kanouni, Toufike;
Arnold, Lee D.; Kania, Robert; Cox, Jason M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021247969 A1 2021-12-09

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethoxy)-2-methoxybenzene
C9H11BrO2
4463-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 Br 8.4700 5.3349 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Methoxyphenoxy)-N-methylethanamine
C10H15NO2
72955-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 1.3337 0.7700 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4463-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72955-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17663432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurans as 5-HT1A receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andersen, Kim; Rottlander, Mario; Bogeso, Klaus Peter; Pedersen, Henrik;
Ruhland, Thomas; Dancer, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000034263 A1 2000-06-15

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromovaleryl chloride
C5H8BrClO
4509-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 Br 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methylpentanamide
C6H12BrNO
121283-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 Br 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4509-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121283-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-6956521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recognition of highly functionalised [3.1.0] bicyclic derivatives by
tailor-made antibodies - Towards the synthesis of Chrysanthemic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Billen, Denis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2002), (20121004), No pp.

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
3-Cyano-5-iodobenzoic acid
C8H4INO2
453566-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 C 6.6686 4.6201 0.0 0
M  V30 5 N 8.0022 5.3901 0.0 0
M  V30 6 I 4.0011 0.0000 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 3 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-5-iodo-N-methylbenzamide
C9H7IN2O
2714348-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 N 0.0000 5.3901 0.0 0
M  V30 7 I 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 453566-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2714348-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31521602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nuclide labeled H-tetrazines for PET and SPECT pretargeted
imaging and radionuclide therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Battisti, Umberto Maria; Herth, Matthias Manfred; Kjaer, Andreas; Garcia,
Rocio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021228992 A1 2021-11-18

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
3-Cyano-5-iodobenzoic acid
C8H4INO2
453566-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 C 6.6686 4.6201 0.0 0
M  V30 5 N 8.0022 5.3901 0.0 0
M  V30 6 I 4.0011 0.0000 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 3 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-5-iodo-N-methylbenzamide
C9H7IN2O
2714348-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 N 0.0000 5.3901 0.0 0
M  V30 7 I 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 453566-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2714348-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31860073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nuclide labeled H-tetrazines for PET and SPECT pretargeted
imaging and radionuclide therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kjaer, Andreas; Herth, Matthias Manfred; Battisti, Umberto Maria; Garcia,
Rocio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3909944 A1 2021-11-17

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
3-Cyano-5-iodobenzoic acid
C8H4INO2
453566-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 C 6.6686 4.6201 0.0 0
M  V30 5 N 8.0022 5.3901 0.0 0
M  V30 6 I 4.0011 0.0000 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 3 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-5-iodo-N-methylbenzamide
C9H7IN2O
2714348-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 N 0.0000 5.3901 0.0 0
M  V30 7 I 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 453566-16-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2714348-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24222077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct Cu-mediated aromatic 18F-labeling of highly reactive tetrazines
for pretargeted bioorthogonal PET imaging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia-Vazquez, Rocio; Battisti, Umberto M.; Joergensen, Jesper T.;
Shalgunov, Vladimir; Hvass, Lars; Stares, Daniel L.; Petersen, Ida N.;
Crestey, Francois; Loffler, Andreas; Svatunek, Dennis; Kristensen, Jesper
L.; Mikula, Hannes; Kjaer, Andreas; Herth, Matthias M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2021), 12(35), 11668-11675

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzaldehyde
C8H5F3O
455-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenemethanamine
C9H10F3N
90390-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90390-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-fluorobenzoic acid
C7H6FNO2
455-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-fluoro-N-methylbenzamide
C8H9FN2O
90663-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 N 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90663-31-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23077737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonylurea compound and compositions for treating
conditions associated with NLRP activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Franchi, Luigi; Ghosh, Shomir; Glick, Gary; Katz, Jason; Opipari, Anthony
William, Jr.; Roush, William; Seidel, Hans Martin; Shen, Dong-Ming;
Venkatraman, Shankar; Winkler, David Guenther
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020102576 A1 2020-05-22

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-fluorobenzoic acid
C7H6FNO2
455-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 5.3901 0.0000 0.0 0
M  V30 5 N 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-3-fluoro-N-methylbenzamide
C8H9FN2O
90663-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 N 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90663-31-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20898296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl and heteroaryl aminocarbonyl sulfonimidamide
compounds and compositions for treating conditions associated with NLRP
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glick, Gary; Roush, William R.; Venkatraman, Shankar; Shen, Dong-Ming;
Ghosh, Shomir; Katz, Jason; Seidel, Hans Martin; Franchi, Luigi; Winkler,
David Guenther; Opipari, Anthony William, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019023147 A1 2019-01-31

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)acetyl chloride
C8H6ClFO
459-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 Cl 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 F 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzeneacetamide
C9H10FNO
152859-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 F 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459-04-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 152859-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-13121907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A) 2-(4-Fluorophenyl)-N-methylacetamide To a solution of methylamine in
THF (2.0 M, 5 mL, 10 mmol) was added 4-fluorophenylacetyl chloride (518
mg, 3.0 mmol) at -78°C. The reaction mixture was stirred from -78°C. to
room temperature for 1 h. The solution was diluted with H2O and extracted
with EtOAc. The organic layer was washed with brine and dried over MgSO4.
Filtration, followed by concentration, provided the title compound (490
mg, 98%). 2-(4-Fluorophenyl)-N-methylacetamide, yield (490 mg, 98%). MS
(ESI+) m/z 168 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of monocyclic heterocycles as kinase inhibitors, particularly
Met kinase, for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borzilleri, Robert M.; Cornelius, Lyndon A.M.; Schmidt, Robert J.;
Schroeder, Gretchen M.; Kim, Kyoung S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050245530 A1 2005-11-03

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)-1-methylbenzimidazole
C9H9ClN2
4760-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 6.0810 1.3627 0.0 0
M  V30 3 Cl 7.4148 2.1327 0.0 0
M  V30 4 C 3.0800 3.9844 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 N 4.5864 3.6643 0.0 0
M  V30 7 C 2.3100 5.3182 0.0 0
M  V30 8 N 3.3406 1.5064 0.0 0
M  V30 9 C 0.7700 2.6508 0.0 0
M  V30 10 C 4.7474 2.1327 0.0 0
M  V30 11 C 0.7700 5.3182 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-benzimidazole-2-methanamine
C10H13N3
137898-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 C 8.8870 4.0442 0.0 0
M  V30 5 C 2.6673 3.4804 0.0 0
M  V30 6 C 2.6673 1.9404 0.0 0
M  V30 7 N 4.1320 3.9564 0.0 0
M  V30 8 C 1.3336 4.2504 0.0 0
M  V30 9 N 4.1320 1.4645 0.0 0
M  V30 10 C 1.3336 1.1704 0.0 0
M  V30 11 C 5.0370 2.7104 0.0 0
M  V30 12 C 0.0000 3.4804 0.0 0
M  V30 13 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4760-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 137898-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36455962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trading Symmetry for Stereoinduction in Tetradentate, non-C2-Symmetric
Fe(II)-Complexes for Asymmetric Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steinlandt, Philipp S.; Hemming, Marcel; Xie, Xiulian; Ivlev, Sergei I.;
Meggers, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(32), e202300267

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1S)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 C 6.6686 3.8500 0.0 0
M  V30 7 C 8.0022 4.6200 0.0 0
M  V30 8 C 6.6686 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 C 8.3224 6.1263 0.0 0
M  V30 11 C 8.0022 1.5400 0.0 0
M  V30 12 S 10.4804 4.8804 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 9.8539 6.2874 0.0 0
M  V30 15 C 2.6675 4.6200 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 2.6675 6.1600 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 19 C 1.3338 6.9300 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γS)-γ-(Benzo[b]thien-4-yloxy)-N-methylbenzenepropanamine
C18H19NOS
476199-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 N 1.5400 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 8.4700 5.3347 0.0 0
M  V30 9 C 6.1600 6.6685 0.0 0
M  V30 10 C 9.2400 6.6685 0.0 0
M  V30 11 C 9.5004 4.1903 0.0 0
M  V30 12 C 6.9300 8.0021 0.0 0
M  V30 13 S 10.7463 6.3482 0.0 0
M  V30 14 C 8.4700 8.0021 0.0 0
M  V30 15 C 10.9072 4.8167 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 1.5400 1.3336 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-35-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476199-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13024739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1S)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 9.3358 2.3100 0.0 0
M  V30 8 C 8.0020 4.6200 0.0 0
M  V30 9 C 10.8004 4.3259 0.0 0
M  V30 10 C 8.0020 1.5400 0.0 0
M  V30 11 S 10.8004 1.8341 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 11.7056 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γS)-γ-(Benzo[b]thien-5-yloxy)-N-methylbenzenepropanamine
C18H19NOS
476199-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 5.3900 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 3 C 4.0011 3.0800 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 N 2.6673 0.7700 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 C 9.3358 3.0800 0.0 0
M  V30 9 C 8.0020 5.3900 0.0 0
M  V30 10 C 10.8004 5.0959 0.0 0
M  V30 11 C 8.0020 2.3100 0.0 0
M  V30 12 S 10.8004 2.6042 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 11.7056 3.8500 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476199-97-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1746702
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(1S)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 9.3358 2.3100 0.0 0
M  V30 8 C 8.0020 4.6200 0.0 0
M  V30 9 S 10.8004 4.3259 0.0 0
M  V30 10 C 8.0020 1.5400 0.0 0
M  V30 11 C 10.8004 1.8341 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 11.7056 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γS)-γ-(Benzo[b]thien-6-yloxy)-N-methylbenzenepropanamine
C18H19NOS
687999-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 5.3900 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 3 C 4.0011 3.0800 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 N 2.6673 0.7700 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 C 9.3358 3.0800 0.0 0
M  V30 9 C 8.0020 5.3900 0.0 0
M  V30 10 S 10.8004 5.0959 0.0 0
M  V30 11 C 8.0020 2.3100 0.0 0
M  V30 12 C 10.8004 2.6042 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 11.7056 3.8500 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 687999-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6015875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 C 6.6686 3.8500 0.0 0
M  V30 7 C 8.0022 4.6200 0.0 0
M  V30 8 C 6.6686 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 S 8.3224 6.1263 0.0 0
M  V30 11 C 8.0022 1.5400 0.0 0
M  V30 12 C 10.4804 4.8804 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 9.8539 6.2874 0.0 0
M  V30 15 C 2.6675 4.6200 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 2.6675 6.1600 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 19 C 1.3338 6.9300 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(Benzo[b]thien-7-yloxy)-N-methylbenzenepropanamine
C18H19NOS
476200-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 N 1.5400 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 8.4700 5.3347 0.0 0
M  V30 9 C 6.1600 6.6685 0.0 0
M  V30 10 C 9.2400 6.6685 0.0 0
M  V30 11 S 9.5004 4.1903 0.0 0
M  V30 12 C 6.9300 8.0021 0.0 0
M  V30 13 C 10.7463 6.3482 0.0 0
M  V30 14 C 8.4700 8.0021 0.0 0
M  V30 15 C 10.9072 4.8167 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 1.5400 1.3336 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8763112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 C 6.6686 3.8500 0.0 0
M  V30 7 C 8.0022 4.6200 0.0 0
M  V30 8 C 6.6686 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 C 8.3224 6.1263 0.0 0
M  V30 11 C 8.0022 1.5400 0.0 0
M  V30 12 S 10.4804 4.8804 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 9.8539 6.2874 0.0 0
M  V30 15 C 2.6675 4.6200 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 2.6675 6.1600 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 19 C 1.3338 6.9300 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(Benzo[b]thien-4-yloxy)-N-methylbenzenepropanamine
C18H19NOS
476200-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 N 1.5400 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 8.4700 5.3347 0.0 0
M  V30 9 C 6.1600 6.6685 0.0 0
M  V30 10 C 9.2400 6.6685 0.0 0
M  V30 11 C 9.5004 4.1903 0.0 0
M  V30 12 C 6.9300 8.0021 0.0 0
M  V30 13 S 10.7463 6.3482 0.0 0
M  V30 14 C 8.4700 8.0021 0.0 0
M  V30 15 C 10.9072 4.8167 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 1.5400 1.3336 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10891297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 9.3358 2.3100 0.0 0
M  V30 8 C 8.0020 4.6200 0.0 0
M  V30 9 C 10.8004 4.3259 0.0 0
M  V30 10 C 8.0020 1.5400 0.0 0
M  V30 11 S 10.8004 1.8341 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 11.7056 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(Benzo[b]thien-5-yloxy)-N-methylbenzenepropanamine
C18H19NOS
476200-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 5.3900 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 3 C 4.0011 3.0800 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 N 2.6673 0.7700 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 C 9.3358 3.0800 0.0 0
M  V30 9 C 8.0020 5.3900 0.0 0
M  V30 10 C 10.8004 5.0959 0.0 0
M  V30 11 C 8.0020 2.3100 0.0 0
M  V30 12 S 10.8004 2.6042 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 11.7056 3.8500 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-64-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15146932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 9.3358 2.3100 0.0 0
M  V30 8 C 8.0020 4.6200 0.0 0
M  V30 9 S 10.8004 4.3259 0.0 0
M  V30 10 C 8.0020 1.5400 0.0 0
M  V30 11 C 10.8004 1.8341 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 11.7056 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-γ-(Benzo[b]thien-6-yloxy)-N-methylbenzenepropanamine
C18H19NOS
764643-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 5.3900 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 3 C 4.0011 3.0800 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 N 2.6673 0.7700 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 9.3358 4.6200 0.0 0
M  V30 8 C 9.3358 3.0800 0.0 0
M  V30 9 C 8.0020 5.3900 0.0 0
M  V30 10 S 10.8004 5.0959 0.0 0
M  V30 11 C 8.0020 2.3100 0.0 0
M  V30 12 C 10.8004 2.6042 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 11.7056 3.8500 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 2.6673 5.3900 0.0 0
M  V30 17 C 2.6673 6.9300 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 764643-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3882124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin
and norepinephrine reuptake
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boot, J. R.; Brace, G.; Delatour, C. L.; Dezutter, N.; Fairhurst, J.;
Findlay, J.; Gallagher, P. T.; Hoes, I.; Mahadevan, S.; Mitchell, S. N.;
Rathmell, R. E.; Richards, S. J.; Simmonds, R. G.; Wallace, L.; Whatton,
M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(21), 5395-5399

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R,5aS,6R,8aS,12R,12aR)-9-(Bromomethyl)-3,4,5,5a,6,7,8,8a-octahydro-3,6-dime...
C16H20BrF3O4
478159-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9226 7.5723 0.0 0
M  V30 2 Br 6.1526 8.9061 0.0 0
M  V30 3 C 0.0000 6.3697 0.0 0
M  V30 4 C 8.4583 4.9038 0.0 0
M  V30 5 F 8.4569 6.4438 0.0 0
M  V30 6 F 9.9983 4.9052 0.0 0
M  V30 7 F 8.4597 3.3638 0.0 0
M  V30 8 C 2.6037 0.0000 0.0 0
M  V30 9 C 3.8244 4.9044 0.0 0 CFG=2
M  V30 10 C 4.6181 6.2336 0.0 0 CFG=1
M  V30 11 C 4.6226 3.5642 0.0 0 CFG=1
M  V30 12 C 2.2658 4.9716 0.0 0 CFG=2
M  V30 13 O 2.6226 3.9362 0.0 0
M  V30 14 C 6.1526 6.2387 0.0 0
M  V30 15 C 3.8945 7.5870 0.0 0
M  V30 16 O 6.1549 3.5645 0.0 0
M  V30 17 O 4.1448 2.1227 0.0 0
M  V30 18 C 1.2235 3.8669 0.0 0
M  V30 19 C 1.5392 6.3205 0.0 0 CFG=2
M  V30 20 O 3.2229 2.8604 0.0 0
M  V30 21 C 6.9183 4.9024 0.0 0
M  V30 22 C 2.3550 7.6272 0.0 0
M  V30 23 C 2.7175 1.5358 0.0 0 CFG=2
M  V30 24 C 1.3838 2.3322 0.0 0
M  V30 25 H 5.4076 7.5559 0.0 0
M  V30 26 H 5.5241 2.3157 0.0 0
M  V30 27 H 0.7390 5.1730 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 19 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 21
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 25 CFG=3
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 11 26 CFG=1
M  V30 19 1 12 18
M  V30 20 1 12 19
M  V30 21 1 12 27 CFG=3
M  V30 22 1 13 20
M  V30 23 2 14 21
M  V30 24 1 15 22
M  V30 25 1 16 21
M  V30 26 1 17 23
M  V30 27 1 18 24
M  V30 28 1 19 22
M  V30 29 1 23 20 CFG=3
M  V30 30 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 10 11 12 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-Octahydro-N,3,6-trimethyl-10-(trif...
C17H24F3NO4
677019-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.7170 3.9969 0.0 0
M  V30 2 N 9.4870 5.3307 0.0 0
M  V30 3 C 11.0270 5.3307 0.0 0
M  V30 4 C 4.2144 9.3906 0.0 0
M  V30 5 C 7.1739 1.3328 0.0 0
M  V30 6 F 8.5068 2.1040 0.0 0
M  V30 7 F 7.9451 0.0000 0.0 0
M  V30 8 F 5.8409 0.5618 0.0 0
M  V30 9 C 0.0000 3.9512 0.0 0
M  V30 10 C 4.8576 5.3462 0.0 0 CFG=2
M  V30 11 C 6.4054 5.3233 0.0 0 CFG=1
M  V30 12 C 4.0960 3.9848 0.0 0 CFG=1
M  V30 13 C 4.1365 6.7294 0.0 0 CFG=2
M  V30 14 O 3.4182 5.9028 0.0 0
M  V30 15 C 7.1771 3.9969 0.0 0
M  V30 16 C 7.2157 6.6267 0.0 0
M  V30 17 O 4.8622 2.6580 0.0 0
M  V30 18 O 2.6088 3.6779 0.0 0
M  V30 19 C 2.6587 7.0798 0.0 0
M  V30 20 C 4.9412 8.0332 0.0 0 CFG=2
M  V30 21 O 2.7865 4.8450 0.0 0
M  V30 22 C 6.4027 2.6658 0.0 0
M  V30 23 C 6.4807 7.9800 0.0 0
M  V30 24 C 1.3869 4.6205 0.0 0 CFG=2
M  V30 25 C 1.4097 6.1735 0.0 0
M  V30 26 H 7.9452 5.3008 0.0 0
M  V30 27 H 3.4655 2.5797 0.0 0
M  V30 28 H 3.5474 8.1523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14 CFG=3
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 26 CFG=3
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 27 CFG=1
M  V30 20 1 13 19
M  V30 21 1 13 20
M  V30 22 1 13 28 CFG=3
M  V30 23 1 14 21
M  V30 24 2 15 22
M  V30 25 1 16 23
M  V30 26 1 17 22
M  V30 27 1 18 24
M  V30 28 1 19 25
M  V30 29 1 20 23
M  V30 30 1 24 21 CFG=3
M  V30 31 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 11 12 13 20 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 478159-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 677019-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5321174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New 10-trifluoromethyl monomers, dimers, and chimeras of artemisinin from
a key allyl bromide precursor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bonnet-Delpon, Daniele; Begue, Jean-Pierre; Crousse, Benoit; Grellepois,
Fabienne; Chollet, Constance; Chorki, Fatima; Magueur, Guillaume;
Ourevitch, Michele; Nguyen, Thi Ngoc Tam; Grellier, Philippe; Nguyen, Van
Hung; Truong, Van Nhu; Nhan, Doan Hanh; Thu, Nguyen Thi Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Symposium Series (2007), 949337-351

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R,5aS,6R,8aS,12R,12aR)-9-(Bromomethyl)-3,4,5,5a,6,7,8,8a-octahydro-3,6-dime...
C16H20BrF3O4
478159-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9226 7.5723 0.0 0
M  V30 2 Br 6.1526 8.9061 0.0 0
M  V30 3 C 0.0000 6.3697 0.0 0
M  V30 4 C 8.4583 4.9038 0.0 0
M  V30 5 F 8.4569 6.4438 0.0 0
M  V30 6 F 9.9983 4.9052 0.0 0
M  V30 7 F 8.4597 3.3638 0.0 0
M  V30 8 C 2.6037 0.0000 0.0 0
M  V30 9 C 3.8244 4.9044 0.0 0 CFG=2
M  V30 10 C 4.6181 6.2336 0.0 0 CFG=1
M  V30 11 C 4.6226 3.5642 0.0 0 CFG=1
M  V30 12 C 2.2658 4.9716 0.0 0 CFG=2
M  V30 13 O 2.6226 3.9362 0.0 0
M  V30 14 C 6.1526 6.2387 0.0 0
M  V30 15 C 3.8945 7.5870 0.0 0
M  V30 16 O 6.1549 3.5645 0.0 0
M  V30 17 O 4.1448 2.1227 0.0 0
M  V30 18 C 1.2235 3.8669 0.0 0
M  V30 19 C 1.5392 6.3205 0.0 0 CFG=2
M  V30 20 O 3.2229 2.8604 0.0 0
M  V30 21 C 6.9183 4.9024 0.0 0
M  V30 22 C 2.3550 7.6272 0.0 0
M  V30 23 C 2.7175 1.5358 0.0 0 CFG=2
M  V30 24 C 1.3838 2.3322 0.0 0
M  V30 25 H 5.4076 7.5559 0.0 0
M  V30 26 H 5.5241 2.3157 0.0 0
M  V30 27 H 0.7390 5.1730 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 19 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 21
M  V30 8 1 8 23
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 25 CFG=3
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 11 26 CFG=1
M  V30 19 1 12 18
M  V30 20 1 12 19
M  V30 21 1 12 27 CFG=3
M  V30 22 1 13 20
M  V30 23 2 14 21
M  V30 24 1 15 22
M  V30 25 1 16 21
M  V30 26 1 17 23
M  V30 27 1 18 24
M  V30 28 1 19 22
M  V30 29 1 23 20 CFG=3
M  V30 30 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 9 10 11 12 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-Octahydro-N,3,6-trimethyl-10-(trif...
C17H24F3NO4
677019-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.7170 3.9969 0.0 0
M  V30 2 N 9.4870 5.3307 0.0 0
M  V30 3 C 11.0270 5.3307 0.0 0
M  V30 4 C 4.2144 9.3906 0.0 0
M  V30 5 C 7.1739 1.3328 0.0 0
M  V30 6 F 8.5068 2.1040 0.0 0
M  V30 7 F 7.9451 0.0000 0.0 0
M  V30 8 F 5.8409 0.5618 0.0 0
M  V30 9 C 0.0000 3.9512 0.0 0
M  V30 10 C 4.8576 5.3462 0.0 0 CFG=2
M  V30 11 C 6.4054 5.3233 0.0 0 CFG=1
M  V30 12 C 4.0960 3.9848 0.0 0 CFG=1
M  V30 13 C 4.1365 6.7294 0.0 0 CFG=2
M  V30 14 O 3.4182 5.9028 0.0 0
M  V30 15 C 7.1771 3.9969 0.0 0
M  V30 16 C 7.2157 6.6267 0.0 0
M  V30 17 O 4.8622 2.6580 0.0 0
M  V30 18 O 2.6088 3.6779 0.0 0
M  V30 19 C 2.6587 7.0798 0.0 0
M  V30 20 C 4.9412 8.0332 0.0 0 CFG=2
M  V30 21 O 2.7865 4.8450 0.0 0
M  V30 22 C 6.4027 2.6658 0.0 0
M  V30 23 C 6.4807 7.9800 0.0 0
M  V30 24 C 1.3869 4.6205 0.0 0 CFG=2
M  V30 25 C 1.4097 6.1735 0.0 0
M  V30 26 H 7.9452 5.3008 0.0 0
M  V30 27 H 3.4655 2.5797 0.0 0
M  V30 28 H 3.5474 8.1523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 20 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14 CFG=3
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 26 CFG=3
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 27 CFG=1
M  V30 20 1 13 19
M  V30 21 1 13 20
M  V30 22 1 13 28 CFG=3
M  V30 23 1 14 21
M  V30 24 2 15 22
M  V30 25 1 16 23
M  V30 26 1 17 22
M  V30 27 1 18 24
M  V30 28 1 19 25
M  V30 29 1 20 23
M  V30 30 1 24 21 CFG=3
M  V30 31 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 11 12 13 20 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 478159-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 677019-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6860893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [(1S,4R,5R,8R,12R,13S)-1,5-Dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]-hexadec-9-ene-9-yl]-N-methylmethanamine
(11d). A solution of allylic bromide 10 (200 mg, 0.48 mmol) in THF (2.5
mL) was added for 45 min at 0 °C and under Ar to a solution of
methylamine (8.03Min EtOH, 598 μL, 4.80 mmol, 10 equiv) in THF (25 mL).
After 2 h and 15 min of supplementary stirring at room temperature, the
reaction mixture was diluted with Et2O and washed with brine. The organic
layer was extracted, dried (MgSO4), and concentrated under reduced
pressure to afford amine 11d (170 mg, 98%) as a yellow oil. [α]20 D +67
(c 0.58, MeOH); 19F NMR δ -64.4 (s, 3F, CF3); 1H NMR δ 0.98 (d, 3 J
H15-H6 = 6 Hz, 3 H, CH3-15), 1.17 (qd, 2 J = 3 J H7ax-H8ax = 3 J H7ax-H6
= 13 Hz, 3 J H7ax-H8eq = 3 Hz, 1 H, H-7ax), 1.24 (qd, 2 J = 3 J H8ax-H8a
= 3 J H8ax-H7ax = 13 Hz, 3 J H8ax-H7eq = 3 Hz, 1 H, H-8ax), 1.40 (m, 1 H,
H-6), 1.41 (s, 3 H, CH3-14), 1.49 (m, 1 H, H-5a), 1.54 (m, 1 H, H-5),
1.69 (qd, 2 J = 13 Hz, 3 J H7eq-H8eq = 3 J H7eq-H8ax = 3 J H7eq-H6 = 3
Hz, 1 H, H-7eq), 1.94 (m, 1 H, H-5'), 2.02 (m, 2 H, H-4, H-8eq), 2.28
(dd, 3 J H8a-H8ax = 13 Hz, 3 J H8a-H8eq = 4 Hz, 1 H, H-8a), 2.39 (m, 1 H,
H-4'), 2.40 (s, 3 H, CH3-17), 3.20 (dd, 2 J = 13.5 Hz, 5 J H16a-F = 2 Hz,
1H, H-16a), 3.48 (d, 2 J = 13.5 Hz, 1H, H-16b), 5.72 (s, 1H, H-12); 13C
NMR δ 19.9 (C-15), 24.3 (C-5), 25.4 (C-14), 28.8 (C-8), 33.8 (C-7), 34.7
(C-17), 35.9 (C-4), 37.5 (C-6), 42.7 (C-8a), 47.3 (C-16), 50.2 (C-5a),
77.7 (C-12a), 90.8 (C-12), 104.9 (C-3), 113.6 (C-9), 120.5 (q, 1 J C-F =
274.5 Hz, CF3), 137.8 (q, 2 J C-F = 34.5 Hz, C-10). Anal. (C17H24F3NO4)
C, H, N.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Orally Active Antimalarials: Hydrolytically Stable Derivatives of
10-Trifluoromethyl Anhydrodihydroartemisinin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grellepois, Fabienne; Chorki, Fatima; Ourevitch, Michele; Charneau,
Sebastien; Grellier, Philippe; McIntosh, Kylie A.; Charman, William N.;
Pradines, Bruno; Crousse, Benoit; Bonnet-Delpon, Daniele; Begue,
Jean-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(6), 1423-1433

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzenesulfonyl chloride
C7H4ClNO2S
49584-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyano-N-methylbenzenesulfonamide
C8H8N2O2S
56236-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 C 8.4700 1.5400 0.0 0
M  V30 7 N 10.0100 1.5400 0.0 0
M  V30 8 C 3.8500 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 6.1600 0.2064 0.0 0
M  V30 12 C 6.1600 2.8736 0.0 0
M  V30 13 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49584-26-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56236-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24264437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Controllable Z/E-selective synthesis of α-amino-ketoximes from
N-nitrososulfonamides and aryl alkenes under neutral conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Pan-Feng; Huang, Tao; He, Jian; Huang, Xie-Tian; Jin, Xiao-Ling;
Sun, Chunlin; Wu, Li-Zhu; Liu, Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(20), 5785-5792

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Citronellic acid
C10H18O2
502-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 4.0012 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 11 C 9.3360 0.0000 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,7-Trimethyl-6-octenamide
C11H21NO
80016-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 C 4.0012 1.5400 0.0 0
M  V30 7 N 10.6697 2.3101 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 9 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 502-47-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 80016-67-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10833560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution containing 3 mL (16 mmol) of citronellic acid in 30 mL of
CH2Cl2 was added 3.2 g (20 mmol) of 1,1'-carbonyldiimidazole. The
reaction mixture was allowed to stir for 1 h, after which time the
mixture was cannulated into a solution of 10 mL of 40% methylamine in 20
mL of CH2Cl2 at 0 °C. The solution was allowed to warm to room
temperature over a period of 4 h and was diluted with 50 mL of water. The
product was extracted with CH2Cl2, and the combined organic extracts were
washed with brine, dried over Na2SO4, and concentrated under reduced
pressure to give 0.3 g (98%) of N-methyl 3,7-dimethyloct-6-enamide as a
thick oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A One-Pot Bicycloannulation Method for the Synthesis of
Tetrahydroisoquinoline Systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padwa, Albert; Beall, L. Scott; Heidelbaugh, Todd M.; Liu, Bing; Sheehan,
Scott M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2000), 65(9), 2684-2695

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-2-chlorobenzene
C9H10BrClO
50912-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Chlorophenoxy)-N-methyl-1-propanamine
C10H14ClNO
883547-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 9.3360 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50912-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883547-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4320528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropoxy)-2-methylbenzene
C10H13BrO
50912-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(2-methylphenoxy)-1-propanamine
C11H17NO
883545-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 9.3360 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50912-60-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883545-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2306231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved model of lanosterol 14α-demethylase by ligand-supported homology
modeling: validation by virtual screening and azole optimization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang,
Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2010), 5(3), 390-397

$RFMT $RIREG SCHEME424 STEP1
$RXN



  3  1
$MOL
1-Methyl-4-[(1E)-2-nitroethenyl]benzene
C9H9NO2
5153-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0 VAL=5
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-N,4-Dimethyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C18H20N2O3
1457935-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 5.3901 8.0023 0.0 0 VAL=5
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 O 6.9302 2.6675 0.0 0
M  V30 8 O 4.6201 9.3360 0.0 0
M  V30 9 O 6.9302 8.0023 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 C 11.5503 5.3348 0.0 0
M  V30 12 C 6.9302 5.3348 0.0 0
M  V30 13 C 7.7002 6.6685 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 9.2402 6.6685 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 C 10.0102 5.3348 0.0 0
M  V30 18 C 3.0801 4.0012 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 2.3101 2.6675 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-68-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-6865440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 78% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME425 STEP1
$RXN



  3  1
$MOL
trans-β-Nitrostyrene
C8H7NO2
5153-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [(4-fluorophenyl)acetyl]-, dimethyl ester
C10H12FO4P
87600-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.6436 0.0 0
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 4 O 4.6200 0.9762 0.0 0
M  V30 5 O 0.7700 2.3100 0.0 0
M  V30 6 O 2.3100 0.7700 0.0 0
M  V30 7 O 2.3100 3.8500 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 F 10.7800 3.6436 0.0 0
M  V30 11 C 6.1600 3.6436 0.0 0
M  V30 12 C 6.9300 4.9773 0.0 0
M  V30 13 C 6.9300 2.3100 0.0 0
M  V30 14 C 8.4700 4.9773 0.0 0
M  V30 15 C 8.4700 2.3100 0.0 0
M  V30 16 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-α-(4-Fluorophenyl)-N-methyl-β-(nitromethyl)benzenepropanamide
C17H17FN2O3
1457935-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.3348 0.0 0 CFG=1
M  V30 2 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 3 C 5.3901 6.6685 0.0 0
M  V30 4 C 4.6201 2.6675 0.0 0
M  V30 5 N 4.6201 8.0023 0.0 0 VAL=5
M  V30 6 N 5.3901 1.3337 0.0 0
M  V30 7 O 3.0801 2.6675 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 3.0801 8.0023 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 F 11.5503 4.0012 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.7700 4.0012 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 7.7002 5.3348 0.0 0
M  V30 20 C 7.7002 2.6675 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 9.2402 2.6675 0.0 0
M  V30 23 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87600-57-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-2272940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 78% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl squarate
C6H6O4
5222-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 4.5536 0.0 0
M  V30 2 C 0.0000 4.5536 0.0 0
M  V30 3 O 5.1314 3.5914 0.0 0
M  V30 4 C 6.4651 2.8213 0.0 0
M  V30 5 O 0.5778 0.9622 0.0 0
M  V30 6 O 4.1690 0.0000 0.0 0
M  V30 7 C 2.3101 3.2199 0.0 0
M  V30 8 C 3.7976 2.8213 0.0 0
M  V30 9 C 1.9115 1.7322 0.0 0
M  V30 10 C 3.3990 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 9
M  V30 6 2 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-(methylamino)-3-cyclobutene-1,2-dione
C6H7NO3
63649-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.5536 0.0 0
M  V30 2 C 0.0000 4.5536 0.0 0
M  V30 3 O 5.1314 3.5914 0.0 0
M  V30 4 C 6.4651 2.8213 0.0 0
M  V30 5 O 0.5778 0.9622 0.0 0
M  V30 6 O 4.1690 0.0000 0.0 0
M  V30 7 C 2.3101 3.2199 0.0 0
M  V30 8 C 3.7976 2.8213 0.0 0
M  V30 9 C 1.9115 1.7322 0.0 0
M  V30 10 C 3.3990 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 9
M  V30 6 2 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5222-73-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63649-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42081653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ionizable lipid compounds for nucleic acid delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wieczorek, Maciej; Mroczkiewicz, Michal; Mach, Mateusz; Dubiel,
Krzysztof; Lemek, Tadeusz; Setner, Bartosz; Juszczyk, Ewelina; Zero,
Pawel; Galazka, Kinga; Marek, Gabriela; Piatkowski, Jakub
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024147060 A1 2024-07-11

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
(3S)-2,3-Dihydro-3-(2E)-2-nonen-1-yl-2-oxo-1H-indole-3-acetic acid
C19H25NO3
524932-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4658 3.2896 0.0 0
M  V30 2 C 6.7995 4.0596 0.0 0
M  V30 3 C 8.1332 3.2896 0.0 0
M  V30 4 C 9.4668 4.0596 0.0 0
M  V30 5 C 10.8006 3.2896 0.0 0
M  V30 6 C 12.1343 4.0596 0.0 0
M  V30 7 C 13.4679 3.2896 0.0 0
M  V30 8 C 14.8016 4.0596 0.0 0
M  V30 9 C 16.1354 3.2896 0.0 0
M  V30 10 C 3.5057 2.6528 0.0 0
M  V30 11 C 4.4109 1.4070 0.0 0
M  V30 12 O 5.9425 1.5679 0.0 0
M  V30 13 O 3.7846 0.0000 0.0 0
M  V30 14 O 6.5773 5.3057 0.0 0
M  V30 15 C 4.1320 4.0596 0.0 0 CFG=1
M  V30 16 C 2.6675 4.5357 0.0 0
M  V30 17 C 5.0373 5.3057 0.0 0
M  V30 18 C 2.6675 6.0757 0.0 0
M  V30 19 C 1.3338 3.7657 0.0 0
M  V30 20 N 4.1320 6.5516 0.0 0
M  V30 21 C 1.3338 6.8457 0.0 0
M  V30 22 C 0.0000 4.5357 0.0 0
M  V30 23 C 0.0000 6.0757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 15 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 17
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-2,3-Dihydro-N-methyl-3-(2E)-2-nonen-1-yl-2-oxo-1H-indole-3-acetamide
C20H28N2O2
524932-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4658 4.5356 0.0 0
M  V30 2 C 6.7994 5.3056 0.0 0
M  V30 3 C 8.1331 4.5356 0.0 0
M  V30 4 C 9.4667 5.3056 0.0 0
M  V30 5 C 10.8005 4.5356 0.0 0
M  V30 6 C 12.1342 5.3056 0.0 0
M  V30 7 C 13.4678 4.5356 0.0 0
M  V30 8 C 14.8015 5.3056 0.0 0
M  V30 9 C 16.1353 4.5356 0.0 0
M  V30 10 C 3.5057 3.8987 0.0 0
M  V30 11 C 4.4109 2.6528 0.0 0
M  V30 12 N 3.7846 1.2459 0.0 0
M  V30 13 O 5.9424 2.8137 0.0 0
M  V30 14 C 4.6896 0.0000 0.0 0
M  V30 15 O 6.5772 6.5515 0.0 0
M  V30 16 C 4.1320 5.3056 0.0 0 CFG=1
M  V30 17 C 2.6674 5.7815 0.0 0
M  V30 18 C 5.0372 6.5515 0.0 0
M  V30 19 C 2.6674 7.3215 0.0 0
M  V30 20 C 1.3338 5.0115 0.0 0
M  V30 21 N 4.1320 7.7974 0.0 0
M  V30 22 C 1.3338 8.0915 0.0 0
M  V30 23 C 0.0000 5.7815 0.0 0
M  V30 24 C 0.0000 7.3215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 16 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 2 15 18
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 524932-53-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 524932-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5364274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective total synthesis of (-)-pseudophrynaminol through tandem
olefination, isomerization and asymmetric Claisen rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasaki, Tomomi; Ogawa, Atsuyo; Takashima, Yasuyuki; Sakamoto, Masanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(8), 1591-1593

